data_2jp1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jp1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 108.446 -0.946 . . . . 74.239999999999995 108.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.4 m -109.59 144.04 38.45 Favored 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 119.531 -0.868 . . . . 71.150000000000006 109.494 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.69 149.32 43.4 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.43 -1.322 . . . . 74.510000000000005 107.43 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 HG13 HG13 ' B' ' 12' ' ' VAL . 58.6 t -140.54 139.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 121.157 -0.217 . . . . 72.040000000000006 110.929 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -110.98 131.0 55.41 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 122.998 0.519 . . . . 73.030000000000001 109.64 172.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.2 pp -119.88 136.27 54.56 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.261 -1.015 . . . . 65.140000000000001 108.261 174.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 m -107.57 120.78 43.15 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.069 -0.715 . . . . 75.439999999999998 109.069 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -131.71 -169.24 2.16 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.392 -0.367 . . . . 65.439999999999998 110.957 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -69.93 104.13 2.43 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.547 1.165 . . . . 73.510000000000005 108.043 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.637 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 1.6 mmp_? -125.53 149.51 48.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 114.871 1.434 . . . . 72.25 114.871 -170.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 19' ' ' LEU . 3.4 pp -101.84 148.26 35.05 Favored Pre-proline 0 N--CA 1.417 -2.093 0 CA-C-N 113.512 -1.677 . . . . 75.329999999999998 107.668 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.25 143.89 32.43 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.051 1.834 . . . . 75.310000000000002 112.496 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -131.36 140.0 49.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.984 -1.117 . . . . 75.340000000000003 107.984 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 p -58.66 -59.81 4.81 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.673 0.62 . . . . 72.200000000000003 112.673 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -115.98 166.92 11.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 112.148 0.425 . . . . 73.239999999999995 112.148 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mm -89.46 125.26 42.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.853 -0.612 . . . . 71.319999999999993 109.445 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 33.7 mmtm -89.57 145.46 25.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.88 -0.728 . . . . 71.099999999999994 109.68 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.6 m -120.86 126.96 51.39 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.101 -1.074 . . . . 70.310000000000002 108.101 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -124.92 129.41 50.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.921 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 37' ' ' VAL . 66.3 p -114.14 130.57 56.59 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.659 -0.7 . . . . 63.520000000000003 111.929 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.51 HD13 HD11 ' B' ' 38' ' ' ILE . 76.1 mt -126.35 126.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.637 -0.711 . . . . 75.129999999999995 109.735 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -102.42 133.8 46.77 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.915 -0.772 . . . . 61.149999999999999 108.915 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' HG2' HG13 ' B' ' 40' ' ' ILE . 11.9 tp10 -141.56 97.65 3.2 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 109.954 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.5 -85.33 0.26 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.501 -0.772 . . . . 75.319999999999993 111.769 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.429 ' HG ' HD22 ' B' ' 19' ' ' LEU . 37.3 p -137.54 14.83 2.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.867 0.841 . . . . 74.25 110.024 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.415 ' CD2' HD11 ' B' ' 40' ' ' ILE . 24.9 tp -106.67 132.49 52.6 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 115.387 -0.824 . . . . 62.450000000000003 110.844 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -108.84 115.88 30.92 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.36 -0.837 . . . . 61.420000000000002 110.339 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.06 120.08 40.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.631 -0.877 . . . . 64.510000000000005 108.631 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.414 HG23 HG23 ' A' ' 28' ' ' THR . 87.5 t -114.79 126.04 72.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.286 0.565 . . . . 55.399999999999999 111.145 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.478 HD12 HD13 ' B' ' 29' ' ' ILE . 77.9 mt -106.16 122.91 60.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 124.259 1.024 . . . . 63.210000000000001 110.009 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 97.8 m-85 -107.8 118.11 35.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.254 -1.017 . . . . 74.209999999999994 108.254 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.491 HG13 ' HG2' ' B' ' 31' ' ' GLU . 45.2 mm -88.58 118.93 35.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.036 -0.727 . . . . 70.239999999999995 109.036 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.2 p -119.7 165.81 14.03 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.0 -0.546 . . . . 71.310000000000002 109.642 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.08 -17.91 63.25 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 122.859 0.463 . . . . 75.329999999999998 111.211 178.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -94.99 -23.79 17.22 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.123 0.487 . . . . 72.030000000000001 110.401 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 160.8 -139.8 6.29 Favored Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 118.497 -1.811 . . . . 74.209999999999994 114.988 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.1 tp -113.07 122.45 47.61 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.474 -0.863 . . . . 72.400000000000006 109.148 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 1.8 tmtm? -116.83 122.12 43.49 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.279 -2.119 . . . . 71.439999999999998 105.279 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.54 140.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 C-N-CA 120.745 -0.382 . . . . 65.019999999999996 110.661 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.455 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 59.3 m -122.94 141.43 51.93 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.259 -0.428 . . . . 62.240000000000002 110.983 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.42 124.85 51.04 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.825 -0.625 . . . . 65.510000000000005 110.421 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -123.31 91.98 49.33 Favored Pre-proline 0 C--N 1.298 -1.668 0 C-N-CA 124.264 1.026 . . . . 74.319999999999993 108.52 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -98.61 133.12 0.26 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.297 1.998 . . . . 72.25 114.15 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.466 ' NE2' ' HG ' ' B' ' 19' ' ' LEU . 56.9 mt-30 . . . . . 0 C--O 1.243 0.729 0 CA-C-N 113.818 -1.537 . . . . 74.129999999999995 114.329 171.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 108.36 -0.978 . . . . 75.340000000000003 108.36 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.9 m -110.29 141.86 42.7 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.975 -0.75 . . . . 63.140000000000001 108.975 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 79.6 m -127.82 148.98 50.47 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.037 -1.097 . . . . 75.209999999999994 108.037 173.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 12' ' ' VAL . 40.7 t -139.77 142.17 32.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.361 -0.607 . . . . 72.450000000000003 109.361 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.9 p -107.49 125.27 51.06 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.874 -1.158 . . . . 71.0 107.874 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' B' ' 45' ' ' LEU . 3.9 pp -112.91 144.02 43.19 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.036 0.446 . . . . 71.0 111.547 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -83.24 135.78 34.64 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.606 -0.724 . . . . 75.140000000000001 110.407 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p -156.44 153.49 28.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.833 0.853 . . . . 62.140000000000001 109.743 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -76.05 93.83 3.35 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.341 1.067 . . . . 75.040000000000006 109.398 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -123.24 148.34 45.97 Favored 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 114.937 -1.028 . . . . 63.0 113.369 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.466 ' HG ' ' NE2' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -80.81 153.81 72.96 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 114.044 -1.434 . . . . 70.310000000000002 109.343 172.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.04 149.94 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.504 2.136 . . . . 54.25 112.586 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.7 124.59 72.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 108.124 -1.065 . . . . 62.340000000000003 108.124 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.9 m -58.7 -47.08 85.79 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.169 0.588 . . . . 50.420000000000002 112.285 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -122.5 145.8 47.98 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.498 -0.556 . . . . 73.400000000000006 109.498 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.58 114.97 16.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.238 -1.023 . . . . 74.099999999999994 108.238 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -92.53 144.34 25.44 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.715 -0.675 . . . . 64.239999999999995 109.678 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 75.2 m -131.24 126.99 36.9 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.421 -0.955 . . . . 73.030000000000001 108.421 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 85.5 m-85 -122.95 131.48 53.74 Favored 'General case' 0 CA--C 1.465 -2.305 0 CA-C-N 115.716 -0.674 . . . . 72.25 110.733 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.513 HG22 HG22 ' B' ' 37' ' ' VAL . 23.1 p -115.35 131.22 57.0 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 124.254 0.971 . . . . 74.230000000000004 111.813 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.478 HD13 HD12 ' A' ' 38' ' ' ILE . 49.2 mt -128.61 134.23 64.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 116.029 -0.532 . . . . 73.109999999999999 109.881 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -110.32 133.11 53.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.898 -0.778 . . . . 75.450000000000003 108.898 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.491 ' HG2' HG13 ' A' ' 40' ' ' ILE . 26.7 tp10 -142.4 102.02 4.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.216 0.531 . . . . 72.439999999999998 109.57 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.08 -78.02 1.29 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.521 -0.763 . . . . 60.109999999999999 111.412 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -157.74 33.64 0.26 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.324 -1.361 . . . . 72.230000000000004 107.324 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.467 HD21 HD11 ' A' ' 40' ' ' ILE . 31.6 tp -120.61 125.26 47.29 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.449 -0.796 . . . . 64.319999999999993 110.307 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 32.7 mmt180 -99.75 115.18 28.92 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.746 0.654 . . . . 74.219999999999999 111.099 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 124.48 49.46 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.418 -0.956 . . . . 73.319999999999993 108.418 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.513 HG22 HG22 ' B' ' 28' ' ' THR . 67.8 t -120.47 135.01 62.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.16 0.505 . . . . 75.200000000000003 110.355 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.51 HD11 HD13 ' A' ' 29' ' ' ILE . 77.2 mt -118.79 122.36 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 CA-C-N 115.293 -0.867 . . . . 74.400000000000006 109.524 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.4 m-85 -107.77 115.78 30.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.063 -1.088 . . . . 73.200000000000003 108.063 176.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.542 HG13 ' HG2' ' A' ' 31' ' ' GLU . 48.5 mm -88.61 114.85 27.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.27 -0.641 . . . . 74.310000000000002 109.27 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 76.7 p -122.43 162.31 21.89 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.156 -0.474 . . . . 75.129999999999995 110.294 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -56.69 -25.58 54.53 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.768 0.827 . . . . 71.439999999999998 112.83 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -89.78 -16.13 30.9 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 111.893 0.331 . . . . 74.329999999999998 111.893 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.89 -134.59 4.41 Favored Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 118.88 -1.629 . . . . 72.030000000000001 113.314 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' B' ' 14' ' ' LEU . 58.9 tp -113.3 125.59 54.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.293 -0.632 . . . . 70.019999999999996 109.293 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 2.6 tmtm? -115.65 121.67 43.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.754 -1.943 . . . . 61.539999999999999 105.754 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 p -114.74 140.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 116.61 -0.268 . . . . 74.450000000000003 110.977 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 47.6 m -130.81 137.93 49.66 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 122.893 0.477 . . . . 74.129999999999995 111.53 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.425 ' CB ' HD13 ' A' ' 14' ' ' LEU . . . -117.68 125.26 50.37 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.058 -0.519 . . . . 62.020000000000003 110.5 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 32.6 t70 -120.99 83.91 38.35 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.347 -0.983 . . . . 74.230000000000004 108.347 174.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo . . . . . 0 N--CA 1.431 -2.196 0 C-N-CA 122.675 2.25 . . . . 74.019999999999996 114.485 -176.146 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 98.8 mtt180 . . . . . 0 CA--C 1.509 -0.627 0 CA-C-O 121.438 0.637 . . . . 72.099999999999994 110.425 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.2 p -86.11 117.86 25.21 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.359 -0.978 . . . . 63.020000000000003 108.359 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 56.7 m -121.48 149.33 43.22 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.672 -0.694 . . . . 70.299999999999997 109.385 -176.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.0 t -142.62 149.71 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 123.468 0.707 . . . . 74.340000000000003 109.383 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 p -106.58 125.72 51.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.978 0.418 . . . . 72.25 111.186 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.9 mm? -102.94 123.57 46.8 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.223 1.009 . . . . 75.349999999999994 110.16 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -107.63 112.26 24.89 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.54 -0.541 . . . . 75.25 109.54 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -151.54 95.68 2.16 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.156 0.503 . . . . 73.439999999999998 111.515 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.48 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 56.3 tp60 48.59 84.06 0.03 OUTLIER 'General case' 0 C--O 1.247 0.943 0 CA-C-N 114.774 -1.103 . . . . 74.519999999999996 111.752 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -124.73 145.7 49.56 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 114.115 1.154 . . . . 74.409999999999997 114.115 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.13 148.15 48.46 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 106.919 -1.511 . . . . 70.200000000000003 106.919 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 36.6 Cg_endo -66.17 136.22 43.29 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.741 1.627 . . . . 73.329999999999998 113.595 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -124.16 139.46 50.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 72.209999999999994 106.675 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 m -98.2 9.3 43.27 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.538 0.57 . . . . 72.140000000000001 112.538 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -131.16 133.33 45.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.867 -0.79 . . . . 74.129999999999995 108.867 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -90.75 116.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.476 -0.935 . . . . 74.450000000000003 108.476 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.71 127.19 45.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.324 -0.551 . . . . 74.129999999999995 110.821 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.0 p -108.68 127.77 54.28 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 107.991 -1.114 . . . . 63.329999999999998 107.991 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -126.5 125.8 42.67 Favored 'General case' 0 CA--C 1.467 -2.22 0 CA-C-N 116.316 -0.402 . . . . 75.310000000000002 109.949 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 37' ' ' VAL . 67.2 p -115.78 121.9 43.83 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.707 -0.679 . . . . 73.400000000000006 111.351 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.461 HD13 HD11 ' B' ' 38' ' ' ILE . 51.1 mt -117.79 123.08 71.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 116.207 -0.451 . . . . 72.409999999999997 110.193 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -105.83 129.06 54.08 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.349 -0.982 . . . . 63.439999999999998 108.349 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.01 111.7 6.68 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.302 -0.863 . . . . 65.040000000000006 109.498 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.21 -67.89 2.09 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.97 -0.559 . . . . 65.099999999999994 111.764 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -162.1 -21.05 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 122.027 0.131 . . . . 62.149999999999999 111.052 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.522 ' H ' HD21 ' A' ' 34' ' ' LEU . 2.3 pt? -89.34 141.71 28.3 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.661 -0.496 . . . . 64.310000000000002 109.661 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -117.86 118.6 32.46 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.764 -0.653 . . . . 72.430000000000007 109.262 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.33 133.72 48.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.005 -0.543 . . . . 75.540000000000006 109.602 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.509 HG23 HG23 ' A' ' 28' ' ' THR . 25.9 t -116.53 130.77 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.121 0.486 . . . . 74.319999999999993 110.435 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.436 HD12 HD13 ' B' ' 29' ' ' ILE . 74.2 mt -108.26 116.95 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 C-N-CA 124.583 1.153 . . . . 64.340000000000003 108.612 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 95.6 m-85 -105.78 116.06 31.29 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.177 -1.046 . . . . 74.349999999999994 108.177 175.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.419 HG23 HD23 ' B' ' 34' ' ' LEU . 44.9 mm -88.85 119.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 108.193 -1.04 . . . . 74.540000000000006 108.193 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -128.1 162.58 26.56 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.099 -0.501 . . . . 75.219999999999999 110.343 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -63.28 -18.21 63.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.214 0.605 . . . . 74.510000000000005 110.969 177.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -94.43 -9.28 36.1 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.541 0.686 . . . . 74.230000000000004 109.837 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.99 -134.37 7.39 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.593 -0.813 . . . . 72.140000000000001 113.119 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.495 ' CD2' ' HB3' ' B' ' 49' ' ' ALA . 56.1 tp -111.76 125.51 54.07 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.901 -0.407 . . . . 74.340000000000003 109.901 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.2 tptm -115.22 121.65 43.59 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.824 -1.546 . . . . 63.130000000000003 106.824 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 14.4 p -112.13 140.57 31.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 116.496 -0.32 . . . . 74.109999999999999 110.646 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -127.55 138.51 52.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.392 -0.367 . . . . 71.120000000000005 111.114 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.1 123.64 48.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.119 -0.491 . . . . 70.239999999999995 109.718 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 29.6 t70 -101.62 119.36 57.5 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.136 -0.69 . . . . 71.25 109.136 176.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' B' ' 17' ' ' GLN . 93.0 Cg_exo -48.65 135.88 27.33 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.247 3.298 . . . . 75.430000000000007 114.536 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 . . . . . 0 N--CA 1.443 -0.777 0 CA-C-N 115.114 -0.948 . . . . 74.400000000000006 110.456 174.427 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 87.1 mtt180 . . . . . 0 C--O 1.242 0.702 0 CA-C-O 121.13 0.491 . . . . 74.409999999999997 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.7 p -91.4 135.5 33.78 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.255 0.55 . . . . 73.150000000000006 110.672 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 55.5 m -131.04 149.79 52.45 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.119 -1.067 . . . . 74.209999999999994 108.119 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 76.1 t -144.29 145.55 21.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.546 -0.539 . . . . 72.219999999999999 109.546 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.6 p -106.88 135.08 49.04 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.12 0.486 . . . . 63.439999999999998 109.833 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 2.8 mm? -109.56 121.56 45.47 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.77 -0.65 . . . . 74.25 110.124 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 27.2 p -106.95 112.75 25.85 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.466 -0.939 . . . . 73.019999999999996 108.466 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' THR . . . . . 0.408 ' O ' ' HG3' ' B' ' 18' ' ' ARG . 10.5 t -134.44 -167.56 1.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.844 -1.169 . . . . 72.319999999999993 107.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 51' ' ' PRO . 56.3 tp60 -62.51 88.08 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.731 0.777 . . . . 54.25 110.251 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 16' ' ' THR . 5.5 ppt_? -126.77 150.15 49.27 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.242 0.83 . . . . 75.239999999999995 113.242 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.15 159.0 31.79 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 107.039 -1.467 . . . . 71.230000000000004 107.039 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.47 135.64 31.66 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.233 1.288 . . . . 73.299999999999997 111.624 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.43 130.52 67.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.774 -0.824 . . . . 71.239999999999995 108.774 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -94.16 1.05 56.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.134 0.492 . . . . 53.340000000000003 112.128 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -112.02 142.82 43.98 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.755 -0.461 . . . . 75.340000000000003 109.755 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.7 131.23 50.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.049 -1.093 . . . . 73.099999999999994 108.049 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.498 ' HZ3' ' CD ' ' A' ' 31' ' ' GLU . 34.3 mmtp -124.97 143.58 50.81 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.163 -0.31 . . . . 72.140000000000001 110.163 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 41.4 p -126.37 127.98 46.33 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.107 -0.701 . . . . 74.530000000000001 109.107 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 80.1 m-85 -127.81 132.28 49.48 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 120.694 0.283 . . . . 72.430000000000007 111.118 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.49 HG22 HG22 ' B' ' 37' ' ' VAL . 36.6 p -115.09 125.31 53.35 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.357 -0.838 . . . . 75.420000000000002 112.405 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.436 HD13 HD12 ' A' ' 38' ' ' ILE . 58.0 mt -127.75 125.3 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-O 120.809 0.338 . . . . 74.319999999999993 110.523 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -108.91 131.68 54.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.469 -0.937 . . . . 72.109999999999999 108.469 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.568 ' O ' HD21 ' B' ' 34' ' ' LEU . 11.6 tp10 -142.99 116.34 9.04 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.68 -0.691 . . . . 74.519999999999996 109.463 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.36 -59.78 2.81 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.669 -0.572 . . . . 38.299999999999997 111.669 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -174.13 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.563 0.745 . . . . 75.099999999999994 110.461 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.568 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -77.5 140.84 39.86 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.158 -0.682 . . . . 70.310000000000002 109.158 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -119.8 121.71 39.75 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.99 -0.55 . . . . 74.010000000000005 109.53 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.54 52.01 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.843 -0.617 . . . . 73.230000000000004 109.888 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.49 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -114.13 125.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.752 -0.658 . . . . 74.230000000000004 109.895 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.461 HD11 HD13 ' A' ' 29' ' ' ILE . 77.9 mt -101.63 119.06 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 C-N-CA 123.664 0.786 . . . . 72.349999999999994 109.297 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.404 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.2 m-85 -104.72 114.86 29.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.411 -0.813 . . . . 72.239999999999995 108.857 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 41.8 mm -89.49 115.24 28.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 106.408 -1.701 . . . . 75.450000000000003 106.408 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.0 p -133.47 163.22 29.87 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.092 0.472 . . . . 63.109999999999999 111.949 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -57.06 -21.83 34.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.829 1.252 . . . . 75.010000000000005 111.413 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -88.22 -16.25 33.75 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.524 0.73 . . . . 70.129999999999995 109.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.43 -122.71 4.3 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 111.072 -0.811 . . . . 72.409999999999997 111.072 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.472 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 56.4 tp -112.19 144.98 40.67 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.653 -0.499 . . . . 71.25 109.653 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -141.41 141.72 33.73 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.479 -1.304 . . . . 74.230000000000004 107.479 168.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 11.8 p -131.51 140.7 47.66 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.029 0 N-CA-C 109.368 -0.604 . . . . 75.340000000000003 109.368 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.404 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.8 m -119.49 138.39 53.18 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.995 -0.548 . . . . 54.539999999999999 110.205 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.41 123.86 49.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.25 -0.648 . . . . 73.049999999999997 109.25 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.417 ' HA ' ' HG2' ' B' ' 9' ' ' ARG . 34.2 t70 -100.45 125.86 37.83 Favored Pre-proline 0 C--N 1.289 -2.036 0 CA-C-N 115.732 -0.667 . . . . 71.200000000000003 109.993 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 17' ' ' GLN . 5.0 Cg_exo . . . . . 0 C--N 1.356 0.945 1 C-N-CA 125.671 4.248 . . . . 62.43 116.018 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.832 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 92.6 mtt180 . . . . . 0 CA--C 1.495 -1.135 0 CA-C-O 121.305 0.574 . . . . 70.230000000000004 111.443 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 p -99.45 134.36 42.43 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.834 -0.621 . . . . 72.219999999999999 109.576 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -130.09 148.94 51.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.488 -0.56 . . . . 73.340000000000003 109.488 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.9 139.14 22.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.365 0.416 . . . . 72.329999999999998 109.9 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 p -112.43 130.9 55.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.761 0.315 . . . . 73.230000000000004 110.75 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mm? -101.73 122.32 43.71 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.921 -0.581 . . . . 74.030000000000001 109.951 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -101.66 113.72 27.13 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 113.838 1.051 . . . . 75.140000000000001 113.838 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.517 HG21 ' CZ ' ' A' ' 18' ' ' ARG . 14.6 t -155.91 165.79 35.42 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.661 -1.978 . . . . 75.439999999999998 105.661 166.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -86.08 90.33 8.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.811 1.291 . . . . 73.219999999999999 110.685 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.517 ' CZ ' HG21 ' A' ' 16' ' ' THR . 80.6 mtt85 -96.61 149.62 21.57 Favored 'General case' 0 N--CA 1.393 -3.282 0 N-CA-C 105.472 -2.048 . . . . 73.25 105.472 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 19' ' ' LEU . 2.3 mm? -73.26 128.33 87.72 Favored Pre-proline 0 C--N 1.284 -2.243 0 C-N-CA 120.725 -0.39 . . . . 63.149999999999999 111.571 -171.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.84 141.97 27.05 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 124.527 3.485 . . . . 70.450000000000003 115.394 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.17 135.17 58.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.332 -1.729 . . . . 73.209999999999994 106.332 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.7 m -59.12 -59.66 5.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.109 0.411 . . . . 71.200000000000003 112.109 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -97.56 146.11 25.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.523 -0.547 . . . . 63.299999999999997 109.523 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.1 mm -79.94 118.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.603 -0.888 . . . . 63.310000000000002 108.603 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.59 146.57 25.16 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.172 0.511 . . . . 62.039999999999999 111.626 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 39.2 p -126.0 127.64 46.21 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.917 -1.038 . . . . 72.140000000000001 108.977 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 79.1 m-85 -124.24 130.46 52.57 Favored 'General case' 0 CA--C 1.468 -2.189 0 CA-C-N 116.197 -0.456 . . . . 70.319999999999993 110.782 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.496 HG23 HG23 ' A' ' 37' ' ' VAL . 61.8 p -114.86 128.67 56.43 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.177 -0.919 . . . . 73.099999999999994 111.103 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 HD11 ' B' ' 38' ' ' ILE . 58.2 mt -126.91 123.46 62.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 120.931 0.396 . . . . 65.049999999999997 110.492 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.7 t -106.15 121.81 44.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.453 -0.943 . . . . 74.340000000000003 108.453 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.19 106.92 4.86 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.36 0.6 . . . . 63.049999999999997 111.279 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.05 -66.8 2.14 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.857 -0.61 . . . . 72.340000000000003 112.931 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -154.11 12.88 0.43 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.483 0.549 . . . . 73.329999999999998 112.483 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.6 pt? -128.58 141.56 51.33 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 118.062 -1.455 . . . . 71.049999999999997 111.877 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.014 -1.476 . . . . 72.530000000000001 107.014 167.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.47 129.4 52.47 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.323 -0.621 . . . . 73.209999999999994 109.323 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 28' ' ' THR . 58.9 t -118.17 126.86 75.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.083 0.468 . . . . 70.530000000000001 110.912 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.6 mt -105.78 122.24 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.206 -0.906 . . . . 64.299999999999997 109.607 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.1 m-85 -103.36 114.89 29.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.885 -0.783 . . . . 74.109999999999999 108.885 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.466 HG23 HD23 ' B' ' 34' ' ' LEU . 40.6 mm -91.98 114.5 29.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.572 -0.899 . . . . 73.319999999999993 108.572 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.4 p -130.74 170.61 14.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.283 -0.636 . . . . 72.409999999999997 109.283 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -83.49 -4.73 58.79 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.876 -0.787 . . . . 73.140000000000001 108.876 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.562 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 3.1 tmt_? -98.64 6.11 47.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 106.949 -1.5 . . . . 72.230000000000004 106.949 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.35 -143.67 18.07 Favored Glycine 0 N--CA 1.423 -2.232 0 CA-C-N 114.228 -1.351 . . . . 53.530000000000001 113.148 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.562 ' CD2' ' HB3' ' B' ' 49' ' ' ALA . 55.0 tp -112.34 136.7 51.48 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.599 -0.519 . . . . 74.209999999999994 109.599 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -128.2 140.71 51.76 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.059 -0.719 . . . . 70.120000000000005 109.059 170.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.443 HG11 HG13 ' B' ' 47' ' ' VAL . 9.6 p -128.72 141.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 115.58 -0.736 . . . . 74.030000000000001 109.996 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.487 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 60.5 m -128.45 137.52 51.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.313 -0.403 . . . . 52.030000000000001 110.705 174.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.832 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.45 121.73 42.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.411 -0.589 . . . . 61.420000000000002 109.411 175.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -119.3 101.94 48.81 Favored Pre-proline 0 C--N 1.284 -2.242 0 C-N-CA 123.837 0.855 . . . . 75.010000000000005 109.718 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.07 133.44 13.58 Favored 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 120.839 1.026 . . . . 70.109999999999999 110.562 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 CA--C 1.546 0.806 0 O-C-N 124.261 0.976 . . . . 64.140000000000001 112.988 177.396 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 92.4 mtt180 . . . . . 0 N--CA 1.403 -2.788 0 N-CA-C 108.19 -1.041 . . . . 74.150000000000006 108.19 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 m -108.49 127.07 53.6 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.507 -1.294 . . . . 74.319999999999993 107.507 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m -121.66 148.97 43.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.947 -1.131 . . . . 72.439999999999998 107.947 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 92.8 t -144.45 146.77 20.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.681 -0.489 . . . . 52.119999999999997 109.681 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.43 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 35.3 p -106.16 135.84 46.91 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.91 -1.145 . . . . 74.430000000000007 107.91 174.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 3.2 mm? -100.2 122.56 43.22 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.497 -0.557 . . . . 74.420000000000002 109.497 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -84.62 112.56 20.56 Favored 'General case' 0 N--CA 1.397 -3.075 0 CA-C-N 115.441 -0.799 . . . . 65.349999999999994 109.803 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -154.65 177.79 10.83 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.191 -1.411 . . . . 75.530000000000001 107.191 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -108.2 108.55 19.63 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.44 0.638 . . . . 75.230000000000004 109.379 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -124.62 150.33 46.11 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.368 -0.833 . . . . 74.150000000000006 110.19 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.93 145.32 81.03 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 114.857 -1.065 . . . . 73.219999999999999 108.86 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.75 135.67 63.17 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 123.02 2.48 . . . . 72.230000000000004 112.806 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.72 131.2 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.658 -1.238 . . . . 72.310000000000002 107.658 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.9 m -56.29 -46.33 79.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 113.798 1.036 . . . . 61.409999999999997 113.798 -174.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.415 ' CZ ' ' HA ' ' B' ' 23' ' ' ARG . 0.4 OUTLIER -127.22 155.45 43.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.783 -0.821 . . . . 71.430000000000007 108.783 -175.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.3 131.53 33.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.947 0.403 . . . . 55.420000000000002 109.968 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.456 ' HB3' ' CE2' ' B' ' 27' ' ' TYR . 1.5 mptm? -116.72 143.5 45.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 112.322 0.49 . . . . 62.32 112.322 177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -125.85 127.12 45.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.444 -1.317 . . . . 74.439999999999998 107.444 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' B' ' 25' ' ' LYS . 75.9 m-85 -124.65 126.85 46.41 Favored 'General case' 0 CA--C 1.45 -2.899 0 CA-C-N 116.244 -0.435 . . . . 75.230000000000004 110.566 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.528 HG22 HG22 ' B' ' 37' ' ' VAL . 81.5 p -114.01 135.47 53.97 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 115.073 -0.967 . . . . 72.319999999999993 109.507 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.445 HD13 HD12 ' A' ' 38' ' ' ILE . 60.6 mt -127.97 121.65 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 116.114 -0.494 . . . . 71.200000000000003 110.772 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.525 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 6.2 t -100.96 117.46 35.05 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.589 -0.732 . . . . 64.319999999999993 109.1 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.452 ' O ' HD21 ' B' ' 34' ' ' LEU . 10.4 tp10 -140.39 110.29 6.47 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.553 -0.749 . . . . 73.530000000000001 110.286 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 -84.7 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.593 -0.73 . . . . 73.329999999999998 114.341 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 47.8 m -137.19 12.73 3.06 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 112.982 0.734 . . . . 71.140000000000001 112.982 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.466 HD23 HG23 ' A' ' 40' ' ' ILE . 2.2 pt? -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.753 -0.779 . . . . 72.420000000000002 112.107 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.525 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 18.6 mmm180 -103.67 113.52 27.1 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.1 -1.444 . . . . 72.349999999999994 107.1 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.37 131.64 52.55 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 110.023 -0.362 . . . . 74.219999999999999 110.023 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.528 HG22 HG22 ' B' ' 28' ' ' THR . 59.8 t -122.61 124.84 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-O 120.836 0.351 . . . . 74.329999999999998 111.031 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 29' ' ' ILE . 94.1 mt -104.53 122.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.651 -0.87 . . . . 75.049999999999997 108.651 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.1 m-85 -104.24 121.04 42.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.233 -1.395 . . . . 74.430000000000007 107.233 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.48 114.68 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.653 0 CA-C-O 122.398 1.094 . . . . 71.120000000000005 110.014 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -127.04 149.47 49.9 Favored 'General case' 1 N--CA 1.369 -4.492 0 CA-C-N 112.503 -2.135 . . . . 74.200000000000003 106.475 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -71.74 -18.93 62.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 118.62 0.645 . . . . 54.200000000000003 112.666 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.522 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 0.1 OUTLIER -86.89 6.14 33.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.165 0.984 . . . . 72.120000000000005 109.056 -172.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.94 -129.33 4.05 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.469 -0.872 . . . . 44.539999999999999 112.738 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 64.6 tp -125.64 144.55 50.54 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.584 0.754 . . . . 64.25 109.003 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.4 tptm -134.75 122.9 22.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.167 -1.42 . . . . 72.530000000000001 107.167 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.443 HG13 HG11 ' A' ' 47' ' ' VAL . 10.2 p -127.23 141.42 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 120.883 -0.327 . . . . 75.299999999999997 110.956 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 56.5 m -123.71 137.02 54.78 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.144 -0.48 . . . . 64.439999999999998 111.012 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.64 122.9 44.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.912 -0.586 . . . . 64.420000000000002 110.971 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -132.33 118.4 16.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 123.688 0.795 . . . . 74.340000000000003 109.324 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.431 -2.153 0 C-N-CA 121.127 1.218 . . . . 71.430000000000007 112.352 179.017 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 . . . . . 0 CA--C 1.493 -1.231 0 N-CA-C 107.325 -1.361 . . . . 74.439999999999998 107.325 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 m -108.8 140.2 42.57 Favored 'General case' 0 N--CA 1.403 -2.801 0 C-N-CA 119.101 -1.04 . . . . 55.420000000000002 109.597 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.94 149.56 50.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.69 -1.226 . . . . 75.519999999999996 107.69 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.5 t -140.69 135.72 34.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 110.068 -0.345 . . . . 62.229999999999997 110.068 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.403 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 30.2 p -107.45 135.9 48.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.58 -0.526 . . . . 74.319999999999993 109.58 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.468 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 4.2 pp -130.66 127.95 39.95 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.057 0.456 . . . . 72.109999999999999 110.595 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 t -110.03 119.51 39.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 74.120000000000005 110.193 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -159.56 114.67 2.42 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.677 -0.692 . . . . 74.340000000000003 109.856 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 35.85 81.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.848 1.659 . . . . 62.329999999999998 114.446 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -125.56 149.59 48.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.591 0.96 . . . . 71.120000000000005 113.591 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.419 HD11 ' N ' ' A' ' 19' ' ' LEU . 3.2 mp -111.26 155.54 42.54 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 107.692 -1.225 . . . . 62.350000000000001 107.692 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.26 142.83 94.76 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.724 2.283 . . . . 75.150000000000006 111.089 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.07 146.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.442 -0.947 . . . . 72.230000000000004 108.442 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.9 m -71.13 -39.9 71.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.738 0.644 . . . . 74.530000000000001 112.738 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -134.46 138.91 45.13 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.778 -0.576 . . . . 72.430000000000007 110.154 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.84 115.32 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 107.624 -1.25 . . . . 72.409999999999997 107.624 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.2 mmtp -101.29 132.16 46.97 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.387 -0.525 . . . . 72.519999999999996 111.388 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 p -113.05 126.65 55.72 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 106.671 -1.603 . . . . 74.099999999999994 106.671 173.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 69.7 m-85 -121.57 129.9 53.17 Favored 'General case' 0 CA--C 1.458 -2.572 0 CA-C-N 116.575 -0.284 . . . . 75.409999999999997 110.693 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.505 HG23 HG23 ' A' ' 37' ' ' VAL . 61.7 p -114.54 127.65 55.91 Favored 'General case' 0 C--N 1.286 -2.161 0 O-C-N 123.86 0.725 . . . . 75.239999999999995 111.171 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.442 HD13 HD11 ' B' ' 38' ' ' ILE . 62.7 mt -127.79 121.73 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.262 -0.644 . . . . 73.439999999999998 109.262 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -106.34 126.34 52.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.326 -0.99 . . . . 74.329999999999998 108.326 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.0 tp10 -142.34 99.97 3.61 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.869 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 -66.36 1.37 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 114.908 0.723 . . . . 53.340000000000003 114.908 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.4 m -139.29 -8.15 1.32 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.314 -0.521 . . . . 74.099999999999994 112.399 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -130.27 140.35 50.69 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 119.043 -1.063 . . . . 63.140000000000001 111.769 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -99.54 119.58 38.26 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.449 -1.315 . . . . 74.209999999999994 107.449 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.16 127.11 51.73 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.489 -0.56 . . . . 75.099999999999994 109.489 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 44.7 t -117.19 128.51 74.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.336 -0.393 . . . . 73.540000000000006 110.425 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.478 HD12 HD13 ' B' ' 29' ' ' ILE . 96.6 mt -108.59 121.29 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 N-CA-C 108.274 -1.01 . . . . 72.530000000000001 108.274 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.44 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 93.2 m-85 -104.88 114.63 28.95 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.197 -1.038 . . . . 74.329999999999998 108.197 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.497 HD11 HD23 ' B' ' 34' ' ' LEU . 48.4 mm -90.79 113.39 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.063 -1.088 . . . . 74.209999999999994 108.063 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -125.65 177.75 6.06 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.181 -1.044 . . . . 72.409999999999997 108.181 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -81.4 -32.67 32.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.956 1.095 . . . . 62.350000000000001 113.956 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -86.65 -20.1 28.31 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.829 -0.749 . . . . 72.25 110.863 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.73 -162.65 29.38 Favored Glycine 0 C--N 1.294 -1.779 0 C-N-CA 119.171 -1.49 . . . . 61.549999999999997 114.134 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 14' ' ' LEU . 2.0 tm? -113.69 122.88 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.475 -0.935 . . . . 70.409999999999997 108.475 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.0 tptm -115.76 122.43 45.44 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.408 -0.96 . . . . 72.329999999999998 108.408 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.444 HG11 HG13 ' B' ' 47' ' ' VAL . 13.8 p -119.23 140.53 42.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.868 -0.419 . . . . 64.230000000000004 109.868 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -125.71 139.79 53.24 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.969 -0.56 . . . . 73.109999999999999 111.332 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.431 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -117.0 123.68 47.5 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 108.429 -0.952 . . . . 54.539999999999999 108.429 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -113.72 87.44 12.19 Favored Pre-proline 0 C--N 1.282 -2.362 0 N-CA-C 108.197 -1.038 . . . . 71.530000000000001 108.197 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.3 Cg_endo -87.79 133.28 3.02 Favored 'Trans proline' 0 N--CA 1.417 -3.023 0 C-N-CA 121.57 1.513 . . . . 75.040000000000006 111.354 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 114.09 -1.414 . . . . 74.439999999999998 113.37 174.435 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 . . . . . 0 N--CA 1.42 -1.964 0 N-CA-C 107.938 -1.134 . . . . 73.439999999999998 107.938 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.438 ' HB ' HD11 ' A' ' 14' ' ' LEU . 25.1 m -109.64 128.59 55.34 Favored 'General case' 0 N--CA 1.393 -3.298 0 N-CA-C 107.564 -1.273 . . . . 74.219999999999999 107.564 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 34.8 m -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.572 -2.011 . . . . 62.119999999999997 105.572 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 141.71 28.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.71 0.291 . . . . 70.340000000000003 110.885 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.5 p -108.7 126.68 53.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.236 -0.438 . . . . 75.319999999999993 110.881 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' B' ' 45' ' ' LEU . 4.3 pp -125.23 137.52 54.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.984 -0.747 . . . . 73.340000000000003 108.984 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -120.19 125.99 49.55 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 109.06 -0.719 . . . . 74.129999999999995 109.06 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -161.85 115.6 1.87 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.277 -0.42 . . . . 71.409999999999997 111.202 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 34.29 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 126.276 1.83 . . . . 65.120000000000005 114.849 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.432 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 53.2 mmm-85 -127.51 146.73 50.41 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 114.008 1.114 . . . . 72.510000000000005 114.008 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.88 153.96 47.53 Favored Pre-proline 0 C--O 1.25 1.126 0 N-CA-C 106.501 -1.666 . . . . 75.329999999999998 106.501 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.78 135.55 38.77 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.705 1.603 . . . . 54.420000000000002 112.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.467 HG12 ' H ' ' B' ' 23' ' ' ARG . 91.4 t -131.39 131.85 62.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.858 -1.164 . . . . 71.450000000000003 107.858 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 m -98.18 3.24 49.01 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 111.959 0.355 . . . . 74.409999999999997 111.959 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.467 ' H ' HG12 ' B' ' 21' ' ' VAL . 6.9 mpt_? -117.22 139.38 50.86 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.666 -0.243 . . . . 53.329999999999998 110.553 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.05 115.44 41.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.996 -1.483 . . . . 62.130000000000003 106.996 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 34.7 mmtp -103.92 141.44 36.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.632 -0.427 . . . . 71.219999999999999 110.41 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 51.3 p -121.89 127.07 50.04 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.79 -0.819 . . . . 75.140000000000001 108.79 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 84.4 m-85 -123.62 129.58 51.36 Favored 'General case' 0 CA--C 1.467 -2.229 0 CA-C-N 116.192 -0.458 . . . . 73.409999999999997 110.391 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.455 HG22 HG22 ' B' ' 37' ' ' VAL . 72.6 p -115.47 130.53 56.91 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.824 -0.625 . . . . 72.230000000000004 112.268 -174.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.478 HD13 HD12 ' A' ' 38' ' ' ILE . 80.2 mt -136.85 127.44 40.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.303 -0.628 . . . . 62.340000000000003 109.303 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.405 ' HB ' ' HD3' ' B' ' 35' ' ' ARG . 12.4 t -119.39 135.73 54.6 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.155 -1.054 . . . . 72.409999999999997 108.155 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.579 ' O ' HD21 ' B' ' 34' ' ' LEU . 12.5 tp10 -142.44 112.23 6.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.614 -0.434 . . . . 72.439999999999998 111.424 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.46 -67.05 1.92 Allowed Glycine 0 C--N 1.311 -0.836 0 CA-C-N 116.156 -0.475 . . . . 52.439999999999998 112.54 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 9.6 m -140.79 -35.93 0.47 Allowed 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 120.683 0.278 . . . . 73.010000000000005 110.582 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.579 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.6 pt? -84.29 141.21 31.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.707 0.632 . . . . 63.25 112.707 -171.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 22.8 tpp180 -101.93 113.77 27.27 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.382 -1.34 . . . . 73.420000000000002 107.382 171.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.2 133.12 52.9 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.13 -0.356 . . . . 65.420000000000002 110.109 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.455 HG22 HG22 ' B' ' 28' ' ' THR . 58.3 t -126.83 130.78 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.172 0.51 . . . . 63.439999999999998 109.974 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.442 HD11 HD13 ' A' ' 29' ' ' ILE . 92.2 mt -106.08 126.24 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 N-CA-C 108.332 -0.988 . . . . 72.109999999999999 108.332 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 87.0 m-85 -109.1 114.33 27.97 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.508 -1.293 . . . . 72.430000000000007 107.508 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.459 HD11 HD23 ' A' ' 34' ' ' LEU . 51.4 mm -92.09 113.97 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 109.037 -0.727 . . . . 71.239999999999995 109.037 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -120.28 177.42 5.03 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.532 -1.284 . . . . 71.420000000000002 107.532 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' B' ' 42' ' ' LYS . 17.2 ptmt -91.66 -12.92 32.78 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.145 -0.687 . . . . 72.439999999999998 109.145 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -86.51 1.62 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.145 0.974 . . . . 74.420000000000002 109.826 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.54 -146.56 18.56 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 114.885 -1.052 . . . . 72.040000000000006 113.357 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' B' ' 14' ' ' LEU . 2.1 tm? -122.26 124.14 43.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.708 0.803 . . . . 71.319999999999993 109.448 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 53.7 tptt -115.42 121.65 43.41 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.594 -1.262 . . . . 71.310000000000002 107.594 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.444 HG13 HG11 ' A' ' 47' ' ' VAL . 13.9 p -111.58 140.81 29.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.279 -1.008 . . . . 50.340000000000003 108.279 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.409 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 15.9 t -139.11 136.72 35.47 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 119.336 -0.946 . . . . 73.420000000000002 108.541 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.21 125.79 35.79 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 120.978 0.418 . . . . 63.340000000000003 111.523 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 26.8 t70 -109.5 97.6 28.04 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 108.016 -1.105 . . . . 71.019999999999996 108.016 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo . . . . . 0 N--CA 1.431 -2.182 0 C-N-CA 122.279 1.986 . . . . 72.099999999999994 112.378 -178.198 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 . . . . . 0 N--CA 1.425 -1.694 0 CA-C-O 121.465 0.65 . . . . 72.099999999999994 110.968 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -92.5 140.99 29.0 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 115.593 -0.731 . . . . 72.319999999999993 109.524 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.6 m -142.17 148.87 38.95 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.471 -0.566 . . . . 65.519999999999996 109.471 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.429 ' CG2' HD21 ' B' ' 14' ' ' LEU . 69.4 t -144.75 145.72 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.274 0.629 . . . . 71.510000000000005 109.696 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 p -109.16 136.14 49.12 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 122.835 0.454 . . . . 72.439999999999998 110.505 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 HD21 ' CG2' ' B' ' 12' ' ' VAL . 95.2 mt -119.62 121.93 40.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.365 0.602 . . . . 70.409999999999997 111.617 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 p -95.17 114.03 25.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.1 -0.955 . . . . 70.209999999999994 109.698 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 t -139.12 -170.55 2.9 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.89 -1.522 . . . . 74.239999999999995 106.89 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -76.86 91.48 3.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.058 0.933 . . . . 71.439999999999998 111.362 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -126.15 141.83 51.77 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.867 -1.06 . . . . 52.509999999999998 109.57 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.4 mm? -82.45 146.34 53.66 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.534 -0.757 . . . . 72.209999999999994 109.031 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 20.7 Cg_exo -64.66 134.87 42.73 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.8 1.666 . . . . 73.519999999999996 112.209 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.74 143.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 114.428 -1.26 . . . . 70.0 108.179 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 m -90.56 -22.35 21.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.204 0.446 . . . . 73.310000000000002 112.204 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -105.88 133.45 50.59 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.472 -0.331 . . . . 71.209999999999994 110.68 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.87 116.41 31.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.789 -0.819 . . . . 71.239999999999995 108.789 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -91.98 133.6 35.56 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 120.313 -0.555 . . . . 73.319999999999993 110.928 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.4 p -118.0 127.36 53.74 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.396 -0.82 . . . . 65.409999999999997 110.426 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 67.9 m-85 -121.5 130.77 53.76 Favored 'General case' 0 CA--C 1.477 -1.845 0 CA-C-N 115.837 -0.62 . . . . 75.209999999999994 111.029 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.43 HG23 HG23 ' A' ' 37' ' ' VAL . 57.4 p -114.56 131.58 56.62 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.382 -0.826 . . . . 73.099999999999994 111.286 -175.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.49 HD13 HD11 ' B' ' 38' ' ' ILE . 40.1 mt -125.23 130.4 73.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 116.432 -0.349 . . . . 73.019999999999996 110.695 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -109.96 115.76 30.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 122.21 1.005 . . . . 62.039999999999999 110.269 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.726 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.3 tp10 -143.13 123.06 13.51 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.197 -0.91 . . . . 65.450000000000003 108.926 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 52.31 32.11 36.3 Favored Glycine 0 C--O 1.218 -0.849 0 O-C-N 123.219 0.325 . . . . 73.120000000000005 113.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 22.2 t 84.55 -10.19 0.87 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.475 1.11 . . . . 75.430000000000007 113.37 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.6 pt? -89.36 140.22 29.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 117.07 -1.852 . . . . 65.120000000000005 109.239 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.73 118.32 36.43 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.309 -1.367 . . . . 72.349999999999994 107.309 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.99 129.54 51.59 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.51 -0.552 . . . . 71.150000000000006 109.51 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 61.9 t -118.91 122.24 68.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.186 0.517 . . . . 73.299999999999997 110.427 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.487 HD12 HD13 ' B' ' 29' ' ' ILE . 87.0 mt -103.54 123.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 C-N-CA 124.093 0.957 . . . . 63.350000000000001 109.075 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.5 114.52 28.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.423 -0.584 . . . . 75.340000000000003 109.423 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 47.2 mm -92.52 114.32 29.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.971 -1.863 . . . . 74.340000000000003 105.971 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.427 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 9.5 t -129.06 173.74 10.18 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.587 -0.445 . . . . 73.209999999999994 111.28 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -70.5 -25.22 63.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.624 . . . . 65.510000000000005 109.96 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -92.02 -4.39 54.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 73.510000000000005 110.675 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.29 -125.43 3.51 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 119.411 -1.376 . . . . 50.119999999999997 114.149 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -126.19 126.81 44.69 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 123.772 0.829 . . . . 75.230000000000004 110.06 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -122.93 141.08 52.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.612 -0.514 . . . . 71.030000000000001 109.612 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.33 140.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 CA-C-N 115.739 -0.664 . . . . 74.140000000000001 110.52 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -129.76 137.72 50.69 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.558 -0.746 . . . . 72.510000000000005 110.664 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.41 123.01 46.49 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.935 -1.505 . . . . 61.32 106.935 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -117.02 101.98 53.09 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 105.684 -1.969 . . . . 70.340000000000003 105.684 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.47 132.07 17.09 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.238 1.292 . . . . 74.129999999999995 111.932 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 33' ' ' SER . 42.3 mt-30 . . . . . 0 CA--C 1.54 0.573 0 O-C-N 124.214 0.946 . . . . 73.310000000000002 110.371 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptm180 . . . . . 0 N--CA 1.418 -2.053 0 CA-C-O 121.598 0.714 . . . . 72.219999999999999 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.2 p -87.1 142.66 27.76 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.56 -0.745 . . . . 74.450000000000003 110.741 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 62.8 m -135.04 149.79 50.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.38 -0.6 . . . . 65.209999999999994 109.38 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.408 ' CG2' HD21 ' A' ' 14' ' ' LEU . 99.2 t -139.42 139.62 38.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.16 -0.473 . . . . 71.209999999999994 110.419 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.6 p -107.92 125.68 51.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.051 -0.722 . . . . 71.409999999999997 109.051 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.429 HD21 ' CG2' ' A' ' 12' ' ' VAL . 96.8 mt -113.6 124.3 52.01 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 122.819 0.448 . . . . 74.239999999999995 111.78 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 24.9 p -85.16 113.63 21.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.493 -0.776 . . . . 70.349999999999994 109.244 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.1 t -139.33 178.4 7.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.483 -0.932 . . . . 74.010000000000005 108.483 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -71.04 88.76 0.78 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.161 0.981 . . . . 72.109999999999999 110.431 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.434 ' NH2' ' HB2' ' B' ' 19' ' ' LEU . 6.9 tpm_? -126.91 129.5 48.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.64 -1.164 . . . . 70.129999999999995 110.173 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.434 ' HB2' ' NH2' ' B' ' 18' ' ' ARG . 1.7 mm? -74.49 146.21 83.44 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.373 -1.343 . . . . 74.0 107.373 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.2 135.04 52.25 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 122.517 2.144 . . . . 63.32 113.881 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.29 127.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.523 -1.658 . . . . 74.109999999999999 106.523 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -88.9 -36.74 15.77 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.587 -0.445 . . . . 74.239999999999995 111.409 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -112.96 134.15 54.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.304 . . . . 71.230000000000004 111.353 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.86 123.86 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.96 -0.564 . . . . 75.010000000000005 111.625 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.51 132.84 35.45 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.577 -0.449 . . . . 62.229999999999997 110.161 173.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 39.1 p -106.66 128.31 54.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.286 -0.87 . . . . 74.5 109.753 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 54.3 m-85 -128.16 126.83 41.83 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 116.052 -0.522 . . . . 73.549999999999997 110.752 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.434 HG22 HG22 ' B' ' 37' ' ' VAL . 77.8 p -114.85 131.19 56.92 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.947 -0.57 . . . . 53.539999999999999 112.069 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.487 HD13 HD12 ' A' ' 38' ' ' ILE . 59.7 mt -136.52 122.21 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.322 -0.992 . . . . 71.409999999999997 108.322 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.3 121.63 40.04 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.786 -0.766 . . . . 75.010000000000005 109.41 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.582 ' O ' HD21 ' B' ' 34' ' ' LEU . 11.7 tp10 -119.7 113.8 21.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.428 -0.806 . . . . 75.230000000000004 110.546 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.26 -75.48 1.35 Allowed Glycine 0 C--N 1.298 -1.568 0 C-N-CA 121.174 -0.536 . . . . 71.239999999999995 112.125 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 13.7 t -153.56 6.99 0.36 Allowed 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 120.797 0.332 . . . . 73.140000000000001 111.403 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.582 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -114.75 140.03 49.22 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 118.522 -1.271 . . . . 73.030000000000001 109.712 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -98.06 131.03 44.82 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.022 -0.732 . . . . 74.319999999999993 109.022 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.37 114.83 23.53 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.353 -0.98 . . . . 75.450000000000003 108.353 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 27' ' ' TYR . 51.6 t -111.52 125.7 68.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.103 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.49 HD11 HD13 ' A' ' 29' ' ' ILE . 81.6 mt -101.59 130.7 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.663 0 C-N-CA 124.017 0.927 . . . . 60.299999999999997 109.573 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.39 114.66 26.16 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.057 -1.09 . . . . 74.030000000000001 108.057 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 50.2 mm -88.64 117.73 32.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.697 -1.223 . . . . 73.409999999999997 107.697 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.7 t -132.04 169.32 16.51 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.402 0.439 . . . . 73.0 110.465 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -18.52 62.93 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.031 0.443 . . . . 73.400000000000006 110.837 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -86.71 -16.48 36.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 73.540000000000006 109.11 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.6 -124.93 2.5 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.268 -0.967 . . . . 62.43 113.223 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.95 124.25 42.18 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.929 -0.636 . . . . 73.349999999999994 110.737 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -121.29 140.69 51.74 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.885 0.374 . . . . 64.510000000000005 110.11 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 13.1 p -131.77 141.37 45.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.806 -0.633 . . . . 74.519999999999996 110.011 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 65.2 m -123.75 136.65 54.56 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 123.242 0.339 . . . . 75.150000000000006 110.531 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.58 123.76 47.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.585 -0.524 . . . . 75.340000000000003 109.585 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.93 105.6 37.51 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.791 -0.818 . . . . 74.510000000000005 108.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.432 -2.139 0 C-N-CA 121.349 1.366 . . . . 74.120000000000005 115.406 -175.937 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 . . . . . 0 N--CA 1.411 -2.403 0 N-CA-C 105.496 -2.039 . . . . 74.450000000000003 105.496 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 p -86.26 117.16 24.9 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.803 -0.759 . . . . 72.030000000000001 109.695 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.6 m -123.94 148.94 46.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.934 -0.575 . . . . 63.439999999999998 109.495 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.6 t -145.45 142.41 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.825 0.45 . . . . 72.510000000000005 110.242 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -111.35 138.37 47.93 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 122.65 0.38 . . . . 72.430000000000007 110.871 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.42 140.54 48.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 112.331 0.493 . . . . 70.209999999999994 112.331 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.312 -0.858 . . . . 74.019999999999996 109.506 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -134.49 -177.7 4.72 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.578 -1.268 . . . . 73.340000000000003 107.578 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -76.31 96.79 4.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.337 1.065 . . . . 74.439999999999998 109.32 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -125.85 140.02 53.0 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.108 -0.951 . . . . 75.340000000000003 111.63 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.426 HD13 ' HB3' ' B' ' 33' ' ' SER . 4.8 mp -82.55 136.5 45.42 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.284 -1.006 . . . . 64.340000000000003 108.284 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.17 137.53 40.8 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 122.48 2.12 . . . . 71.409999999999997 112.675 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -131.8 148.96 32.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.618 -1.174 . . . . 73.310000000000002 107.973 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -97.49 -23.83 15.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.009 0.433 . . . . 62.210000000000001 111.71 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -102.91 132.12 49.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.293 -0.632 . . . . 74.450000000000003 109.293 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -98.07 129.99 47.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.837 -0.62 . . . . 74.340000000000003 109.592 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.83 141.51 30.74 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.359 -0.536 . . . . 73.540000000000006 110.894 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.1 p -119.76 127.66 53.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.077 -0.965 . . . . 74.450000000000003 108.767 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 70.5 m-85 -126.35 126.27 43.63 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 110.17 -0.307 . . . . 74.019999999999996 110.17 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.511 HG23 HG23 ' A' ' 37' ' ' VAL . 59.3 p -115.89 131.35 56.96 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.754 -0.657 . . . . 72.209999999999994 111.405 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.447 HD13 HD11 ' B' ' 38' ' ' ILE . 50.2 mt -127.39 121.33 57.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.116 -0.493 . . . . 71.109999999999999 110.004 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -103.88 121.47 43.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.779 -1.193 . . . . 65.25 107.779 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' HD21 ' A' ' 34' ' ' LEU . 13.6 tp10 -142.62 100.43 3.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 112.242 0.46 . . . . 74.120000000000005 112.242 -174.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.54 -66.15 3.55 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 114.592 0.597 . . . . 54.530000000000001 114.592 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 p -158.94 18.8 0.19 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.655 0.613 . . . . 72.099999999999994 112.655 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.568 HD22 ' CZ ' ' B' ' 18' ' ' ARG . 2.1 pt? -145.27 140.35 27.75 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.499 -0.556 . . . . 74.329999999999998 109.499 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -107.77 120.88 43.5 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.46 -0.941 . . . . 75.340000000000003 108.46 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.32 134.92 46.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.785 -0.45 . . . . 71.439999999999998 109.785 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.511 HG23 HG23 ' A' ' 28' ' ' THR . 48.5 t -118.22 125.41 74.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 75.150000000000006 110.184 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.475 HD12 HD13 ' B' ' 29' ' ' ILE . 74.6 mt -101.77 120.61 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 CA-C-N 115.555 -0.748 . . . . 75.209999999999994 109.077 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 94.7 m-85 -102.58 115.44 30.59 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.819 -0.808 . . . . 75.319999999999993 108.819 175.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.429 HD11 HD23 ' B' ' 34' ' ' LEU . 37.1 mm -88.29 112.24 23.49 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 106.504 -1.665 . . . . 62.509999999999998 106.504 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.443 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 7.0 t -126.09 153.04 45.06 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.922 -0.581 . . . . 73.319999999999993 112.553 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.546 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -52.33 -32.82 39.88 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.948 1.299 . . . . 42.32 113.233 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -87.64 -12.64 44.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.369 0.604 . . . . 73.219999999999999 110.706 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.27 -109.97 0.43 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.673 -1.251 . . . . 53.140000000000001 113.624 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.7 tp -134.09 145.99 49.87 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 123.911 0.885 . . . . 73.420000000000002 109.846 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -141.04 142.66 34.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.251 -0.648 . . . . 61.130000000000003 109.251 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.03 140.62 48.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.872 -0.604 . . . . 62.229999999999997 109.949 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.413 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 33.7 m -125.15 143.19 51.06 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 116.119 -0.491 . . . . 74.310000000000002 110.871 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.82 124.14 49.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.973 -1.121 . . . . 73.109999999999999 107.973 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.03 101.22 54.48 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 107.47 -1.307 . . . . 63.399999999999999 107.47 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.96 150.3 72.91 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 122.59 2.193 . . . . 74.129999999999995 111.763 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? . . . . . 0 N--CA 1.428 -1.572 0 CA-C-N 114.967 -1.015 . . . . 73.219999999999999 110.349 172.807 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.423 ' HG2' ' HD2' ' B' ' 51' ' ' PRO . 35.0 mtp180 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 108.097 -1.075 . . . . 74.239999999999995 108.097 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -89.39 148.17 23.64 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.541 -0.754 . . . . 64.409999999999997 111.446 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 84.0 m -133.16 149.69 52.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.716 -1.216 . . . . 62.32 107.716 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 65.8 t -136.86 140.53 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 120.81 -0.356 . . . . 74.329999999999998 111.434 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 22.4 p -106.81 125.81 51.49 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.495 0.718 . . . . 73.140000000000001 109.912 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -106.44 129.67 54.38 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.424 -0.584 . . . . 75.530000000000001 109.424 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 12.1 p -123.84 112.36 17.19 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.934 0.873 . . . . 63.100000000000001 111.559 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -141.69 -166.43 2.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.502 -1.666 . . . . 72.109999999999999 106.502 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -66.99 94.89 0.35 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.212 0.914 . . . . 65.340000000000003 112.146 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.568 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 7.2 tpt180 -126.38 137.95 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.993 -1.003 . . . . 41.229999999999997 110.878 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.59 136.23 42.61 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.119 -1.067 . . . . 75.150000000000006 108.119 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' B' ' 42' ' ' LYS . 57.9 Cg_endo -70.13 148.65 63.16 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.352 2.035 . . . . 72.129999999999995 113.236 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.436 HG23 ' H ' ' B' ' 23' ' ' ARG . 12.0 p -131.88 142.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 75.150000000000006 107.923 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 16.1 m -91.52 9.93 29.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.293 0.568 . . . . 75.310000000000002 111.074 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.436 ' H ' HG23 ' B' ' 21' ' ' VAL . 35.6 mmt180 -128.87 133.9 48.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.443 -0.577 . . . . 70.5 109.443 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.48 117.17 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.397 -0.594 . . . . 63.509999999999998 109.397 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.1 139.31 34.94 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.899 0.38 . . . . 74.129999999999995 111.617 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.8 p -117.89 127.77 54.17 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.298 -0.865 . . . . 74.400000000000006 108.884 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.15 124.21 34.1 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 108.683 -0.858 . . . . 72.239999999999995 108.683 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 18.8 m -118.07 122.01 42.05 Favored 'General case' 0 C--N 1.264 -3.144 0 C-N-CA 119.507 -0.877 . . . . 63.200000000000003 111.859 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 38' ' ' ILE . 60.4 mt -112.9 123.49 68.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.279 -0.637 . . . . 65.430000000000007 109.279 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -104.82 121.48 43.75 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.654 0.74 . . . . 73.140000000000001 109.239 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.468 ' O ' HD21 ' B' ' 34' ' ' LEU . 13.9 tp10 -136.7 97.33 3.52 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.18 0.514 . . . . 75.299999999999997 111.592 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.53 -80.2 0.23 Allowed Glycine 0 C--N 1.312 -0.778 0 CA-C-N 115.615 -0.72 . . . . 44.329999999999998 114.831 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' SER . . . . . 0.426 ' HB3' HD13 ' A' ' 19' ' ' LEU . 28.1 m -123.69 6.59 8.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.685 0.624 . . . . 74.0 112.685 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.468 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.1 pt? -147.0 140.97 25.93 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 119.11 -1.036 . . . . 71.120000000000005 111.517 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.422 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 86.8 mtm180 -108.18 119.47 39.56 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 114.784 -1.098 . . . . 75.340000000000003 109.088 170.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 126.99 51.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.632 -0.507 . . . . 72.329999999999998 109.632 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' B' ' 47' ' ' VAL . 46.3 t -109.41 124.92 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.083 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.447 HD11 HD13 ' A' ' 29' ' ' ILE . 70.3 mt -101.33 119.7 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.661 -0.866 . . . . 75.140000000000001 108.661 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.479 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.9 m-85 -102.92 114.56 28.95 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.255 -1.017 . . . . 75.400000000000006 108.255 175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.434 HD11 HD23 ' A' ' 34' ' ' LEU . 48.4 mm -89.97 112.88 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 106.014 -1.847 . . . . 75.510000000000005 106.014 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -115.66 -178.02 3.29 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 115.555 -0.748 . . . . 74.140000000000001 109.372 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -73.0 -45.24 58.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 113.972 1.101 . . . . 75.209999999999994 113.972 -173.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -93.81 -6.32 46.18 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.802 -0.759 . . . . 72.109999999999999 111.955 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.93 -143.12 6.39 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.354 -1.879 . . . . 62.109999999999999 114.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 59.0 tp -114.53 149.13 36.91 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.43 1.092 . . . . 64.129999999999995 109.689 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -143.56 143.11 31.38 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.234 -0.654 . . . . 61.439999999999998 109.234 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' B' ' 37' ' ' VAL . 11.7 p -131.52 141.22 46.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.649 -0.5 . . . . 71.340000000000003 109.649 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.479 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 63.5 m -121.29 146.21 47.07 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 110.32 -0.252 . . . . 42.140000000000001 110.32 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.81 124.3 50.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 121.265 0.555 . . . . 75.310000000000002 109.748 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 20.4 t70 -114.87 108.46 48.69 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 115.085 -0.961 . . . . 75.230000000000004 109.136 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' HG2' ' B' ' 9' ' ' ARG . 87.4 Cg_endo . . . . . 0 N--CA 1.434 -1.98 0 C-N-CA 122.174 1.916 . . . . 74.519999999999996 110.875 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 . . . . . 0 CA--C 1.475 -1.911 0 N-CA-C 109.948 -0.39 . . . . 74.430000000000007 109.948 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m -108.67 132.48 53.87 Favored 'General case' 0 C--N 1.262 -3.217 0 C-N-CA 119.835 -0.746 . . . . 71.540000000000006 110.058 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.25 147.88 45.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.312 . . . . 62.130000000000003 107.459 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.14 150.44 15.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.561 -0.533 . . . . 72.200000000000003 109.561 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 p -107.18 140.49 39.95 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 121.229 0.538 . . . . 72.5 111.433 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 3.7 mm? -104.79 135.42 46.2 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 124.305 1.042 . . . . 74.510000000000005 110.536 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -108.59 117.99 35.61 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-N 115.348 -0.842 . . . . 73.209999999999994 110.122 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -147.2 177.38 9.23 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 107.49 -1.3 . . . . 63.32 107.49 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -68.59 96.18 0.69 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.28 1.038 . . . . 72.420000000000002 111.706 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.452 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 14.5 mmm180 -126.03 141.69 51.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.138 1.162 . . . . 74.430000000000007 114.138 -174.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.5 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.5 pt? -89.57 150.37 44.18 Favored Pre-proline 0 C--N 1.293 -1.849 0 CA-C-N 113.944 -1.48 . . . . 61.329999999999998 108.377 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.85 137.35 41.37 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.489 2.126 . . . . 54.219999999999999 113.028 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.14 142.36 43.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.626 -1.17 . . . . 62.109999999999999 108.024 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -89.77 -40.53 12.43 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.787 0.327 . . . . 75.340000000000003 111.728 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -91.2 135.0 34.09 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.953 0.406 . . . . 72.120000000000005 111.963 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.62 115.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.079 -1.082 . . . . 71.549999999999997 108.079 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.73 127.6 42.87 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.29 -0.564 . . . . 75.530000000000001 110.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 30.1 p -106.62 128.6 54.29 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.442 -0.799 . . . . 72.200000000000003 109.461 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.2 126.33 42.6 Favored 'General case' 0 CA--C 1.463 -2.379 0 CA-C-N 116.118 -0.492 . . . . 75.239999999999995 109.945 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.505 HG23 HG23 ' A' ' 37' ' ' VAL . 81.9 p -114.94 124.25 51.21 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.445 -0.798 . . . . 73.140000000000001 110.861 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.481 HD13 HD11 ' B' ' 38' ' ' ILE . 50.0 mt -116.24 124.63 72.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.798 -0.637 . . . . 73.230000000000004 110.286 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' ' NH1' ' A' ' 35' ' ' ARG . 6.2 t -100.19 127.32 46.48 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.76 -1.109 . . . . 74.519999999999996 109.682 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.2 tp10 -142.13 103.39 4.29 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.638 -0.71 . . . . 71.420000000000002 110.209 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -91.05 0.73 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 115.231 -0.895 . . . . 37.170000000000002 111.523 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 31.3 p -134.62 6.36 3.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.801 0.81 . . . . 75.450000000000003 109.339 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.487 HD21 HD11 ' B' ' 40' ' ' ILE . 52.2 tp -98.22 136.08 38.94 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.387 -0.824 . . . . 74.209999999999994 110.7 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.462 ' NH1' ' HB ' ' A' ' 30' ' ' THR . 22.2 mmm180 -111.44 112.91 24.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.466 -0.788 . . . . 72.420000000000002 108.946 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.8 124.58 49.67 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.971 -0.751 . . . . 71.120000000000005 108.971 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 28' ' ' THR . 60.4 t -116.38 129.09 73.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.205 0.526 . . . . 70.209999999999994 111.298 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.501 HD12 HD13 ' B' ' 29' ' ' ILE . 59.2 mt -108.43 129.31 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-N 115.058 -0.974 . . . . 43.420000000000002 109.956 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 97.3 m-85 -113.41 117.35 31.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.305 -0.998 . . . . 73.319999999999993 108.305 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.509 HD11 HD21 ' B' ' 34' ' ' LEU . 35.0 mm -90.45 116.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 107.742 -1.207 . . . . 73.510000000000005 107.742 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.8 p -118.72 177.91 4.67 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.429 0.633 . . . . 74.420000000000002 111.261 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.439 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.99 -22.03 62.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.326 -0.852 . . . . 75.450000000000003 110.011 175.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -87.36 -29.73 21.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.443 -0.947 . . . . 54.229999999999997 108.443 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.452 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 150.64 -112.59 0.55 Allowed Glycine 0 N--CA 1.413 -2.862 0 C-N-CA 120.311 -0.947 . . . . 72.319999999999993 113.108 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 55.2 tp -119.84 139.94 51.58 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.64 -0.28 . . . . 74.319999999999993 110.331 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.7 143.32 48.44 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.483 -0.932 . . . . 62.030000000000001 108.483 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.4 p -123.92 140.8 46.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-N 116.146 -0.479 . . . . 75.140000000000001 110.574 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 22.9 m -124.88 138.78 54.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.096 -0.502 . . . . 70.129999999999995 110.967 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.44 124.1 49.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.769 -0.65 . . . . 65.329999999999998 110.067 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 21.1 t70 -116.71 110.4 42.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.021 . . . . 73.430000000000007 108.245 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -84.21 134.61 6.0 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 122.418 2.079 . . . . 61.439999999999998 114.301 -173.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.1 mt-30 . . . . . 0 C--O 1.255 1.377 0 C-N-CA 125.672 1.589 . . . . 73.25 113.836 172.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' B' ' 9' ' ' ARG . 4.6 mpt_? . . . . . 0 N--CA 1.415 -2.213 0 CA-C-O 121.358 0.599 . . . . 71.140000000000001 111.972 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -96.26 148.38 22.8 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.932 -1.031 . . . . 71.239999999999995 110.508 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.8 m -137.14 155.98 48.92 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.518 -0.919 . . . . 73.140000000000001 108.518 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.01 138.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.288 0.235 . . . . 71.340000000000003 111.364 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.9 p -107.38 125.66 51.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.325 0.65 . . . . 74.400000000000006 109.715 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.24 122.0 44.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.608 -0.724 . . . . 70.340000000000003 110.823 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 37.5 p -85.76 113.76 22.18 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.469 -0.937 . . . . 64.109999999999999 108.469 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -139.26 -173.86 3.71 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.668 -0.493 . . . . 55.509999999999998 109.668 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.32 105.64 11.74 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.796 -0.816 . . . . 71.530000000000001 108.796 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.447 ' NH1' ' HB2' ' A' ' 34' ' ' LEU . 20.3 mmm180 -125.64 141.07 52.21 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.682 -0.69 . . . . 72.299999999999997 112.703 -172.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.442 ' H ' HD22 ' B' ' 19' ' ' LEU . 1.9 pt? -90.35 159.62 41.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 107.15 -1.426 . . . . 73.329999999999998 107.15 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.36 135.55 54.49 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.565 1.51 . . . . 63.130000000000003 112.244 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.22 141.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.065 -1.457 . . . . 74.430000000000007 107.065 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -85.83 -68.38 0.74 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.806 0.336 . . . . 63.130000000000003 111.032 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -99.47 139.65 34.81 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 120.844 -0.342 . . . . 74.299999999999997 111.185 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.61 133.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.983 -0.747 . . . . 74.120000000000005 108.983 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 39' ' ' PHE . 43.9 mmtm -100.13 138.81 36.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.322 -0.551 . . . . 63.420000000000002 110.161 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.1 p -115.84 127.22 54.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.256 -0.646 . . . . 72.420000000000002 109.256 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -128.75 130.82 47.6 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-N 116.411 -0.359 . . . . 70.439999999999998 111.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.463 HG22 HG22 ' B' ' 37' ' ' VAL . 57.6 p -114.94 132.62 56.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.698 -0.683 . . . . 72.129999999999995 111.936 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.501 HD13 HD12 ' A' ' 38' ' ' ILE . 72.3 mt -134.73 128.48 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.817 -0.629 . . . . 74.120000000000005 109.719 176.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -112.33 136.96 51.15 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 108.713 -0.847 . . . . 73.5 108.713 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.477 ' HG2' HG13 ' A' ' 40' ' ' ILE . 12.0 tp10 -141.57 112.12 7.07 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.543 -0.54 . . . . 73.299999999999997 109.543 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.98 -104.12 0.55 Allowed Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 110.834 -0.906 . . . . 62.450000000000003 110.834 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 45.4 m -126.49 69.6 1.24 Allowed 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.839 -0.801 . . . . 75.030000000000001 108.839 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 40' ' ' ILE . 28.4 tp -159.13 137.2 10.44 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.045 -0.98 . . . . 75.239999999999995 109.61 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 18.8 mmm180 -113.89 116.88 29.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 123.673 0.608 . . . . 73.019999999999996 110.108 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 130.18 55.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.9 -0.408 . . . . 70.430000000000007 109.9 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.463 HG22 HG22 ' B' ' 28' ' ' THR . 86.7 t -121.64 130.87 74.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.851 0.357 . . . . 73.310000000000002 110.538 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.481 HD11 HD13 ' A' ' 29' ' ' ILE . 80.8 mt -110.28 130.51 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 C-N-CA 123.442 0.697 . . . . 64.049999999999997 109.863 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 95.7 m-85 -114.57 114.76 26.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.908 -1.145 . . . . 75.230000000000004 107.908 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.487 HD11 HD21 ' A' ' 34' ' ' LEU . 40.7 mm -89.58 113.92 26.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.335 -0.987 . . . . 75.010000000000005 108.335 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -106.55 175.3 5.55 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.731 -0.47 . . . . 74.299999999999997 109.731 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.585 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -85.37 -18.05 34.89 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.775 -0.648 . . . . 62.109999999999999 110.978 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -104.31 -17.22 14.91 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.13 0.49 . . . . 73.200000000000003 110.641 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . -174.06 -139.22 2.89 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 119.097 -1.525 . . . . 64.150000000000006 114.164 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 40.6 tp -135.63 134.73 39.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 125.184 1.394 . . . . 55.340000000000003 107.513 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -128.96 140.72 51.53 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.341 -0.944 . . . . 71.439999999999998 110.132 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 11.4 p -131.51 141.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.775 -0.648 . . . . 52.140000000000001 109.754 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 66.7 m -123.87 140.23 53.18 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.683 0.278 . . . . 74.239999999999995 111.061 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.92 125.24 51.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.876 -0.602 . . . . 75.150000000000006 110.681 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 21.6 t70 -114.96 125.1 29.37 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.434 -0.803 . . . . 74.319999999999993 109.348 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.446 -1.295 0 C-N-CA 122.16 1.907 . . . . 43.420000000000002 113.508 -174.87 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 N--CA 1.42 -1.973 0 CA-C-O 122.335 1.064 . . . . 73.409999999999997 112.805 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.405 ' HG1' HD12 ' B' ' 14' ' ' LEU . 7.1 p -87.74 120.11 28.73 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.194 -1.366 . . . . 60.439999999999998 109.945 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 m -133.81 146.41 50.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.798 -1.186 . . . . 75.129999999999995 107.798 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.1 t -146.93 153.76 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 122.702 0.401 . . . . 62.219999999999999 110.085 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.3 p -121.57 125.77 47.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.876 -0.416 . . . . 73.319999999999993 109.876 173.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.457 HD21 ' CG2' ' B' ' 12' ' ' VAL . 97.7 mt -101.23 122.4 43.59 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 123.16 0.584 . . . . 74.450000000000003 112.197 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 p -85.79 114.31 22.63 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.075 -0.966 . . . . 73.530000000000001 110.733 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -147.43 166.99 25.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.474 -0.935 . . . . 72.409999999999997 108.474 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -82.24 102.37 11.1 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.465 0.65 . . . . 73.340000000000003 110.007 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' NH1' ' HB3' ' B' ' 51' ' ' PRO . 65.8 mmt-85 -125.93 150.21 48.15 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 114.938 -1.028 . . . . 74.209999999999994 109.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.22 134.16 80.55 Favored Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.718 -0.845 . . . . 73.420000000000002 108.718 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.51 135.28 48.68 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.813 2.342 . . . . 62.240000000000002 114.899 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.23 133.75 60.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.468 -1.696 . . . . 73.420000000000002 107.671 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -89.87 -18.51 26.05 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.436 0.636 . . . . 74.140000000000001 110.734 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -91.38 132.65 36.06 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.108 -0.701 . . . . 74.420000000000002 109.108 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.4 mm -98.72 135.14 34.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.336 -0.616 . . . . 74.510000000000005 109.336 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -110.95 150.7 28.85 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.196 0.522 . . . . 75.349999999999994 111.905 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 91.1 m -129.74 127.09 39.71 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.057 -1.09 . . . . 72.109999999999999 108.057 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -128.46 128.66 44.83 Favored 'General case' 0 CA--C 1.477 -1.843 0 CA-C-N 116.189 -0.459 . . . . 71.540000000000006 110.914 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.505 HG23 HG23 ' A' ' 37' ' ' VAL . 55.7 p -114.36 124.98 53.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.419 -0.81 . . . . 75.439999999999998 110.646 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.512 HD13 HD11 ' B' ' 38' ' ' ILE . 62.5 mt -119.12 138.79 48.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.556 -0.535 . . . . 75.409999999999997 109.556 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.425 ' HB ' HH11 ' A' ' 35' ' ' ARG . 10.6 t -118.68 127.48 53.61 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.098 -0.705 . . . . 74.349999999999994 109.098 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.7 tp10 -139.24 97.27 3.26 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 108.507 -0.923 . . . . 74.310000000000002 108.507 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.09 -119.34 7.94 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 110.533 -1.027 . . . . 72.129999999999995 110.533 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 36.8 m -102.01 3.31 38.72 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.45 0.643 . . . . 74.129999999999995 110.091 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.471 HD21 HD11 ' B' ' 40' ' ' ILE . 47.1 tp -99.75 131.61 45.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 C-N-CA 123.676 0.79 . . . . 72.120000000000005 110.138 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 50' ' ' ASP . 28.8 tpt180 -121.37 122.46 39.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.12 -1.067 . . . . 74.329999999999998 108.12 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.07 141.53 46.78 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.953 -0.467 . . . . 73.109999999999999 110.603 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 28' ' ' THR . 58.3 t -125.09 131.08 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 74.099999999999994 111.144 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.444 HD12 HD13 ' B' ' 29' ' ' ILE . 75.6 mt -108.41 125.86 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 124.274 1.03 . . . . 72.010000000000005 109.383 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.6 m-85 -112.14 119.04 37.04 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.098 -1.075 . . . . 75.340000000000003 108.098 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.453 HG23 HD23 ' B' ' 34' ' ' LEU . 36.7 mm -88.8 121.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.602 -0.726 . . . . 63.009999999999998 109.233 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.4 p -124.99 164.66 19.67 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.372 -0.603 . . . . 73.0 109.372 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -70.96 -21.69 62.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.875 0.369 . . . . 72.230000000000004 110.734 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -94.73 1.6 55.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.087 0.47 . . . . 72.25 110.689 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.62 -142.47 13.08 Favored Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 119.434 -1.365 . . . . 43.43 113.329 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.6 tp -114.9 134.52 55.08 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.303 -0.449 . . . . 72.530000000000001 111.241 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 78.7 tttt -115.58 137.01 52.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.398 0.618 . . . . 71.0 110.264 170.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.62 140.58 45.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.747 -1.115 . . . . 70.010000000000005 108.357 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.3 t -137.85 143.13 40.8 Favored 'General case' 0 C--N 1.27 -2.873 0 N-CA-C 107.456 -1.313 . . . . 61.219999999999999 107.456 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.68 125.26 53.53 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.026 -0.67 . . . . 75.400000000000006 110.202 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.6 t70 -101.44 100.7 14.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 106.278 -1.749 . . . . 72.319999999999993 106.278 175.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HB3' HH12 ' B' ' 18' ' ' ARG . 95.0 Cg_endo -79.0 132.97 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.501 2.134 . . . . 70.310000000000002 115.276 -172.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 33' ' ' SER . 41.4 mt-30 . . . . . 0 C--O 1.236 0.381 0 C-N-CA 126.494 1.917 . . . . 75.200000000000003 114.252 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptp180 . . . . . 0 N--CA 1.42 -1.937 0 CA-C-O 121.259 0.552 . . . . 75.219999999999999 110.981 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -89.59 123.04 33.31 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 108.413 -0.958 . . . . 70.340000000000003 108.413 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 81.5 m -125.35 149.17 48.36 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.75 -0.463 . . . . 71.409999999999997 109.75 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.457 ' CG2' HD21 ' A' ' 14' ' ' LEU . 98.1 t -140.68 133.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.258 -0.428 . . . . 74.420000000000002 110.222 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.8 p -107.42 125.68 51.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.585 -0.895 . . . . 74.129999999999995 108.585 174.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.405 HD12 ' HG1' ' A' ' 10' ' ' THR . 79.9 mt -101.52 140.84 35.26 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.751 -0.659 . . . . 72.140000000000001 110.968 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 22.1 p -99.38 113.82 26.37 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.674 0.749 . . . . 72.519999999999996 111.528 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -158.64 159.86 35.84 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.67 -1.233 . . . . 72.319999999999993 107.67 173.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -78.27 106.51 10.23 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.919 0.866 . . . . 71.129999999999995 110.275 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.524 ' HE ' ' HA ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -109.95 151.16 27.45 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 113.921 -1.491 . . . . 75.5 110.126 -176.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -73.52 143.88 82.93 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.143 -1.058 . . . . 65.310000000000002 108.143 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -65.72 135.0 39.93 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.688 1.592 . . . . 75.120000000000005 111.461 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.23 139.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 107.731 -1.211 . . . . 74.200000000000003 107.731 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.6 m -84.22 -50.67 7.67 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.786 -0.365 . . . . 64.120000000000005 111.537 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -89.38 142.23 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.649 -0.871 . . . . 73.329999999999998 108.649 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.77 121.19 37.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.791 -0.818 . . . . 75.209999999999994 108.791 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -89.86 138.86 31.13 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.549 -0.86 . . . . 72.200000000000003 111.477 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 89.0 m -128.95 127.34 41.53 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.537 -1.21 . . . . 73.420000000000002 108.381 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 81.1 m-85 -122.11 130.45 53.25 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.66 -0.7 . . . . 75.129999999999995 110.798 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.426 HG22 HG22 ' B' ' 37' ' ' VAL . 57.0 p -115.12 130.78 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.1 -0.955 . . . . 74.540000000000006 111.173 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.444 HD13 HD12 ' A' ' 38' ' ' ILE . 55.0 mt -131.01 120.65 47.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.307 -0.627 . . . . 73.030000000000001 109.307 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -103.87 121.59 43.39 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.565 -0.902 . . . . 71.230000000000004 108.565 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.424 ' O ' HD21 ' B' ' 34' ' ' LEU . 9.6 tp10 -136.68 100.88 4.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.72 -0.673 . . . . 73.209999999999994 111.065 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.22 -102.59 0.61 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.619 -0.719 . . . . 74.400000000000006 112.966 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 33.9 m -112.45 13.05 20.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 112.049 0.389 . . . . 51.229999999999997 112.049 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.453 HD23 HG23 ' A' ' 40' ' ' ILE . 2.4 pt? -137.83 140.62 40.58 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.669 0.747 . . . . 75.109999999999999 110.396 175.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.418 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 33.7 ttt180 -117.27 134.07 55.24 Favored 'General case' 0 C--N 1.258 -3.394 0 CA-C-N 114.737 -1.12 . . . . 72.239999999999995 108.608 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.98 140.97 47.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 122.347 -0.221 . . . . 65.200000000000003 110.821 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' B' ' 27' ' ' TYR . 96.4 t -127.46 127.94 69.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.007 -0.542 . . . . 71.430000000000007 110.07 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.512 HD11 HD13 ' A' ' 29' ' ' ILE . 92.6 mt -113.15 126.77 70.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 123.4 0.68 . . . . 74.409999999999997 109.884 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.8 118.5 36.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.9 -0.778 . . . . 74.439999999999998 108.9 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.471 HD11 HD21 ' A' ' 34' ' ' LEU . 35.9 mm -94.61 115.58 33.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.26 -1.015 . . . . 71.120000000000005 108.26 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -129.68 162.97 27.13 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 110.07 -0.345 . . . . 75.340000000000003 110.07 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -20.8 66.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.023 0.44 . . . . 74.530000000000001 110.863 177.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -91.2 -17.23 26.39 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 111.946 0.351 . . . . 74.120000000000005 111.946 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 14' ' ' LEU . . . 158.49 -156.29 27.28 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.69 -1.719 . . . . 71.140000000000001 113.583 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -112.81 122.69 48.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.698 -0.853 . . . . 70.329999999999998 108.698 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -117.39 138.45 51.8 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.119 -0.632 . . . . 64.319999999999993 110.013 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.1 140.95 47.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.207 -0.906 . . . . 73.140000000000001 109.334 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.52 143.21 51.21 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 116.295 -0.411 . . . . 75.120000000000005 110.641 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.42 122.92 47.27 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.406 -0.961 . . . . 72.209999999999994 108.406 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.418 ' OD2' ' HD3' ' B' ' 35' ' ' ARG . 32.1 t70 -112.99 126.9 27.51 Favored Pre-proline 0 C--N 1.275 -2.641 0 CA-C-N 114.918 -1.037 . . . . 73.409999999999997 108.294 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.508 ' HB3' ' NH1' ' A' ' 18' ' ' ARG . 61.2 Cg_endo . . . . . 0 N--CA 1.446 -1.296 0 C-N-CA 121.553 1.502 . . . . 70.150000000000006 114.564 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.406 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 94.7 mtt180 . . . . . 0 N--CA 1.42 -1.926 0 CA-C-O 121.86 0.838 . . . . 73.340000000000003 110.042 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p -87.41 143.82 27.05 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.638 -1.164 . . . . 73.430000000000007 111.422 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.7 m -132.74 148.51 52.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.784 -0.821 . . . . 54.109999999999999 108.784 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.0 t -143.68 142.02 25.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 110.055 -0.35 . . . . 71.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.3 t -107.92 128.45 54.64 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.51 -0.922 . . . . 62.240000000000002 108.51 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.7 mm? -100.94 121.61 42.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.134 -0.691 . . . . 73.510000000000005 109.134 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 p -97.35 114.24 26.01 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-O 121.797 0.808 . . . . 72.239999999999995 109.682 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -139.33 -169.72 2.73 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.38 -1.341 . . . . 74.549999999999997 107.38 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -73.04 101.13 3.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.389 -0.967 . . . . 71.430000000000007 108.389 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' HG3' ' CA ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -125.31 149.21 48.28 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.076 -0.65 . . . . 75.150000000000006 112.29 -173.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.3 pt? -89.99 148.73 40.25 Favored Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 107.639 -1.245 . . . . 75.200000000000003 107.639 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.44 136.35 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 121.519 1.479 . . . . 64.409999999999997 110.655 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -108.48 148.49 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.429 -0.582 . . . . 44.039999999999999 109.429 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 p -67.9 -57.26 6.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.005 0.431 . . . . 74.109999999999999 111.881 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -117.07 157.87 25.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.357 -0.383 . . . . 74.209999999999994 110.023 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -80.75 115.09 22.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.131 -1.433 . . . . 72.230000000000004 107.131 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -94.29 131.83 39.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.327 -0.549 . . . . 72.239999999999995 109.682 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.6 p -106.23 128.11 53.71 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.13 0.491 . . . . 72.430000000000007 109.861 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 80.0 m-85 -123.3 125.74 45.6 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 116.04 -0.527 . . . . 73.209999999999994 109.906 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.461 HG23 HG23 ' A' ' 37' ' ' VAL . 41.1 p -114.53 118.18 33.01 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.071 -0.968 . . . . 72.319999999999993 112.278 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.486 HD13 HD11 ' B' ' 38' ' ' ILE . 54.7 mt -121.95 121.51 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.095 -0.705 . . . . 75.319999999999993 109.095 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.2 t -118.28 124.7 48.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 CA-C-O 122.164 0.983 . . . . 64.310000000000002 109.683 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.4 tp10 -124.38 98.37 5.72 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.573 -1.649 . . . . 64.099999999999994 108.479 -175.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.5 -132.44 27.33 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 109.976 -1.25 . . . . 71.510000000000005 109.976 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.2 m -90.61 18.48 6.3 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.226 0.536 . . . . 65.430000000000007 110.878 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.45 HD21 HD11 ' B' ' 40' ' ' ILE . 32.8 tp -121.06 136.06 55.06 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.726 -0.472 . . . . 73.120000000000005 109.726 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -129.85 135.34 48.27 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 116.287 -0.415 . . . . 71.349999999999994 111.294 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.26 140.2 52.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.562 -0.533 . . . . 73.409999999999997 109.562 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.461 HG23 HG23 ' A' ' 28' ' ' THR . 63.6 t -121.97 125.92 73.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.969 0.414 . . . . 73.549999999999997 110.861 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 86.1 mt -102.15 124.94 56.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.384 -0.825 . . . . 74.030000000000001 109.629 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -110.72 119.04 37.81 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.797 -1.186 . . . . 74.120000000000005 107.797 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.491 HD11 HD21 ' B' ' 34' ' ' LEU . 34.4 mm -88.18 114.83 27.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.272 -1.381 . . . . 73.340000000000003 107.272 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -130.99 165.66 22.68 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.078 0.466 . . . . 74.540000000000006 111.275 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -68.04 -16.1 63.89 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.434 0.694 . . . . 74.200000000000003 109.994 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -86.83 -14.76 41.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.403 -0.962 . . . . 74.239999999999995 108.403 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' CA ' ' HG3' ' A' ' 18' ' ' ARG . . . 129.6 -117.34 2.35 Favored Glycine 0 CA--C 1.48 -2.125 0 CA-C-N 114.977 -1.011 . . . . 71.349999999999994 112.478 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 64.5 tp -113.41 132.87 55.46 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.583 -0.525 . . . . 64.5 109.583 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -128.42 134.99 48.91 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.484 -0.561 . . . . 71.140000000000001 109.484 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.43 HG11 HG13 ' B' ' 47' ' ' VAL . 12.4 p -128.57 140.59 48.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.043 0 CA-C-N 115.721 -0.672 . . . . 74.040000000000006 109.95 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.3 m -120.0 147.83 44.31 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 115.587 -0.733 . . . . 73.010000000000005 109.743 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.19 124.53 51.67 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 106.845 -1.539 . . . . 44.049999999999997 106.845 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.406 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 17.7 t70 -124.01 83.69 55.35 Favored Pre-proline 0 C--N 1.271 -2.819 0 N-CA-C 107.146 -1.427 . . . . 71.439999999999998 107.146 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -93.18 134.79 1.11 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 122.318 2.012 . . . . 71.439999999999998 112.661 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 114.209 -1.359 . . . . 74.349999999999994 111.912 178.437 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 109.287 -0.635 . . . . 74.010000000000005 109.287 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -90.25 143.31 26.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 110.384 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 69.5 m -144.91 149.39 35.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.827 -0.349 . . . . 74.420000000000002 110.116 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 92.7 t -141.2 141.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.741 0.416 . . . . 65.530000000000001 110.074 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.43 ' HB2' ' HD3' ' B' ' 46' ' ' LYS . 21.7 t -107.65 132.39 53.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.216 0.531 . . . . 61.299999999999997 109.687 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.77 120.84 43.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.704 -0.68 . . . . 71.209999999999994 110.661 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 34.1 p -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.291 -1.003 . . . . 65.519999999999996 108.291 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 t -142.57 -169.02 2.89 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.528 -0.915 . . . . 74.099999999999994 108.528 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.36 85.11 1.96 Allowed 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.292 1.044 . . . . 64.549999999999997 110.655 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -125.89 121.75 34.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.783 -1.099 . . . . 74.349999999999994 110.919 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.506 ' H ' HD22 ' B' ' 19' ' ' LEU . 1.7 pt? -74.66 147.56 84.59 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.019 -0.991 . . . . 74.239999999999995 108.535 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.74 147.56 81.43 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.383 2.055 . . . . 54.43 114.933 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.66 141.36 45.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.636 -1.616 . . . . 63.409999999999997 106.636 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 p -82.79 -14.15 54.96 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.316 0.858 . . . . 74.239999999999995 113.316 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -127.39 146.75 50.36 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.354 -0.216 . . . . 74.549999999999997 111.012 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -91.79 115.79 31.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.659 -0.867 . . . . 75.209999999999994 108.659 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -89.83 131.55 35.71 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.28 -0.568 . . . . 72.450000000000003 109.795 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 23.8 p -109.65 127.2 54.39 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.634 -0.712 . . . . 71.430000000000007 109.936 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -128.35 126.24 40.33 Favored 'General case' 0 CA--C 1.468 -2.197 0 CA-C-N 116.404 -0.362 . . . . 72.010000000000005 110.811 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.478 HG22 HG22 ' B' ' 37' ' ' VAL . 76.0 p -115.16 132.6 56.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.431 -0.804 . . . . 71.140000000000001 112.023 -175.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.433 HD11 HD11 ' A' ' 29' ' ' ILE . 66.9 mt -136.64 124.8 34.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.184 -0.672 . . . . 75.409999999999997 109.184 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -115.35 140.89 48.72 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.808 -0.812 . . . . 73.420000000000002 108.808 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.435 ' HG2' HG13 ' A' ' 40' ' ' ILE . 9.5 tp10 -142.06 116.59 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.263 -0.88 . . . . 70.109999999999999 110.168 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.66 -76.66 1.33 Allowed Glycine 0 C--O 1.222 -0.655 0 N-CA-C 111.058 -0.817 . . . . 53.030000000000001 111.058 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 37.9 m -153.14 -5.09 0.2 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.499 -0.926 . . . . 72.400000000000006 108.499 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.491 HD21 HD11 ' A' ' 40' ' ' ILE . 21.5 tp -88.2 140.13 29.79 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.377 1.071 . . . . 72.349999999999994 109.057 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -129.92 132.39 46.35 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.16 -0.616 . . . . 73.219999999999999 111.898 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.91 44.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 110.238 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.478 HG22 HG22 ' B' ' 28' ' ' THR . 60.2 t -127.84 127.26 67.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.465 -0.569 . . . . 55.100000000000001 109.465 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.486 HD11 HD13 ' A' ' 29' ' ' ILE . 77.3 mt -104.93 128.92 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 115.457 -0.792 . . . . 73.340000000000003 109.051 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 96.9 m-85 -113.2 116.6 30.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.939 -1.134 . . . . 72.099999999999994 107.939 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 34' ' ' LEU . 39.1 mm -88.7 114.66 27.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 107.471 -1.307 . . . . 75.420000000000002 107.471 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -116.13 -179.83 3.78 Favored 'General case' 0 N--CA 1.412 -2.337 0 C-N-CA 120.549 -0.46 . . . . 74.450000000000003 110.642 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -82.73 -31.39 28.47 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.327 0.862 . . . . 74.329999999999998 113.327 -172.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -102.36 -5.04 24.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.138 -0.625 . . . . 75.230000000000004 110.636 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.58 -136.74 4.0 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.154 -1.498 . . . . 53.310000000000002 114.195 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 67.3 tp -118.83 143.05 47.19 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 124.226 1.011 . . . . 62.030000000000001 108.998 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -129.83 121.68 27.22 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.262 -1.384 . . . . 75.109999999999999 107.262 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.43 HG13 HG11 ' A' ' 47' ' ' VAL . 13.9 p -114.81 140.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.423 -0.353 . . . . 72.120000000000005 110.464 -176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 46.4 m -131.11 141.63 50.16 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.513 0.508 . . . . 64.510000000000005 111.804 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.86 124.74 51.43 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.399 -0.819 . . . . 71.019999999999996 109.295 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.73 103.78 52.6 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.052 -1.092 . . . . 72.030000000000001 108.052 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.44 -1.655 0 C-N-CA 121.603 1.535 . . . . 62.240000000000002 112.632 -176.872 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 C--O 1.243 0.759 0 N-CA-C 108.925 -0.768 . . . . 74.349999999999994 108.925 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.555 ' OG1' HD12 ' B' ' 14' ' ' LEU . 3.5 p -108.23 149.51 28.49 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 112.237 0.458 . . . . 75.239999999999995 112.237 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.2 m -133.79 149.32 51.41 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.264 -1.384 . . . . 71.120000000000005 107.264 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.21 148.95 20.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.828 0.347 . . . . 73.400000000000006 110.698 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 32.5 t -125.06 144.63 50.31 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.818 -0.628 . . . . 73.430000000000007 109.655 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.453 ' O ' HD12 ' A' ' 14' ' ' LEU . 3.9 pp -125.96 142.59 51.45 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.648 -0.705 . . . . 75.219999999999999 109.719 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 p -98.6 119.54 37.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.095 -0.706 . . . . 54.340000000000003 109.095 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -143.63 -171.84 3.6 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.219 -0.592 . . . . 75.329999999999998 110.288 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.0 88.93 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.407 0.683 . . . . 75.340000000000003 110.948 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 23.5 mmm180 -126.38 149.24 49.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.442 0.904 . . . . 75.450000000000003 113.442 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.473 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.9 pt? -108.4 158.11 34.71 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.508 -1.293 . . . . 64.109999999999999 107.508 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 27.6 Cg_endo -62.28 136.06 57.71 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.29 1.993 . . . . 72.439999999999998 112.533 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -116.49 141.77 32.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.943 -1.026 . . . . 71.209999999999994 109.666 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.9 m -67.33 -34.59 77.66 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.204 0.816 . . . . 75.099999999999994 113.204 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -132.3 149.87 52.27 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.813 -0.554 . . . . 75.129999999999995 111.4 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.9 mm -86.05 115.5 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.59 -1.633 . . . . 64.209999999999994 106.59 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.82 128.67 45.1 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 116.125 -0.489 . . . . 75.209999999999994 109.695 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.9 p -106.6 127.68 53.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.366 -0.605 . . . . 75.329999999999998 109.366 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -123.07 127.96 49.47 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.911 -0.586 . . . . 72.409999999999997 110.71 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.535 HG23 HG23 ' A' ' 37' ' ' VAL . 12.1 p -114.41 126.68 55.25 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 74.109999999999999 112.329 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.47 HD13 HD11 ' B' ' 38' ' ' ILE . 49.0 mt -123.66 121.66 62.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.754 -0.657 . . . . 75.430000000000007 109.729 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -110.25 120.97 44.14 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.622 -1.251 . . . . 74.150000000000006 107.622 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.547 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.7 tp10 -134.4 106.6 7.15 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.709 -0.396 . . . . 64.200000000000003 111.402 -175.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.82 -67.39 1.68 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 116.053 -0.521 . . . . 52.229999999999997 113.138 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.5 m -154.91 10.15 0.33 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.257 0.466 . . . . 71.010000000000005 112.257 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.547 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -128.13 140.74 51.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 118.701 -1.2 . . . . 74.409999999999997 111.06 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.0 121.99 46.53 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.307 -0.86 . . . . 75.200000000000003 110.32 175.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.42 130.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.323 -0.399 . . . . 73.439999999999998 110.007 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.535 HG23 HG23 ' A' ' 28' ' ' THR . 49.8 t -110.06 125.19 67.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.243 -0.435 . . . . 73.329999999999998 109.912 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 HD12 HD13 ' B' ' 29' ' ' ILE . 70.6 mt -101.19 122.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 108.561 -0.903 . . . . 63.439999999999998 108.561 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 75.8 m-85 -104.39 119.08 38.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.608 -1.256 . . . . 71.019999999999996 107.608 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.48 113.97 25.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 107.641 -1.244 . . . . 70.430000000000007 107.641 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -119.75 -177.7 3.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.89 -0.596 . . . . 74.540000000000006 110.674 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -97.26 -20.55 17.82 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.474 0.546 . . . . 74.019999999999996 112.474 -177.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 45.6 ttp180 -91.34 -29.27 17.22 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.773 0.797 . . . . 73.120000000000005 109.996 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 178.82 -121.79 0.77 Allowed Glycine 0 C--N 1.293 -1.825 0 C-N-CA 119.18 -1.486 . . . . 71.120000000000005 113.276 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.7 tp -137.61 147.05 44.68 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.085 -0.709 . . . . 71.329999999999998 109.085 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.0 tptm -139.42 129.24 24.78 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.208 -1.405 . . . . 73.230000000000004 107.208 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 11.4 p -131.13 140.99 47.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.97 -0.382 . . . . 74.019999999999996 109.97 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.5 m -119.85 137.91 53.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.314 -0.403 . . . . 71.129999999999995 110.707 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.33 124.73 47.34 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.286 0.565 . . . . 73.519999999999996 110.554 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.65 104.02 55.31 Favored Pre-proline 0 C--N 1.278 -2.507 0 N-CA-C 107.315 -1.365 . . . . 71.420000000000002 107.315 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -95.39 133.46 0.56 Allowed 'Trans proline' 0 N--CA 1.409 -3.497 0 C-N-CA 120.846 1.031 . . . . 70.239999999999995 114.076 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 C--N 1.311 -1.083 0 C-N-CA 126.101 1.76 . . . . 71.040000000000006 114.339 167.486 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 CA--C 1.481 -1.709 0 N-CA-C 107.158 -1.423 . . . . 72.230000000000004 107.158 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.435 ' HB ' HD11 ' A' ' 14' ' ' LEU . 8.6 m -102.54 142.98 32.83 Favored 'General case' 0 N--CA 1.382 -3.834 0 N-CA-C 107.041 -1.466 . . . . 62.43 107.041 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 73.3 m -134.46 148.36 50.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.805 -1.183 . . . . 70.409999999999997 107.805 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.66 156.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 123.903 0.752 . . . . 75.200000000000003 109.344 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -130.69 145.82 52.02 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.752 -0.462 . . . . 54.43 109.752 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.555 HD12 ' OG1' ' A' ' 10' ' ' THR . 4.2 pp -130.04 134.98 47.76 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 109.062 -0.718 . . . . 74.549999999999997 109.062 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 34.0 p -106.73 141.79 37.41 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 120.414 -0.514 . . . . 73.510000000000005 110.726 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -157.41 -171.47 3.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.81 -1.182 . . . . 75.209999999999994 107.81 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -69.08 104.41 2.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.888 0.851 . . . . 53.439999999999998 109.91 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -125.95 148.08 49.33 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.085 -0.961 . . . . 73.040000000000006 111.405 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.471 ' H ' HD22 ' B' ' 19' ' ' LEU . 2.0 pt? -103.52 152.88 38.88 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.067 -1.086 . . . . 64.439999999999998 108.067 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.56 136.45 54.46 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.048 1.832 . . . . 61.039999999999999 111.788 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.93 149.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 108.351 -0.981 . . . . 74.510000000000005 108.351 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -79.53 -41.29 27.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.828 0.347 . . . . 73.310000000000002 111.431 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -125.23 134.15 52.44 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.319 -0.238 . . . . 71.439999999999998 110.662 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.16 119.92 20.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 107.712 -1.218 . . . . 73.219999999999999 107.712 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -91.29 139.12 31.04 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.997 -0.681 . . . . 72.319999999999993 110.368 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.1 p -120.37 127.56 52.42 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.87 -0.789 . . . . 72.319999999999993 108.87 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -126.84 126.65 43.7 Favored 'General case' 0 CA--C 1.458 -2.593 0 CA-C-N 116.022 -0.536 . . . . 73.319999999999993 110.154 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.51 HG22 HG22 ' B' ' 37' ' ' VAL . 53.0 p -115.9 127.46 55.01 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.549 -0.75 . . . . 74.019999999999996 111.056 -176.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.425 HD13 HD12 ' A' ' 38' ' ' ILE . 54.9 mt -121.12 121.27 64.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.098 -0.704 . . . . 63.450000000000003 109.098 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 9.2 t -112.39 115.92 29.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.528 -0.916 . . . . 75.209999999999994 108.528 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.463 ' O ' HD21 ' B' ' 34' ' ' LEU . 9.2 tp10 -120.71 97.6 5.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.915 -1.039 . . . . 74.400000000000006 111.048 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -66.12 0.47 Allowed Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.689 -0.687 . . . . 62.32 114.601 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.2 m -145.15 23.83 1.48 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.34 -0.506 . . . . 75.400000000000006 111.688 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.463 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -148.49 134.92 19.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 119.049 -1.06 . . . . 71.140000000000001 111.767 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 8.6 tpp180 -101.44 114.08 27.76 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.111 -1.404 . . . . 71.310000000000002 108.559 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.65 133.36 51.43 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.584 -0.525 . . . . 71.439999999999998 109.584 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.51 HG22 HG22 ' B' ' 28' ' ' THR . 48.2 t -118.85 127.0 75.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.738 0.304 . . . . 74.219999999999999 110.967 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.47 HD11 HD13 ' A' ' 29' ' ' ILE . 73.5 mt -102.77 121.87 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 C-N-CA 123.946 0.898 . . . . 75.219999999999999 109.039 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.41 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 93.7 m-85 -103.86 114.3 28.46 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.309 -0.997 . . . . 74.219999999999999 108.309 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 51.1 mm -88.44 112.61 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 106.697 -1.594 . . . . 75.040000000000006 106.697 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -121.13 -179.57 4.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 116.424 -0.353 . . . . 74.109999999999999 110.181 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -95.93 -17.8 20.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.902 0.382 . . . . 73.239999999999995 111.145 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 73.6 ttt180 -98.83 -17.92 18.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.128 0.49 . . . . 75.409999999999997 109.842 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.51 -143.07 5.51 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.027 -1.082 . . . . 61.520000000000003 113.37 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.51 ' HB3' ' CD1' ' B' ' 14' ' ' LEU . 1.9 tm? -139.38 122.86 17.25 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 124.673 1.189 . . . . 74.219999999999999 108.04 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -118.53 143.68 46.58 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.961 0.41 . . . . 71.329999999999998 110.977 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.57 141.25 46.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.62 -0.718 . . . . 74.420000000000002 110.559 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.41 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 62.3 m -127.69 142.17 51.41 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.118 -0.492 . . . . 63.340000000000003 111.045 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.04 124.01 48.25 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.187 -0.461 . . . . 37.75 110.202 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 24.2 t70 -118.15 88.09 31.15 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 107.552 -1.277 . . . . 73.140000000000001 107.552 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 85.9 Cg_endo . . . . . 0 N--CA 1.42 -2.851 0 C-N-CA 121.64 1.56 . . . . 73.409999999999997 114.034 -173.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.659 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 6.1 ppt_? . . . . . 0 N--CA 1.425 -1.701 0 N-CA-C 108.759 -0.83 . . . . 71.439999999999998 108.759 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.442 ' CB ' HD12 ' B' ' 14' ' ' LEU . 18.9 p -101.57 148.62 25.01 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 122.112 -0.368 . . . . 74.010000000000005 110.959 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.1 m -136.49 157.35 46.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.008 0.432 . . . . 74.409999999999997 111.021 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.453 HG23 HD11 ' B' ' 14' ' ' LEU . 86.5 t -130.77 134.71 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.58 -0.737 . . . . 75.420000000000002 110.776 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -117.93 125.62 50.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.522 -0.547 . . . . 61.32 109.522 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.97 121.77 27.2 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 123.311 0.644 . . . . 72.150000000000006 109.817 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 p -125.17 112.79 16.86 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.228 -0.442 . . . . 64.420000000000002 111.753 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.538 HG23 ' H ' ' A' ' 17' ' ' GLN . 4.2 t -156.52 -92.07 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.265 1.209 . . . . 74.209999999999994 114.265 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.538 ' H ' HG23 ' A' ' 16' ' ' THR . 26.7 tp60 -94.07 91.68 6.95 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.659 0.742 . . . . 74.140000000000001 109.198 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.511 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 2.5 ppt_? -126.72 149.25 49.68 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.479 -0.782 . . . . 75.140000000000001 112.776 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 19' ' ' LEU . 2.2 pt? -110.33 155.19 42.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.283 -1.006 . . . . 70.430000000000007 108.283 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.84 136.64 49.93 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.874 1.716 . . . . 50.039999999999999 110.986 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.04 144.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.405 -0.816 . . . . 72.519999999999996 109.295 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.8 m -87.09 -35.41 18.71 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.259 0.552 . . . . 75.530000000000001 111.32 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -123.25 133.14 54.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.782 -0.645 . . . . 61.310000000000002 110.976 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.16 115.63 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 107.164 -1.421 . . . . 73.129999999999995 107.164 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.1 mmtp -99.35 134.95 41.48 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 120.372 -0.531 . . . . 75.530000000000001 110.859 -176.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -114.33 127.16 55.72 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.893 -1.151 . . . . 72.340000000000003 107.893 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -120.25 130.39 54.49 Favored 'General case' 0 CA--C 1.457 -2.599 0 CA-C-N 116.224 -0.444 . . . . 75.319999999999993 109.992 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 37' ' ' VAL . 68.4 p -114.68 122.59 46.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 119.766 -0.773 . . . . 74.239999999999995 111.183 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.496 HD13 HD11 ' B' ' 38' ' ' ILE . 89.5 mt -115.82 124.67 72.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.628 -0.878 . . . . 64.129999999999995 108.628 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -117.02 116.18 26.86 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.117 0.96 . . . . 72.140000000000001 108.794 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.584 ' O ' HD21 ' A' ' 34' ' ' LEU . 15.3 tp10 -136.96 123.18 20.51 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.284 -0.871 . . . . 74.019999999999996 110.388 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.81 -84.99 0.37 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.21 -0.756 . . . . 72.140000000000001 111.21 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 m -150.47 10.56 0.66 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 122.726 -0.279 . . . . 74.420000000000002 111.06 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.584 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -114.81 140.21 49.11 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 119.193 -1.003 . . . . 73.409999999999997 111.584 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -100.08 118.05 35.62 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.112 -0.949 . . . . 62.210000000000001 108.781 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.07 116.18 31.48 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.471 -0.566 . . . . 70.430000000000007 109.471 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.504 HG23 HG23 ' A' ' 28' ' ' THR . 60.1 t -108.48 120.7 60.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.167 0.508 . . . . 71.340000000000003 110.179 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.49 HD12 HD13 ' B' ' 29' ' ' ILE . 95.0 mt -101.34 124.7 55.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 115.147 -0.933 . . . . 64.319999999999993 108.721 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -106.92 115.14 29.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.378 -0.971 . . . . 63.109999999999999 108.378 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.533 HD11 HD21 ' B' ' 34' ' ' LEU . 37.3 mm -90.69 114.53 28.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.326 -1.361 . . . . 72.430000000000007 107.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -129.47 156.46 44.08 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 120.543 -0.463 . . . . 73.239999999999995 110.609 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -67.4 -13.74 62.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.447 0.699 . . . . 73.420000000000002 110.793 -178.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -87.18 -22.56 25.21 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.724 -0.473 . . . . 70.209999999999994 109.724 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.17 -138.02 6.5 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.259 -0.972 . . . . 72.019999999999996 113.629 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -113.37 128.59 56.51 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.159 0.504 . . . . 72.329999999999998 110.597 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 54.4 tptt -137.1 127.96 27.34 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.454 -1.313 . . . . 73.329999999999998 107.454 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.1 139.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 110.599 -0.149 . . . . 71.25 110.599 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.4 137.71 54.02 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.621 0.248 . . . . 70.409999999999997 110.446 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.79 43.07 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.411 -0.359 . . . . 43.350000000000001 110.245 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -115.0 104.62 53.89 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.334 -0.848 . . . . 74.120000000000005 109.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -94.73 134.72 0.72 Allowed 'Trans proline' 0 N--CA 1.427 -2.408 0 C-N-CA 121.712 1.608 . . . . 72.099999999999994 114.641 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 126.446 1.898 . . . . 75.439999999999998 115.546 170.031 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.489 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 69.2 mtt180 . . . . . 0 N--CA 1.433 -1.29 0 N-CA-C 108.003 -1.11 . . . . 75.219999999999999 108.003 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -87.8 143.42 27.15 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.168 -0.924 . . . . 71.340000000000003 112.378 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 66.8 m -141.51 149.45 40.88 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.114 -1.069 . . . . 53.240000000000002 108.114 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.58 146.21 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 110.339 -0.245 . . . . 62.140000000000001 110.339 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 22.5 p -107.26 135.51 48.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.214 0.606 . . . . 70.150000000000006 110.767 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.464 HD13 HD13 ' B' ' 45' ' ' LEU . 96.7 mt -116.73 130.59 56.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.122 -0.49 . . . . 73.450000000000003 110.642 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -101.66 122.67 44.32 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.871 -0.789 . . . . 54.310000000000002 108.871 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.7 t -151.27 -174.96 4.98 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 120.725 0.298 . . . . 75.129999999999995 110.58 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -72.06 86.42 1.03 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.522 0.729 . . . . 75.219999999999999 109.947 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -126.52 149.24 49.49 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 114.204 1.187 . . . . 71.349999999999994 114.204 -179.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -78.5 134.73 61.56 Favored Pre-proline 0 C--N 1.29 -1.996 0 CA-C-N 114.944 -1.025 . . . . 73.099999999999994 109.361 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.96 136.33 34.85 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.093 1.862 . . . . 54.530000000000001 111.468 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' B' ' 42' ' ' LYS . 10.9 p -131.29 133.27 62.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.372 -0.831 . . . . 71.150000000000006 108.912 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.4 m -84.79 -13.43 51.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.084 0.468 . . . . 73.150000000000006 111.928 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.408 ' H ' HG23 ' B' ' 21' ' ' VAL . 30.5 mmm180 -105.94 133.83 50.04 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.812 -0.81 . . . . 75.219999999999999 108.812 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -94.29 115.39 32.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.591 -0.892 . . . . 75.409999999999997 108.591 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.65 128.72 39.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.905 -0.588 . . . . 71.430000000000007 110.39 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.2 p -110.63 127.98 55.49 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.457 -0.792 . . . . 73.049999999999997 109.951 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -126.19 127.44 45.7 Favored 'General case' 0 CA--C 1.459 -2.549 0 CA-C-N 115.887 -0.597 . . . . 74.450000000000003 110.674 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.506 HG22 HG22 ' B' ' 37' ' ' VAL . 78.0 p -115.14 139.54 49.83 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.942 -1.026 . . . . 72.230000000000004 110.802 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.49 HD13 HD12 ' A' ' 38' ' ' ILE . 49.4 mt -136.89 133.84 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.674 -0.491 . . . . 74.200000000000003 109.674 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -117.47 131.91 56.65 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.636 -0.505 . . . . 72.140000000000001 109.636 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.408 ' OE1' ' HG3' ' A' ' 25' ' ' LYS . 10.9 tp10 -142.43 114.77 8.38 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.636 -0.711 . . . . 73.510000000000005 109.788 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -76.73 0.86 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.118 -0.793 . . . . 72.140000000000001 111.118 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 39.8 m -156.92 10.52 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.625 -1.25 . . . . 71.310000000000002 107.625 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.533 HD21 HD11 ' A' ' 40' ' ' ILE . 45.5 tp -95.52 115.67 27.76 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 115.28 -0.873 . . . . 72.319999999999993 108.871 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -107.12 113.54 27.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.983 -1.118 . . . . 71.299999999999997 107.983 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.45 34.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.882 -0.414 . . . . 71.099999999999994 109.882 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.506 HG22 HG22 ' B' ' 28' ' ' THR . 67.1 t -129.0 129.97 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.849 -0.426 . . . . 65.230000000000004 109.849 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.496 HD11 HD13 ' A' ' 29' ' ' ILE . 80.1 mt -114.78 125.15 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 109.09 -0.707 . . . . 63.210000000000001 109.09 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 64.6 m-85 -106.84 116.68 32.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.534 -1.284 . . . . 74.319999999999993 107.534 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.17 114.28 26.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 105.922 -1.881 . . . . 63.539999999999999 105.922 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -125.6 156.74 38.68 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.117 0.484 . . . . 70.140000000000001 110.593 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' B' ' 21' ' ' VAL . 0.1 OUTLIER -60.03 -25.91 65.69 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.47 -0.786 . . . . 72.239999999999995 112.435 -177.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -97.1 -8.29 30.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.515 -0.474 . . . . 73.519999999999996 111.528 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.0 -153.88 24.79 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 118.305 -1.902 . . . . 70.450000000000003 114.547 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.464 HD13 HD13 ' B' ' 14' ' ' LEU . 3.2 tm? -113.66 122.28 46.69 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.19 -1.041 . . . . 64.129999999999995 108.19 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.51 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 56.9 tptt -117.38 122.13 42.98 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.004 -1.11 . . . . 64.030000000000001 108.004 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 11.1 p -115.42 139.7 40.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 110.338 -0.245 . . . . 74.540000000000006 110.338 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.28 140.44 52.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.127 -0.488 . . . . 60.43 111.585 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.57 124.16 48.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 108.817 -0.809 . . . . 64.150000000000006 108.817 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.489 ' OD2' ' HD3' ' B' ' 9' ' ' ARG . 15.1 t70 -119.07 95.23 49.18 Favored Pre-proline 0 C--N 1.284 -2.249 0 N-CA-C 104.875 -2.268 . . . . 70.120000000000005 104.875 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo . . . . . 0 N--CA 1.429 -2.275 0 C-N-CA 121.935 1.757 . . . . 71.129999999999995 116.357 -171.194 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 50' ' ' ASP . 18.0 ptt180 . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 121.635 0.731 . . . . 74.019999999999996 110.892 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -96.97 148.83 22.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.931 -1.032 . . . . 74.420000000000002 111.945 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -127.21 156.23 42.16 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.396 -0.964 . . . . 52.210000000000001 108.396 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.48 ' CG2' HD21 ' B' ' 14' ' ' LEU . 94.2 t -134.49 140.76 45.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.663 0.268 . . . . 61.509999999999998 110.661 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 p -109.83 125.83 53.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.44 -0.948 . . . . 71.510000000000005 108.44 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.444 HD12 HD23 ' A' ' 45' ' ' LEU . 86.5 mt -109.57 127.84 54.78 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.018 0.437 . . . . 65.129999999999995 111.987 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.93 114.1 25.79 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.434 -0.95 . . . . 72.010000000000005 108.434 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -143.6 -169.89 3.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.861 -1.163 . . . . 72.140000000000001 107.861 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.65 99.76 1.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 72.109999999999999 109.645 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -125.44 148.38 48.85 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.792 1.034 . . . . 73.040000000000006 113.792 -175.311 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -102.46 161.75 22.32 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 114.094 -1.412 . . . . 73.150000000000006 108.9 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.62 135.98 51.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.587 1.525 . . . . 62.530000000000001 111.647 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.7 t -123.91 124.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.347 -0.982 . . . . 64.010000000000005 108.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.0 m -86.5 -56.39 3.45 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.432 0.53 . . . . 73.319999999999993 112.432 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -93.47 133.39 36.81 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.138 -0.625 . . . . 74.519999999999996 110.109 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -83.27 123.31 38.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.533 -0.914 . . . . 75.340000000000003 108.533 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -106.5 143.01 35.22 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.318 -0.401 . . . . 74.5 110.303 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -119.72 127.69 53.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.684 -0.858 . . . . 75.030000000000001 108.684 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -124.44 130.26 52.15 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-N 115.994 -0.548 . . . . 65.340000000000003 110.806 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.469 HG23 HG23 ' A' ' 37' ' ' VAL . 44.9 p -115.22 125.03 52.87 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.103 -0.953 . . . . 71.099999999999994 112.158 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.47 HD13 HD11 ' B' ' 38' ' ' ILE . 59.5 mt -129.9 128.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.299 -0.63 . . . . 63.520000000000003 109.299 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -119.46 137.16 53.96 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.44 -0.948 . . . . 72.450000000000003 108.44 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.86 111.37 6.23 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.814 0.34 . . . . 73.540000000000006 110.195 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.64 -67.94 3.28 Favored Glycine 0 C--N 1.298 -1.528 0 C-N-CA 120.749 -0.738 . . . . 74.219999999999999 112.572 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.2 m -156.93 -16.21 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.791 0.437 . . . . 52.0 112.063 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.548 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -88.67 140.59 29.3 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 118.468 -1.293 . . . . 64.219999999999999 110.615 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 19.8 mmt180 -103.49 119.37 38.76 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.951 -1.5 . . . . 75.239999999999995 106.951 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.98 124.74 51.95 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.215 -0.661 . . . . 73.109999999999999 109.215 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 28' ' ' THR . 99.1 t -117.02 125.52 73.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.035 0.445 . . . . 71.450000000000003 111.417 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.479 HD12 HD13 ' B' ' 29' ' ' ILE . 92.4 mt -104.59 121.45 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 C-N-CA 124.033 0.933 . . . . 70.049999999999997 109.144 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.0 m-85 -108.54 117.15 33.42 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.767 -1.197 . . . . 71.540000000000006 107.767 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.473 HG23 HD23 ' B' ' 34' ' ' LEU . 45.9 mm -88.41 118.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.674 -0.861 . . . . 75.200000000000003 108.674 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -134.59 171.95 13.61 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.5 0.667 . . . . 75.140000000000001 110.402 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -77.21 -15.38 59.51 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.879 0.872 . . . . 75.040000000000006 110.419 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -87.88 10.42 18.71 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.162 -1.422 . . . . 73.109999999999999 107.162 -177.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -124.73 8.0 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.626 -1.17 . . . . 74.299999999999997 112.549 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.444 HD23 HD12 ' A' ' 14' ' ' LEU . 64.4 tp -112.26 135.04 53.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.865 -0.421 . . . . 74.010000000000005 109.865 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.507 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 1.5 tmtm? -128.85 122.4 30.32 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.158 -2.164 . . . . 62.43 105.158 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.449 HG11 HG13 ' B' ' 47' ' ' VAL . 13.6 p -128.29 140.96 47.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 110.171 -0.307 . . . . 72.409999999999997 110.171 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.507 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 93.7 m -121.07 143.12 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 122.319 0.248 . . . . 71.310000000000002 111.035 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.45 123.85 48.51 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.044 -0.724 . . . . 64.340000000000003 109.044 177.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 18.5 t70 -124.25 100.53 35.76 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 107.693 -1.225 . . . . 73.140000000000001 107.693 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.13 134.19 4.27 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 122.067 1.845 . . . . 37.299999999999997 115.143 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.47 ' NE2' ' HG3' ' B' ' 17' ' ' GLN . 49.9 mt-30 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 113.916 -1.493 . . . . 71.439999999999998 112.006 169.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 109.292 -0.632 . . . . 65.340000000000003 109.292 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.8 p -92.45 145.65 24.29 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.311 -0.404 . . . . 73.510000000000005 111.631 -175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.21 149.44 47.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.7 -0.481 . . . . 75.120000000000005 109.7 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -142.74 148.73 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.915 0.486 . . . . 73.430000000000007 110.147 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 60.5 p -110.62 146.21 36.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 122.482 0.313 . . . . 64.040000000000006 110.343 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.48 HD21 ' CG2' ' A' ' 12' ' ' VAL . 96.2 mt -125.74 125.74 43.47 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 123.053 0.541 . . . . 65.439999999999998 111.079 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.7 p -104.69 114.31 28.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.939 -0.763 . . . . 71.010000000000005 108.939 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -166.75 120.19 1.03 Allowed 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.225 0.328 . . . . 73.239999999999995 110.671 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . 0.47 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 6.6 tp-100 34.89 72.55 0.09 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.04 1.736 . . . . 64.519999999999996 112.252 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.638 ' NH2' HG21 ' B' ' 21' ' ' VAL . 24.5 tpt180 -126.11 109.98 13.0 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 119.673 -0.811 . . . . 74.099999999999994 112.512 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.23 153.88 88.28 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 114.368 -1.287 . . . . 50.130000000000003 112.313 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.16 135.63 65.16 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.52 2.813 . . . . 72.150000000000006 114.2 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.638 HG21 ' NH2' ' B' ' 18' ' ' ARG . 55.9 t -132.11 137.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.268 -1.333 . . . . 74.409999999999997 107.998 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 38.3 m -92.56 -26.94 17.67 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.467 0.914 . . . . 74.239999999999995 113.467 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -127.69 154.61 45.1 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.36 0.504 . . . . 70.129999999999995 112.36 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.94 132.75 47.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.76 -0.459 . . . . 50.219999999999999 109.76 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.441 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 39.8 mmtm -106.27 159.72 15.9 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.638 -0.425 . . . . 64.120000000000005 110.028 177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -133.67 126.41 30.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.038 -1.097 . . . . 72.409999999999997 108.038 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 74.3 m-85 -126.57 128.6 47.08 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.48 -0.327 . . . . 61.450000000000003 110.795 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.489 HG22 HG22 ' B' ' 37' ' ' VAL . 62.2 p -115.93 135.66 53.77 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.858 0.724 . . . . 74.340000000000003 111.3 -176.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.479 HD13 HD12 ' A' ' 38' ' ' ILE . 58.4 mt -131.13 127.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 109.937 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.404 ' HB ' ' NE ' ' B' ' 35' ' ' ARG . 11.5 t -104.35 123.99 48.39 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.226 0.536 . . . . 73.310000000000002 109.682 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.626 ' O ' HD21 ' B' ' 34' ' ' LEU . 10.6 tp10 -142.88 123.55 14.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.65 -0.5 . . . . 73.299999999999997 109.65 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.08 -77.71 0.3 Allowed Glycine 0 C--O 1.217 -0.938 0 N-CA-C 111.208 -0.757 . . . . 64.329999999999998 111.208 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 69.4 m -157.65 -0.22 0.11 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.838 0.855 . . . . 54.420000000000002 110.847 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.626 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -101.34 137.84 39.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.422 -1.311 . . . . 54.439999999999998 110.106 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 38.3 mmm-85 -100.92 122.82 44.14 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.285 -1.376 . . . . 70.219999999999999 107.285 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.87 117.77 35.12 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.949 -1.13 . . . . 55.009999999999998 107.949 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.489 HG22 HG22 ' B' ' 28' ' ' THR . 58.0 t -110.29 128.05 66.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.37 0.605 . . . . 72.439999999999998 110.308 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.47 HD11 HD13 ' A' ' 29' ' ' ILE . 85.3 mt -111.55 120.08 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.908 -1.042 . . . . 64.120000000000005 109.257 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 95.8 m-85 -102.65 116.43 32.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.965 -1.124 . . . . 75.019999999999996 107.965 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.497 HD11 HD23 ' A' ' 34' ' ' LEU . 49.7 mm -88.47 114.03 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.28 -1.007 . . . . 63.240000000000002 108.28 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 t -127.3 169.47 13.51 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 115.623 -0.717 . . . . 70.200000000000003 109.729 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -83.0 -13.48 55.87 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.746 -0.465 . . . . 73.549999999999997 109.746 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.657 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.5 tmt_? -87.68 3.17 48.92 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.317 1.056 . . . . 72.140000000000001 108.6 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.431 ' HA2' ' HG2' ' B' ' 18' ' ' ARG . . . 128.17 -138.42 10.37 Favored Glycine 0 CA--C 1.504 -0.608 0 CA-C-N 115.26 -0.882 . . . . 75.420000000000002 113.087 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 68.1 tp -112.24 126.05 54.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.733 -0.84 . . . . 74.209999999999994 108.733 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.52 ' HE3' ' SG ' ' B' ' 48' ' ' CYS . 1.8 tmtm? -116.78 121.13 40.69 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.526 -2.027 . . . . 73.049999999999997 105.526 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.449 HG13 HG11 ' A' ' 47' ' ' VAL . 14.0 p -116.58 140.84 37.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 116.639 -0.255 . . . . 72.310000000000002 110.722 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.52 ' SG ' ' HE3' ' B' ' 46' ' ' LYS . 68.4 m -130.41 140.78 50.56 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.656 0.382 . . . . 73.510000000000005 111.237 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.4 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . . . -116.2 123.25 47.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.564 -0.902 . . . . 73.329999999999998 108.564 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 13.7 t70 -122.42 103.0 38.83 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.877 -1.157 . . . . 71.209999999999994 107.877 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 N--CA 1.434 -1.976 0 C-N-CA 122.263 1.975 . . . . 74.450000000000003 116.549 -173.911 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 108.315 -0.994 . . . . 73.310000000000002 108.315 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -87.73 135.65 33.28 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.822 -0.627 . . . . 53.200000000000003 111.406 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.6 m -130.38 148.45 52.2 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.201 -0.666 . . . . 53.310000000000002 109.201 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.9 t -144.66 141.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.473 -0.331 . . . . 62.119999999999997 110.174 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 p -109.24 130.71 55.49 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.21 0.528 . . . . 73.319999999999993 109.896 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.73 120.33 40.18 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.448 -1.686 . . . . 74.530000000000001 106.448 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.5 m -97.26 111.71 23.83 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.831 -1.544 . . . . 65.140000000000001 106.831 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.473 ' OG1' ' HG3' ' B' ' 51' ' ' PRO . 8.6 t -133.47 154.11 51.07 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.206 -0.907 . . . . 72.420000000000002 110.199 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -72.4 99.44 2.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.888 0.852 . . . . 65.099999999999994 110.383 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.507 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -126.71 148.47 49.86 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.079 -1.452 . . . . 53.240000000000002 107.079 178.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.549 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.4 pt? -73.19 127.71 88.78 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.191 -1.041 . . . . 74.129999999999995 108.191 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.86 152.91 60.52 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 123.904 3.07 . . . . 72.420000000000002 116.772 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 13.1 p -131.82 149.18 32.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.298 -1.774 . . . . 74.0 106.908 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.6 m -102.1 16.24 26.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.751 -0.38 . . . . 74.230000000000004 111.53 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -134.0 152.79 51.99 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 122.196 -0.315 . . . . 71.150000000000006 110.795 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -101.72 132.12 48.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.955 -0.757 . . . . 73.120000000000005 108.955 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -121.65 126.28 48.63 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.602 -0.888 . . . . 74.510000000000005 108.602 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -106.38 127.75 53.51 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.092 -0.707 . . . . 72.349999999999994 109.092 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -123.89 126.58 46.64 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.123 -0.489 . . . . 61.030000000000001 110.865 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.506 HG23 HG23 ' A' ' 37' ' ' VAL . 81.6 p -115.04 131.42 56.93 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.213 -0.903 . . . . 74.120000000000005 111.106 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.468 HD13 HD11 ' B' ' 38' ' ' ILE . 52.8 mt -128.63 121.54 55.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.173 -0.677 . . . . 72.030000000000001 109.173 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -111.48 128.26 55.95 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.737 -1.208 . . . . 71.540000000000006 107.737 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' O ' HD21 ' A' ' 34' ' ' LEU . 9.3 tp10 -140.4 119.44 12.73 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.145 -176.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.91 -86.76 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 116.164 -0.471 . . . . 73.340000000000003 112.937 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.463 ' CB ' HD22 ' B' ' 19' ' ' LEU . 40.5 m -142.58 15.34 1.98 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.012 0.434 . . . . 74.5 110.446 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.463 HD23 HG22 ' B' ' 40' ' ' ILE . 2.0 pt? -127.35 141.35 51.72 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.552 -0.459 . . . . 74.510000000000005 109.841 176.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -122.14 131.82 54.15 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.685 -0.689 . . . . 54.149999999999999 110.169 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.47 143.88 49.0 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.248 -0.433 . . . . 63.340000000000003 110.435 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.506 HG23 HG23 ' A' ' 28' ' ' THR . 96.6 t -124.85 127.05 72.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.067 -0.515 . . . . 72.530000000000001 110.986 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.423 HD12 HD13 ' B' ' 29' ' ' ILE . 75.8 mt -103.43 122.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 C-N-CA 123.984 0.914 . . . . 71.519999999999996 109.174 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.9 m-85 -106.1 114.8 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.427 -0.953 . . . . 75.510000000000005 108.427 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.429 HG23 HD23 ' B' ' 34' ' ' LEU . 42.0 mm -88.51 114.67 27.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.416 -0.811 . . . . 73.540000000000006 108.834 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -126.96 162.05 26.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.662 -0.699 . . . . 62.200000000000003 109.405 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HE2' ' N ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -71.11 -0.69 10.18 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 121.037 0.446 . . . . 75.420000000000002 112.087 173.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -87.69 -22.07 24.86 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.304 -0.998 . . . . 73.299999999999997 108.304 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.507 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 133.77 -119.93 2.4 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.849 -1.068 . . . . 61.229999999999997 110.844 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.4 tp -115.51 143.88 44.67 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 115.236 -0.482 . . . . 74.230000000000004 111.18 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -140.87 139.56 34.43 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.949 -0.76 . . . . 55.210000000000001 108.949 170.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.01 141.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 116.332 -0.394 . . . . 75.530000000000001 111.134 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.413 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 49.5 m -120.2 139.29 52.87 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.979 -0.555 . . . . 63.039999999999999 110.684 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.53 125.28 51.67 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.001 -0.545 . . . . 74.400000000000006 110.448 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -124.43 108.92 29.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.046 -0.525 . . . . 74.319999999999993 109.833 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HB3' ' NE ' ' B' ' 18' ' ' ARG . 73.6 Cg_endo -94.22 134.26 0.82 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 121.786 1.657 . . . . 70.140000000000001 114.99 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 . . . . . 0 CA--C 1.556 1.185 0 CA-C-N 114.049 -1.432 . . . . 74.239999999999995 114.065 165.616 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 . . . . . 0 C--O 1.237 0.419 0 N-CA-C 110.241 -0.281 . . . . 74.400000000000006 110.241 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -87.77 128.74 35.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 110.267 -0.272 . . . . 52.140000000000001 110.267 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 82.2 m -129.88 149.37 51.65 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.831 -0.433 . . . . 74.120000000000005 109.831 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.2 t -144.14 138.57 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.47 0.481 . . . . 73.340000000000003 110.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -107.58 129.01 55.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.311 0.577 . . . . 60.210000000000001 111.499 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.82 121.67 44.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.387 -0.824 . . . . 70.109999999999999 109.754 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 18.0 m -106.82 116.19 31.49 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 108.056 -1.091 . . . . 74.129999999999995 108.056 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -138.68 -169.76 2.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.287 -0.87 . . . . 72.219999999999999 108.763 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -74.12 93.7 2.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.607 -0.886 . . . . 61.119999999999997 108.607 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.507 ' NE ' ' HB3' ' A' ' 51' ' ' PRO . 8.5 tpp85 -127.51 133.94 49.81 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.696 -0.853 . . . . 74.049999999999997 108.696 -177.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.463 HD22 ' CB ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -74.95 162.63 72.68 Favored Pre-proline 0 C--N 1.294 -1.832 0 CA-C-N 116.232 -0.44 . . . . 71.409999999999997 111.705 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 36.0 Cg_endo -66.73 147.95 82.07 Favored 'Trans proline' 0 C--O 1.254 1.32 0 C-N-CA 122.123 1.882 . . . . 71.340000000000003 112.17 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -125.78 146.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.244 -1.021 . . . . 70.430000000000007 108.244 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 m -67.73 -53.15 29.77 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 123.104 0.253 . . . . 62.229999999999997 111.574 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -125.36 151.31 46.27 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 110.018 -0.364 . . . . 73.319999999999993 110.018 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.75 114.58 23.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.762 -1.199 . . . . 62.240000000000002 107.762 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.15 148.19 22.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.587 -0.523 . . . . 71.219999999999999 109.587 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.7 m -128.46 127.54 42.68 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.075 -1.083 . . . . 74.140000000000001 108.075 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -123.59 127.14 47.86 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-O 121.046 0.45 . . . . 74.540000000000006 111.296 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.532 HG22 HG22 ' B' ' 37' ' ' VAL . 76.7 p -114.52 132.99 56.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 114.879 -1.055 . . . . 75.540000000000006 110.02 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.423 HD13 HD12 ' A' ' 38' ' ' ILE . 51.2 mt -129.51 120.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 109.285 -0.635 . . . . 63.420000000000002 109.285 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 7.2 t -100.12 124.66 45.77 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.908 -1.145 . . . . 75.129999999999995 107.908 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.434 ' O ' HD21 ' B' ' 34' ' ' LEU . 9.0 tp10 -142.41 101.0 3.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.92 -0.582 . . . . 75.120000000000005 112.353 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.85 -67.65 0.45 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 116.071 1.188 . . . . 72.310000000000002 116.071 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 42.1 m -137.8 -3.38 1.85 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.458 0.54 . . . . 73.099999999999994 112.458 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.434 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.3 pt? -140.65 141.09 35.09 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 120.235 -0.586 . . . . 72.319999999999993 109.883 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -109.48 125.42 52.44 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 119.558 -0.857 . . . . 71.25 108.885 171.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.27 145.0 30.86 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.564 -0.289 . . . . 71.450000000000003 110.777 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.532 HG22 HG22 ' B' ' 28' ' ' THR . 95.0 t -124.05 128.18 73.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.888 -0.596 . . . . 72.209999999999994 110.725 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.468 HD11 HD13 ' A' ' 29' ' ' ILE . 68.9 mt -108.36 123.78 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 C-N-CA 124.334 1.054 . . . . 75.219999999999999 109.454 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.441 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 99.1 m-85 -103.29 120.19 40.29 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.859 -0.793 . . . . 75.450000000000003 108.859 175.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.463 HG22 HD23 ' A' ' 34' ' ' LEU . 39.7 mm -87.73 114.47 26.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 107.688 -1.227 . . . . 62.43 107.688 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -135.34 154.97 51.33 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.917 -0.583 . . . . 75.540000000000006 111.263 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.575 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -71.77 -14.7 62.07 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.972 -0.558 . . . . 71.0 111.219 177.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' B' ' 15' ' ' THR . 54.0 mtp180 -86.34 -16.19 38.2 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.536 0.684 . . . . 73.340000000000003 109.366 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.16 -108.16 0.44 Allowed Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 119.916 -1.135 . . . . 41.43 112.67 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.433 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 53.0 tp -139.36 143.7 37.87 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.833 -0.684 . . . . 64.329999999999998 109.47 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -131.5 140.46 49.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.262 -1.014 . . . . 75.329999999999998 108.262 167.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.7 140.48 48.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.719 -0.673 . . . . 63.399999999999999 110.209 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.453 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 36.5 m -127.58 141.11 51.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.88 -0.6 . . . . 73.25 110.967 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.38 124.39 49.93 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.899 -0.591 . . . . 71.420000000000002 110.308 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -110.72 95.91 25.87 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.014 -1.106 . . . . 53.520000000000003 108.014 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.473 ' HG3' ' OG1' ' A' ' 16' ' ' THR . 93.6 Cg_endo . . . . . 0 N--CA 1.411 -3.361 0 C-N-CA 120.097 0.531 . . . . 74.420000000000002 111.597 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 . . . . . 0 CA--C 1.476 -1.889 0 N-CA-C 107.665 -1.235 . . . . 73.400000000000006 107.665 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -108.04 134.98 50.17 Favored 'General case' 0 C--N 1.272 -2.792 0 C-N-CA 120.077 -0.649 . . . . 70.439999999999998 111.073 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.3 m -125.55 147.56 49.22 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.606 -0.516 . . . . 75.420000000000002 109.606 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -145.99 147.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.721 0.808 . . . . 73.430000000000007 109.741 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 17.9 t -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.222 -0.659 . . . . 73.209999999999994 109.222 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.47 132.39 47.11 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 123.572 0.749 . . . . 74.140000000000001 110.522 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -99.84 110.93 23.28 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.108 0.956 . . . . 75.310000000000002 109.474 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.0 p -140.95 179.81 6.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.082 -0.963 . . . . 75.329999999999998 110.68 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' B' ' 51' ' ' PRO . 22.3 tp60 -67.55 95.8 0.49 Allowed 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.839 -0.8 . . . . 75.409999999999997 108.839 174.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.54 149.37 45.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.826 -0.749 . . . . 73.120000000000005 110.999 -173.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mp -77.04 140.3 66.26 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 106.159 -1.793 . . . . 74.019999999999996 106.159 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.68 134.66 45.05 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.023 1.149 . . . . 72.349999999999994 109.551 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.52 138.87 48.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.8 -0.637 . . . . 73.549999999999997 110.108 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.2 m -90.28 -58.98 2.31 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.184 -0.462 . . . . 74.519999999999996 111.022 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -89.78 133.99 34.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.834 -0.432 . . . . 73.409999999999997 109.834 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.23 122.56 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.637 -0.505 . . . . 65.439999999999998 109.637 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.43 153.94 20.44 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.057 0.456 . . . . 70.430000000000007 110.994 178.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.4 m -132.69 127.97 35.94 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.459 -0.941 . . . . 62.340000000000003 108.459 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -127.35 126.8 43.17 Favored 'General case' 0 CA--C 1.467 -2.245 0 CA-C-N 115.863 -0.608 . . . . 71.040000000000006 110.088 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.494 HG23 HG23 ' A' ' 37' ' ' VAL . 69.2 p -115.82 131.69 56.86 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.317 -0.856 . . . . 74.109999999999999 111.795 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 38' ' ' ILE . 49.4 mt -131.27 124.57 55.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.129 -0.487 . . . . 50.399999999999999 109.867 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -102.45 132.46 48.47 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.46 -0.941 . . . . 74.430000000000007 108.46 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.521 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.5 tp10 -140.25 106.44 5.24 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.271 -0.64 . . . . 64.230000000000004 109.271 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -96.97 0.33 Allowed Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.823 -0.626 . . . . 64.219999999999999 112.289 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -120.34 1.53 10.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 111.983 0.364 . . . . 64.420000000000002 111.983 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.521 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.4 pt? -118.14 140.87 49.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.891 -1.124 . . . . 74.310000000000002 111.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.62 120.94 43.6 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.618 -1.174 . . . . 73.519999999999996 108.114 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.28 128.91 52.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.847 -0.797 . . . . 75.349999999999994 108.847 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 HG23 ' A' ' 28' ' ' THR . 67.1 t -119.1 135.23 60.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.017 0.437 . . . . 71.310000000000002 110.693 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.504 HD12 HD13 ' B' ' 29' ' ' ILE . 72.4 mt -116.14 131.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-N 115.525 -0.761 . . . . 72.400000000000006 109.966 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 99.2 m-85 -115.22 120.61 40.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.387 -0.968 . . . . 74.439999999999998 108.387 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.519 HG13 ' HG2' ' B' ' 31' ' ' GLU . 32.1 mm -92.59 114.88 30.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.065 -1.457 . . . . 75.439999999999998 107.065 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -120.32 178.23 4.73 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.897 -0.592 . . . . 75.450000000000003 111.426 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -71.77 -16.7 62.2 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.559 0.695 . . . . 73.430000000000007 110.112 175.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.562 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 75.9 ttt180 -90.17 -12.62 37.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.718 -1.128 . . . . 63.039999999999999 108.176 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -109.84 1.42 Allowed Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 114.526 -1.215 . . . . 63.219999999999999 112.216 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.408 ' CD2' ' HB3' ' B' ' 49' ' ' ALA . 64.1 tp -113.06 143.78 43.75 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.15 -0.525 . . . . 74.040000000000006 110.26 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 87.2 tttt -141.01 142.85 34.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.041 -0.725 . . . . 72.5 109.041 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.7 140.59 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-N 115.615 -0.72 . . . . 65.040000000000006 109.677 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.4 m -126.76 142.02 51.66 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.561 -0.745 . . . . 74.420000000000002 110.687 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.82 124.78 52.62 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.659 -0.701 . . . . 72.040000000000006 109.574 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -126.3 90.02 50.97 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.479 -0.934 . . . . 72.230000000000004 108.479 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 97.7 Cg_endo -103.13 148.39 0.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 122.952 2.435 . . . . 73.129999999999995 115.045 -177.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.625 ' CD ' ' HG ' ' B' ' 19' ' ' LEU . 17.7 mt-30 . . . . . 0 C--O 1.244 0.789 0 CA-C-N 113.83 -1.532 . . . . 64.439999999999998 114.616 163.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 . . . . . 0 N--CA 1.437 -1.094 0 N-CA-C 109.831 -0.433 . . . . 74.219999999999999 109.831 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -103.25 148.47 25.77 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.177 0.513 . . . . 52.399999999999999 111.469 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 67.9 m -134.61 149.4 50.57 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.906 -1.146 . . . . 73.219999999999999 107.906 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -141.56 143.05 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.192 0.308 . . . . 60.240000000000002 110.253 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 47.1 t -107.26 137.13 45.88 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.806 -0.812 . . . . 62.210000000000001 108.806 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.15 121.47 43.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.394 -0.821 . . . . 72.140000000000001 109.641 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 9.6 p -95.19 111.52 23.35 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.369 -0.974 . . . . 71.310000000000002 108.369 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -126.75 165.62 18.93 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.92 -1.037 . . . . 62.32 109.086 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -70.59 105.84 3.27 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.468 -1.678 . . . . 74.430000000000007 106.468 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.621 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 35.4 mmm-85 -125.98 148.37 49.28 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 117.639 2.459 . . . . 71.230000000000004 117.639 -168.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.625 ' HG ' ' CD ' ' A' ' 52' ' ' GLN . 68.9 mt -84.79 131.61 48.8 Favored Pre-proline 0 C--O 1.255 1.391 0 CA-C-N 112.878 -1.965 . . . . 74.310000000000002 106.469 168.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.56 136.23 41.99 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.909 1.739 . . . . 72.310000000000002 111.626 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 94.7 t -114.03 135.14 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.968 -1.015 . . . . 51.340000000000003 108.452 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -78.18 -22.58 48.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.058 0.762 . . . . 51.130000000000003 113.058 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -127.95 139.44 52.58 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.596 -0.841 . . . . 74.450000000000003 109.61 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.9 138.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.597 -0.52 . . . . 75.099999999999994 109.597 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -118.39 157.18 27.64 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.451 0.643 . . . . 74.209999999999994 112.134 178.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.1 m -133.5 126.4 31.01 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.973 -1.012 . . . . 70.299999999999997 108.952 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -124.77 135.77 53.26 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 116.121 -0.49 . . . . 74.329999999999998 111.43 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.469 HG22 HG22 ' B' ' 37' ' ' VAL . 44.9 p -115.17 128.36 56.13 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.196 -0.911 . . . . 75.219999999999999 111.278 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.504 HD13 HD12 ' A' ' 38' ' ' ILE . 72.0 mt -124.7 127.72 72.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.286 0.634 . . . . 71.099999999999994 109.578 177.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -112.83 128.41 56.44 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 109.515 -0.55 . . . . 75.150000000000006 109.515 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.519 ' HG2' HG13 ' A' ' 40' ' ' ILE . 11.5 tp10 -132.06 97.87 4.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.412 0.625 . . . . 70.239999999999995 110.205 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.49 -74.41 1.08 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 114.742 -1.117 . . . . 71.040000000000006 112.421 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.1 t -144.94 -1.62 0.85 Allowed 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.658 0.742 . . . . 64.239999999999995 109.075 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.468 HD21 HD11 ' A' ' 40' ' ' ILE . 35.5 tp -99.32 118.63 36.4 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 115.89 -0.595 . . . . 74.109999999999999 110.71 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.416 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 21.2 tpp180 -98.86 114.75 27.47 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.513 -0.767 . . . . 72.450000000000003 109.657 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.13 136.26 48.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 110.087 -0.338 . . . . 72.030000000000001 110.087 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.469 HG22 HG22 ' B' ' 28' ' ' THR . 97.0 t -121.52 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.866 0.365 . . . . 74.219999999999999 111.341 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.465 HD11 HD13 ' A' ' 29' ' ' ILE . 82.8 mt -105.73 117.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 C-N-CA 124.586 1.154 . . . . 74.200000000000003 109.175 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.52 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.1 m-85 -102.78 116.22 32.13 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.893 -0.78 . . . . 75.400000000000006 108.893 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mm -89.06 113.54 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.187 -1.412 . . . . 73.400000000000006 107.187 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 39.7 p -115.03 170.17 8.55 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 116.136 -0.484 . . . . 72.200000000000003 110.201 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.547 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -80.48 -19.93 44.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.854 0.359 . . . . 64.099999999999994 111.346 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.547 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 70.2 ttt180 -94.97 -17.49 21.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.59 0.71 . . . . 75.010000000000005 109.905 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.471 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . 164.08 -128.94 1.9 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.427 -1.368 . . . . 55.009999999999998 113.921 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 67.7 tp -130.41 147.36 52.1 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 109.031 -0.729 . . . . 61.520000000000003 109.031 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -139.75 143.16 36.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.148 -0.686 . . . . 73.530000000000001 109.148 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 13.7 p -130.45 140.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.877 -0.602 . . . . 74.420000000000002 109.915 -175.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.52 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.6 m -124.84 138.51 54.26 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.37 -0.377 . . . . 72.400000000000006 110.839 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.408 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . . . -115.86 124.75 51.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.082 -0.508 . . . . 71.140000000000001 112.034 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 18.0 t70 -122.37 95.84 46.64 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 108.636 -0.876 . . . . 63.25 108.636 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.472 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 56.5 Cg_endo . . . . . 0 N--CA 1.411 -3.364 0 C-N-CA 121.456 1.438 . . . . 64.400000000000006 113.48 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 3.8 ppt_? . . . . . 0 N--CA 1.413 -2.315 0 N-CA-C 108.272 -1.01 . . . . 74.230000000000004 108.272 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -94.18 138.97 31.61 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 115.912 -0.586 . . . . 73.519999999999996 111.141 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 79.7 m -137.13 147.6 46.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.454 -0.943 . . . . 62.439999999999998 108.454 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.9 t -144.4 144.42 22.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 123.078 0.236 . . . . 74.120000000000005 110.38 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -107.24 138.26 43.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 109.408 -0.59 . . . . 73.549999999999997 109.408 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mp -114.91 133.67 55.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.467 -0.333 . . . . 70.040000000000006 110.618 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 p -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.599 0.714 . . . . 72.219999999999999 111.319 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -150.05 167.87 25.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.942 -1.503 . . . . 72.319999999999993 106.942 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 100.44 1.46 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 122.368 1.08 . . . . 71.230000000000004 111.905 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -125.64 139.98 53.1 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.108 -0.951 . . . . 71.450000000000003 110.219 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 mm? -74.73 141.73 76.15 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.973 -1.012 . . . . 75.010000000000005 109.067 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.07 135.89 42.38 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.171 1.914 . . . . 73.239999999999995 111.784 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 23' ' ' ARG . 11.6 p -131.98 136.15 57.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.006 -1.109 . . . . 73.409999999999997 108.006 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 m -84.23 2.18 41.13 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.371 0.508 . . . . 73.099999999999994 112.371 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.436 ' H ' HG23 ' A' ' 21' ' ' VAL . 29.0 mmm180 -116.56 155.66 28.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.529 -0.545 . . . . 65.340000000000003 109.529 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.22 114.88 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.035 0 N-CA-C 105.121 -2.177 . . . . 73.040000000000006 105.121 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 25' ' ' LYS . 35.1 tptt -100.74 125.57 47.21 Favored 'General case' 0 N--CA 1.406 -2.645 0 C-N-CA 117.45 -1.7 . . . . 71.219999999999999 108.904 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 31.2 m -109.81 128.41 55.3 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.92 -0.582 . . . . 74.420000000000002 109.975 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -125.76 128.02 47.08 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.954 -0.566 . . . . 72.049999999999997 109.846 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.46 HG23 HG23 ' A' ' 37' ' ' VAL . 79.3 p -115.37 119.02 34.88 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.218 -0.593 . . . . 70.340000000000003 111.914 -175.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.484 HD13 HD11 ' B' ' 38' ' ' ILE . 63.8 mt -120.6 121.42 65.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 109.336 -0.616 . . . . 73.349999999999994 109.336 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.416 ' CB ' HH11 ' A' ' 35' ' ' ARG . 5.7 t -108.49 134.25 51.52 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.449 -0.945 . . . . 74.530000000000001 108.449 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 97.52 3.48 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-O 121.751 0.786 . . . . 73.209999999999994 110.231 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.96 -82.85 1.5 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 114.692 -1.14 . . . . 72.549999999999997 112.123 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -144.34 32.73 1.2 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.139 -1.43 . . . . 74.230000000000004 107.139 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.486 HD21 HD11 ' B' ' 40' ' ' ILE . 33.7 tp -135.76 117.8 15.37 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 115.276 -0.874 . . . . 65.319999999999993 110.694 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.416 HH11 ' CB ' ' A' ' 30' ' ' THR . 30.4 mmt180 -96.79 116.5 29.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.159 -0.682 . . . . 74.25 109.159 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.9 126.88 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.347 -0.612 . . . . 61.240000000000002 109.347 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG23 HG23 ' A' ' 28' ' ' THR . 97.2 t -120.16 126.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.964 0.411 . . . . 63.109999999999999 110.741 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.496 HD12 HD13 ' B' ' 29' ' ' ILE . 80.2 mt -105.41 131.61 54.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.656 -0.702 . . . . 73.150000000000006 109.596 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 95.6 m-85 -115.9 114.88 25.28 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.327 -0.99 . . . . 74.019999999999996 108.327 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.472 HD11 HD21 ' B' ' 34' ' ' LEU . 37.3 mm -89.53 121.4 39.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.665 -1.235 . . . . 75.109999999999999 107.665 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 p -125.52 174.53 8.16 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.535 0.683 . . . . 73.239999999999995 110.942 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.9 -19.86 56.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.676 -1.147 . . . . 71.030000000000001 109.025 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -86.6 -25.73 24.79 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.648 -1.241 . . . . 74.150000000000006 107.648 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -130.92 3.66 Favored Glycine 0 C--N 1.291 -1.948 0 CA-C-N 114.098 -1.41 . . . . 63.310000000000002 112.942 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' B' ' 49' ' ' ALA . 61.5 tp -113.22 137.12 51.94 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.601 -0.518 . . . . 74.329999999999998 109.601 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -134.63 142.36 46.86 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.938 -0.764 . . . . 75.329999999999998 108.938 171.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 7.2 p -131.58 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.999 -0.546 . . . . 74.109999999999999 110.041 -175.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.428 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 52.6 m -123.1 139.41 54.09 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.119 -0.492 . . . . 71.340000000000003 111.045 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.405 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -117.36 124.32 48.62 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.903 -0.777 . . . . 72.439999999999998 108.903 177.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 12.2 t70 -127.58 82.64 67.9 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 106.615 -1.624 . . . . 45.240000000000002 106.615 176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD2' ' OE1' ' B' ' 17' ' ' GLN . 3.3 Cg_exo -76.82 145.67 25.66 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.093 1.862 . . . . 72.219999999999999 112.688 -176.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 125.536 1.534 . . . . 74.040000000000006 114.252 175.477 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 15.8 ptt-85 . . . . . 0 N--CA 1.425 -1.722 0 N-CA-C 108.748 -0.834 . . . . 75.030000000000001 108.748 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -91.81 144.73 25.2 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.839 -0.345 . . . . 73.019999999999996 110.906 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -141.43 149.46 41.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 62.210000000000001 108.595 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 55.3 t -141.85 138.01 31.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.495 -0.321 . . . . 72.25 110.257 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 26.5 p -107.37 125.23 50.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.553 -0.906 . . . . 75.209999999999994 108.553 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.401 ' N ' HD13 ' B' ' 14' ' ' LEU . 4.4 mp -101.61 123.66 45.98 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.047 -0.524 . . . . 65.430000000000007 109.931 -175.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 37.0 p -89.17 112.42 23.42 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.504 -0.554 . . . . 74.409999999999997 109.504 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -141.49 -172.47 3.53 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.551 -0.907 . . . . 73.109999999999999 108.551 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . 0.447 ' OE1' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -79.95 89.26 5.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.285 1.041 . . . . 74.439999999999998 110.934 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -126.34 142.57 51.48 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.418 -0.81 . . . . 70.010000000000005 111.236 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.03 152.09 52.77 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.05 -0.977 . . . . 62.530000000000001 108.628 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.94 145.81 86.4 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.945 1.763 . . . . 74.519999999999996 111.052 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -131.53 141.71 45.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.41 -0.814 . . . . 70.329999999999998 109.298 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 49.7 m -82.0 -27.04 33.34 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.07 0.396 . . . . 74.310000000000002 112.07 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -113.99 132.75 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 120.729 -0.388 . . . . 72.430000000000007 110.649 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -90.69 115.11 29.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.789 -1.189 . . . . 73.109999999999999 107.789 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' B' ' 39' ' ' PHE . 75.3 mmtt -94.15 137.92 32.78 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.034 -0.53 . . . . 53.039999999999999 111.391 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.4 m -116.27 127.93 55.14 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.992 -1.004 . . . . 60.420000000000002 108.867 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -127.88 126.64 41.94 Favored 'General case' 0 CA--C 1.461 -2.46 0 CA-C-N 115.605 -0.725 . . . . 74.409999999999997 109.749 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.515 HG22 HG22 ' B' ' 37' ' ' VAL . 64.4 p -115.38 132.56 56.58 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.76 -0.654 . . . . 73.420000000000002 111.13 -177.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.496 HD13 HD12 ' A' ' 38' ' ' ILE . 55.1 mt -126.04 136.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 109.213 -0.662 . . . . 72.409999999999997 109.213 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 10.1 t -119.15 127.28 53.18 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 121.744 0.783 . . . . 63.100000000000001 109.653 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -135.86 110.61 8.7 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.37 -0.832 . . . . 74.310000000000002 110.236 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -68.12 3.05 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.143 -0.783 . . . . 75.25 111.143 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.9 t -165.82 11.71 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.065 -1.457 . . . . 74.019999999999996 107.065 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' B' ' 30' ' ' THR . 29.4 tp -102.13 123.65 46.37 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.494 -0.775 . . . . 63.229999999999997 111.56 -174.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 35.5 mmt180 -94.46 113.7 25.6 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.021 -0.536 . . . . 71.329999999999998 110.501 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.1 124.55 49.73 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.79 -1.189 . . . . 73.409999999999997 107.79 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.515 HG22 HG22 ' B' ' 28' ' ' THR . 65.8 t -117.2 128.64 74.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.002 0.43 . . . . 62.329999999999998 111.373 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.484 HD11 HD13 ' A' ' 29' ' ' ILE . 67.3 mt -106.96 128.19 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.283 -0.871 . . . . 71.109999999999999 109.995 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 98.8 m-85 -111.74 118.37 35.43 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.418 -0.956 . . . . 74.420000000000002 108.418 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.486 HD11 HD21 ' A' ' 34' ' ' LEU . 38.2 mm -87.87 114.62 26.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.441 -1.688 . . . . 75.219999999999999 106.441 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 69.5 p -123.1 -177.93 3.82 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.63 0.729 . . . . 74.239999999999995 112.323 -173.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.585 ' HG3' ' N ' ' B' ' 43' ' ' ARG . 54.7 pttt -80.2 -29.81 38.63 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.886 -1.506 . . . . 75.540000000000006 109.488 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.585 ' N ' ' HG3' ' B' ' 42' ' ' LYS . 77.1 ttt180 -88.02 -17.41 31.24 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.211 1.005 . . . . 74.450000000000003 109.19 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.83 -121.99 1.46 Allowed Glycine 0 N--CA 1.425 -2.055 0 CA-C-N 114.305 -1.316 . . . . 73.099999999999994 112.549 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 67.0 tp -119.47 133.77 55.54 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.646 -0.777 . . . . 72.140000000000001 109.285 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -124.77 141.53 52.05 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.455 -0.572 . . . . 72.239999999999995 109.455 172.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.23 141.11 46.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 115.673 -0.694 . . . . 54.439999999999998 110.231 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.405 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 65.9 m -125.63 141.59 51.94 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 116.29 -0.414 . . . . 73.450000000000003 110.577 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.424 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . . . -116.31 123.89 48.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.741 -0.837 . . . . 63.340000000000003 108.741 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 13.2 t70 -132.26 97.8 17.68 Favored Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 107.516 -1.29 . . . . 75.310000000000002 107.516 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.425 -2.523 0 C-N-CA 121.775 1.65 . . . . 72.140000000000001 115.357 -174.267 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 97.3 mtt180 . . . . . 0 N--CA 1.434 -1.235 0 N-CA-C 109.021 -0.733 . . . . 75.219999999999999 109.021 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 p -98.57 125.48 43.83 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 109.972 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.2 m -127.83 148.59 50.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.442 -0.503 . . . . 73.420000000000002 110.125 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.46 ' CG2' HD12 ' B' ' 14' ' ' LEU . 98.7 t -144.17 143.25 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.774 0.429 . . . . 73.299999999999997 109.994 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.8 p -123.56 125.49 44.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.377 0.423 . . . . 65.430000000000007 110.397 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 mm? -106.56 121.84 45.11 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.189 -0.46 . . . . 64.329999999999998 111.243 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.5 p -92.28 112.88 24.99 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.757 0.789 . . . . 71.200000000000003 109.071 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.428 ' CG2' ' HG3' ' B' ' 51' ' ' PRO . 5.1 t -134.54 -172.62 3.07 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.918 -1.037 . . . . 60.539999999999999 109.367 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -74.69 81.98 2.06 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.469 1.128 . . . . 71.310000000000002 111.251 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -127.21 142.37 51.5 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.283 -0.871 . . . . 72.150000000000006 110.297 -178.016 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.46 147.73 85.2 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.342 -0.984 . . . . 71.129999999999995 108.342 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.52 136.89 29.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.944 1.763 . . . . 71.129999999999995 112.03 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.492 HG13 ' H ' ' A' ' 23' ' ' ARG . 34.6 t -115.41 142.68 27.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.753 -1.203 . . . . 75.109999999999999 107.753 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 m -88.43 -2.28 58.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.631 0.604 . . . . 71.540000000000006 112.631 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.492 ' H ' HG13 ' A' ' 21' ' ' VAL . 64.0 ttt180 -134.58 148.75 50.52 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.953 -0.467 . . . . 75.150000000000006 110.44 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -92.4 120.45 41.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.503 -0.925 . . . . 74.010000000000005 108.503 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 35.0 mmtp -96.96 132.21 42.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.917 -0.713 . . . . 72.400000000000006 109.914 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 p -107.25 128.04 54.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.66 -0.7 . . . . 72.299999999999997 109.75 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 67.2 m-85 -128.24 126.79 41.62 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 116.144 -0.48 . . . . 73.540000000000006 110.699 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 37' ' ' VAL . 47.9 p -115.13 129.84 56.77 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.423 -0.808 . . . . 74.140000000000001 112.696 -174.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.487 HD13 HD11 ' B' ' 38' ' ' ILE . 59.0 mt -137.41 121.6 22.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.912 -0.585 . . . . 74.230000000000004 109.467 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -113.23 126.48 55.46 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 119.666 -0.813 . . . . 74.299999999999997 109.162 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.501 ' O ' HD21 ' A' ' 34' ' ' LEU . 9.8 tp10 -121.35 103.61 9.09 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.861 -0.609 . . . . 72.519999999999996 109.598 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.13 -93.57 0.23 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.612 -0.722 . . . . 60.240000000000002 112.967 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.7 m -113.75 -7.18 13.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.268 0.84 . . . . 65.109999999999999 113.268 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.501 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -114.5 140.67 48.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.142 -1.023 . . . . 75.549999999999997 111.125 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 1.9 mpt_? -108.71 119.58 39.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.249 -0.887 . . . . 75.200000000000003 108.69 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.31 130.92 55.48 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.754 0.312 . . . . 75.299999999999997 110.247 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG23 HG23 ' A' ' 28' ' ' THR . 60.1 t -121.19 127.17 75.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.476 -0.564 . . . . 74.219999999999999 109.476 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.515 HD12 HD13 ' B' ' 29' ' ' ILE . 83.7 mt -101.66 125.85 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.587 0 N-CA-C 108.672 -0.862 . . . . 75.319999999999993 108.672 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -108.69 114.65 28.63 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.238 -1.023 . . . . 72.319999999999993 108.238 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 49.9 mm -88.84 113.14 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.353 0 N-CA-C 106.499 -1.667 . . . . 73.129999999999995 106.499 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.2 p -109.99 -177.07 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.816 -0.629 . . . . 71.150000000000006 110.343 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.8 -13.0 32.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.941 -0.762 . . . . 75.409999999999997 108.941 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -96.55 -24.61 15.97 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.182 -0.917 . . . . 71.540000000000006 110.705 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.488 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 171.27 -133.52 2.78 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 118.394 -1.86 . . . . 54.140000000000001 114.368 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -126.99 122.59 34.92 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 124.186 0.994 . . . . 62.5 108.567 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -123.07 143.02 50.25 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-O 121.093 0.473 . . . . 75.400000000000006 110.74 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.55 140.81 47.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 115.455 -0.793 . . . . 70.040000000000006 109.14 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.8 m -124.05 136.88 54.56 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.089 -0.505 . . . . 70.409999999999997 110.302 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -117.21 124.3 48.74 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.636 -0.711 . . . . 53.049999999999997 110.015 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -110.88 104.28 55.9 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.001 -0.74 . . . . 65.129999999999995 109.001 175.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HG3' ' OG1' ' B' ' 16' ' ' THR . 83.2 Cg_endo -79.44 158.22 25.67 Favored 'Trans proline' 0 N--CA 1.423 -2.659 0 C-N-CA 121.563 1.509 . . . . 41.450000000000003 111.411 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.309 -1.166 0 C-N-CA 125.424 1.49 . . . . 71.019999999999996 113.517 172.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 93.3 mtt180 . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 121.063 0.458 . . . . 73.430000000000007 110.368 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 30.9 p -89.03 128.75 35.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.695 -0.684 . . . . 73.140000000000001 110.713 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 63.8 m -131.62 148.47 52.61 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.543 -0.91 . . . . 62.340000000000003 108.543 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.43 145.31 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 109.445 -0.576 . . . . 71.239999999999995 109.445 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 65.9 p -115.33 125.45 53.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.136 0.493 . . . . 64.409999999999997 110.838 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.46 HD12 ' CG2' ' A' ' 12' ' ' VAL . 3.2 mm? -103.47 121.51 42.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 116.045 -0.525 . . . . 75.420000000000002 111.094 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 38.7 p -93.8 113.31 25.33 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.805 -0.634 . . . . 71.129999999999995 109.748 176.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' THR . . . . . 0.409 ' OG1' ' HG3' ' A' ' 51' ' ' PRO . 9.1 t -129.09 -171.0 2.38 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.623 -1.251 . . . . 73.109999999999999 107.623 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -77.55 108.19 10.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.54 1.162 . . . . 72.349999999999994 110.117 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 150.9 46.83 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.89 -1.505 . . . . 75.430000000000007 114.199 -174.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.415 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 2.2 pt? -74.64 167.42 36.46 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.297 -1.32 . . . . 53.219999999999999 108.636 175.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 19.0 Cg_endo -65.2 135.07 41.79 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.131 1.22 . . . . 70.019999999999996 109.951 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 86.2 t -129.81 123.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.726 -0.842 . . . . 72.329999999999998 108.726 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.8 m -90.11 -73.71 0.51 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.037 0.446 . . . . 73.510000000000005 110.064 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -92.38 146.94 23.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.475 -0.784 . . . . 75.140000000000001 109.301 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.07 134.78 26.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.96 -0.385 . . . . 73.549999999999997 109.96 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -100.77 125.72 47.27 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.036 -1.098 . . . . 62.149999999999999 108.036 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 31.7 p -106.3 128.38 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.113 0.482 . . . . 74.030000000000001 110.414 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 71.3 m-85 -127.07 126.91 43.83 Favored 'General case' 0 CA--C 1.473 -2.017 0 CA-C-N 116.038 -0.528 . . . . 74.430000000000007 110.688 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.472 HG22 HG22 ' B' ' 37' ' ' VAL . 58.8 p -115.38 131.47 56.92 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.349 -0.842 . . . . 73.310000000000002 112.416 -173.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.515 HD13 HD12 ' A' ' 38' ' ' ILE . 54.8 mt -133.6 124.32 47.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.656 0.382 . . . . 71.439999999999998 110.199 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -111.19 127.09 55.48 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.87 -0.789 . . . . 75.019999999999996 108.87 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.53 ' O ' HD21 ' B' ' 34' ' ' LEU . 12.6 tp10 -130.22 97.89 4.57 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.731 -0.668 . . . . 75.420000000000002 109.848 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.68 -87.32 0.35 Allowed Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.436 -0.802 . . . . 64.400000000000006 112.021 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 54.8 m -119.89 -13.18 9.08 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 112.847 0.684 . . . . 73.010000000000005 112.847 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.53 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -107.85 136.5 47.46 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 117.736 -1.586 . . . . 75.409999999999997 112.293 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -102.84 120.09 39.99 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.489 -1.232 . . . . 74.109999999999999 108.405 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.32 53.17 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.689 -0.485 . . . . 75.439999999999998 109.689 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.472 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -124.64 128.66 73.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.979 -0.378 . . . . 72.540000000000006 109.979 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.487 HD11 HD13 ' A' ' 29' ' ' ILE . 83.8 mt -102.2 124.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 C-N-CA 123.923 0.889 . . . . 73.540000000000006 108.696 178.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.21 116.6 32.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.445 -0.946 . . . . 73.430000000000007 108.445 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mm -87.82 113.69 25.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.031 -1.84 . . . . 75.040000000000006 106.031 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 76.0 p -123.4 179.51 4.71 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.745 -0.661 . . . . 71.530000000000001 111.338 -171.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -83.1 -7.41 59.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 72.430000000000007 110.276 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' B' ' 15' ' ' THR . 98.8 mtt180 -87.04 -16.73 34.76 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.848 -1.538 . . . . 75.200000000000003 106.848 170.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.18 -103.28 1.03 Allowed Glycine 0 N--CA 1.423 -2.202 0 CA-C-N 114.507 -1.224 . . . . 63.310000000000002 112.039 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -116.38 122.68 45.56 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.106 0.479 . . . . 53.399999999999999 111.856 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.0 143.83 50.18 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.68 -0.691 . . . . 71.5 109.152 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 11.0 p -131.18 140.93 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.307 -0.406 . . . . 64.530000000000001 110.085 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 52.9 m -122.42 136.51 54.91 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.336 -0.393 . . . . 72.329999999999998 110.689 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.89 124.59 48.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.535 -0.757 . . . . 62.119999999999997 111.291 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -122.76 95.81 46.05 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.87 -0.789 . . . . 70.549999999999997 108.87 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 91.1 Cg_endo . . . . . 0 N--CA 1.411 -3.36 0 C-N-CA 120.477 0.785 . . . . 71.340000000000003 112.35 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.41 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.25 0 N-CA-C 112.409 0.522 . . . . 72.400000000000006 112.409 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.47 127.89 49.32 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.955 -0.566 . . . . 64.310000000000002 111.024 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.496 ' CB ' ' HA ' ' A' ' 48' ' ' CYS . 20.0 m -140.55 148.05 40.41 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.772 -1.196 . . . . 51.439999999999998 107.772 -174.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.34 145.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.421 0.555 . . . . 73.230000000000004 110.753 -175.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.45 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 39.9 p -107.56 125.87 51.84 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.201 0.524 . . . . 70.340000000000003 110.377 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.07 137.84 45.36 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.819 -0.628 . . . . 65.519999999999996 111.442 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -98.51 112.58 24.56 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 115.445 -0.798 . . . . 65.150000000000006 109.293 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -142.4 -176.56 4.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.763 -1.199 . . . . 72.299999999999997 107.763 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -79.33 105.11 10.41 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.604 0.716 . . . . 72.25 110.436 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.551 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.01 147.46 49.54 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.349 -0.841 . . . . 75.340000000000003 109.559 -178.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.5 pt? -74.55 136.07 74.89 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 107.682 -1.229 . . . . 73.239999999999995 107.682 174.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.49 133.9 27.21 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 120.825 1.017 . . . . 71.140000000000001 110.562 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.452 HG23 ' H ' ' A' ' 23' ' ' ARG . 14.5 p -133.42 137.33 53.28 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.737 -0.665 . . . . 63.450000000000003 109.352 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 m -87.86 -19.27 27.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.338 0.59 . . . . 63.43 110.036 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.452 ' H ' HG23 ' A' ' 21' ' ' VAL . 37.6 mmt180 -102.86 133.12 48.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.078 -0.712 . . . . 74.329999999999998 109.078 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mm -93.58 115.71 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.873 -0.788 . . . . 75.030000000000001 108.873 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.78 135.93 33.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 120.384 -0.526 . . . . 75.439999999999998 111.196 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 p -114.55 128.24 56.22 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.959 -1.019 . . . . 64.420000000000002 109.715 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 68.0 m-85 -126.44 125.67 42.52 Favored 'General case' 0 CA--C 1.462 -2.419 0 N-CA-C 109.401 -0.592 . . . . 73.349999999999994 109.401 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.498 HG23 HG23 ' A' ' 37' ' ' VAL . 63.7 p -116.73 131.72 56.88 Favored 'General case' 0 C--N 1.283 -2.308 0 O-C-N 123.861 0.726 . . . . 74.530000000000001 112.344 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.462 HD13 HD11 ' B' ' 38' ' ' ILE . 56.5 mt -127.55 121.17 56.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 120.905 0.383 . . . . 74.129999999999995 110.05 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -102.97 123.58 46.86 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.776 -1.194 . . . . 71.519999999999996 107.776 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -142.31 97.11 3.06 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.354 -0.538 . . . . 74.530000000000001 111.642 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -72.96 0.38 Allowed Glycine 0 C--N 1.319 -0.378 0 N-CA-C 115.287 0.875 . . . . 64.319999999999993 115.287 171.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.504 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.1 m -126.94 -1.09 6.58 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 112.719 0.637 . . . . 71.019999999999996 112.719 -173.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.434 HD23 HG22 ' B' ' 40' ' ' ILE . 2.0 pt? -146.33 140.46 26.44 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.271 -0.972 . . . . 73.400000000000006 112.278 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 121.55 44.99 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.006 -1.452 . . . . 64.25 108.956 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.23 137.2 49.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.805 -0.18 . . . . 73.019999999999996 110.531 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.498 HG23 HG23 ' A' ' 28' ' ' THR . 39.2 t -124.31 125.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.215 -0.661 . . . . 72.219999999999999 109.215 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.498 HD12 HD13 ' B' ' 29' ' ' ILE . 86.4 mt -102.95 123.49 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 108.654 -0.869 . . . . 75.329999999999998 108.654 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 92.9 m-85 -106.79 114.48 28.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.362 -0.977 . . . . 70.150000000000006 108.362 177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.428 HG13 ' HG2' ' B' ' 31' ' ' GLU . 49.0 mm -89.42 114.75 27.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.208 -1.404 . . . . 72.310000000000002 107.208 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.78 156.87 47.94 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 115.806 -0.633 . . . . 63.140000000000001 110.953 -175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -62.59 -14.58 44.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.579 0.752 . . . . 74.450000000000003 110.734 176.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -85.35 -18.71 32.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.618 0.723 . . . . 75.420000000000002 109.491 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.35 -138.79 9.28 Favored Glycine 0 CA--C 1.48 -2.155 0 C-N-CA 119.909 -1.138 . . . . 72.349999999999994 112.176 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.31 121.32 44.07 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.61 -0.885 . . . . 72.209999999999994 108.61 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 23.0 tptm -118.62 121.81 41.06 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.383 -0.969 . . . . 74.049999999999997 108.383 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.408 HG11 HG13 ' B' ' 47' ' ' VAL . 14.9 p -116.97 140.33 40.06 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 107.765 -1.198 . . . . 72.299999999999997 107.765 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.496 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 13.6 t -132.76 136.04 46.1 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 106.716 -1.587 . . . . 72.040000000000006 106.716 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.456 ' CB ' ' HG ' ' B' ' 45' ' ' LEU . . . -136.18 124.57 23.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 119.328 -0.949 . . . . 72.010000000000005 111.312 -177.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.63 108.81 62.51 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 114.84 -1.073 . . . . 74.439999999999998 109.792 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -89.04 148.13 5.6 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.342 2.028 . . . . 75.109999999999999 111.079 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 33' ' ' SER . 9.2 pt20 . . . . . 0 C--N 1.297 -1.686 0 CA-C-N 115.905 -0.589 . . . . 73.299999999999997 109.778 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.547 ' HD2' ' H ' ' B' ' 9' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.391 -3.383 0 CA-C-O 122.152 0.977 . . . . 75.019999999999996 110.053 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.1 p -87.12 117.79 26.09 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.539 -1.664 . . . . 64.129999999999995 110.099 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.458 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 19.4 m -137.28 148.22 46.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.945 -1.131 . . . . 63.509999999999998 107.945 -175.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -142.96 146.79 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.833 -0.432 . . . . 75.439999999999998 109.833 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 23.7 p -106.96 125.56 51.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.17 0.588 . . . . 72.109999999999999 110.46 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.34 119.41 39.38 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.236 -1.024 . . . . 73.400000000000006 108.236 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -121.59 112.69 18.77 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.267 -1.012 . . . . 72.329999999999998 108.267 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -173.29 113.44 0.22 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.348 0.499 . . . . 74.129999999999995 112.348 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' B' ' 17' ' ' GLN . 5.9 tp60 59.42 22.47 10.94 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.581 1.152 . . . . 74.209999999999994 112.887 174.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.456 ' HD2' ' HA2' ' B' ' 44' ' ' GLY . 27.3 mtt180 -105.74 121.51 44.17 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.107 -0.996 . . . . 73.209999999999994 108.853 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.525 ' H ' HD22 ' B' ' 19' ' ' LEU . 1.6 pt? -74.39 152.28 87.78 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 116.095 -0.502 . . . . 74.439999999999998 111.885 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.19 136.65 74.07 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.379 2.719 . . . . 75.200000000000003 113.648 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.73 149.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.659 -1.237 . . . . 75.129999999999995 107.659 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 -36.42 59.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.022 0.378 . . . . 64.450000000000003 112.022 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -124.18 135.89 53.79 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.939 -0.304 . . . . 72.109999999999999 110.787 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.57 115.16 19.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.755 -1.202 . . . . 74.209999999999994 107.755 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.19 126.47 43.67 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.161 -0.472 . . . . 62.109999999999999 110.444 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.421 HG22 ' CD1' ' B' ' 39' ' ' PHE . 41.1 p -106.66 127.36 53.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.436 -0.579 . . . . 72.340000000000003 109.436 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 75.3 m-85 -126.57 127.45 45.3 Favored 'General case' 0 CA--C 1.474 -1.956 0 CA-C-N 116.092 -0.504 . . . . 73.540000000000006 110.626 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' THR . . . . . 0.493 HG22 HG22 ' B' ' 37' ' ' VAL . 43.4 p -114.51 121.3 43.07 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.618 -0.719 . . . . 72.140000000000001 112.021 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.498 HD13 HD12 ' A' ' 38' ' ' ILE . 94.5 mt -119.48 121.46 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.785 -0.643 . . . . 71.409999999999997 110.864 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -105.71 139.84 39.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.257 -1.016 . . . . 71.420000000000002 108.257 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.428 ' HG2' HG13 ' A' ' 40' ' ' ILE . 17.0 tp10 -142.51 97.59 3.14 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.404 0.621 . . . . 74.319999999999993 109.566 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.22 2.59 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.218 -0.901 . . . . 71.530000000000001 112.834 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 39.8 m -146.12 -25.25 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.279 0.844 . . . . 72.439999999999998 113.279 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.445 ' H ' HD21 ' B' ' 34' ' ' LEU . 2.6 pt? -92.89 141.39 28.47 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.037 -0.665 . . . . 64.319999999999993 110.534 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -111.51 123.15 49.62 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.049 -0.523 . . . . 73.540000000000006 110.006 177.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.4 54.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.714 -0.476 . . . . 73.150000000000006 109.714 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.493 HG22 HG22 ' B' ' 28' ' ' THR . 39.2 t -119.76 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.273 0.559 . . . . 74.109999999999999 110.538 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.462 HD11 HD13 ' A' ' 29' ' ' ILE . 97.0 mt -103.91 116.65 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 107.846 -1.168 . . . . 63.399999999999999 107.846 177.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.465 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 97.8 m-85 -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.472 -0.936 . . . . 73.420000000000002 108.472 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.434 HG22 HD23 ' A' ' 34' ' ' LEU . 41.9 mm -88.5 113.7 25.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 106.501 -1.666 . . . . 73.239999999999995 106.501 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.9 t -119.5 166.02 13.64 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 120.356 -0.538 . . . . 72.450000000000003 111.479 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.97 -3.76 43.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.426 0.898 . . . . 73.439999999999998 113.426 -173.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -116.22 -1.75 12.31 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.195 0.521 . . . . 75.400000000000006 110.518 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' B' ' 18' ' ' ARG . . . 155.52 -140.65 7.47 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.04 -1.553 . . . . 64.239999999999995 113.96 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.456 ' HG ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 tm? -122.13 126.58 48.66 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.441 0.696 . . . . 74.5 109.355 -177.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -117.45 121.75 41.88 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.821 -0.807 . . . . 74.510000000000005 108.821 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 47' ' ' VAL . 9.7 p -108.23 140.39 26.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.621 -0.881 . . . . 61.310000000000002 108.621 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.458 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 10.5 t -139.7 136.86 34.66 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 107.752 -1.203 . . . . 44.439999999999998 107.752 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.55 125.77 43.75 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 110.144 -0.317 . . . . 55.030000000000001 110.144 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -115.07 109.69 46.62 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-O 121.278 0.561 . . . . 75.530000000000001 109.827 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.439 -1.713 0 C-N-CA 122.719 2.279 . . . . 70.329999999999998 112.939 -177.456 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 14.5 ptt180 . . . . . 0 N--CA 1.444 -0.74 0 CA-C-O 121.529 0.681 . . . . 63.539999999999999 111.904 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.408 ' HG1' HD13 ' B' ' 14' ' ' LEU . 22.4 p -88.86 148.07 24.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.198 -0.91 . . . . 74.209999999999994 110.98 -175.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 65.9 m -141.71 149.23 40.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.458 -1.312 . . . . 64.340000000000003 107.458 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.458 HG13 HG13 ' B' ' 12' ' ' VAL . 57.1 t -139.76 145.15 27.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 110.163 -0.31 . . . . 75.239999999999995 110.163 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 m -111.77 124.8 53.12 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.216 -1.031 . . . . 73.109999999999999 108.216 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -132.09 141.01 49.03 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 123.749 0.819 . . . . 74.109999999999999 108.802 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 t -123.32 141.9 51.51 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.843 -0.743 . . . . 52.210000000000001 111.004 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 t -111.56 26.61 10.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.245 -1.02 . . . . 74.310000000000002 108.245 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 77.43 117.26 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 112.998 -1.91 . . . . 72.120000000000005 108.468 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.511 HH12 HD22 ' B' ' 34' ' ' LEU . 14.9 mmm180 -95.46 148.01 22.93 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 116.561 2.06 . . . . 74.409999999999997 116.561 -172.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.9 mt -114.37 153.83 46.49 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 112.922 -1.945 . . . . 62.140000000000001 106.358 172.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.45 145.08 16.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.349 3.366 . . . . 74.239999999999995 115.286 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.34 137.86 54.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 114.084 -1.417 . . . . 73.439999999999998 109.164 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 m -98.11 -45.09 6.36 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.712 0.292 . . . . 73.010000000000005 110.848 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -119.3 133.84 55.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 62.340000000000003 109.757 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -85.48 135.91 23.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.767 -0.457 . . . . 64.200000000000003 109.767 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.03 151.63 33.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.9 0.704 . . . . 73.400000000000006 112.9 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 m -133.99 127.22 31.89 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.607 -1.178 . . . . 72.140000000000001 108.38 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 74.8 m-85 -127.61 134.7 49.67 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 111.879 0.325 . . . . 74.549999999999997 111.879 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.507 HG23 HG23 ' A' ' 37' ' ' VAL . 36.1 p -115.51 139.23 50.25 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.64 -0.709 . . . . 71.219999999999999 111.556 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.523 HD13 HD11 ' B' ' 38' ' ' ILE . 82.3 mt -130.72 133.14 63.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.216 -0.902 . . . . 75.099999999999994 108.78 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -117.19 123.65 47.2 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 121.631 0.729 . . . . 73.140000000000001 109.171 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.8 tp10 -125.16 98.35 5.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.752 0.787 . . . . 65.140000000000001 108.965 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.52 -71.9 2.91 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 109.703 -1.359 . . . . 64.310000000000002 109.703 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -154.97 -22.7 0.12 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.519 0.933 . . . . 73.209999999999994 113.519 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.23 141.06 54.54 Favored 'General case' 0 C--N 1.367 1.37 0 CA-C-N 118.934 0.788 . . . . 72.230000000000004 110.817 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 31.6 mmt180 -100.58 118.71 37.31 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.884 -0.598 . . . . 73.200000000000003 109.745 174.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 123.97 49.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.894 -0.78 . . . . 65.310000000000002 108.894 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 71.5 t -110.89 133.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.3 -0.409 . . . . 75.030000000000001 110.142 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.431 HD12 HD13 ' B' ' 29' ' ' ILE . 75.6 mt -115.49 118.29 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 C-N-CA 123.702 0.801 . . . . 63.350000000000001 108.997 176.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.52 122.1 43.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.567 -0.901 . . . . 75.230000000000004 108.567 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.408 HD11 HD23 ' B' ' 34' ' ' LEU . 47.6 mm -100.63 113.37 36.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.684 -1.228 . . . . 75.030000000000001 107.684 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -131.92 177.03 7.85 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.635 -0.876 . . . . 74.129999999999995 108.635 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.5 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -90.51 -1.74 57.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.487 -0.931 . . . . 73.310000000000002 108.487 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -89.63 -30.83 17.85 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.558 -0.904 . . . . 63.43 108.558 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.12 -157.53 29.85 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.702 -1.136 . . . . 74.340000000000003 111.737 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -113.63 121.57 44.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.888 -1.523 . . . . 73.450000000000003 106.888 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -121.08 140.16 52.33 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 121.202 0.525 . . . . 74.420000000000002 111.381 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 23.2 m -131.45 141.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.035 -0.984 . . . . 74.530000000000001 110.866 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.6 m -121.35 137.52 54.66 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.936 -0.575 . . . . 73.420000000000002 110.623 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.75 124.58 47.62 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.294 -0.632 . . . . 64.329999999999998 109.294 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 14.2 t70 -115.84 127.13 27.03 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.933 -0.765 . . . . 65.219999999999999 108.933 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.8 148.17 22.96 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.915 3.077 . . . . 62.450000000000003 113.854 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.537 ' NE2' ' H ' ' A' ' 52' ' ' GLN . 1.2 mp0 . . . . . 0 C--N 1.321 -0.632 0 C-N-CA 124.227 1.011 . . . . 74.109999999999999 110.937 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 121.767 0.794 . . . . 75.420000000000002 113.046 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.1 p -103.21 149.76 24.35 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-N 114.846 -1.07 . . . . 72.409999999999997 111.282 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 63.1 m -139.85 148.84 42.68 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.352 -1.722 . . . . 62.409999999999997 106.352 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 12' ' ' VAL . 60.2 t -141.88 144.0 26.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.592 -0.521 . . . . 53.100000000000001 109.592 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -107.98 124.82 50.73 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.091 -1.077 . . . . 75.439999999999998 108.091 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.429 HD22 ' N ' ' B' ' 14' ' ' LEU . 0.3 OUTLIER -119.41 122.73 42.43 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.08 -0.711 . . . . 62.130000000000003 109.08 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -107.22 130.64 54.71 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.87 0.843 . . . . 70.409999999999997 111.01 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -144.78 -162.45 1.49 Allowed 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.001 -1.481 . . . . 65.439999999999998 107.001 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -71.1 102.73 2.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.701 0.762 . . . . 63.329999999999998 109.177 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 mmm-85 -125.0 139.49 53.77 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 114.874 -1.057 . . . . 63.240000000000002 109.214 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 46.8 mt -89.02 137.24 29.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 106.649 -1.612 . . . . 71.019999999999996 106.649 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.68 135.17 41.6 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.647 2.231 . . . . 74.510000000000005 112.695 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.91 135.83 61.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.834 -1.543 . . . . 73.329999999999998 106.834 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 26.3 m -89.79 -20.28 23.7 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.32 0.489 . . . . 74.510000000000005 112.32 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -112.73 138.63 49.26 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.783 -0.19 . . . . 52.520000000000003 110.779 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mm -89.93 118.95 36.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.305 -0.628 . . . . 74.109999999999999 109.305 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.07 152.53 18.68 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.312 0.577 . . . . 64.0 112.333 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 73.1 m -131.31 127.91 38.67 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.693 -1.14 . . . . 73.329999999999998 108.595 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -129.35 125.58 36.98 Favored 'General case' 0 CA--C 1.452 -2.793 0 N-CA-C 108.94 -0.763 . . . . 63.130000000000003 108.94 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 18.6 m -117.88 122.07 42.37 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 119.686 -0.806 . . . . 74.200000000000003 112.544 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.431 HD13 HD12 ' A' ' 38' ' ' ILE . 64.2 mt -116.48 121.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.509 . . . . 74.120000000000005 109.9 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -105.02 128.42 53.31 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.225 -1.398 . . . . 72.549999999999997 107.225 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.569 ' O ' HD21 ' B' ' 34' ' ' LEU . 14.7 tp10 -139.38 118.49 12.65 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.258 -0.645 . . . . 71.299999999999997 109.258 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.73 -78.79 1.16 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.858 -1.163 . . . . 74.400000000000006 110.271 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -155.37 -14.58 0.11 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 112.924 0.712 . . . . 70.519999999999996 112.924 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.569 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.4 pt? -84.2 142.07 30.57 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.329 0.513 . . . . 75.019999999999996 110.818 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -100.66 118.08 36.08 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.324 -1.361 . . . . 74.129999999999995 107.324 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.98 29.53 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.43 -0.581 . . . . 72.120000000000005 109.43 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.37 124.02 64.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.211 -0.449 . . . . 50.130000000000003 110.626 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.523 HD11 HD13 ' A' ' 29' ' ' ILE . 63.2 mt -102.97 123.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 C-N-CA 123.429 0.691 . . . . 62.200000000000003 109.205 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -104.85 114.88 29.36 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.219 -1.03 . . . . 75.120000000000005 108.219 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.401 HG13 ' HG2' ' A' ' 31' ' ' GLU . 47.5 mm -90.18 112.57 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 106.869 -1.53 . . . . 75.420000000000002 106.869 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -110.61 -176.58 3.01 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.922 -0.77 . . . . 64.109999999999999 108.922 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.455 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -92.11 -17.98 24.19 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 120.968 0.413 . . . . 74.049999999999997 110.219 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -100.58 -16.94 17.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.127 -0.488 . . . . 64.129999999999995 111.01 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.34 -145.59 7.28 Favored Glycine 0 C--N 1.295 -1.711 0 C-N-CA 118.7 -1.714 . . . . 70.299999999999997 113.199 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.2 122.82 23.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.574 -1.269 . . . . 75.129999999999995 107.574 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -125.04 141.57 52.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.215 0.531 . . . . 73.230000000000004 110.383 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.495 HG13 HG12 ' A' ' 47' ' ' VAL . 30.8 m -131.9 141.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.298 -0.865 . . . . 75.25 111.03 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -120.03 136.98 54.36 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 115.929 -0.578 . . . . 72.109999999999999 110.11 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.69 123.91 47.24 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.186 -0.672 . . . . 75.349999999999994 109.186 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -102.04 135.73 19.61 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 107.655 -1.239 . . . . 73.420000000000002 107.655 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 CA--C 1.505 -0.944 0 C-N-CA 123.49 2.793 . . . . 73.439999999999998 114.34 -174.278 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 49' ' ' ALA . 97.2 mtt180 . . . . . 0 CA--C 1.498 -1.042 0 N-CA-C 107.06 -1.459 . . . . 74.129999999999995 107.06 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 120.241 -0.584 . . . . 70.420000000000002 110.859 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.7 m -129.85 148.94 51.77 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.089 -1.078 . . . . 65.319999999999993 108.089 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.3 147.01 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 120.84 -0.344 . . . . 63.140000000000001 110.883 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.3 p -112.21 126.94 55.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.903 0.382 . . . . 73.140000000000001 110.003 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.08 141.95 47.3 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.771 -0.825 . . . . 72.209999999999994 108.771 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -127.9 112.98 15.3 Favored 'General case' 0 N--CA 1.405 -2.693 0 C-N-CA 119.534 -0.866 . . . . 72.409999999999997 111.04 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' B' ' 10' ' ' THR . 9.0 t -121.71 -170.09 1.98 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.3 -1.0 . . . . 64.099999999999994 108.3 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -72.38 93.36 1.51 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.712 0.768 . . . . 51.420000000000002 110.822 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.416 HH22 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -126.5 148.17 49.73 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.95 -1.023 . . . . 74.099999999999994 108.838 -178.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.07 141.42 46.86 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.347 -0.983 . . . . 71.209999999999994 108.347 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 39.9 Cg_endo -65.91 143.83 74.49 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.541 2.161 . . . . 75.219999999999999 112.715 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 21.4 t -122.4 148.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.404 -1.332 . . . . 73.420000000000002 107.404 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -92.38 -39.84 11.23 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 120.305 -0.558 . . . . 73.340000000000003 110.843 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -89.61 133.15 34.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.31 -0.405 . . . . 65.129999999999995 111.246 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.73 124.11 42.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.761 -0.829 . . . . 72.329999999999998 108.761 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -104.53 146.57 28.7 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.009 -0.676 . . . . 70.319999999999993 111.292 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 m -127.29 127.79 44.91 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.436 -0.949 . . . . 75.209999999999994 108.436 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 88.2 m-85 -128.13 134.73 49.15 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-N 116.352 -0.385 . . . . 74.439999999999998 111.8 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.466 HG23 HG23 ' A' ' 37' ' ' VAL . 17.7 p -114.64 120.08 38.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.295 -0.866 . . . . 74.510000000000005 111.711 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.536 HD13 HD11 ' B' ' 38' ' ' ILE . 93.9 mt -114.94 125.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.569 -0.741 . . . . 71.129999999999995 109.589 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -106.91 128.87 54.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.277 0.56 . . . . 75.040000000000006 109.794 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' O ' HD21 ' A' ' 34' ' ' LEU . 17.1 tp10 -142.99 119.18 10.78 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.715 -0.675 . . . . 73.549999999999997 109.59 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.59 -87.37 0.12 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 111.6 -0.6 . . . . 50.140000000000001 111.6 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 t -151.14 13.88 0.69 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.406 -0.59 . . . . 71.219999999999999 109.406 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -110.49 140.51 44.69 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.7 -0.8 . . . . 73.340000000000003 108.891 174.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -116.3 134.03 55.35 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.58 -0.736 . . . . 73.150000000000006 110.192 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.97 131.46 55.38 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.383 -0.599 . . . . 52.0 109.383 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 87.5 t -113.11 120.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.014 -0.539 . . . . 74.549999999999997 110.139 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.479 HD12 HD13 ' B' ' 29' ' ' ILE . 96.2 mt -101.33 117.39 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 N-CA-C 109.003 -0.739 . . . . 74.230000000000004 109.003 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.2 m-85 -102.96 114.82 29.43 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.554 -0.906 . . . . 75.340000000000003 108.554 177.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 HD23 ' B' ' 34' ' ' LEU . 47.7 mm -90.75 112.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 106.57 -1.641 . . . . 75.409999999999997 106.57 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -116.62 173.28 6.71 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.525 0.516 . . . . 70.200000000000003 110.248 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.564 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.91 -33.01 71.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 116.482 2.03 . . . . 75.310000000000002 116.482 -171.145 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.564 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 1.5 tmt_? -117.21 3.76 12.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 119.694 -0.803 . . . . 70.25 109.472 -176.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.5 -158.73 12.03 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 118.353 -1.88 . . . . 44.240000000000002 115.058 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.29 123.1 24.87 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 125.636 1.575 . . . . 73.510000000000005 108.457 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -121.45 143.4 49.26 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.745 0.307 . . . . 74.439999999999998 110.721 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.92 140.2 48.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 115.948 -0.569 . . . . 72.340000000000003 110.126 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 26.7 m -118.9 145.05 46.04 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.5 -0.773 . . . . 74.299999999999997 110.232 172.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 9' ' ' ARG . . . -115.76 125.75 53.16 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.252 -1.018 . . . . 61.530000000000001 108.252 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.93 78.43 31.81 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.218 -1.401 . . . . 72.400000000000006 107.218 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 27.8 Cg_endo -99.53 134.13 0.23 Allowed 'Trans proline' 0 N--CA 1.413 -3.229 0 C-N-CA 122.303 2.002 . . . . 74.450000000000003 113.858 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 114.052 -1.431 . . . . 63.399999999999999 113.229 173.194 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 . . . . . 0 N--CA 1.41 -2.441 0 N-CA-C 108.173 -1.047 . . . . 73.420000000000002 108.173 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 16' ' ' THR . 49.5 m -108.88 116.66 32.42 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.334 -1.358 . . . . 73.129999999999995 107.334 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -135.61 146.76 48.24 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.115 -1.068 . . . . 65.25 108.115 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 12.4 p -147.12 156.06 10.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 117.486 0.13 . . . . 60.020000000000003 110.788 -176.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -117.16 126.69 53.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.345 0.258 . . . . 73.310000000000002 110.618 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.409 HD22 ' N ' ' B' ' 14' ' ' LEU . 1.7 mm? -112.11 121.12 44.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.98 -1.119 . . . . 73.439999999999998 107.98 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -93.05 111.81 23.56 Favored 'General case' 0 C--N 1.284 -2.246 0 C-N-CA 118.271 -1.372 . . . . 71.439999999999998 109.147 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.6 t -153.58 107.81 3.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.181 -0.918 . . . . 64.0 112.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . 0.423 ' HA ' ' OE1' ' B' ' 17' ' ' GLN . 6.1 tp60 43.1 85.66 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.708 1.603 . . . . 75.209999999999994 113.259 174.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.428 ' HD3' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -125.57 148.47 48.92 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.173 -1.011 . . . . 72.010000000000005 110.275 -173.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.402 HD12 ' H ' ' B' ' 19' ' ' LEU . 2.8 mp -84.21 159.46 59.36 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.676 -1.231 . . . . 72.140000000000001 107.676 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.88 133.85 28.3 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 N-CA-C 108.54 -1.369 . . . . 61.219999999999999 108.54 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.558 ' H ' ' HB3' ' B' ' 42' ' ' LYS . 32.5 t -132.15 136.64 56.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.098 -1.075 . . . . 72.239999999999995 108.098 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -85.89 -30.31 22.98 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.057 0.456 . . . . 74.219999999999999 111.767 -175.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -114.63 166.74 11.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.745 0.307 . . . . 74.329999999999998 111.689 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.04 115.12 40.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 106.799 -1.556 . . . . 64.319999999999993 106.799 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 35.4 mmtp -90.62 147.18 23.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.733 -0.787 . . . . 65.040000000000006 110.482 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 90.4 m -133.13 127.88 34.88 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.648 -0.871 . . . . 73.430000000000007 108.648 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 70.9 m-85 -128.51 125.78 39.09 Favored 'General case' 0 CA--C 1.446 -3.021 0 N-CA-C 109.474 -0.565 . . . . 75.329999999999998 109.474 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.8 m -117.61 130.93 56.69 Favored 'General case' 0 C--N 1.266 -3.048 0 O-C-N 123.996 0.81 . . . . 71.219999999999999 112.022 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.479 HD13 HD12 ' A' ' 38' ' ' ILE . 49.7 mt -125.01 129.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.866 -0.606 . . . . 75.450000000000003 109.988 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.444 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 9.7 t -106.82 122.27 46.06 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.461 -0.94 . . . . 72.540000000000006 108.461 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.406 ' O ' HD21 ' B' ' 34' ' ' LEU . 19.8 tp10 -142.69 97.82 3.18 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.359 -0.536 . . . . 75.439999999999998 111.69 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.81 -69.97 1.48 Allowed Glycine 0 C--N 1.313 -0.741 0 N-CA-C 115.324 0.89 . . . . 75.109999999999999 115.324 172.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -137.13 0.38 2.34 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.56 0.578 . . . . 55.539999999999999 112.56 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.425 HD23 HD11 ' A' ' 40' ' ' ILE . 2.2 pt? -141.16 141.52 34.12 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.062 -1.055 . . . . 64.099999999999994 112.667 -175.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.444 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 19.2 mmm180 -98.31 113.72 25.77 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.382 -1.71 . . . . 75.129999999999995 106.382 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.77 120.0 40.07 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.743 -0.465 . . . . 73.230000000000004 109.743 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' B' ' 27' ' ' TYR . 90.1 t -113.65 129.31 69.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.755 -0.657 . . . . 70.120000000000005 110.325 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.536 HD11 HD13 ' A' ' 29' ' ' ILE . 67.3 mt -113.25 131.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 123.387 0.675 . . . . 75.230000000000004 109.807 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 96.3 m-85 -112.44 118.29 34.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.958 -0.756 . . . . 75.120000000000005 108.958 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' B' ' 25' ' ' LYS . 47.2 mm -96.92 118.99 44.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.518 -0.919 . . . . 75.409999999999997 108.518 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.34 157.99 45.49 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 109.43 -0.581 . . . . 64.549999999999997 109.43 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.558 ' HB3' ' H ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -67.2 -17.87 65.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.812 -0.631 . . . . 74.439999999999998 111.666 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.664 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.6 tmt_? -90.91 -17.31 26.65 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.309 -0.626 . . . . 73.109999999999999 109.309 -176.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -172.28 43.32 Favored Glycine 0 C--O 1.223 -0.567 0 C-N-CA 118.942 -1.599 . . . . 74.319999999999993 114.611 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -112.85 121.4 44.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.977 -1.49 . . . . 73.540000000000006 106.977 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' B' ' 12' ' ' VAL . 86.8 tttt -119.66 142.01 48.84 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.484 0.659 . . . . 72.109999999999999 111.231 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.13 140.68 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 107.607 -1.257 . . . . 70.540000000000006 107.607 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 34.1 t -138.54 136.56 36.18 Favored 'General case' 0 C--N 1.268 -2.948 0 N-CA-C 108.107 -1.072 . . . . 72.200000000000003 108.107 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.28 123.74 44.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.027 -0.669 . . . . 62.340000000000003 110.485 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.87 122.43 34.85 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.753 -1.203 . . . . 74.329999999999998 107.753 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 N--CA 1.44 -1.64 0 C-N-CA 121.862 1.708 . . . . 72.239999999999995 112.944 -173.551 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 107.22 -1.4 . . . . 72.040000000000006 107.22 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.421 ' HG1' HD12 ' B' ' 14' ' ' LEU . 19.2 p -91.1 144.0 26.1 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.028 -0.533 . . . . 74.109999999999999 112.378 -172.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -138.4 149.89 45.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.132 -0.692 . . . . 74.019999999999996 109.132 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' B' ' 14' ' ' LEU . 60.5 t -143.3 139.79 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 110.232 -0.285 . . . . 75.230000000000004 110.232 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 p -112.45 124.93 53.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.719 -0.475 . . . . 65.340000000000003 109.719 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.12 120.35 39.47 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.122 -0.49 . . . . 70.430000000000007 109.899 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 p -105.54 118.07 35.62 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.045 -0.525 . . . . 64.049999999999997 109.686 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -161.12 116.15 2.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.367 -0.379 . . . . 73.519999999999996 111.743 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 43.45 78.06 0.06 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 125.22 1.408 . . . . 55.299999999999997 113.029 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.481 HH22 ' HB1' ' B' ' 49' ' ' ALA . 34.7 mmt-85 -125.91 149.61 48.58 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.503 0.668 . . . . 73.230000000000004 111.878 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.9 pt? -99.67 159.16 30.69 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 106.036 -1.839 . . . . 75.329999999999998 106.036 172.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.65 135.98 67.78 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.766 1.644 . . . . 62.240000000000002 111.133 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.58 149.18 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 74.400000000000006 108.19 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -85.54 -35.63 20.99 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.404 0.52 . . . . 71.099999999999994 112.404 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -131.11 147.73 52.65 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.217 -0.302 . . . . 61.43 110.665 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -86.63 124.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.678 -0.86 . . . . 73.25 108.678 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.25 150.44 25.13 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.361 0.601 . . . . 72.25 112.506 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 m -133.43 126.94 32.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.244 -1.391 . . . . 73.310000000000002 107.244 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -128.36 134.91 48.95 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-N 116.419 -0.355 . . . . 71.230000000000004 110.672 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.525 HG23 HG23 ' A' ' 37' ' ' VAL . 31.7 p -113.56 117.49 31.78 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.462 -0.79 . . . . 71.450000000000003 110.864 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.504 HD13 HD11 ' B' ' 38' ' ' ILE . 64.3 mt -110.49 123.02 66.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.295 -0.631 . . . . 64.310000000000002 109.295 177.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -116.3 115.89 26.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.135 -0.939 . . . . 73.129999999999995 109.127 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -129.55 107.01 9.13 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.186 -0.916 . . . . 55.509999999999998 109.748 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.68 -72.74 1.73 Allowed Glycine 0 C--N 1.303 -1.274 0 C-N-CA 121.121 -0.561 . . . . 51.009999999999998 111.95 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -154.91 4.63 0.22 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.172 0.804 . . . . 75.450000000000003 113.172 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.517 HD23 HD11 ' B' ' 40' ' ' ILE . 2.0 pt? -107.25 136.45 47.04 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 117.205 -1.798 . . . . 61.350000000000001 111.379 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -93.84 113.41 25.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.274 -0.875 . . . . 64.099999999999994 109.268 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.29 119.23 38.89 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.918 -0.771 . . . . 74.430000000000007 108.918 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 28' ' ' THR . 66.5 t -108.39 123.09 63.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 116.519 -0.309 . . . . 74.519999999999996 111.224 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.415 HD12 HD13 ' B' ' 29' ' ' ILE . 84.5 mt -102.06 116.2 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.511 -0.768 . . . . 71.129999999999995 109.163 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -102.6 116.94 33.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.817 -1.179 . . . . 74.109999999999999 107.817 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.426 HG23 HD23 ' B' ' 34' ' ' LEU . 40.6 mm -93.54 114.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 108.109 -1.071 . . . . 73.549999999999997 108.109 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -124.23 178.54 5.29 Favored 'General case' 0 N--CA 1.406 -2.649 0 C-N-CA 120.476 -0.489 . . . . 75.319999999999993 110.209 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -74.83 -41.58 59.63 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 113.968 1.099 . . . . 73.299999999999997 113.968 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -98.97 -10.73 22.32 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.765 -0.774 . . . . 74.450000000000003 110.045 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.22 -145.89 4.9 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 117.484 -2.293 . . . . 75.109999999999999 116.61 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.456 ' CD2' ' HB3' ' B' ' 49' ' ' ALA . 47.1 tp -130.36 141.45 50.57 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 125.26 1.424 . . . . 74.040000000000006 108.166 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.44 139.98 47.03 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.975 -0.69 . . . . 74.129999999999995 109.579 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 11.4 p -131.57 141.04 46.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 115.913 -0.585 . . . . 64.439999999999998 110.213 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.3 m -122.17 139.38 53.83 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.187 -0.461 . . . . 70.099999999999994 111.023 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.454 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.62 124.45 49.82 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 72.549999999999997 108.566 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -138.5 91.27 12.46 Favored Pre-proline 0 C--N 1.281 -2.402 0 CA-C-N 115.452 -0.794 . . . . 64.239999999999995 108.947 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.2 Cg_exo -80.83 141.45 13.45 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 122.829 2.353 . . . . 75.219999999999999 113.149 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 . . . . . 0 C--N 1.339 0.131 0 CA-C-N 114.749 -1.114 . . . . 74.040000000000006 110.84 172.194 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 2.8 ptm180 . . . . . 0 C--O 1.245 0.844 0 N-CA-C 115.267 1.58 . . . . 74.230000000000004 115.267 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 28.5 p -109.08 145.94 34.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.089 -1.078 . . . . 71.409999999999997 108.089 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 77.8 m -144.47 151.16 38.78 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.045 -0.724 . . . . 74.450000000000003 109.045 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 91.4 t -144.41 141.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 73.409999999999997 109.284 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -107.38 130.69 54.77 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.211 0.529 . . . . 74.219999999999999 109.8 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' LEU . . . . . 0.523 HD21 ' CG2' ' A' ' 12' ' ' VAL . 95.3 mt -102.23 121.36 42.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.781 -0.645 . . . . 71.409999999999997 110.694 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -85.25 113.93 21.96 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.616 -1.253 . . . . 74.439999999999998 107.616 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -153.76 170.05 21.88 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.22 -0.592 . . . . 75.329999999999998 109.878 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -72.2 93.52 1.46 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.295 0.569 . . . . 73.340000000000003 110.826 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ARG . . . . . 0.463 ' HE ' HD22 ' A' ' 34' ' ' LEU . 1.5 tmt_? -126.08 132.31 51.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.181 -1.785 . . . . 73.439999999999998 106.181 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.04 155.67 90.16 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 112.653 0.612 . . . . 71.219999999999999 112.653 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.97 140.39 23.99 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.937 3.091 . . . . 72.129999999999995 114.648 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.404 ' HB ' ' NH1' ' B' ' 18' ' ' ARG . 12.4 p -131.81 149.14 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.303 -1.369 . . . . 74.510000000000005 107.303 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -89.37 -45.57 9.38 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.754 0.312 . . . . 74.310000000000002 111.776 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -117.81 141.68 48.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.319 -0.4 . . . . 75.5 110.844 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.047 -0.723 . . . . 63.5 109.047 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.525 0.678 . . . . 73.010000000000005 112.03 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 77.1 m -130.64 128.51 41.12 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.751 -1.203 . . . . 75.109999999999999 107.751 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.36 125.03 37.86 Favored 'General case' 0 CA--C 1.446 -3.039 0 N-CA-C 108.617 -0.882 . . . . 75.140000000000001 108.617 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 19.7 m -117.61 119.51 35.22 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 115.202 -0.908 . . . . 71.430000000000007 111.317 -176.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.415 HD13 HD12 ' A' ' 38' ' ' ILE . 52.4 mt -111.97 121.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 109.654 -0.499 . . . . 63.229999999999997 109.654 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -101.74 118.88 37.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.992 -1.484 . . . . 73.319999999999993 106.992 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.446 ' O ' HD21 ' B' ' 34' ' ' LEU . 14.1 tp10 -132.87 122.37 24.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.481 -0.781 . . . . 73.519999999999996 109.397 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.23 -96.13 0.16 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 111.096 -0.802 . . . . 72.150000000000006 111.096 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 18.0 m -138.12 10.93 2.82 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.906 0.384 . . . . 53.200000000000003 110.364 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.446 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.1 pt? -118.3 141.38 48.58 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 120.57 -0.452 . . . . 75.310000000000002 109.827 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -112.48 134.31 54.08 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 115.894 -0.594 . . . . 74.109999999999999 112.216 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.97 53.14 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.088 -0.96 . . . . 75.030000000000001 109.272 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' B' ' 48' ' ' CYS . 76.1 t -114.17 127.12 71.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.019 -0.537 . . . . 74.299999999999997 110.151 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' B' ' 26' ' ' THR . 62.9 mt -110.62 129.52 65.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 115.826 -0.625 . . . . 74.319999999999993 110.599 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . 0.454 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.4 m-85 -109.48 116.92 32.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.824 -0.806 . . . . 72.109999999999999 108.824 176.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ILE . . . . . 0.517 HD11 HD23 ' A' ' 34' ' ' LEU . 49.1 mm -91.39 116.43 32.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.745 -0.662 . . . . 73.430000000000007 109.547 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.2 t -133.15 167.87 19.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.029 -0.73 . . . . 74.099999999999994 109.029 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.57 ' C ' ' HE3' ' B' ' 42' ' ' LYS 0.349 0.0 OUTLIER -86.37 2.42 47.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.639 0.978 . . . . 72.120000000000005 113.639 179.425 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -90.14 -13.26 36.05 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.036 -1.098 . . . . 74.549999999999997 108.036 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.07 -134.34 6.11 Favored Glycine 0 N--CA 1.424 -2.153 0 CA-C-N 115.245 -0.889 . . . . 73.099999999999994 112.059 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.454 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 60.1 tp -113.51 144.32 43.05 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 122.873 0.469 . . . . 74.25 109.833 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.409 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 83.3 tttt -129.37 136.12 49.59 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.618 -0.512 . . . . 60.109999999999999 109.618 168.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.42 140.69 43.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.094 -0.957 . . . . 63.0 110.512 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' CYS . . . . . 0.454 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 36.4 m -129.39 137.3 50.85 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.666 -0.697 . . . . 61.030000000000001 110.654 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' ALA . . . . . 0.481 ' HB1' HH22 ' A' ' 18' ' ' ARG . . . -117.8 124.02 47.39 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 107.803 -1.184 . . . . 71.420000000000002 107.803 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -121.82 110.88 33.04 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.946 -1.131 . . . . 64.319999999999993 107.946 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.434 -1.981 0 C-N-CA 121.408 1.405 . . . . 74.099999999999994 112.712 -177.184 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 109.992 -0.373 . . . . 74.109999999999999 109.992 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.97 36.25 6.09 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 109.979 -1.249 . . . . 65.010000000000005 109.979 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t 73.62 87.59 0.1 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.598 1.159 . . . . 65.329999999999998 110.229 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.2 119.12 22.45 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.283 -0.872 . . . . 62.340000000000003 108.703 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.62 90.97 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.0 0.905 . . . . 63.240000000000002 111.336 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -91.41 156.23 17.89 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.749 -0.834 . . . . 72.019999999999996 108.749 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.51 -6.89 21.32 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.752 -0.462 . . . . 74.319999999999993 109.752 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -92.62 -77.26 0.44 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.509 -0.552 . . . . 74.319999999999993 109.509 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -143.04 119.21 10.77 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.446 -0.946 . . . . 74.239999999999995 108.446 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.4 m -109.59 144.04 38.45 Favored 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 119.531 -0.868 . . . . 71.150000000000006 109.494 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.69 149.32 43.4 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.43 -1.322 . . . . 74.510000000000005 107.43 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 HG13 HG13 ' B' ' 12' ' ' VAL . 58.6 t -140.54 139.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 121.157 -0.217 . . . . 72.040000000000006 110.929 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -110.98 131.0 55.41 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 122.998 0.519 . . . . 73.030000000000001 109.64 172.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 14' ' ' LEU . 4.2 pp -119.88 136.27 54.56 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.261 -1.015 . . . . 65.140000000000001 108.261 174.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 m -107.57 120.78 43.15 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.069 -0.715 . . . . 75.439999999999998 109.069 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -131.71 -169.24 2.16 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.392 -0.367 . . . . 65.439999999999998 110.957 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' B' ' 7' ' ' ASP . 18.6 pt20 -69.93 104.13 2.43 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.547 1.165 . . . . 73.510000000000005 108.043 174.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.637 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 1.6 mmp_? -125.53 149.51 48.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 114.871 1.434 . . . . 72.25 114.871 -170.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.421 HD11 ' O ' ' A' ' 19' ' ' LEU . 3.4 pp -101.84 148.26 35.05 Favored Pre-proline 0 N--CA 1.417 -2.093 0 CA-C-N 113.512 -1.677 . . . . 75.329999999999998 107.668 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.25 143.89 32.43 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.051 1.834 . . . . 75.310000000000002 112.496 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -131.36 140.0 49.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.984 -1.117 . . . . 75.340000000000003 107.984 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 p -58.66 -59.81 4.81 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.673 0.62 . . . . 72.200000000000003 112.673 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -115.98 166.92 11.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 112.148 0.425 . . . . 73.239999999999995 112.148 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mm -89.46 125.26 42.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.853 -0.612 . . . . 71.319999999999993 109.445 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 33.7 mmtm -89.57 145.46 25.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.88 -0.728 . . . . 71.099999999999994 109.68 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.6 m -120.86 126.96 51.39 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.101 -1.074 . . . . 70.310000000000002 108.101 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -124.92 129.41 50.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.921 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 37' ' ' VAL . 66.3 p -114.14 130.57 56.59 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.659 -0.7 . . . . 63.520000000000003 111.929 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.51 HD13 HD11 ' B' ' 38' ' ' ILE . 76.1 mt -126.35 126.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.637 -0.711 . . . . 75.129999999999995 109.735 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -102.42 133.8 46.77 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.915 -0.772 . . . . 61.149999999999999 108.915 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' HG2' HG13 ' B' ' 40' ' ' ILE . 11.9 tp10 -141.56 97.65 3.2 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 109.954 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.5 -85.33 0.26 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.501 -0.772 . . . . 75.319999999999993 111.769 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.543 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 37.3 p -137.54 14.83 2.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.867 0.841 . . . . 74.25 110.024 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' CD2' HD11 ' B' ' 40' ' ' ILE . 24.9 tp -106.67 132.49 52.6 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 115.387 -0.824 . . . . 62.450000000000003 110.844 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -108.84 115.88 30.92 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.36 -0.837 . . . . 61.420000000000002 110.339 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.06 120.08 40.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.631 -0.877 . . . . 64.510000000000005 108.631 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.414 HG23 HG23 ' A' ' 28' ' ' THR . 87.5 t -114.79 126.04 72.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.286 0.565 . . . . 55.399999999999999 111.145 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.478 HD12 HD13 ' B' ' 29' ' ' ILE . 77.9 mt -106.16 122.91 60.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 124.259 1.024 . . . . 63.210000000000001 110.009 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 97.8 m-85 -107.8 118.11 35.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.254 -1.017 . . . . 74.209999999999994 108.254 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.491 HG13 ' HG2' ' B' ' 31' ' ' GLU . 45.2 mm -88.58 118.93 35.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.036 -0.727 . . . . 70.239999999999995 109.036 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.2 p -119.7 165.81 14.03 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.0 -0.546 . . . . 71.310000000000002 109.642 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' N ' ' HD3' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.08 -17.91 63.25 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 122.859 0.463 . . . . 75.329999999999998 111.211 178.041 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -94.99 -23.79 17.22 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.123 0.487 . . . . 72.030000000000001 110.401 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.47 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 160.8 -139.8 6.29 Favored Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 118.497 -1.811 . . . . 74.209999999999994 114.988 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.1 tp -113.07 122.45 47.61 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.474 -0.863 . . . . 72.400000000000006 109.148 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 1.8 tmtm? -116.83 122.12 43.49 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.279 -2.119 . . . . 71.439999999999998 105.279 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.54 140.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 C-N-CA 120.745 -0.382 . . . . 65.019999999999996 110.661 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.455 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 59.3 m -122.94 141.43 51.93 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.259 -0.428 . . . . 62.240000000000002 110.983 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.42 124.85 51.04 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.825 -0.625 . . . . 65.510000000000005 110.421 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -123.31 91.98 49.33 Favored Pre-proline 0 C--N 1.298 -1.668 0 C-N-CA 124.264 1.026 . . . . 74.319999999999993 108.52 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -98.61 133.12 0.26 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.297 1.998 . . . . 72.25 114.15 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.466 ' NE2' ' HG ' ' B' ' 19' ' ' LEU . 56.9 mt-30 52.04 22.51 1.88 Allowed 'General case' 0 C--O 1.243 0.729 0 CA-C-N 113.818 -1.537 . . . . 74.129999999999995 114.329 171.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.09 -60.63 2.99 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.826 0.822 . . . . 55.140000000000001 109.517 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.2 p -105.16 175.05 5.62 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 114.479 -1.237 . . . . 53.299999999999997 107.792 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -80.89 116.75 21.02 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.008 -0.677 . . . . 75.150000000000006 109.328 174.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 33' ' ' SER . 38.6 t -107.8 153.47 9.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.148 -0.933 . . . . 71.430000000000007 108.656 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -86.61 145.36 26.77 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.359 -0.608 . . . . 73.219999999999999 109.359 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -80.64 59.74 3.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.872 0.844 . . . . 74.329999999999998 110.032 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.2 t 64.41 112.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.869 0 C-N-CA 125.046 1.338 . . . . 71.040000000000006 112.767 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.305 -1.358 0 CA-C-N 115.614 -0.721 . . . . 72.239999999999995 110.49 179.795 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.24 0.584 0 N-CA-C 109.518 -0.549 . . . . 75.430000000000007 109.518 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.62 39.57 3.01 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 121.073 -0.584 . . . . 70.409999999999997 112.204 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 22.2 t 64.62 15.71 9.86 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.184 0.994 . . . . 72.530000000000001 110.309 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -144.3 143.06 30.82 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.587 -0.733 . . . . 72.519999999999996 109.597 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.22 133.62 63.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.512 -1.662 . . . . 70.400000000000006 106.512 171.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 39.2 t -127.32 140.48 52.17 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.867 -0.733 . . . . 74.120000000000005 111.408 -172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 13.7 m-20 -63.36 -32.37 73.78 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.393 -0.821 . . . . 74.239999999999995 110.037 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.582 ' O ' ' HD2' ' B' ' 51' ' ' PRO . 93.4 mttt -59.28 -66.2 0.55 Allowed 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 124.381 1.051 . . . . 65.409999999999997 110.194 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -156.41 124.0 5.47 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.36 -0.978 . . . . 75.340000000000003 108.36 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.9 m -110.29 141.86 42.7 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.975 -0.75 . . . . 63.140000000000001 108.975 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 79.6 m -127.82 148.98 50.47 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.037 -1.097 . . . . 75.209999999999994 108.037 173.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.407 HG13 HG13 ' A' ' 12' ' ' VAL . 40.7 t -139.77 142.17 32.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.361 -0.607 . . . . 72.450000000000003 109.361 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.9 p -107.49 125.27 51.06 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.874 -1.158 . . . . 71.0 107.874 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' B' ' 45' ' ' LEU . 3.9 pp -112.91 144.02 43.19 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.036 0.446 . . . . 71.0 111.547 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -83.24 135.78 34.64 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.606 -0.724 . . . . 75.140000000000001 110.407 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p -156.44 153.49 28.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.833 0.853 . . . . 62.140000000000001 109.743 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -76.05 93.83 3.35 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.341 1.067 . . . . 75.040000000000006 109.398 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -123.24 148.34 45.97 Favored 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 114.937 -1.028 . . . . 63.0 113.369 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.466 ' HG ' ' NE2' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -80.81 153.81 72.96 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 114.044 -1.434 . . . . 70.310000000000002 109.343 172.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.04 149.94 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.504 2.136 . . . . 54.25 112.586 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.7 124.59 72.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 108.124 -1.065 . . . . 62.340000000000003 108.124 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.9 m -58.7 -47.08 85.79 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.169 0.588 . . . . 50.420000000000002 112.285 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -122.5 145.8 47.98 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.498 -0.556 . . . . 73.400000000000006 109.498 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.58 114.97 16.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.238 -1.023 . . . . 74.099999999999994 108.238 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -92.53 144.34 25.44 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.715 -0.675 . . . . 64.239999999999995 109.678 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 75.2 m -131.24 126.99 36.9 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.421 -0.955 . . . . 73.030000000000001 108.421 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 85.5 m-85 -122.95 131.48 53.74 Favored 'General case' 0 CA--C 1.465 -2.305 0 CA-C-N 115.716 -0.674 . . . . 72.25 110.733 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.513 HG22 HG22 ' B' ' 37' ' ' VAL . 23.1 p -115.35 131.22 57.0 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 124.254 0.971 . . . . 74.230000000000004 111.813 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.478 HD13 HD12 ' A' ' 38' ' ' ILE . 49.2 mt -128.61 134.23 64.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 116.029 -0.532 . . . . 73.109999999999999 109.881 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -110.32 133.11 53.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.898 -0.778 . . . . 75.450000000000003 108.898 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.491 ' HG2' HG13 ' A' ' 40' ' ' ILE . 26.7 tp10 -142.4 102.02 4.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.216 0.531 . . . . 72.439999999999998 109.57 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.08 -78.02 1.29 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.521 -0.763 . . . . 60.109999999999999 111.412 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -157.74 33.64 0.26 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.324 -1.361 . . . . 72.230000000000004 107.324 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.467 HD21 HD11 ' A' ' 40' ' ' ILE . 31.6 tp -120.61 125.26 47.29 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.449 -0.796 . . . . 64.319999999999993 110.307 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 32.7 mmt180 -99.75 115.18 28.92 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.746 0.654 . . . . 74.219999999999999 111.099 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 124.48 49.46 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.418 -0.956 . . . . 73.319999999999993 108.418 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.513 HG22 HG22 ' B' ' 28' ' ' THR . 67.8 t -120.47 135.01 62.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.16 0.505 . . . . 75.200000000000003 110.355 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.51 HD11 HD13 ' A' ' 29' ' ' ILE . 77.2 mt -118.79 122.36 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 CA-C-N 115.293 -0.867 . . . . 74.400000000000006 109.524 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.4 m-85 -107.77 115.78 30.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.063 -1.088 . . . . 73.200000000000003 108.063 176.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.542 HG13 ' HG2' ' A' ' 31' ' ' GLU . 48.5 mm -88.61 114.85 27.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.27 -0.641 . . . . 74.310000000000002 109.27 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 76.7 p -122.43 162.31 21.89 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.156 -0.474 . . . . 75.129999999999995 110.294 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -56.69 -25.58 54.53 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.768 0.827 . . . . 71.439999999999998 112.83 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -89.78 -16.13 30.9 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 111.893 0.331 . . . . 74.329999999999998 111.893 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.89 -134.59 4.41 Favored Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 118.88 -1.629 . . . . 72.030000000000001 113.314 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' B' ' 14' ' ' LEU . 58.9 tp -113.3 125.59 54.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.293 -0.632 . . . . 70.019999999999996 109.293 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.426 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 2.6 tmtm? -115.65 121.67 43.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.754 -1.943 . . . . 61.539999999999999 105.754 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 p -114.74 140.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 116.61 -0.268 . . . . 74.450000000000003 110.977 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 47.6 m -130.81 137.93 49.66 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 122.893 0.477 . . . . 74.129999999999995 111.53 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.425 ' CB ' HD13 ' A' ' 14' ' ' LEU . . . -117.68 125.26 50.37 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.058 -0.519 . . . . 62.020000000000003 110.5 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 32.6 t70 -120.99 83.91 38.35 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.347 -0.983 . . . . 74.230000000000004 108.347 174.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' B' ' 8' ' ' LYS . 80.6 Cg_endo -89.07 135.44 2.74 Favored 'Trans proline' 0 N--CA 1.431 -2.196 0 C-N-CA 122.675 2.25 . . . . 74.019999999999996 114.485 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 69.5 -74.77 0.08 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 125.639 1.576 . . . . 74.519999999999996 113.294 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 52.66 -91.52 0.02 OUTLIER 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.509 1.124 . . . . 70.219999999999999 112.924 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 29.8 p -137.39 -73.05 0.42 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-O 120.619 0.247 . . . . 75.420000000000002 111.508 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -126.87 92.22 3.49 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.208 0.527 . . . . 73.5 112.194 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 68.2 t -97.26 113.0 30.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.617 -1.253 . . . . 63.219999999999999 107.617 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -86.77 163.66 17.15 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 112.445 0.535 . . . . 70.129999999999995 112.445 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.85 -25.97 59.36 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 114.839 -1.073 . . . . 72.329999999999998 109.104 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 61.4 t 66.82 74.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 114.872 -1.058 . . . . 75.219999999999999 110.848 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.431 -1.42 0 CA-C-N 114.476 -1.238 . . . . 72.25 110.136 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 110.139 -0.319 . . . . 62.240000000000002 110.139 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.47 38.03 18.77 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.178 -1.169 . . . . 70.299999999999997 110.178 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.7 m -60.56 135.54 57.79 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.314 0.645 . . . . 74.439999999999998 111.704 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.08 117.83 16.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.304 -0.862 . . . . 72.450000000000003 108.778 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 m -79.78 87.04 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.236 1.017 . . . . 74.439999999999998 112.082 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 m -73.38 -15.44 61.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.577 -1.192 . . . . 42.140000000000001 111.929 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -79.98 -18.43 50.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.95 -0.389 . . . . 70.109999999999999 109.95 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.52 ' HE3' ' N ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -76.56 93.43 3.58 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.785 -1.561 . . . . 74.150000000000006 106.785 167.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 98.8 mtt180 70.28 100.5 0.06 Allowed 'General case' 0 C--N 1.313 -1.014 0 O-C-N 124.508 1.13 . . . . 72.099999999999994 110.425 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.2 p -86.11 117.86 25.21 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.359 -0.978 . . . . 63.020000000000003 108.359 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 56.7 m -121.48 149.33 43.22 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.672 -0.694 . . . . 70.299999999999997 109.385 -176.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.0 t -142.62 149.71 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 123.468 0.707 . . . . 74.340000000000003 109.383 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 p -106.58 125.72 51.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.978 0.418 . . . . 72.25 111.186 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.9 mm? -102.94 123.57 46.8 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.223 1.009 . . . . 75.349999999999994 110.16 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -107.63 112.26 24.89 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.54 -0.541 . . . . 75.25 109.54 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -151.54 95.68 2.16 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.156 0.503 . . . . 73.439999999999998 111.515 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.48 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 56.3 tp60 48.59 84.06 0.03 OUTLIER 'General case' 0 C--O 1.247 0.943 0 CA-C-N 114.774 -1.103 . . . . 74.519999999999996 111.752 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -124.73 145.7 49.56 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 114.115 1.154 . . . . 74.409999999999997 114.115 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.13 148.15 48.46 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 106.919 -1.511 . . . . 70.200000000000003 106.919 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 36.6 Cg_endo -66.17 136.22 43.29 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.741 1.627 . . . . 73.329999999999998 113.595 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -124.16 139.46 50.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 72.209999999999994 106.675 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 m -98.2 9.3 43.27 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.538 0.57 . . . . 72.140000000000001 112.538 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -131.16 133.33 45.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.867 -0.79 . . . . 74.129999999999995 108.867 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -90.75 116.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.476 -0.935 . . . . 74.450000000000003 108.476 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.71 127.19 45.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.324 -0.551 . . . . 74.129999999999995 110.821 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 54.0 p -108.68 127.77 54.28 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 107.991 -1.114 . . . . 63.329999999999998 107.991 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -126.5 125.8 42.67 Favored 'General case' 0 CA--C 1.467 -2.22 0 CA-C-N 116.316 -0.402 . . . . 75.310000000000002 109.949 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 37' ' ' VAL . 67.2 p -115.78 121.9 43.83 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.707 -0.679 . . . . 73.400000000000006 111.351 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.461 HD13 HD11 ' B' ' 38' ' ' ILE . 51.1 mt -117.79 123.08 71.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 116.207 -0.451 . . . . 72.409999999999997 110.193 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -105.83 129.06 54.08 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.349 -0.982 . . . . 63.439999999999998 108.349 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.01 111.7 6.68 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.302 -0.863 . . . . 65.040000000000006 109.498 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.21 -67.89 2.09 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.97 -0.559 . . . . 65.099999999999994 111.764 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.0 t -162.1 -21.05 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 122.027 0.131 . . . . 62.149999999999999 111.052 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.522 ' H ' HD21 ' A' ' 34' ' ' LEU . 2.3 pt? -89.34 141.71 28.3 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.661 -0.496 . . . . 64.310000000000002 109.661 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -117.86 118.6 32.46 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.764 -0.653 . . . . 72.430000000000007 109.262 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.33 133.72 48.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.005 -0.543 . . . . 75.540000000000006 109.602 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.509 HG23 HG23 ' A' ' 28' ' ' THR . 25.9 t -116.53 130.77 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.121 0.486 . . . . 74.319999999999993 110.435 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.436 HD12 HD13 ' B' ' 29' ' ' ILE . 74.2 mt -108.26 116.95 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 C-N-CA 124.583 1.153 . . . . 64.340000000000003 108.612 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.528 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 95.6 m-85 -105.78 116.06 31.29 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.177 -1.046 . . . . 74.349999999999994 108.177 175.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.419 HG23 HD23 ' B' ' 34' ' ' LEU . 44.9 mm -88.85 119.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 108.193 -1.04 . . . . 74.540000000000006 108.193 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -128.1 162.58 26.56 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.099 -0.501 . . . . 75.219999999999999 110.343 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -63.28 -18.21 63.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.214 0.605 . . . . 74.510000000000005 110.969 177.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -94.43 -9.28 36.1 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.541 0.686 . . . . 74.230000000000004 109.837 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.99 -134.37 7.39 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.593 -0.813 . . . . 72.140000000000001 113.119 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.495 ' CD2' ' HB3' ' B' ' 49' ' ' ALA . 56.1 tp -111.76 125.51 54.07 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.901 -0.407 . . . . 74.340000000000003 109.901 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.2 tptm -115.22 121.65 43.59 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.824 -1.546 . . . . 63.130000000000003 106.824 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 14.4 p -112.13 140.57 31.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 116.496 -0.32 . . . . 74.109999999999999 110.646 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -127.55 138.51 52.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.392 -0.367 . . . . 71.120000000000005 111.114 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.591 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.1 123.64 48.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.119 -0.491 . . . . 70.239999999999995 109.718 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 29.6 t70 -101.62 119.36 57.5 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.136 -0.69 . . . . 71.25 109.136 176.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' B' ' 17' ' ' GLN . 93.0 Cg_exo -48.65 135.88 27.33 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.247 3.298 . . . . 75.430000000000007 114.536 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -51.18 112.2 0.69 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.114 -0.948 . . . . 74.400000000000006 110.456 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.08 -66.56 1.06 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.973 -0.558 . . . . 73.340000000000003 110.215 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.4 m -104.08 135.86 44.78 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.977 -1.12 . . . . 74.420000000000002 107.977 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -71.21 126.55 29.91 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.359 -1.348 . . . . 75.319999999999993 107.359 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.8 p -75.08 113.39 13.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.933 0.873 . . . . 71.200000000000003 112.287 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -104.37 75.0 1.21 Allowed 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.345 -0.983 . . . . 74.230000000000004 108.345 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t70 170.39 87.93 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.273 1.429 . . . . 54.32 108.622 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.35 133.17 61.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.333 0.587 . . . . 74.239999999999995 111.55 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.299 -1.606 0 CA-C-N 115.519 -0.764 . . . . 72.040000000000006 109.833 179.361 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.246 0.895 0 CA-C-O 121.656 0.741 . . . . 75.319999999999993 109.839 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.43 63.47 0.55 Allowed Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 114.641 -1.163 . . . . 74.450000000000003 111.088 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 30.4 p -57.58 111.69 1.2 Allowed 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.72 0.772 . . . . 61.329999999999998 111.727 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.26 151.6 35.02 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.002 -0.999 . . . . 74.230000000000004 110.877 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' B' ' 8' ' ' LYS . 27.7 m -67.06 104.24 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 122.078 0.942 . . . . 61.32 111.963 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 48.2 m -98.44 -67.31 0.85 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.254 -0.885 . . . . 72.010000000000005 110.037 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.45 -3.7 30.38 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.168 0.508 . . . . 73.439999999999998 109.868 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.508 ' O ' ' HB ' ' B' ' 5' ' ' VAL . 39.9 ttmt -88.28 102.79 15.18 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.302 -0.999 . . . . 74.439999999999998 108.302 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 87.1 mtt180 60.68 92.64 0.05 OUTLIER 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.748 1.219 . . . . 74.409999999999997 111.193 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.7 p -91.4 135.5 33.78 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.255 0.55 . . . . 73.150000000000006 110.672 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 55.5 m -131.04 149.79 52.45 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.119 -1.067 . . . . 74.209999999999994 108.119 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 76.1 t -144.29 145.55 21.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.546 -0.539 . . . . 72.219999999999999 109.546 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.6 p -106.88 135.08 49.04 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.12 0.486 . . . . 63.439999999999998 109.833 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 2.8 mm? -109.56 121.56 45.47 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.77 -0.65 . . . . 74.25 110.124 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 27.2 p -106.95 112.75 25.85 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.466 -0.939 . . . . 73.019999999999996 108.466 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.408 ' O ' ' HG3' ' B' ' 18' ' ' ARG . 10.5 t -134.44 -167.56 1.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.844 -1.169 . . . . 72.319999999999993 107.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 51' ' ' PRO . 56.3 tp60 -62.51 88.08 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.731 0.777 . . . . 54.25 110.251 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' B' ' 16' ' ' THR . 5.5 ppt_? -126.77 150.15 49.27 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.242 0.83 . . . . 75.239999999999995 113.242 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.15 159.0 31.79 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 107.039 -1.467 . . . . 71.230000000000004 107.039 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.47 135.64 31.66 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.233 1.288 . . . . 73.299999999999997 111.624 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.43 130.52 67.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.774 -0.824 . . . . 71.239999999999995 108.774 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -94.16 1.05 56.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.134 0.492 . . . . 53.340000000000003 112.128 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -112.02 142.82 43.98 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.755 -0.461 . . . . 75.340000000000003 109.755 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.7 131.23 50.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.049 -1.093 . . . . 73.099999999999994 108.049 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.498 ' HZ3' ' CD ' ' A' ' 31' ' ' GLU . 34.3 mmtp -124.97 143.58 50.81 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.163 -0.31 . . . . 72.140000000000001 110.163 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 41.4 p -126.37 127.98 46.33 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.107 -0.701 . . . . 74.530000000000001 109.107 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 80.1 m-85 -127.81 132.28 49.48 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 120.694 0.283 . . . . 72.430000000000007 111.118 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.49 HG22 HG22 ' B' ' 37' ' ' VAL . 36.6 p -115.09 125.31 53.35 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.357 -0.838 . . . . 75.420000000000002 112.405 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.436 HD13 HD12 ' A' ' 38' ' ' ILE . 58.0 mt -127.75 125.3 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-O 120.809 0.338 . . . . 74.319999999999993 110.523 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -108.91 131.68 54.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.469 -0.937 . . . . 72.109999999999999 108.469 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.568 ' O ' HD21 ' B' ' 34' ' ' LEU . 11.6 tp10 -142.99 116.34 9.04 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.68 -0.691 . . . . 74.519999999999996 109.463 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.36 -59.78 2.81 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.669 -0.572 . . . . 38.299999999999997 111.669 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -174.13 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.563 0.745 . . . . 75.099999999999994 110.461 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.568 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -77.5 140.84 39.86 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.158 -0.682 . . . . 70.310000000000002 109.158 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -119.8 121.71 39.75 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.99 -0.55 . . . . 74.010000000000005 109.53 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.54 52.01 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.843 -0.617 . . . . 73.230000000000004 109.888 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.49 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -114.13 125.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.752 -0.658 . . . . 74.230000000000004 109.895 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.461 HD11 HD13 ' A' ' 29' ' ' ILE . 77.9 mt -101.63 119.06 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 C-N-CA 123.664 0.786 . . . . 72.349999999999994 109.297 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.404 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.2 m-85 -104.72 114.86 29.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.411 -0.813 . . . . 72.239999999999995 108.857 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 41.8 mm -89.49 115.24 28.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 106.408 -1.701 . . . . 75.450000000000003 106.408 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.0 p -133.47 163.22 29.87 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.092 0.472 . . . . 63.109999999999999 111.949 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -57.06 -21.83 34.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.829 1.252 . . . . 75.010000000000005 111.413 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -88.22 -16.25 33.75 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.524 0.73 . . . . 70.129999999999995 109.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.43 -122.71 4.3 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 111.072 -0.811 . . . . 72.409999999999997 111.072 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.472 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 56.4 tp -112.19 144.98 40.67 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.653 -0.499 . . . . 71.25 109.653 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -141.41 141.72 33.73 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.479 -1.304 . . . . 74.230000000000004 107.479 168.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 11.8 p -131.51 140.7 47.66 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.029 0 N-CA-C 109.368 -0.604 . . . . 75.340000000000003 109.368 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.404 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.8 m -119.49 138.39 53.18 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.995 -0.548 . . . . 54.539999999999999 110.205 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.41 123.86 49.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.25 -0.648 . . . . 73.049999999999997 109.25 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.417 ' HA ' ' HG2' ' B' ' 9' ' ' ARG . 34.2 t70 -100.45 125.86 37.83 Favored Pre-proline 0 C--N 1.289 -2.036 0 CA-C-N 115.732 -0.667 . . . . 71.200000000000003 109.993 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 17' ' ' GLN . 5.0 Cg_exo -38.72 140.3 0.39 Allowed 'Trans proline' 0 C--N 1.356 0.945 1 C-N-CA 125.671 4.248 . . . . 62.43 116.018 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -68.65 73.65 0.25 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.395 -0.82 . . . . 70.230000000000004 110.575 170.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.49 8.03 2.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.911 -0.774 . . . . 73.019999999999996 108.911 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 4.8 m -82.35 136.38 35.01 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.125 -0.943 . . . . 61.450000000000003 108.938 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -85.33 89.14 7.59 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.713 -0.847 . . . . 72.439999999999998 108.713 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.78 107.11 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 121.806 0.813 . . . . 63.450000000000003 111.012 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -123.59 92.01 3.59 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.349 -0.842 . . . . 72.209999999999994 108.997 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -178.88 88.99 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.565 -1.198 . . . . 71.209999999999994 108.987 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.05 152.58 31.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.488 -0.778 . . . . 74.540000000000006 109.507 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.299 -1.599 0 CA-C-N 116.556 -0.293 . . . . 71.430000000000007 110.624 -179.894 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 110.093 -0.336 . . . . 71.25 110.093 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.55 31.33 8.38 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.726 -0.75 . . . . 72.140000000000001 113.053 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 p -93.86 136.87 33.69 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.664 0.232 . . . . 63.030000000000001 110.486 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.6 149.28 23.66 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.093 -0.706 . . . . 64.450000000000003 109.093 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t 70.07 107.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.629 1.172 . . . . 73.140000000000001 112.686 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -99.36 106.73 18.85 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.151 -0.685 . . . . 72.409999999999997 109.151 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.432 ' CG ' ' H ' ' A' ' 8' ' ' LYS . 16.7 t70 -152.08 -167.57 2.81 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.354 -0.98 . . . . 73.420000000000002 108.354 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.432 ' H ' ' CG ' ' A' ' 7' ' ' ASP . 95.4 mttt -85.11 119.08 25.1 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.255 0.55 . . . . 74.140000000000001 110.012 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.832 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 92.6 mtt180 68.83 90.33 0.1 Allowed 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 125.965 1.706 . . . . 70.230000000000004 111.443 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 p -99.45 134.36 42.43 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.834 -0.621 . . . . 72.219999999999999 109.576 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -130.09 148.94 51.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.488 -0.56 . . . . 73.340000000000003 109.488 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.9 139.14 22.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.365 0.416 . . . . 72.329999999999998 109.9 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 p -112.43 130.9 55.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.761 0.315 . . . . 73.230000000000004 110.75 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mm? -101.73 122.32 43.71 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.921 -0.581 . . . . 74.030000000000001 109.951 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -101.66 113.72 27.13 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 113.838 1.051 . . . . 75.140000000000001 113.838 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.517 HG21 ' CZ ' ' A' ' 18' ' ' ARG . 14.6 t -155.91 165.79 35.42 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.661 -1.978 . . . . 75.439999999999998 105.661 166.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -86.08 90.33 8.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.811 1.291 . . . . 73.219999999999999 110.685 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.517 ' CZ ' HG21 ' A' ' 16' ' ' THR . 80.6 mtt85 -96.61 149.62 21.57 Favored 'General case' 0 N--CA 1.393 -3.282 0 N-CA-C 105.472 -2.048 . . . . 73.25 105.472 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 19' ' ' LEU . 2.3 mm? -73.26 128.33 87.72 Favored Pre-proline 0 C--N 1.284 -2.243 0 C-N-CA 120.725 -0.39 . . . . 63.149999999999999 111.571 -171.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.84 141.97 27.05 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 124.527 3.485 . . . . 70.450000000000003 115.394 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.17 135.17 58.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.332 -1.729 . . . . 73.209999999999994 106.332 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.7 m -59.12 -59.66 5.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.109 0.411 . . . . 71.200000000000003 112.109 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -97.56 146.11 25.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.523 -0.547 . . . . 63.299999999999997 109.523 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.1 mm -79.94 118.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.603 -0.888 . . . . 63.310000000000002 108.603 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.59 146.57 25.16 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.172 0.511 . . . . 62.039999999999999 111.626 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 39.2 p -126.0 127.64 46.21 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.917 -1.038 . . . . 72.140000000000001 108.977 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 79.1 m-85 -124.24 130.46 52.57 Favored 'General case' 0 CA--C 1.468 -2.189 0 CA-C-N 116.197 -0.456 . . . . 70.319999999999993 110.782 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.496 HG23 HG23 ' A' ' 37' ' ' VAL . 61.8 p -114.86 128.67 56.43 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.177 -0.919 . . . . 73.099999999999994 111.103 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 HD11 ' B' ' 38' ' ' ILE . 58.2 mt -126.91 123.46 62.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 120.931 0.396 . . . . 65.049999999999997 110.492 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.7 t -106.15 121.81 44.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.453 -0.943 . . . . 74.340000000000003 108.453 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.19 106.92 4.86 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.36 0.6 . . . . 63.049999999999997 111.279 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.05 -66.8 2.14 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.857 -0.61 . . . . 72.340000000000003 112.931 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -154.11 12.88 0.43 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.483 0.549 . . . . 73.329999999999998 112.483 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 30' ' ' THR . 1.6 pt? -128.58 141.56 51.33 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 118.062 -1.455 . . . . 71.049999999999997 111.877 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HG3' ' HB1' ' A' ' 53' ' ' ALA . 23.5 mmm180 -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.014 -1.476 . . . . 72.530000000000001 107.014 167.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.47 129.4 52.47 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.323 -0.621 . . . . 73.209999999999994 109.323 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 28' ' ' THR . 58.9 t -118.17 126.86 75.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.083 0.468 . . . . 70.530000000000001 110.912 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' THR . 69.6 mt -105.78 122.24 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.206 -0.906 . . . . 64.299999999999997 109.607 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.487 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.1 m-85 -103.36 114.89 29.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.885 -0.783 . . . . 74.109999999999999 108.885 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.466 HG23 HD23 ' B' ' 34' ' ' LEU . 40.6 mm -91.98 114.5 29.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.572 -0.899 . . . . 73.319999999999993 108.572 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.4 p -130.74 170.61 14.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.283 -0.636 . . . . 72.409999999999997 109.283 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -83.49 -4.73 58.79 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.876 -0.787 . . . . 73.140000000000001 108.876 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.562 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 3.1 tmt_? -98.64 6.11 47.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 106.949 -1.5 . . . . 72.230000000000004 106.949 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.35 -143.67 18.07 Favored Glycine 0 N--CA 1.423 -2.232 0 CA-C-N 114.228 -1.351 . . . . 53.530000000000001 113.148 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.562 ' CD2' ' HB3' ' B' ' 49' ' ' ALA . 55.0 tp -112.34 136.7 51.48 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.599 -0.519 . . . . 74.209999999999994 109.599 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -128.2 140.71 51.76 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.059 -0.719 . . . . 70.120000000000005 109.059 170.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.443 HG11 HG13 ' B' ' 47' ' ' VAL . 9.6 p -128.72 141.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 115.58 -0.736 . . . . 74.030000000000001 109.996 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.487 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 60.5 m -128.45 137.52 51.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.313 -0.403 . . . . 52.030000000000001 110.705 174.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.832 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.45 121.73 42.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.411 -0.589 . . . . 61.420000000000002 109.411 175.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -119.3 101.94 48.81 Favored Pre-proline 0 C--N 1.284 -2.242 0 C-N-CA 123.837 0.855 . . . . 75.010000000000005 109.718 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.07 133.44 13.58 Favored 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 120.839 1.026 . . . . 70.109999999999999 110.562 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 47.78 75.47 0.13 Allowed 'General case' 0 CA--C 1.546 0.806 0 O-C-N 124.261 0.976 . . . . 64.140000000000001 112.988 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HB1' ' HG3' ' A' ' 35' ' ' ARG . . . -59.03 -52.14 67.05 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.278 0.561 . . . . 43.409999999999997 111.813 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.1 t -161.92 -51.97 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.55 -0.907 . . . . 74.209999999999994 108.55 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -148.88 112.54 5.06 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.071 -1.455 . . . . 73.120000000000005 107.071 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.9 128.68 39.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 109.569 -0.53 . . . . 74.099999999999994 109.569 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.1 161.77 13.51 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.302 -0.559 . . . . 75.150000000000006 110.842 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -83.72 4.89 26.8 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.292 -0.867 . . . . 63.25 110.375 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t 76.08 105.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.796 1.239 . . . . 70.209999999999994 110.215 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.305 -1.369 0 CA-C-N 115.845 -0.616 . . . . 73.109999999999999 110.319 -178.261 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 49.6 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.36 -0.607 . . . . 74.310000000000002 109.36 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.8 -77.87 0.78 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.471 -0.786 . . . . 53.020000000000003 113.729 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 43.8 m -81.26 88.18 6.07 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.499 0.666 . . . . 72.420000000000002 112.067 -176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -159.92 116.06 2.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.198 -1.779 . . . . 75.310000000000002 106.198 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 53.8 t 58.52 74.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 107.747 -1.205 . . . . 64.540000000000006 107.747 -170.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -122.44 160.16 26.09 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 114.64 -1.164 . . . . 73.109999999999999 110.855 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' B' ' 8' ' ' LYS . 25.3 t70 -135.31 -160.52 1.06 Allowed 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 104.577 -2.379 . . . . 63.530000000000001 104.577 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.429 ' H ' ' CG ' ' B' ' 7' ' ' ASP 0.372 97.4 mttt -74.92 -2.07 25.31 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 119.573 1.079 . . . . 72.329999999999998 113.422 178.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.662 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 92.4 mtt180 -129.01 109.75 11.48 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 108.19 -1.041 . . . . 74.150000000000006 108.19 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 m -108.49 127.07 53.6 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.507 -1.294 . . . . 74.319999999999993 107.507 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m -121.66 148.97 43.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.947 -1.131 . . . . 72.439999999999998 107.947 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 92.8 t -144.45 146.77 20.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.681 -0.489 . . . . 52.119999999999997 109.681 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.43 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 35.3 p -106.16 135.84 46.91 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.91 -1.145 . . . . 74.430000000000007 107.91 174.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 3.2 mm? -100.2 122.56 43.22 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.497 -0.557 . . . . 74.420000000000002 109.497 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -84.62 112.56 20.56 Favored 'General case' 0 N--CA 1.397 -3.075 0 CA-C-N 115.441 -0.799 . . . . 65.349999999999994 109.803 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -154.65 177.79 10.83 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.191 -1.411 . . . . 75.530000000000001 107.191 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -108.2 108.55 19.63 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.44 0.638 . . . . 75.230000000000004 109.379 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -124.62 150.33 46.11 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.368 -0.833 . . . . 74.150000000000006 110.19 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.93 145.32 81.03 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 114.857 -1.065 . . . . 73.219999999999999 108.86 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.75 135.67 63.17 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 123.02 2.48 . . . . 72.230000000000004 112.806 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.72 131.2 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.658 -1.238 . . . . 72.310000000000002 107.658 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.9 m -56.29 -46.33 79.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 113.798 1.036 . . . . 61.409999999999997 113.798 -174.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.415 ' CZ ' ' HA ' ' B' ' 23' ' ' ARG . 0.4 OUTLIER -127.22 155.45 43.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.783 -0.821 . . . . 71.430000000000007 108.783 -175.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.3 131.53 33.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.947 0.403 . . . . 55.420000000000002 109.968 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.456 ' HB3' ' CE2' ' B' ' 27' ' ' TYR . 1.5 mptm? -116.72 143.5 45.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 112.322 0.49 . . . . 62.32 112.322 177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -125.85 127.12 45.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.444 -1.317 . . . . 74.439999999999998 107.444 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' B' ' 25' ' ' LYS . 75.9 m-85 -124.65 126.85 46.41 Favored 'General case' 0 CA--C 1.45 -2.899 0 CA-C-N 116.244 -0.435 . . . . 75.230000000000004 110.566 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.528 HG22 HG22 ' B' ' 37' ' ' VAL . 81.5 p -114.01 135.47 53.97 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 115.073 -0.967 . . . . 72.319999999999993 109.507 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.445 HD13 HD12 ' A' ' 38' ' ' ILE . 60.6 mt -127.97 121.65 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 116.114 -0.494 . . . . 71.200000000000003 110.772 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.525 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 6.2 t -100.96 117.46 35.05 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.589 -0.732 . . . . 64.319999999999993 109.1 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.452 ' O ' HD21 ' B' ' 34' ' ' LEU . 10.4 tp10 -140.39 110.29 6.47 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.553 -0.749 . . . . 73.530000000000001 110.286 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 -84.7 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.593 -0.73 . . . . 73.329999999999998 114.341 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.459 ' HA ' HG13 ' B' ' 56' ' ' VAL . 47.8 m -137.19 12.73 3.06 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 112.982 0.734 . . . . 71.140000000000001 112.982 -176.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.466 HD23 HG23 ' A' ' 40' ' ' ILE . 2.2 pt? -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.753 -0.779 . . . . 72.420000000000002 112.107 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.525 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 18.6 mmm180 -103.67 113.52 27.1 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.1 -1.444 . . . . 72.349999999999994 107.1 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.37 131.64 52.55 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 110.023 -0.362 . . . . 74.219999999999999 110.023 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.528 HG22 HG22 ' B' ' 28' ' ' THR . 59.8 t -122.61 124.84 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-O 120.836 0.351 . . . . 74.329999999999998 111.031 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.466 HD11 HD13 ' A' ' 29' ' ' ILE . 94.1 mt -104.53 122.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.651 -0.87 . . . . 75.049999999999997 108.651 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.1 m-85 -104.24 121.04 42.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.233 -1.395 . . . . 74.430000000000007 107.233 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.48 114.68 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.653 0 CA-C-O 122.398 1.094 . . . . 71.120000000000005 110.014 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -127.04 149.47 49.9 Favored 'General case' 1 N--CA 1.369 -4.492 0 CA-C-N 112.503 -2.135 . . . . 74.200000000000003 106.475 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -71.74 -18.93 62.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 118.62 0.645 . . . . 54.200000000000003 112.666 -177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.522 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 0.1 OUTLIER -86.89 6.14 33.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.165 0.984 . . . . 72.120000000000005 109.056 -172.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.94 -129.33 4.05 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.469 -0.872 . . . . 44.539999999999999 112.738 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 64.6 tp -125.64 144.55 50.54 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.584 0.754 . . . . 64.25 109.003 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.4 tptm -134.75 122.9 22.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.167 -1.42 . . . . 72.530000000000001 107.167 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.443 HG13 HG11 ' A' ' 47' ' ' VAL . 10.2 p -127.23 141.42 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 120.883 -0.327 . . . . 75.299999999999997 110.956 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 56.5 m -123.71 137.02 54.78 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.144 -0.48 . . . . 64.439999999999998 111.012 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.64 122.9 44.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.912 -0.586 . . . . 64.420000000000002 110.971 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -132.33 118.4 16.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 123.688 0.795 . . . . 74.340000000000003 109.324 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.62 134.24 15.0 Favored 'Trans proline' 0 N--CA 1.431 -2.153 0 C-N-CA 121.127 1.218 . . . . 71.430000000000007 112.352 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.497 ' HA ' ' CG1' ' B' ' 56' ' ' VAL . 41.8 mt-30 65.87 -57.48 0.34 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.974 1.71 . . . . 73.549999999999997 115.297 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 68.69 -75.77 0.06 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.161 1.384 . . . . 63.130000000000003 110.47 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.2 t -149.32 -48.46 0.14 Allowed 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.993 -0.743 . . . . 72.200000000000003 108.993 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -139.86 92.11 2.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.154 0.502 . . . . 74.510000000000005 111.826 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.497 ' CG1' ' HA ' ' B' ' 52' ' ' GLN . 8.6 p -100.97 131.16 49.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.123 -1.065 . . . . 73.030000000000001 108.123 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' B' ' 57' ' ' ARG . 0.2 OUTLIER -125.27 172.59 9.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.598 -0.841 . . . . 54.200000000000003 111.403 -177.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.6 49.11 0.85 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.497 1.519 . . . . 73.409999999999997 109.725 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.4 t 65.01 80.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.499 1.12 . . . . 74.430000000000007 110.457 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.248 0.987 0 CA-C-N 115.072 -0.967 . . . . 72.420000000000002 109.279 -178.568 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 110.068 -0.345 . . . . 63.539999999999999 110.068 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.416 ' C ' ' HG ' ' A' ' 3' ' ' SER . . . -89.43 131.38 10.69 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.976 -0.85 . . . . 74.010000000000005 110.976 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.416 ' HG ' ' C ' ' A' ' 2' ' ' GLY . 50.0 m -154.81 109.59 3.02 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 122.568 0.347 . . . . 74.329999999999998 110.543 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -77.61 115.05 17.06 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.849 -0.426 . . . . 74.200000000000003 109.849 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.7 m -81.72 99.37 4.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.692 0.758 . . . . 74.409999999999997 111.024 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.5 m -154.84 178.29 10.32 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.396 0.678 . . . . 73.140000000000001 109.416 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -77.97 86.88 4.15 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 112.796 0.665 . . . . 74.150000000000006 112.796 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -154.8 -82.36 0.08 Allowed 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 126.88 2.072 . . . . 75.329999999999998 106.834 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -151.09 120.99 7.09 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 107.325 -1.361 . . . . 74.439999999999998 107.325 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 m -108.8 140.2 42.57 Favored 'General case' 0 N--CA 1.403 -2.801 0 C-N-CA 119.101 -1.04 . . . . 55.420000000000002 109.597 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.94 149.56 50.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.69 -1.226 . . . . 75.519999999999996 107.69 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.5 t -140.69 135.72 34.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 110.068 -0.345 . . . . 62.229999999999997 110.068 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.403 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 30.2 p -107.45 135.9 48.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.58 -0.526 . . . . 74.319999999999993 109.58 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.468 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 4.2 pp -130.66 127.95 39.95 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.057 0.456 . . . . 72.109999999999999 110.595 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 t -110.03 119.51 39.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 74.120000000000005 110.193 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -159.56 114.67 2.42 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.677 -0.692 . . . . 74.340000000000003 109.856 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 35.85 81.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.848 1.659 . . . . 62.329999999999998 114.446 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -125.56 149.59 48.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.591 0.96 . . . . 71.120000000000005 113.591 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.419 HD11 ' N ' ' A' ' 19' ' ' LEU . 3.2 mp -111.26 155.54 42.54 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 107.692 -1.225 . . . . 62.350000000000001 107.692 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.26 142.83 94.76 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.724 2.283 . . . . 75.150000000000006 111.089 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.07 146.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.442 -0.947 . . . . 72.230000000000004 108.442 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.9 m -71.13 -39.9 71.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.738 0.644 . . . . 74.530000000000001 112.738 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -134.46 138.91 45.13 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.778 -0.576 . . . . 72.430000000000007 110.154 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.84 115.32 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 107.624 -1.25 . . . . 72.409999999999997 107.624 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.2 mmtp -101.29 132.16 46.97 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.387 -0.525 . . . . 72.519999999999996 111.388 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 p -113.05 126.65 55.72 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 106.671 -1.603 . . . . 74.099999999999994 106.671 173.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.577 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 69.7 m-85 -121.57 129.9 53.17 Favored 'General case' 0 CA--C 1.458 -2.572 0 CA-C-N 116.575 -0.284 . . . . 75.409999999999997 110.693 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.505 HG23 HG23 ' A' ' 37' ' ' VAL . 61.7 p -114.54 127.65 55.91 Favored 'General case' 0 C--N 1.286 -2.161 0 O-C-N 123.86 0.725 . . . . 75.239999999999995 111.171 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.442 HD13 HD11 ' B' ' 38' ' ' ILE . 62.7 mt -127.79 121.73 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.262 -0.644 . . . . 73.439999999999998 109.262 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -106.34 126.34 52.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.326 -0.99 . . . . 74.329999999999998 108.326 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.0 tp10 -142.34 99.97 3.61 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 111.869 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 -66.36 1.37 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 114.908 0.723 . . . . 53.340000000000003 114.908 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.4 m -139.29 -8.15 1.32 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.314 -0.521 . . . . 74.099999999999994 112.399 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -130.27 140.35 50.69 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 119.043 -1.063 . . . . 63.140000000000001 111.769 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -99.54 119.58 38.26 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.449 -1.315 . . . . 74.209999999999994 107.449 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.16 127.11 51.73 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.489 -0.56 . . . . 75.099999999999994 109.489 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 44.7 t -117.19 128.51 74.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.336 -0.393 . . . . 73.540000000000006 110.425 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.478 HD12 HD13 ' B' ' 29' ' ' ILE . 96.6 mt -108.59 121.29 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 N-CA-C 108.274 -1.01 . . . . 72.530000000000001 108.274 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.44 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 93.2 m-85 -104.88 114.63 28.95 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.197 -1.038 . . . . 74.329999999999998 108.197 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.497 HD11 HD23 ' B' ' 34' ' ' LEU . 48.4 mm -90.79 113.39 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.063 -1.088 . . . . 74.209999999999994 108.063 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -125.65 177.75 6.06 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.181 -1.044 . . . . 72.409999999999997 108.181 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -81.4 -32.67 32.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.956 1.095 . . . . 62.350000000000001 113.956 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -86.65 -20.1 28.31 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.829 -0.749 . . . . 72.25 110.863 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.73 -162.65 29.38 Favored Glycine 0 C--N 1.294 -1.779 0 C-N-CA 119.171 -1.49 . . . . 61.549999999999997 114.134 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 14' ' ' LEU . 2.0 tm? -113.69 122.88 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.475 -0.935 . . . . 70.409999999999997 108.475 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.0 tptm -115.76 122.43 45.44 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.408 -0.96 . . . . 72.329999999999998 108.408 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG11 HG13 ' B' ' 47' ' ' VAL . 13.8 p -119.23 140.53 42.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.868 -0.419 . . . . 64.230000000000004 109.868 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -125.71 139.79 53.24 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.969 -0.56 . . . . 73.109999999999999 111.332 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.431 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -117.0 123.68 47.5 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 108.429 -0.952 . . . . 54.539999999999999 108.429 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -113.72 87.44 12.19 Favored Pre-proline 0 C--N 1.282 -2.362 0 N-CA-C 108.197 -1.038 . . . . 71.530000000000001 108.197 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.3 Cg_endo -87.79 133.28 3.02 Favored 'Trans proline' 0 N--CA 1.417 -3.023 0 C-N-CA 121.57 1.513 . . . . 75.040000000000006 111.354 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 58.78 -176.46 0.08 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.09 -1.414 . . . . 74.439999999999998 113.37 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 179.45 -71.44 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.192 1.397 . . . . 74.519999999999996 107.725 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.6 p -143.61 -62.2 0.4 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.275 -1.75 . . . . 73.129999999999995 106.275 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -131.88 141.1 49.28 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.128 -1.434 . . . . 71.200000000000003 107.128 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.6 t -104.94 122.73 58.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.72 -0.844 . . . . 74.409999999999997 108.72 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -77.6 146.92 35.91 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.237 0.542 . . . . 74.329999999999998 111.673 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -97.57 108.32 21.01 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.247 -1.02 . . . . 73.230000000000004 108.247 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.04 127.37 33.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.109 0.481 . . . . 65.129999999999995 110.275 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--O 1.251 1.143 0 CA-C-N 115.668 -0.697 . . . . 65.519999999999996 110.218 -177.517 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.427 HG21 ' H ' ' B' ' 3' ' ' SER . 32.2 m . . . . . 0 C--O 1.239 0.537 0 N-CA-C 109.451 -0.574 . . . . 75.439999999999998 109.451 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.03 -1.49 63.18 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.176 0.298 . . . . 73.0 113.418 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.427 ' H ' HG21 ' B' ' 1' ' ' VAL . 18.2 m -86.94 112.34 21.7 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.661 -0.496 . . . . 75.140000000000001 109.661 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -90.54 102.64 15.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.723 -1.584 . . . . 63.219999999999999 106.723 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' B' ' 10' ' ' THR . 31.6 m -128.75 117.3 44.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 112.935 0.717 . . . . 74.310000000000002 112.935 -172.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -149.71 -80.44 0.12 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.952 -0.567 . . . . 73.209999999999994 112.393 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -121.05 -7.26 9.44 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 113.783 1.031 . . . . 74.519999999999996 113.783 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.73 -56.19 3.34 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 109.393 -0.595 . . . . 72.329999999999998 109.393 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -140.57 132.57 27.77 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 107.938 -1.134 . . . . 73.439999999999998 107.938 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.438 ' HB ' HD11 ' A' ' 14' ' ' LEU . 25.1 m -109.64 128.59 55.34 Favored 'General case' 0 N--CA 1.393 -3.298 0 N-CA-C 107.564 -1.273 . . . . 74.219999999999999 107.564 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 34.8 m -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.572 -2.011 . . . . 62.119999999999997 105.572 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 141.71 28.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.71 0.291 . . . . 70.340000000000003 110.885 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.5 p -108.7 126.68 53.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.236 -0.438 . . . . 75.319999999999993 110.881 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' B' ' 45' ' ' LEU . 4.3 pp -125.23 137.52 54.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.984 -0.747 . . . . 73.340000000000003 108.984 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -120.19 125.99 49.55 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 109.06 -0.719 . . . . 74.129999999999995 109.06 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -161.85 115.6 1.87 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.277 -0.42 . . . . 71.409999999999997 111.202 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 34.29 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 126.276 1.83 . . . . 65.120000000000005 114.849 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.432 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 53.2 mmm-85 -127.51 146.73 50.41 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 114.008 1.114 . . . . 72.510000000000005 114.008 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.88 153.96 47.53 Favored Pre-proline 0 C--O 1.25 1.126 0 N-CA-C 106.501 -1.666 . . . . 75.329999999999998 106.501 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.78 135.55 38.77 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.705 1.603 . . . . 54.420000000000002 112.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.467 HG12 ' H ' ' B' ' 23' ' ' ARG . 91.4 t -131.39 131.85 62.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.858 -1.164 . . . . 71.450000000000003 107.858 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 m -98.18 3.24 49.01 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 111.959 0.355 . . . . 74.409999999999997 111.959 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.467 ' H ' HG12 ' B' ' 21' ' ' VAL . 6.9 mpt_? -117.22 139.38 50.86 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.666 -0.243 . . . . 53.329999999999998 110.553 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.05 115.44 41.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.996 -1.483 . . . . 62.130000000000003 106.996 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 34.7 mmtp -103.92 141.44 36.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.632 -0.427 . . . . 71.219999999999999 110.41 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 51.3 p -121.89 127.07 50.04 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.79 -0.819 . . . . 75.140000000000001 108.79 176.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 84.4 m-85 -123.62 129.58 51.36 Favored 'General case' 0 CA--C 1.467 -2.229 0 CA-C-N 116.192 -0.458 . . . . 73.409999999999997 110.391 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.455 HG22 HG22 ' B' ' 37' ' ' VAL . 72.6 p -115.47 130.53 56.91 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.824 -0.625 . . . . 72.230000000000004 112.268 -174.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.478 HD13 HD12 ' A' ' 38' ' ' ILE . 80.2 mt -136.85 127.44 40.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.303 -0.628 . . . . 62.340000000000003 109.303 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.405 ' HB ' ' HD3' ' B' ' 35' ' ' ARG . 12.4 t -119.39 135.73 54.6 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.155 -1.054 . . . . 72.409999999999997 108.155 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.579 ' O ' HD21 ' B' ' 34' ' ' LEU . 12.5 tp10 -142.44 112.23 6.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.614 -0.434 . . . . 72.439999999999998 111.424 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.46 -67.05 1.92 Allowed Glycine 0 C--N 1.311 -0.836 0 CA-C-N 116.156 -0.475 . . . . 52.439999999999998 112.54 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 9.6 m -140.79 -35.93 0.47 Allowed 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 120.683 0.278 . . . . 73.010000000000005 110.582 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.579 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.6 pt? -84.29 141.21 31.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.707 0.632 . . . . 63.25 112.707 -171.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 22.8 tpp180 -101.93 113.77 27.27 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.382 -1.34 . . . . 73.420000000000002 107.382 171.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.2 133.12 52.9 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.13 -0.356 . . . . 65.420000000000002 110.109 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.455 HG22 HG22 ' B' ' 28' ' ' THR . 58.3 t -126.83 130.78 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.172 0.51 . . . . 63.439999999999998 109.974 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.442 HD11 HD13 ' A' ' 29' ' ' ILE . 92.2 mt -106.08 126.24 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 N-CA-C 108.332 -0.988 . . . . 72.109999999999999 108.332 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 87.0 m-85 -109.1 114.33 27.97 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.508 -1.293 . . . . 72.430000000000007 107.508 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.459 HD11 HD23 ' A' ' 34' ' ' LEU . 51.4 mm -92.09 113.97 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 109.037 -0.727 . . . . 71.239999999999995 109.037 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -120.28 177.42 5.03 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.532 -1.284 . . . . 71.420000000000002 107.532 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' B' ' 42' ' ' LYS . 17.2 ptmt -91.66 -12.92 32.78 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.145 -0.687 . . . . 72.439999999999998 109.145 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -86.51 1.62 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.145 0.974 . . . . 74.420000000000002 109.826 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.54 -146.56 18.56 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 114.885 -1.052 . . . . 72.040000000000006 113.357 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' B' ' 14' ' ' LEU . 2.1 tm? -122.26 124.14 43.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.708 0.803 . . . . 71.319999999999993 109.448 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 53.7 tptt -115.42 121.65 43.41 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.594 -1.262 . . . . 71.310000000000002 107.594 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.444 HG13 HG11 ' A' ' 47' ' ' VAL . 13.9 p -111.58 140.81 29.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.279 -1.008 . . . . 50.340000000000003 108.279 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.409 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 15.9 t -139.11 136.72 35.47 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 119.336 -0.946 . . . . 73.420000000000002 108.541 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.21 125.79 35.79 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 120.978 0.418 . . . . 63.340000000000003 111.523 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 26.8 t70 -109.5 97.6 28.04 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 108.016 -1.105 . . . . 71.019999999999996 108.016 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.49 134.39 24.32 Favored 'Trans proline' 0 N--CA 1.431 -2.182 0 C-N-CA 122.279 1.986 . . . . 72.099999999999994 112.378 -178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 68.35 80.54 0.2 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.635 -1.62 . . . . 53.100000000000001 112.938 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.04 145.11 27.22 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.567 -1.197 . . . . 53.399999999999999 108.667 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 28.7 p -58.92 -40.68 85.31 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 112.285 0.476 . . . . 70.030000000000001 112.285 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -126.78 105.83 8.94 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.156 0.503 . . . . 73.239999999999995 110.429 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 91.9 t -104.6 140.53 22.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.572 -0.74 . . . . 73.299999999999997 109.469 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -135.01 136.03 41.83 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.039 -0.726 . . . . 74.329999999999998 109.039 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -65.69 107.81 1.88 Allowed 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.446 0.466 . . . . 72.230000000000004 110.126 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.35 110.91 23.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.977 0.894 . . . . 70.129999999999995 111.404 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.301 -1.501 0 N-CA-C 107.633 -1.247 . . . . 71.109999999999999 107.633 178.498 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 111.995 0.368 . . . . 75.340000000000003 111.995 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.0 -166.01 53.67 Favored Glycine 0 C--O 1.246 0.898 0 C-N-CA 121.051 -0.595 . . . . 71.329999999999998 111.921 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.4 t -125.04 97.49 5.27 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.688 -0.856 . . . . 71.299999999999997 108.688 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.64 -37.08 42.92 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.951 -1.129 . . . . 64.439999999999998 107.951 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.77 157.0 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.589 -1.187 . . . . 74.120000000000005 108.216 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.7 p -105.79 -25.27 12.25 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.586 0.708 . . . . 71.310000000000002 109.192 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.89 83.12 7.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.672 -0.695 . . . . 71.439999999999998 109.604 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt 174.96 155.0 0.14 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.191 -1.781 . . . . 75.150000000000006 106.191 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -73.12 115.25 12.22 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 121.465 0.65 . . . . 72.099999999999994 110.968 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -92.5 140.99 29.0 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 115.593 -0.731 . . . . 72.319999999999993 109.524 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.6 m -142.17 148.87 38.95 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.471 -0.566 . . . . 65.519999999999996 109.471 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.429 ' CG2' HD21 ' B' ' 14' ' ' LEU . 69.4 t -144.75 145.72 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.274 0.629 . . . . 71.510000000000005 109.696 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 p -109.16 136.14 49.12 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 122.835 0.454 . . . . 72.439999999999998 110.505 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.408 HD21 ' CG2' ' B' ' 12' ' ' VAL . 95.2 mt -119.62 121.93 40.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.365 0.602 . . . . 70.409999999999997 111.617 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 p -95.17 114.03 25.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.1 -0.955 . . . . 70.209999999999994 109.698 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 t -139.12 -170.55 2.9 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.89 -1.522 . . . . 74.239999999999995 106.89 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -76.86 91.48 3.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.058 0.933 . . . . 71.439999999999998 111.362 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -126.15 141.83 51.77 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.867 -1.06 . . . . 52.509999999999998 109.57 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD21 ' OE1' ' B' ' 52' ' ' GLN . 1.4 mm? -82.45 146.34 53.66 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.534 -0.757 . . . . 72.209999999999994 109.031 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.441 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 20.7 Cg_exo -64.66 134.87 42.73 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.8 1.666 . . . . 73.519999999999996 112.209 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.74 143.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 114.428 -1.26 . . . . 70.0 108.179 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 m -90.56 -22.35 21.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.204 0.446 . . . . 73.310000000000002 112.204 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -105.88 133.45 50.59 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.472 -0.331 . . . . 71.209999999999994 110.68 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.87 116.41 31.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.789 -0.819 . . . . 71.239999999999995 108.789 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -91.98 133.6 35.56 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 120.313 -0.555 . . . . 73.319999999999993 110.928 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.4 p -118.0 127.36 53.74 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.396 -0.82 . . . . 65.409999999999997 110.426 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 67.9 m-85 -121.5 130.77 53.76 Favored 'General case' 0 CA--C 1.477 -1.845 0 CA-C-N 115.837 -0.62 . . . . 75.209999999999994 111.029 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.43 HG23 HG23 ' A' ' 37' ' ' VAL . 57.4 p -114.56 131.58 56.62 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.382 -0.826 . . . . 73.099999999999994 111.286 -175.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.49 HD13 HD11 ' B' ' 38' ' ' ILE . 40.1 mt -125.23 130.4 73.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 116.432 -0.349 . . . . 73.019999999999996 110.695 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -109.96 115.76 30.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 122.21 1.005 . . . . 62.039999999999999 110.269 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.726 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.3 tp10 -143.13 123.06 13.51 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.197 -0.91 . . . . 65.450000000000003 108.926 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 52.31 32.11 36.3 Favored Glycine 0 C--O 1.218 -0.849 0 O-C-N 123.219 0.325 . . . . 73.120000000000005 113.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 22.2 t 84.55 -10.19 0.87 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.475 1.11 . . . . 75.430000000000007 113.37 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.6 pt? -89.36 140.22 29.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 117.07 -1.852 . . . . 65.120000000000005 109.239 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.73 118.32 36.43 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.309 -1.367 . . . . 72.349999999999994 107.309 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.99 129.54 51.59 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.51 -0.552 . . . . 71.150000000000006 109.51 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 61.9 t -118.91 122.24 68.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.186 0.517 . . . . 73.299999999999997 110.427 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.487 HD12 HD13 ' B' ' 29' ' ' ILE . 87.0 mt -103.54 123.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 C-N-CA 124.093 0.957 . . . . 63.350000000000001 109.075 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.5 114.52 28.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.423 -0.584 . . . . 75.340000000000003 109.423 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 47.2 mm -92.52 114.32 29.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.971 -1.863 . . . . 74.340000000000003 105.971 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.427 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 9.5 t -129.06 173.74 10.18 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.587 -0.445 . . . . 73.209999999999994 111.28 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -70.5 -25.22 63.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.624 . . . . 65.510000000000005 109.96 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -92.02 -4.39 54.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 73.510000000000005 110.675 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.29 -125.43 3.51 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 119.411 -1.376 . . . . 50.119999999999997 114.149 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -126.19 126.81 44.69 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 123.772 0.829 . . . . 75.230000000000004 110.06 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -122.93 141.08 52.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.612 -0.514 . . . . 71.030000000000001 109.612 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.4 p -123.33 140.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 CA-C-N 115.739 -0.664 . . . . 74.140000000000001 110.52 -174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -129.76 137.72 50.69 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.558 -0.746 . . . . 72.510000000000005 110.664 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.41 123.01 46.49 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.935 -1.505 . . . . 61.32 106.935 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -117.02 101.98 53.09 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 105.684 -1.969 . . . . 70.340000000000003 105.684 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.47 132.07 17.09 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.238 1.292 . . . . 74.129999999999995 111.932 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 33' ' ' SER . 42.3 mt-30 48.87 37.17 9.46 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 124.214 0.946 . . . . 73.310000000000002 110.371 175.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -38.74 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.512 1.925 . . . . 73.099999999999994 115.405 -172.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 m 68.32 -69.59 0.15 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.526 1.13 . . . . 45.399999999999999 110.809 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -156.28 110.09 2.73 Favored 'General case' 0 N--CA 1.395 -3.193 0 N-CA-C 106.927 -1.509 . . . . 75.319999999999993 106.927 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.425 ' CG1' ' HA ' ' A' ' 33' ' ' SER . 42.3 t -135.92 98.92 2.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.151 -0.685 . . . . 74.150000000000006 109.151 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -85.16 125.33 32.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.614 -0.884 . . . . 75.409999999999997 108.614 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -75.07 101.4 4.52 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.459 0.647 . . . . 71.230000000000004 110.431 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.76 -27.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.266 -0.879 . . . . 71.310000000000002 109.715 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.304 -1.392 0 CA-C-N 115.641 -0.709 . . . . 73.430000000000007 110.983 -178.395 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 121.394 0.616 . . . . 75.209999999999994 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.47 -24.35 70.83 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.417 -0.81 . . . . 62.229999999999997 113.094 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -81.53 111.64 18.03 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.738 0.304 . . . . 73.25 110.209 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.15 -70.78 0.7 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.923 0.392 . . . . 61.420000000000002 111.093 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.58 -177.68 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.845 -0.616 . . . . 63.43 111.638 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 20.9 p -89.39 -40.94 12.41 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.036 -0.529 . . . . 51.43 111.77 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -133.85 123.88 25.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.223 -0.444 . . . . 65.430000000000007 111.009 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.404 ' HG2' ' N ' ' B' ' 9' ' ' ARG . 39.5 ttmt 177.89 154.42 0.32 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.309 -1.367 . . . . 75.510000000000005 107.309 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptm180 -72.71 97.23 2.15 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 121.598 0.714 . . . . 72.219999999999999 110.179 171.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.2 p -87.1 142.66 27.76 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.56 -0.745 . . . . 74.450000000000003 110.741 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 62.8 m -135.04 149.79 50.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.38 -0.6 . . . . 65.209999999999994 109.38 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.408 ' CG2' HD21 ' A' ' 14' ' ' LEU . 99.2 t -139.42 139.62 38.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.16 -0.473 . . . . 71.209999999999994 110.419 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.6 p -107.92 125.68 51.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.051 -0.722 . . . . 71.409999999999997 109.051 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.429 HD21 ' CG2' ' A' ' 12' ' ' VAL . 96.8 mt -113.6 124.3 52.01 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 122.819 0.448 . . . . 74.239999999999995 111.78 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 24.9 p -85.16 113.63 21.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.493 -0.776 . . . . 70.349999999999994 109.244 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.1 t -139.33 178.4 7.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.483 -0.932 . . . . 74.010000000000005 108.483 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -71.04 88.76 0.78 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.161 0.981 . . . . 72.109999999999999 110.431 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.434 ' NH2' ' HB2' ' B' ' 19' ' ' LEU . 6.9 tpm_? -126.91 129.5 48.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.64 -1.164 . . . . 70.129999999999995 110.173 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.434 ' HB2' ' NH2' ' B' ' 18' ' ' ARG . 1.7 mm? -74.49 146.21 83.44 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.373 -1.343 . . . . 74.0 107.373 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.2 135.04 52.25 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 122.517 2.144 . . . . 63.32 113.881 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.29 127.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.523 -1.658 . . . . 74.109999999999999 106.523 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -88.9 -36.74 15.77 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.587 -0.445 . . . . 74.239999999999995 111.409 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -112.96 134.15 54.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.304 . . . . 71.230000000000004 111.353 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.86 123.86 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.96 -0.564 . . . . 75.010000000000005 111.625 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.51 132.84 35.45 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.577 -0.449 . . . . 62.229999999999997 110.161 173.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 39.1 p -106.66 128.31 54.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.286 -0.87 . . . . 74.5 109.753 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 54.3 m-85 -128.16 126.83 41.83 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 116.052 -0.522 . . . . 73.549999999999997 110.752 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.434 HG22 HG22 ' B' ' 37' ' ' VAL . 77.8 p -114.85 131.19 56.92 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.947 -0.57 . . . . 53.539999999999999 112.069 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.487 HD13 HD12 ' A' ' 38' ' ' ILE . 59.7 mt -136.52 122.21 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.322 -0.992 . . . . 71.409999999999997 108.322 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.3 121.63 40.04 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.786 -0.766 . . . . 75.010000000000005 109.41 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.582 ' O ' HD21 ' B' ' 34' ' ' LEU . 11.7 tp10 -119.7 113.8 21.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.428 -0.806 . . . . 75.230000000000004 110.546 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.26 -75.48 1.35 Allowed Glycine 0 C--N 1.298 -1.568 0 C-N-CA 121.174 -0.536 . . . . 71.239999999999995 112.125 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.443 ' HA ' ' HB ' ' B' ' 56' ' ' VAL . 13.7 t -153.56 6.99 0.36 Allowed 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 120.797 0.332 . . . . 73.140000000000001 111.403 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.582 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -114.75 140.03 49.22 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 118.522 -1.271 . . . . 73.030000000000001 109.712 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -98.06 131.03 44.82 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.022 -0.732 . . . . 74.319999999999993 109.022 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.37 114.83 23.53 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.353 -0.98 . . . . 75.450000000000003 108.353 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 27' ' ' TYR . 51.6 t -111.52 125.7 68.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.103 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.49 HD11 HD13 ' A' ' 29' ' ' ILE . 81.6 mt -101.59 130.7 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.663 0 C-N-CA 124.017 0.927 . . . . 60.299999999999997 109.573 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.39 114.66 26.16 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.057 -1.09 . . . . 74.030000000000001 108.057 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 50.2 mm -88.64 117.73 32.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.697 -1.223 . . . . 73.409999999999997 107.697 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.7 t -132.04 169.32 16.51 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.402 0.439 . . . . 73.0 110.465 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -18.52 62.93 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.031 0.443 . . . . 73.400000000000006 110.837 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -86.71 -16.48 36.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 73.540000000000006 109.11 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.6 -124.93 2.5 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.268 -0.967 . . . . 62.43 113.223 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.95 124.25 42.18 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.929 -0.636 . . . . 73.349999999999994 110.737 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -121.29 140.69 51.74 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.885 0.374 . . . . 64.510000000000005 110.11 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 13.1 p -131.77 141.37 45.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.806 -0.633 . . . . 74.519999999999996 110.011 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 65.2 m -123.75 136.65 54.56 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 123.242 0.339 . . . . 75.150000000000006 110.531 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.58 123.76 47.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.585 -0.524 . . . . 75.340000000000003 109.585 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.93 105.6 37.51 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.791 -0.818 . . . . 74.510000000000005 108.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -92.01 133.06 1.28 Allowed 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 121.349 1.366 . . . . 74.120000000000005 115.406 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.469 ' OE1' HD21 ' A' ' 19' ' ' LEU . 35.9 mt-30 55.9 -3.24 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 118.507 2.78 . . . . 73.349999999999994 118.507 165.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.58 121.81 7.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.993 0.738 . . . . 73.010000000000005 112.993 -176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 40.9 m 76.03 -75.39 0.07 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.918 1.287 . . . . 62.109999999999999 112.587 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -175.81 134.79 0.29 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 122.877 0.471 . . . . 74.140000000000001 110.294 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' B' ' 33' ' ' SER . 39.4 t -141.5 130.78 24.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.68 -1.23 . . . . 75.200000000000003 107.68 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -162.94 135.81 5.63 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.642 -0.503 . . . . 74.140000000000001 109.642 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -123.54 166.05 16.09 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.506 -1.294 . . . . 73.140000000000001 107.506 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -82.9 -37.56 14.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 120.712 0.292 . . . . 71.209999999999994 111.705 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.253 1.255 0 N-CA-C 109.334 -0.617 . . . . 71.049999999999997 109.334 -175.615 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.795 0.331 . . . . 74.230000000000004 111.473 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.55 124.98 5.53 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.777 -0.725 . . . . 71.340000000000003 112.111 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 m -91.52 -15.11 29.23 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.861 0.362 . . . . 71.400000000000006 110.517 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.18 88.5 4.87 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 109.057 -0.72 . . . . 74.040000000000006 109.057 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.99 -69.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.976 -0.556 . . . . 72.439999999999998 110.04 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.0 m -86.71 132.98 33.72 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.357 -0.383 . . . . 71.109999999999999 110.289 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -83.41 86.93 6.99 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.954 0.883 . . . . 74.239999999999995 110.278 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -140.65 -62.84 0.48 Allowed 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.294 -1.743 . . . . 72.340000000000003 106.294 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -133.48 113.38 12.43 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 105.496 -2.039 . . . . 74.450000000000003 105.496 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 p -86.26 117.16 24.9 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.803 -0.759 . . . . 72.030000000000001 109.695 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.6 m -123.94 148.94 46.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.934 -0.575 . . . . 63.439999999999998 109.495 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.6 t -145.45 142.41 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.825 0.45 . . . . 72.510000000000005 110.242 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -111.35 138.37 47.93 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 122.65 0.38 . . . . 72.430000000000007 110.871 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.42 140.54 48.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 112.331 0.493 . . . . 70.209999999999994 112.331 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.312 -0.858 . . . . 74.019999999999996 109.506 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -134.49 -177.7 4.72 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.578 -1.268 . . . . 73.340000000000003 107.578 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -76.31 96.79 4.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.337 1.065 . . . . 74.439999999999998 109.32 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -125.85 140.02 53.0 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.108 -0.951 . . . . 75.340000000000003 111.63 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.426 HD13 ' HB3' ' B' ' 33' ' ' SER . 4.8 mp -82.55 136.5 45.42 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.284 -1.006 . . . . 64.340000000000003 108.284 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.17 137.53 40.8 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 122.48 2.12 . . . . 71.409999999999997 112.675 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -131.8 148.96 32.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.618 -1.174 . . . . 73.310000000000002 107.973 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -97.49 -23.83 15.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.009 0.433 . . . . 62.210000000000001 111.71 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -102.91 132.12 49.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.293 -0.632 . . . . 74.450000000000003 109.293 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -98.07 129.99 47.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.837 -0.62 . . . . 74.340000000000003 109.592 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.83 141.51 30.74 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.359 -0.536 . . . . 73.540000000000006 110.894 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.1 p -119.76 127.66 53.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.077 -0.965 . . . . 74.450000000000003 108.767 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 70.5 m-85 -126.35 126.27 43.63 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 110.17 -0.307 . . . . 74.019999999999996 110.17 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.511 HG23 HG23 ' A' ' 37' ' ' VAL . 59.3 p -115.89 131.35 56.96 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.754 -0.657 . . . . 72.209999999999994 111.405 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.447 HD13 HD11 ' B' ' 38' ' ' ILE . 50.2 mt -127.39 121.33 57.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.116 -0.493 . . . . 71.109999999999999 110.004 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -103.88 121.47 43.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.779 -1.193 . . . . 65.25 107.779 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' O ' HD21 ' A' ' 34' ' ' LEU . 13.6 tp10 -142.62 100.43 3.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 112.242 0.46 . . . . 74.120000000000005 112.242 -174.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.54 -66.15 3.55 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 114.592 0.597 . . . . 54.530000000000001 114.592 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 p -158.94 18.8 0.19 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.655 0.613 . . . . 72.099999999999994 112.655 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.568 HD22 ' CZ ' ' B' ' 18' ' ' ARG . 2.1 pt? -145.27 140.35 27.75 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.499 -0.556 . . . . 74.329999999999998 109.499 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -107.77 120.88 43.5 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.46 -0.941 . . . . 75.340000000000003 108.46 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.32 134.92 46.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.785 -0.45 . . . . 71.439999999999998 109.785 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.511 HG23 HG23 ' A' ' 28' ' ' THR . 48.5 t -118.22 125.41 74.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 75.150000000000006 110.184 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.475 HD12 HD13 ' B' ' 29' ' ' ILE . 74.6 mt -101.77 120.61 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 CA-C-N 115.555 -0.748 . . . . 75.209999999999994 109.077 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 94.7 m-85 -102.58 115.44 30.59 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.819 -0.808 . . . . 75.319999999999993 108.819 175.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.429 HD11 HD23 ' B' ' 34' ' ' LEU . 37.1 mm -88.29 112.24 23.49 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 106.504 -1.665 . . . . 62.509999999999998 106.504 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.443 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 7.0 t -126.09 153.04 45.06 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.922 -0.581 . . . . 73.319999999999993 112.553 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.546 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -52.33 -32.82 39.88 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.948 1.299 . . . . 42.32 113.233 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -87.64 -12.64 44.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.369 0.604 . . . . 73.219999999999999 110.706 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.27 -109.97 0.43 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.673 -1.251 . . . . 53.140000000000001 113.624 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.7 tp -134.09 145.99 49.87 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 123.911 0.885 . . . . 73.420000000000002 109.846 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -141.04 142.66 34.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.251 -0.648 . . . . 61.130000000000003 109.251 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.03 140.62 48.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.872 -0.604 . . . . 62.229999999999997 109.949 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.413 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 33.7 m -125.15 143.19 51.06 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 116.119 -0.491 . . . . 74.310000000000002 110.871 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.82 124.14 49.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.973 -1.121 . . . . 73.109999999999999 107.973 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.03 101.22 54.48 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 107.47 -1.307 . . . . 63.399999999999999 107.47 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.96 150.3 72.91 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 122.59 2.193 . . . . 74.129999999999995 111.763 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -47.4 132.63 13.15 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.967 -1.015 . . . . 73.219999999999999 110.349 172.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' C ' ' HG1' ' A' ' 54' ' ' THR . . . -81.86 -43.36 18.33 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.816 0.817 . . . . 62.299999999999997 109.759 -177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.434 ' HG1' ' C ' ' A' ' 53' ' ' ALA . 32.0 m -153.74 69.61 0.81 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.725 -1.954 . . . . 70.530000000000001 105.725 173.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 60.46 -166.96 0.19 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 114.653 -1.158 . . . . 74.409999999999997 109.524 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.14 146.23 16.18 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 108.364 -0.976 . . . . 73.239999999999995 108.364 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -72.8 177.86 4.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.582 -0.525 . . . . 73.25 109.582 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -74.41 97.78 3.14 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.315 0.579 . . . . 62.509999999999998 111.548 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.24 131.87 2.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.285 -1.005 . . . . 72.430000000000007 108.285 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 120.858 -0.337 . . . . 73.329999999999998 110.7 -176.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.242 0.709 0 N-CA-C 109.428 -0.582 . . . . 72.299999999999997 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.89 43.49 41.36 Favored Glycine 0 CA--C 1.501 -0.83 0 N-CA-C 110.609 -0.996 . . . . 53.32 110.609 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 31.1 m -78.55 -69.9 0.53 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.079 -0.56 . . . . 75.299999999999997 112.074 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -93.77 95.47 9.16 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.923 -0.769 . . . . 64.329999999999998 108.923 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -119.8 -70.81 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 115.708 -0.678 . . . . 75.040000000000006 109.899 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 27.0 m -92.04 131.32 37.41 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.297 -0.631 . . . . 74.140000000000001 109.297 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.05 87.24 6.9 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.022 -0.733 . . . . 51.039999999999999 109.022 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.4 ' HG3' ' HG3' ' B' ' 9' ' ' ARG . 23.3 tptm -168.79 -71.41 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.787 -1.097 . . . . 72.510000000000005 108.199 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.423 ' HG2' ' HD2' ' B' ' 51' ' ' PRO . 35.0 mtp180 -120.47 92.65 3.82 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.097 -1.075 . . . . 74.239999999999995 108.097 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -89.39 148.17 23.64 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.541 -0.754 . . . . 64.409999999999997 111.446 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 84.0 m -133.16 149.69 52.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.716 -1.216 . . . . 62.32 107.716 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 65.8 t -136.86 140.53 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 120.81 -0.356 . . . . 74.329999999999998 111.434 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 22.4 p -106.81 125.81 51.49 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.495 0.718 . . . . 73.140000000000001 109.912 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -106.44 129.67 54.38 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.424 -0.584 . . . . 75.530000000000001 109.424 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 12.1 p -123.84 112.36 17.19 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.934 0.873 . . . . 63.100000000000001 111.559 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -141.69 -166.43 2.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.502 -1.666 . . . . 72.109999999999999 106.502 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -66.99 94.89 0.35 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.212 0.914 . . . . 65.340000000000003 112.146 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.568 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 7.2 tpt180 -126.38 137.95 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.993 -1.003 . . . . 41.229999999999997 110.878 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.59 136.23 42.61 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.119 -1.067 . . . . 75.150000000000006 108.119 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' B' ' 42' ' ' LYS . 57.9 Cg_endo -70.13 148.65 63.16 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.352 2.035 . . . . 72.129999999999995 113.236 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.436 HG23 ' H ' ' B' ' 23' ' ' ARG . 12.0 p -131.88 142.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 75.150000000000006 107.923 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 16.1 m -91.52 9.93 29.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.293 0.568 . . . . 75.310000000000002 111.074 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.436 ' H ' HG23 ' B' ' 21' ' ' VAL . 35.6 mmt180 -128.87 133.9 48.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.443 -0.577 . . . . 70.5 109.443 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.48 117.17 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.397 -0.594 . . . . 63.509999999999998 109.397 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.1 139.31 34.94 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.899 0.38 . . . . 74.129999999999995 111.617 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.8 p -117.89 127.77 54.17 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.298 -0.865 . . . . 74.400000000000006 108.884 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.15 124.21 34.1 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 108.683 -0.858 . . . . 72.239999999999995 108.683 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 18.8 m -118.07 122.01 42.05 Favored 'General case' 0 C--N 1.264 -3.144 0 C-N-CA 119.507 -0.877 . . . . 63.200000000000003 111.859 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.475 HD13 HD12 ' A' ' 38' ' ' ILE . 60.4 mt -112.9 123.49 68.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.279 -0.637 . . . . 65.430000000000007 109.279 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -104.82 121.48 43.75 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.654 0.74 . . . . 73.140000000000001 109.239 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.468 ' O ' HD21 ' B' ' 34' ' ' LEU . 13.9 tp10 -136.7 97.33 3.52 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.18 0.514 . . . . 75.299999999999997 111.592 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.53 -80.2 0.23 Allowed Glycine 0 C--N 1.312 -0.778 0 CA-C-N 115.615 -0.72 . . . . 44.329999999999998 114.831 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.426 ' HB3' HD13 ' A' ' 19' ' ' LEU . 28.1 m -123.69 6.59 8.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.685 0.624 . . . . 74.0 112.685 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.468 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.1 pt? -147.0 140.97 25.93 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 119.11 -1.036 . . . . 71.120000000000005 111.517 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.422 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 86.8 mtm180 -108.18 119.47 39.56 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 114.784 -1.098 . . . . 75.340000000000003 109.088 170.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 126.99 51.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.632 -0.507 . . . . 72.329999999999998 109.632 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' B' ' 47' ' ' VAL . 46.3 t -109.41 124.92 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.083 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.447 HD11 HD13 ' A' ' 29' ' ' ILE . 70.3 mt -101.33 119.7 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.661 -0.866 . . . . 75.140000000000001 108.661 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.479 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.9 m-85 -102.92 114.56 28.95 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.255 -1.017 . . . . 75.400000000000006 108.255 175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.434 HD11 HD23 ' A' ' 34' ' ' LEU . 48.4 mm -89.97 112.88 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 106.014 -1.847 . . . . 75.510000000000005 106.014 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -115.66 -178.02 3.29 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 115.555 -0.748 . . . . 74.140000000000001 109.372 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -73.0 -45.24 58.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 113.972 1.101 . . . . 75.209999999999994 113.972 -173.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -93.81 -6.32 46.18 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.802 -0.759 . . . . 72.109999999999999 111.955 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.93 -143.12 6.39 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.354 -1.879 . . . . 62.109999999999999 114.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 59.0 tp -114.53 149.13 36.91 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.43 1.092 . . . . 64.129999999999995 109.689 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -143.56 143.11 31.38 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.234 -0.654 . . . . 61.439999999999998 109.234 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' B' ' 37' ' ' VAL . 11.7 p -131.52 141.22 46.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.649 -0.5 . . . . 71.340000000000003 109.649 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.479 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 63.5 m -121.29 146.21 47.07 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 110.32 -0.252 . . . . 42.140000000000001 110.32 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.81 124.3 50.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 121.265 0.555 . . . . 75.310000000000002 109.748 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 20.4 t70 -114.87 108.46 48.69 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 115.085 -0.961 . . . . 75.230000000000004 109.136 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' HG2' ' B' ' 9' ' ' ARG . 87.4 Cg_endo -79.58 151.92 22.65 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 C-N-CA 122.174 1.916 . . . . 74.519999999999996 110.875 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.473 ' OE1' ' HA ' ' B' ' 55' ' ' TRP . 2.1 pp0? -43.92 133.39 4.97 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 113.972 -1.467 . . . . 73.030000000000001 113.911 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.93 -3.85 15.43 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.033 -0.985 . . . . 75.120000000000005 109.899 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.413 ' C ' ' H ' ' B' ' 56' ' ' VAL . 45.5 p -115.83 19.77 14.96 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.109 -0.951 . . . . 71.140000000000001 108.918 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . 0.473 ' HA ' ' OE1' ' B' ' 52' ' ' GLN . 29.9 m-90 73.86 -38.59 0.41 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.936 1.295 . . . . 72.319999999999993 111.755 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' B' ' 54' ' ' THR . 7.4 p 170.74 149.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 126.791 2.036 . . . . 75.200000000000003 105.689 173.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -143.25 157.68 44.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 120.526 -0.47 . . . . 73.510000000000005 110.297 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.32 93.08 8.62 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.77 -0.826 . . . . 64.450000000000003 108.77 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.19 92.74 2.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-O 122.153 0.977 . . . . 74.439999999999998 110.904 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.292 -1.9 0 N-CA-C 108.103 -1.073 . . . . 64.299999999999997 108.103 -179.687 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 CA--C 1.513 -0.445 0 CA-C-O 120.799 0.333 . . . . 74.0 110.656 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.17 -26.57 1.65 Allowed Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 110.214 -1.154 . . . . 64.439999999999998 110.214 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.8 t -178.73 -74.57 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.304 -1.369 . . . . 75.400000000000006 107.304 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 67.13 134.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.849 1.26 . . . . 74.319999999999993 113.763 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 m -105.01 171.35 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.65 -0.704 . . . . 75.409999999999997 110.488 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' B' ' 15' ' ' THR . 52.3 p -100.51 10.57 41.01 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.088 0.47 . . . . 65.239999999999995 110.785 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.49 110.53 14.89 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 112.727 0.639 . . . . 64.030000000000001 112.727 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 56.21 -96.37 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.643 1.577 . . . . 70.25 114.861 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -122.34 117.84 27.04 Favored 'General case' 0 CA--C 1.475 -1.911 0 C-N-CA 120.548 -0.461 . . . . 74.430000000000007 109.948 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m -108.67 132.48 53.87 Favored 'General case' 0 C--N 1.262 -3.217 0 C-N-CA 119.835 -0.746 . . . . 71.540000000000006 110.058 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.25 147.88 45.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.312 . . . . 62.130000000000003 107.459 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.14 150.44 15.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.561 -0.533 . . . . 72.200000000000003 109.561 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 p -107.18 140.49 39.95 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 121.229 0.538 . . . . 72.5 111.433 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 3.7 mm? -104.79 135.42 46.2 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 124.305 1.042 . . . . 74.510000000000005 110.536 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -108.59 117.99 35.61 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-N 115.348 -0.842 . . . . 73.209999999999994 110.122 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -147.2 177.38 9.23 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 107.49 -1.3 . . . . 63.32 107.49 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -68.59 96.18 0.69 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.28 1.038 . . . . 72.420000000000002 111.706 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.452 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 14.5 mmm180 -126.03 141.69 51.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.138 1.162 . . . . 74.430000000000007 114.138 -174.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.5 pt? -89.57 150.37 44.18 Favored Pre-proline 0 C--N 1.293 -1.849 0 CA-C-N 113.944 -1.48 . . . . 61.329999999999998 108.377 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.85 137.35 41.37 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.489 2.126 . . . . 54.219999999999999 113.028 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.14 142.36 43.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.626 -1.17 . . . . 62.109999999999999 108.024 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -89.77 -40.53 12.43 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.787 0.327 . . . . 75.340000000000003 111.728 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -91.2 135.0 34.09 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.953 0.406 . . . . 72.120000000000005 111.963 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.62 115.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.079 -1.082 . . . . 71.549999999999997 108.079 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.73 127.6 42.87 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.29 -0.564 . . . . 75.530000000000001 110.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 30.1 p -106.62 128.6 54.29 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.442 -0.799 . . . . 72.200000000000003 109.461 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.2 126.33 42.6 Favored 'General case' 0 CA--C 1.463 -2.379 0 CA-C-N 116.118 -0.492 . . . . 75.239999999999995 109.945 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.505 HG23 HG23 ' A' ' 37' ' ' VAL . 81.9 p -114.94 124.25 51.21 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.445 -0.798 . . . . 73.140000000000001 110.861 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.481 HD13 HD11 ' B' ' 38' ' ' ILE . 50.0 mt -116.24 124.63 72.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.798 -0.637 . . . . 73.230000000000004 110.286 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' ' NH1' ' A' ' 35' ' ' ARG . 6.2 t -100.19 127.32 46.48 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.76 -1.109 . . . . 74.519999999999996 109.682 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.2 tp10 -142.13 103.39 4.29 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.638 -0.71 . . . . 71.420000000000002 110.209 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -91.05 0.73 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 115.231 -0.895 . . . . 37.170000000000002 111.523 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 31.3 p -134.62 6.36 3.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.801 0.81 . . . . 75.450000000000003 109.339 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.487 HD21 HD11 ' B' ' 40' ' ' ILE . 52.2 tp -98.22 136.08 38.94 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.387 -0.824 . . . . 74.209999999999994 110.7 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.462 ' NH1' ' HB ' ' A' ' 30' ' ' THR . 22.2 mmm180 -111.44 112.91 24.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.466 -0.788 . . . . 72.420000000000002 108.946 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.8 124.58 49.67 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.971 -0.751 . . . . 71.120000000000005 108.971 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 28' ' ' THR . 60.4 t -116.38 129.09 73.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.205 0.526 . . . . 70.209999999999994 111.298 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.501 HD12 HD13 ' B' ' 29' ' ' ILE . 59.2 mt -108.43 129.31 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-N 115.058 -0.974 . . . . 43.420000000000002 109.956 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 97.3 m-85 -113.41 117.35 31.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.305 -0.998 . . . . 73.319999999999993 108.305 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.509 HD11 HD21 ' B' ' 34' ' ' LEU . 35.0 mm -90.45 116.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 107.742 -1.207 . . . . 73.510000000000005 107.742 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.8 p -118.72 177.91 4.67 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.429 0.633 . . . . 74.420000000000002 111.261 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.439 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.99 -22.03 62.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.326 -0.852 . . . . 75.450000000000003 110.011 175.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -87.36 -29.73 21.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.443 -0.947 . . . . 54.229999999999997 108.443 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.452 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 150.64 -112.59 0.55 Allowed Glycine 0 N--CA 1.413 -2.862 0 C-N-CA 120.311 -0.947 . . . . 72.319999999999993 113.108 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 55.2 tp -119.84 139.94 51.58 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.64 -0.28 . . . . 74.319999999999993 110.331 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.7 143.32 48.44 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.483 -0.932 . . . . 62.030000000000001 108.483 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.4 p -123.92 140.8 46.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-N 116.146 -0.479 . . . . 75.140000000000001 110.574 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.444 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 22.9 m -124.88 138.78 54.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.096 -0.502 . . . . 70.129999999999995 110.967 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.44 124.1 49.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.769 -0.65 . . . . 65.329999999999998 110.067 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 21.1 t70 -116.71 110.4 42.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.021 . . . . 73.430000000000007 108.245 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -84.21 134.61 6.0 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 122.418 2.079 . . . . 61.439999999999998 114.301 -173.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.1 mt-30 39.09 79.39 0.03 OUTLIER 'General case' 0 C--O 1.255 1.377 0 C-N-CA 125.672 1.589 . . . . 73.25 113.836 172.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.93 155.6 17.07 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.071 -1.422 . . . . 73.25 111.168 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.3 m -68.7 -52.29 32.43 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.542 -0.91 . . . . 73.129999999999995 108.542 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -94.12 96.85 9.9 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.946 -1.131 . . . . 71.420000000000002 107.946 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.451 HG23 ' HA ' ' A' ' 33' ' ' SER . 9.4 p -120.82 -41.8 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 120.217 -0.593 . . . . 51.549999999999997 111.603 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 61.0 93.61 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.663 0.785 . . . . 72.540000000000006 111.317 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.66 96.91 4.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.285 0.564 . . . . 73.010000000000005 109.87 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.28 -26.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.319 -0.855 . . . . 74.530000000000001 110.625 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 30' ' ' THR . 61.0 t . . . . . 0 C--N 1.315 -0.92 0 N-CA-C 109.427 -0.583 . . . . 62.43 109.427 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.247 0.95 0 CA-C-O 121.141 0.496 . . . . 72.0 111.307 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.74 -73.15 0.71 Allowed Glycine 0 CA--C 1.493 -1.323 0 C-N-CA 120.618 -0.801 . . . . 74.150000000000006 111.139 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 41.1 t -150.6 -59.15 0.18 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.754 -1.202 . . . . 63.409999999999997 107.754 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 46.26 82.93 0.03 OUTLIER 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.505 1.522 . . . . 73.230000000000004 114.049 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -104.34 141.33 20.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.335 -0.987 . . . . 72.040000000000006 108.335 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.7 p -84.71 31.1 0.54 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.226 0.536 . . . . 72.340000000000003 111.451 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -118.39 125.98 51.12 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.137 -0.483 . . . . 72.310000000000002 111.643 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.569 ' HG2' ' H ' ' B' ' 9' ' ' ARG . 39.9 ttmt 69.45 -174.82 0.19 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.022 0.929 . . . . 61.450000000000003 110.158 176.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.569 ' H ' ' HG2' ' B' ' 8' ' ' LYS . 4.6 mpt_? -88.63 113.21 23.97 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 121.358 0.599 . . . . 71.140000000000001 111.972 -173.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -96.26 148.38 22.8 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.932 -1.031 . . . . 71.239999999999995 110.508 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.8 m -137.14 155.98 48.92 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.518 -0.919 . . . . 73.140000000000001 108.518 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.01 138.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.288 0.235 . . . . 71.340000000000003 111.364 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.9 p -107.38 125.66 51.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.325 0.65 . . . . 74.400000000000006 109.715 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.24 122.0 44.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.608 -0.724 . . . . 70.340000000000003 110.823 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 6' ' ' SER . 37.5 p -85.76 113.76 22.18 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.469 -0.937 . . . . 64.109999999999999 108.469 173.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -139.26 -173.86 3.71 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.668 -0.493 . . . . 55.509999999999998 109.668 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.32 105.64 11.74 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.796 -0.816 . . . . 71.530000000000001 108.796 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.447 ' NH1' ' HB2' ' A' ' 34' ' ' LEU . 20.3 mmm180 -125.64 141.07 52.21 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.682 -0.69 . . . . 72.299999999999997 112.703 -172.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.442 ' H ' HD22 ' B' ' 19' ' ' LEU . 1.9 pt? -90.35 159.62 41.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 107.15 -1.426 . . . . 73.329999999999998 107.15 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.36 135.55 54.49 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.565 1.51 . . . . 63.130000000000003 112.244 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.22 141.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.065 -1.457 . . . . 74.430000000000007 107.065 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -85.83 -68.38 0.74 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.806 0.336 . . . . 63.130000000000003 111.032 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -99.47 139.65 34.81 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 120.844 -0.342 . . . . 74.299999999999997 111.185 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.61 133.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.983 -0.747 . . . . 74.120000000000005 108.983 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 39' ' ' PHE . 43.9 mmtm -100.13 138.81 36.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.322 -0.551 . . . . 63.420000000000002 110.161 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.1 p -115.84 127.22 54.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.256 -0.646 . . . . 72.420000000000002 109.256 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -128.75 130.82 47.6 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-N 116.411 -0.359 . . . . 70.439999999999998 111.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.463 HG22 HG22 ' B' ' 37' ' ' VAL . 57.6 p -114.94 132.62 56.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.698 -0.683 . . . . 72.129999999999995 111.936 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.501 HD13 HD12 ' A' ' 38' ' ' ILE . 72.3 mt -134.73 128.48 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.817 -0.629 . . . . 74.120000000000005 109.719 176.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.428 ' HG1' HG23 ' B' ' 56' ' ' VAL . 9.3 t -112.33 136.96 51.15 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 108.713 -0.847 . . . . 73.5 108.713 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.477 ' HG2' HG13 ' A' ' 40' ' ' ILE . 12.0 tp10 -141.57 112.12 7.07 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.543 -0.54 . . . . 73.299999999999997 109.543 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.98 -104.12 0.55 Allowed Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 110.834 -0.906 . . . . 62.450000000000003 110.834 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.429 ' C ' ' HA ' ' B' ' 52' ' ' GLN . 45.4 m -126.49 69.6 1.24 Allowed 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.839 -0.801 . . . . 75.030000000000001 108.839 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.509 HD21 HD11 ' A' ' 40' ' ' ILE . 28.4 tp -159.13 137.2 10.44 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.045 -0.98 . . . . 75.239999999999995 109.61 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 18.8 mmm180 -113.89 116.88 29.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 123.673 0.608 . . . . 73.019999999999996 110.108 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 130.18 55.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.9 -0.408 . . . . 70.430000000000007 109.9 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.463 HG22 HG22 ' B' ' 28' ' ' THR . 86.7 t -121.64 130.87 74.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.851 0.357 . . . . 73.310000000000002 110.538 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.481 HD11 HD13 ' A' ' 29' ' ' ILE . 80.8 mt -110.28 130.51 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 C-N-CA 123.442 0.697 . . . . 64.049999999999997 109.863 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 95.7 m-85 -114.57 114.76 26.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.908 -1.145 . . . . 75.230000000000004 107.908 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.487 HD11 HD21 ' A' ' 34' ' ' LEU . 40.7 mm -89.58 113.92 26.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.335 -0.987 . . . . 75.010000000000005 108.335 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -106.55 175.3 5.55 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.731 -0.47 . . . . 74.299999999999997 109.731 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.585 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -85.37 -18.05 34.89 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.775 -0.648 . . . . 62.109999999999999 110.978 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -104.31 -17.22 14.91 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.13 0.49 . . . . 73.200000000000003 110.641 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.432 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . -174.06 -139.22 2.89 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 119.097 -1.525 . . . . 64.150000000000006 114.164 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 40.6 tp -135.63 134.73 39.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 125.184 1.394 . . . . 55.340000000000003 107.513 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -128.96 140.72 51.53 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.341 -0.944 . . . . 71.439999999999998 110.132 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 11.4 p -131.51 141.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.775 -0.648 . . . . 52.140000000000001 109.754 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 66.7 m -123.87 140.23 53.18 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.683 0.278 . . . . 74.239999999999995 111.061 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.92 125.24 51.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.876 -0.602 . . . . 75.150000000000006 110.681 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 21.6 t70 -114.96 125.1 29.37 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.434 -0.803 . . . . 74.319999999999993 109.348 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.26 133.95 23.87 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.16 1.907 . . . . 43.420000000000002 113.508 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.429 ' HA ' ' C ' ' B' ' 33' ' ' SER . 67.9 mt-30 46.32 99.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.227 1.811 . . . . 74.329999999999998 115.154 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.65 105.65 0.1 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.501 -1.681 . . . . 71.420000000000002 113.612 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 27.8 m -69.1 -38.78 79.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.796 -1.928 . . . . 70.400000000000006 105.796 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -106.26 104.54 14.26 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 114.285 -1.325 . . . . 72.329999999999998 107.7 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.428 HG23 ' HG1' ' B' ' 30' ' ' THR . 7.5 p -119.66 -42.63 2.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.099 -0.501 . . . . 74.120000000000005 111.24 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 62.58 179.99 0.14 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.583 0.753 . . . . 74.239999999999995 110.0 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -101.42 69.69 1.26 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.597 -1.241 . . . . 75.510000000000005 109.782 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -115.11 -3.76 11.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 114.262 -1.336 . . . . 74.310000000000002 107.898 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 108.051 -1.092 . . . . 75.239999999999995 108.051 179.468 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.233 0.231 0 N-CA-C 109.223 -0.658 . . . . 61.229999999999997 109.223 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.54 -95.21 0.15 Allowed Glycine 0 N--CA 1.428 -1.895 0 CA-C-N 115.941 -0.572 . . . . 73.120000000000005 111.998 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 p -79.85 -4.39 52.01 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 114.208 1.188 . . . . 74.109999999999999 114.208 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.47 98.71 9.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.983 0.896 . . . . 71.200000000000003 111.149 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 m -88.79 107.25 17.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.566 -0.743 . . . . 74.400000000000006 111.138 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.2 t -167.7 156.4 9.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.592 -0.731 . . . . 73.540000000000006 109.507 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.631 ' OD1' ' HB2' ' A' ' 51' ' ' PRO . 27.4 t70 -80.27 115.82 20.02 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.956 -1.127 . . . . 70.430000000000007 107.956 173.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -154.11 159.54 41.53 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.768 0.318 . . . . 75.329999999999998 110.692 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -97.63 95.19 7.43 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 122.335 1.064 . . . . 73.409999999999997 112.805 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.405 ' HG1' HD12 ' B' ' 14' ' ' LEU . 7.1 p -87.74 120.11 28.73 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.194 -1.366 . . . . 60.439999999999998 109.945 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 m -133.81 146.41 50.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.798 -1.186 . . . . 75.129999999999995 107.798 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.1 t -146.93 153.76 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 122.702 0.401 . . . . 62.219999999999999 110.085 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.3 p -121.57 125.77 47.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.876 -0.416 . . . . 73.319999999999993 109.876 173.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.457 HD21 ' CG2' ' B' ' 12' ' ' VAL . 97.7 mt -101.23 122.4 43.59 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 123.16 0.584 . . . . 74.450000000000003 112.197 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 p -85.79 114.31 22.63 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.075 -0.966 . . . . 73.530000000000001 110.733 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -147.43 166.99 25.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.474 -0.935 . . . . 72.409999999999997 108.474 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -82.24 102.37 11.1 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.465 0.65 . . . . 73.340000000000003 110.007 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' NH1' ' HB3' ' B' ' 51' ' ' PRO . 65.8 mmt-85 -125.93 150.21 48.15 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 114.938 -1.028 . . . . 74.209999999999994 109.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.22 134.16 80.55 Favored Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.718 -0.845 . . . . 73.420000000000002 108.718 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.51 135.28 48.68 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.813 2.342 . . . . 62.240000000000002 114.899 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.23 133.75 60.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.468 -1.696 . . . . 73.420000000000002 107.671 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -89.87 -18.51 26.05 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.436 0.636 . . . . 74.140000000000001 110.734 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -91.38 132.65 36.06 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.108 -0.701 . . . . 74.420000000000002 109.108 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.4 mm -98.72 135.14 34.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.336 -0.616 . . . . 74.510000000000005 109.336 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -110.95 150.7 28.85 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.196 0.522 . . . . 75.349999999999994 111.905 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 91.1 m -129.74 127.09 39.71 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.057 -1.09 . . . . 72.109999999999999 108.057 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -128.46 128.66 44.83 Favored 'General case' 0 CA--C 1.477 -1.843 0 CA-C-N 116.189 -0.459 . . . . 71.540000000000006 110.914 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.505 HG23 HG23 ' A' ' 37' ' ' VAL . 55.7 p -114.36 124.98 53.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.419 -0.81 . . . . 75.439999999999998 110.646 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.512 HD13 HD11 ' B' ' 38' ' ' ILE . 62.5 mt -119.12 138.79 48.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.556 -0.535 . . . . 75.409999999999997 109.556 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.425 ' HB ' HH11 ' A' ' 35' ' ' ARG . 10.6 t -118.68 127.48 53.61 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.098 -0.705 . . . . 74.349999999999994 109.098 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.7 tp10 -139.24 97.27 3.26 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 108.507 -0.923 . . . . 74.310000000000002 108.507 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.09 -119.34 7.94 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 110.533 -1.027 . . . . 72.129999999999995 110.533 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 36.8 m -102.01 3.31 38.72 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.45 0.643 . . . . 74.129999999999995 110.091 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.471 HD21 HD11 ' B' ' 40' ' ' ILE . 47.1 tp -99.75 131.61 45.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 C-N-CA 123.676 0.79 . . . . 72.120000000000005 110.138 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 50' ' ' ASP . 28.8 tpt180 -121.37 122.46 39.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.12 -1.067 . . . . 74.329999999999998 108.12 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.07 141.53 46.78 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.953 -0.467 . . . . 73.109999999999999 110.603 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.505 HG23 HG23 ' A' ' 28' ' ' THR . 58.3 t -125.09 131.08 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 74.099999999999994 111.144 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.444 HD12 HD13 ' B' ' 29' ' ' ILE . 75.6 mt -108.41 125.86 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 124.274 1.03 . . . . 72.010000000000005 109.383 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.6 m-85 -112.14 119.04 37.04 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.098 -1.075 . . . . 75.340000000000003 108.098 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.453 HG23 HD23 ' B' ' 34' ' ' LEU . 36.7 mm -88.8 121.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.602 -0.726 . . . . 63.009999999999998 109.233 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.4 p -124.99 164.66 19.67 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.372 -0.603 . . . . 73.0 109.372 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -70.96 -21.69 62.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.875 0.369 . . . . 72.230000000000004 110.734 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -94.73 1.6 55.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.087 0.47 . . . . 72.25 110.689 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.62 -142.47 13.08 Favored Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 119.434 -1.365 . . . . 43.43 113.329 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.6 tp -114.9 134.52 55.08 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.303 -0.449 . . . . 72.530000000000001 111.241 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 78.7 tttt -115.58 137.01 52.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.398 0.618 . . . . 71.0 110.264 170.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.62 140.58 45.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.747 -1.115 . . . . 70.010000000000005 108.357 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.3 t -137.85 143.13 40.8 Favored 'General case' 0 C--N 1.27 -2.873 0 N-CA-C 107.456 -1.313 . . . . 61.219999999999999 107.456 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.68 125.26 53.53 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.026 -0.67 . . . . 75.400000000000006 110.202 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.6 t70 -101.44 100.7 14.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 106.278 -1.749 . . . . 72.319999999999993 106.278 175.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.631 ' HB2' ' OD1' ' A' ' 7' ' ' ASP . 95.0 Cg_endo -79.0 132.97 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.501 2.134 . . . . 70.310000000000002 115.276 -172.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 33' ' ' SER . 41.4 mt-30 31.46 -104.97 0.02 OUTLIER 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.494 1.917 . . . . 75.200000000000003 114.252 169.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 157.73 167.98 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 129.049 2.94 . . . . 64.519999999999996 103.22 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.1 m -67.85 -31.52 71.4 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.391 -0.966 . . . . 75.510000000000005 108.391 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -127.53 112.55 15.05 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.219 -0.9 . . . . 74.120000000000005 109.252 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.94 157.18 6.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 109.621 -0.511 . . . . 71.439999999999998 109.621 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -135.85 172.92 12.31 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.643 -0.873 . . . . 75.310000000000002 108.643 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -54.15 -50.06 67.84 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.047 0.451 . . . . 74.409999999999997 110.245 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.4 99.5 8.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.769 -0.651 . . . . 70.519999999999996 109.28 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--O 1.246 0.898 0 C-N-CA 124.817 1.247 . . . . 64.340000000000003 112.524 178.72 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--O 1.243 0.754 0 N-CA-C 109.07 -0.715 . . . . 74.219999999999999 109.07 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.48 124.12 3.09 Favored Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 110.268 -1.133 . . . . 70.030000000000001 110.268 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -88.37 -27.26 21.73 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.213 0.449 . . . . 74.219999999999999 112.213 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' B' ' 4' ' ' GLU . 0.1 OUTLIER -82.95 92.75 7.39 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.083 0.944 . . . . 61.299999999999997 111.235 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.82 114.09 30.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 115.065 -0.97 . . . . 74.340000000000003 110.735 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 31.6 m -154.82 -168.92 3.04 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.098 -1.075 . . . . 70.349999999999994 108.098 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.01 100.55 0.75 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.854 -1.165 . . . . 74.310000000000002 107.854 172.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -163.96 161.38 22.77 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 116.338 -0.392 . . . . 63.530000000000001 110.308 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptp180 -109.14 114.56 28.38 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 115.351 -0.841 . . . . 75.219999999999999 110.981 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -89.59 123.04 33.31 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 108.413 -0.958 . . . . 70.340000000000003 108.413 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 81.5 m -125.35 149.17 48.36 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.75 -0.463 . . . . 71.409999999999997 109.75 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.457 ' CG2' HD21 ' A' ' 14' ' ' LEU . 98.1 t -140.68 133.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.258 -0.428 . . . . 74.420000000000002 110.222 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.8 p -107.42 125.68 51.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.585 -0.895 . . . . 74.129999999999995 108.585 174.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.405 HD12 ' HG1' ' A' ' 10' ' ' THR . 79.9 mt -101.52 140.84 35.26 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.751 -0.659 . . . . 72.140000000000001 110.968 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 22.1 p -99.38 113.82 26.37 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.674 0.749 . . . . 72.519999999999996 111.528 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -158.64 159.86 35.84 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.67 -1.233 . . . . 72.319999999999993 107.67 173.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -78.27 106.51 10.23 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.919 0.866 . . . . 71.129999999999995 110.275 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.524 ' HE ' ' HA ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -109.95 151.16 27.45 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 113.921 -1.491 . . . . 75.5 110.126 -176.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 mp -73.52 143.88 82.93 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.143 -1.058 . . . . 65.310000000000002 108.143 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -65.72 135.0 39.93 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.688 1.592 . . . . 75.120000000000005 111.461 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.23 139.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 107.731 -1.211 . . . . 74.200000000000003 107.731 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.6 m -84.22 -50.67 7.67 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.786 -0.365 . . . . 64.120000000000005 111.537 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -89.38 142.23 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.649 -0.871 . . . . 73.329999999999998 108.649 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.77 121.19 37.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.791 -0.818 . . . . 75.209999999999994 108.791 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -89.86 138.86 31.13 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.549 -0.86 . . . . 72.200000000000003 111.477 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 89.0 m -128.95 127.34 41.53 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.537 -1.21 . . . . 73.420000000000002 108.381 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 81.1 m-85 -122.11 130.45 53.25 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.66 -0.7 . . . . 75.129999999999995 110.798 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.426 HG22 HG22 ' B' ' 37' ' ' VAL . 57.0 p -115.12 130.78 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.1 -0.955 . . . . 74.540000000000006 111.173 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.444 HD13 HD12 ' A' ' 38' ' ' ILE . 55.0 mt -131.01 120.65 47.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.307 -0.627 . . . . 73.030000000000001 109.307 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -103.87 121.59 43.39 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.565 -0.902 . . . . 71.230000000000004 108.565 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.424 ' O ' HD21 ' B' ' 34' ' ' LEU . 9.6 tp10 -136.68 100.88 4.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.72 -0.673 . . . . 73.209999999999994 111.065 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.22 -102.59 0.61 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.619 -0.719 . . . . 74.400000000000006 112.966 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 33.9 m -112.45 13.05 20.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 112.049 0.389 . . . . 51.229999999999997 112.049 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.453 HD23 HG23 ' A' ' 40' ' ' ILE . 2.4 pt? -137.83 140.62 40.58 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.669 0.747 . . . . 75.109999999999999 110.396 175.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.418 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 33.7 ttt180 -117.27 134.07 55.24 Favored 'General case' 0 C--N 1.258 -3.394 0 CA-C-N 114.737 -1.12 . . . . 72.239999999999995 108.608 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.98 140.97 47.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 122.347 -0.221 . . . . 65.200000000000003 110.821 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' B' ' 27' ' ' TYR . 96.4 t -127.46 127.94 69.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.007 -0.542 . . . . 71.430000000000007 110.07 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.512 HD11 HD13 ' A' ' 29' ' ' ILE . 92.6 mt -113.15 126.77 70.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 123.4 0.68 . . . . 74.409999999999997 109.884 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.8 118.5 36.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.9 -0.778 . . . . 74.439999999999998 108.9 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.471 HD11 HD21 ' A' ' 34' ' ' LEU . 35.9 mm -94.61 115.58 33.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.26 -1.015 . . . . 71.120000000000005 108.26 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -129.68 162.97 27.13 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 110.07 -0.345 . . . . 75.340000000000003 110.07 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -20.8 66.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.023 0.44 . . . . 74.530000000000001 110.863 177.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -91.2 -17.23 26.39 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 111.946 0.351 . . . . 74.120000000000005 111.946 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' B' ' 14' ' ' LEU . . . 158.49 -156.29 27.28 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.69 -1.719 . . . . 71.140000000000001 113.583 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -112.81 122.69 48.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.698 -0.853 . . . . 70.329999999999998 108.698 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -117.39 138.45 51.8 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.119 -0.632 . . . . 64.319999999999993 110.013 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.1 140.95 47.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.207 -0.906 . . . . 73.140000000000001 109.334 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.52 143.21 51.21 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 116.295 -0.411 . . . . 75.120000000000005 110.641 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.42 122.92 47.27 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.406 -0.961 . . . . 72.209999999999994 108.406 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.418 ' OD2' ' HD3' ' B' ' 35' ' ' ARG . 32.1 t70 -112.99 126.9 27.51 Favored Pre-proline 0 C--N 1.275 -2.641 0 CA-C-N 114.918 -1.037 . . . . 73.409999999999997 108.294 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.508 ' HB3' ' NH1' ' A' ' 18' ' ' ARG . 61.2 Cg_endo -76.95 133.06 13.39 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.553 1.502 . . . . 70.150000000000006 114.564 -175.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 41.09 -141.47 0.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.497 1.519 . . . . 73.450000000000003 113.768 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.52 176.06 10.82 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 104.016 -2.587 . . . . 41.420000000000002 104.016 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 23.5 p -58.25 -51.43 69.78 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.614 0.721 . . . . 60.549999999999997 109.707 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -123.53 118.9 28.42 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.13 -1.433 . . . . 75.019999999999996 107.13 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.15 107.92 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.998 0.904 . . . . 74.540000000000006 110.641 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -89.61 130.78 35.86 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.049 -0.978 . . . . 72.239999999999995 110.033 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -75.67 -27.05 58.18 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.257 0.551 . . . . 75.019999999999996 110.799 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.72 102.98 13.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.774 -0.824 . . . . 75.319999999999993 108.774 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--O 1.261 1.698 0 C-N-CA 123.467 0.707 . . . . 52.200000000000003 110.858 -179.008 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.588 0.232 . . . . 73.219999999999999 111.428 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.14 141.13 15.53 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.138 -1.185 . . . . 74.340000000000003 110.138 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.7 m -79.11 95.06 5.46 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.479 -0.563 . . . . 65.209999999999994 109.479 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 59.72 -171.09 0.13 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.785 0.834 . . . . 72.209999999999994 111.326 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 m -110.86 92.97 2.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 120.018 -0.673 . . . . 62.329999999999998 112.731 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' B' ' 15' ' ' THR . 50.4 m 53.75 33.33 16.58 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.518 -1.219 . . . . 54.210000000000001 113.126 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -139.36 157.86 45.15 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.966 -0.753 . . . . 70.310000000000002 108.966 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 74.16 -178.8 0.18 Allowed 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.732 1.213 . . . . 71.319999999999993 112.465 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.406 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 94.7 mtt180 -100.2 106.41 18.09 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.085 -0.961 . . . . 73.340000000000003 110.042 -173.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p -87.41 143.82 27.05 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.638 -1.164 . . . . 73.430000000000007 111.422 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.7 m -132.74 148.51 52.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.784 -0.821 . . . . 54.109999999999999 108.784 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.0 t -143.68 142.02 25.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 110.055 -0.35 . . . . 71.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.3 t -107.92 128.45 54.64 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.51 -0.922 . . . . 62.240000000000002 108.51 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.7 mm? -100.94 121.61 42.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.134 -0.691 . . . . 73.510000000000005 109.134 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 p -97.35 114.24 26.01 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-O 121.797 0.808 . . . . 72.239999999999995 109.682 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -139.33 -169.72 2.73 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.38 -1.341 . . . . 74.549999999999997 107.38 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -73.04 101.13 3.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.389 -0.967 . . . . 71.430000000000007 108.389 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' HG3' ' CA ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -125.31 149.21 48.28 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.076 -0.65 . . . . 75.150000000000006 112.29 -173.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.3 pt? -89.99 148.73 40.25 Favored Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 107.639 -1.245 . . . . 75.200000000000003 107.639 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.44 136.35 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 121.519 1.479 . . . . 64.409999999999997 110.655 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -108.48 148.49 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.429 -0.582 . . . . 44.039999999999999 109.429 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 p -67.9 -57.26 6.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.005 0.431 . . . . 74.109999999999999 111.881 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -117.07 157.87 25.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.357 -0.383 . . . . 74.209999999999994 110.023 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -80.75 115.09 22.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.131 -1.433 . . . . 72.230000000000004 107.131 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -94.29 131.83 39.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.327 -0.549 . . . . 72.239999999999995 109.682 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.6 p -106.23 128.11 53.71 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.13 0.491 . . . . 72.430000000000007 109.861 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 80.0 m-85 -123.3 125.74 45.6 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 116.04 -0.527 . . . . 73.209999999999994 109.906 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.461 HG23 HG23 ' A' ' 37' ' ' VAL . 41.1 p -114.53 118.18 33.01 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.071 -0.968 . . . . 72.319999999999993 112.278 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.486 HD13 HD11 ' B' ' 38' ' ' ILE . 54.7 mt -121.95 121.51 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.095 -0.705 . . . . 75.319999999999993 109.095 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 57' ' ' ARG . 5.2 t -118.28 124.7 48.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 CA-C-O 122.164 0.983 . . . . 64.310000000000002 109.683 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.4 tp10 -124.38 98.37 5.72 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.573 -1.649 . . . . 64.099999999999994 108.479 -175.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.447 ' H ' ' HB3' ' A' ' 58' ' ' ASP . . . 68.5 -132.44 27.33 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 109.976 -1.25 . . . . 71.510000000000005 109.976 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.2 m -90.61 18.48 6.3 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.226 0.536 . . . . 65.430000000000007 110.878 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.45 HD21 HD11 ' B' ' 40' ' ' ILE . 32.8 tp -121.06 136.06 55.06 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.726 -0.472 . . . . 73.120000000000005 109.726 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -129.85 135.34 48.27 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 116.287 -0.415 . . . . 71.349999999999994 111.294 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.26 140.2 52.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.562 -0.533 . . . . 73.409999999999997 109.562 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG23 HG23 ' A' ' 28' ' ' THR . 63.6 t -121.97 125.92 73.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.969 0.414 . . . . 73.549999999999997 110.861 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 86.1 mt -102.15 124.94 56.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.384 -0.825 . . . . 74.030000000000001 109.629 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -110.72 119.04 37.81 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.797 -1.186 . . . . 74.120000000000005 107.797 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.491 HD11 HD21 ' B' ' 34' ' ' LEU . 34.4 mm -88.18 114.83 27.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.272 -1.381 . . . . 73.340000000000003 107.272 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -130.99 165.66 22.68 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.078 0.466 . . . . 74.540000000000006 111.275 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -68.04 -16.1 63.89 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.434 0.694 . . . . 74.200000000000003 109.994 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -86.83 -14.76 41.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.403 -0.962 . . . . 74.239999999999995 108.403 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' CA ' ' HG3' ' A' ' 18' ' ' ARG . . . 129.6 -117.34 2.35 Favored Glycine 0 CA--C 1.48 -2.125 0 CA-C-N 114.977 -1.011 . . . . 71.349999999999994 112.478 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 64.5 tp -113.41 132.87 55.46 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.583 -0.525 . . . . 64.5 109.583 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -128.42 134.99 48.91 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.484 -0.561 . . . . 71.140000000000001 109.484 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.43 HG11 HG13 ' B' ' 47' ' ' VAL . 12.4 p -128.57 140.59 48.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.043 0 CA-C-N 115.721 -0.672 . . . . 74.040000000000006 109.95 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.3 m -120.0 147.83 44.31 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 115.587 -0.733 . . . . 73.010000000000005 109.743 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.19 124.53 51.67 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 106.845 -1.539 . . . . 44.049999999999997 106.845 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.406 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 17.7 t70 -124.01 83.69 55.35 Favored Pre-proline 0 C--N 1.271 -2.819 0 N-CA-C 107.146 -1.427 . . . . 71.439999999999998 107.146 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -93.18 134.79 1.11 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 122.318 2.012 . . . . 71.439999999999998 112.661 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 49.39 83.66 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.209 -1.359 . . . . 74.349999999999994 111.912 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.86 -167.13 1.76 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.463 -0.789 . . . . 72.530000000000001 109.932 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.9 m -58.37 -56.62 19.8 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 123.637 0.585 . . . . 74.230000000000004 111.201 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -113.98 91.71 3.73 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 120.159 -0.616 . . . . 74.329999999999998 111.946 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.2 m -129.49 120.69 51.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.245 -0.888 . . . . 64.329999999999998 109.562 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.422 ' O ' HG21 ' A' ' 30' ' ' THR . 44.5 ttp180 -165.66 143.18 5.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.959 -1.126 . . . . 70.310000000000002 107.959 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 4.8 p-10 -74.43 95.97 2.81 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.405 -0.918 . . . . 71.510000000000005 110.951 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.33 2.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.434 -1.257 . . . . 63.020000000000003 111.638 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.514 HG23 ' OH ' ' B' ' 27' ' ' TYR . 27.2 m . . . . . 0 C--N 1.296 -1.734 0 CA-C-N 115.844 -0.616 . . . . 63.149999999999999 110.469 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.239 0.507 0 CA-C-O 121.191 0.52 . . . . 73.319999999999993 111.164 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.26 68.73 2.41 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.132 -0.787 . . . . 53.350000000000001 111.132 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 46.0 m -71.18 106.73 3.89 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 122.694 0.398 . . . . 74.049999999999997 111.59 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.433 ' OE2' ' HD3' ' B' ' 8' ' ' LYS . 40.1 mt-10 58.36 -162.97 0.21 Allowed 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.531 -0.759 . . . . 75.5 111.48 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.03 34.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.578 0.751 . . . . 73.409999999999997 110.882 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.414 ' H ' ' C ' ' B' ' 4' ' ' GLU . 50.7 m 68.05 79.46 0.22 Allowed 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.083 0.953 . . . . 64.200000000000003 109.794 -174.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -150.93 157.75 43.28 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 114.872 -1.058 . . . . 70.230000000000004 108.866 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.433 ' HD3' ' OE2' ' B' ' 4' ' ' GLU . 12.7 mptt 68.47 -176.59 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.914 0.886 . . . . 75.129999999999995 111.01 -173.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -79.31 110.33 14.49 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.287 -0.635 . . . . 74.010000000000005 109.287 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -90.25 143.31 26.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.238 -0.437 . . . . 72.219999999999999 110.384 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 69.5 m -144.91 149.39 35.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.827 -0.349 . . . . 74.420000000000002 110.116 -177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 92.7 t -141.2 141.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.741 0.416 . . . . 65.530000000000001 110.074 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.43 ' HB2' ' HD3' ' B' ' 46' ' ' LYS . 21.7 t -107.65 132.39 53.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.216 0.531 . . . . 61.299999999999997 109.687 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.77 120.84 43.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.704 -0.68 . . . . 71.209999999999994 110.661 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.1 p -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.291 -1.003 . . . . 65.519999999999996 108.291 173.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 t -142.57 -169.02 2.89 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.528 -0.915 . . . . 74.099999999999994 108.528 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.36 85.11 1.96 Allowed 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.292 1.044 . . . . 64.549999999999997 110.655 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -125.89 121.75 34.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.783 -1.099 . . . . 74.349999999999994 110.919 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.506 ' H ' HD22 ' B' ' 19' ' ' LEU . 1.7 pt? -74.66 147.56 84.59 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.019 -0.991 . . . . 74.239999999999995 108.535 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.74 147.56 81.43 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.383 2.055 . . . . 54.43 114.933 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 13.4 p -131.66 141.36 45.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.636 -1.616 . . . . 63.409999999999997 106.636 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 p -82.79 -14.15 54.96 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.316 0.858 . . . . 74.239999999999995 113.316 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -127.39 146.75 50.36 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.354 -0.216 . . . . 74.549999999999997 111.012 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -91.79 115.79 31.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.659 -0.867 . . . . 75.209999999999994 108.659 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -89.83 131.55 35.71 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.28 -0.568 . . . . 72.450000000000003 109.795 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 23.8 p -109.65 127.2 54.39 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.634 -0.712 . . . . 71.430000000000007 109.936 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.514 ' OH ' HG23 ' A' ' 60' ' ' VAL . 87.4 m-85 -128.35 126.24 40.33 Favored 'General case' 0 CA--C 1.468 -2.197 0 CA-C-N 116.404 -0.362 . . . . 72.010000000000005 110.811 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.478 HG22 HG22 ' B' ' 37' ' ' VAL . 76.0 p -115.16 132.6 56.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.431 -0.804 . . . . 71.140000000000001 112.023 -175.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.433 HD11 HD11 ' A' ' 29' ' ' ILE . 66.9 mt -136.64 124.8 34.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.184 -0.672 . . . . 75.409999999999997 109.184 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -115.35 140.89 48.72 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.808 -0.812 . . . . 73.420000000000002 108.808 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.435 ' HG2' HG13 ' A' ' 40' ' ' ILE . 9.5 tp10 -142.06 116.59 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.263 -0.88 . . . . 70.109999999999999 110.168 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' B' ' 56' ' ' VAL . . . 75.66 -76.66 1.33 Allowed Glycine 0 C--O 1.222 -0.655 0 N-CA-C 111.058 -0.817 . . . . 53.030000000000001 111.058 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.607 ' O ' ' HA ' ' B' ' 52' ' ' GLN . 37.9 m -153.14 -5.09 0.2 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.499 -0.926 . . . . 72.400000000000006 108.499 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.491 HD21 HD11 ' A' ' 40' ' ' ILE . 21.5 tp -88.2 140.13 29.79 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.377 1.071 . . . . 72.349999999999994 109.057 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -129.92 132.39 46.35 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.16 -0.616 . . . . 73.219999999999999 111.898 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.91 44.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 110.238 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.478 HG22 HG22 ' B' ' 28' ' ' THR . 60.2 t -127.84 127.26 67.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.465 -0.569 . . . . 55.100000000000001 109.465 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.486 HD11 HD13 ' A' ' 29' ' ' ILE . 77.3 mt -104.93 128.92 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 115.457 -0.792 . . . . 73.340000000000003 109.051 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 96.9 m-85 -113.2 116.6 30.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.939 -1.134 . . . . 72.099999999999994 107.939 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 34' ' ' LEU . 39.1 mm -88.7 114.66 27.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 107.471 -1.307 . . . . 75.420000000000002 107.471 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -116.13 -179.83 3.78 Favored 'General case' 0 N--CA 1.412 -2.337 0 C-N-CA 120.549 -0.46 . . . . 74.450000000000003 110.642 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -82.73 -31.39 28.47 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.327 0.862 . . . . 74.329999999999998 113.327 -172.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -102.36 -5.04 24.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.138 -0.625 . . . . 75.230000000000004 110.636 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.58 -136.74 4.0 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.154 -1.498 . . . . 53.310000000000002 114.195 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 67.3 tp -118.83 143.05 47.19 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 124.226 1.011 . . . . 62.030000000000001 108.998 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -129.83 121.68 27.22 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.262 -1.384 . . . . 75.109999999999999 107.262 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.43 HG13 HG11 ' A' ' 47' ' ' VAL . 13.9 p -114.81 140.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.423 -0.353 . . . . 72.120000000000005 110.464 -176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 46.4 m -131.11 141.63 50.16 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.513 0.508 . . . . 64.510000000000005 111.804 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.86 124.74 51.43 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.399 -0.819 . . . . 71.019999999999996 109.295 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.73 103.78 52.6 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.052 -1.092 . . . . 72.030000000000001 108.052 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.67 133.91 24.92 Favored 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 121.603 1.535 . . . . 62.240000000000002 112.632 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' B' ' 33' ' ' SER . 77.4 mt-30 47.32 91.6 0.01 OUTLIER 'General case' 0 C--O 1.24 0.554 0 N-CA-C 116.13 1.9 . . . . 73.109999999999999 116.13 174.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.35 146.21 34.81 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.054 -1.091 . . . . 70.340000000000003 108.054 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 89.7 m -72.46 -36.53 68.51 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.278 -0.638 . . . . 71.120000000000005 109.278 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -100.31 105.73 17.29 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.168 -1.049 . . . . 75.340000000000003 108.168 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' B' ' 32' ' ' GLY . 32.7 m -89.65 1.06 7.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.236 -0.893 . . . . 73.200000000000003 113.006 -171.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -59.2 116.25 3.74 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.924 -0.399 . . . . 72.219999999999999 109.924 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.28 134.06 50.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.413 0.625 . . . . 63.240000000000002 110.597 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.42 12.8 5.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.339 -0.846 . . . . 55.140000000000001 111.726 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 118.277 -0.868 . . . . 75.239999999999995 111.542 -178.325 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 110.049 -0.352 . . . . 73.109999999999999 110.049 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.96 59.07 0.37 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.483 -1.047 . . . . 73.200000000000003 110.483 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 m -118.63 105.79 11.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 109.802 -0.444 . . . . 70.310000000000002 109.802 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -131.9 -36.81 1.18 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.882 -0.414 . . . . 72.129999999999995 109.882 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -46.62 125.63 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 112.985 0.735 . . . . 61.240000000000002 112.985 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' B' ' 15' ' ' THR . 50.2 m -130.82 5.9 4.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.712 -0.677 . . . . 71.329999999999998 111.417 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -122.75 142.09 51.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.388 -0.597 . . . . 70.420000000000002 109.388 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.8 tttt 75.04 164.51 0.27 Allowed 'General case' 0 C--O 1.242 0.709 0 O-C-N 124.447 1.092 . . . . 52.229999999999997 111.83 176.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -56.52 116.86 3.35 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.925 -0.768 . . . . 74.349999999999994 108.925 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.555 ' OG1' HD12 ' B' ' 14' ' ' LEU . 3.5 p -108.23 149.51 28.49 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 112.237 0.458 . . . . 75.239999999999995 112.237 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.2 m -133.79 149.32 51.41 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.264 -1.384 . . . . 71.120000000000005 107.264 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.21 148.95 20.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.828 0.347 . . . . 73.400000000000006 110.698 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 32.5 t -125.06 144.63 50.31 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.818 -0.628 . . . . 73.430000000000007 109.655 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.453 ' O ' HD12 ' A' ' 14' ' ' LEU . 3.9 pp -125.96 142.59 51.45 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.648 -0.705 . . . . 75.219999999999999 109.719 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 p -98.6 119.54 37.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.095 -0.706 . . . . 54.340000000000003 109.095 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -143.63 -171.84 3.6 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.219 -0.592 . . . . 75.329999999999998 110.288 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.0 88.93 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.407 0.683 . . . . 75.340000000000003 110.948 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 23.5 mmm180 -126.38 149.24 49.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.442 0.904 . . . . 75.450000000000003 113.442 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.473 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.9 pt? -108.4 158.11 34.71 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.508 -1.293 . . . . 64.109999999999999 107.508 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 27.6 Cg_endo -62.28 136.06 57.71 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.29 1.993 . . . . 72.439999999999998 112.533 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -116.49 141.77 32.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.943 -1.026 . . . . 71.209999999999994 109.666 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.9 m -67.33 -34.59 77.66 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.204 0.816 . . . . 75.099999999999994 113.204 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -132.3 149.87 52.27 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.813 -0.554 . . . . 75.129999999999995 111.4 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.9 mm -86.05 115.5 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.59 -1.633 . . . . 64.209999999999994 106.59 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.82 128.67 45.1 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 116.125 -0.489 . . . . 75.209999999999994 109.695 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.9 p -106.6 127.68 53.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.366 -0.605 . . . . 75.329999999999998 109.366 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -123.07 127.96 49.47 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.911 -0.586 . . . . 72.409999999999997 110.71 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.535 HG23 HG23 ' A' ' 37' ' ' VAL . 12.1 p -114.41 126.68 55.25 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 74.109999999999999 112.329 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.47 HD13 HD11 ' B' ' 38' ' ' ILE . 49.0 mt -123.66 121.66 62.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.754 -0.657 . . . . 75.430000000000007 109.729 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -110.25 120.97 44.14 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.622 -1.251 . . . . 74.150000000000006 107.622 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.547 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.7 tp10 -134.4 106.6 7.15 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.709 -0.396 . . . . 64.200000000000003 111.402 -175.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.82 -67.39 1.68 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 116.053 -0.521 . . . . 52.229999999999997 113.138 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.5 m -154.91 10.15 0.33 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.257 0.466 . . . . 71.010000000000005 112.257 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.547 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -128.13 140.74 51.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 118.701 -1.2 . . . . 74.409999999999997 111.06 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.52 ' NH2' ' HB3' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -110.0 121.99 46.53 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.307 -0.86 . . . . 75.200000000000003 110.32 175.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.42 130.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.323 -0.399 . . . . 73.439999999999998 110.007 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.535 HG23 HG23 ' A' ' 28' ' ' THR . 49.8 t -110.06 125.19 67.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.243 -0.435 . . . . 73.329999999999998 109.912 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 HD12 HD13 ' B' ' 29' ' ' ILE . 70.6 mt -101.19 122.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 108.561 -0.903 . . . . 63.439999999999998 108.561 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 75.8 m-85 -104.39 119.08 38.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.608 -1.256 . . . . 71.019999999999996 107.608 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.48 113.97 25.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 107.641 -1.244 . . . . 70.430000000000007 107.641 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -119.75 -177.7 3.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.89 -0.596 . . . . 74.540000000000006 110.674 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -97.26 -20.55 17.82 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.474 0.546 . . . . 74.019999999999996 112.474 -177.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 45.6 ttp180 -91.34 -29.27 17.22 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.773 0.797 . . . . 73.120000000000005 109.996 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 178.82 -121.79 0.77 Allowed Glycine 0 C--N 1.293 -1.825 0 C-N-CA 119.18 -1.486 . . . . 71.120000000000005 113.276 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.7 tp -137.61 147.05 44.68 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.085 -0.709 . . . . 71.329999999999998 109.085 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.0 tptm -139.42 129.24 24.78 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.208 -1.405 . . . . 73.230000000000004 107.208 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 11.4 p -131.13 140.99 47.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.97 -0.382 . . . . 74.019999999999996 109.97 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.5 m -119.85 137.91 53.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.314 -0.403 . . . . 71.129999999999995 110.707 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.33 124.73 47.34 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.286 0.565 . . . . 73.519999999999996 110.554 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.65 104.02 55.31 Favored Pre-proline 0 C--N 1.278 -2.507 0 N-CA-C 107.315 -1.365 . . . . 71.420000000000002 107.315 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -95.39 133.46 0.56 Allowed 'Trans proline' 0 N--CA 1.409 -3.497 0 C-N-CA 120.846 1.031 . . . . 70.239999999999995 114.076 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 45.84 44.61 11.09 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 126.101 1.76 . . . . 71.040000000000006 114.339 167.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.52 ' HB3' ' NH2' ' A' ' 35' ' ' ARG . . . -82.82 72.29 9.9 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 119.686 -0.805 . . . . 54.0 111.892 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 m 61.48 -79.38 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 125.008 1.323 . . . . 74.010000000000005 113.786 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -97.46 120.69 38.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.037 -0.727 . . . . 74.25 109.037 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.504 ' O ' ' HD2' ' A' ' 35' ' ' ARG . 9.0 p -58.55 -37.19 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 O-C-N 123.658 0.599 . . . . 64.25 112.487 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 69.64 137.33 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.038 0.935 . . . . 72.450000000000003 112.724 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.59 161.21 16.28 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.681 -0.69 . . . . 75.540000000000006 109.75 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -156.98 152.88 7.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.414 -0.588 . . . . 74.099999999999994 109.414 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.6 t . . . . . 0 C--N 1.307 -1.253 0 N-CA-C 109.815 -0.439 . . . . 71.019999999999996 109.815 177.891 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 108.647 -0.871 . . . . 64.310000000000002 108.647 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.63 42.34 0.09 OUTLIER Glycine 0 C--N 1.298 -1.56 0 C-N-CA 119.699 -1.239 . . . . 74.109999999999999 112.976 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -89.18 91.58 8.84 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.769 -0.456 . . . . 75.230000000000004 109.769 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.31 -29.71 60.11 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 122.101 0.953 . . . . 71.230000000000004 109.232 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.43 134.77 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.816 -1.084 . . . . 72.299999999999997 108.981 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 38.3 m -111.75 20.42 17.08 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.452 -0.944 . . . . 73.209999999999994 108.452 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -152.18 -177.72 6.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 104.555 -2.387 . . . . 72.340000000000003 104.555 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt 67.4 -92.42 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.733 0.697 . . . . 64.230000000000004 110.834 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -161.21 124.4 3.24 Favored 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 107.158 -1.423 . . . . 72.230000000000004 107.158 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.435 ' HB ' HD11 ' A' ' 14' ' ' LEU . 8.6 m -102.54 142.98 32.83 Favored 'General case' 0 N--CA 1.382 -3.834 0 N-CA-C 107.041 -1.466 . . . . 62.43 107.041 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 73.3 m -134.46 148.36 50.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.805 -1.183 . . . . 70.409999999999997 107.805 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.66 156.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 123.903 0.752 . . . . 75.200000000000003 109.344 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -130.69 145.82 52.02 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.752 -0.462 . . . . 54.43 109.752 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.555 HD12 ' OG1' ' A' ' 10' ' ' THR . 4.2 pp -130.04 134.98 47.76 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 109.062 -0.718 . . . . 74.549999999999997 109.062 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.0 p -106.73 141.79 37.41 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 120.414 -0.514 . . . . 73.510000000000005 110.726 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -157.41 -171.47 3.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.81 -1.182 . . . . 75.209999999999994 107.81 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -69.08 104.41 2.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.888 0.851 . . . . 53.439999999999998 109.91 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -125.95 148.08 49.33 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.085 -0.961 . . . . 73.040000000000006 111.405 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.471 ' H ' HD22 ' B' ' 19' ' ' LEU . 2.0 pt? -103.52 152.88 38.88 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.067 -1.086 . . . . 64.439999999999998 108.067 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.56 136.45 54.46 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.048 1.832 . . . . 61.039999999999999 111.788 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.93 149.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 108.351 -0.981 . . . . 74.510000000000005 108.351 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -79.53 -41.29 27.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.828 0.347 . . . . 73.310000000000002 111.431 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -125.23 134.15 52.44 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.319 -0.238 . . . . 71.439999999999998 110.662 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.16 119.92 20.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 107.712 -1.218 . . . . 73.219999999999999 107.712 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -91.29 139.12 31.04 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.997 -0.681 . . . . 72.319999999999993 110.368 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.1 p -120.37 127.56 52.42 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.87 -0.789 . . . . 72.319999999999993 108.87 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -126.84 126.65 43.7 Favored 'General case' 0 CA--C 1.458 -2.593 0 CA-C-N 116.022 -0.536 . . . . 73.319999999999993 110.154 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.51 HG22 HG22 ' B' ' 37' ' ' VAL . 53.0 p -115.9 127.46 55.01 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.549 -0.75 . . . . 74.019999999999996 111.056 -176.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.425 HD13 HD12 ' A' ' 38' ' ' ILE . 54.9 mt -121.12 121.27 64.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.098 -0.704 . . . . 63.450000000000003 109.098 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 9.2 t -112.39 115.92 29.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.528 -0.916 . . . . 75.209999999999994 108.528 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.463 ' O ' HD21 ' B' ' 34' ' ' LEU . 9.2 tp10 -120.71 97.6 5.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.915 -1.039 . . . . 74.400000000000006 111.048 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -66.12 0.47 Allowed Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.689 -0.687 . . . . 62.32 114.601 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' B' ' 52' ' ' GLN . 48.2 m -145.15 23.83 1.48 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.34 -0.506 . . . . 75.400000000000006 111.688 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.463 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -148.49 134.92 19.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 119.049 -1.06 . . . . 71.140000000000001 111.767 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 8.6 tpp180 -101.44 114.08 27.76 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.111 -1.404 . . . . 71.310000000000002 108.559 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.65 133.36 51.43 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.584 -0.525 . . . . 71.439999999999998 109.584 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.51 HG22 HG22 ' B' ' 28' ' ' THR . 48.2 t -118.85 127.0 75.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.738 0.304 . . . . 74.219999999999999 110.967 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.47 HD11 HD13 ' A' ' 29' ' ' ILE . 73.5 mt -102.77 121.87 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 C-N-CA 123.946 0.898 . . . . 75.219999999999999 109.039 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.41 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 93.7 m-85 -103.86 114.3 28.46 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.309 -0.997 . . . . 74.219999999999999 108.309 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 51.1 mm -88.44 112.61 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 106.697 -1.594 . . . . 75.040000000000006 106.697 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -121.13 -179.57 4.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 116.424 -0.353 . . . . 74.109999999999999 110.181 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -95.93 -17.8 20.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.902 0.382 . . . . 73.239999999999995 111.145 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 73.6 ttt180 -98.83 -17.92 18.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.128 0.49 . . . . 75.409999999999997 109.842 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.51 -143.07 5.51 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.027 -1.082 . . . . 61.520000000000003 113.37 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.51 ' HB3' ' CD1' ' B' ' 14' ' ' LEU . 1.9 tm? -139.38 122.86 17.25 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 124.673 1.189 . . . . 74.219999999999999 108.04 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -118.53 143.68 46.58 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.961 0.41 . . . . 71.329999999999998 110.977 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.57 141.25 46.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.62 -0.718 . . . . 74.420000000000002 110.559 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.41 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 62.3 m -127.69 142.17 51.41 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.118 -0.492 . . . . 63.340000000000003 111.045 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.04 124.01 48.25 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.187 -0.461 . . . . 37.75 110.202 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 24.2 t70 -118.15 88.09 31.15 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 107.552 -1.277 . . . . 73.140000000000001 107.552 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 85.9 Cg_endo -91.6 134.43 1.56 Allowed 'Trans proline' 0 N--CA 1.42 -2.851 0 C-N-CA 121.64 1.56 . . . . 73.409999999999997 114.034 -173.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.421 ' HG2' ' HB3' ' B' ' 33' ' ' SER . 40.2 mt-30 62.21 15.55 7.62 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.73 -1.123 . . . . 64.409999999999997 113.411 172.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.71 148.5 23.79 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.255 0.55 . . . . 65.310000000000002 112.447 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 62.5 m 68.95 -75.19 0.07 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.185 1.394 . . . . 73.129999999999995 113.212 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -177.41 151.47 0.77 Allowed 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 106.999 -1.482 . . . . 72.420000000000002 106.999 -173.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.41 -47.41 92.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 123.266 0.354 . . . . 61.539999999999999 111.816 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 63.19 85.75 0.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.853 1.261 . . . . 75.329999999999998 111.211 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -119.51 105.49 11.29 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.931 -1.137 . . . . 63.329999999999998 107.931 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.98 155.02 40.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.785 -1.098 . . . . 72.200000000000003 110.566 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.312 -1.056 0 N-CA-C 108.541 -0.911 . . . . 74.530000000000001 108.541 177.794 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 111.828 0.307 . . . . 74.310000000000002 111.828 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.89 -133.55 4.21 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 119.938 -1.125 . . . . 71.129999999999995 112.315 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -149.59 135.31 18.59 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.867 -0.42 . . . . 71.409999999999997 109.867 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.277 0.9 OUTLIER -106.6 98.04 7.76 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.141 0.972 . . . . 73.239999999999995 111.025 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -98.77 128.01 50.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.056 -0.974 . . . . 64.209999999999994 111.269 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.2 m -156.1 170.41 22.24 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.801 -1.555 . . . . 73.329999999999998 106.801 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.5 93.76 6.72 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.345 -1.354 . . . . 73.200000000000003 107.345 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -159.7 166.23 30.96 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.533 -0.758 . . . . 72.200000000000003 110.168 -171.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.659 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 6.1 ppt_? -111.12 128.87 56.02 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.759 -0.83 . . . . 71.439999999999998 108.759 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.442 ' CB ' HD12 ' B' ' 14' ' ' LEU . 18.9 p -101.57 148.62 25.01 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 122.112 -0.368 . . . . 74.010000000000005 110.959 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.1 m -136.49 157.35 46.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.008 0.432 . . . . 74.409999999999997 111.021 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.453 HG23 HD11 ' B' ' 14' ' ' LEU . 86.5 t -130.77 134.71 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.58 -0.737 . . . . 75.420000000000002 110.776 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -117.93 125.62 50.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.522 -0.547 . . . . 61.32 109.522 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.97 121.77 27.2 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 123.311 0.644 . . . . 72.150000000000006 109.817 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 p -125.17 112.79 16.86 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.228 -0.442 . . . . 64.420000000000002 111.753 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.538 HG23 ' H ' ' A' ' 17' ' ' GLN . 4.2 t -156.52 -92.07 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.265 1.209 . . . . 74.209999999999994 114.265 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.538 ' H ' HG23 ' A' ' 16' ' ' THR . 26.7 tp60 -94.07 91.68 6.95 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.659 0.742 . . . . 74.140000000000001 109.198 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 2.5 ppt_? -126.72 149.25 49.68 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.479 -0.782 . . . . 75.140000000000001 112.776 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 19' ' ' LEU . 2.2 pt? -110.33 155.19 42.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.283 -1.006 . . . . 70.430000000000007 108.283 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.84 136.64 49.93 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.874 1.716 . . . . 50.039999999999999 110.986 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.04 144.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.405 -0.816 . . . . 72.519999999999996 109.295 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.8 m -87.09 -35.41 18.71 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.259 0.552 . . . . 75.530000000000001 111.32 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -123.25 133.14 54.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.782 -0.645 . . . . 61.310000000000002 110.976 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.16 115.63 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 107.164 -1.421 . . . . 73.129999999999995 107.164 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.1 mmtp -99.35 134.95 41.48 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 120.372 -0.531 . . . . 75.530000000000001 110.859 -176.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -114.33 127.16 55.72 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.893 -1.151 . . . . 72.340000000000003 107.893 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -120.25 130.39 54.49 Favored 'General case' 0 CA--C 1.457 -2.599 0 CA-C-N 116.224 -0.444 . . . . 75.319999999999993 109.992 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.504 HG23 HG23 ' A' ' 37' ' ' VAL . 68.4 p -114.68 122.59 46.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 119.766 -0.773 . . . . 74.239999999999995 111.183 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.496 HD13 HD11 ' B' ' 38' ' ' ILE . 89.5 mt -115.82 124.67 72.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.628 -0.878 . . . . 64.129999999999995 108.628 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -117.02 116.18 26.86 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.117 0.96 . . . . 72.140000000000001 108.794 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.584 ' O ' HD21 ' A' ' 34' ' ' LEU . 15.3 tp10 -136.96 123.18 20.51 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.284 -0.871 . . . . 74.019999999999996 110.388 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.81 -84.99 0.37 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.21 -0.756 . . . . 72.140000000000001 111.21 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 m -150.47 10.56 0.66 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 122.726 -0.279 . . . . 74.420000000000002 111.06 177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.584 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -114.81 140.21 49.11 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 119.193 -1.003 . . . . 73.409999999999997 111.584 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.416 ' NH2' ' HA ' ' A' ' 56' ' ' VAL . 2.8 mpt_? -100.08 118.05 35.62 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.112 -0.949 . . . . 62.210000000000001 108.781 176.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.07 116.18 31.48 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.471 -0.566 . . . . 70.430000000000007 109.471 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.504 HG23 HG23 ' A' ' 28' ' ' THR . 60.1 t -108.48 120.7 60.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.167 0.508 . . . . 71.340000000000003 110.179 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.49 HD12 HD13 ' B' ' 29' ' ' ILE . 95.0 mt -101.34 124.7 55.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 115.147 -0.933 . . . . 64.319999999999993 108.721 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -106.92 115.14 29.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.378 -0.971 . . . . 63.109999999999999 108.378 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.533 HD11 HD21 ' B' ' 34' ' ' LEU . 37.3 mm -90.69 114.53 28.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.326 -1.361 . . . . 72.430000000000007 107.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -129.47 156.46 44.08 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 120.543 -0.463 . . . . 73.239999999999995 110.609 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -67.4 -13.74 62.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.447 0.699 . . . . 73.420000000000002 110.793 -178.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -87.18 -22.56 25.21 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.724 -0.473 . . . . 70.209999999999994 109.724 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.17 -138.02 6.5 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.259 -0.972 . . . . 72.019999999999996 113.629 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -113.37 128.59 56.51 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.159 0.504 . . . . 72.329999999999998 110.597 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 54.4 tptt -137.1 127.96 27.34 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.454 -1.313 . . . . 73.329999999999998 107.454 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -132.1 139.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 110.599 -0.149 . . . . 71.25 110.599 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.4 137.71 54.02 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.621 0.248 . . . . 70.409999999999997 110.446 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.79 43.07 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.411 -0.359 . . . . 43.350000000000001 110.245 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -115.0 104.62 53.89 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.334 -0.848 . . . . 74.120000000000005 109.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -94.73 134.72 0.72 Allowed 'Trans proline' 0 N--CA 1.427 -2.408 0 C-N-CA 121.712 1.608 . . . . 72.099999999999994 114.641 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 53.03 -83.12 0.01 OUTLIER 'General case' 0 C--O 1.247 0.949 0 C-N-CA 126.446 1.898 . . . . 75.439999999999998 115.546 170.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 71.44 -74.1 0.09 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.999 1.32 . . . . 72.319999999999993 112.123 -177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.6 m -138.8 -71.38 0.41 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.415 -0.957 . . . . 75.239999999999995 108.415 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -123.25 149.88 44.18 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.013 -1.106 . . . . 74.230000000000004 108.013 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.416 ' HA ' ' NH2' ' A' ' 35' ' ' ARG . 7.2 p -130.74 120.57 48.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.433 0.635 . . . . 75.239999999999995 110.767 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.444 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 1.7 tpm_? -95.92 90.34 5.56 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.011 -1.477 . . . . 73.420000000000002 107.011 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.6 95.71 9.85 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.287 1.041 . . . . 55.420000000000002 110.217 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.9 t -80.09 108.85 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.498 -1.228 . . . . 73.420000000000002 110.695 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 115.964 -0.562 . . . . 75.219999999999999 110.609 178.868 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.292 0.568 . . . . 74.150000000000006 110.121 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.71 64.7 3.58 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.296 -0.866 . . . . 44.520000000000003 113.321 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 16.0 p -88.8 112.71 23.54 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.231 0.539 . . . . 74.129999999999995 110.238 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.21 97.03 5.06 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.55 0.69 . . . . 64.230000000000004 111.794 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -96.25 114.67 33.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.652 -0.703 . . . . 61.439999999999998 110.326 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -148.21 178.42 8.57 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.941 -0.763 . . . . 75.129999999999995 108.941 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.77 9.17 6.64 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.721 0.296 . . . . 73.510000000000005 111.203 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -67.44 114.44 6.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.047 0.927 . . . . 75.040000000000006 111.628 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.489 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 69.2 mtt180 -98.3 105.63 17.8 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.003 -1.11 . . . . 75.219999999999999 108.003 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -87.8 143.42 27.15 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.168 -0.924 . . . . 71.340000000000003 112.378 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 66.8 m -141.51 149.45 40.88 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.114 -1.069 . . . . 53.240000000000002 108.114 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.58 146.21 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 110.339 -0.245 . . . . 62.140000000000001 110.339 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 22.5 p -107.26 135.51 48.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.214 0.606 . . . . 70.150000000000006 110.767 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.464 HD13 HD13 ' B' ' 45' ' ' LEU . 96.7 mt -116.73 130.59 56.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.122 -0.49 . . . . 73.450000000000003 110.642 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -101.66 122.67 44.32 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.871 -0.789 . . . . 54.310000000000002 108.871 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.7 t -151.27 -174.96 4.98 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 120.725 0.298 . . . . 75.129999999999995 110.58 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -72.06 86.42 1.03 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.522 0.729 . . . . 75.219999999999999 109.947 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -126.52 149.24 49.49 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 114.204 1.187 . . . . 71.349999999999994 114.204 -179.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -78.5 134.73 61.56 Favored Pre-proline 0 C--N 1.29 -1.996 0 CA-C-N 114.944 -1.025 . . . . 73.099999999999994 109.361 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.96 136.33 34.85 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.093 1.862 . . . . 54.530000000000001 111.468 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' B' ' 42' ' ' LYS . 10.9 p -131.29 133.27 62.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.372 -0.831 . . . . 71.150000000000006 108.912 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.4 m -84.79 -13.43 51.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.084 0.468 . . . . 73.150000000000006 111.928 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.408 ' H ' HG23 ' B' ' 21' ' ' VAL . 30.5 mmm180 -105.94 133.83 50.04 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.812 -0.81 . . . . 75.219999999999999 108.812 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -94.29 115.39 32.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.591 -0.892 . . . . 75.409999999999997 108.591 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.65 128.72 39.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.905 -0.588 . . . . 71.430000000000007 110.39 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.2 p -110.63 127.98 55.49 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.457 -0.792 . . . . 73.049999999999997 109.951 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -126.19 127.44 45.7 Favored 'General case' 0 CA--C 1.459 -2.549 0 CA-C-N 115.887 -0.597 . . . . 74.450000000000003 110.674 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.506 HG22 HG22 ' B' ' 37' ' ' VAL . 78.0 p -115.14 139.54 49.83 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.942 -1.026 . . . . 72.230000000000004 110.802 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.49 HD13 HD12 ' A' ' 38' ' ' ILE . 49.4 mt -136.89 133.84 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.674 -0.491 . . . . 74.200000000000003 109.674 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' B' ' 56' ' ' VAL . 7.9 t -117.47 131.91 56.65 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.636 -0.505 . . . . 72.140000000000001 109.636 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.408 ' OE1' ' HG3' ' A' ' 25' ' ' LYS . 10.9 tp10 -142.43 114.77 8.38 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.636 -0.711 . . . . 73.510000000000005 109.788 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -76.73 0.86 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.118 -0.793 . . . . 72.140000000000001 111.118 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.416 ' HB3' ' HA ' ' B' ' 52' ' ' GLN . 39.8 m -156.92 10.52 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.625 -1.25 . . . . 71.310000000000002 107.625 174.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.533 HD21 HD11 ' A' ' 40' ' ' ILE . 45.5 tp -95.52 115.67 27.76 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 115.28 -0.873 . . . . 72.319999999999993 108.871 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -107.12 113.54 27.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.983 -1.118 . . . . 71.299999999999997 107.983 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.45 34.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.882 -0.414 . . . . 71.099999999999994 109.882 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.506 HG22 HG22 ' B' ' 28' ' ' THR . 67.1 t -129.0 129.97 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.849 -0.426 . . . . 65.230000000000004 109.849 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.496 HD11 HD13 ' A' ' 29' ' ' ILE . 80.1 mt -114.78 125.15 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 109.09 -0.707 . . . . 63.210000000000001 109.09 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 64.6 m-85 -106.84 116.68 32.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.534 -1.284 . . . . 74.319999999999993 107.534 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.17 114.28 26.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 105.922 -1.881 . . . . 63.539999999999999 105.922 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -125.6 156.74 38.68 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.117 0.484 . . . . 70.140000000000001 110.593 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' B' ' 21' ' ' VAL . 0.1 OUTLIER -60.03 -25.91 65.69 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.47 -0.786 . . . . 72.239999999999995 112.435 -177.571 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -97.1 -8.29 30.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.515 -0.474 . . . . 73.519999999999996 111.528 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.0 -153.88 24.79 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 118.305 -1.902 . . . . 70.450000000000003 114.547 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.464 HD13 HD13 ' B' ' 14' ' ' LEU . 3.2 tm? -113.66 122.28 46.69 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.19 -1.041 . . . . 64.129999999999995 108.19 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.51 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 56.9 tptt -117.38 122.13 42.98 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.004 -1.11 . . . . 64.030000000000001 108.004 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 11.1 p -115.42 139.7 40.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 110.338 -0.245 . . . . 74.540000000000006 110.338 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.28 140.44 52.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.127 -0.488 . . . . 60.43 111.585 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.57 124.16 48.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 108.817 -0.809 . . . . 64.150000000000006 108.817 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.489 ' OD2' ' HD3' ' B' ' 9' ' ' ARG . 15.1 t70 -119.07 95.23 49.18 Favored Pre-proline 0 C--N 1.284 -2.249 0 N-CA-C 104.875 -2.268 . . . . 70.120000000000005 104.875 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -98.7 135.08 0.29 Allowed 'Trans proline' 0 N--CA 1.429 -2.275 0 C-N-CA 121.935 1.757 . . . . 71.129999999999995 116.357 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.416 ' HA ' ' HB3' ' B' ' 33' ' ' SER . 53.0 mt-30 60.78 14.84 5.41 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 116.192 1.923 . . . . 63.409999999999997 116.192 170.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.11 -48.39 7.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.426 -0.953 . . . . 61.219999999999999 108.426 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.0 m -107.41 143.7 35.36 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 108.16 -1.052 . . . . 53.329999999999998 108.16 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -80.79 -178.02 6.61 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 116.05 -0.523 . . . . 74.040000000000006 111.244 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.499 ' HA ' ' OG1' ' B' ' 30' ' ' THR . 12.6 p -92.96 142.9 12.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.299 -0.41 . . . . 73.409999999999997 110.774 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -168.25 105.52 0.47 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.203 1.001 . . . . 60.310000000000002 109.012 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.41 133.47 44.9 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.748 -0.834 . . . . 72.120000000000005 108.748 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.07 121.32 4.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 O-C-N 123.735 0.647 . . . . 64.129999999999995 112.509 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.43 -1.435 0 CA-C-O 118.465 -0.779 . . . . 43.009999999999998 110.428 176.163 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--O 1.238 0.461 0 N-CA-C 109.342 -0.614 . . . . 73.439999999999998 109.342 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.16 -151.6 7.73 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.798 -1.321 . . . . 53.439999999999998 109.798 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 t -100.39 95.81 7.0 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.95 -0.759 . . . . 71.439999999999998 108.95 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -133.11 117.32 17.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.275 -0.639 . . . . 65.340000000000003 109.275 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.01 78.76 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-O 121.785 0.802 . . . . 74.340000000000003 109.161 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.8 p -100.83 137.68 38.89 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.984 -1.007 . . . . 74.329999999999998 108.745 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -81.75 92.28 6.61 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.845 0.831 . . . . 73.530000000000001 111.693 -172.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -145.28 144.9 31.02 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.608 -1.627 . . . . 73.439999999999998 106.608 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.41 ' HD3' ' OD1' ' A' ' 50' ' ' ASP . 18.0 ptt180 -66.1 105.85 1.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.635 0.731 . . . . 74.019999999999996 110.892 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -96.97 148.83 22.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.931 -1.032 . . . . 74.420000000000002 111.945 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -127.21 156.23 42.16 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.396 -0.964 . . . . 52.210000000000001 108.396 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.48 ' CG2' HD21 ' B' ' 14' ' ' LEU . 94.2 t -134.49 140.76 45.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.663 0.268 . . . . 61.509999999999998 110.661 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 p -109.83 125.83 53.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.44 -0.948 . . . . 71.510000000000005 108.44 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.444 HD12 HD23 ' A' ' 45' ' ' LEU . 86.5 mt -109.57 127.84 54.78 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.018 0.437 . . . . 65.129999999999995 111.987 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.93 114.1 25.79 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.434 -0.95 . . . . 72.010000000000005 108.434 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -143.6 -169.89 3.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.861 -1.163 . . . . 72.140000000000001 107.861 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.65 99.76 1.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 72.109999999999999 109.645 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -125.44 148.38 48.85 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.792 1.034 . . . . 73.040000000000006 113.792 -175.311 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pp -102.46 161.75 22.32 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 114.094 -1.412 . . . . 73.150000000000006 108.9 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.62 135.98 51.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.587 1.525 . . . . 62.530000000000001 111.647 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.7 t -123.91 124.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.347 -0.982 . . . . 64.010000000000005 108.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.0 m -86.5 -56.39 3.45 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.432 0.53 . . . . 73.319999999999993 112.432 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -93.47 133.39 36.81 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.138 -0.625 . . . . 74.519999999999996 110.109 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -83.27 123.31 38.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.533 -0.914 . . . . 75.340000000000003 108.533 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -106.5 143.01 35.22 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.318 -0.401 . . . . 74.5 110.303 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -119.72 127.69 53.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.684 -0.858 . . . . 75.030000000000001 108.684 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -124.44 130.26 52.15 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-N 115.994 -0.548 . . . . 65.340000000000003 110.806 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.469 HG23 HG23 ' A' ' 37' ' ' VAL . 44.9 p -115.22 125.03 52.87 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.103 -0.953 . . . . 71.099999999999994 112.158 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.47 HD13 HD11 ' B' ' 38' ' ' ILE . 59.5 mt -129.9 128.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.299 -0.63 . . . . 63.520000000000003 109.299 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -119.46 137.16 53.96 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.44 -0.948 . . . . 72.450000000000003 108.44 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.86 111.37 6.23 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.814 0.34 . . . . 73.540000000000006 110.195 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.64 -67.94 3.28 Favored Glycine 0 C--N 1.298 -1.528 0 C-N-CA 120.749 -0.738 . . . . 74.219999999999999 112.572 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.2 m -156.93 -16.21 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.791 0.437 . . . . 52.0 112.063 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.548 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -88.67 140.59 29.3 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 118.468 -1.293 . . . . 64.219999999999999 110.615 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 19.8 mmt180 -103.49 119.37 38.76 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.951 -1.5 . . . . 75.239999999999995 106.951 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.98 124.74 51.95 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.215 -0.661 . . . . 73.109999999999999 109.215 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG23 HG23 ' A' ' 28' ' ' THR . 99.1 t -117.02 125.52 73.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.035 0.445 . . . . 71.450000000000003 111.417 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.479 HD12 HD13 ' B' ' 29' ' ' ILE . 92.4 mt -104.59 121.45 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 C-N-CA 124.033 0.933 . . . . 70.049999999999997 109.144 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.448 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.0 m-85 -108.54 117.15 33.42 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.767 -1.197 . . . . 71.540000000000006 107.767 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.473 HG23 HD23 ' B' ' 34' ' ' LEU . 45.9 mm -88.41 118.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.674 -0.861 . . . . 75.200000000000003 108.674 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -134.59 171.95 13.61 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.5 0.667 . . . . 75.140000000000001 110.402 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -77.21 -15.38 59.51 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.879 0.872 . . . . 75.040000000000006 110.419 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -87.88 10.42 18.71 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.162 -1.422 . . . . 73.109999999999999 107.162 -177.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -124.73 8.0 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.626 -1.17 . . . . 74.299999999999997 112.549 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.444 HD23 HD12 ' A' ' 14' ' ' LEU . 64.4 tp -112.26 135.04 53.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.865 -0.421 . . . . 74.010000000000005 109.865 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.507 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 1.5 tmtm? -128.85 122.4 30.32 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.158 -2.164 . . . . 62.43 105.158 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.449 HG11 HG13 ' B' ' 47' ' ' VAL . 13.6 p -128.29 140.96 47.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 110.171 -0.307 . . . . 72.409999999999997 110.171 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.507 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 93.7 m -121.07 143.12 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 122.319 0.248 . . . . 71.310000000000002 111.035 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.45 123.85 48.51 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.044 -0.724 . . . . 64.340000000000003 109.044 177.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 18.5 t70 -124.25 100.53 35.76 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 107.693 -1.225 . . . . 73.140000000000001 107.693 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.13 134.19 4.27 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 122.067 1.845 . . . . 37.299999999999997 115.143 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.47 ' NE2' ' HG3' ' B' ' 17' ' ' GLN . 49.9 mt-30 57.0 42.37 26.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.916 -1.493 . . . . 71.439999999999998 112.006 169.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.41 -78.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.199 1.0 . . . . 60.130000000000003 113.685 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 33.3 p -132.29 -82.07 0.5 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.635 0.255 . . . . 71.510000000000005 111.54 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -139.43 148.59 42.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.976 -0.556 . . . . 74.310000000000002 109.537 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 p -95.38 161.24 2.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.674 -0.861 . . . . 71.0 108.674 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -124.64 176.96 6.21 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.744 -0.836 . . . . 64.510000000000005 108.744 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -70.87 115.52 10.11 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 108.186 -1.042 . . . . 75.109999999999999 108.186 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -69.87 115.16 8.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.714 -0.676 . . . . 70.530000000000001 110.469 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 115.676 -0.693 . . . . 75.319999999999993 109.896 178.847 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 57.1 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 109.519 -0.549 . . . . 75.040000000000006 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.61 173.09 20.73 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.138 -1.185 . . . . 64.430000000000007 110.138 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 19.9 t -84.36 129.45 34.87 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.096 -1.075 . . . . 74.010000000000005 108.096 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.1 114.24 8.96 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-O 120.802 0.334 . . . . 72.150000000000006 111.044 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -80.14 96.34 2.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.496 -0.928 . . . . 64.340000000000003 108.496 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 62.7 p -146.56 -177.54 5.69 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.741 -0.663 . . . . 74.209999999999994 109.242 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -92.92 108.71 20.21 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.315 0.579 . . . . 70.439999999999998 109.998 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -174.97 157.42 2.35 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.897 -1.89 . . . . 64.319999999999993 105.897 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -63.61 110.47 2.01 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.793 0.683 . . . . 65.340000000000003 109.292 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.8 p -92.45 145.65 24.29 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.311 -0.404 . . . . 73.510000000000005 111.631 -175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.21 149.44 47.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.7 -0.481 . . . . 75.120000000000005 109.7 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -142.74 148.73 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.915 0.486 . . . . 73.430000000000007 110.147 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 60.5 p -110.62 146.21 36.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 122.482 0.313 . . . . 64.040000000000006 110.343 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.48 HD21 ' CG2' ' A' ' 12' ' ' VAL . 96.2 mt -125.74 125.74 43.47 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 123.053 0.541 . . . . 65.439999999999998 111.079 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.7 p -104.69 114.31 28.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.939 -0.763 . . . . 71.010000000000005 108.939 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -166.75 120.19 1.03 Allowed 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.225 0.328 . . . . 73.239999999999995 110.671 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . 0.47 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 6.6 tp-100 34.89 72.55 0.09 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.04 1.736 . . . . 64.519999999999996 112.252 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.638 ' NH2' HG21 ' B' ' 21' ' ' VAL . 24.5 tpt180 -126.11 109.98 13.0 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 119.673 -0.811 . . . . 74.099999999999994 112.512 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.23 153.88 88.28 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 114.368 -1.287 . . . . 50.130000000000003 112.313 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.16 135.63 65.16 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.52 2.813 . . . . 72.150000000000006 114.2 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.638 HG21 ' NH2' ' B' ' 18' ' ' ARG . 55.9 t -132.11 137.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.268 -1.333 . . . . 74.409999999999997 107.998 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 38.3 m -92.56 -26.94 17.67 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.467 0.914 . . . . 74.239999999999995 113.467 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -127.69 154.61 45.1 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.36 0.504 . . . . 70.129999999999995 112.36 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.94 132.75 47.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.76 -0.459 . . . . 50.219999999999999 109.76 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.441 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 39.8 mmtm -106.27 159.72 15.9 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.638 -0.425 . . . . 64.120000000000005 110.028 177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -133.67 126.41 30.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.038 -1.097 . . . . 72.409999999999997 108.038 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 74.3 m-85 -126.57 128.6 47.08 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.48 -0.327 . . . . 61.450000000000003 110.795 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.489 HG22 HG22 ' B' ' 37' ' ' VAL . 62.2 p -115.93 135.66 53.77 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.858 0.724 . . . . 74.340000000000003 111.3 -176.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.479 HD13 HD12 ' A' ' 38' ' ' ILE . 58.4 mt -131.13 127.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 109.937 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.404 ' HB ' ' NE ' ' B' ' 35' ' ' ARG . 11.5 t -104.35 123.99 48.39 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.226 0.536 . . . . 73.310000000000002 109.682 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.626 ' O ' HD21 ' B' ' 34' ' ' LEU . 10.6 tp10 -142.88 123.55 14.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.65 -0.5 . . . . 73.299999999999997 109.65 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.08 -77.71 0.3 Allowed Glycine 0 C--O 1.217 -0.938 0 N-CA-C 111.208 -0.757 . . . . 64.329999999999998 111.208 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 69.4 m -157.65 -0.22 0.11 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.838 0.855 . . . . 54.420000000000002 110.847 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.626 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -101.34 137.84 39.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.422 -1.311 . . . . 54.439999999999998 110.106 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 38.3 mmm-85 -100.92 122.82 44.14 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.285 -1.376 . . . . 70.219999999999999 107.285 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.87 117.77 35.12 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.949 -1.13 . . . . 55.009999999999998 107.949 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.489 HG22 HG22 ' B' ' 28' ' ' THR . 58.0 t -110.29 128.05 66.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.37 0.605 . . . . 72.439999999999998 110.308 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.47 HD11 HD13 ' A' ' 29' ' ' ILE . 85.3 mt -111.55 120.08 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.908 -1.042 . . . . 64.120000000000005 109.257 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 95.8 m-85 -102.65 116.43 32.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.965 -1.124 . . . . 75.019999999999996 107.965 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.497 HD11 HD23 ' A' ' 34' ' ' LEU . 49.7 mm -88.47 114.03 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.28 -1.007 . . . . 63.240000000000002 108.28 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 t -127.3 169.47 13.51 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 115.623 -0.717 . . . . 70.200000000000003 109.729 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -83.0 -13.48 55.87 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.746 -0.465 . . . . 73.549999999999997 109.746 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.657 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.5 tmt_? -87.68 3.17 48.92 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.317 1.056 . . . . 72.140000000000001 108.6 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.431 ' HA2' ' HG2' ' B' ' 18' ' ' ARG . . . 128.17 -138.42 10.37 Favored Glycine 0 CA--C 1.504 -0.608 0 CA-C-N 115.26 -0.882 . . . . 75.420000000000002 113.087 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 68.1 tp -112.24 126.05 54.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.733 -0.84 . . . . 74.209999999999994 108.733 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.52 ' HE3' ' SG ' ' B' ' 48' ' ' CYS . 1.8 tmtm? -116.78 121.13 40.69 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.526 -2.027 . . . . 73.049999999999997 105.526 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.449 HG13 HG11 ' A' ' 47' ' ' VAL . 14.0 p -116.58 140.84 37.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 116.639 -0.255 . . . . 72.310000000000002 110.722 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.52 ' SG ' ' HE3' ' B' ' 46' ' ' LYS . 68.4 m -130.41 140.78 50.56 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.656 0.382 . . . . 73.510000000000005 111.237 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.4 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . . . -116.2 123.25 47.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.564 -0.902 . . . . 73.329999999999998 108.564 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 13.7 t70 -122.42 103.0 38.83 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.877 -1.157 . . . . 71.209999999999994 107.877 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -98.25 134.99 0.32 Allowed 'Trans proline' 0 N--CA 1.434 -1.976 0 C-N-CA 122.263 1.975 . . . . 74.450000000000003 116.549 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 64.66 15.31 9.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.589 1.556 . . . . 73.510000000000005 114.976 165.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.54 -52.37 6.91 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.204 0.526 . . . . 74.239999999999995 110.079 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 70.9 p -100.87 171.52 7.61 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.751 -0.659 . . . . 71.25 110.81 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -81.27 -177.5 6.5 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.609 -0.723 . . . . 72.129999999999995 111.352 175.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.59 156.53 29.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 116.236 -0.438 . . . . 71.129999999999995 110.476 -174.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -125.84 167.45 15.2 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.79 -1.189 . . . . 75.219999999999999 107.79 172.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.49 98.12 8.11 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.022 -1.473 . . . . 72.400000000000006 107.022 172.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.12 105.36 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.587 -0.733 . . . . 74.019999999999996 112.882 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.417 -2.091 0 CA-C-N 113.987 -1.46 . . . . 73.109999999999999 107.878 175.723 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 CA--C 1.518 -0.259 0 N-CA-C 108.885 -0.783 . . . . 54.539999999999999 108.885 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.11 106.21 0.25 Allowed Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.69 -0.767 . . . . 44.439999999999998 111.826 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -94.65 -172.67 2.81 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.92 -0.771 . . . . 71.329999999999998 108.92 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.19 -32.13 70.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.075 0.464 . . . . 73.340000000000003 110.36 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.98 104.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.758 0.789 . . . . 64.329999999999998 110.112 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.0 m -102.61 100.7 10.79 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.495 -0.928 . . . . 73.129999999999995 108.495 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.94 86.69 4.14 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.44 -0.346 . . . . 74.319999999999993 111.388 -174.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 pttt 178.82 -176.22 0.23 Allowed 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.9 1.28 . . . . 62.439999999999998 108.562 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -80.99 102.36 10.11 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.315 -0.994 . . . . 73.310000000000002 108.315 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -87.73 135.65 33.28 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.822 -0.627 . . . . 53.200000000000003 111.406 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.6 m -130.38 148.45 52.2 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.201 -0.666 . . . . 53.310000000000002 109.201 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.9 t -144.66 141.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.473 -0.331 . . . . 62.119999999999997 110.174 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 p -109.24 130.71 55.49 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.21 0.528 . . . . 73.319999999999993 109.896 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.73 120.33 40.18 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.448 -1.686 . . . . 74.530000000000001 106.448 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.5 m -97.26 111.71 23.83 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.831 -1.544 . . . . 65.140000000000001 106.831 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.473 ' OG1' ' HG3' ' B' ' 51' ' ' PRO . 8.6 t -133.47 154.11 51.07 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.206 -0.907 . . . . 72.420000000000002 110.199 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -72.4 99.44 2.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.888 0.852 . . . . 65.099999999999994 110.383 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.507 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -126.71 148.47 49.86 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.079 -1.452 . . . . 53.240000000000002 107.079 178.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.549 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.4 pt? -73.19 127.71 88.78 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.191 -1.041 . . . . 74.129999999999995 108.191 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.86 152.91 60.52 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 123.904 3.07 . . . . 72.420000000000002 116.772 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 13.1 p -131.82 149.18 32.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.298 -1.774 . . . . 74.0 106.908 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.6 m -102.1 16.24 26.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.751 -0.38 . . . . 74.230000000000004 111.53 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -134.0 152.79 51.99 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 122.196 -0.315 . . . . 71.150000000000006 110.795 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -101.72 132.12 48.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.955 -0.757 . . . . 73.120000000000005 108.955 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -121.65 126.28 48.63 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.602 -0.888 . . . . 74.510000000000005 108.602 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -106.38 127.75 53.51 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.092 -0.707 . . . . 72.349999999999994 109.092 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -123.89 126.58 46.64 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.123 -0.489 . . . . 61.030000000000001 110.865 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.506 HG23 HG23 ' A' ' 37' ' ' VAL . 81.6 p -115.04 131.42 56.93 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.213 -0.903 . . . . 74.120000000000005 111.106 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.468 HD13 HD11 ' B' ' 38' ' ' ILE . 52.8 mt -128.63 121.54 55.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.173 -0.677 . . . . 72.030000000000001 109.173 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.614 ' OG1' ' HA ' ' A' ' 56' ' ' VAL . 9.9 t -111.48 128.26 55.95 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.737 -1.208 . . . . 71.540000000000006 107.737 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' O ' HD21 ' A' ' 34' ' ' LEU . 9.3 tp10 -140.4 119.44 12.73 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.145 -176.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.91 -86.76 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 116.164 -0.471 . . . . 73.340000000000003 112.937 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.463 ' CB ' HD22 ' B' ' 19' ' ' LEU . 40.5 m -142.58 15.34 1.98 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.012 0.434 . . . . 74.5 110.446 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.463 HD23 HG22 ' B' ' 40' ' ' ILE . 2.0 pt? -127.35 141.35 51.72 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.552 -0.459 . . . . 74.510000000000005 109.841 176.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -122.14 131.82 54.15 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.685 -0.689 . . . . 54.149999999999999 110.169 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.47 143.88 49.0 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.248 -0.433 . . . . 63.340000000000003 110.435 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.506 HG23 HG23 ' A' ' 28' ' ' THR . 96.6 t -124.85 127.05 72.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.067 -0.515 . . . . 72.530000000000001 110.986 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.423 HD12 HD13 ' B' ' 29' ' ' ILE . 75.8 mt -103.43 122.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 C-N-CA 123.984 0.914 . . . . 71.519999999999996 109.174 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.9 m-85 -106.1 114.8 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.427 -0.953 . . . . 75.510000000000005 108.427 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.429 HG23 HD23 ' B' ' 34' ' ' LEU . 42.0 mm -88.51 114.67 27.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.416 -0.811 . . . . 73.540000000000006 108.834 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -126.96 162.05 26.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.662 -0.699 . . . . 62.200000000000003 109.405 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HE2' ' N ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -71.11 -0.69 10.18 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 121.037 0.446 . . . . 75.420000000000002 112.087 173.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -87.69 -22.07 24.86 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.304 -0.998 . . . . 73.299999999999997 108.304 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.507 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 133.77 -119.93 2.4 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.849 -1.068 . . . . 61.229999999999997 110.844 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.4 tp -115.51 143.88 44.67 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 115.236 -0.482 . . . . 74.230000000000004 111.18 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -140.87 139.56 34.43 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.949 -0.76 . . . . 55.210000000000001 108.949 170.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.01 141.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 116.332 -0.394 . . . . 75.530000000000001 111.134 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.413 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 49.5 m -120.2 139.29 52.87 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.979 -0.555 . . . . 63.039999999999999 110.684 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.53 125.28 51.67 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.001 -0.545 . . . . 74.400000000000006 110.448 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -124.43 108.92 29.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.046 -0.525 . . . . 74.319999999999993 109.833 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HB3' ' NE ' ' B' ' 18' ' ' ARG . 73.6 Cg_endo -94.22 134.26 0.82 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 121.786 1.657 . . . . 70.140000000000001 114.99 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 52.9 25.99 4.34 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 114.049 -1.432 . . . . 74.239999999999995 114.065 165.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.27 -81.36 0.09 Allowed 'General case' 0 C--O 1.241 0.612 0 N-CA-C 114.126 1.158 . . . . 73.010000000000005 114.126 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.7 p -124.5 -85.19 0.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 114.0 1.111 . . . . 75.129999999999995 114.0 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -88.28 109.03 19.62 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.633 0.73 . . . . 73.530000000000001 112.283 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.614 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 31.1 m -136.2 141.56 41.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.796 -1.093 . . . . 71.420000000000002 108.962 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -162.45 172.65 15.2 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 110.308 -0.256 . . . . 74.140000000000001 110.308 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -91.95 118.78 31.08 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.156 -1.053 . . . . 72.310000000000002 108.156 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.96 102.98 14.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.481 0.657 . . . . 71.420000000000002 112.374 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.4 t . . . . . 0 C--O 1.24 0.586 0 CA-C-N 115.171 -0.922 . . . . 74.340000000000003 111.383 -179.444 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 C--O 1.241 0.618 0 N-CA-C 109.68 -0.489 . . . . 73.430000000000007 109.68 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.1 -154.21 12.35 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.925 -0.87 . . . . 75.530000000000001 110.925 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -133.91 173.87 11.08 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.124 -0.695 . . . . 72.329999999999998 109.124 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -57.55 -46.5 83.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.034 0.534 . . . . 70.25 111.345 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.12 90.52 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.353 1.073 . . . . 72.25 109.927 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 18.0 m -105.18 91.52 3.83 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.219 -0.901 . . . . 71.209999999999994 109.322 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -92.22 -16.29 26.39 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.814 0.816 . . . . 71.239999999999995 109.08 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -75.13 167.86 21.1 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.746 -1.115 . . . . 73.030000000000001 109.914 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -75.46 109.58 9.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 110.241 -0.281 . . . . 74.400000000000006 110.241 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -87.77 128.74 35.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 110.267 -0.272 . . . . 52.140000000000001 110.267 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 82.2 m -129.88 149.37 51.65 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.831 -0.433 . . . . 74.120000000000005 109.831 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.2 t -144.14 138.57 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.47 0.481 . . . . 73.340000000000003 110.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -107.58 129.01 55.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.311 0.577 . . . . 60.210000000000001 111.499 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.82 121.67 44.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.387 -0.824 . . . . 70.109999999999999 109.754 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 18.0 m -106.82 116.19 31.49 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 108.056 -1.091 . . . . 74.129999999999995 108.056 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -138.68 -169.76 2.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.287 -0.87 . . . . 72.219999999999999 108.763 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -74.12 93.7 2.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.607 -0.886 . . . . 61.119999999999997 108.607 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.507 ' NE ' ' HB3' ' A' ' 51' ' ' PRO . 8.5 tpp85 -127.51 133.94 49.81 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.696 -0.853 . . . . 74.049999999999997 108.696 -177.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.463 HD22 ' CB ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -74.95 162.63 72.68 Favored Pre-proline 0 C--N 1.294 -1.832 0 CA-C-N 116.232 -0.44 . . . . 71.409999999999997 111.705 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 36.0 Cg_endo -66.73 147.95 82.07 Favored 'Trans proline' 0 C--O 1.254 1.32 0 C-N-CA 122.123 1.882 . . . . 71.340000000000003 112.17 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -125.78 146.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.244 -1.021 . . . . 70.430000000000007 108.244 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 m -67.73 -53.15 29.77 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 123.104 0.253 . . . . 62.229999999999997 111.574 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -125.36 151.31 46.27 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 110.018 -0.364 . . . . 73.319999999999993 110.018 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.75 114.58 23.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.762 -1.199 . . . . 62.240000000000002 107.762 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.15 148.19 22.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.587 -0.523 . . . . 71.219999999999999 109.587 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.7 m -128.46 127.54 42.68 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.075 -1.083 . . . . 74.140000000000001 108.075 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -123.59 127.14 47.86 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-O 121.046 0.45 . . . . 74.540000000000006 111.296 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.532 HG22 HG22 ' B' ' 37' ' ' VAL . 76.7 p -114.52 132.99 56.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 114.879 -1.055 . . . . 75.540000000000006 110.02 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.423 HD13 HD12 ' A' ' 38' ' ' ILE . 51.2 mt -129.51 120.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 109.285 -0.635 . . . . 63.420000000000002 109.285 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' B' ' 56' ' ' VAL . 7.2 t -100.12 124.66 45.77 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.908 -1.145 . . . . 75.129999999999995 107.908 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.434 ' O ' HD21 ' B' ' 34' ' ' LEU . 9.0 tp10 -142.41 101.0 3.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.92 -0.582 . . . . 75.120000000000005 112.353 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.85 -67.65 0.45 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 116.071 1.188 . . . . 72.310000000000002 116.071 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 42.1 m -137.8 -3.38 1.85 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.458 0.54 . . . . 73.099999999999994 112.458 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.434 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.3 pt? -140.65 141.09 35.09 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 120.235 -0.586 . . . . 72.319999999999993 109.883 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.496 ' NH2' HG22 ' B' ' 54' ' ' THR . 18.8 ttp180 -109.48 125.42 52.44 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 119.558 -0.857 . . . . 71.25 108.885 171.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.27 145.0 30.86 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.564 -0.289 . . . . 71.450000000000003 110.777 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.532 HG22 HG22 ' B' ' 28' ' ' THR . 95.0 t -124.05 128.18 73.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.888 -0.596 . . . . 72.209999999999994 110.725 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.468 HD11 HD13 ' A' ' 29' ' ' ILE . 68.9 mt -108.36 123.78 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 C-N-CA 124.334 1.054 . . . . 75.219999999999999 109.454 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.441 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 99.1 m-85 -103.29 120.19 40.29 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.859 -0.793 . . . . 75.450000000000003 108.859 175.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.463 HG22 HD23 ' A' ' 34' ' ' LEU . 39.7 mm -87.73 114.47 26.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 107.688 -1.227 . . . . 62.43 107.688 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -135.34 154.97 51.33 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.917 -0.583 . . . . 75.540000000000006 111.263 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.575 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -71.77 -14.7 62.07 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.972 -0.558 . . . . 71.0 111.219 177.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' B' ' 15' ' ' THR . 54.0 mtp180 -86.34 -16.19 38.2 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.536 0.684 . . . . 73.340000000000003 109.366 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.16 -108.16 0.44 Allowed Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 119.916 -1.135 . . . . 41.43 112.67 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.433 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 53.0 tp -139.36 143.7 37.87 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.833 -0.684 . . . . 64.329999999999998 109.47 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -131.5 140.46 49.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.262 -1.014 . . . . 75.329999999999998 108.262 167.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.7 140.48 48.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.719 -0.673 . . . . 63.399999999999999 110.209 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.453 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 36.5 m -127.58 141.11 51.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.88 -0.6 . . . . 73.25 110.967 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.38 124.39 49.93 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.899 -0.591 . . . . 71.420000000000002 110.308 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -110.72 95.91 25.87 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.014 -1.106 . . . . 53.520000000000003 108.014 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.473 ' HG3' ' OG1' ' A' ' 16' ' ' THR . 93.6 Cg_endo -89.56 132.1 2.07 Favored 'Trans proline' 0 N--CA 1.411 -3.361 0 C-N-CA 120.097 0.531 . . . . 74.420000000000002 111.597 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 57.0 -0.89 0.06 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 116.146 1.906 . . . . 74.140000000000001 116.146 170.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.6 -60.79 2.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 118.388 0.54 . . . . 75.109999999999999 110.643 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.496 HG22 ' NH2' ' B' ' 35' ' ' ARG . 36.5 p -77.14 175.98 9.14 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.693 -0.685 . . . . 72.150000000000006 111.349 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -69.35 110.92 4.92 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.573 0.702 . . . . 74.549999999999997 111.044 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.488 ' HA ' ' OG1' ' B' ' 30' ' ' THR . 31.4 m -99.78 140.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 115.349 -0.841 . . . . 63.030000000000001 110.764 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -139.8 136.97 34.61 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.796 -0.638 . . . . 73.329999999999998 109.448 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.46 116.7 20.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.694 -1.225 . . . . 73.409999999999997 107.694 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.6 m -109.88 107.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 113.989 1.107 . . . . 74.409999999999997 113.989 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 C--O 1.25 1.091 0 C-N-CA 124.92 1.288 . . . . 74.519999999999996 110.736 178.797 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.256 0.55 . . . . 71.219999999999999 110.111 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.85 -5.33 27.49 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 109.57 -1.412 . . . . 74.239999999999995 109.57 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -90.72 -25.53 19.98 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.918 -0.641 . . . . 64.400000000000006 109.65 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.36 107.14 19.12 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.536 -0.756 . . . . 75.129999999999995 109.654 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.0 t -85.2 -42.39 16.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.211 0.529 . . . . 63.210000000000001 109.941 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.6 p -140.86 95.08 2.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.601 0.715 . . . . 72.140000000000001 110.146 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -109.8 161.33 15.55 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.996 -1.112 . . . . 61.240000000000002 107.996 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.8 -57.37 3.89 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 112.207 0.447 . . . . 73.400000000000006 112.207 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -143.59 115.56 8.32 Favored 'General case' 0 CA--C 1.476 -1.889 0 N-CA-C 107.665 -1.235 . . . . 73.400000000000006 107.665 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -108.04 134.98 50.17 Favored 'General case' 0 C--N 1.272 -2.792 0 C-N-CA 120.077 -0.649 . . . . 70.439999999999998 111.073 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.3 m -125.55 147.56 49.22 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.606 -0.516 . . . . 75.420000000000002 109.606 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -145.99 147.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.721 0.808 . . . . 73.430000000000007 109.741 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 17.9 t -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.222 -0.659 . . . . 73.209999999999994 109.222 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.47 132.39 47.11 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 123.572 0.749 . . . . 74.140000000000001 110.522 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -99.84 110.93 23.28 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.108 0.956 . . . . 75.310000000000002 109.474 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.0 p -140.95 179.81 6.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.082 -0.963 . . . . 75.329999999999998 110.68 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' B' ' 51' ' ' PRO . 22.3 tp60 -67.55 95.8 0.49 Allowed 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.839 -0.8 . . . . 75.409999999999997 108.839 174.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.54 149.37 45.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.826 -0.749 . . . . 73.120000000000005 110.999 -173.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mp -77.04 140.3 66.26 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 106.159 -1.793 . . . . 74.019999999999996 106.159 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.68 134.66 45.05 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.023 1.149 . . . . 72.349999999999994 109.551 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.52 138.87 48.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.8 -0.637 . . . . 73.549999999999997 110.108 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.2 m -90.28 -58.98 2.31 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.184 -0.462 . . . . 74.519999999999996 111.022 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -89.78 133.99 34.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.834 -0.432 . . . . 73.409999999999997 109.834 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.23 122.56 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.637 -0.505 . . . . 65.439999999999998 109.637 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.43 153.94 20.44 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.057 0.456 . . . . 70.430000000000007 110.994 178.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.4 m -132.69 127.97 35.94 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.459 -0.941 . . . . 62.340000000000003 108.459 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -127.35 126.8 43.17 Favored 'General case' 0 CA--C 1.467 -2.245 0 CA-C-N 115.863 -0.608 . . . . 71.040000000000006 110.088 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.494 HG23 HG23 ' A' ' 37' ' ' VAL . 69.2 p -115.82 131.69 56.86 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.317 -0.856 . . . . 74.109999999999999 111.795 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.465 HD13 HD11 ' B' ' 38' ' ' ILE . 49.4 mt -131.27 124.57 55.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.129 -0.487 . . . . 50.399999999999999 109.867 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -102.45 132.46 48.47 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.46 -0.941 . . . . 74.430000000000007 108.46 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.521 ' O ' HD21 ' A' ' 34' ' ' LEU . 11.5 tp10 -140.25 106.44 5.24 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.271 -0.64 . . . . 64.230000000000004 109.271 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -96.97 0.33 Allowed Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.823 -0.626 . . . . 64.219999999999999 112.289 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -120.34 1.53 10.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 111.983 0.364 . . . . 64.420000000000002 111.983 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.521 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.4 pt? -118.14 140.87 49.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.891 -1.124 . . . . 74.310000000000002 111.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.62 120.94 43.6 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.618 -1.174 . . . . 73.519999999999996 108.114 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.28 128.91 52.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.847 -0.797 . . . . 75.349999999999994 108.847 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.494 HG23 HG23 ' A' ' 28' ' ' THR . 67.1 t -119.1 135.23 60.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.017 0.437 . . . . 71.310000000000002 110.693 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.504 HD12 HD13 ' B' ' 29' ' ' ILE . 72.4 mt -116.14 131.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-N 115.525 -0.761 . . . . 72.400000000000006 109.966 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 99.2 m-85 -115.22 120.61 40.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.387 -0.968 . . . . 74.439999999999998 108.387 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.519 HG13 ' HG2' ' B' ' 31' ' ' GLU . 32.1 mm -92.59 114.88 30.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.065 -1.457 . . . . 75.439999999999998 107.065 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -120.32 178.23 4.73 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.897 -0.592 . . . . 75.450000000000003 111.426 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -71.77 -16.7 62.2 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.559 0.695 . . . . 73.430000000000007 110.112 175.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.562 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 75.9 ttt180 -90.17 -12.62 37.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.718 -1.128 . . . . 63.039999999999999 108.176 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -109.84 1.42 Allowed Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 114.526 -1.215 . . . . 63.219999999999999 112.216 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.408 ' CD2' ' HB3' ' B' ' 49' ' ' ALA . 64.1 tp -113.06 143.78 43.75 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.15 -0.525 . . . . 74.040000000000006 110.26 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 87.2 tttt -141.01 142.85 34.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.041 -0.725 . . . . 72.5 109.041 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.7 140.59 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-N 115.615 -0.72 . . . . 65.040000000000006 109.677 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.4 m -126.76 142.02 51.66 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.561 -0.745 . . . . 74.420000000000002 110.687 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.82 124.78 52.62 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.659 -0.701 . . . . 72.040000000000006 109.574 177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -126.3 90.02 50.97 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.479 -0.934 . . . . 72.230000000000004 108.479 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 97.7 Cg_endo -103.13 148.39 0.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 122.952 2.435 . . . . 73.129999999999995 115.045 -177.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.625 ' CD ' ' HG ' ' B' ' 19' ' ' LEU . 17.7 mt-30 67.33 -175.64 0.2 Allowed 'General case' 0 C--O 1.244 0.789 0 CA-C-N 113.83 -1.532 . . . . 64.439999999999998 114.616 163.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 72.24 -64.1 0.4 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.201 1.401 . . . . 62.340000000000003 114.316 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.9 p -101.13 -88.62 0.37 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 115.681 1.734 . . . . 74.319999999999993 115.681 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.9 t90 -81.68 114.15 20.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.639 0.733 . . . . 74.209999999999994 112.684 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.97 134.04 60.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.417 -0.81 . . . . 71.239999999999995 109.046 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -149.55 95.27 2.32 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.618 0.723 . . . . 63.439999999999998 109.121 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -86.87 -19.52 28.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.718 -1.128 . . . . 64.109999999999999 111.121 -175.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.62 15.57 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 N-CA-C 113.137 0.791 . . . . 71.129999999999995 113.137 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 120.826 0.346 . . . . 75.120000000000005 110.527 179.524 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--O 1.237 0.4 0 CA-C-O 121.59 0.709 . . . . 62.32 109.32 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.09 -18.09 4.79 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.116 -1.194 . . . . 62.340000000000003 110.116 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -69.78 -34.91 74.4 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.242 -1.021 . . . . 65.420000000000002 108.242 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.53 134.65 42.09 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.589 -1.187 . . . . 75.0 108.727 177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.7 -45.78 20.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.414 -0.958 . . . . 71.209999999999994 108.414 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 27.6 p -151.44 96.68 2.31 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.844 -1.071 . . . . 75.049999999999997 110.265 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -94.05 172.28 8.32 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.383 -0.969 . . . . 73.420000000000002 108.383 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -66.87 -70.76 0.23 Allowed 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 117.847 0.294 . . . . 74.140000000000001 111.175 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -135.74 108.56 7.56 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.831 -0.433 . . . . 74.219999999999999 109.831 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -103.25 148.47 25.77 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.177 0.513 . . . . 52.399999999999999 111.469 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 67.9 m -134.61 149.4 50.57 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.906 -1.146 . . . . 73.219999999999999 107.906 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -141.56 143.05 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.192 0.308 . . . . 60.240000000000002 110.253 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 47.1 t -107.26 137.13 45.88 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.806 -0.812 . . . . 62.210000000000001 108.806 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.15 121.47 43.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.394 -0.821 . . . . 72.140000000000001 109.641 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 9.6 p -95.19 111.52 23.35 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.369 -0.974 . . . . 71.310000000000002 108.369 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -126.75 165.62 18.93 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.92 -1.037 . . . . 62.32 109.086 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -70.59 105.84 3.27 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.468 -1.678 . . . . 74.430000000000007 106.468 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.621 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 35.4 mmm-85 -125.98 148.37 49.28 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 117.639 2.459 . . . . 71.230000000000004 117.639 -168.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.625 ' HG ' ' CD ' ' A' ' 52' ' ' GLN . 68.9 mt -84.79 131.61 48.8 Favored Pre-proline 0 C--O 1.255 1.391 0 CA-C-N 112.878 -1.965 . . . . 74.310000000000002 106.469 168.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.56 136.23 41.99 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.909 1.739 . . . . 72.310000000000002 111.626 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 94.7 t -114.03 135.14 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.968 -1.015 . . . . 51.340000000000003 108.452 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -78.18 -22.58 48.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.058 0.762 . . . . 51.130000000000003 113.058 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -127.95 139.44 52.58 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.596 -0.841 . . . . 74.450000000000003 109.61 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.9 138.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.597 -0.52 . . . . 75.099999999999994 109.597 -177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.401 ' HD2' ' N ' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -118.39 157.18 27.64 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.451 0.643 . . . . 74.209999999999994 112.134 178.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.1 m -133.5 126.4 31.01 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.973 -1.012 . . . . 70.299999999999997 108.952 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -124.77 135.77 53.26 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 116.121 -0.49 . . . . 74.329999999999998 111.43 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.469 HG22 HG22 ' B' ' 37' ' ' VAL . 44.9 p -115.17 128.36 56.13 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.196 -0.911 . . . . 75.219999999999999 111.278 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.504 HD13 HD12 ' A' ' 38' ' ' ILE . 72.0 mt -124.7 127.72 72.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.286 0.634 . . . . 71.099999999999994 109.578 177.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -112.83 128.41 56.44 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 109.515 -0.55 . . . . 75.150000000000006 109.515 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.519 ' HG2' HG13 ' A' ' 40' ' ' ILE . 11.5 tp10 -132.06 97.87 4.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.412 0.625 . . . . 70.239999999999995 110.205 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.49 -74.41 1.08 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 114.742 -1.117 . . . . 71.040000000000006 112.421 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' B' ' 52' ' ' GLN . 24.1 t -144.94 -1.62 0.85 Allowed 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.658 0.742 . . . . 64.239999999999995 109.075 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.468 HD21 HD11 ' A' ' 40' ' ' ILE . 35.5 tp -99.32 118.63 36.4 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 115.89 -0.595 . . . . 74.109999999999999 110.71 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.416 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 21.2 tpp180 -98.86 114.75 27.47 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.513 -0.767 . . . . 72.450000000000003 109.657 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.13 136.26 48.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 110.087 -0.338 . . . . 72.030000000000001 110.087 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.469 HG22 HG22 ' B' ' 28' ' ' THR . 97.0 t -121.52 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.866 0.365 . . . . 74.219999999999999 111.341 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.465 HD11 HD13 ' A' ' 29' ' ' ILE . 82.8 mt -105.73 117.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 C-N-CA 124.586 1.154 . . . . 74.200000000000003 109.175 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.52 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.1 m-85 -102.78 116.22 32.13 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.893 -0.78 . . . . 75.400000000000006 108.893 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 47.1 mm -89.06 113.54 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.187 -1.412 . . . . 73.400000000000006 107.187 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 39.7 p -115.03 170.17 8.55 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 116.136 -0.484 . . . . 72.200000000000003 110.201 -177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.547 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -80.48 -19.93 44.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.854 0.359 . . . . 64.099999999999994 111.346 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.547 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 70.2 ttt180 -94.97 -17.49 21.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.59 0.71 . . . . 75.010000000000005 109.905 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.471 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . 164.08 -128.94 1.9 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.427 -1.368 . . . . 55.009999999999998 113.921 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 67.7 tp -130.41 147.36 52.1 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 109.031 -0.729 . . . . 61.520000000000003 109.031 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -139.75 143.16 36.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.148 -0.686 . . . . 73.530000000000001 109.148 172.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 13.7 p -130.45 140.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.877 -0.602 . . . . 74.420000000000002 109.915 -175.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.52 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.6 m -124.84 138.51 54.26 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.37 -0.377 . . . . 72.400000000000006 110.839 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.408 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . . . -115.86 124.75 51.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.082 -0.508 . . . . 71.140000000000001 112.034 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 18.0 t70 -122.37 95.84 46.64 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 108.636 -0.876 . . . . 63.25 108.636 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.472 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 56.5 Cg_endo -96.53 134.98 0.47 Allowed 'Trans proline' 0 N--CA 1.411 -3.364 0 C-N-CA 121.456 1.438 . . . . 64.400000000000006 113.48 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.549 ' HA ' ' OG ' ' B' ' 33' ' ' SER . 22.6 mt-30 71.38 -11.46 0.7 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.129 1.529 . . . . 63.039999999999999 115.129 171.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.2 -60.04 2.12 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.411 -0.516 . . . . 45.240000000000002 112.389 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.0 p -61.82 -53.01 61.79 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.441 1.275 . . . . 64.549999999999997 114.441 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . 0.477 ' CZ2' ' HB3' ' B' ' 57' ' ' ARG . 9.3 t90 -139.97 158.24 44.39 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.23 -0.588 . . . . 74.329999999999998 110.082 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.48 95.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.469 0.652 . . . . 75.329999999999998 110.769 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.477 ' HB3' ' CZ2' ' B' ' 55' ' ' TRP . 63.8 ttt180 -172.97 112.53 0.23 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.654 -0.703 . . . . 71.140000000000001 109.131 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -86.88 90.49 8.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.678 0.751 . . . . 62.329999999999998 112.532 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.2 m -133.49 16.86 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.834 -1.075 . . . . 74.430000000000007 108.931 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--N 1.31 -1.139 0 CA-C-N 115.371 -0.831 . . . . 60.210000000000001 109.297 -176.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.566 -0.902 . . . . 73.439999999999998 108.566 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.89 -129.03 1.75 Allowed Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 120.577 -0.821 . . . . 65.129999999999995 111.552 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t -136.93 16.06 3.06 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.784 0.326 . . . . 74.040000000000006 110.225 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -77.86 91.35 4.14 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.902 0.858 . . . . 61.539999999999999 111.872 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 8' ' ' LYS . 35.2 m -84.42 -31.08 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-N 114.117 -1.402 . . . . 74.349999999999994 110.081 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.9 m 49.55 -72.99 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 116.422 2.008 . . . . 54.109999999999999 116.422 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -105.89 7.0 31.98 Favored 'General case' 0 CA--C 1.493 -1.216 0 O-C-N 121.826 -0.546 . . . . 71.340000000000003 111.538 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 87.3 tttt -65.33 101.29 0.55 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.186 0.517 . . . . 65.430000000000007 111.708 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 3.8 ppt_? -83.18 124.92 30.98 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.914 -1.039 . . . . 74.230000000000004 108.272 172.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -94.18 138.97 31.61 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 115.912 -0.586 . . . . 73.519999999999996 111.141 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 79.7 m -137.13 147.6 46.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.454 -0.943 . . . . 62.439999999999998 108.454 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.9 t -144.4 144.42 22.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 123.078 0.236 . . . . 74.120000000000005 110.38 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -107.24 138.26 43.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 109.408 -0.59 . . . . 73.549999999999997 109.408 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mp -114.91 133.67 55.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.467 -0.333 . . . . 70.040000000000006 110.618 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 p -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.599 0.714 . . . . 72.219999999999999 111.319 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -150.05 167.87 25.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.942 -1.503 . . . . 72.319999999999993 106.942 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 100.44 1.46 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 122.368 1.08 . . . . 71.230000000000004 111.905 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -125.64 139.98 53.1 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.108 -0.951 . . . . 71.450000000000003 110.219 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.406 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 mm? -74.73 141.73 76.15 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.973 -1.012 . . . . 75.010000000000005 109.067 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.07 135.89 42.38 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.171 1.914 . . . . 73.239999999999995 111.784 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 23' ' ' ARG . 11.6 p -131.98 136.15 57.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.006 -1.109 . . . . 73.409999999999997 108.006 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 m -84.23 2.18 41.13 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.371 0.508 . . . . 73.099999999999994 112.371 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.436 ' H ' HG23 ' A' ' 21' ' ' VAL . 29.0 mmm180 -116.56 155.66 28.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.529 -0.545 . . . . 65.340000000000003 109.529 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.22 114.88 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.035 0 N-CA-C 105.121 -2.177 . . . . 73.040000000000006 105.121 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 25' ' ' LYS . 35.1 tptt -100.74 125.57 47.21 Favored 'General case' 0 N--CA 1.406 -2.645 0 C-N-CA 117.45 -1.7 . . . . 71.219999999999999 108.904 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 31.2 m -109.81 128.41 55.3 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.92 -0.582 . . . . 74.420000000000002 109.975 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -125.76 128.02 47.08 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.954 -0.566 . . . . 72.049999999999997 109.846 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.46 HG23 HG23 ' A' ' 37' ' ' VAL . 79.3 p -115.37 119.02 34.88 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.218 -0.593 . . . . 70.340000000000003 111.914 -175.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.484 HD13 HD11 ' B' ' 38' ' ' ILE . 63.8 mt -120.6 121.42 65.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 109.336 -0.616 . . . . 73.349999999999994 109.336 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.416 ' CB ' HH11 ' A' ' 35' ' ' ARG . 5.7 t -108.49 134.25 51.52 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.449 -0.945 . . . . 74.530000000000001 108.449 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 97.52 3.48 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-O 121.751 0.786 . . . . 73.209999999999994 110.231 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.96 -82.85 1.5 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 114.692 -1.14 . . . . 72.549999999999997 112.123 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.416 ' HA ' HG13 ' A' ' 56' ' ' VAL . 22.9 t -144.34 32.73 1.2 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.139 -1.43 . . . . 74.230000000000004 107.139 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.486 HD21 HD11 ' B' ' 40' ' ' ILE . 33.7 tp -135.76 117.8 15.37 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 115.276 -0.874 . . . . 65.319999999999993 110.694 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.416 HH11 ' CB ' ' A' ' 30' ' ' THR . 30.4 mmt180 -96.79 116.5 29.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.159 -0.682 . . . . 74.25 109.159 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.9 126.88 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.347 -0.612 . . . . 61.240000000000002 109.347 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG23 HG23 ' A' ' 28' ' ' THR . 97.2 t -120.16 126.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.964 0.411 . . . . 63.109999999999999 110.741 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.496 HD12 HD13 ' B' ' 29' ' ' ILE . 80.2 mt -105.41 131.61 54.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.656 -0.702 . . . . 73.150000000000006 109.596 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 95.6 m-85 -115.9 114.88 25.28 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.327 -0.99 . . . . 74.019999999999996 108.327 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.472 HD11 HD21 ' B' ' 34' ' ' LEU . 37.3 mm -89.53 121.4 39.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.665 -1.235 . . . . 75.109999999999999 107.665 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 p -125.52 174.53 8.16 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.535 0.683 . . . . 73.239999999999995 110.942 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.9 -19.86 56.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.676 -1.147 . . . . 71.030000000000001 109.025 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -86.6 -25.73 24.79 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.648 -1.241 . . . . 74.150000000000006 107.648 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -130.92 3.66 Favored Glycine 0 C--N 1.291 -1.948 0 CA-C-N 114.098 -1.41 . . . . 63.310000000000002 112.942 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.424 ' CD2' ' HB3' ' B' ' 49' ' ' ALA . 61.5 tp -113.22 137.12 51.94 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.601 -0.518 . . . . 74.329999999999998 109.601 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -134.63 142.36 46.86 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.938 -0.764 . . . . 75.329999999999998 108.938 171.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 7.2 p -131.58 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.999 -0.546 . . . . 74.109999999999999 110.041 -175.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.428 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 52.6 m -123.1 139.41 54.09 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.119 -0.492 . . . . 71.340000000000003 111.045 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.405 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -117.36 124.32 48.62 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.903 -0.777 . . . . 72.439999999999998 108.903 177.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 35' ' ' ARG . 12.2 t70 -127.58 82.64 67.9 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 106.615 -1.624 . . . . 45.240000000000002 106.615 176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD2' ' OE1' ' B' ' 17' ' ' GLN . 3.3 Cg_exo -76.82 145.67 25.66 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.093 1.862 . . . . 72.219999999999999 112.688 -176.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 69.82 -41.34 0.48 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.536 1.534 . . . . 74.040000000000006 114.252 175.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 67.84 -78.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.008 1.323 . . . . 61.229999999999997 112.166 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.8 m -162.38 -60.14 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.527 -2.027 . . . . 73.239999999999995 105.527 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -142.36 95.8 2.85 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 106.469 -1.678 . . . . 72.510000000000005 106.469 172.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 33' ' ' SER . 8.3 p -67.08 117.25 7.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 114.182 1.178 . . . . 63.32 114.182 -172.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.33 97.58 11.19 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 107.39 -1.337 . . . . 74.340000000000003 107.39 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.99 76.03 9.85 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.329 1.062 . . . . 40.340000000000003 112.346 -174.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.68 137.95 23.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 113.669 -1.605 . . . . 74.219999999999999 110.673 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 C--N 1.311 -1.082 0 O-C-N 121.774 -0.579 . . . . 72.409999999999997 110.239 179.114 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.251 1.146 0 N-CA-C 109.466 -0.568 . . . . 75.209999999999994 109.466 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.08 79.01 1.75 Allowed Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.849 -1.3 . . . . 74.519999999999996 109.849 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 45.3 t -78.97 -54.79 5.68 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.96 0.41 . . . . 63.340000000000003 111.127 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -85.67 90.98 8.16 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.252 -0.647 . . . . 72.510000000000005 109.252 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 31.5 m -136.84 14.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.79 -0.641 . . . . 65.329999999999998 111.359 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 42.3 m 73.09 -37.34 0.38 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.316 1.046 . . . . 73.310000000000002 112.894 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.89 -10.56 59.45 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.419 0.896 . . . . 64.239999999999995 113.419 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -86.15 79.6 9.07 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.129 0.966 . . . . 73.420000000000002 110.413 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 15.8 ptt-85 -94.43 135.48 35.81 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.991 -1.459 . . . . 75.030000000000001 108.748 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -91.81 144.73 25.2 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.839 -0.345 . . . . 73.019999999999996 110.906 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -141.43 149.46 41.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 62.210000000000001 108.595 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 55.3 t -141.85 138.01 31.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.495 -0.321 . . . . 72.25 110.257 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 26.5 p -107.37 125.23 50.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.553 -0.906 . . . . 75.209999999999994 108.553 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.401 ' N ' HD13 ' B' ' 14' ' ' LEU . 4.4 mp -101.61 123.66 45.98 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.047 -0.524 . . . . 65.430000000000007 109.931 -175.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 37.0 p -89.17 112.42 23.42 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.504 -0.554 . . . . 74.409999999999997 109.504 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -141.49 -172.47 3.53 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.551 -0.907 . . . . 73.109999999999999 108.551 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . 0.447 ' OE1' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -79.95 89.26 5.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.285 1.041 . . . . 74.439999999999998 110.934 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -126.34 142.57 51.48 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.418 -0.81 . . . . 70.010000000000005 111.236 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.03 152.09 52.77 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.05 -0.977 . . . . 62.530000000000001 108.628 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.94 145.81 86.4 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.945 1.763 . . . . 74.519999999999996 111.052 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.3 p -131.53 141.71 45.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.41 -0.814 . . . . 70.329999999999998 109.298 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 49.7 m -82.0 -27.04 33.34 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.07 0.396 . . . . 74.310000000000002 112.07 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -113.99 132.75 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 120.729 -0.388 . . . . 72.430000000000007 110.649 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -90.69 115.11 29.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.789 -1.189 . . . . 73.109999999999999 107.789 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' B' ' 39' ' ' PHE . 75.3 mmtt -94.15 137.92 32.78 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.034 -0.53 . . . . 53.039999999999999 111.391 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.4 m -116.27 127.93 55.14 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.992 -1.004 . . . . 60.420000000000002 108.867 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -127.88 126.64 41.94 Favored 'General case' 0 CA--C 1.461 -2.46 0 CA-C-N 115.605 -0.725 . . . . 74.409999999999997 109.749 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.515 HG22 HG22 ' B' ' 37' ' ' VAL . 64.4 p -115.38 132.56 56.58 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.76 -0.654 . . . . 73.420000000000002 111.13 -177.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.496 HD13 HD12 ' A' ' 38' ' ' ILE . 55.1 mt -126.04 136.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 109.213 -0.662 . . . . 72.409999999999997 109.213 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.51 HG23 ' H ' ' B' ' 57' ' ' ARG . 10.1 t -119.15 127.28 53.18 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 121.744 0.783 . . . . 63.100000000000001 109.653 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -135.86 110.61 8.7 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.37 -0.832 . . . . 74.310000000000002 110.236 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -68.12 3.05 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.143 -0.783 . . . . 75.25 111.143 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' B' ' 52' ' ' GLN . 24.9 t -165.82 11.71 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.065 -1.457 . . . . 74.019999999999996 107.065 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' B' ' 30' ' ' THR . 29.4 tp -102.13 123.65 46.37 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.494 -0.775 . . . . 63.229999999999997 111.56 -174.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 35.5 mmt180 -94.46 113.7 25.6 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.021 -0.536 . . . . 71.329999999999998 110.501 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.1 124.55 49.73 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.79 -1.189 . . . . 73.409999999999997 107.79 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.515 HG22 HG22 ' B' ' 28' ' ' THR . 65.8 t -117.2 128.64 74.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.002 0.43 . . . . 62.329999999999998 111.373 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.484 HD11 HD13 ' A' ' 29' ' ' ILE . 67.3 mt -106.96 128.19 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.283 -0.871 . . . . 71.109999999999999 109.995 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 98.8 m-85 -111.74 118.37 35.43 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.418 -0.956 . . . . 74.420000000000002 108.418 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.486 HD11 HD21 ' A' ' 34' ' ' LEU . 38.2 mm -87.87 114.62 26.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.441 -1.688 . . . . 75.219999999999999 106.441 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 69.5 p -123.1 -177.93 3.82 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.63 0.729 . . . . 74.239999999999995 112.323 -173.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.585 ' HG3' ' N ' ' B' ' 43' ' ' ARG . 54.7 pttt -80.2 -29.81 38.63 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.886 -1.506 . . . . 75.540000000000006 109.488 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.585 ' N ' ' HG3' ' B' ' 42' ' ' LYS . 77.1 ttt180 -88.02 -17.41 31.24 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.211 1.005 . . . . 74.450000000000003 109.19 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.83 -121.99 1.46 Allowed Glycine 0 N--CA 1.425 -2.055 0 CA-C-N 114.305 -1.316 . . . . 73.099999999999994 112.549 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.405 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 67.0 tp -119.47 133.77 55.54 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.646 -0.777 . . . . 72.140000000000001 109.285 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -124.77 141.53 52.05 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.455 -0.572 . . . . 72.239999999999995 109.455 172.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 p -131.23 141.11 46.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 115.673 -0.694 . . . . 54.439999999999998 110.231 -175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.405 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 65.9 m -125.63 141.59 51.94 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 116.29 -0.414 . . . . 73.450000000000003 110.577 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.424 ' HB3' ' CD2' ' A' ' 45' ' ' LEU . . . -116.31 123.89 48.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.741 -0.837 . . . . 63.340000000000003 108.741 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 13.2 t70 -132.26 97.8 17.68 Favored Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 107.516 -1.29 . . . . 75.310000000000002 107.516 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -94.15 138.61 1.19 Allowed 'Trans proline' 0 N--CA 1.425 -2.523 0 C-N-CA 121.775 1.65 . . . . 72.140000000000001 115.357 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.411 ' HA ' ' OG ' ' B' ' 33' ' ' SER . 45.2 mt-30 62.91 14.29 7.33 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.04 -1.436 . . . . 74.120000000000005 114.282 169.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.31 -70.4 0.55 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 113.736 1.013 . . . . 73.030000000000001 113.736 -176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.6 p -83.96 -99.56 0.05 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 116.261 1.948 . . . . 52.109999999999999 116.261 -173.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -145.65 166.34 26.07 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-O 120.919 0.39 . . . . 75.329999999999998 110.488 -172.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 8.6 p -119.97 104.23 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.938 0.875 . . . . 73.530000000000001 109.984 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.51 ' H ' HG23 ' B' ' 30' ' ' THR . 74.9 ttt180 -149.87 113.78 5.09 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.845 -1.168 . . . . 74.540000000000006 107.845 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.62 113.88 26.01 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.245 0.545 . . . . 74.450000000000003 112.023 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.57 113.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.28 -0.873 . . . . 64.340000000000003 109.381 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.312 -1.025 0 CA-C-O 118.456 -0.783 . . . . 72.310000000000002 109.462 -178.176 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.243 0.714 0 CA-C-O 120.916 0.389 . . . . 70.019999999999996 111.617 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.18 101.36 0.62 Allowed Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.21 -0.995 . . . . 75.140000000000001 112.022 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 m -138.82 18.12 2.67 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.799 -1.185 . . . . 71.040000000000006 107.799 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.58 100.45 0.88 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.316 -1.311 . . . . 71.120000000000005 111.437 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.63 118.52 56.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.551 -0.749 . . . . 72.430000000000007 110.75 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.1 m -160.6 179.74 8.32 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.883 -1.525 . . . . 74.329999999999998 106.883 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -76.12 -1.65 27.13 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.77 0.795 . . . . 71.400000000000006 110.281 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -87.95 -174.34 4.66 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.867 -1.061 . . . . 75.329999999999998 109.45 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 97.3 mtt180 -68.53 119.77 13.51 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.021 -0.733 . . . . 75.219999999999999 109.021 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 p -98.57 125.48 43.83 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.151 -0.477 . . . . 72.230000000000004 109.972 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.2 m -127.83 148.59 50.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.442 -0.503 . . . . 73.420000000000002 110.125 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.46 ' CG2' HD12 ' B' ' 14' ' ' LEU . 98.7 t -144.17 143.25 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.774 0.429 . . . . 73.299999999999997 109.994 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.8 p -123.56 125.49 44.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.377 0.423 . . . . 65.430000000000007 110.397 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 mm? -106.56 121.84 45.11 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.189 -0.46 . . . . 64.329999999999998 111.243 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.5 p -92.28 112.88 24.99 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.757 0.789 . . . . 71.200000000000003 109.071 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.428 ' CG2' ' HG3' ' B' ' 51' ' ' PRO . 5.1 t -134.54 -172.62 3.07 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.918 -1.037 . . . . 60.539999999999999 109.367 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' B' ' 7' ' ' ASP . 29.2 pt20 -74.69 81.98 2.06 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.469 1.128 . . . . 71.310000000000002 111.251 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -127.21 142.37 51.5 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.283 -0.871 . . . . 72.150000000000006 110.297 -178.016 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -74.46 147.73 85.2 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.342 -0.984 . . . . 71.129999999999995 108.342 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.52 136.89 29.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.944 1.763 . . . . 71.129999999999995 112.03 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.492 HG13 ' H ' ' A' ' 23' ' ' ARG . 34.6 t -115.41 142.68 27.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.753 -1.203 . . . . 75.109999999999999 107.753 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 m -88.43 -2.28 58.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.631 0.604 . . . . 71.540000000000006 112.631 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' H ' HG13 ' A' ' 21' ' ' VAL . 64.0 ttt180 -134.58 148.75 50.52 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.953 -0.467 . . . . 75.150000000000006 110.44 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -92.4 120.45 41.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.503 -0.925 . . . . 74.010000000000005 108.503 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 35.0 mmtp -96.96 132.21 42.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.917 -0.713 . . . . 72.400000000000006 109.914 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 p -107.25 128.04 54.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.66 -0.7 . . . . 72.299999999999997 109.75 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 67.2 m-85 -128.24 126.79 41.62 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 116.144 -0.48 . . . . 73.540000000000006 110.699 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 37' ' ' VAL . 47.9 p -115.13 129.84 56.77 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.423 -0.808 . . . . 74.140000000000001 112.696 -174.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.487 HD13 HD11 ' B' ' 38' ' ' ILE . 59.0 mt -137.41 121.6 22.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.912 -0.585 . . . . 74.230000000000004 109.467 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -113.23 126.48 55.46 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 119.666 -0.813 . . . . 74.299999999999997 109.162 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' O ' HD21 ' A' ' 34' ' ' LEU . 9.8 tp10 -121.35 103.61 9.09 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.861 -0.609 . . . . 72.519999999999996 109.598 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.13 -93.57 0.23 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.612 -0.722 . . . . 60.240000000000002 112.967 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.7 m -113.75 -7.18 13.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.268 0.84 . . . . 65.109999999999999 113.268 -175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.501 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -114.5 140.67 48.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.142 -1.023 . . . . 75.549999999999997 111.125 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' A' ' 35' ' ' ARG . 1.9 mpt_? -108.71 119.58 39.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.249 -0.887 . . . . 75.200000000000003 108.69 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.31 130.92 55.48 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.754 0.312 . . . . 75.299999999999997 110.247 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG23 HG23 ' A' ' 28' ' ' THR . 60.1 t -121.19 127.17 75.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.476 -0.564 . . . . 74.219999999999999 109.476 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.515 HD12 HD13 ' B' ' 29' ' ' ILE . 83.7 mt -101.66 125.85 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.587 0 N-CA-C 108.672 -0.862 . . . . 75.319999999999993 108.672 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -108.69 114.65 28.63 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.238 -1.023 . . . . 72.319999999999993 108.238 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 49.9 mm -88.84 113.14 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.353 0 N-CA-C 106.499 -1.667 . . . . 73.129999999999995 106.499 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.2 p -109.99 -177.07 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.816 -0.629 . . . . 71.150000000000006 110.343 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.8 -13.0 32.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.941 -0.762 . . . . 75.409999999999997 108.941 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -96.55 -24.61 15.97 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.182 -0.917 . . . . 71.540000000000006 110.705 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.488 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 171.27 -133.52 2.78 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 118.394 -1.86 . . . . 54.140000000000001 114.368 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -126.99 122.59 34.92 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 124.186 0.994 . . . . 62.5 108.567 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -123.07 143.02 50.25 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-O 121.093 0.473 . . . . 75.400000000000006 110.74 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.55 140.81 47.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 115.455 -0.793 . . . . 70.040000000000006 109.14 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.8 m -124.05 136.88 54.56 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.089 -0.505 . . . . 70.409999999999997 110.302 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -117.21 124.3 48.74 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.636 -0.711 . . . . 53.049999999999997 110.015 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -110.88 104.28 55.9 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.001 -0.74 . . . . 65.129999999999995 109.001 175.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.409 ' HG3' ' OG1' ' B' ' 16' ' ' THR . 83.2 Cg_endo -79.44 158.22 25.67 Favored 'Trans proline' 0 N--CA 1.423 -2.659 0 C-N-CA 121.563 1.509 . . . . 41.450000000000003 111.411 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -36.71 -49.83 0.79 Allowed 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 125.424 1.49 . . . . 71.019999999999996 113.517 172.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.543 ' HA ' ' NE2' ' B' ' 17' ' ' GLN . . . 66.9 -69.09 0.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.556 1.142 . . . . 74.319999999999993 113.248 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.6 p -86.99 -76.65 0.35 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.203 0.525 . . . . 73.299999999999997 110.204 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -168.08 157.83 9.89 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.597 -1.631 . . . . 75.420000000000002 106.597 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.89 162.98 35.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 120.981 0.419 . . . . 65.219999999999999 110.557 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -119.09 179.21 4.23 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 104.696 -2.335 . . . . 73.430000000000007 104.696 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -69.04 90.39 0.45 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.2 1.185 . . . . 74.140000000000001 114.2 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.6 t -95.41 111.87 26.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.849 -1.167 . . . . 74.400000000000006 107.849 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.6 m . . . . . 0 C--N 1.298 -1.661 0 CA-C-N 116.225 -0.443 . . . . 62.229999999999997 111.58 -177.976 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.243 0.73 0 CA-C-O 121.9 0.857 . . . . 74.409999999999997 110.41 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.97 6.84 24.12 Favored Glycine 0 N--CA 1.432 -1.597 0 CA-C-N 114.787 -1.097 . . . . 63.229999999999997 112.085 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 25.4 m -63.6 100.23 0.26 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.121 0.486 . . . . 75.430000000000007 111.322 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -144.83 126.52 15.19 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.893 -0.594 . . . . 74.409999999999997 110.143 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.96 125.55 54.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 121.374 0.607 . . . . 53.43 110.302 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -154.4 172.71 17.29 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.906 -1.146 . . . . 74.450000000000003 107.906 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 8.0 m-20 -85.08 -14.94 45.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.884 0.849 . . . . 74.150000000000006 109.236 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -78.31 -173.76 3.42 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.213 -0.903 . . . . 61.030000000000001 110.552 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 93.3 mtt180 -68.63 107.39 2.95 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.826 -0.624 . . . . 73.430000000000007 110.368 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 30.9 p -89.03 128.75 35.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.695 -0.684 . . . . 73.140000000000001 110.713 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 63.8 m -131.62 148.47 52.61 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.543 -0.91 . . . . 62.340000000000003 108.543 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.43 145.31 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 109.445 -0.576 . . . . 71.239999999999995 109.445 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 65.9 p -115.33 125.45 53.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.136 0.493 . . . . 64.409999999999997 110.838 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.46 HD12 ' CG2' ' A' ' 12' ' ' VAL . 3.2 mm? -103.47 121.51 42.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 116.045 -0.525 . . . . 75.420000000000002 111.094 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 38.7 p -93.8 113.31 25.33 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.805 -0.634 . . . . 71.129999999999995 109.748 176.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' THR . . . . . 0.409 ' OG1' ' HG3' ' A' ' 51' ' ' PRO . 9.1 t -129.09 -171.0 2.38 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.623 -1.251 . . . . 73.109999999999999 107.623 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . 0.543 ' NE2' ' HA ' ' A' ' 53' ' ' ALA . 27.6 pt20 -77.55 108.19 10.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.54 1.162 . . . . 72.349999999999994 110.117 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 150.9 46.83 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.89 -1.505 . . . . 75.430000000000007 114.199 -174.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.415 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 2.2 pt? -74.64 167.42 36.46 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.297 -1.32 . . . . 53.219999999999999 108.636 175.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 19.0 Cg_endo -65.2 135.07 41.79 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.131 1.22 . . . . 70.019999999999996 109.951 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 86.2 t -129.81 123.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.726 -0.842 . . . . 72.329999999999998 108.726 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.8 m -90.11 -73.71 0.51 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.037 0.446 . . . . 73.510000000000005 110.064 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -92.38 146.94 23.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.475 -0.784 . . . . 75.140000000000001 109.301 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.07 134.78 26.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.96 -0.385 . . . . 73.549999999999997 109.96 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -100.77 125.72 47.27 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.036 -1.098 . . . . 62.149999999999999 108.036 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 31.7 p -106.3 128.38 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.113 0.482 . . . . 74.030000000000001 110.414 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 71.3 m-85 -127.07 126.91 43.83 Favored 'General case' 0 CA--C 1.473 -2.017 0 CA-C-N 116.038 -0.528 . . . . 74.430000000000007 110.688 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.472 HG22 HG22 ' B' ' 37' ' ' VAL . 58.8 p -115.38 131.47 56.92 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.349 -0.842 . . . . 73.310000000000002 112.416 -173.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.515 HD13 HD12 ' A' ' 38' ' ' ILE . 54.8 mt -133.6 124.32 47.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.656 0.382 . . . . 71.439999999999998 110.199 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -111.19 127.09 55.48 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.87 -0.789 . . . . 75.019999999999996 108.87 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.53 ' O ' HD21 ' B' ' 34' ' ' LEU . 12.6 tp10 -130.22 97.89 4.57 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.731 -0.668 . . . . 75.420000000000002 109.848 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.68 -87.32 0.35 Allowed Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.436 -0.802 . . . . 64.400000000000006 112.021 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' B' ' 52' ' ' GLN . 54.8 m -119.89 -13.18 9.08 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 112.847 0.684 . . . . 73.010000000000005 112.847 -177.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.53 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -107.85 136.5 47.46 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 117.736 -1.586 . . . . 75.409999999999997 112.293 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -102.84 120.09 39.99 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.489 -1.232 . . . . 74.109999999999999 108.405 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.32 53.17 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.689 -0.485 . . . . 75.439999999999998 109.689 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.472 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -124.64 128.66 73.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.979 -0.378 . . . . 72.540000000000006 109.979 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.487 HD11 HD13 ' A' ' 29' ' ' ILE . 83.8 mt -102.2 124.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 C-N-CA 123.923 0.889 . . . . 73.540000000000006 108.696 178.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.21 116.6 32.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.445 -0.946 . . . . 73.430000000000007 108.445 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mm -87.82 113.69 25.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.031 -1.84 . . . . 75.040000000000006 106.031 176.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 76.0 p -123.4 179.51 4.71 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.745 -0.661 . . . . 71.530000000000001 111.338 -171.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -83.1 -7.41 59.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 72.430000000000007 110.276 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' B' ' 15' ' ' THR . 98.8 mtt180 -87.04 -16.73 34.76 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.848 -1.538 . . . . 75.200000000000003 106.848 170.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.18 -103.28 1.03 Allowed Glycine 0 N--CA 1.423 -2.202 0 CA-C-N 114.507 -1.224 . . . . 63.310000000000002 112.039 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -116.38 122.68 45.56 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.106 0.479 . . . . 53.399999999999999 111.856 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.0 143.83 50.18 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.68 -0.691 . . . . 71.5 109.152 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 11.0 p -131.18 140.93 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.307 -0.406 . . . . 64.530000000000001 110.085 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 52.9 m -122.42 136.51 54.91 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.336 -0.393 . . . . 72.329999999999998 110.689 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.89 124.59 48.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.535 -0.757 . . . . 62.119999999999997 111.291 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -122.76 95.81 46.05 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.87 -0.789 . . . . 70.549999999999997 108.87 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 91.1 Cg_endo -96.39 132.64 0.43 Allowed 'Trans proline' 0 N--CA 1.411 -3.36 0 C-N-CA 120.477 0.785 . . . . 71.340000000000003 112.35 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.416 ' HB3' ' HB3' ' B' ' 33' ' ' SER 0.302 2.3 pt20 36.04 -50.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 121.158 3.762 . . . . 74.310000000000002 121.158 169.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' B' ' 51' ' ' PRO . . . 78.21 -31.55 0.16 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.194 1.798 . . . . 74.239999999999995 111.363 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.401 ' H ' ' C ' ' B' ' 52' ' ' GLN . 56.5 m -152.92 -58.58 0.14 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.924 -1.51 . . . . 71.519999999999996 106.924 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -175.4 177.11 1.88 Allowed 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.052 -2.203 . . . . 74.319999999999993 105.052 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 34.6 m -134.69 179.3 4.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 119.161 0.891 . . . . 72.109999999999999 112.788 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -131.56 152.54 50.69 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.544 -2.021 . . . . 72.340000000000003 105.544 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -66.94 88.85 0.16 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.372 0.606 . . . . 63.219999999999999 111.725 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 83.0 t -138.6 109.24 4.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.699 -1.223 . . . . 71.409999999999997 107.699 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.428 -1.529 0 CA-C-O 118.602 -0.713 . . . . 71.420000000000002 110.562 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.556 1.199 0 N-CA-C 112.877 0.695 . . . . 74.519999999999996 112.877 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.8 -145.39 5.48 Favored Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 119.64 -1.267 . . . . 61.210000000000001 112.484 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 m 66.31 100.75 0.04 OUTLIER 'General case' 0 C--O 1.248 0.992 0 C-N-CA 124.225 1.01 . . . . 75.200000000000003 113.031 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -78.39 111.61 14.58 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.119 -1.808 . . . . 73.349999999999994 106.119 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' CG1' ' HB3' ' A' ' 8' ' ' LYS . 46.3 t -83.07 -77.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 112.39 0.515 . . . . 63.32 112.39 -172.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.1 m 70.13 134.81 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.866 1.266 . . . . 74.540000000000006 111.636 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 72.05 -54.59 0.68 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.488 1.115 . . . . 74.319999999999993 112.011 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.5 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 86.8 tttt -70.91 111.13 6.07 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 122.165 0.983 . . . . 74.310000000000002 110.417 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.41 ' H ' ' HD2' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -40.42 132.3 2.07 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 112.859 -1.973 . . . . 72.400000000000006 112.409 172.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.47 127.89 49.32 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.955 -0.566 . . . . 64.310000000000002 111.024 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.496 ' CB ' ' HA ' ' A' ' 48' ' ' CYS . 20.0 m -140.55 148.05 40.41 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.772 -1.196 . . . . 51.439999999999998 107.772 -174.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.34 145.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.421 0.555 . . . . 73.230000000000004 110.753 -175.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.45 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 39.9 p -107.56 125.87 51.84 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.201 0.524 . . . . 70.340000000000003 110.377 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.07 137.84 45.36 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.819 -0.628 . . . . 65.519999999999996 111.442 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -98.51 112.58 24.56 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 115.445 -0.798 . . . . 65.150000000000006 109.293 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -142.4 -176.56 4.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.763 -1.199 . . . . 72.299999999999997 107.763 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -79.33 105.11 10.41 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.604 0.716 . . . . 72.25 110.436 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.551 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.01 147.46 49.54 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.349 -0.841 . . . . 75.340000000000003 109.559 -178.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.5 pt? -74.55 136.07 74.89 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 107.682 -1.229 . . . . 73.239999999999995 107.682 174.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.49 133.9 27.21 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 120.825 1.017 . . . . 71.140000000000001 110.562 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.452 HG23 ' H ' ' A' ' 23' ' ' ARG . 14.5 p -133.42 137.33 53.28 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.737 -0.665 . . . . 63.450000000000003 109.352 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 m -87.86 -19.27 27.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.338 0.59 . . . . 63.43 110.036 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.452 ' H ' HG23 ' A' ' 21' ' ' VAL . 37.6 mmt180 -102.86 133.12 48.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.078 -0.712 . . . . 74.329999999999998 109.078 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mm -93.58 115.71 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.873 -0.788 . . . . 75.030000000000001 108.873 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.78 135.93 33.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 120.384 -0.526 . . . . 75.439999999999998 111.196 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 p -114.55 128.24 56.22 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.959 -1.019 . . . . 64.420000000000002 109.715 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 68.0 m-85 -126.44 125.67 42.52 Favored 'General case' 0 CA--C 1.462 -2.419 0 N-CA-C 109.401 -0.592 . . . . 73.349999999999994 109.401 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.498 HG23 HG23 ' A' ' 37' ' ' VAL . 63.7 p -116.73 131.72 56.88 Favored 'General case' 0 C--N 1.283 -2.308 0 O-C-N 123.861 0.726 . . . . 74.530000000000001 112.344 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.462 HD13 HD11 ' B' ' 38' ' ' ILE . 56.5 mt -127.55 121.17 56.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 120.905 0.383 . . . . 74.129999999999995 110.05 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -102.97 123.58 46.86 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.776 -1.194 . . . . 71.519999999999996 107.776 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -142.31 97.11 3.06 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.354 -0.538 . . . . 74.530000000000001 111.642 -177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -72.96 0.38 Allowed Glycine 0 C--N 1.319 -0.378 0 N-CA-C 115.287 0.875 . . . . 64.319999999999993 115.287 171.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.504 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.1 m -126.94 -1.09 6.58 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 112.719 0.637 . . . . 71.019999999999996 112.719 -173.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.434 HD23 HG22 ' B' ' 40' ' ' ILE . 2.0 pt? -146.33 140.46 26.44 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.271 -0.972 . . . . 73.400000000000006 112.278 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 121.55 44.99 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.006 -1.452 . . . . 64.25 108.956 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.23 137.2 49.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.805 -0.18 . . . . 73.019999999999996 110.531 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.498 HG23 HG23 ' A' ' 28' ' ' THR . 39.2 t -124.31 125.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.215 -0.661 . . . . 72.219999999999999 109.215 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.498 HD12 HD13 ' B' ' 29' ' ' ILE . 86.4 mt -102.95 123.49 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 108.654 -0.869 . . . . 75.329999999999998 108.654 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 92.9 m-85 -106.79 114.48 28.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.362 -0.977 . . . . 70.150000000000006 108.362 177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.428 HG13 ' HG2' ' B' ' 31' ' ' GLU . 49.0 mm -89.42 114.75 27.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.208 -1.404 . . . . 72.310000000000002 107.208 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.78 156.87 47.94 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 115.806 -0.633 . . . . 63.140000000000001 110.953 -175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -62.59 -14.58 44.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.579 0.752 . . . . 74.450000000000003 110.734 176.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -85.35 -18.71 32.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.618 0.723 . . . . 75.420000000000002 109.491 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.35 -138.79 9.28 Favored Glycine 0 CA--C 1.48 -2.155 0 C-N-CA 119.909 -1.138 . . . . 72.349999999999994 112.176 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.31 121.32 44.07 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.61 -0.885 . . . . 72.209999999999994 108.61 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.45 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 23.0 tptm -118.62 121.81 41.06 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.383 -0.969 . . . . 74.049999999999997 108.383 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG11 HG13 ' B' ' 47' ' ' VAL . 14.9 p -116.97 140.33 40.06 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 107.765 -1.198 . . . . 72.299999999999997 107.765 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.496 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 13.6 t -132.76 136.04 46.1 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 106.716 -1.587 . . . . 72.040000000000006 106.716 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.456 ' CB ' ' HG ' ' B' ' 45' ' ' LEU . . . -136.18 124.57 23.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 119.328 -0.949 . . . . 72.010000000000005 111.312 -177.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.63 108.81 62.51 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 114.84 -1.073 . . . . 74.439999999999998 109.792 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -89.04 148.13 5.6 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.342 2.028 . . . . 75.109999999999999 111.079 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 33' ' ' SER . 9.2 pt20 -62.87 129.77 41.89 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.905 -0.589 . . . . 73.299999999999997 109.778 174.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.44 -55.92 2.27 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.306 -0.627 . . . . 72.040000000000006 109.306 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.5 p -107.21 -66.3 1.03 Allowed 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.702 -0.681 . . . . 73.239999999999995 110.328 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -109.38 166.67 10.7 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.651 -0.5 . . . . 73.030000000000001 109.651 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.86 122.56 11.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.476 0.655 . . . . 73.230000000000004 111.787 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -98.87 108.38 21.05 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.083 -1.451 . . . . 72.140000000000001 107.083 170.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -153.9 142.46 20.79 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.313 -0.403 . . . . 70.25 111.444 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.3 t -109.64 -17.9 7.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.425 -0.807 . . . . 75.430000000000007 110.324 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 C--O 1.246 0.918 0 O-C-N 122.103 -0.373 . . . . 74.430000000000007 111.416 -176.284 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . 0.574 ' N ' ' HZ3' ' B' ' 8' ' ' LYS . 8.7 p . . . . . 0 C--O 1.238 0.488 0 CA-C-O 121.514 0.673 . . . . 73.519999999999996 109.797 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.87 141.92 12.42 Favored Glycine 0 N--CA 1.434 -1.497 0 N-CA-C 109.423 -1.471 . . . . 63.140000000000001 109.423 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 46.1 t 71.68 134.04 0.04 OUTLIER 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.706 0.803 . . . . 72.510000000000005 110.615 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -76.6 97.84 4.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.052 0.453 . . . . 74.140000000000001 110.148 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 56.3 t -90.8 -24.43 5.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.813 -0.63 . . . . 64.239999999999995 109.458 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m 67.28 -73.25 0.08 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.51 1.124 . . . . 61.329999999999998 110.437 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -87.44 83.86 7.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 122.164 0.983 . . . . 72.049999999999997 109.606 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.574 ' HZ3' ' N ' ' B' ' 1' ' ' VAL . 86.5 tttt -143.91 128.61 18.22 Favored 'General case' 0 CA--C 1.467 -2.219 0 CA-C-N 114.289 -1.323 . . . . 74.430000000000007 108.606 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.547 ' HD2' ' H ' ' B' ' 9' ' ' ARG . 0.0 OUTLIER -80.18 100.27 8.2 Favored 'General case' 0 N--CA 1.391 -3.383 0 CA-C-N 114.63 -1.168 . . . . 75.019999999999996 110.053 177.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.1 p -87.12 117.79 26.09 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.539 -1.664 . . . . 64.129999999999995 110.099 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.458 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 19.4 m -137.28 148.22 46.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.945 -1.131 . . . . 63.509999999999998 107.945 -175.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -142.96 146.79 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.833 -0.432 . . . . 75.439999999999998 109.833 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 23.7 p -106.96 125.56 51.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.17 0.588 . . . . 72.109999999999999 110.46 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.34 119.41 39.38 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.236 -1.024 . . . . 73.400000000000006 108.236 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -121.59 112.69 18.77 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.267 -1.012 . . . . 72.329999999999998 108.267 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -173.29 113.44 0.22 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.348 0.499 . . . . 74.129999999999995 112.348 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' B' ' 17' ' ' GLN . 5.9 tp60 59.42 22.47 10.94 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.581 1.152 . . . . 74.209999999999994 112.887 174.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.456 ' HD2' ' HA2' ' B' ' 44' ' ' GLY . 27.3 mtt180 -105.74 121.51 44.17 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.107 -0.996 . . . . 73.209999999999994 108.853 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.525 ' H ' HD22 ' B' ' 19' ' ' LEU . 1.6 pt? -74.39 152.28 87.78 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 116.095 -0.502 . . . . 74.439999999999998 111.885 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.19 136.65 74.07 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.379 2.719 . . . . 75.200000000000003 113.648 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.73 149.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.659 -1.237 . . . . 75.129999999999995 107.659 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 -36.42 59.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.022 0.378 . . . . 64.450000000000003 112.022 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -124.18 135.89 53.79 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.939 -0.304 . . . . 72.109999999999999 110.787 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.5 mm -77.57 115.16 19.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.755 -1.202 . . . . 74.209999999999994 107.755 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.19 126.47 43.67 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.161 -0.472 . . . . 62.109999999999999 110.444 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.421 HG22 ' CD1' ' B' ' 39' ' ' PHE . 41.1 p -106.66 127.36 53.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.436 -0.579 . . . . 72.340000000000003 109.436 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 75.3 m-85 -126.57 127.45 45.3 Favored 'General case' 0 CA--C 1.474 -1.956 0 CA-C-N 116.092 -0.504 . . . . 73.540000000000006 110.626 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' THR . . . . . 0.493 HG22 HG22 ' B' ' 37' ' ' VAL . 43.4 p -114.51 121.3 43.07 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.618 -0.719 . . . . 72.140000000000001 112.021 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.498 HD13 HD12 ' A' ' 38' ' ' ILE . 94.5 mt -119.48 121.46 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.785 -0.643 . . . . 71.409999999999997 110.864 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -105.71 139.84 39.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.257 -1.016 . . . . 71.420000000000002 108.257 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.428 ' HG2' HG13 ' A' ' 40' ' ' ILE . 17.0 tp10 -142.51 97.59 3.14 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.404 0.621 . . . . 74.319999999999993 109.566 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.22 2.59 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.218 -0.901 . . . . 71.530000000000001 112.834 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' SER . . . . . 0.467 ' HA ' HG21 ' B' ' 56' ' ' VAL . 39.8 m -146.12 -25.25 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.279 0.844 . . . . 72.439999999999998 113.279 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.445 ' H ' HD21 ' B' ' 34' ' ' LEU . 2.6 pt? -92.89 141.39 28.47 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.037 -0.665 . . . . 64.319999999999993 110.534 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -111.51 123.15 49.62 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.049 -0.523 . . . . 73.540000000000006 110.006 177.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.4 54.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.714 -0.476 . . . . 73.150000000000006 109.714 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.493 HG22 HG22 ' B' ' 28' ' ' THR . 39.2 t -119.76 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.273 0.559 . . . . 74.109999999999999 110.538 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.462 HD11 HD13 ' A' ' 29' ' ' ILE . 97.0 mt -103.91 116.65 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 107.846 -1.168 . . . . 63.399999999999999 107.846 177.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.465 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 97.8 m-85 -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.472 -0.936 . . . . 73.420000000000002 108.472 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.434 HG22 HD23 ' A' ' 34' ' ' LEU . 41.9 mm -88.5 113.7 25.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 106.501 -1.666 . . . . 73.239999999999995 106.501 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.9 t -119.5 166.02 13.64 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 120.356 -0.538 . . . . 72.450000000000003 111.479 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.97 -3.76 43.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.426 0.898 . . . . 73.439999999999998 113.426 -173.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -116.22 -1.75 12.31 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.195 0.521 . . . . 75.400000000000006 110.518 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . 0.456 ' HA2' ' HD2' ' B' ' 18' ' ' ARG . . . 155.52 -140.65 7.47 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.04 -1.553 . . . . 64.239999999999995 113.96 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.456 ' HG ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 tm? -122.13 126.58 48.66 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.441 0.696 . . . . 74.5 109.355 -177.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -117.45 121.75 41.88 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.821 -0.807 . . . . 74.510000000000005 108.821 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.408 HG13 HG11 ' A' ' 47' ' ' VAL . 9.7 p -108.23 140.39 26.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.621 -0.881 . . . . 61.310000000000002 108.621 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.458 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 10.5 t -139.7 136.86 34.66 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 107.752 -1.203 . . . . 44.439999999999998 107.752 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.55 125.77 43.75 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 110.144 -0.317 . . . . 55.030000000000001 110.144 -177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -115.07 109.69 46.62 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-O 121.278 0.561 . . . . 75.530000000000001 109.827 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.87 158.56 49.84 Favored 'Trans proline' 0 N--CA 1.439 -1.713 0 C-N-CA 122.719 2.279 . . . . 70.329999999999998 112.939 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -55.63 99.21 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.539 -1.664 . . . . 70.329999999999998 111.036 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.91 -91.53 0.08 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.134 -0.485 . . . . 53.130000000000003 112.089 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.7 p -119.22 3.07 11.41 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.05 0.453 . . . . 72.540000000000006 110.684 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -161.59 168.21 23.92 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.66 -0.7 . . . . 73.439999999999998 109.708 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' B' ' 33' ' ' SER . 5.5 p -151.79 135.77 8.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 123.713 0.805 . . . . 72.420000000000002 108.948 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -122.51 83.1 2.06 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.204 -1.036 . . . . 71.400000000000006 108.204 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.95 105.41 16.19 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.856 -1.065 . . . . 61.240000000000002 108.529 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.34 -36.91 3.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.512 0.93 . . . . 72.219999999999999 113.512 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 108.169 -1.049 . . . . 72.340000000000003 108.169 178.27 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 C--O 1.236 0.35 0 N-CA-C 110.289 -0.263 . . . . 74.349999999999994 110.289 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.06 152.0 19.73 Favored Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 110.847 -0.901 . . . . 65.150000000000006 110.847 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 t 64.87 12.62 7.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.259 1.024 . . . . 74.120000000000005 111.639 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.15 168.41 24.74 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.653 -0.499 . . . . 60.100000000000001 109.653 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -109.06 100.36 10.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.875 0.845 . . . . 73.340000000000003 111.07 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 8' ' ' LYS . 24.4 t -160.49 144.63 14.03 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.33 -1.359 . . . . 64.209999999999994 107.33 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.557 ' H ' ' HB2' ' B' ' 17' ' ' GLN . 5.0 m-20 71.52 -33.87 0.28 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.079 1.352 . . . . 75.150000000000006 112.662 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 6' ' ' SER . 55.8 mtpt -72.92 115.44 12.23 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.372 -1.344 . . . . 63.119999999999997 107.372 174.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 14.5 ptt180 -68.85 114.49 7.22 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.529 0.681 . . . . 63.539999999999999 111.904 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.408 ' HG1' HD13 ' B' ' 14' ' ' LEU . 22.4 p -88.86 148.07 24.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.198 -0.91 . . . . 74.209999999999994 110.98 -175.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 65.9 m -141.71 149.23 40.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.458 -1.312 . . . . 64.340000000000003 107.458 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.458 HG13 HG13 ' B' ' 12' ' ' VAL . 57.1 t -139.76 145.15 27.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 110.163 -0.31 . . . . 75.239999999999995 110.163 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 m -111.77 124.8 53.12 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.216 -1.031 . . . . 73.109999999999999 108.216 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER -132.09 141.01 49.03 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 123.749 0.819 . . . . 74.109999999999999 108.802 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 t -123.32 141.9 51.51 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.843 -0.743 . . . . 52.210000000000001 111.004 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 t -111.56 26.61 10.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.245 -1.02 . . . . 74.310000000000002 108.245 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 77.43 117.26 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 112.998 -1.91 . . . . 72.120000000000005 108.468 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.511 HH12 HD22 ' B' ' 34' ' ' LEU . 14.9 mmm180 -95.46 148.01 22.93 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 116.561 2.06 . . . . 74.409999999999997 116.561 -172.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.9 mt -114.37 153.83 46.49 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 112.922 -1.945 . . . . 62.140000000000001 106.358 172.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.45 145.08 16.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.349 3.366 . . . . 74.239999999999995 115.286 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.34 137.86 54.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 114.084 -1.417 . . . . 73.439999999999998 109.164 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 m -98.11 -45.09 6.36 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.712 0.292 . . . . 73.010000000000005 110.848 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -119.3 133.84 55.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 62.340000000000003 109.757 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -85.48 135.91 23.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.767 -0.457 . . . . 64.200000000000003 109.767 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.03 151.63 33.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.9 0.704 . . . . 73.400000000000006 112.9 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 m -133.99 127.22 31.89 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.607 -1.178 . . . . 72.140000000000001 108.38 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 74.8 m-85 -127.61 134.7 49.67 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 111.879 0.325 . . . . 74.549999999999997 111.879 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.507 HG23 HG23 ' A' ' 37' ' ' VAL . 36.1 p -115.51 139.23 50.25 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.64 -0.709 . . . . 71.219999999999999 111.556 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.523 HD13 HD11 ' B' ' 38' ' ' ILE . 82.3 mt -130.72 133.14 63.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.216 -0.902 . . . . 75.099999999999994 108.78 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -117.19 123.65 47.2 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 121.631 0.729 . . . . 73.140000000000001 109.171 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.8 tp10 -125.16 98.35 5.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.752 0.787 . . . . 65.140000000000001 108.965 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.52 -71.9 2.91 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 109.703 -1.359 . . . . 64.310000000000002 109.703 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -154.97 -22.7 0.12 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.519 0.933 . . . . 73.209999999999994 113.519 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.23 141.06 54.54 Favored 'General case' 0 C--N 1.367 1.37 0 CA-C-N 118.934 0.788 . . . . 72.230000000000004 110.817 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 31.6 mmt180 -100.58 118.71 37.31 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.884 -0.598 . . . . 73.200000000000003 109.745 174.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 123.97 49.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.894 -0.78 . . . . 65.310000000000002 108.894 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 47' ' ' VAL . 71.5 t -110.89 133.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.3 -0.409 . . . . 75.030000000000001 110.142 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.431 HD12 HD13 ' B' ' 29' ' ' ILE . 75.6 mt -115.49 118.29 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 C-N-CA 123.702 0.801 . . . . 63.350000000000001 108.997 176.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.52 122.1 43.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.567 -0.901 . . . . 75.230000000000004 108.567 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.408 HD11 HD23 ' B' ' 34' ' ' LEU . 47.6 mm -100.63 113.37 36.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.684 -1.228 . . . . 75.030000000000001 107.684 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -131.92 177.03 7.85 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.635 -0.876 . . . . 74.129999999999995 108.635 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.5 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -90.51 -1.74 57.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.487 -0.931 . . . . 73.310000000000002 108.487 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -89.63 -30.83 17.85 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.558 -0.904 . . . . 63.43 108.558 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.12 -157.53 29.85 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.702 -1.136 . . . . 74.340000000000003 111.737 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -113.63 121.57 44.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.888 -1.523 . . . . 73.450000000000003 106.888 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -121.08 140.16 52.33 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 121.202 0.525 . . . . 74.420000000000002 111.381 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 23.2 m -131.45 141.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.035 -0.984 . . . . 74.530000000000001 110.866 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.6 m -121.35 137.52 54.66 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.936 -0.575 . . . . 73.420000000000002 110.623 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.75 124.58 47.62 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.294 -0.632 . . . . 64.329999999999998 109.294 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 14.2 t70 -115.84 127.13 27.03 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.933 -0.765 . . . . 65.219999999999999 108.933 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.8 148.17 22.96 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.915 3.077 . . . . 62.450000000000003 113.854 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.537 ' NE2' ' H ' ' A' ' 52' ' ' GLN . 1.2 mp0 -51.93 107.41 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.227 1.011 . . . . 74.109999999999999 110.937 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.13 147.75 25.33 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 106.194 -1.78 . . . . 73.209999999999994 106.194 173.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.0 m -74.03 83.77 1.77 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.861 0.839 . . . . 73.549999999999997 109.501 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -165.06 148.7 8.56 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 105.642 -1.984 . . . . 72.239999999999995 105.642 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t 75.05 94.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.027 0.931 . . . . 75.420000000000002 110.229 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -80.05 -47.39 14.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.701 -1.222 . . . . 74.5 107.701 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.42 -91.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.159 1.384 . . . . 73.0 112.368 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t 42.58 81.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.118 0 C-N-CA 124.43 1.092 . . . . 74.420000000000002 112.81 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.895 -0.593 . . . . 63.409999999999997 109.52 -179.2 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.242 0.662 0 N-CA-C 110.222 -0.288 . . . . 74.239999999999995 110.222 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.03 151.72 23.84 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 109.731 -1.348 . . . . 73.140000000000001 109.731 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 37.7 t 74.42 -45.55 0.59 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.446 1.098 . . . . 72.030000000000001 111.357 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -93.81 157.23 16.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.136 -0.483 . . . . 71.329999999999998 109.891 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.99 149.4 26.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 120.937 0.398 . . . . 75.010000000000005 110.438 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 59.4 m -150.19 122.27 8.28 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.84 -0.538 . . . . 75.5 111.006 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 63.35 24.22 14.11 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.888 0.875 . . . . 74.129999999999995 112.74 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.33 107.24 19.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.606 -0.887 . . . . 71.209999999999994 108.606 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -64.88 121.29 14.28 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 115.177 -0.92 . . . . 75.420000000000002 113.046 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.1 p -103.21 149.76 24.35 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-N 114.846 -1.07 . . . . 72.409999999999997 111.282 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 63.1 m -139.85 148.84 42.68 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.352 -1.722 . . . . 62.409999999999997 106.352 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.458 HG13 HG13 ' A' ' 12' ' ' VAL . 60.2 t -141.88 144.0 26.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.592 -0.521 . . . . 53.100000000000001 109.592 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -107.98 124.82 50.73 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.091 -1.077 . . . . 75.439999999999998 108.091 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.429 HD22 ' N ' ' B' ' 14' ' ' LEU . 0.3 OUTLIER -119.41 122.73 42.43 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.08 -0.711 . . . . 62.130000000000003 109.08 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -107.22 130.64 54.71 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.87 0.843 . . . . 70.409999999999997 111.01 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -144.78 -162.45 1.49 Allowed 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.001 -1.481 . . . . 65.439999999999998 107.001 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . 0.557 ' HB2' ' H ' ' A' ' 7' ' ' ASP . 6.5 tp-100 -71.1 102.73 2.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.701 0.762 . . . . 63.329999999999998 109.177 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 mmm-85 -125.0 139.49 53.77 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 114.874 -1.057 . . . . 63.240000000000002 109.214 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 46.8 mt -89.02 137.24 29.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 106.649 -1.612 . . . . 71.019999999999996 106.649 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.68 135.17 41.6 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.647 2.231 . . . . 74.510000000000005 112.695 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.91 135.83 61.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.834 -1.543 . . . . 73.329999999999998 106.834 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 26.3 m -89.79 -20.28 23.7 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.32 0.489 . . . . 74.510000000000005 112.32 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -112.73 138.63 49.26 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.783 -0.19 . . . . 52.520000000000003 110.779 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mm -89.93 118.95 36.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.305 -0.628 . . . . 74.109999999999999 109.305 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.07 152.53 18.68 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.312 0.577 . . . . 64.0 112.333 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 73.1 m -131.31 127.91 38.67 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.693 -1.14 . . . . 73.329999999999998 108.595 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -129.35 125.58 36.98 Favored 'General case' 0 CA--C 1.452 -2.793 0 N-CA-C 108.94 -0.763 . . . . 63.130000000000003 108.94 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 18.6 m -117.88 122.07 42.37 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 119.686 -0.806 . . . . 74.200000000000003 112.544 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.431 HD13 HD12 ' A' ' 38' ' ' ILE . 64.2 mt -116.48 121.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.509 . . . . 74.120000000000005 109.9 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -105.02 128.42 53.31 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.225 -1.398 . . . . 72.549999999999997 107.225 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.569 ' O ' HD21 ' B' ' 34' ' ' LEU . 14.7 tp10 -139.38 118.49 12.65 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.258 -0.645 . . . . 71.299999999999997 109.258 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.73 -78.79 1.16 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.858 -1.163 . . . . 74.400000000000006 110.271 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -155.37 -14.58 0.11 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 112.924 0.712 . . . . 70.519999999999996 112.924 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.569 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.4 pt? -84.2 142.07 30.57 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.329 0.513 . . . . 75.019999999999996 110.818 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -100.66 118.08 36.08 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.324 -1.361 . . . . 74.129999999999995 107.324 175.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.98 29.53 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.43 -0.581 . . . . 72.120000000000005 109.43 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -108.37 124.02 64.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.211 -0.449 . . . . 50.130000000000003 110.626 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.523 HD11 HD13 ' A' ' 29' ' ' ILE . 63.2 mt -102.97 123.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 C-N-CA 123.429 0.691 . . . . 62.200000000000003 109.205 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -104.85 114.88 29.36 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.219 -1.03 . . . . 75.120000000000005 108.219 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.401 HG13 ' HG2' ' A' ' 31' ' ' GLU . 47.5 mm -90.18 112.57 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 106.869 -1.53 . . . . 75.420000000000002 106.869 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -110.61 -176.58 3.01 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.922 -0.77 . . . . 64.109999999999999 108.922 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.455 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -92.11 -17.98 24.19 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 120.968 0.413 . . . . 74.049999999999997 110.219 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -100.58 -16.94 17.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.127 -0.488 . . . . 64.129999999999995 111.01 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.34 -145.59 7.28 Favored Glycine 0 C--N 1.295 -1.711 0 C-N-CA 118.7 -1.714 . . . . 70.299999999999997 113.199 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.2 122.82 23.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.574 -1.269 . . . . 75.129999999999995 107.574 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -125.04 141.57 52.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.215 0.531 . . . . 73.230000000000004 110.383 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.495 HG13 HG12 ' A' ' 47' ' ' VAL . 30.8 m -131.9 141.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.298 -0.865 . . . . 75.25 111.03 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -120.03 136.98 54.36 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 115.929 -0.578 . . . . 72.109999999999999 110.11 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.69 123.91 47.24 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.186 -0.672 . . . . 75.349999999999994 109.186 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -102.04 135.73 19.61 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 107.655 -1.239 . . . . 73.420000000000002 107.655 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -55.92 143.28 82.73 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 123.49 2.793 . . . . 73.439999999999998 114.34 -174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . 0.448 ' H ' ' CD ' ' B' ' 52' ' ' GLN . 1.1 mp0 -50.56 110.72 0.44 Allowed 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.588 -1.187 . . . . 73.150000000000006 108.891 174.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.97 175.56 8.99 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.965 -0.561 . . . . 61.409999999999997 110.717 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.2 m -86.01 12.17 10.04 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 122.236 1.017 . . . . 74.420000000000002 109.206 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -121.54 -174.81 2.94 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.182 -1.414 . . . . 74.140000000000001 107.182 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 41.1 t 76.24 107.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.688 1.195 . . . . 72.409999999999997 110.626 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -134.68 -75.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.54 -0.755 . . . . 62.219999999999999 109.64 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 65.71 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.832 0.853 . . . . 71.299999999999997 111.782 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t 37.24 80.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.042 1.737 . . . . 73.540000000000006 114.698 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 52.4 t . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 107.741 -1.207 . . . . 71.319999999999993 107.741 177.651 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.241 0.63 0 N-CA-C 110.135 -0.32 . . . . 75.230000000000004 110.135 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.45 74.93 1.29 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.638 -0.791 . . . . 41.530000000000001 111.92 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.6 m -102.96 -12.68 17.31 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 110.037 -0.357 . . . . 73.230000000000004 110.037 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 59.55 88.32 0.07 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.721 1.208 . . . . 73.129999999999995 112.196 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.0 p -130.16 100.11 4.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.98 0.895 . . . . 73.409999999999997 110.941 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.7 p -106.45 120.25 41.42 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.22 -0.9 . . . . 63.229999999999997 109.637 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.71 99.82 0.49 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.481 0.657 . . . . 71.019999999999996 110.432 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 173.88 -68.22 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.223 -2.14 . . . . 74.340000000000003 105.223 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.427 ' HB3' ' O ' ' A' ' 49' ' ' ALA . 97.2 mtt180 -152.27 115.57 4.72 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.06 -1.459 . . . . 74.129999999999995 107.06 176.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 120.241 -0.584 . . . . 70.420000000000002 110.859 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.7 m -129.85 148.94 51.77 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.089 -1.078 . . . . 65.319999999999993 108.089 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.3 147.01 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 120.84 -0.344 . . . . 63.140000000000001 110.883 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.3 p -112.21 126.94 55.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.903 0.382 . . . . 73.140000000000001 110.003 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.08 141.95 47.3 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.771 -0.825 . . . . 72.209999999999994 108.771 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -127.9 112.98 15.3 Favored 'General case' 0 N--CA 1.405 -2.693 0 C-N-CA 119.534 -0.866 . . . . 72.409999999999997 111.04 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' B' ' 10' ' ' THR . 9.0 t -121.71 -170.09 1.98 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.3 -1.0 . . . . 64.099999999999994 108.3 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -72.38 93.36 1.51 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.712 0.768 . . . . 51.420000000000002 110.822 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.416 HH22 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -126.5 148.17 49.73 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.95 -1.023 . . . . 74.099999999999994 108.838 -178.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.07 141.42 46.86 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.347 -0.983 . . . . 71.209999999999994 108.347 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 39.9 Cg_endo -65.91 143.83 74.49 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.541 2.161 . . . . 75.219999999999999 112.715 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 21.4 t -122.4 148.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.404 -1.332 . . . . 73.420000000000002 107.404 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -92.38 -39.84 11.23 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 120.305 -0.558 . . . . 73.340000000000003 110.843 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -89.61 133.15 34.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.31 -0.405 . . . . 65.129999999999995 111.246 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.73 124.11 42.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.761 -0.829 . . . . 72.329999999999998 108.761 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -104.53 146.57 28.7 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.009 -0.676 . . . . 70.319999999999993 111.292 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 m -127.29 127.79 44.91 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.436 -0.949 . . . . 75.209999999999994 108.436 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 88.2 m-85 -128.13 134.73 49.15 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-N 116.352 -0.385 . . . . 74.439999999999998 111.8 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.466 HG23 HG23 ' A' ' 37' ' ' VAL . 17.7 p -114.64 120.08 38.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.295 -0.866 . . . . 74.510000000000005 111.711 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.536 HD13 HD11 ' B' ' 38' ' ' ILE . 93.9 mt -114.94 125.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.569 -0.741 . . . . 71.129999999999995 109.589 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.417 HG23 ' HB3' ' A' ' 58' ' ' ASP . 9.0 t -106.91 128.87 54.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.277 0.56 . . . . 75.040000000000006 109.794 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' O ' HD21 ' A' ' 34' ' ' LEU . 17.1 tp10 -142.99 119.18 10.78 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.715 -0.675 . . . . 73.549999999999997 109.59 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.59 -87.37 0.12 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 111.6 -0.6 . . . . 50.140000000000001 111.6 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 t -151.14 13.88 0.69 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.406 -0.59 . . . . 71.219999999999999 109.406 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -110.49 140.51 44.69 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.7 -0.8 . . . . 73.340000000000003 108.891 174.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -116.3 134.03 55.35 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.58 -0.736 . . . . 73.150000000000006 110.192 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.97 131.46 55.38 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.383 -0.599 . . . . 52.0 109.383 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 87.5 t -113.11 120.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.014 -0.539 . . . . 74.549999999999997 110.139 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.479 HD12 HD13 ' B' ' 29' ' ' ILE . 96.2 mt -101.33 117.39 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 N-CA-C 109.003 -0.739 . . . . 74.230000000000004 109.003 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.2 m-85 -102.96 114.82 29.43 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.554 -0.906 . . . . 75.340000000000003 108.554 177.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 HD23 ' B' ' 34' ' ' LEU . 47.7 mm -90.75 112.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 106.57 -1.641 . . . . 75.409999999999997 106.57 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -116.62 173.28 6.71 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.525 0.516 . . . . 70.200000000000003 110.248 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.564 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.91 -33.01 71.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 116.482 2.03 . . . . 75.310000000000002 116.482 -171.145 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.564 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 1.5 tmt_? -117.21 3.76 12.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 119.694 -0.803 . . . . 70.25 109.472 -176.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.5 -158.73 12.03 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 118.353 -1.88 . . . . 44.240000000000002 115.058 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.29 123.1 24.87 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 125.636 1.575 . . . . 73.510000000000005 108.457 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -121.45 143.4 49.26 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.745 0.307 . . . . 74.439999999999998 110.721 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.92 140.2 48.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 115.948 -0.569 . . . . 72.340000000000003 110.126 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 26.7 m -118.9 145.05 46.04 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.5 -0.773 . . . . 74.299999999999997 110.232 172.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 9' ' ' ARG . . . -115.76 125.75 53.16 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.252 -1.018 . . . . 61.530000000000001 108.252 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.93 78.43 31.81 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.218 -1.401 . . . . 72.400000000000006 107.218 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 27.8 Cg_endo -99.53 134.13 0.23 Allowed 'Trans proline' 0 N--CA 1.413 -3.229 0 C-N-CA 122.303 2.002 . . . . 74.450000000000003 113.858 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 50.74 68.76 0.72 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.052 -1.431 . . . . 63.399999999999999 113.229 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.83 -53.38 4.94 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.152 -0.619 . . . . 63.039999999999999 111.279 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 m -153.45 29.86 0.48 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 107.33 -1.359 . . . . 72.510000000000005 107.33 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.1 m95 73.33 130.32 0.04 OUTLIER 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.566 -1.197 . . . . 74.0 110.666 -173.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.96 118.14 57.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.795 -0.639 . . . . 74.329999999999998 112.382 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -126.24 105.67 8.99 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.834 -1.913 . . . . 71.530000000000001 105.834 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' OD1' HG13 ' A' ' 60' ' ' VAL . 12.5 t70 -111.04 161.99 15.33 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.226 -1.027 . . . . 74.319999999999993 108.226 -176.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.16 -25.72 23.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 111.802 0.297 . . . . 71.430000000000007 111.802 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.488 HG13 ' OD1' ' A' ' 58' ' ' ASP . 14.4 p . . . . . 0 C--O 1.25 1.081 0 C-N-CA 120.336 -0.546 . . . . 75.319999999999993 110.649 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 109.609 -0.515 . . . . 70.019999999999996 109.609 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.33 5.24 28.45 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.29 -0.957 . . . . 75.230000000000004 112.601 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -75.02 -33.72 61.83 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.554 -0.535 . . . . 61.140000000000001 109.554 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 58.47 90.92 0.04 OUTLIER 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.451 1.101 . . . . 73.219999999999999 113.376 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.435 ' HA ' HG22 ' B' ' 10' ' ' THR . 6.8 p -159.54 84.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 114.472 -1.24 . . . . 74.450000000000003 110.189 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.4 p -85.21 138.63 32.23 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.491 -1.231 . . . . 72.420000000000002 112.084 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.87 90.15 2.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.576 -0.738 . . . . 73.239999999999995 110.813 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt 163.54 -73.09 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.655 0 C-N-CA 127.424 2.29 . . . . 75.230000000000004 105.336 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -126.24 129.42 48.9 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 108.173 -1.047 . . . . 73.420000000000002 108.173 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.435 HG22 ' HA ' ' B' ' 5' ' ' VAL . 49.5 m -108.88 116.66 32.42 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.334 -1.358 . . . . 73.129999999999995 107.334 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -135.61 146.76 48.24 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.115 -1.068 . . . . 65.25 108.115 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 12.4 p -147.12 156.06 10.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 117.486 0.13 . . . . 60.020000000000003 110.788 -176.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -117.16 126.69 53.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.345 0.258 . . . . 73.310000000000002 110.618 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.409 HD22 ' N ' ' B' ' 14' ' ' LEU . 1.7 mm? -112.11 121.12 44.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.98 -1.119 . . . . 73.439999999999998 107.98 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -93.05 111.81 23.56 Favored 'General case' 0 C--N 1.284 -2.246 0 C-N-CA 118.271 -1.372 . . . . 71.439999999999998 109.147 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.6 t -153.58 107.81 3.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.181 -0.918 . . . . 64.0 112.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . 0.423 ' HA ' ' OE1' ' B' ' 17' ' ' GLN . 6.1 tp60 43.1 85.66 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.708 1.603 . . . . 75.209999999999994 113.259 174.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.428 ' HD3' ' N ' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -125.57 148.47 48.92 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.173 -1.011 . . . . 72.010000000000005 110.275 -173.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.402 HD12 ' H ' ' B' ' 19' ' ' LEU . 2.8 mp -84.21 159.46 59.36 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.676 -1.231 . . . . 72.140000000000001 107.676 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.88 133.85 28.3 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 N-CA-C 108.54 -1.369 . . . . 61.219999999999999 108.54 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.558 ' H ' ' HB3' ' B' ' 42' ' ' LYS . 32.5 t -132.15 136.64 56.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.098 -1.075 . . . . 72.239999999999995 108.098 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -85.89 -30.31 22.98 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.057 0.456 . . . . 74.219999999999999 111.767 -175.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -114.63 166.74 11.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.745 0.307 . . . . 74.329999999999998 111.689 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.04 115.12 40.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 106.799 -1.556 . . . . 64.319999999999993 106.799 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 35.4 mmtp -90.62 147.18 23.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.733 -0.787 . . . . 65.040000000000006 110.482 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 90.4 m -133.13 127.88 34.88 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.648 -0.871 . . . . 73.430000000000007 108.648 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 70.9 m-85 -128.51 125.78 39.09 Favored 'General case' 0 CA--C 1.446 -3.021 0 N-CA-C 109.474 -0.565 . . . . 75.329999999999998 109.474 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.8 m -117.61 130.93 56.69 Favored 'General case' 0 C--N 1.266 -3.048 0 O-C-N 123.996 0.81 . . . . 71.219999999999999 112.022 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.479 HD13 HD12 ' A' ' 38' ' ' ILE . 49.7 mt -125.01 129.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.866 -0.606 . . . . 75.450000000000003 109.988 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.444 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 9.7 t -106.82 122.27 46.06 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.461 -0.94 . . . . 72.540000000000006 108.461 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.406 ' O ' HD21 ' B' ' 34' ' ' LEU . 19.8 tp10 -142.69 97.82 3.18 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.359 -0.536 . . . . 75.439999999999998 111.69 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.81 -69.97 1.48 Allowed Glycine 0 C--N 1.313 -0.741 0 N-CA-C 115.324 0.89 . . . . 75.109999999999999 115.324 172.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -137.13 0.38 2.34 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.56 0.578 . . . . 55.539999999999999 112.56 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.425 HD23 HD11 ' A' ' 40' ' ' ILE . 2.2 pt? -141.16 141.52 34.12 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.062 -1.055 . . . . 64.099999999999994 112.667 -175.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.444 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 19.2 mmm180 -98.31 113.72 25.77 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.382 -1.71 . . . . 75.129999999999995 106.382 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.77 120.0 40.07 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.743 -0.465 . . . . 73.230000000000004 109.743 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' B' ' 27' ' ' TYR . 90.1 t -113.65 129.31 69.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.755 -0.657 . . . . 70.120000000000005 110.325 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.536 HD11 HD13 ' A' ' 29' ' ' ILE . 67.3 mt -113.25 131.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 123.387 0.675 . . . . 75.230000000000004 109.807 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 96.3 m-85 -112.44 118.29 34.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.958 -0.756 . . . . 75.120000000000005 108.958 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' B' ' 25' ' ' LYS . 47.2 mm -96.92 118.99 44.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.518 -0.919 . . . . 75.409999999999997 108.518 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.34 157.99 45.49 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 109.43 -0.581 . . . . 64.549999999999997 109.43 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.558 ' HB3' ' H ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -67.2 -17.87 65.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.812 -0.631 . . . . 74.439999999999998 111.666 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.664 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.6 tmt_? -90.91 -17.31 26.65 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.309 -0.626 . . . . 73.109999999999999 109.309 -176.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -172.28 43.32 Favored Glycine 0 C--O 1.223 -0.567 0 C-N-CA 118.942 -1.599 . . . . 74.319999999999993 114.611 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -112.85 121.4 44.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.977 -1.49 . . . . 73.540000000000006 106.977 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' B' ' 12' ' ' VAL . 86.8 tttt -119.66 142.01 48.84 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.484 0.659 . . . . 72.109999999999999 111.231 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.13 140.68 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 107.607 -1.257 . . . . 70.540000000000006 107.607 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 34.1 t -138.54 136.56 36.18 Favored 'General case' 0 C--N 1.268 -2.948 0 N-CA-C 108.107 -1.072 . . . . 72.200000000000003 108.107 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.28 123.74 44.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.027 -0.669 . . . . 62.340000000000003 110.485 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -113.87 122.43 34.85 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.753 -1.203 . . . . 74.329999999999998 107.753 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.54 134.43 13.81 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.862 1.708 . . . . 72.239999999999995 112.944 -173.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 55.29 -167.1 0.1 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.662 -1.154 . . . . 74.319999999999993 112.841 174.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -169.9 -163.38 0.36 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 104.197 -2.519 . . . . 62.039999999999999 104.197 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 35.6 m -76.98 83.93 3.51 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.338 -0.945 . . . . 73.230000000000004 109.36 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 82.2 m95 59.74 84.34 0.12 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.917 1.287 . . . . 72.209999999999994 113.007 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -74.61 99.73 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 116.008 -0.542 . . . . 74.450000000000003 110.125 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -125.55 101.78 7.07 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.671 -0.695 . . . . 75.230000000000004 109.196 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -89.07 97.51 11.24 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.496 -0.775 . . . . 61.100000000000001 110.056 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 30.1 m -90.6 -15.24 8.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.824 0.821 . . . . 65.109999999999999 109.112 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.416 -2.159 0 CA-C-N 114.434 -1.257 . . . . 70.319999999999993 108.348 177.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.247 0.925 0 N-CA-C 110.233 -0.284 . . . . 74.010000000000005 110.233 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.38 143.72 16.76 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.441 -0.409 . . . . 72.439999999999998 112.134 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -88.67 -17.65 29.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.756 0.312 . . . . 72.209999999999994 111.795 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -70.48 -27.37 64.15 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.089 0.403 . . . . 72.409999999999997 112.089 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.8 7.8 9.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 112.146 0.424 . . . . 71.010000000000005 112.146 -176.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.8 m -72.6 120.56 18.39 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.016 0.436 . . . . 73.319999999999993 110.493 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -92.45 155.5 17.81 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.624 -0.716 . . . . 72.510000000000005 112.231 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 mttp 59.5 -101.45 0.12 Allowed 'General case' 0 C--O 1.242 0.663 0 C-N-CA 126.193 1.797 . . . . 71.430000000000007 115.784 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 121.05 0.96 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.22 -1.4 . . . . 72.040000000000006 107.22 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.421 ' HG1' HD12 ' B' ' 14' ' ' LEU . 19.2 p -91.1 144.0 26.1 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.028 -0.533 . . . . 74.109999999999999 112.378 -172.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -138.4 149.89 45.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.132 -0.692 . . . . 74.019999999999996 109.132 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.523 ' CG2' HD21 ' B' ' 14' ' ' LEU . 60.5 t -143.3 139.79 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 110.232 -0.285 . . . . 75.230000000000004 110.232 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 p -112.45 124.93 53.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.719 -0.475 . . . . 65.340000000000003 109.719 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.12 120.35 39.47 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.122 -0.49 . . . . 70.430000000000007 109.899 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' B' ' 3' ' ' SER . 11.9 p -105.54 118.07 35.62 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.045 -0.525 . . . . 64.049999999999997 109.686 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -161.12 116.15 2.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.367 -0.379 . . . . 73.519999999999996 111.743 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 43.45 78.06 0.06 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 125.22 1.408 . . . . 55.299999999999997 113.029 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.481 HH22 ' HB1' ' B' ' 49' ' ' ALA . 34.7 mmt-85 -125.91 149.61 48.58 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.503 0.668 . . . . 73.230000000000004 111.878 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.9 pt? -99.67 159.16 30.69 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 106.036 -1.839 . . . . 75.329999999999998 106.036 172.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.65 135.98 67.78 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.766 1.644 . . . . 62.240000000000002 111.133 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.58 149.18 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 74.400000000000006 108.19 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -85.54 -35.63 20.99 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.404 0.52 . . . . 71.099999999999994 112.404 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -131.11 147.73 52.65 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.217 -0.302 . . . . 61.43 110.665 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -86.63 124.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.678 -0.86 . . . . 73.25 108.678 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.25 150.44 25.13 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.361 0.601 . . . . 72.25 112.506 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 m -133.43 126.94 32.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.244 -1.391 . . . . 73.310000000000002 107.244 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -128.36 134.91 48.95 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-N 116.419 -0.355 . . . . 71.230000000000004 110.672 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.525 HG23 HG23 ' A' ' 37' ' ' VAL . 31.7 p -113.56 117.49 31.78 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.462 -0.79 . . . . 71.450000000000003 110.864 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.504 HD13 HD11 ' B' ' 38' ' ' ILE . 64.3 mt -110.49 123.02 66.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.295 -0.631 . . . . 64.310000000000002 109.295 177.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -116.3 115.89 26.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.135 -0.939 . . . . 73.129999999999995 109.127 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -129.55 107.01 9.13 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.186 -0.916 . . . . 55.509999999999998 109.748 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.68 -72.74 1.73 Allowed Glycine 0 C--N 1.303 -1.274 0 C-N-CA 121.121 -0.561 . . . . 51.009999999999998 111.95 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -154.91 4.63 0.22 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.172 0.804 . . . . 75.450000000000003 113.172 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.517 HD23 HD11 ' B' ' 40' ' ' ILE . 2.0 pt? -107.25 136.45 47.04 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 117.205 -1.798 . . . . 61.350000000000001 111.379 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -93.84 113.41 25.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.274 -0.875 . . . . 64.099999999999994 109.268 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.29 119.23 38.89 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.918 -0.771 . . . . 74.430000000000007 108.918 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 28' ' ' THR . 66.5 t -108.39 123.09 63.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 116.519 -0.309 . . . . 74.519999999999996 111.224 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.415 HD12 HD13 ' B' ' 29' ' ' ILE . 84.5 mt -102.06 116.2 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.511 -0.768 . . . . 71.129999999999995 109.163 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -102.6 116.94 33.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.817 -1.179 . . . . 74.109999999999999 107.817 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.426 HG23 HD23 ' B' ' 34' ' ' LEU . 40.6 mm -93.54 114.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 108.109 -1.071 . . . . 73.549999999999997 108.109 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -124.23 178.54 5.29 Favored 'General case' 0 N--CA 1.406 -2.649 0 C-N-CA 120.476 -0.489 . . . . 75.319999999999993 110.209 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -74.83 -41.58 59.63 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 113.968 1.099 . . . . 73.299999999999997 113.968 -171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -98.97 -10.73 22.32 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.765 -0.774 . . . . 74.450000000000003 110.045 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.22 -145.89 4.9 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 117.484 -2.293 . . . . 75.109999999999999 116.61 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.456 ' CD2' ' HB3' ' B' ' 49' ' ' ALA . 47.1 tp -130.36 141.45 50.57 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 125.26 1.424 . . . . 74.040000000000006 108.166 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.44 139.98 47.03 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.975 -0.69 . . . . 74.129999999999995 109.579 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 11.4 p -131.57 141.04 46.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 115.913 -0.585 . . . . 64.439999999999998 110.213 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.3 m -122.17 139.38 53.83 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.187 -0.461 . . . . 70.099999999999994 111.023 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.454 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.62 124.45 49.82 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 72.549999999999997 108.566 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -138.5 91.27 12.46 Favored Pre-proline 0 C--N 1.281 -2.402 0 CA-C-N 115.452 -0.794 . . . . 64.239999999999995 108.947 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.2 Cg_exo -80.83 141.45 13.45 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 122.829 2.353 . . . . 75.219999999999999 113.149 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 65.32 34.12 8.54 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 114.749 -1.114 . . . . 74.040000000000006 110.84 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.43 -171.35 0.77 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.604 -1.18 . . . . 64.120000000000005 112.152 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 p -69.3 106.36 2.87 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.887 -0.597 . . . . 75.120000000000005 112.356 -177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.453 ' CH2' ' HD3' ' A' ' 57' ' ' ARG . 46.3 t90 67.06 103.84 0.05 OUTLIER 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.756 1.223 . . . . 71.409999999999997 112.574 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.68 143.63 21.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.556 -0.747 . . . . 71.439999999999998 110.916 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' HD3' ' CH2' ' A' ' 55' ' ' TRP . 37.8 ptt180 -134.21 152.55 51.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.802 -1.185 . . . . 75.340000000000003 107.802 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -106.58 -13.76 15.22 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.695 -0.802 . . . . 75.450000000000003 112.044 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.02 104.15 7.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 120.38 -0.528 . . . . 74.530000000000001 109.958 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 115.611 -0.722 . . . . 75.439999999999998 109.936 -179.748 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.908 -0.404 . . . . 74.239999999999995 109.908 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.44 51.13 0.73 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 110.927 -0.869 . . . . 70.109999999999999 110.927 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 15' ' ' THR . 46.1 m -89.72 3.1 53.8 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.571 0.952 . . . . 63.130000000000003 113.571 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.63 -19.94 58.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.785 0.802 . . . . 74.209999999999994 109.96 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.12 4.52 10.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.191 -0.913 . . . . 54.329999999999998 110.272 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 36.8 m -92.58 104.29 16.6 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.307 0.575 . . . . 61.409999999999997 109.931 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.62 161.37 13.92 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.28 -0.873 . . . . 55.100000000000001 109.508 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.485 ' NZ ' ' HB2' ' B' ' 8' ' ' LYS . 8.7 mtmp? 78.77 158.16 0.17 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.057 1.132 . . . . 73.129999999999995 114.057 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 2.8 ptm180 -55.83 131.98 48.28 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.593 -1.64 . . . . 74.230000000000004 115.267 -176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 28.5 p -109.08 145.94 34.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.089 -1.078 . . . . 71.409999999999997 108.089 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 77.8 m -144.47 151.16 38.78 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.045 -0.724 . . . . 74.450000000000003 109.045 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 91.4 t -144.41 141.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 73.409999999999997 109.284 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -107.38 130.69 54.77 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.211 0.529 . . . . 74.219999999999999 109.8 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.523 HD21 ' CG2' ' A' ' 12' ' ' VAL . 95.3 mt -102.23 121.36 42.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.781 -0.645 . . . . 71.409999999999997 110.694 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -85.25 113.93 21.96 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.616 -1.253 . . . . 74.439999999999998 107.616 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -153.76 170.05 21.88 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.22 -0.592 . . . . 75.329999999999998 109.878 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -72.2 93.52 1.46 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.295 0.569 . . . . 73.340000000000003 110.826 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ARG . . . . . 0.463 ' HE ' HD22 ' A' ' 34' ' ' LEU . 1.5 tmt_? -126.08 132.31 51.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.181 -1.785 . . . . 73.439999999999998 106.181 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.04 155.67 90.16 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 112.653 0.612 . . . . 71.219999999999999 112.653 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.97 140.39 23.99 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.937 3.091 . . . . 72.129999999999995 114.648 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.404 ' HB ' ' NH1' ' B' ' 18' ' ' ARG . 12.4 p -131.81 149.14 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.303 -1.369 . . . . 74.510000000000005 107.303 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -89.37 -45.57 9.38 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.754 0.312 . . . . 74.310000000000002 111.776 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -117.81 141.68 48.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.319 -0.4 . . . . 75.5 110.844 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.047 -0.723 . . . . 63.5 109.047 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.525 0.678 . . . . 73.010000000000005 112.03 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 77.1 m -130.64 128.51 41.12 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.751 -1.203 . . . . 75.109999999999999 107.751 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.36 125.03 37.86 Favored 'General case' 0 CA--C 1.446 -3.039 0 N-CA-C 108.617 -0.882 . . . . 75.140000000000001 108.617 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 19.7 m -117.61 119.51 35.22 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 115.202 -0.908 . . . . 71.430000000000007 111.317 -176.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.415 HD13 HD12 ' A' ' 38' ' ' ILE . 52.4 mt -111.97 121.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 109.654 -0.499 . . . . 63.229999999999997 109.654 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -101.74 118.88 37.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.992 -1.484 . . . . 73.319999999999993 106.992 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.446 ' O ' HD21 ' B' ' 34' ' ' LEU . 14.1 tp10 -132.87 122.37 24.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.481 -0.781 . . . . 73.519999999999996 109.397 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.23 -96.13 0.16 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 111.096 -0.802 . . . . 72.150000000000006 111.096 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 18.0 m -138.12 10.93 2.82 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.906 0.384 . . . . 53.200000000000003 110.364 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.446 HD21 ' O ' ' B' ' 31' ' ' GLU . 2.1 pt? -118.3 141.38 48.58 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 120.57 -0.452 . . . . 75.310000000000002 109.827 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -112.48 134.31 54.08 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 115.894 -0.594 . . . . 74.109999999999999 112.216 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.97 53.14 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.088 -0.96 . . . . 75.030000000000001 109.272 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' B' ' 48' ' ' CYS . 76.1 t -114.17 127.12 71.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.019 -0.537 . . . . 74.299999999999997 110.151 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' B' ' 26' ' ' THR . 62.9 mt -110.62 129.52 65.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 115.826 -0.625 . . . . 74.319999999999993 110.599 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . 0.454 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.4 m-85 -109.48 116.92 32.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.824 -0.806 . . . . 72.109999999999999 108.824 176.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ILE . . . . . 0.517 HD11 HD23 ' A' ' 34' ' ' LEU . 49.1 mm -91.39 116.43 32.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.745 -0.662 . . . . 73.430000000000007 109.547 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.2 t -133.15 167.87 19.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.029 -0.73 . . . . 74.099999999999994 109.029 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.57 ' C ' ' HE3' ' B' ' 42' ' ' LYS 0.349 0.0 OUTLIER -86.37 2.42 47.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.639 0.978 . . . . 72.120000000000005 113.639 179.425 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -90.14 -13.26 36.05 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.036 -1.098 . . . . 74.549999999999997 108.036 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.07 -134.34 6.11 Favored Glycine 0 N--CA 1.424 -2.153 0 CA-C-N 115.245 -0.889 . . . . 73.099999999999994 112.059 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.454 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 60.1 tp -113.51 144.32 43.05 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 122.873 0.469 . . . . 74.25 109.833 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.409 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 83.3 tttt -129.37 136.12 49.59 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.618 -0.512 . . . . 60.109999999999999 109.618 168.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 p -120.42 140.69 43.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.094 -0.957 . . . . 63.0 110.512 -173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . 0.454 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 36.4 m -129.39 137.3 50.85 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.666 -0.697 . . . . 61.030000000000001 110.654 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . 0.481 ' HB1' HH22 ' A' ' 18' ' ' ARG . . . -117.8 124.02 47.39 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 107.803 -1.184 . . . . 71.420000000000002 107.803 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -121.82 110.88 33.04 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.946 -1.131 . . . . 64.319999999999993 107.946 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.16 132.62 11.62 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.408 1.405 . . . . 74.099999999999994 112.712 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 39.24 73.53 0.11 Allowed 'General case' 0 C--O 1.242 0.66 0 O-C-N 125.021 1.45 . . . . 72.5 113.582 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.46 -154.11 0.09 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.188 -0.914 . . . . 73.400000000000006 110.626 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.9 p -65.73 -161.6 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.746 0.819 . . . . 70.209999999999994 111.04 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 70.6 t90 -52.6 106.0 0.14 Allowed 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.36 0.6 . . . . 74.140000000000001 112.427 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 34.4 m -90.03 160.83 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 108.651 -0.87 . . . . 71.519999999999996 108.651 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.438 ' HE ' ' HA ' ' B' ' 60' ' ' VAL . 12.4 ptt180 -140.18 154.12 46.83 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.326 -0.549 . . . . 73.310000000000002 109.798 -175.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -83.29 -27.5 29.77 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.03 0.443 . . . . 72.420000000000002 110.695 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.73 98.62 7.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.769 -0.826 . . . . 63.030000000000001 108.769 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.438 ' HA ' ' HE ' ' B' ' 57' ' ' ARG . 3.8 p . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 115.888 -0.596 . . . . 72.040000000000006 112.394 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 108.446 -0.946 . . . . 74.24 108.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.4 ' HB ' HD13 ' B' ' 14' ' ' LEU . 24.4 m -109.59 144.04 38.45 Favored 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 119.531 -0.868 . . . . 71.15 109.494 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.69 149.32 43.4 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.43 -1.322 . . . . 74.51 107.43 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 12' ' ' VAL . 58.6 t -140.54 139.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 121.157 -0.217 . . . . 72.04 110.929 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -110.98 131.0 55.41 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 122.998 0.519 . . . . 73.03 109.64 172.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 14' ' ' LEU . 4.2 pp -119.88 136.27 54.56 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.261 -1.015 . . . . 60.54 108.261 174.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 m -107.57 120.78 43.15 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.069 -0.715 . . . . 75.44 109.069 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -131.71 -169.24 2.16 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.392 -0.367 . . . . 54.43 110.957 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -69.93 104.13 2.43 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.547 1.165 . . . . 73.51 108.043 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 18' ' ' ARG . 1.6 mmp_? -125.53 149.51 48.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 114.871 1.434 . . . . 61.14 114.871 -170.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.4 pp -101.84 148.26 35.05 Favored Pre-proline 0 N--CA 1.417 -2.093 0 CA-C-N 113.512 -1.677 . . . . 75.33 107.668 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.25 143.89 32.43 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.051 1.834 . . . . 75.31 112.496 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -131.36 140.0 49.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.984 -1.117 . . . . 74.12 107.984 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 p -58.66 -59.81 4.81 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.673 0.62 . . . . 64.11 112.673 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -115.98 166.92 11.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 112.148 0.425 . . . . 73.24 112.148 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mm -89.46 125.26 42.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.853 -0.612 . . . . 71.32 109.445 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 33.7 mmtm -89.57 145.46 25.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.88 -0.728 . . . . 71.1 109.68 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.6 m -120.86 126.96 51.39 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.101 -1.074 . . . . 61.5 108.101 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.429 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 67.8 m-85 -124.92 129.41 50.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.921 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 37' ' ' VAL . 66.3 p -114.14 130.57 56.59 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.659 -0.7 . . . . 63.52 111.929 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.717 HD12 HD12 ' B' ' 38' ' ' ILE . 76.1 mt -126.35 126.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.637 -0.711 . . . . 75.13 109.735 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -102.42 133.8 46.77 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.915 -0.772 . . . . 61.15 108.915 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HG2' HG13 ' B' ' 40' ' ' ILE . 11.9 tp10 -141.56 97.65 3.2 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.232 -0.44 . . . . 74.21 109.954 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.5 -85.33 0.26 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.501 -0.772 . . . . 75.32 111.769 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.3 p -137.54 14.83 2.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.867 0.841 . . . . 74.25 110.024 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' CD2' HD12 ' B' ' 40' ' ' ILE . 24.9 tp -106.67 132.49 52.6 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 115.387 -0.824 . . . . 62.45 110.844 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -108.84 115.88 30.92 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.36 -0.837 . . . . 61.42 110.339 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.06 120.08 40.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.631 -0.877 . . . . 64.51 108.631 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 28' ' ' THR . 87.5 t -114.79 126.04 72.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.286 0.565 . . . . 55.4 111.145 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.579 HD11 HD11 ' B' ' 38' ' ' ILE . 77.9 mt -106.16 122.91 60.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 124.259 1.024 . . . . 63.21 110.009 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 97.8 m-85 -107.8 118.11 35.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.254 -1.017 . . . . 74.21 108.254 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.546 HG13 ' HG2' ' B' ' 31' ' ' GLU . 45.2 mm -88.58 118.93 35.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.036 -0.727 . . . . 70.24 109.036 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.2 p -119.7 165.81 14.03 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.0 -0.546 . . . . 71.31 109.642 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.08 -17.91 63.25 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 122.859 0.463 . . . . 75.33 111.211 178.041 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -94.99 -23.79 17.22 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.123 0.487 . . . . 54.02 110.401 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.541 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 160.8 -139.8 6.29 Favored Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 118.497 -1.811 . . . . 74.21 114.988 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.1 tp -113.07 122.45 47.61 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.474 -0.863 . . . . 72.4 109.148 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 1.8 tmtm? -116.83 122.12 43.49 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.279 -2.119 . . . . 71.44 105.279 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.54 140.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 C-N-CA 120.745 -0.382 . . . . 65.02 110.661 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.461 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 59.3 m -122.94 141.43 51.93 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.259 -0.428 . . . . 62.24 110.983 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.42 124.85 51.04 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.825 -0.625 . . . . 65.51 110.421 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -123.31 91.98 49.33 Favored Pre-proline 0 C--N 1.298 -1.668 0 C-N-CA 124.264 1.026 . . . . 65.21 108.52 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -98.61 133.12 0.26 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.297 1.998 . . . . 72.25 114.15 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 . . . . . 0 C--O 1.243 0.729 0 CA-C-N 113.818 -1.537 . . . . 74.13 114.329 171.782 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' B' ' 9' ' ' ARG . 60.1 mtt180 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 108.36 -0.978 . . . . 75.34 108.36 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.9 m -110.29 141.86 42.7 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.975 -0.75 . . . . 63.14 108.975 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 79.6 m -127.82 148.98 50.47 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.037 -1.097 . . . . 73.24 108.037 173.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 12' ' ' VAL . 40.7 t -139.77 142.17 32.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.361 -0.607 . . . . 63.22 109.361 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.9 p -107.49 125.27 51.06 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.874 -1.158 . . . . 52.21 107.874 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' B' ' 45' ' ' LEU . 3.9 pp -112.91 144.02 43.19 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.036 0.446 . . . . 71.0 111.547 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -83.24 135.78 34.64 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.606 -0.724 . . . . 74.02 110.407 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p -156.44 153.49 28.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.833 0.853 . . . . 62.14 109.743 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -76.05 93.83 3.35 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.341 1.067 . . . . 75.04 109.398 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -123.24 148.34 45.97 Favored 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 114.937 -1.028 . . . . 62.32 113.369 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.81 153.81 72.96 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 114.044 -1.434 . . . . 61.31 109.343 172.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.04 149.94 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.504 2.136 . . . . 54.25 112.586 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.7 124.59 72.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 108.124 -1.065 . . . . 62.34 108.124 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.9 m -58.7 -47.08 85.79 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.169 0.588 . . . . 50.42 112.285 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -122.5 145.8 47.98 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.498 -0.556 . . . . 72.04 109.498 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.58 114.97 16.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.238 -1.023 . . . . 74.04 108.238 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -92.53 144.34 25.44 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.715 -0.675 . . . . 64.24 109.678 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 75.2 m -131.24 126.99 36.9 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.421 -0.955 . . . . 73.03 108.421 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 85.5 m-85 -122.95 131.48 53.74 Favored 'General case' 0 CA--C 1.465 -2.305 0 CA-C-N 115.716 -0.674 . . . . 72.25 110.733 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.614 HG22 HG22 ' B' ' 37' ' ' VAL . 23.1 p -115.35 131.22 57.0 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 124.254 0.971 . . . . 62.41 111.813 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 38' ' ' ILE . 49.2 mt -128.61 134.23 64.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 116.029 -0.532 . . . . 73.11 109.881 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -110.32 133.11 53.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.898 -0.778 . . . . 74.05 108.898 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.546 ' HG2' HG13 ' A' ' 40' ' ' ILE . 26.7 tp10 -142.4 102.02 4.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.216 0.531 . . . . 72.44 109.57 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.08 -78.02 1.29 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.521 -0.763 . . . . 43.23 111.412 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -157.74 33.64 0.26 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.324 -1.361 . . . . 72.23 107.324 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 40' ' ' ILE . 31.6 tp -120.61 125.26 47.29 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.449 -0.796 . . . . 64.32 110.307 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 32.7 mmt180 -99.75 115.18 28.92 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.746 0.654 . . . . 74.22 111.099 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 124.48 49.46 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.418 -0.956 . . . . 73.32 108.418 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.614 HG22 HG22 ' B' ' 28' ' ' THR . 67.8 t -120.47 135.01 62.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.16 0.505 . . . . 75.2 110.355 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.717 HD12 HD12 ' A' ' 29' ' ' ILE . 77.2 mt -118.79 122.36 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 CA-C-N 115.293 -0.867 . . . . 74.4 109.524 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.479 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.4 m-85 -107.77 115.78 30.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.063 -1.088 . . . . 73.2 108.063 176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.515 HG13 ' HG2' ' A' ' 31' ' ' GLU . 48.5 mm -88.61 114.85 27.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.27 -0.641 . . . . 72.24 109.27 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 76.7 p -122.43 162.31 21.89 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.156 -0.474 . . . . 75.13 110.294 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.503 ' N ' ' HD3' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -56.69 -25.58 54.53 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.768 0.827 . . . . 71.44 112.83 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -89.78 -16.13 30.9 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 111.893 0.331 . . . . 74.33 111.893 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.89 -134.59 4.41 Favored Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 118.88 -1.629 . . . . 72.03 113.314 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.507 ' HB3' HD11 ' B' ' 14' ' ' LEU . 58.9 tp -113.3 125.59 54.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.293 -0.632 . . . . 70.02 109.293 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 2.6 tmtm? -115.65 121.67 43.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.754 -1.943 . . . . 61.54 105.754 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 p -114.74 140.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 116.61 -0.268 . . . . 74.45 110.977 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 47.6 m -130.81 137.93 49.66 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 122.893 0.477 . . . . 74.13 111.53 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -117.68 125.26 50.37 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.058 -0.519 . . . . 33.43 110.5 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 32.6 t70 -120.99 83.91 38.35 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.347 -0.983 . . . . 64.53 108.347 174.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo . . . . . 0 N--CA 1.431 -2.196 0 C-N-CA 122.675 2.25 . . . . 45.03 114.485 -176.146 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 98.8 mtt180 . . . . . 0 CA--C 1.509 -0.627 0 CA-C-O 121.438 0.637 . . . . 72.1 110.425 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.2 p -86.11 117.86 25.21 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.359 -0.978 . . . . 63.02 108.359 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 56.7 m -121.48 149.33 43.22 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.672 -0.694 . . . . 70.3 109.385 -176.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG23 HD11 ' B' ' 14' ' ' LEU . 78.0 t -142.62 149.71 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 123.468 0.707 . . . . 71.1 109.383 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 p -106.58 125.72 51.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.978 0.418 . . . . 72.25 111.186 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.9 mm? -102.94 123.57 46.8 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.223 1.009 . . . . 75.35 110.16 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -107.63 112.26 24.89 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.54 -0.541 . . . . 72.44 109.54 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' B' ' 9' ' ' ARG . 7.1 t -151.54 95.68 2.16 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.156 0.503 . . . . 73.44 111.515 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.55 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 56.3 tp60 48.59 84.06 0.03 OUTLIER 'General case' 0 C--O 1.247 0.943 0 CA-C-N 114.774 -1.103 . . . . 74.52 111.752 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -124.73 145.7 49.56 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 114.115 1.154 . . . . 74.41 114.115 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.13 148.15 48.46 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 106.919 -1.511 . . . . 70.2 106.919 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 136.22 43.29 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.741 1.627 . . . . 73.33 113.595 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 23' ' ' ARG . 11.3 p -124.16 139.46 50.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 64.24 106.675 175.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 m -98.2 9.3 43.27 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.538 0.57 . . . . 72.14 112.538 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.42 ' H ' HG22 ' A' ' 21' ' ' VAL . 31.1 tpt180 -131.16 133.33 45.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.867 -0.79 . . . . 74.13 108.867 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -90.75 116.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.476 -0.935 . . . . 74.45 108.476 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.71 127.19 45.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.324 -0.551 . . . . 74.13 110.821 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.4 HG22 ' CD1' ' A' ' 39' ' ' PHE . 54.0 p -108.68 127.77 54.28 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 107.991 -1.114 . . . . 53.33 107.991 175.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -126.5 125.8 42.67 Favored 'General case' 0 CA--C 1.467 -2.22 0 CA-C-N 116.316 -0.402 . . . . 70.43 109.949 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.601 HG22 HG22 ' A' ' 37' ' ' VAL . 67.2 p -115.78 121.9 43.83 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.707 -0.679 . . . . 52.33 111.351 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.626 HD12 HD12 ' B' ' 38' ' ' ILE . 51.1 mt -117.79 123.08 71.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 116.207 -0.451 . . . . 72.41 110.193 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -105.83 129.06 54.08 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.349 -0.982 . . . . 54.2 108.349 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.01 111.7 6.68 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.302 -0.863 . . . . 65.04 109.498 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.21 -67.89 2.09 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.97 -0.559 . . . . 64.51 111.764 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 23.0 t -162.1 -21.05 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 122.027 0.131 . . . . 62.15 111.052 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 34' ' ' LEU . 2.3 pt? -89.34 141.71 28.3 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.661 -0.496 . . . . 61.04 109.661 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -117.86 118.6 32.46 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.764 -0.653 . . . . 72.43 109.262 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.33 133.72 48.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.005 -0.543 . . . . 75.54 109.602 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.601 HG22 HG22 ' A' ' 28' ' ' THR . 25.9 t -116.53 130.77 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.121 0.486 . . . . 74.32 110.435 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.537 HD12 HD12 ' B' ' 29' ' ' ILE . 74.2 mt -108.26 116.95 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 C-N-CA 124.583 1.153 . . . . 64.34 108.612 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.634 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 95.6 m-85 -105.78 116.06 31.29 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.177 -1.046 . . . . 72.15 108.177 175.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.542 HG23 HD21 ' B' ' 34' ' ' LEU . 44.9 mm -88.85 119.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 108.193 -1.04 . . . . 71.34 108.193 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -128.1 162.58 26.56 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.099 -0.501 . . . . 75.22 110.343 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -63.28 -18.21 63.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.214 0.605 . . . . 74.51 110.969 177.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -94.43 -9.28 36.1 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.541 0.686 . . . . 74.23 109.837 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.99 -134.37 7.39 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.593 -0.813 . . . . 72.14 113.119 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 56.1 tp -111.76 125.51 54.07 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.901 -0.407 . . . . 74.34 109.901 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.2 tptm -115.22 121.65 43.59 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.824 -1.546 . . . . 52.14 106.824 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.547 HG11 HG11 ' B' ' 47' ' ' VAL . 14.4 p -112.13 140.57 31.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 116.496 -0.32 . . . . 74.11 110.646 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -127.55 138.51 52.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.392 -0.367 . . . . 71.12 111.114 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.1 123.64 48.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.119 -0.491 . . . . 70.24 109.718 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 29.6 t70 -101.62 119.36 57.5 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.136 -0.69 . . . . 71.25 109.136 176.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HB3' ' HB3' ' B' ' 17' ' ' GLN . 93.0 Cg_exo -48.65 135.88 27.33 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.247 3.298 . . . . 75.43 114.536 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.9 mt-30 . . . . . 0 N--CA 1.443 -0.777 0 CA-C-N 115.114 -0.948 . . . . 74.4 110.456 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 87.1 mtt180 . . . . . 0 C--O 1.242 0.702 0 CA-C-O 121.13 0.491 . . . . 73.04 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.7 p -91.4 135.5 33.78 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.255 0.55 . . . . 73.15 110.672 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 55.5 m -131.04 149.79 52.45 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.119 -1.067 . . . . 74.21 108.119 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.444 HG23 HD11 ' A' ' 14' ' ' LEU . 76.1 t -144.29 145.55 21.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.546 -0.539 . . . . 64.42 109.546 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.6 p -106.88 135.08 49.04 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.12 0.486 . . . . 63.44 109.833 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 2.8 mm? -109.56 121.56 45.47 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.77 -0.65 . . . . 74.25 110.124 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 27.2 p -106.95 112.75 25.85 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.466 -0.939 . . . . 51.13 108.466 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' B' ' 18' ' ' ARG . 10.5 t -134.44 -167.56 1.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.844 -1.169 . . . . 72.32 107.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLN . . . . . 0.519 ' HB3' ' HB3' ' A' ' 51' ' ' PRO . 56.3 tp60 -62.51 88.08 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.731 0.777 . . . . 54.25 110.251 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' B' ' 16' ' ' THR . 5.5 ppt_? -126.77 150.15 49.27 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.242 0.83 . . . . 75.24 113.242 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.15 159.0 31.79 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 107.039 -1.467 . . . . 71.23 107.039 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.47 135.64 31.66 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.233 1.288 . . . . 73.3 111.624 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.479 HG22 ' H ' ' B' ' 23' ' ' ARG . 7.4 p -129.43 130.52 67.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.774 -0.824 . . . . 71.24 108.774 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -94.16 1.05 56.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.134 0.492 . . . . 53.34 112.128 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.479 ' H ' HG22 ' B' ' 21' ' ' VAL . 22.6 tpt180 -112.02 142.82 43.98 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.755 -0.461 . . . . 75.34 109.755 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.7 131.23 50.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.049 -1.093 . . . . 61.25 108.049 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 34.3 mmtp -124.97 143.58 50.81 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.163 -0.31 . . . . 72.14 110.163 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 41.4 p -126.37 127.98 46.33 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.107 -0.701 . . . . 74.53 109.107 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 80.1 m-85 -127.81 132.28 49.48 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 120.694 0.283 . . . . 72.43 111.118 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.533 HG22 HG22 ' B' ' 37' ' ' VAL . 36.6 p -115.09 125.31 53.35 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.357 -0.838 . . . . 63.34 112.405 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 38' ' ' ILE . 58.0 mt -127.75 125.3 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-O 120.809 0.338 . . . . 74.32 110.523 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -108.91 131.68 54.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.469 -0.937 . . . . 72.11 108.469 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.605 ' O ' HD23 ' B' ' 34' ' ' LEU . 11.6 tp10 -142.99 116.34 9.04 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.68 -0.691 . . . . 74.52 109.463 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.36 -59.78 2.81 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.669 -0.572 . . . . 32.22 111.669 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -174.13 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.563 0.745 . . . . 75.1 110.461 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.605 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -77.5 140.84 39.86 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.158 -0.682 . . . . 70.31 109.158 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -119.8 121.71 39.75 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.99 -0.55 . . . . 74.01 109.53 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.54 52.01 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.843 -0.617 . . . . 73.23 109.888 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.533 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -114.13 125.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.752 -0.658 . . . . 41.31 109.895 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.626 HD12 HD12 ' A' ' 29' ' ' ILE . 77.9 mt -101.63 119.06 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 C-N-CA 123.664 0.786 . . . . 72.35 109.297 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.402 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.2 m-85 -104.72 114.86 29.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.411 -0.813 . . . . 72.24 108.857 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.501 HG23 HD21 ' A' ' 34' ' ' LEU . 41.8 mm -89.49 115.24 28.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 106.408 -1.701 . . . . 75.45 106.408 176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.0 p -133.47 163.22 29.87 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.092 0.472 . . . . 62.25 111.949 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.557 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -57.06 -21.83 34.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.829 1.252 . . . . 75.01 111.413 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -88.22 -16.25 33.75 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.524 0.73 . . . . 70.13 109.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.43 -122.71 4.3 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 111.072 -0.811 . . . . 72.41 111.072 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.506 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 56.4 tp -112.19 144.98 40.67 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.653 -0.499 . . . . 71.25 109.653 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -141.41 141.72 33.73 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.479 -1.304 . . . . 74.23 107.479 168.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.547 HG11 HG11 ' A' ' 47' ' ' VAL . 11.8 p -131.51 140.7 47.66 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.029 0 N-CA-C 109.368 -0.604 . . . . 75.34 109.368 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.402 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.8 m -119.49 138.39 53.18 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.995 -0.548 . . . . 54.53 110.205 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.41 123.86 49.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.25 -0.648 . . . . 73.05 109.25 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' B' ' 9' ' ' ARG . 34.2 t70 -100.45 125.86 37.83 Favored Pre-proline 0 C--N 1.289 -2.036 0 CA-C-N 115.732 -0.667 . . . . 71.2 109.993 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.55 ' HB3' ' HB3' ' A' ' 17' ' ' GLN . 5.0 Cg_exo . . . . . 0 C--N 1.356 0.945 1 C-N-CA 125.671 4.248 . . . . 62.43 116.018 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 92.6 mtt180 . . . . . 0 CA--C 1.495 -1.135 0 CA-C-O 121.305 0.574 . . . . 70.23 111.443 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 p -99.45 134.36 42.43 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.834 -0.621 . . . . 72.22 109.576 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -130.09 148.94 51.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.488 -0.56 . . . . 73.34 109.488 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.9 139.14 22.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.365 0.416 . . . . 72.04 109.9 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 p -112.43 130.9 55.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.761 0.315 . . . . 73.23 110.75 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.421 HD11 HG23 ' B' ' 12' ' ' VAL . 1.7 mm? -101.73 122.32 43.71 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.921 -0.581 . . . . 74.03 109.951 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -101.66 113.72 27.13 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 113.838 1.051 . . . . 75.14 113.838 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.516 HG22 ' CZ ' ' A' ' 18' ' ' ARG . 14.6 t -155.91 165.79 35.42 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.661 -1.978 . . . . 75.44 105.661 166.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -86.08 90.33 8.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.811 1.291 . . . . 73.22 110.685 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.516 ' CZ ' HG22 ' A' ' 16' ' ' THR . 80.6 mtt85 -96.61 149.62 21.57 Favored 'General case' 0 N--CA 1.393 -3.282 0 N-CA-C 105.472 -2.048 . . . . 73.25 105.472 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 2.3 mm? -73.26 128.33 87.72 Favored Pre-proline 0 C--N 1.284 -2.243 0 C-N-CA 120.725 -0.39 . . . . 63.15 111.571 -171.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 72.9 Cg_exo -49.84 141.97 27.05 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 124.527 3.485 . . . . 70.45 115.394 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.17 135.17 58.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.332 -1.729 . . . . 73.21 106.332 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.7 m -59.12 -59.66 5.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.109 0.411 . . . . 64.52 112.109 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -97.56 146.11 25.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.523 -0.547 . . . . 63.3 109.523 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 41' ' ' THR . 52.1 mm -79.94 118.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.603 -0.888 . . . . 63.31 108.603 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.59 146.57 25.16 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.172 0.511 . . . . 62.04 111.626 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 39.2 p -126.0 127.64 46.21 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.917 -1.038 . . . . 72.14 108.977 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -124.24 130.46 52.57 Favored 'General case' 0 CA--C 1.468 -2.189 0 CA-C-N 116.197 -0.456 . . . . 70.32 110.782 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.529 HG22 HG22 ' A' ' 37' ' ' VAL . 61.8 p -114.86 128.67 56.43 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.177 -0.919 . . . . 73.1 111.103 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.67 HD12 HD12 ' B' ' 38' ' ' ILE . 58.2 mt -126.91 123.46 62.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 120.931 0.396 . . . . 65.05 110.492 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.7 t -106.15 121.81 44.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.453 -0.943 . . . . 74.03 108.453 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.19 106.92 4.86 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.36 0.6 . . . . 63.01 111.279 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.05 -66.8 2.14 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.857 -0.61 . . . . 72.34 112.931 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -154.11 12.88 0.43 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.483 0.549 . . . . 73.33 112.483 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.516 HD21 HD12 ' B' ' 40' ' ' ILE . 1.6 pt? -128.58 141.56 51.33 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 118.062 -1.455 . . . . 71.05 111.877 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.014 -1.476 . . . . 72.53 107.014 167.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.47 129.4 52.47 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.323 -0.621 . . . . 73.21 109.323 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 28' ' ' THR . 58.9 t -118.17 126.86 75.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.083 0.468 . . . . 70.53 110.912 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.576 HD12 HD12 ' B' ' 29' ' ' ILE . 69.6 mt -105.78 122.24 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.206 -0.906 . . . . 64.3 109.607 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.489 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.1 m-85 -103.36 114.89 29.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.885 -0.783 . . . . 74.11 108.885 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.71 HG23 HD21 ' B' ' 34' ' ' LEU . 40.6 mm -91.98 114.5 29.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.572 -0.899 . . . . 73.32 108.572 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.438 HG22 HD12 ' A' ' 24' ' ' ILE . 70.4 p -130.74 170.61 14.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.283 -0.636 . . . . 64.53 109.283 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -83.49 -4.73 58.79 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.876 -0.787 . . . . 73.14 108.876 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 3.1 tmt_? -98.64 6.11 47.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 106.949 -1.5 . . . . 71.05 106.949 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.35 -143.67 18.07 Favored Glycine 0 N--CA 1.423 -2.232 0 CA-C-N 114.228 -1.351 . . . . 52.31 113.148 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.631 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 55.0 tp -112.34 136.7 51.48 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.599 -0.519 . . . . 74.21 109.599 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 82.8 tttt -128.2 140.71 51.76 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.059 -0.719 . . . . 70.12 109.059 170.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.693 HG11 HG11 ' B' ' 47' ' ' VAL . 9.6 p -128.72 141.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 115.58 -0.736 . . . . 74.03 109.996 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.489 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 60.5 m -128.45 137.52 51.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.313 -0.403 . . . . 52.03 110.705 174.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.831 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.45 121.73 42.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.411 -0.589 . . . . 61.42 109.411 175.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -119.3 101.94 48.81 Favored Pre-proline 0 C--N 1.284 -2.242 0 C-N-CA 123.837 0.855 . . . . 75.01 109.718 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.07 133.44 13.58 Favored 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 120.839 1.026 . . . . 64.12 110.562 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 CA--C 1.546 0.806 0 O-C-N 124.261 0.976 . . . . 64.14 112.988 177.396 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 92.4 mtt180 . . . . . 0 N--CA 1.403 -2.788 0 N-CA-C 108.19 -1.041 . . . . 74.15 108.19 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 m -108.49 127.07 53.6 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.507 -1.294 . . . . 74.32 107.507 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 61.9 m -121.66 148.97 43.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.947 -1.131 . . . . 64.12 107.947 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.421 HG23 HD11 ' A' ' 14' ' ' LEU . 92.8 t -144.45 146.77 20.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.681 -0.489 . . . . 43.4 109.681 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.505 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 35.3 p -106.16 135.84 46.91 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.91 -1.145 . . . . 74.43 107.91 174.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 3.2 mm? -100.2 122.56 43.22 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.497 -0.557 . . . . 74.42 109.497 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -84.62 112.56 20.56 Favored 'General case' 0 N--CA 1.397 -3.075 0 CA-C-N 115.441 -0.799 . . . . 61.4 109.803 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -154.65 177.79 10.83 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.191 -1.411 . . . . 75.53 107.191 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -108.2 108.55 19.63 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.44 0.638 . . . . 75.23 109.379 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.419 HH22 HG21 ' B' ' 21' ' ' VAL . 19.2 mtm105 -124.62 150.33 46.11 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.368 -0.833 . . . . 74.15 110.19 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.45 HD22 ' H ' ' B' ' 19' ' ' LEU . 2.1 mm? -74.93 145.32 81.03 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 114.857 -1.065 . . . . 73.22 108.86 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.75 135.67 63.17 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 123.02 2.48 . . . . 72.23 112.806 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.419 HG21 HH22 ' B' ' 18' ' ' ARG . 61.3 t -103.72 131.2 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.658 -1.238 . . . . 72.31 107.658 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.9 m -56.29 -46.33 79.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 113.798 1.036 . . . . 61.41 113.798 -174.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' B' ' 23' ' ' ARG . 0.4 OUTLIER -127.22 155.45 43.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.783 -0.821 . . . . 71.35 108.783 -175.441 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.3 131.53 33.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.947 0.403 . . . . 55.42 109.968 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' B' ' 27' ' ' TYR . 1.5 mptm? -116.72 143.5 45.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 112.322 0.49 . . . . 61.14 112.322 177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -125.85 127.12 45.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.444 -1.317 . . . . 70.22 107.444 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' B' ' 25' ' ' LYS . 75.9 m-85 -124.65 126.85 46.41 Favored 'General case' 0 CA--C 1.45 -2.899 0 CA-C-N 116.244 -0.435 . . . . 75.23 110.566 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.606 HG22 HG22 ' B' ' 37' ' ' VAL . 81.5 p -114.01 135.47 53.97 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 115.073 -0.967 . . . . 72.32 109.507 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.576 HD12 HD12 ' A' ' 38' ' ' ILE . 60.6 mt -127.97 121.65 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 116.114 -0.494 . . . . 63.2 110.772 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.516 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 6.2 t -100.96 117.46 35.05 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.589 -0.732 . . . . 54.42 109.1 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.517 ' O ' HD23 ' B' ' 34' ' ' LEU . 10.4 tp10 -140.39 110.29 6.47 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.553 -0.749 . . . . 63.22 110.286 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 -84.7 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.593 -0.73 . . . . 73.33 114.341 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 47.8 m -137.19 12.73 3.06 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 112.982 0.734 . . . . 52.54 112.982 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.71 HD21 HG23 ' A' ' 40' ' ' ILE . 2.2 pt? -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.753 -0.779 . . . . 72.42 112.107 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.516 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 18.6 mmm180 -103.67 113.52 27.1 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.1 -1.444 . . . . 72.35 107.1 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.37 131.64 52.55 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 110.023 -0.362 . . . . 74.22 110.023 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.606 HG22 HG22 ' B' ' 28' ' ' THR . 59.8 t -122.61 124.84 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-O 120.836 0.351 . . . . 74.33 111.031 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.67 HD12 HD12 ' A' ' 29' ' ' ILE . 94.1 mt -104.53 122.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.651 -0.87 . . . . 64.22 108.651 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.1 m-85 -104.24 121.04 42.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.233 -1.395 . . . . 74.43 107.233 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.516 HD12 HD21 ' A' ' 34' ' ' LEU . 50.6 mm -89.48 114.68 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.653 0 CA-C-O 122.398 1.094 . . . . 71.12 110.014 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -127.04 149.47 49.9 Favored 'General case' 1 N--CA 1.369 -4.492 0 CA-C-N 112.503 -2.135 . . . . 74.2 106.475 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' B' ' 42' ' ' LYS . 17.5 ptmt -71.74 -18.93 62.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 118.62 0.645 . . . . 54.2 112.666 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 0.1 OUTLIER -86.89 6.14 33.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.165 0.984 . . . . 72.12 109.056 -172.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.94 -129.33 4.05 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.469 -0.872 . . . . 44.54 112.738 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.492 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 64.6 tp -125.64 144.55 50.54 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.584 0.754 . . . . 64.25 109.003 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.4 tptm -134.75 122.9 22.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.167 -1.42 . . . . 72.53 107.167 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.693 HG11 HG11 ' A' ' 47' ' ' VAL . 10.2 p -127.23 141.42 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 120.883 -0.327 . . . . 75.3 110.956 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 56.5 m -123.71 137.02 54.78 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.144 -0.48 . . . . 64.44 111.012 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.64 122.9 44.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.912 -0.586 . . . . 64.42 110.971 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -132.33 118.4 16.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 123.688 0.795 . . . . 74.34 109.324 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 48.3 Cg_endo . . . . . 0 N--CA 1.431 -2.153 0 C-N-CA 121.127 1.218 . . . . 71.43 112.352 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 . . . . . 0 CA--C 1.493 -1.231 0 N-CA-C 107.325 -1.361 . . . . 72.41 107.325 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.427 ' HB ' HD13 ' B' ' 14' ' ' LEU . 28.3 m -108.8 140.2 42.57 Favored 'General case' 0 N--CA 1.403 -2.801 0 C-N-CA 119.101 -1.04 . . . . 55.42 109.597 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.94 149.56 50.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.69 -1.226 . . . . 75.52 107.69 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.5 t -140.69 135.72 34.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 110.068 -0.345 . . . . 62.23 110.068 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.471 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 30.2 p -107.45 135.9 48.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.58 -0.526 . . . . 74.32 109.58 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 4.2 pp -130.66 127.95 39.95 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.057 0.456 . . . . 72.0 110.595 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 t -110.03 119.51 39.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 55.42 110.193 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -159.56 114.67 2.42 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.677 -0.692 . . . . 74.34 109.856 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HG3' ' HB2' ' B' ' 51' ' ' PRO . 12.0 pt20 35.85 81.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.848 1.659 . . . . 62.33 114.446 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -125.56 149.59 48.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.591 0.96 . . . . 71.12 113.591 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 19' ' ' LEU . 3.2 mp -111.26 155.54 42.54 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 107.692 -1.225 . . . . 62.35 107.692 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.26 142.83 94.76 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.724 2.283 . . . . 75.15 111.089 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.07 146.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.442 -0.947 . . . . 72.23 108.442 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.9 m -71.13 -39.9 71.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.738 0.644 . . . . 74.53 112.738 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 29.2 tpt180 -134.46 138.91 45.13 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.778 -0.576 . . . . 72.43 110.154 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.84 115.32 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 107.624 -1.25 . . . . 72.41 107.624 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.2 mmtp -101.29 132.16 46.97 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.387 -0.525 . . . . 72.52 111.388 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 p -113.05 126.65 55.72 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 106.671 -1.603 . . . . 63.32 106.671 173.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 69.7 m-85 -121.57 129.9 53.17 Favored 'General case' 0 CA--C 1.458 -2.572 0 CA-C-N 116.575 -0.284 . . . . 75.41 110.693 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.558 HG22 HG22 ' A' ' 37' ' ' VAL . 61.7 p -114.54 127.65 55.91 Favored 'General case' 0 C--N 1.286 -2.161 0 O-C-N 123.86 0.725 . . . . 75.24 111.171 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.651 HD12 HD12 ' B' ' 38' ' ' ILE . 62.7 mt -127.79 121.73 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.262 -0.644 . . . . 73.44 109.262 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -106.34 126.34 52.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.326 -0.99 . . . . 74.33 108.326 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.0 tp10 -142.34 99.97 3.61 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.183 -0.462 . . . . 74.11 111.869 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 -66.36 1.37 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 114.908 0.723 . . . . 44.31 114.908 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.4 m -139.29 -8.15 1.32 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.314 -0.521 . . . . 74.1 112.399 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.511 HD21 HD12 ' B' ' 40' ' ' ILE . 2.3 pt? -130.27 140.35 50.69 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 119.043 -1.063 . . . . 63.14 111.769 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 3.1 mpt_? -99.54 119.58 38.26 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.449 -1.315 . . . . 74.21 107.449 169.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.16 127.11 51.73 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.489 -0.56 . . . . 75.1 109.489 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 44.7 t -117.19 128.51 74.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.336 -0.393 . . . . 73.54 110.425 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.695 HD12 HD12 ' B' ' 29' ' ' ILE . 96.6 mt -108.59 121.29 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 N-CA-C 108.274 -1.01 . . . . 72.53 108.274 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 93.2 m-85 -104.88 114.63 28.95 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.197 -1.038 . . . . 74.33 108.197 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.539 HD12 HD21 ' B' ' 34' ' ' LEU . 48.4 mm -90.79 113.39 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.063 -1.088 . . . . 74.21 108.063 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -125.65 177.75 6.06 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.181 -1.044 . . . . 72.41 108.181 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -81.4 -32.67 32.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.956 1.095 . . . . 62.35 113.956 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -86.65 -20.1 28.31 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.829 -0.749 . . . . 72.25 110.863 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.73 -162.65 29.38 Favored Glycine 0 C--N 1.294 -1.779 0 C-N-CA 119.171 -1.49 . . . . 61.55 114.134 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 14' ' ' LEU . 2.0 tm? -113.69 122.88 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.475 -0.935 . . . . 70.41 108.475 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.0 tptm -115.76 122.43 45.44 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.408 -0.96 . . . . 72.33 108.408 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.601 HG11 HG11 ' B' ' 47' ' ' VAL . 13.8 p -119.23 140.53 42.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.868 -0.419 . . . . 64.23 109.868 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -125.71 139.79 53.24 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.969 -0.56 . . . . 63.25 111.332 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.446 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -117.0 123.68 47.5 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 108.429 -0.952 . . . . 54.54 108.429 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 18.1 t70 -113.72 87.44 12.19 Favored Pre-proline 0 C--N 1.282 -2.362 0 N-CA-C 108.197 -1.038 . . . . 71.53 108.197 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.3 Cg_endo -87.79 133.28 3.02 Favored 'Trans proline' 0 N--CA 1.417 -3.023 0 C-N-CA 121.57 1.513 . . . . 75.04 111.354 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 114.09 -1.414 . . . . 74.44 113.37 174.435 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 . . . . . 0 N--CA 1.42 -1.964 0 N-CA-C 107.938 -1.134 . . . . 73.44 107.938 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.48 ' HB ' HD13 ' A' ' 14' ' ' LEU . 25.1 m -109.64 128.59 55.34 Favored 'General case' 0 N--CA 1.393 -3.298 0 N-CA-C 107.564 -1.273 . . . . 74.22 107.564 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.439 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 34.8 m -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.572 -2.011 . . . . 62.12 105.572 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 141.71 28.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.71 0.291 . . . . 63.23 110.885 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.5 p -108.7 126.68 53.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.236 -0.438 . . . . 75.32 110.881 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' B' ' 45' ' ' LEU . 4.3 pp -125.23 137.52 54.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.984 -0.747 . . . . 63.13 108.984 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -120.19 125.99 49.55 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 109.06 -0.719 . . . . 74.13 109.06 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -161.85 115.6 1.87 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.277 -0.42 . . . . 55.4 111.202 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 34.29 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 126.276 1.83 . . . . 65.12 114.849 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.432 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 53.2 mmm-85 -127.51 146.73 50.41 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 114.008 1.114 . . . . 54.52 114.008 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.88 153.96 47.53 Favored Pre-proline 0 C--O 1.25 1.126 0 N-CA-C 106.501 -1.666 . . . . 73.13 106.501 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.78 135.55 38.77 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.705 1.603 . . . . 54.42 112.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.548 HG12 ' H ' ' B' ' 23' ' ' ARG . 91.4 t -131.39 131.85 62.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.858 -1.164 . . . . 64.12 107.858 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 m -98.18 3.24 49.01 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 111.959 0.355 . . . . 74.41 111.959 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.548 ' H ' HG12 ' B' ' 21' ' ' VAL . 6.9 mpt_? -117.22 139.38 50.86 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.666 -0.243 . . . . 53.33 110.553 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.05 115.44 41.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.996 -1.483 . . . . 62.13 106.996 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.485 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 34.7 mmtp -103.92 141.44 36.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.632 -0.427 . . . . 71.22 110.41 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.408 HG22 ' CD2' ' B' ' 39' ' ' PHE . 51.3 p -121.89 127.07 50.04 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.79 -0.819 . . . . 75.14 108.79 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -123.62 129.58 51.36 Favored 'General case' 0 CA--C 1.467 -2.229 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.391 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.544 HG22 HG22 ' B' ' 37' ' ' VAL . 72.6 p -115.47 130.53 56.91 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.824 -0.625 . . . . 72.23 112.268 -174.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 38' ' ' ILE . 80.2 mt -136.85 127.44 40.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.303 -0.628 . . . . 43.11 109.303 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.422 ' HB ' ' HD3' ' B' ' 35' ' ' ARG . 12.4 t -119.39 135.73 54.6 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.155 -1.054 . . . . 72.41 108.155 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.596 ' O ' HD23 ' B' ' 34' ' ' LEU . 12.5 tp10 -142.44 112.23 6.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.614 -0.434 . . . . 72.44 111.424 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.46 -67.05 1.92 Allowed Glycine 0 C--N 1.311 -0.836 0 CA-C-N 116.156 -0.475 . . . . 52.44 112.54 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 9.6 m -140.79 -35.93 0.47 Allowed 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 120.683 0.278 . . . . 14.11 110.582 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.596 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.6 pt? -84.29 141.21 31.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.707 0.632 . . . . 63.25 112.707 -171.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 22.8 tpp180 -101.93 113.77 27.27 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.382 -1.34 . . . . 73.42 107.382 171.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.2 133.12 52.9 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.13 -0.356 . . . . 65.42 110.109 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.544 HG22 HG22 ' B' ' 28' ' ' THR . 58.3 t -126.83 130.78 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.172 0.51 . . . . 63.44 109.974 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.651 HD12 HD12 ' A' ' 29' ' ' ILE . 92.2 mt -106.08 126.24 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 N-CA-C 108.332 -0.988 . . . . 72.11 108.332 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 87.0 m-85 -109.1 114.33 27.97 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.508 -1.293 . . . . 61.32 107.508 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.511 HD12 HD21 ' A' ' 34' ' ' LEU . 51.4 mm -92.09 113.97 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 109.037 -0.727 . . . . 61.14 109.037 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -120.28 177.42 5.03 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.532 -1.284 . . . . 71.42 107.532 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.447 ' HB3' ' H ' ' B' ' 21' ' ' VAL . 17.2 ptmt -91.66 -12.92 32.78 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.145 -0.687 . . . . 72.44 109.145 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -86.51 1.62 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.145 0.974 . . . . 74.42 109.826 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.54 -146.56 18.56 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 114.885 -1.052 . . . . 43.34 113.357 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.45 ' HB3' ' CD1' ' B' ' 14' ' ' LEU . 2.1 tm? -122.26 124.14 43.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.708 0.803 . . . . 71.32 109.448 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 53.7 tptt -115.42 121.65 43.41 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.594 -1.262 . . . . 71.31 107.594 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.601 HG11 HG11 ' A' ' 47' ' ' VAL . 13.9 p -111.58 140.81 29.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.279 -1.008 . . . . 42.32 108.279 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.439 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 15.9 t -139.11 136.72 35.47 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 119.336 -0.946 . . . . 73.42 108.541 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.21 125.79 35.79 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 120.978 0.418 . . . . 45.32 111.523 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 26.8 t70 -109.5 97.6 28.04 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 108.016 -1.105 . . . . 60.23 108.016 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.503 ' HB2' ' HG3' ' A' ' 17' ' ' GLN . 12.6 Cg_exo . . . . . 0 N--CA 1.431 -2.182 0 C-N-CA 122.279 1.986 . . . . 64.55 112.378 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 . . . . . 0 N--CA 1.425 -1.694 0 CA-C-O 121.465 0.65 . . . . 72.1 110.968 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -92.5 140.99 29.0 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 115.593 -0.731 . . . . 54.14 109.524 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.6 m -142.17 148.87 38.95 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.471 -0.566 . . . . 65.52 109.471 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.489 HG23 HD21 ' B' ' 14' ' ' LEU . 69.4 t -144.75 145.72 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.274 0.629 . . . . 71.51 109.696 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 p -109.16 136.14 49.12 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 122.835 0.454 . . . . 63.42 110.505 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.427 HD21 ' CG2' ' B' ' 12' ' ' VAL . 95.2 mt -119.62 121.93 40.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.365 0.602 . . . . 70.41 111.617 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 p -95.17 114.03 25.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.1 -0.955 . . . . 70.21 109.698 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 t -139.12 -170.55 2.9 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.89 -1.522 . . . . 74.24 106.89 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -76.86 91.48 3.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.058 0.933 . . . . 63.13 111.362 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -126.15 141.83 51.77 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.867 -1.06 . . . . 43.2 109.57 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.4 mm? -82.45 146.34 53.66 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.534 -0.757 . . . . 54.31 109.031 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 20.7 Cg_exo -64.66 134.87 42.73 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.8 1.666 . . . . 73.52 112.209 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 23' ' ' ARG . 43.7 t -131.74 143.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 114.428 -1.26 . . . . 70.0 108.179 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 m -90.56 -22.35 21.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.204 0.446 . . . . 73.31 112.204 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' H ' HG12 ' A' ' 21' ' ' VAL . 28.9 mmm180 -105.88 133.45 50.59 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.472 -0.331 . . . . 71.21 110.68 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.87 116.41 31.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.789 -0.819 . . . . 71.24 108.789 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -91.98 133.6 35.56 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 120.313 -0.555 . . . . 73.32 110.928 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.4 p -118.0 127.36 53.74 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.396 -0.82 . . . . 65.41 110.426 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 67.9 m-85 -121.5 130.77 53.76 Favored 'General case' 0 CA--C 1.477 -1.845 0 CA-C-N 115.837 -0.62 . . . . 75.21 111.029 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 37' ' ' VAL . 57.4 p -114.56 131.58 56.62 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.382 -0.826 . . . . 73.1 111.286 -175.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 38' ' ' ILE . 40.1 mt -125.23 130.4 73.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 116.432 -0.349 . . . . 73.02 110.695 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -109.96 115.76 30.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 122.21 1.005 . . . . 54.32 110.269 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.3 tp10 -143.13 123.06 13.51 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.197 -0.91 . . . . 65.45 108.926 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 52.31 32.11 36.3 Favored Glycine 0 C--O 1.218 -0.849 0 O-C-N 123.219 0.325 . . . . 73.12 113.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.2 t 84.55 -10.19 0.87 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.475 1.11 . . . . 75.43 113.37 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.6 pt? -89.36 140.22 29.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 117.07 -1.852 . . . . 65.12 109.239 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.73 118.32 36.43 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.309 -1.367 . . . . 72.35 107.309 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.99 129.54 51.59 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.51 -0.552 . . . . 71.15 109.51 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 61.9 t -118.91 122.24 68.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.186 0.517 . . . . 73.3 110.427 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.659 HD12 HD12 ' B' ' 29' ' ' ILE . 87.0 mt -103.54 123.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 C-N-CA 124.093 0.957 . . . . 52.42 109.075 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.5 114.52 28.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.423 -0.584 . . . . 64.12 109.423 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 47.2 mm -92.52 114.32 29.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.971 -1.863 . . . . 74.34 105.971 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.441 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 9.5 t -129.06 173.74 10.18 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.587 -0.445 . . . . 65.12 111.28 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -70.5 -25.22 63.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.624 . . . . 65.51 109.96 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -92.02 -4.39 54.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 73.51 110.675 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.29 -125.43 3.51 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 119.411 -1.376 . . . . 42.32 114.149 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 2.1 tm? -126.19 126.81 44.69 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 123.772 0.829 . . . . 74.41 110.06 -176.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -122.93 141.08 52.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.612 -0.514 . . . . 71.03 109.612 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.415 HG11 HG11 ' B' ' 47' ' ' VAL . 13.4 p -123.33 140.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 CA-C-N 115.739 -0.664 . . . . 70.12 110.52 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -129.76 137.72 50.69 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.558 -0.746 . . . . 72.12 110.664 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.41 123.01 46.49 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.935 -1.505 . . . . 54.2 106.935 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -117.02 101.98 53.09 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 105.684 -1.969 . . . . 70.34 105.684 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.47 132.07 17.09 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.238 1.292 . . . . 74.13 111.932 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 . . . . . 0 CA--C 1.54 0.573 0 O-C-N 124.214 0.946 . . . . 65.22 110.371 175.903 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptm180 . . . . . 0 N--CA 1.418 -2.053 0 CA-C-O 121.598 0.714 . . . . 72.22 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.2 p -87.1 142.66 27.76 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.56 -0.745 . . . . 42.52 110.741 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 62.8 m -135.04 149.79 50.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.38 -0.6 . . . . 55.25 109.38 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.427 ' CG2' HD21 ' A' ' 14' ' ' LEU . 99.2 t -139.42 139.62 38.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.16 -0.473 . . . . 71.21 110.419 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.6 p -107.92 125.68 51.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.051 -0.722 . . . . 71.41 109.051 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.489 HD21 HG23 ' A' ' 12' ' ' VAL . 96.8 mt -113.6 124.3 52.01 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 122.819 0.448 . . . . 74.24 111.78 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 24.9 p -85.16 113.63 21.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.493 -0.776 . . . . 62.11 109.244 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.1 t -139.33 178.4 7.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.483 -0.932 . . . . 74.01 108.483 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -71.04 88.76 0.78 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.161 0.981 . . . . 72.11 110.431 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.442 ' NH2' ' HB2' ' B' ' 19' ' ' LEU . 6.9 tpm_? -126.91 129.5 48.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.64 -1.164 . . . . 70.13 110.173 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.445 HD22 ' H ' ' B' ' 19' ' ' LEU . 1.7 mm? -74.49 146.21 83.44 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.373 -1.343 . . . . 74.0 107.373 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.2 135.04 52.25 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 122.517 2.144 . . . . 61.22 113.881 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.29 127.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.523 -1.658 . . . . 74.11 106.523 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -88.9 -36.74 15.77 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.587 -0.445 . . . . 74.24 111.409 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -112.96 134.15 54.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.304 . . . . 71.23 111.353 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.86 123.86 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.96 -0.564 . . . . 75.01 111.625 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 0.6 OUTLIER -90.51 132.84 35.45 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.577 -0.449 . . . . 62.23 110.161 173.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 39.1 p -106.66 128.31 54.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.286 -0.87 . . . . 74.5 109.753 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 54.3 m-85 -128.16 126.83 41.83 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 116.052 -0.522 . . . . 73.55 110.752 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.498 HG22 HG22 ' B' ' 37' ' ' VAL . 77.8 p -114.85 131.19 56.92 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.947 -0.57 . . . . 53.54 112.069 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.659 HD12 HD12 ' A' ' 38' ' ' ILE . 59.7 mt -136.52 122.21 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.322 -0.992 . . . . 71.41 108.322 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.3 121.63 40.04 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.786 -0.766 . . . . 75.01 109.41 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.598 ' O ' HD23 ' B' ' 34' ' ' LEU . 11.7 tp10 -119.7 113.8 21.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.428 -0.806 . . . . 75.23 110.546 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.26 -75.48 1.35 Allowed Glycine 0 C--N 1.298 -1.568 0 C-N-CA 121.174 -0.536 . . . . 71.24 112.125 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 13.7 t -153.56 6.99 0.36 Allowed 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 120.797 0.332 . . . . 71.32 111.403 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.598 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -114.75 140.03 49.22 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 118.522 -1.271 . . . . 54.24 109.712 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -98.06 131.03 44.82 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.022 -0.732 . . . . 74.32 109.022 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.37 114.83 23.53 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.353 -0.98 . . . . 74.43 108.353 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.498 HG22 HG22 ' B' ' 28' ' ' THR . 51.6 t -111.52 125.7 68.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.103 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 29' ' ' ILE . 81.6 mt -101.59 130.7 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.663 0 C-N-CA 124.017 0.927 . . . . 60.3 109.573 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.39 114.66 26.16 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.057 -1.09 . . . . 74.03 108.057 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' B' ' 25' ' ' LYS . 50.2 mm -88.64 117.73 32.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.697 -1.223 . . . . 73.41 107.697 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.7 t -132.04 169.32 16.51 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.402 0.439 . . . . 73.0 110.465 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.454 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -70.53 -18.52 62.93 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.031 0.443 . . . . 72.01 110.837 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -86.71 -16.48 36.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 70.13 109.11 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.6 -124.93 2.5 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.268 -0.967 . . . . 62.43 113.223 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.95 124.25 42.18 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.929 -0.636 . . . . 60.13 110.737 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -121.29 140.69 51.74 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.885 0.374 . . . . 64.51 110.11 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.415 HG11 HG11 ' A' ' 47' ' ' VAL . 13.1 p -131.77 141.37 45.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.806 -0.633 . . . . 74.52 110.011 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 65.2 m -123.75 136.65 54.56 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 123.242 0.339 . . . . 75.15 110.531 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.58 123.76 47.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.585 -0.524 . . . . 41.34 109.585 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.93 105.6 37.51 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.791 -0.818 . . . . 74.51 108.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.432 -2.139 0 C-N-CA 121.349 1.366 . . . . 74.12 115.406 -175.937 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 . . . . . 0 N--CA 1.411 -2.403 0 N-CA-C 105.496 -2.039 . . . . 74.45 105.496 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 p -86.26 117.16 24.9 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.803 -0.759 . . . . 72.03 109.695 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.6 m -123.94 148.94 46.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.934 -0.575 . . . . 63.44 109.495 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG23 HD11 ' B' ' 14' ' ' LEU . 89.6 t -145.45 142.41 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.825 0.45 . . . . 72.51 110.242 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -111.35 138.37 47.93 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 122.65 0.38 . . . . 72.43 110.871 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.438 HD11 ' CG2' ' B' ' 12' ' ' VAL . 3.5 mm? -114.42 140.54 48.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 112.331 0.493 . . . . 70.21 112.331 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.312 -0.858 . . . . 74.02 109.506 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -134.49 -177.7 4.72 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.578 -1.268 . . . . 73.34 107.578 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -76.31 96.79 4.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.337 1.065 . . . . 74.44 109.32 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -125.85 140.02 53.0 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.108 -0.951 . . . . 75.34 111.63 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' B' ' 33' ' ' SER . 4.8 mp -82.55 136.5 45.42 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.284 -1.006 . . . . 64.34 108.284 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.17 137.53 40.8 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 122.48 2.12 . . . . 71.41 112.675 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -131.8 148.96 32.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.618 -1.174 . . . . 73.31 107.973 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -97.49 -23.83 15.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.009 0.433 . . . . 62.21 111.71 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -102.91 132.12 49.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.293 -0.632 . . . . 74.45 109.293 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -98.07 129.99 47.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.837 -0.62 . . . . 74.34 109.592 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.83 141.51 30.74 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.359 -0.536 . . . . 73.54 110.894 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.1 p -119.76 127.66 53.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.077 -0.965 . . . . 74.45 108.767 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 70.5 m-85 -126.35 126.27 43.63 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 110.17 -0.307 . . . . 74.02 110.17 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 37' ' ' VAL . 59.3 p -115.89 131.35 56.96 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.754 -0.657 . . . . 72.21 111.405 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.572 HD12 HD12 ' B' ' 38' ' ' ILE . 50.2 mt -127.39 121.33 57.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.116 -0.493 . . . . 71.11 110.004 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -103.88 121.47 43.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.779 -1.193 . . . . 65.25 107.779 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 34' ' ' LEU . 13.6 tp10 -142.62 100.43 3.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 112.242 0.46 . . . . 74.12 112.242 -174.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.54 -66.15 3.55 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 114.592 0.597 . . . . 54.53 114.592 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 p -158.94 18.8 0.19 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.655 0.613 . . . . 72.1 112.655 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.566 HD22 ' CZ ' ' B' ' 18' ' ' ARG . 2.1 pt? -145.27 140.35 27.75 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.499 -0.556 . . . . 74.33 109.499 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -107.77 120.88 43.5 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.46 -0.941 . . . . 75.34 108.46 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.32 134.92 46.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.785 -0.45 . . . . 71.44 109.785 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 48.5 t -118.22 125.41 74.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 60.53 110.184 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.637 HD12 HD12 ' B' ' 29' ' ' ILE . 74.6 mt -101.77 120.61 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 CA-C-N 115.555 -0.748 . . . . 63.45 109.077 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 94.7 m-85 -102.58 115.44 30.59 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.819 -0.808 . . . . 75.32 108.819 175.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.563 HG23 HD21 ' B' ' 34' ' ' LEU . 37.1 mm -88.29 112.24 23.49 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 106.504 -1.665 . . . . 33.12 106.504 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.443 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 7.0 t -126.09 153.04 45.06 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.922 -0.581 . . . . 73.32 112.553 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -52.33 -32.82 39.88 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.948 1.299 . . . . 42.32 113.233 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -87.64 -12.64 44.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.369 0.604 . . . . 73.22 110.706 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.27 -109.97 0.43 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.673 -1.251 . . . . 52.04 113.624 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 60.7 tp -134.09 145.99 49.87 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 123.911 0.885 . . . . 73.42 109.846 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -141.04 142.66 34.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.251 -0.648 . . . . 61.13 109.251 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.459 HG11 HG11 ' B' ' 47' ' ' VAL . 12.9 p -127.03 140.62 48.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.872 -0.604 . . . . 62.23 109.949 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 33.7 m -125.15 143.19 51.06 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 116.119 -0.491 . . . . 74.31 110.871 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.82 124.14 49.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.973 -1.121 . . . . 73.11 107.973 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.03 101.22 54.48 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 107.47 -1.307 . . . . 63.4 107.47 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.96 150.3 72.91 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 122.59 2.193 . . . . 74.13 111.763 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? . . . . . 0 N--CA 1.428 -1.572 0 CA-C-N 114.967 -1.015 . . . . 71.14 110.349 172.807 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.523 ' HG2' ' HD2' ' B' ' 51' ' ' PRO . 35.0 mtp180 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 108.097 -1.075 . . . . 74.24 108.097 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -89.39 148.17 23.64 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.541 -0.754 . . . . 64.41 111.446 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 84.0 m -133.16 149.69 52.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.716 -1.216 . . . . 62.32 107.716 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.438 ' CG2' HD11 ' A' ' 14' ' ' LEU . 65.8 t -136.86 140.53 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 120.81 -0.356 . . . . 74.33 111.434 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 22.4 p -106.81 125.81 51.49 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.495 0.718 . . . . 53.23 109.912 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.419 HD11 HG23 ' A' ' 12' ' ' VAL . 2.7 mm? -106.44 129.67 54.38 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.424 -0.584 . . . . 75.53 109.424 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 12.1 p -123.84 112.36 17.19 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.934 0.873 . . . . 62.34 111.559 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -141.69 -166.43 2.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.502 -1.666 . . . . 65.22 106.502 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -66.99 94.89 0.35 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.212 0.914 . . . . 51.32 112.146 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.566 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 7.2 tpt180 -126.38 137.95 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.993 -1.003 . . . . 41.23 110.878 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.59 136.23 42.61 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.119 -1.067 . . . . 75.15 108.119 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' B' ' 42' ' ' LYS . 57.9 Cg_endo -70.13 148.65 63.16 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.352 2.035 . . . . 72.13 113.236 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 23' ' ' ARG . 12.0 p -131.88 142.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 71.35 107.923 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 16.1 m -91.52 9.93 29.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.293 0.568 . . . . 75.31 111.074 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.516 ' H ' HG22 ' B' ' 21' ' ' VAL . 35.6 mmt180 -128.87 133.9 48.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.443 -0.577 . . . . 70.5 109.443 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.48 117.17 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.397 -0.594 . . . . 62.04 109.397 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.1 139.31 34.94 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.899 0.38 . . . . 74.13 111.617 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.403 HG22 ' CD1' ' B' ' 39' ' ' PHE . 37.8 p -117.89 127.77 54.17 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.298 -0.865 . . . . 74.4 108.884 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.15 124.21 34.1 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 108.683 -0.858 . . . . 64.31 108.683 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.448 HG23 HG22 ' B' ' 37' ' ' VAL . 18.8 m -118.07 122.01 42.05 Favored 'General case' 0 C--N 1.264 -3.144 0 C-N-CA 119.507 -0.877 . . . . 63.2 111.859 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.637 HD12 HD12 ' A' ' 38' ' ' ILE . 60.4 mt -112.9 123.49 68.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.279 -0.637 . . . . 65.43 109.279 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -104.82 121.48 43.75 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.654 0.74 . . . . 73.14 109.239 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.513 ' O ' HD23 ' B' ' 34' ' ' LEU . 13.9 tp10 -136.7 97.33 3.52 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.18 0.514 . . . . 75.3 111.592 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.53 -80.2 0.23 Allowed Glycine 0 C--N 1.312 -0.778 0 CA-C-N 115.615 -0.72 . . . . 44.33 114.831 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.45 ' HB3' HD13 ' A' ' 19' ' ' LEU . 28.1 m -123.69 6.59 8.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.685 0.624 . . . . 74.0 112.685 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.563 HD21 HG23 ' A' ' 40' ' ' ILE . 2.1 pt? -147.0 140.97 25.93 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 119.11 -1.036 . . . . 71.12 111.517 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 86.8 mtm180 -108.18 119.47 39.56 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 114.784 -1.098 . . . . 75.34 109.088 170.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 126.99 51.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.632 -0.507 . . . . 72.33 109.632 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.448 HG22 HG23 ' B' ' 28' ' ' THR . 46.3 t -109.41 124.92 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.083 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 29' ' ' ILE . 70.3 mt -101.33 119.7 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.661 -0.866 . . . . 60.33 108.661 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.479 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.9 m-85 -102.92 114.56 28.95 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.255 -1.017 . . . . 73.02 108.255 175.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.485 HD12 HD21 ' A' ' 34' ' ' LEU . 48.4 mm -89.97 112.88 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 106.014 -1.847 . . . . 75.51 106.014 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -115.66 -178.02 3.29 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 115.555 -0.748 . . . . 74.14 109.372 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.664 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -73.0 -45.24 58.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 113.972 1.101 . . . . 75.21 113.972 -173.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -93.81 -6.32 46.18 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.802 -0.759 . . . . 72.11 111.955 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.93 -143.12 6.39 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.354 -1.879 . . . . 62.11 114.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' B' ' 14' ' ' LEU . 59.0 tp -114.53 149.13 36.91 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.43 1.092 . . . . 64.13 109.689 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' B' ' 12' ' ' VAL . 84.7 tttt -143.56 143.11 31.38 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.234 -0.654 . . . . 61.44 109.234 170.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.459 HG11 HG11 ' A' ' 47' ' ' VAL . 11.7 p -131.52 141.22 46.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.649 -0.5 . . . . 71.01 109.649 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.479 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 63.5 m -121.29 146.21 47.07 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 110.32 -0.252 . . . . 42.14 110.32 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -115.81 124.3 50.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 121.265 0.555 . . . . 75.31 109.748 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 20.4 t70 -114.87 108.46 48.69 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 115.085 -0.961 . . . . 75.23 109.136 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.523 ' HD2' ' HG2' ' B' ' 9' ' ' ARG . 87.4 Cg_endo . . . . . 0 N--CA 1.434 -1.98 0 C-N-CA 122.174 1.916 . . . . 74.52 110.875 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 . . . . . 0 CA--C 1.475 -1.911 0 N-CA-C 109.948 -0.39 . . . . 71.24 109.948 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m -108.67 132.48 53.87 Favored 'General case' 0 C--N 1.262 -3.217 0 C-N-CA 119.835 -0.746 . . . . 71.54 110.058 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.25 147.88 45.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.312 . . . . 62.13 107.459 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.14 150.44 15.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.561 -0.533 . . . . 72.2 109.561 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 p -107.18 140.49 39.95 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 121.229 0.538 . . . . 72.5 111.433 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 3.7 mm? -104.79 135.42 46.2 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 124.305 1.042 . . . . 74.51 110.536 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -108.59 117.99 35.61 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-N 115.348 -0.842 . . . . 72.22 110.122 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -147.2 177.38 9.23 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 107.49 -1.3 . . . . 63.32 107.49 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -68.59 96.18 0.69 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.28 1.038 . . . . 61.44 111.706 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.553 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 14.5 mmm180 -126.03 141.69 51.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.138 1.162 . . . . 74.43 114.138 -174.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.5 pt? -89.57 150.37 44.18 Favored Pre-proline 0 C--N 1.293 -1.849 0 CA-C-N 113.944 -1.48 . . . . 55.21 108.377 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.85 137.35 41.37 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.489 2.126 . . . . 54.22 113.028 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.14 142.36 43.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.626 -1.17 . . . . 62.11 108.024 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -89.77 -40.53 12.43 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.787 0.327 . . . . 75.34 111.728 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -91.2 135.0 34.09 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.953 0.406 . . . . 72.12 111.963 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.62 115.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.079 -1.082 . . . . 71.55 108.079 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.73 127.6 42.87 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.29 -0.564 . . . . 75.53 110.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.1 p -106.62 128.6 54.29 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.442 -0.799 . . . . 72.04 109.461 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.2 126.33 42.6 Favored 'General case' 0 CA--C 1.463 -2.379 0 CA-C-N 116.118 -0.492 . . . . 72.11 109.945 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.554 HG22 HG22 ' A' ' 37' ' ' VAL . 81.9 p -114.94 124.25 51.21 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.445 -0.798 . . . . 73.14 110.861 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.695 HD12 HD12 ' B' ' 38' ' ' ILE . 50.0 mt -116.24 124.63 72.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.798 -0.637 . . . . 73.23 110.286 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.47 ' HB ' ' NH1' ' A' ' 35' ' ' ARG . 6.2 t -100.19 127.32 46.48 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.76 -1.109 . . . . 74.52 109.682 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.2 tp10 -142.13 103.39 4.29 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.638 -0.71 . . . . 71.42 110.209 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -91.05 0.73 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 115.231 -0.895 . . . . 34.42 111.523 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 31.3 p -134.62 6.36 3.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.801 0.81 . . . . 71.33 109.339 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.555 HD23 HD12 ' B' ' 40' ' ' ILE . 52.2 tp -98.22 136.08 38.94 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.387 -0.824 . . . . 74.21 110.7 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.47 ' NH1' ' HB ' ' A' ' 30' ' ' THR . 22.2 mmm180 -111.44 112.91 24.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.466 -0.788 . . . . 64.21 108.946 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.8 124.58 49.67 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.971 -0.751 . . . . 62.44 108.971 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 28' ' ' THR . 60.4 t -116.38 129.09 73.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.205 0.526 . . . . 70.21 111.298 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.608 HD12 HD12 ' B' ' 29' ' ' ILE . 59.2 mt -108.43 129.31 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-N 115.058 -0.974 . . . . 34.2 109.956 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.445 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 97.3 m-85 -113.41 117.35 31.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.305 -0.998 . . . . 70.41 108.305 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.642 HD12 HD23 ' B' ' 34' ' ' LEU . 35.0 mm -90.45 116.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 107.742 -1.207 . . . . 73.51 107.742 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.8 p -118.72 177.91 4.67 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.429 0.633 . . . . 74.31 111.261 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.99 -22.03 62.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.326 -0.852 . . . . 75.45 110.011 175.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -87.36 -29.73 21.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.443 -0.947 . . . . 54.23 108.443 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 150.64 -112.59 0.55 Allowed Glycine 0 N--CA 1.413 -2.862 0 C-N-CA 120.311 -0.947 . . . . 55.51 113.108 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 55.2 tp -119.84 139.94 51.58 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.64 -0.28 . . . . 71.41 110.331 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.7 143.32 48.44 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.483 -0.932 . . . . 62.03 108.483 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.442 HG11 HG11 ' B' ' 47' ' ' VAL . 12.4 p -123.92 140.8 46.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-N 116.146 -0.479 . . . . 75.14 110.574 -174.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 22.9 m -124.88 138.78 54.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.096 -0.502 . . . . 70.13 110.967 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.44 124.1 49.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.769 -0.65 . . . . 65.33 110.067 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 21.1 t70 -116.71 110.4 42.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.021 . . . . 73.43 108.245 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -84.21 134.61 6.0 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 122.418 2.079 . . . . 61.44 114.301 -173.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.1 mt-30 . . . . . 0 C--O 1.255 1.377 0 C-N-CA 125.672 1.589 . . . . 53.02 113.836 172.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' B' ' 50' ' ' ASP . 4.6 mpt_? . . . . . 0 N--CA 1.415 -2.213 0 CA-C-O 121.358 0.599 . . . . 71.14 111.972 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -96.26 148.38 22.8 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.932 -1.031 . . . . 71.24 110.508 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.8 m -137.14 155.98 48.92 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.518 -0.919 . . . . 73.14 108.518 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.01 138.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.288 0.235 . . . . 64.12 111.364 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.9 p -107.38 125.66 51.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.325 0.65 . . . . 63.42 109.715 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.24 122.0 44.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.608 -0.724 . . . . 40.03 110.823 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 37.5 p -85.76 113.76 22.18 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.469 -0.937 . . . . 53.24 108.469 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -139.26 -173.86 3.71 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.668 -0.493 . . . . 54.44 109.668 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.32 105.64 11.74 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.796 -0.816 . . . . 71.53 108.796 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.541 ' HG3' ' HA2' ' B' ' 44' ' ' GLY . 20.3 mmm180 -125.64 141.07 52.21 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.682 -0.69 . . . . 70.12 112.703 -172.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.561 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.9 pt? -90.35 159.62 41.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 107.15 -1.426 . . . . 73.33 107.15 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.36 135.55 54.49 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.565 1.51 . . . . 63.13 112.244 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.22 141.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.065 -1.457 . . . . 74.43 107.065 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -85.83 -68.38 0.74 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.806 0.336 . . . . 63.13 111.032 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -99.47 139.65 34.81 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 120.844 -0.342 . . . . 74.3 111.185 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.61 133.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.983 -0.747 . . . . 74.12 108.983 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' B' ' 39' ' ' PHE . 43.9 mmtm -100.13 138.81 36.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.322 -0.551 . . . . 63.42 110.161 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.1 p -115.84 127.22 54.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.256 -0.646 . . . . 72.42 109.256 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -128.75 130.82 47.6 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-N 116.411 -0.359 . . . . 64.2 111.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.528 HG22 HG22 ' B' ' 37' ' ' VAL . 57.6 p -114.94 132.62 56.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.698 -0.683 . . . . 72.13 111.936 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.608 HD12 HD12 ' A' ' 38' ' ' ILE . 72.3 mt -134.73 128.48 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.817 -0.629 . . . . 73.34 109.719 176.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -112.33 136.96 51.15 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 108.713 -0.847 . . . . 62.55 108.713 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.516 ' HG2' HG13 ' A' ' 40' ' ' ILE . 12.0 tp10 -141.57 112.12 7.07 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.543 -0.54 . . . . 73.3 109.543 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.98 -104.12 0.55 Allowed Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 110.834 -0.906 . . . . 62.45 110.834 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 45.4 m -126.49 69.6 1.24 Allowed 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.839 -0.801 . . . . 75.03 108.839 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.642 HD23 HD12 ' A' ' 40' ' ' ILE . 28.4 tp -159.13 137.2 10.44 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.045 -0.98 . . . . 74.41 109.61 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 18.8 mmm180 -113.89 116.88 29.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 123.673 0.608 . . . . 73.02 110.108 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 130.18 55.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.9 -0.408 . . . . 70.43 109.9 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.528 HG22 HG22 ' B' ' 28' ' ' THR . 86.7 t -121.64 130.87 74.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.851 0.357 . . . . 71.44 110.538 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 29' ' ' ILE . 80.8 mt -110.28 130.51 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 C-N-CA 123.442 0.697 . . . . 62.42 109.863 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 95.7 m-85 -114.57 114.76 26.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.908 -1.145 . . . . 74.55 107.908 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.555 HD12 HD23 ' A' ' 34' ' ' LEU . 40.7 mm -89.58 113.92 26.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.335 -0.987 . . . . 75.01 108.335 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -106.55 175.3 5.55 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.731 -0.47 . . . . 74.3 109.731 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.724 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -85.37 -18.05 34.89 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.775 -0.648 . . . . 61.31 110.978 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -104.31 -17.22 14.91 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.13 0.49 . . . . 73.2 110.641 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.541 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . -174.06 -139.22 2.89 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 119.097 -1.525 . . . . 64.15 114.164 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.413 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 40.6 tp -135.63 134.73 39.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 125.184 1.394 . . . . 43.32 107.513 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -128.96 140.72 51.53 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.341 -0.944 . . . . 71.44 110.132 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 47' ' ' VAL . 11.4 p -131.51 141.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.775 -0.648 . . . . 52.14 109.754 -175.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 66.7 m -123.87 140.23 53.18 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.683 0.278 . . . . 74.2 111.061 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' A' ' 45' ' ' LEU . . . -116.92 125.24 51.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.876 -0.602 . . . . 75.15 110.681 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 21.6 t70 -114.96 125.1 29.37 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.434 -0.803 . . . . 74.32 109.348 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.446 -1.295 0 C-N-CA 122.16 1.907 . . . . 43.42 113.508 -174.87 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 N--CA 1.42 -1.973 0 CA-C-O 122.335 1.064 . . . . 73.41 112.805 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -87.74 120.11 28.73 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.194 -1.366 . . . . 60.33 109.945 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 m -133.81 146.41 50.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.798 -1.186 . . . . 55.11 107.798 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.1 t -146.93 153.76 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 122.702 0.401 . . . . 62.22 110.085 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.3 p -121.57 125.77 47.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.876 -0.416 . . . . 73.32 109.876 173.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.466 HD21 ' CG2' ' B' ' 12' ' ' VAL . 97.7 mt -101.23 122.4 43.59 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 123.16 0.584 . . . . 71.12 112.197 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 p -85.79 114.31 22.63 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.075 -0.966 . . . . 73.53 110.733 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -147.43 166.99 25.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.474 -0.935 . . . . 72.41 108.474 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -82.24 102.37 11.1 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.465 0.65 . . . . 73.34 110.007 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' NH1' ' HB3' ' B' ' 51' ' ' PRO . 65.8 mmt-85 -125.93 150.21 48.15 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 114.938 -1.028 . . . . 74.21 109.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.22 134.16 80.55 Favored Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.718 -0.845 . . . . 73.42 108.718 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.51 135.28 48.68 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.813 2.342 . . . . 62.24 114.899 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.23 133.75 60.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.468 -1.696 . . . . 73.31 107.671 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -89.87 -18.51 26.05 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.436 0.636 . . . . 55.45 110.734 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -91.38 132.65 36.06 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.108 -0.701 . . . . 74.42 109.108 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.4 mm -98.72 135.14 34.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.336 -0.616 . . . . 74.51 109.336 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -110.95 150.7 28.85 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.196 0.522 . . . . 75.35 111.905 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 91.1 m -129.74 127.09 39.71 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.057 -1.09 . . . . 72.11 108.057 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -128.46 128.66 44.83 Favored 'General case' 0 CA--C 1.477 -1.843 0 CA-C-N 116.189 -0.459 . . . . 71.54 110.914 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.612 HG22 HG22 ' A' ' 37' ' ' VAL . 55.7 p -114.36 124.98 53.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.419 -0.81 . . . . 75.44 110.646 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.692 HD12 HD12 ' B' ' 38' ' ' ILE . 62.5 mt -119.12 138.79 48.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.556 -0.535 . . . . 73.43 109.556 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' HH11 ' A' ' 35' ' ' ARG . 10.6 t -118.68 127.48 53.61 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.098 -0.705 . . . . 74.14 109.098 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.7 tp10 -139.24 97.27 3.26 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 108.507 -0.923 . . . . 74.31 108.507 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.09 -119.34 7.94 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 110.533 -1.027 . . . . 72.13 110.533 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 36.8 m -102.01 3.31 38.72 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.45 0.643 . . . . 72.23 110.091 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.524 HD23 HD12 ' B' ' 40' ' ' ILE . 47.1 tp -99.75 131.61 45.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 C-N-CA 123.676 0.79 . . . . 72.12 110.138 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' A' ' 50' ' ' ASP . 28.8 tpt180 -121.37 122.46 39.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.12 -1.067 . . . . 74.33 108.12 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.07 141.53 46.78 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.953 -0.467 . . . . 54.42 110.603 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG22 HG22 ' A' ' 28' ' ' THR . 58.3 t -125.09 131.08 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 63.31 111.144 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.626 HD11 HD11 ' B' ' 38' ' ' ILE . 75.6 mt -108.41 125.86 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 124.274 1.03 . . . . 72.01 109.383 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.6 m-85 -112.14 119.04 37.04 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.098 -1.075 . . . . 75.34 108.098 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.587 HG23 HD21 ' B' ' 34' ' ' LEU . 36.7 mm -88.8 121.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.602 -0.726 . . . . 63.01 109.233 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.4 p -124.99 164.66 19.67 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.372 -0.603 . . . . 53.25 109.372 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -70.96 -21.69 62.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.875 0.369 . . . . 72.23 110.734 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -94.73 1.6 55.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.087 0.47 . . . . 72.25 110.689 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.62 -142.47 13.08 Favored Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 119.434 -1.365 . . . . 43.43 113.329 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD11 HG23 ' A' ' 38' ' ' ILE . 59.6 tp -114.9 134.52 55.08 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.303 -0.449 . . . . 72.53 111.241 -173.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 78.7 tttt -115.58 137.01 52.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.398 0.618 . . . . 71.0 110.264 170.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.473 HG11 HG11 ' B' ' 47' ' ' VAL . 10.7 p -121.62 140.58 45.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.747 -1.115 . . . . 70.01 108.357 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.3 t -137.85 143.13 40.8 Favored 'General case' 0 C--N 1.27 -2.873 0 N-CA-C 107.456 -1.313 . . . . 61.22 107.456 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.68 125.26 53.53 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.026 -0.67 . . . . 75.4 110.202 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.6 t70 -101.44 100.7 14.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 106.278 -1.749 . . . . 72.32 106.278 175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HB3' HH12 ' B' ' 18' ' ' ARG . 95.0 Cg_endo -79.0 132.97 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.501 2.134 . . . . 70.31 115.276 -172.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 41.4 mt-30 . . . . . 0 C--O 1.236 0.381 0 C-N-CA 126.494 1.917 . . . . 75.2 114.252 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptp180 . . . . . 0 N--CA 1.42 -1.937 0 CA-C-O 121.259 0.552 . . . . 74.32 110.981 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -89.59 123.04 33.31 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 108.413 -0.958 . . . . 70.34 108.413 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 81.5 m -125.35 149.17 48.36 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.75 -0.463 . . . . 71.41 109.75 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.466 ' CG2' HD21 ' A' ' 14' ' ' LEU . 98.1 t -140.68 133.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.258 -0.428 . . . . 74.42 110.222 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.8 p -107.42 125.68 51.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.585 -0.895 . . . . 71.43 108.585 174.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.418 ' O ' ' HA3' ' B' ' 44' ' ' GLY . 79.9 mt -101.52 140.84 35.26 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.751 -0.659 . . . . 54.54 110.968 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 22.1 p -99.38 113.82 26.37 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.674 0.749 . . . . 72.52 111.528 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -158.64 159.86 35.84 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.67 -1.233 . . . . 72.32 107.67 173.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -78.27 106.51 10.23 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.919 0.866 . . . . 71.13 110.275 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.561 ' HA ' ' HE ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -109.95 151.16 27.45 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 113.921 -1.491 . . . . 75.5 110.126 -176.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.441 ' H ' HD12 ' B' ' 19' ' ' LEU . 3.6 mp -73.52 143.88 82.93 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.143 -1.058 . . . . 65.31 108.143 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -65.72 135.0 39.93 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.688 1.592 . . . . 75.12 111.461 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.23 139.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 107.731 -1.211 . . . . 74.2 107.731 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.6 m -84.22 -50.67 7.67 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.786 -0.365 . . . . 55.22 111.537 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -89.38 142.23 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.649 -0.871 . . . . 73.33 108.649 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.77 121.19 37.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.791 -0.818 . . . . 75.21 108.791 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -89.86 138.86 31.13 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.549 -0.86 . . . . 72.2 111.477 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 89.0 m -128.95 127.34 41.53 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.537 -1.21 . . . . 73.42 108.381 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 81.1 m-85 -122.11 130.45 53.25 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.66 -0.7 . . . . 75.13 110.798 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.475 HG22 HG22 ' B' ' 37' ' ' VAL . 57.0 p -115.12 130.78 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.1 -0.955 . . . . 74.54 111.173 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.596 HD12 HD12 ' A' ' 38' ' ' ILE . 55.0 mt -131.01 120.65 47.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.307 -0.627 . . . . 72.43 109.307 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -103.87 121.59 43.39 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.565 -0.902 . . . . 71.23 108.565 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.484 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.6 tp10 -136.68 100.88 4.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.72 -0.673 . . . . 73.21 111.065 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.22 -102.59 0.61 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.619 -0.719 . . . . 74.4 112.966 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 33.9 m -112.45 13.05 20.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 112.049 0.389 . . . . 34.43 112.049 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.587 HD21 HG23 ' A' ' 40' ' ' ILE . 2.4 pt? -137.83 140.62 40.58 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.669 0.747 . . . . 75.11 110.396 175.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.426 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 33.7 ttt180 -117.27 134.07 55.24 Favored 'General case' 0 C--N 1.258 -3.394 0 CA-C-N 114.737 -1.12 . . . . 72.24 108.608 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.98 140.97 47.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 122.347 -0.221 . . . . 65.2 110.821 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.475 HG22 HG22 ' B' ' 28' ' ' THR . 96.4 t -127.46 127.94 69.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.007 -0.542 . . . . 71.34 110.07 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.692 HD12 HD12 ' A' ' 29' ' ' ILE . 92.6 mt -113.15 126.77 70.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 123.4 0.68 . . . . 74.41 109.884 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.8 118.5 36.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.9 -0.778 . . . . 73.42 108.9 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.524 HD12 HD23 ' A' ' 34' ' ' LEU . 35.9 mm -94.61 115.58 33.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.26 -1.015 . . . . 71.12 108.26 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -129.68 162.97 27.13 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 110.07 -0.345 . . . . 74.21 110.07 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -20.8 66.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.023 0.44 . . . . 74.53 110.863 177.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -91.2 -17.23 26.39 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 111.946 0.351 . . . . 74.12 111.946 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' B' ' 14' ' ' LEU . . . 158.49 -156.29 27.28 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.69 -1.719 . . . . 71.14 113.583 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -112.81 122.69 48.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.698 -0.853 . . . . 70.33 108.698 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -117.39 138.45 51.8 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.119 -0.632 . . . . 64.31 110.013 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 47' ' ' VAL . 9.8 p -131.1 140.95 47.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.207 -0.906 . . . . 53.31 109.334 -176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.52 143.21 51.21 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 116.295 -0.411 . . . . 75.12 110.641 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.42 122.92 47.27 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.406 -0.961 . . . . 72.21 108.406 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' B' ' 35' ' ' ARG . 32.1 t70 -112.99 126.9 27.51 Favored Pre-proline 0 C--N 1.275 -2.641 0 CA-C-N 114.918 -1.037 . . . . 73.41 108.294 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.508 ' HB3' ' NH1' ' A' ' 18' ' ' ARG . 61.2 Cg_endo . . . . . 0 N--CA 1.446 -1.296 0 C-N-CA 121.553 1.502 . . . . 70.15 114.564 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.415 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 94.7 mtt180 . . . . . 0 N--CA 1.42 -1.926 0 CA-C-O 121.86 0.838 . . . . 73.34 110.042 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p -87.41 143.82 27.05 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.638 -1.164 . . . . 73.43 111.422 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.7 m -132.74 148.51 52.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.784 -0.821 . . . . 54.11 108.784 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.0 t -143.68 142.02 25.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 110.055 -0.35 . . . . 71.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.3 t -107.92 128.45 54.64 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.51 -0.922 . . . . 62.24 108.51 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.7 mm? -100.94 121.61 42.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.134 -0.691 . . . . 55.21 109.134 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 p -97.35 114.24 26.01 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-O 121.797 0.808 . . . . 65.34 109.682 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -139.33 -169.72 2.73 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.38 -1.341 . . . . 63.02 107.38 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -73.04 101.13 3.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.389 -0.967 . . . . 71.43 108.389 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -125.31 149.21 48.28 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.076 -0.65 . . . . 72.03 112.29 -173.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.3 pt? -89.99 148.73 40.25 Favored Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 107.639 -1.245 . . . . 75.2 107.639 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.44 136.35 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 121.519 1.479 . . . . 64.41 110.655 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -108.48 148.49 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.429 -0.582 . . . . 41.44 109.429 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 p -67.9 -57.26 6.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.005 0.431 . . . . 73.24 111.881 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -117.07 157.87 25.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.357 -0.383 . . . . 71.22 110.023 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -80.75 115.09 22.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.131 -1.433 . . . . 71.33 107.131 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -94.29 131.83 39.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.327 -0.549 . . . . 61.23 109.682 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.6 p -106.23 128.11 53.71 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.13 0.491 . . . . 72.43 109.861 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.521 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 80.0 m-85 -123.3 125.74 45.6 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 116.04 -0.527 . . . . 73.21 109.906 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.53 HG22 HG22 ' A' ' 37' ' ' VAL . 41.1 p -114.53 118.18 33.01 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.071 -0.968 . . . . 63.22 112.278 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.609 HD12 HD12 ' B' ' 38' ' ' ILE . 54.7 mt -121.95 121.51 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.095 -0.705 . . . . 73.44 109.095 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.2 t -118.28 124.7 48.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 CA-C-O 122.164 0.983 . . . . 64.31 109.683 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.4 tp10 -124.38 98.37 5.72 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.573 -1.649 . . . . 64.1 108.479 -175.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.5 -132.44 27.33 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 109.976 -1.25 . . . . 71.51 109.976 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.2 m -90.61 18.48 6.3 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.226 0.536 . . . . 65.43 110.878 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 HG23 ' B' ' 40' ' ' ILE . 32.8 tp -121.06 136.06 55.06 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.726 -0.472 . . . . 73.12 109.726 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -129.85 135.34 48.27 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 116.287 -0.415 . . . . 71.35 111.294 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.26 140.2 52.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.562 -0.533 . . . . 73.41 109.562 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.53 HG22 HG22 ' A' ' 28' ' ' THR . 63.6 t -121.97 125.92 73.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.969 0.414 . . . . 73.55 110.861 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 86.1 mt -102.15 124.94 56.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.384 -0.825 . . . . 74.03 109.629 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -110.72 119.04 37.81 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.797 -1.186 . . . . 62.25 107.797 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.575 HD12 HD23 ' B' ' 34' ' ' LEU . 34.4 mm -88.18 114.83 27.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.272 -1.381 . . . . 73.34 107.272 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.413 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 7.2 t -130.99 165.66 22.68 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.078 0.466 . . . . 74.54 111.275 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -68.04 -16.1 63.89 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.434 0.694 . . . . 74.2 109.994 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -86.83 -14.76 41.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.403 -0.962 . . . . 74.24 108.403 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 129.6 -117.34 2.35 Favored Glycine 0 CA--C 1.48 -2.125 0 CA-C-N 114.977 -1.011 . . . . 71.35 112.478 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 64.5 tp -113.41 132.87 55.46 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.583 -0.525 . . . . 64.5 109.583 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -128.42 134.99 48.91 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.484 -0.561 . . . . 52.12 109.484 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.563 HG11 HG11 ' B' ' 47' ' ' VAL . 12.4 p -128.57 140.59 48.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.043 0 CA-C-N 115.721 -0.672 . . . . 74.04 109.95 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.3 m -120.0 147.83 44.31 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 115.587 -0.733 . . . . 71.42 109.743 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' B' ' 45' ' ' LEU . . . -115.19 124.53 51.67 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 106.845 -1.539 . . . . 44.05 106.845 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.415 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 17.7 t70 -124.01 83.69 55.35 Favored Pre-proline 0 C--N 1.271 -2.819 0 N-CA-C 107.146 -1.427 . . . . 71.44 107.146 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 9' ' ' ARG . 11.2 Cg_endo -93.18 134.79 1.11 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 122.318 2.012 . . . . 71.44 112.661 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 114.209 -1.359 . . . . 74.35 111.912 178.437 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' ' 9' ' ' ARG . 56.9 mtt180 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 109.287 -0.635 . . . . 74.01 109.287 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -90.25 143.31 26.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.238 -0.437 . . . . 65.12 110.384 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.414 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 69.5 m -144.91 149.39 35.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.827 -0.349 . . . . 74.42 110.116 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 92.7 t -141.2 141.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.741 0.416 . . . . 65.53 110.074 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' B' ' 46' ' ' LYS . 21.7 t -107.65 132.39 53.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.216 0.531 . . . . 61.3 109.687 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.77 120.84 43.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.704 -0.68 . . . . 71.21 110.661 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 34.1 p -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.291 -1.003 . . . . 65.52 108.291 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 t -142.57 -169.02 2.89 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.528 -0.915 . . . . 74.1 108.528 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.36 85.11 1.96 Allowed 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.292 1.044 . . . . 64.55 110.655 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -125.89 121.75 34.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.783 -1.099 . . . . 74.35 110.919 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.651 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.7 pt? -74.66 147.56 84.59 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.019 -0.991 . . . . 74.24 108.535 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.74 147.56 81.43 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.383 2.055 . . . . 54.43 114.933 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.405 HG22 ' H ' ' B' ' 23' ' ' ARG . 13.4 p -131.66 141.36 45.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.636 -1.616 . . . . 63.41 106.636 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 p -82.79 -14.15 54.96 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.316 0.858 . . . . 74.24 113.316 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.405 ' H ' HG22 ' B' ' 21' ' ' VAL . 52.8 mtm180 -127.39 146.75 50.36 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.354 -0.216 . . . . 74.55 111.012 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -91.79 115.79 31.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.659 -0.867 . . . . 75.21 108.659 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 14.4 mmmm -89.83 131.55 35.71 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.28 -0.568 . . . . 72.45 109.795 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 23.8 p -109.65 127.2 54.39 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.634 -0.712 . . . . 71.43 109.936 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.403 ' HB2' ' HB ' ' B' ' 38' ' ' ILE . 87.4 m-85 -128.35 126.24 40.33 Favored 'General case' 0 CA--C 1.468 -2.197 0 CA-C-N 116.404 -0.362 . . . . 72.01 110.811 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.532 HG22 HG22 ' B' ' 37' ' ' VAL . 76.0 p -115.16 132.6 56.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.431 -0.804 . . . . 62.34 112.023 -175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.509 HD12 HD12 ' A' ' 38' ' ' ILE . 66.9 mt -136.64 124.8 34.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.184 -0.672 . . . . 75.41 109.184 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -115.35 140.89 48.72 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.808 -0.812 . . . . 73.42 108.808 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 40' ' ' ILE . 9.5 tp10 -142.06 116.59 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.263 -0.88 . . . . 70.11 110.168 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.66 -76.66 1.33 Allowed Glycine 0 C--O 1.222 -0.655 0 N-CA-C 111.058 -0.817 . . . . 53.03 111.058 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 37.9 m -153.14 -5.09 0.2 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.499 -0.926 . . . . 52.05 108.499 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.575 HD23 HD12 ' A' ' 40' ' ' ILE . 21.5 tp -88.2 140.13 29.79 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.377 1.071 . . . . 72.35 109.057 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -129.92 132.39 46.35 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.16 -0.616 . . . . 73.22 111.898 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.91 44.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.238 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.532 HG22 HG22 ' B' ' 28' ' ' THR . 60.2 t -127.84 127.26 67.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.465 -0.569 . . . . 55.1 109.465 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 29' ' ' ILE . 77.3 mt -104.93 128.92 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 115.457 -0.792 . . . . 60.23 109.051 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.6 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 96.9 m-85 -113.2 116.6 30.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.939 -1.134 . . . . 63.03 107.939 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.513 HG23 HD23 ' A' ' 34' ' ' LEU . 39.1 mm -88.7 114.66 27.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 107.471 -1.307 . . . . 75.42 107.471 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -116.13 -179.83 3.78 Favored 'General case' 0 N--CA 1.412 -2.337 0 C-N-CA 120.549 -0.46 . . . . 62.15 110.642 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.655 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -82.73 -31.39 28.47 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.327 0.862 . . . . 74.33 113.327 -172.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -102.36 -5.04 24.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.138 -0.625 . . . . 75.23 110.636 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.58 -136.74 4.0 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.154 -1.498 . . . . 53.31 114.195 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 49' ' ' ALA . 67.3 tp -118.83 143.05 47.19 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 124.226 1.011 . . . . 44.12 108.998 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.6 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -129.83 121.68 27.22 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.262 -1.384 . . . . 55.41 107.262 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.563 HG11 HG11 ' A' ' 47' ' ' VAL . 13.9 p -114.81 140.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.423 -0.353 . . . . 72.12 110.464 -176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 46.4 m -131.11 141.63 50.16 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.513 0.508 . . . . 64.51 111.804 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.86 124.74 51.43 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.399 -0.819 . . . . 71.02 109.295 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.73 103.78 52.6 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.052 -1.092 . . . . 72.03 108.052 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.44 -1.655 0 C-N-CA 121.603 1.535 . . . . 62.24 112.632 -176.872 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 C--O 1.243 0.759 0 N-CA-C 108.925 -0.768 . . . . 74.35 108.925 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.555 ' OG1' HD13 ' B' ' 14' ' ' LEU . 3.5 p -108.23 149.51 28.49 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 112.237 0.458 . . . . 75.24 112.237 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 72.2 m -133.79 149.32 51.41 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.264 -1.384 . . . . 71.12 107.264 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.429 HG22 HD23 ' B' ' 14' ' ' LEU . 27.1 m -141.21 148.95 20.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.828 0.347 . . . . 73.4 110.698 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.523 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 32.5 t -125.06 144.63 50.31 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.818 -0.628 . . . . 73.43 109.655 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.469 HD13 ' HB ' ' B' ' 10' ' ' THR . 3.9 pp -125.96 142.59 51.45 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.648 -0.705 . . . . 75.22 109.719 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 p -98.6 119.54 37.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.095 -0.706 . . . . 53.23 109.095 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -143.63 -171.84 3.6 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.219 -0.592 . . . . 75.33 110.288 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.0 88.93 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.407 0.683 . . . . 75.34 110.948 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 23.5 mmm180 -126.38 149.24 49.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.442 0.904 . . . . 75.45 113.442 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -108.4 158.11 34.71 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.508 -1.293 . . . . 64.11 107.508 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 27.6 Cg_endo -62.28 136.06 57.71 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.29 1.993 . . . . 72.44 112.533 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -116.49 141.77 32.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.943 -1.026 . . . . 71.21 109.666 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.9 m -67.33 -34.59 77.66 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.204 0.816 . . . . 74.31 113.204 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -132.3 149.87 52.27 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.813 -0.554 . . . . 75.13 111.4 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.9 mm -86.05 115.5 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.59 -1.633 . . . . 51.5 106.59 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.82 128.67 45.1 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 116.125 -0.489 . . . . 64.45 109.695 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.9 p -106.6 127.68 53.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.366 -0.605 . . . . 75.33 109.366 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -123.07 127.96 49.47 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.911 -0.586 . . . . 72.41 110.71 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.688 HG22 HG22 ' A' ' 37' ' ' VAL . 12.1 p -114.41 126.68 55.25 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 74.11 112.329 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.646 HD12 HD12 ' B' ' 38' ' ' ILE . 49.0 mt -123.66 121.66 62.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.754 -0.657 . . . . 75.43 109.729 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -110.25 120.97 44.14 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.622 -1.251 . . . . 73.31 107.622 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.7 tp10 -134.4 106.6 7.15 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.709 -0.396 . . . . 64.2 111.402 -175.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.82 -67.39 1.68 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 116.053 -0.521 . . . . 52.23 113.138 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.5 m -154.91 10.15 0.33 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.257 0.466 . . . . 71.01 112.257 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -128.13 140.74 51.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 118.701 -1.2 . . . . 72.21 111.06 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.0 121.99 46.53 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.307 -0.86 . . . . 75.2 110.32 175.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.42 130.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.323 -0.399 . . . . 42.33 110.007 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.688 HG22 HG22 ' A' ' 28' ' ' THR . 49.8 t -110.06 125.19 67.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.243 -0.435 . . . . 73.24 109.912 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.609 HD12 HD12 ' B' ' 29' ' ' ILE . 70.6 mt -101.19 122.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 108.561 -0.903 . . . . 61.13 108.561 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 75.8 m-85 -104.39 119.08 38.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.608 -1.256 . . . . 71.02 107.608 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HD21 ' B' ' 34' ' ' LEU . 47.2 mm -87.48 113.97 25.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 107.641 -1.244 . . . . 70.43 107.641 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -119.75 -177.7 3.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.89 -0.596 . . . . 74.54 110.674 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -97.26 -20.55 17.82 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.474 0.546 . . . . 74.02 112.474 -177.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.522 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 45.6 ttp180 -91.34 -29.27 17.22 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.773 0.797 . . . . 73.12 109.996 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 178.82 -121.79 0.77 Allowed Glycine 0 C--N 1.293 -1.825 0 C-N-CA 119.18 -1.486 . . . . 71.12 113.276 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HB3' HD11 ' A' ' 14' ' ' LEU . 61.7 tp -137.61 147.05 44.68 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.085 -0.709 . . . . 71.33 109.085 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HD3' ' HB2' ' A' ' 13' ' ' SER . 24.0 tptm -139.42 129.24 24.78 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.208 -1.405 . . . . 73.23 107.208 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 11.4 p -131.13 140.99 47.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.97 -0.382 . . . . 74.02 109.97 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.5 m -119.85 137.91 53.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.314 -0.403 . . . . 71.13 110.707 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.33 124.73 47.34 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.286 0.565 . . . . 65.21 110.554 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.65 104.02 55.31 Favored Pre-proline 0 C--N 1.278 -2.507 0 N-CA-C 107.315 -1.365 . . . . 71.42 107.315 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -95.39 133.46 0.56 Allowed 'Trans proline' 0 N--CA 1.409 -3.497 0 C-N-CA 120.846 1.031 . . . . 70.24 114.076 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 C--N 1.311 -1.083 0 C-N-CA 126.101 1.76 . . . . 61.12 114.339 167.486 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' B' ' 50' ' ' ASP . 99.2 mtt180 . . . . . 0 CA--C 1.481 -1.709 0 N-CA-C 107.158 -1.423 . . . . 72.23 107.158 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.469 ' HB ' HD13 ' A' ' 14' ' ' LEU . 8.6 m -102.54 142.98 32.83 Favored 'General case' 0 N--CA 1.382 -3.834 0 N-CA-C 107.041 -1.466 . . . . 62.43 107.041 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 73.3 m -134.46 148.36 50.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.805 -1.183 . . . . 70.41 107.805 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.66 156.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 123.903 0.752 . . . . 75.2 109.344 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -130.69 145.82 52.02 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.752 -0.462 . . . . 54.43 109.752 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' B' ' 45' ' ' LEU . 4.2 pp -130.04 134.98 47.76 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 109.062 -0.718 . . . . 73.11 109.062 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 34.0 p -106.73 141.79 37.41 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 120.414 -0.514 . . . . 73.51 110.726 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -157.41 -171.47 3.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.81 -1.182 . . . . 75.21 107.81 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -69.08 104.41 2.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.888 0.851 . . . . 53.44 109.91 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.427 ' HG3' ' HA2' ' B' ' 44' ' ' GLY . 20.6 mmm180 -125.95 148.08 49.33 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.085 -0.961 . . . . 65.43 111.405 -174.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.602 ' H ' HD23 ' B' ' 19' ' ' LEU . 2.0 pt? -103.52 152.88 38.88 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.067 -1.086 . . . . 64.44 108.067 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.56 136.45 54.46 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.048 1.832 . . . . 61.04 111.788 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.93 149.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 108.351 -0.981 . . . . 74.51 108.351 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -79.53 -41.29 27.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.828 0.347 . . . . 63.01 111.431 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -125.23 134.15 52.44 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.319 -0.238 . . . . 71.44 110.662 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.16 119.92 20.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 107.712 -1.218 . . . . 73.22 107.712 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -91.29 139.12 31.04 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.997 -0.681 . . . . 72.32 110.368 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.1 p -120.37 127.56 52.42 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.87 -0.789 . . . . 35.52 108.87 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -126.84 126.65 43.7 Favored 'General case' 0 CA--C 1.458 -2.593 0 CA-C-N 116.022 -0.536 . . . . 71.01 110.154 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.674 HG22 HG22 ' B' ' 37' ' ' VAL . 53.0 p -115.9 127.46 55.01 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.549 -0.75 . . . . 72.53 111.056 -176.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 38' ' ' ILE . 54.9 mt -121.12 121.27 64.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.098 -0.704 . . . . 61.44 109.098 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 9.2 t -112.39 115.92 29.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.528 -0.916 . . . . 75.21 108.528 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.491 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.2 tp10 -120.71 97.6 5.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.915 -1.039 . . . . 74.4 111.048 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -66.12 0.47 Allowed Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.689 -0.687 . . . . 53.23 114.601 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.2 m -145.15 23.83 1.48 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.34 -0.506 . . . . 72.43 111.688 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 40' ' ' ILE . 2.5 pt? -148.49 134.92 19.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 119.049 -1.06 . . . . 71.14 111.767 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.532 ' HD2' ' HB ' ' B' ' 28' ' ' THR . 8.6 tpp180 -101.44 114.08 27.76 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.111 -1.404 . . . . 71.31 108.559 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.65 133.36 51.43 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.584 -0.525 . . . . 71.44 109.584 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.674 HG22 HG22 ' B' ' 28' ' ' THR . 48.2 t -118.85 127.0 75.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.738 0.304 . . . . 71.34 110.967 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.646 HD12 HD12 ' A' ' 29' ' ' ILE . 73.5 mt -102.77 121.87 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 C-N-CA 123.946 0.898 . . . . 75.22 109.039 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.411 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 93.7 m-85 -103.86 114.3 28.46 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.309 -0.997 . . . . 74.22 108.309 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 34' ' ' LEU . 51.1 mm -88.44 112.61 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 106.697 -1.594 . . . . 75.04 106.697 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -121.13 -179.57 4.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 116.424 -0.353 . . . . 74.11 110.181 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -95.93 -17.8 20.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.902 0.382 . . . . 73.24 111.145 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 73.6 ttt180 -98.83 -17.92 18.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.128 0.49 . . . . 73.32 109.842 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . 179.51 -143.07 5.51 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.027 -1.082 . . . . 61.52 113.37 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' B' ' 14' ' ' LEU . 1.9 tm? -139.38 122.86 17.25 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 124.673 1.189 . . . . 74.22 108.04 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -118.53 143.68 46.58 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.961 0.41 . . . . 71.33 110.977 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.57 141.25 46.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.62 -0.718 . . . . 74.42 110.559 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.411 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 62.3 m -127.69 142.17 51.41 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.118 -0.492 . . . . 63.34 111.045 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.04 124.01 48.25 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.187 -0.461 . . . . 33.42 110.202 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 24.2 t70 -118.15 88.09 31.15 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 107.552 -1.277 . . . . 73.14 107.552 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 85.9 Cg_endo . . . . . 0 N--CA 1.42 -2.851 0 C-N-CA 121.64 1.56 . . . . 73.41 114.034 -173.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.671 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 6.1 ppt_? . . . . . 0 N--CA 1.425 -1.701 0 N-CA-C 108.759 -0.83 . . . . 71.44 108.759 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.445 ' CB ' HD13 ' B' ' 14' ' ' LEU . 18.9 p -101.57 148.62 25.01 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 122.112 -0.368 . . . . 71.54 110.959 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.1 m -136.49 157.35 46.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.008 0.432 . . . . 74.41 111.021 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG23 HD11 ' B' ' 14' ' ' LEU . 86.5 t -130.77 134.71 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.58 -0.737 . . . . 52.14 110.776 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -117.93 125.62 50.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.522 -0.547 . . . . 54.24 109.522 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.97 121.77 27.2 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 123.311 0.644 . . . . 72.15 109.817 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 p -125.17 112.79 16.86 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.228 -0.442 . . . . 64.42 111.753 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.587 HG23 ' H ' ' A' ' 17' ' ' GLN . 4.2 t -156.52 -92.07 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.265 1.209 . . . . 74.21 114.265 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.587 ' H ' HG23 ' A' ' 16' ' ' THR . 26.7 tp60 -94.07 91.68 6.95 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.659 0.742 . . . . 74.14 109.198 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 2.5 ppt_? -126.72 149.25 49.68 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.479 -0.782 . . . . 75.14 112.776 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.642 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.2 pt? -110.33 155.19 42.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.283 -1.006 . . . . 70.43 108.283 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.84 136.64 49.93 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.874 1.716 . . . . 43.14 110.986 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.04 144.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.405 -0.816 . . . . 54.3 109.295 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.8 m -87.09 -35.41 18.71 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.259 0.552 . . . . 53.41 111.32 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -123.25 133.14 54.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.782 -0.645 . . . . 54.43 110.976 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.16 115.63 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 107.164 -1.421 . . . . 55.41 107.164 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.1 mmtp -99.35 134.95 41.48 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 120.372 -0.531 . . . . 75.53 110.859 -176.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -114.33 127.16 55.72 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.893 -1.151 . . . . 72.34 107.893 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -120.25 130.39 54.49 Favored 'General case' 0 CA--C 1.457 -2.599 0 CA-C-N 116.224 -0.444 . . . . 75.32 109.992 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.54 HG22 HG22 ' A' ' 37' ' ' VAL . 68.4 p -114.68 122.59 46.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 119.766 -0.773 . . . . 74.24 111.183 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.71 HD12 HD12 ' B' ' 38' ' ' ILE . 89.5 mt -115.82 124.67 72.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.628 -0.878 . . . . 64.13 108.628 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -117.02 116.18 26.86 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.117 0.96 . . . . 71.41 108.794 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.616 ' O ' HD23 ' A' ' 34' ' ' LEU . 15.3 tp10 -136.96 123.18 20.51 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.284 -0.871 . . . . 74.02 110.388 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.81 -84.99 0.37 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.21 -0.756 . . . . 72.14 111.21 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.424 ' HB2' HD22 ' B' ' 19' ' ' LEU . 33.6 m -150.47 10.56 0.66 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 122.726 -0.279 . . . . 63.24 111.06 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -114.81 140.21 49.11 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 119.193 -1.003 . . . . 73.41 111.584 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -100.08 118.05 35.62 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.112 -0.949 . . . . 62.21 108.781 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.07 116.18 31.48 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.471 -0.566 . . . . 70.11 109.471 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 28' ' ' THR . 60.1 t -108.48 120.7 60.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.167 0.508 . . . . 71.34 110.179 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.66 HD12 HD12 ' B' ' 29' ' ' ILE . 95.0 mt -101.34 124.7 55.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 115.147 -0.933 . . . . 64.32 108.721 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -106.92 115.14 29.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.378 -0.971 . . . . 63.11 108.378 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.69 HD12 HD23 ' B' ' 34' ' ' LEU . 37.3 mm -90.69 114.53 28.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.326 -1.361 . . . . 72.43 107.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -129.47 156.46 44.08 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 120.543 -0.463 . . . . 73.24 110.609 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.529 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -67.4 -13.74 62.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.447 0.699 . . . . 73.42 110.793 -178.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -87.18 -22.56 25.21 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.724 -0.473 . . . . 70.21 109.724 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.17 -138.02 6.5 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.259 -0.972 . . . . 72.02 113.629 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -113.37 128.59 56.51 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.159 0.504 . . . . 62.44 110.597 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 54.4 tptt -137.1 127.96 27.34 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.454 -1.313 . . . . 65.41 107.454 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG11 HG21 ' B' ' 47' ' ' VAL . 9.9 p -132.1 139.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 110.599 -0.149 . . . . 63.13 110.599 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.4 137.71 54.02 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.621 0.248 . . . . 65.54 110.446 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.79 43.07 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.411 -0.359 . . . . 43.35 110.245 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -115.0 104.62 53.89 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.334 -0.848 . . . . 63.54 109.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 89.3 Cg_endo -94.73 134.72 0.72 Allowed 'Trans proline' 0 N--CA 1.427 -2.408 0 C-N-CA 121.712 1.608 . . . . 72.1 114.641 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG2' ' HB3' ' A' ' 33' ' ' SER . 41.7 mt-30 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 126.446 1.898 . . . . 75.44 115.546 170.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 69.2 mtt180 . . . . . 0 N--CA 1.433 -1.29 0 N-CA-C 108.003 -1.11 . . . . 75.22 108.003 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -87.8 143.42 27.15 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.168 -0.924 . . . . 71.34 112.378 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 66.8 m -141.51 149.45 40.88 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.114 -1.069 . . . . 53.24 108.114 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.58 146.21 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 110.339 -0.245 . . . . 62.14 110.339 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 22.5 p -107.26 135.51 48.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.214 0.606 . . . . 70.15 110.767 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.519 HD11 HG23 ' A' ' 12' ' ' VAL . 96.7 mt -116.73 130.59 56.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.122 -0.49 . . . . 73.45 110.642 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -101.66 122.67 44.32 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.871 -0.789 . . . . 52.34 108.871 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.7 t -151.27 -174.96 4.98 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 120.725 0.298 . . . . 75.13 110.58 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -72.06 86.42 1.03 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.522 0.729 . . . . 74.34 109.947 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -126.52 149.24 49.49 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 114.204 1.187 . . . . 71.35 114.204 -179.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.553 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.7 pt? -78.5 134.73 61.56 Favored Pre-proline 0 C--N 1.29 -1.996 0 CA-C-N 114.944 -1.025 . . . . 70.41 109.361 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.96 136.33 34.85 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.093 1.862 . . . . 54.53 111.468 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' B' ' 42' ' ' LYS . 10.9 p -131.29 133.27 62.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.372 -0.831 . . . . 54.23 108.912 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.4 m -84.79 -13.43 51.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.084 0.468 . . . . 73.15 111.928 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.47 ' H ' HG22 ' B' ' 21' ' ' VAL . 30.5 mmm180 -105.94 133.83 50.04 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.812 -0.81 . . . . 75.22 108.812 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -94.29 115.39 32.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.591 -0.892 . . . . 62.25 108.591 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.65 128.72 39.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.905 -0.588 . . . . 71.43 110.39 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.2 p -110.63 127.98 55.49 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.457 -0.792 . . . . 42.04 109.951 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.481 ' HB3' HD13 ' A' ' 29' ' ' ILE . 70.4 m-85 -126.19 127.44 45.7 Favored 'General case' 0 CA--C 1.459 -2.549 0 CA-C-N 115.887 -0.597 . . . . 74.45 110.674 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.546 HG22 HG22 ' B' ' 37' ' ' VAL . 78.0 p -115.14 139.54 49.83 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.942 -1.026 . . . . 72.23 110.802 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 38' ' ' ILE . 49.4 mt -136.89 133.84 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.674 -0.491 . . . . 74.2 109.674 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -117.47 131.91 56.65 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.636 -0.505 . . . . 72.14 109.636 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.416 ' OE1' ' HG3' ' A' ' 25' ' ' LYS . 10.9 tp10 -142.43 114.77 8.38 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.636 -0.711 . . . . 73.51 109.788 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -76.73 0.86 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.118 -0.793 . . . . 72.14 111.118 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 39.8 m -156.92 10.52 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.625 -1.25 . . . . 71.31 107.625 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.69 HD23 HD12 ' A' ' 40' ' ' ILE . 45.5 tp -95.52 115.67 27.76 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 115.28 -0.873 . . . . 72.23 108.871 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -107.12 113.54 27.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.983 -1.118 . . . . 71.3 107.983 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.45 34.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.882 -0.414 . . . . 71.1 109.882 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.546 HG22 HG22 ' B' ' 28' ' ' THR . 67.1 t -129.0 129.97 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.849 -0.426 . . . . 44.03 109.849 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 29' ' ' ILE . 80.1 mt -114.78 125.15 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 109.09 -0.707 . . . . 63.21 109.09 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 64.6 m-85 -106.84 116.68 32.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.534 -1.284 . . . . 74.32 107.534 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.17 114.28 26.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 105.922 -1.881 . . . . 63.54 105.922 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -125.6 156.74 38.68 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.117 0.484 . . . . 51.12 110.593 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' B' ' 21' ' ' VAL . 0.1 OUTLIER -60.03 -25.91 65.69 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.47 -0.786 . . . . 72.24 112.435 -177.571 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -97.1 -8.29 30.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.515 -0.474 . . . . 73.52 111.528 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.0 -153.88 24.79 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 118.305 -1.902 . . . . 70.45 114.547 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.5 HD12 HD12 ' B' ' 14' ' ' LEU . 3.2 tm? -113.66 122.28 46.69 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.19 -1.041 . . . . 64.13 108.19 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 56.9 tptt -117.38 122.13 42.98 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.004 -1.11 . . . . 62.21 108.004 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 47' ' ' VAL . 11.1 p -115.42 139.7 40.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 110.338 -0.245 . . . . 74.54 110.338 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.28 140.44 52.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.127 -0.488 . . . . 60.43 111.585 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.57 124.16 48.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 108.817 -0.809 . . . . 64.15 108.817 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' B' ' 9' ' ' ARG . 15.1 t70 -119.07 95.23 49.18 Favored Pre-proline 0 C--N 1.284 -2.249 0 N-CA-C 104.875 -2.268 . . . . 63.21 104.875 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.408 ' CD ' ' HG2' ' B' ' 9' ' ' ARG . 79.5 Cg_endo . . . . . 0 N--CA 1.429 -2.275 0 C-N-CA 121.935 1.757 . . . . 71.13 116.357 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.437 ' HD3' ' OD1' ' A' ' 50' ' ' ASP . 18.0 ptt180 . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 121.635 0.731 . . . . 74.02 110.892 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -96.97 148.83 22.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.931 -1.032 . . . . 55.35 111.945 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -127.21 156.23 42.16 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.396 -0.964 . . . . 52.21 108.396 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG2' HD21 ' B' ' 14' ' ' LEU . 94.2 t -134.49 140.76 45.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.663 0.268 . . . . 54.53 110.661 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 p -109.83 125.83 53.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.44 -0.948 . . . . 71.51 108.44 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.51 HD12 HD23 ' A' ' 45' ' ' LEU . 86.5 mt -109.57 127.84 54.78 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.018 0.437 . . . . 65.13 111.987 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.93 114.1 25.79 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.434 -0.95 . . . . 64.1 108.434 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -143.6 -169.89 3.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.861 -1.163 . . . . 64.13 107.861 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.65 99.76 1.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 72.11 109.645 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -125.44 148.38 48.85 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.792 1.034 . . . . 73.04 113.792 -175.311 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' B' ' 33' ' ' SER . 1.7 pp -102.46 161.75 22.32 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 114.094 -1.412 . . . . 71.3 108.9 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.62 135.98 51.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.587 1.525 . . . . 62.53 111.647 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.7 t -123.91 124.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.347 -0.982 . . . . 64.01 108.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.0 m -86.5 -56.39 3.45 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.432 0.53 . . . . 70.11 112.432 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -93.47 133.39 36.81 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.138 -0.625 . . . . 74.52 110.109 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -83.27 123.31 38.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.533 -0.914 . . . . 65.41 108.533 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -106.5 143.01 35.22 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.318 -0.401 . . . . 74.5 110.303 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -119.72 127.69 53.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.684 -0.858 . . . . 75.03 108.684 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 78.4 m-85 -124.44 130.26 52.15 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-N 115.994 -0.548 . . . . 65.34 110.806 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.526 HG22 HG22 ' A' ' 37' ' ' VAL . 44.9 p -115.22 125.03 52.87 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.103 -0.953 . . . . 71.1 112.158 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.582 HD12 HD12 ' B' ' 38' ' ' ILE . 59.5 mt -129.9 128.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.299 -0.63 . . . . 63.52 109.299 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -119.46 137.16 53.96 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.44 -0.948 . . . . 72.45 108.44 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.567 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.86 111.37 6.23 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.814 0.34 . . . . 73.54 110.195 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.64 -67.94 3.28 Favored Glycine 0 C--N 1.298 -1.528 0 C-N-CA 120.749 -0.738 . . . . 74.22 112.572 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.2 m -156.93 -16.21 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.791 0.437 . . . . 44.55 112.063 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -88.67 140.59 29.3 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 118.468 -1.293 . . . . 64.22 110.615 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 19.8 mmt180 -103.49 119.37 38.76 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.951 -1.5 . . . . 75.24 106.951 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.98 124.74 51.95 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.215 -0.661 . . . . 73.11 109.215 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.526 HG22 HG22 ' A' ' 28' ' ' THR . 99.1 t -117.02 125.52 73.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.035 0.445 . . . . 71.45 111.417 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.564 HD12 HD12 ' B' ' 29' ' ' ILE . 92.4 mt -104.59 121.45 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 C-N-CA 124.033 0.933 . . . . 70.05 109.144 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.0 m-85 -108.54 117.15 33.42 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.767 -1.197 . . . . 71.54 107.767 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.629 HG23 HD21 ' B' ' 34' ' ' LEU . 45.9 mm -88.41 118.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.674 -0.861 . . . . 75.2 108.674 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -134.59 171.95 13.61 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.5 0.667 . . . . 62.01 110.402 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 42' ' ' LYS . 19.4 ptmt -77.21 -15.38 59.51 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.879 0.872 . . . . 75.04 110.419 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -87.88 10.42 18.71 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.162 -1.422 . . . . 73.11 107.162 -177.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -124.73 8.0 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.626 -1.17 . . . . 74.3 112.549 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 14' ' ' LEU . 64.4 tp -112.26 135.04 53.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.865 -0.421 . . . . 74.01 109.865 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.511 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 1.5 tmtm? -128.85 122.4 30.32 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.158 -2.164 . . . . 62.43 105.158 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG11 HG11 ' B' ' 47' ' ' VAL . 13.6 p -128.29 140.96 47.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 110.171 -0.307 . . . . 72.41 110.171 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 93.7 m -121.07 143.12 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 122.319 0.248 . . . . 43.32 111.035 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.45 123.85 48.51 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.044 -0.724 . . . . 64.34 109.044 177.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 18.5 t70 -124.25 100.53 35.76 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 107.693 -1.225 . . . . 73.14 107.693 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.13 134.19 4.27 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 122.067 1.845 . . . . 32.31 115.143 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.474 ' NE2' ' HG3' ' B' ' 17' ' ' GLN . 49.9 mt-30 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 113.916 -1.493 . . . . 61.34 112.006 169.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 109.292 -0.632 . . . . 44.51 109.292 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.8 p -92.45 145.65 24.29 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.311 -0.404 . . . . 42.41 111.631 -175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.21 149.44 47.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.7 -0.481 . . . . 75.12 109.7 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -142.74 148.73 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.915 0.486 . . . . 72.21 110.147 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 60.5 p -110.62 146.21 36.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 122.482 0.313 . . . . 61.34 110.343 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.499 HD21 ' CG2' ' A' ' 12' ' ' VAL . 96.2 mt -125.74 125.74 43.47 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 123.053 0.541 . . . . 65.44 111.079 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.7 p -104.69 114.31 28.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.939 -0.763 . . . . 71.01 108.939 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -166.75 120.19 1.03 Allowed 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.225 0.328 . . . . 73.24 110.671 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLN . . . . . 0.474 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 6.6 tp-100 34.89 72.55 0.09 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.04 1.736 . . . . 64.52 112.252 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.647 ' NH2' HG21 ' B' ' 21' ' ' VAL . 24.5 tpt180 -126.11 109.98 13.0 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 119.673 -0.811 . . . . 60.04 112.512 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.23 153.88 88.28 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 114.368 -1.287 . . . . 43.33 112.313 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.16 135.63 65.16 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.52 2.813 . . . . 72.15 114.2 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.647 HG21 ' NH2' ' B' ' 18' ' ' ARG . 55.9 t -132.11 137.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.268 -1.333 . . . . 74.41 107.998 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 38.3 m -92.56 -26.94 17.67 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.467 0.914 . . . . 71.05 113.467 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -127.69 154.61 45.1 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.36 0.504 . . . . 70.13 112.36 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.94 132.75 47.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.76 -0.459 . . . . 50.22 109.76 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.511 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 39.8 mmtm -106.27 159.72 15.9 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.638 -0.425 . . . . 64.12 110.028 177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -133.67 126.41 30.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.038 -1.097 . . . . 72.41 108.038 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 74.3 m-85 -126.57 128.6 47.08 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.48 -0.327 . . . . 54.11 110.795 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.608 HG22 HG22 ' B' ' 37' ' ' VAL . 62.2 p -115.93 135.66 53.77 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.858 0.724 . . . . 74.34 111.3 -176.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.564 HD12 HD12 ' A' ' 38' ' ' ILE . 58.4 mt -131.13 127.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.184 -0.462 . . . . 75.42 109.937 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.404 ' HB ' ' NE ' ' B' ' 35' ' ' ARG . 11.5 t -104.35 123.99 48.39 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.226 0.536 . . . . 73.31 109.682 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.668 ' O ' HD23 ' B' ' 34' ' ' LEU . 10.6 tp10 -142.88 123.55 14.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.65 -0.5 . . . . 73.3 109.65 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.08 -77.71 0.3 Allowed Glycine 0 C--O 1.217 -0.938 0 N-CA-C 111.208 -0.757 . . . . 64.33 111.208 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.416 ' HB2' HD21 ' A' ' 19' ' ' LEU . 69.4 m -157.65 -0.22 0.11 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.838 0.855 . . . . 54.42 110.847 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.668 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -101.34 137.84 39.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.422 -1.311 . . . . 54.44 110.106 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.442 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 38.3 mmm-85 -100.92 122.82 44.14 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.285 -1.376 . . . . 64.23 107.285 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.87 117.77 35.12 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.949 -1.13 . . . . 55.01 107.949 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.608 HG22 HG22 ' B' ' 28' ' ' THR . 58.0 t -110.29 128.05 66.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.37 0.605 . . . . 64.11 110.308 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 29' ' ' ILE . 85.3 mt -111.55 120.08 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.908 -1.042 . . . . 64.12 109.257 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 95.8 m-85 -102.65 116.43 32.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.965 -1.124 . . . . 72.43 107.965 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.547 HD12 HD21 ' A' ' 34' ' ' LEU . 49.7 mm -88.47 114.03 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.28 -1.007 . . . . 63.24 108.28 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 t -127.3 169.47 13.51 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 115.623 -0.717 . . . . 70.2 109.729 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -83.0 -13.48 55.87 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.746 -0.465 . . . . 73.55 109.746 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.66 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.5 tmt_? -87.68 3.17 48.92 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.317 1.056 . . . . 65.43 108.6 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' B' ' 18' ' ' ARG . . . 128.17 -138.42 10.37 Favored Glycine 0 CA--C 1.504 -0.608 0 CA-C-N 115.26 -0.882 . . . . 75.42 113.087 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 68.1 tp -112.24 126.05 54.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.733 -0.84 . . . . 74.21 108.733 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 1.8 tmtm? -116.78 121.13 40.69 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.526 -2.027 . . . . 73.05 105.526 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 47' ' ' VAL . 14.0 p -116.58 140.84 37.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 116.639 -0.255 . . . . 72.31 110.722 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.523 ' SG ' ' HE3' ' B' ' 46' ' ' LYS . 68.4 m -130.41 140.78 50.56 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.656 0.382 . . . . 73.51 111.237 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -116.2 123.25 47.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.564 -0.902 . . . . 73.33 108.564 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 13.7 t70 -122.42 103.0 38.83 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.877 -1.157 . . . . 71.21 107.877 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 N--CA 1.434 -1.976 0 C-N-CA 122.263 1.975 . . . . 74.45 116.549 -173.911 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 108.315 -0.994 . . . . 70.4 108.315 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -87.73 135.65 33.28 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.822 -0.627 . . . . 53.2 111.406 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.6 m -130.38 148.45 52.2 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.201 -0.666 . . . . 53.31 109.201 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.9 t -144.66 141.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.473 -0.331 . . . . 62.12 110.174 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 p -109.24 130.71 55.49 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.21 0.528 . . . . 71.35 109.896 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.73 120.33 40.18 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.448 -1.686 . . . . 73.12 106.448 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.5 m -97.26 111.71 23.83 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.831 -1.544 . . . . 54.11 106.831 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' B' ' 51' ' ' PRO . 8.6 t -133.47 154.11 51.07 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.206 -0.907 . . . . 51.12 110.199 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -72.4 99.44 2.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.888 0.852 . . . . 65.1 110.383 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -126.71 148.47 49.86 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.079 -1.452 . . . . 53.24 107.079 178.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.677 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.4 pt? -73.19 127.71 88.78 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.191 -1.041 . . . . 74.13 108.191 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.86 152.91 60.52 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 123.904 3.07 . . . . 72.42 116.772 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 13.1 p -131.82 149.18 32.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.298 -1.774 . . . . 74.0 106.908 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.6 m -102.1 16.24 26.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.751 -0.38 . . . . 74.23 111.53 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -134.0 152.79 51.99 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 122.196 -0.315 . . . . 71.15 110.795 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -101.72 132.12 48.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.955 -0.757 . . . . 73.12 108.955 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 14.0 mmmm -121.65 126.28 48.63 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.602 -0.888 . . . . 44.53 108.602 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -106.38 127.75 53.51 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.092 -0.707 . . . . 42.53 109.092 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -123.89 126.58 46.64 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.123 -0.489 . . . . 61.03 110.865 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.59 HG22 HG22 ' A' ' 37' ' ' VAL . 81.6 p -115.04 131.42 56.93 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.213 -0.903 . . . . 71.43 111.106 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.597 HD12 HD12 ' B' ' 38' ' ' ILE . 52.8 mt -128.63 121.54 55.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.173 -0.677 . . . . 54.42 109.173 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -111.48 128.26 55.95 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.737 -1.208 . . . . 71.54 107.737 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.3 tp10 -140.4 119.44 12.73 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.145 -176.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.91 -86.76 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 116.164 -0.471 . . . . 73.34 112.937 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.473 ' CB ' HD21 ' B' ' 19' ' ' LEU . 40.5 m -142.58 15.34 1.98 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.012 0.434 . . . . 74.5 110.446 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.657 HD21 HG23 ' B' ' 40' ' ' ILE . 2.0 pt? -127.35 141.35 51.72 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.552 -0.459 . . . . 72.45 109.841 176.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -122.14 131.82 54.15 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.685 -0.689 . . . . 54.15 110.169 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.47 143.88 49.0 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.248 -0.433 . . . . 63.34 110.435 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 28' ' ' THR . 96.6 t -124.85 127.05 72.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.067 -0.515 . . . . 72.53 110.986 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.568 HD12 HD12 ' B' ' 29' ' ' ILE . 75.8 mt -103.43 122.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 C-N-CA 123.984 0.914 . . . . 71.52 109.174 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.9 m-85 -106.1 114.8 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.427 -0.953 . . . . 75.51 108.427 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.608 HG23 HD21 ' B' ' 34' ' ' LEU . 42.0 mm -88.51 114.67 27.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.416 -0.811 . . . . 71.42 108.834 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -126.96 162.05 26.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.662 -0.699 . . . . 53.41 109.405 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -71.11 -0.69 10.18 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 121.037 0.446 . . . . 75.42 112.087 173.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -87.69 -22.07 24.86 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.304 -0.998 . . . . 65.33 108.304 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.555 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 133.77 -119.93 2.4 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.849 -1.068 . . . . 61.23 110.844 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.4 tp -115.51 143.88 44.67 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 115.236 -0.482 . . . . 74.23 111.18 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -140.87 139.56 34.43 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.949 -0.76 . . . . 55.21 108.949 170.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.01 141.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 116.332 -0.394 . . . . 75.53 111.134 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.414 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 49.5 m -120.2 139.29 52.87 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.979 -0.555 . . . . 63.04 110.684 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HB1' HH22 ' B' ' 18' ' ' ARG . . . -116.53 125.28 51.67 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.001 -0.545 . . . . 74.4 110.448 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -124.43 108.92 29.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.046 -0.525 . . . . 74.32 109.833 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HB3' ' NE ' ' B' ' 18' ' ' ARG . 73.6 Cg_endo -94.22 134.26 0.82 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 121.786 1.657 . . . . 30.11 114.99 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 . . . . . 0 CA--C 1.556 1.185 0 CA-C-N 114.049 -1.432 . . . . 62.53 114.065 165.616 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 . . . . . 0 C--O 1.237 0.419 0 N-CA-C 110.241 -0.281 . . . . 74.4 110.241 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -87.77 128.74 35.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 110.267 -0.272 . . . . 52.14 110.267 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 82.2 m -129.88 149.37 51.65 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.831 -0.433 . . . . 74.12 109.831 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.2 t -144.14 138.57 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.47 0.481 . . . . 73.34 110.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -107.58 129.01 55.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.311 0.577 . . . . 60.21 111.499 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.82 121.67 44.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.387 -0.824 . . . . 70.11 109.754 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 18.0 m -106.82 116.19 31.49 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 108.056 -1.091 . . . . 73.45 108.056 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -138.68 -169.76 2.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.287 -0.87 . . . . 72.22 108.763 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -74.12 93.7 2.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.607 -0.886 . . . . 61.12 108.607 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.52 ' NE ' ' HB3' ' A' ' 51' ' ' PRO . 8.5 tpp85 -127.51 133.94 49.81 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.696 -0.853 . . . . 74.05 108.696 -177.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -74.95 162.63 72.68 Favored Pre-proline 0 C--N 1.294 -1.832 0 CA-C-N 116.232 -0.44 . . . . 71.41 111.705 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 36.0 Cg_endo -66.73 147.95 82.07 Favored 'Trans proline' 0 C--O 1.254 1.32 0 C-N-CA 122.123 1.882 . . . . 71.34 112.17 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -125.78 146.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.244 -1.021 . . . . 63.11 108.244 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 m -67.73 -53.15 29.77 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 123.104 0.253 . . . . 62.23 111.574 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -125.36 151.31 46.27 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 110.018 -0.364 . . . . 73.32 110.018 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.75 114.58 23.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.762 -1.199 . . . . 61.23 107.762 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.15 148.19 22.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.587 -0.523 . . . . 71.22 109.587 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.7 m -128.46 127.54 42.68 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.075 -1.083 . . . . 64.4 108.075 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -123.59 127.14 47.86 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-O 121.046 0.45 . . . . 74.54 111.296 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.582 HG22 HG22 ' B' ' 37' ' ' VAL . 76.7 p -114.52 132.99 56.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 114.879 -1.055 . . . . 75.54 110.02 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 38' ' ' ILE . 51.2 mt -129.51 120.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 109.285 -0.635 . . . . 63.42 109.285 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 7.2 t -100.12 124.66 45.77 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.908 -1.145 . . . . 75.13 107.908 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.493 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.0 tp10 -142.41 101.0 3.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.92 -0.582 . . . . 75.12 112.353 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.85 -67.65 0.45 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 116.071 1.188 . . . . 72.31 116.071 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 42.1 m -137.8 -3.38 1.85 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.458 0.54 . . . . 54.34 112.458 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 40' ' ' ILE . 2.3 pt? -140.65 141.09 35.09 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 120.235 -0.586 . . . . 72.32 109.883 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -109.48 125.42 52.44 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 119.558 -0.857 . . . . 71.25 108.885 171.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.27 145.0 30.86 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.564 -0.289 . . . . 71.45 110.777 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.582 HG22 HG22 ' B' ' 28' ' ' THR . 95.0 t -124.05 128.18 73.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.888 -0.596 . . . . 72.21 110.725 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 29' ' ' ILE . 68.9 mt -108.36 123.78 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 C-N-CA 124.334 1.054 . . . . 75.22 109.454 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.442 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 99.1 m-85 -103.29 120.19 40.29 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.859 -0.793 . . . . 75.45 108.859 175.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.657 HG23 HD21 ' A' ' 34' ' ' LEU . 39.7 mm -87.73 114.47 26.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 107.688 -1.227 . . . . 62.43 107.688 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -135.34 154.97 51.33 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.917 -0.583 . . . . 75.54 111.263 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.728 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -71.77 -14.7 62.07 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.972 -0.558 . . . . 71.0 111.219 177.544 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' B' ' 15' ' ' THR . 54.0 mtp180 -86.34 -16.19 38.2 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.536 0.684 . . . . 73.34 109.366 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.16 -108.16 0.44 Allowed Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 119.916 -1.135 . . . . 31.52 112.67 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 53.0 tp -139.36 143.7 37.87 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.833 -0.684 . . . . 64.33 109.47 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -131.5 140.46 49.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.262 -1.014 . . . . 75.33 108.262 167.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.7 140.48 48.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.719 -0.673 . . . . 63.4 110.209 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.492 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 36.5 m -127.58 141.11 51.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.88 -0.6 . . . . 73.25 110.967 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.38 124.39 49.93 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.899 -0.591 . . . . 71.42 110.308 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -110.72 95.91 25.87 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.014 -1.106 . . . . 53.52 108.014 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.485 ' HG3' ' OG1' ' A' ' 16' ' ' THR . 93.6 Cg_endo . . . . . 0 N--CA 1.411 -3.361 0 C-N-CA 120.097 0.531 . . . . 74.42 111.597 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 . . . . . 0 CA--C 1.476 -1.889 0 N-CA-C 107.665 -1.235 . . . . 73.4 107.665 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -108.04 134.98 50.17 Favored 'General case' 0 C--N 1.272 -2.792 0 C-N-CA 120.077 -0.649 . . . . 64.44 111.073 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.3 m -125.55 147.56 49.22 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.606 -0.516 . . . . 75.42 109.606 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -145.99 147.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.721 0.808 . . . . 73.43 109.741 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 17.9 t -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.222 -0.659 . . . . 73.21 109.222 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.7 mm? -101.47 132.39 47.11 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 123.572 0.749 . . . . 74.14 110.522 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -99.84 110.93 23.28 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.108 0.956 . . . . 75.31 109.474 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.0 p -140.95 179.81 6.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.082 -0.963 . . . . 75.33 110.68 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' B' ' 51' ' ' PRO . 22.3 tp60 -67.55 95.8 0.49 Allowed 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.839 -0.8 . . . . 74.13 108.839 174.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.54 149.37 45.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.826 -0.749 . . . . 73.12 110.999 -173.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mp -77.04 140.3 66.26 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 106.159 -1.793 . . . . 74.02 106.159 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.68 134.66 45.05 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.023 1.149 . . . . 62.24 109.551 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.52 138.87 48.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.8 -0.637 . . . . 73.55 110.108 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.2 m -90.28 -58.98 2.31 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.184 -0.462 . . . . 74.52 111.022 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -89.78 133.99 34.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.834 -0.432 . . . . 73.41 109.834 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.23 122.56 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.637 -0.505 . . . . 65.44 109.637 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.43 153.94 20.44 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.057 0.456 . . . . 70.43 110.994 178.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.4 m -132.69 127.97 35.94 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.459 -0.941 . . . . 55.42 108.459 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' B' ' 29' ' ' ILE . 72.5 m-85 -127.35 126.8 43.17 Favored 'General case' 0 CA--C 1.467 -2.245 0 CA-C-N 115.863 -0.608 . . . . 63.04 110.088 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 37' ' ' VAL . 69.2 p -115.82 131.69 56.86 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.317 -0.856 . . . . 71.23 111.795 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.596 HD12 HD12 ' B' ' 38' ' ' ILE . 49.4 mt -131.27 124.57 55.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.129 -0.487 . . . . 50.4 109.867 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -102.45 132.46 48.47 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.46 -0.941 . . . . 74.43 108.46 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.5 tp10 -140.25 106.44 5.24 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.271 -0.64 . . . . 64.23 109.271 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -96.97 0.33 Allowed Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.823 -0.626 . . . . 64.22 112.289 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -120.34 1.53 10.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 111.983 0.364 . . . . 64.42 111.983 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.4 pt? -118.14 140.87 49.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.891 -1.124 . . . . 74.31 111.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.62 120.94 43.6 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.618 -1.174 . . . . 72.03 108.114 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.28 128.91 52.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.847 -0.797 . . . . 75.35 108.847 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 28' ' ' THR . 67.1 t -119.1 135.23 60.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.017 0.437 . . . . 63.24 110.693 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.772 HD12 HD12 ' B' ' 29' ' ' ILE . 72.4 mt -116.14 131.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-N 115.525 -0.761 . . . . 62.4 109.966 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 99.2 m-85 -115.22 120.61 40.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.387 -0.968 . . . . 74.44 108.387 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.622 HG13 ' HG2' ' B' ' 31' ' ' GLU . 32.1 mm -92.59 114.88 30.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.065 -1.457 . . . . 75.44 107.065 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -120.32 178.23 4.73 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.897 -0.592 . . . . 75.45 111.426 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -71.77 -16.7 62.2 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.559 0.695 . . . . 73.43 110.112 175.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.563 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 75.9 ttt180 -90.17 -12.62 37.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.718 -1.128 . . . . 63.04 108.176 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -109.84 1.42 Allowed Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 114.526 -1.215 . . . . 63.22 112.216 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.45 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 64.1 tp -113.06 143.78 43.75 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.15 -0.525 . . . . 74.04 110.26 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 87.2 tttt -141.01 142.85 34.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.041 -0.725 . . . . 65.04 109.041 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.7 140.59 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-N 115.615 -0.72 . . . . 64.41 109.677 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.4 m -126.76 142.02 51.66 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.561 -0.745 . . . . 74.42 110.687 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -114.82 124.78 52.62 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.659 -0.701 . . . . 72.04 109.574 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -126.3 90.02 50.97 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.479 -0.934 . . . . 72.23 108.479 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 97.7 Cg_endo -103.13 148.39 0.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 122.952 2.435 . . . . 73.13 115.045 -177.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' B' ' 18' ' ' ARG . 17.7 mt-30 . . . . . 0 C--O 1.244 0.789 0 CA-C-N 113.83 -1.532 . . . . 64.44 114.616 163.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 . . . . . 0 N--CA 1.437 -1.094 0 N-CA-C 109.831 -0.433 . . . . 74.22 109.831 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -103.25 148.47 25.77 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.177 0.513 . . . . 52.4 111.469 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 67.9 m -134.61 149.4 50.57 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.906 -1.146 . . . . 73.22 107.906 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -141.56 143.05 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.192 0.308 . . . . 60.24 110.253 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 47.1 t -107.26 137.13 45.88 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.806 -0.812 . . . . 22.41 108.806 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.15 121.47 43.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.394 -0.821 . . . . 72.14 109.641 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 9.6 p -95.19 111.52 23.35 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.369 -0.974 . . . . 71.31 108.369 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -126.75 165.62 18.93 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.92 -1.037 . . . . 60.4 109.086 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -70.59 105.84 3.27 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.468 -1.678 . . . . 74.43 106.468 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.641 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 35.4 mmm-85 -125.98 148.37 49.28 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 117.639 2.459 . . . . 71.23 117.639 -168.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.631 ' HG ' ' CD ' ' A' ' 52' ' ' GLN . 68.9 mt -84.79 131.61 48.8 Favored Pre-proline 0 C--O 1.255 1.391 0 CA-C-N 112.878 -1.965 . . . . 74.31 106.469 168.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.56 136.23 41.99 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.909 1.739 . . . . 72.31 111.626 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.422 HG12 ' H ' ' B' ' 23' ' ' ARG . 94.7 t -114.03 135.14 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.968 -1.015 . . . . 51.34 108.452 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -78.18 -22.58 48.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.058 0.762 . . . . 51.13 113.058 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.422 ' H ' HG12 ' B' ' 21' ' ' VAL . 14.7 tpt180 -127.95 139.44 52.58 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.596 -0.841 . . . . 74.45 109.61 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' B' ' 41' ' ' THR . 50.4 mm -90.9 138.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.597 -0.52 . . . . 71.34 109.597 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -118.39 157.18 27.64 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.451 0.643 . . . . 74.21 112.134 178.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.1 m -133.5 126.4 31.01 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.973 -1.012 . . . . 70.3 108.952 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.43 ' HB2' ' HB ' ' B' ' 38' ' ' ILE . 68.7 m-85 -124.77 135.77 53.26 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 116.121 -0.49 . . . . 74.33 111.43 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.556 HG22 HG22 ' B' ' 37' ' ' VAL . 44.9 p -115.17 128.36 56.13 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.196 -0.911 . . . . 75.22 111.278 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.772 HD12 HD12 ' A' ' 38' ' ' ILE . 72.0 mt -124.7 127.72 72.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.286 0.634 . . . . 71.1 109.578 177.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -112.83 128.41 56.44 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 109.515 -0.55 . . . . 75.15 109.515 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.622 ' HG2' HG13 ' A' ' 40' ' ' ILE . 11.5 tp10 -132.06 97.87 4.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.412 0.625 . . . . 70.24 110.205 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.49 -74.41 1.08 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 114.742 -1.117 . . . . 71.04 112.421 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.1 t -144.94 -1.62 0.85 Allowed 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.658 0.742 . . . . 64.24 109.075 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.552 HD23 HD12 ' A' ' 40' ' ' ILE . 35.5 tp -99.32 118.63 36.4 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 115.89 -0.595 . . . . 63.55 110.71 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 21.2 tpp180 -98.86 114.75 27.47 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.513 -0.767 . . . . 72.45 109.657 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.13 136.26 48.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 110.087 -0.338 . . . . 72.03 110.087 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.556 HG22 HG22 ' B' ' 28' ' ' THR . 97.0 t -121.52 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.866 0.365 . . . . 74.22 111.341 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.596 HD12 HD12 ' A' ' 29' ' ' ILE . 82.8 mt -105.73 117.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 C-N-CA 124.586 1.154 . . . . 74.2 109.175 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.522 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.1 m-85 -102.78 116.22 32.13 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.893 -0.78 . . . . 71.12 108.893 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 34' ' ' LEU . 47.1 mm -89.06 113.54 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.187 -1.412 . . . . 73.4 107.187 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' THR . . . . . 0.408 ' HA ' HD12 ' B' ' 24' ' ' ILE . 39.7 p -115.03 170.17 8.55 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 116.136 -0.484 . . . . 72.2 110.201 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.551 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -80.48 -19.93 44.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.854 0.359 . . . . 53.15 111.346 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.551 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 70.2 ttt180 -94.97 -17.49 21.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.59 0.71 . . . . 75.01 109.905 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.526 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . 164.08 -128.94 1.9 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.427 -1.368 . . . . 55.01 113.921 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.409 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 67.7 tp -130.41 147.36 52.1 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 109.031 -0.729 . . . . 61.52 109.031 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 85.5 tttt -139.75 143.16 36.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.148 -0.686 . . . . 73.53 109.148 172.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 13.7 p -130.45 140.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.877 -0.602 . . . . 74.42 109.915 -175.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.522 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.6 m -124.84 138.51 54.26 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.37 -0.377 . . . . 72.4 110.839 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -115.86 124.75 51.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.082 -0.508 . . . . 71.14 112.034 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 18.0 t70 -122.37 95.84 46.64 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 108.636 -0.876 . . . . 63.25 108.636 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.491 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 56.5 Cg_endo . . . . . 0 N--CA 1.411 -3.364 0 C-N-CA 121.456 1.438 . . . . 64.4 113.48 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 3.8 ppt_? . . . . . 0 N--CA 1.413 -2.315 0 N-CA-C 108.272 -1.01 . . . . 74.23 108.272 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -94.18 138.97 31.61 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 115.912 -0.586 . . . . 64.22 111.141 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 79.7 m -137.13 147.6 46.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.454 -0.943 . . . . 53.14 108.454 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG11 HG11 ' B' ' 12' ' ' VAL . 53.9 t -144.4 144.42 22.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 123.078 0.236 . . . . 74.12 110.38 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -107.24 138.26 43.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 109.408 -0.59 . . . . 53.55 109.408 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mp -114.91 133.67 55.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.467 -0.333 . . . . 70.04 110.618 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 p -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.599 0.714 . . . . 72.22 111.319 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -150.05 167.87 25.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.942 -1.503 . . . . 72.32 106.942 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 100.44 1.46 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 122.368 1.08 . . . . 61.41 111.905 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -125.64 139.98 53.1 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.108 -0.951 . . . . 62.12 110.219 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.46 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.9 mm? -74.73 141.73 76.15 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.973 -1.012 . . . . 75.01 109.067 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.07 135.89 42.38 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.171 1.914 . . . . 73.24 111.784 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 23' ' ' ARG . 11.6 p -131.98 136.15 57.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.006 -1.109 . . . . 73.41 108.006 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 m -84.23 2.18 41.13 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.371 0.508 . . . . 73.1 112.371 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 21' ' ' VAL . 29.0 mmm180 -116.56 155.66 28.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.529 -0.545 . . . . 65.34 109.529 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.22 114.88 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.035 0 N-CA-C 105.121 -2.177 . . . . 73.04 105.121 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 35.1 tptt -100.74 125.57 47.21 Favored 'General case' 0 N--CA 1.406 -2.645 0 C-N-CA 117.45 -1.7 . . . . 71.22 108.904 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 31.2 m -109.81 128.41 55.3 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.92 -0.582 . . . . 74.42 109.975 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 76.2 m-85 -125.76 128.02 47.08 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.954 -0.566 . . . . 72.05 109.846 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.492 HG22 HG22 ' A' ' 37' ' ' VAL . 79.3 p -115.37 119.02 34.88 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.218 -0.593 . . . . 70.34 111.914 -175.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.604 HD12 HD12 ' B' ' 38' ' ' ILE . 63.8 mt -120.6 121.42 65.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 109.336 -0.616 . . . . 73.35 109.336 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.417 ' CB ' HH11 ' A' ' 35' ' ' ARG . 5.7 t -108.49 134.25 51.52 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.449 -0.945 . . . . 74.53 108.449 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 97.52 3.48 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-O 121.751 0.786 . . . . 73.21 110.231 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.96 -82.85 1.5 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 114.692 -1.14 . . . . 72.55 112.123 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -144.34 32.73 1.2 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.139 -1.43 . . . . 71.13 107.139 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.648 HD23 HD12 ' B' ' 40' ' ' ILE . 33.7 tp -135.76 117.8 15.37 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 115.276 -0.874 . . . . 63.53 110.694 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' CB ' ' A' ' 30' ' ' THR . 30.4 mmt180 -96.79 116.5 29.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.159 -0.682 . . . . 53.44 109.159 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.9 126.88 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.347 -0.612 . . . . 61.24 109.347 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 28' ' ' THR . 97.2 t -120.16 126.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.964 0.411 . . . . 63.11 110.741 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.62 HD12 HD12 ' B' ' 29' ' ' ILE . 80.2 mt -105.41 131.61 54.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.656 -0.702 . . . . 73.15 109.596 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 95.6 m-85 -115.9 114.88 25.28 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.327 -0.99 . . . . 73.12 108.327 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.539 HD12 HD23 ' B' ' 34' ' ' LEU . 37.3 mm -89.53 121.4 39.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.665 -1.235 . . . . 75.11 107.665 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 p -125.52 174.53 8.16 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.535 0.683 . . . . 73.24 110.942 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.9 -19.86 56.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.676 -1.147 . . . . 54.14 109.025 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -86.6 -25.73 24.79 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.648 -1.241 . . . . 74.15 107.648 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -130.92 3.66 Favored Glycine 0 C--N 1.291 -1.948 0 CA-C-N 114.098 -1.41 . . . . 63.31 112.942 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 61.5 tp -113.22 137.12 51.94 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.601 -0.518 . . . . 74.22 109.601 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -134.63 142.36 46.86 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.938 -0.764 . . . . 62.11 108.938 171.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 7.2 p -131.58 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.999 -0.546 . . . . 64.02 110.041 -175.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.428 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 52.6 m -123.1 139.41 54.09 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.119 -0.492 . . . . 52.14 111.045 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -117.36 124.32 48.62 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.903 -0.777 . . . . 64.34 108.903 177.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.58 82.64 67.9 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 106.615 -1.624 . . . . 45.24 106.615 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HD2' ' OE1' ' B' ' 17' ' ' GLN . 3.3 Cg_exo -76.82 145.67 25.66 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.093 1.862 . . . . 72.22 112.688 -176.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 125.536 1.534 . . . . 74.04 114.252 175.477 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 15.8 ptt-85 . . . . . 0 N--CA 1.425 -1.722 0 N-CA-C 108.748 -0.834 . . . . 75.03 108.748 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -91.81 144.73 25.2 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.839 -0.345 . . . . 65.24 110.906 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -141.43 149.46 41.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 62.21 108.595 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.425 HG11 HG11 ' A' ' 12' ' ' VAL . 55.3 t -141.85 138.01 31.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.495 -0.321 . . . . 72.25 110.257 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 26.5 p -107.37 125.23 50.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.553 -0.906 . . . . 75.21 108.553 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.61 123.66 45.98 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.047 -0.524 . . . . 64.22 109.931 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 37.0 p -89.17 112.42 23.42 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.504 -0.554 . . . . 74.41 109.504 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -141.49 -172.47 3.53 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.551 -0.907 . . . . 73.11 108.551 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' GLN . . . . . 0.452 ' OE1' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -79.95 89.26 5.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.285 1.041 . . . . 74.32 110.934 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.409 ' CB ' ' HA2' ' B' ' 44' ' ' GLY . 26.4 tpt180 -126.34 142.57 51.48 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.418 -0.81 . . . . 70.01 111.236 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.03 152.09 52.77 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.05 -0.977 . . . . 62.53 108.628 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.94 145.81 86.4 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.945 1.763 . . . . 74.52 111.052 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.416 HG22 ' H ' ' B' ' 23' ' ' ARG . 14.3 p -131.53 141.71 45.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.41 -0.814 . . . . 62.44 109.298 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 49.7 m -82.0 -27.04 33.34 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.07 0.396 . . . . 74.31 112.07 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.416 ' H ' HG22 ' B' ' 21' ' ' VAL . 30.1 mmm180 -113.99 132.75 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 120.729 -0.388 . . . . 64.35 110.649 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -90.69 115.11 29.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.789 -1.189 . . . . 73.11 107.789 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.407 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 75.3 mmtt -94.15 137.92 32.78 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.034 -0.53 . . . . 53.04 111.391 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.4 m -116.27 127.93 55.14 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.992 -1.004 . . . . 60.42 108.867 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -127.88 126.64 41.94 Favored 'General case' 0 CA--C 1.461 -2.46 0 CA-C-N 115.605 -0.725 . . . . 74.41 109.749 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.667 HG22 HG22 ' B' ' 37' ' ' VAL . 64.4 p -115.38 132.56 56.58 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.76 -0.654 . . . . 73.42 111.13 -177.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.62 HD12 HD12 ' A' ' 38' ' ' ILE . 55.1 mt -126.04 136.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 109.213 -0.662 . . . . 63.31 109.213 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 10.1 t -119.15 127.28 53.18 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 121.744 0.783 . . . . 63.1 109.653 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -135.86 110.61 8.7 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.37 -0.832 . . . . 74.31 110.236 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -68.12 3.05 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.143 -0.783 . . . . 75.25 111.143 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.9 t -165.82 11.71 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.065 -1.457 . . . . 74.02 107.065 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.539 HD23 HD12 ' A' ' 40' ' ' ILE . 29.4 tp -102.13 123.65 46.37 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.494 -0.775 . . . . 63.23 111.56 -174.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 35.5 mmt180 -94.46 113.7 25.6 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.021 -0.536 . . . . 63.21 110.501 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.1 124.55 49.73 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.79 -1.189 . . . . 73.41 107.79 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.667 HG22 HG22 ' B' ' 28' ' ' THR . 65.8 t -117.2 128.64 74.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.002 0.43 . . . . 54.12 111.373 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.604 HD12 HD12 ' A' ' 29' ' ' ILE . 67.3 mt -106.96 128.19 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.283 -0.871 . . . . 71.11 109.995 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.8 m-85 -111.74 118.37 35.43 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.418 -0.956 . . . . 74.2 108.418 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.648 HD12 HD23 ' A' ' 34' ' ' LEU . 38.2 mm -87.87 114.62 26.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.441 -1.688 . . . . 75.22 106.441 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 69.5 p -123.1 -177.93 3.82 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.63 0.729 . . . . 74.24 112.323 -173.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' B' ' 43' ' ' ARG . 54.7 pttt -80.2 -29.81 38.63 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.886 -1.506 . . . . 75.54 109.488 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.579 ' N ' ' HG3' ' B' ' 42' ' ' LYS . 77.1 ttt180 -88.02 -17.41 31.24 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.211 1.005 . . . . 74.45 109.19 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' B' ' 18' ' ' ARG . . . 147.83 -121.99 1.46 Allowed Glycine 0 N--CA 1.425 -2.055 0 CA-C-N 114.305 -1.316 . . . . 73.1 112.549 177.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 67.0 tp -119.47 133.77 55.54 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.646 -0.777 . . . . 72.14 109.285 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 82.7 tttt -124.77 141.53 52.05 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.455 -0.572 . . . . 65.0 109.455 172.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.42 HG11 HG11 ' A' ' 47' ' ' VAL . 12.1 p -131.23 141.11 46.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 115.673 -0.694 . . . . 54.44 110.231 -175.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.434 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 65.9 m -125.63 141.59 51.94 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 116.29 -0.414 . . . . 73.45 110.577 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -116.31 123.89 48.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.741 -0.837 . . . . 61.3 108.741 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 13.2 t70 -132.26 97.8 17.68 Favored Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 107.516 -1.29 . . . . 61.21 107.516 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.425 -2.523 0 C-N-CA 121.775 1.65 . . . . 72.14 115.357 -174.267 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 97.3 mtt180 . . . . . 0 N--CA 1.434 -1.235 0 N-CA-C 109.021 -0.733 . . . . 74.22 109.021 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 p -98.57 125.48 43.83 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.151 -0.477 . . . . 72.23 109.972 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.2 m -127.83 148.59 50.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.442 -0.503 . . . . 73.42 110.125 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' CG2' HD11 ' B' ' 14' ' ' LEU . 98.7 t -144.17 143.25 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.774 0.429 . . . . 73.3 109.994 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.8 p -123.56 125.49 44.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.377 0.423 . . . . 65.43 110.397 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 mm? -106.56 121.84 45.11 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.189 -0.46 . . . . 63.03 111.243 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.5 p -92.28 112.88 24.99 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.757 0.789 . . . . 71.2 109.071 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.454 ' CG2' ' HG3' ' B' ' 51' ' ' PRO . 5.1 t -134.54 -172.62 3.07 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.918 -1.037 . . . . 60.54 109.367 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -74.69 81.98 2.06 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.469 1.128 . . . . 71.31 111.251 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.528 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -127.21 142.37 51.5 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.283 -0.871 . . . . 71.31 110.297 -178.016 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -74.46 147.73 85.2 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.342 -0.984 . . . . 55.51 108.342 176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.52 136.89 29.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.944 1.763 . . . . 54.23 112.03 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 23' ' ' ARG . 34.6 t -115.41 142.68 27.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.753 -1.203 . . . . 75.11 107.753 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 m -88.43 -2.28 58.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.631 0.604 . . . . 71.54 112.631 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.567 ' H ' HG12 ' A' ' 21' ' ' VAL . 64.0 ttt180 -134.58 148.75 50.52 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.953 -0.467 . . . . 75.15 110.44 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -92.4 120.45 41.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.503 -0.925 . . . . 74.01 108.503 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 35.0 mmtp -96.96 132.21 42.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.917 -0.713 . . . . 72.4 109.914 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 p -107.25 128.04 54.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.66 -0.7 . . . . 72.3 109.75 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.467 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 67.2 m-85 -128.24 126.79 41.62 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.699 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 37' ' ' VAL . 47.9 p -115.13 129.84 56.77 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.423 -0.808 . . . . 55.11 112.696 -174.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.652 HD12 HD12 ' B' ' 38' ' ' ILE . 59.0 mt -137.41 121.6 22.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.912 -0.585 . . . . 74.23 109.467 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -113.23 126.48 55.46 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 119.666 -0.813 . . . . 64.42 109.162 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.8 tp10 -121.35 103.61 9.09 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.861 -0.609 . . . . 72.52 109.598 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.13 -93.57 0.23 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.612 -0.722 . . . . 60.24 112.967 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.456 ' HB2' HD22 ' B' ' 19' ' ' LEU . 43.7 m -113.75 -7.18 13.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.268 0.84 . . . . 65.11 113.268 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -114.5 140.67 48.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.142 -1.023 . . . . 75.55 111.125 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 1.9 mpt_? -108.71 119.58 39.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.249 -0.887 . . . . 75.2 108.69 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.31 130.92 55.48 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.754 0.312 . . . . 75.3 110.247 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 28' ' ' THR . 60.1 t -121.19 127.17 75.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.476 -0.564 . . . . 74.22 109.476 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.628 HD12 HD12 ' B' ' 29' ' ' ILE . 83.7 mt -101.66 125.85 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.587 0 N-CA-C 108.672 -0.862 . . . . 70.42 108.672 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -108.69 114.65 28.63 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.238 -1.023 . . . . 72.32 108.238 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 49.9 mm -88.84 113.14 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.353 0 N-CA-C 106.499 -1.667 . . . . 73.13 106.499 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.2 p -109.99 -177.07 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.816 -0.629 . . . . 71.15 110.343 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.8 -13.0 32.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.941 -0.762 . . . . 55.01 108.941 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -96.55 -24.61 15.97 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.182 -0.917 . . . . 71.54 110.705 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 171.27 -133.52 2.78 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 118.394 -1.86 . . . . 54.14 114.368 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 1.6 tm? -126.99 122.59 34.92 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 124.186 0.994 . . . . 62.5 108.567 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -123.07 143.02 50.25 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-O 121.093 0.473 . . . . 75.4 110.74 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.55 140.81 47.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 115.455 -0.793 . . . . 63.33 109.14 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.8 m -124.05 136.88 54.56 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.089 -0.505 . . . . 70.41 110.302 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HB2' ' HG ' ' B' ' 45' ' ' LEU . . . -117.21 124.3 48.74 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.636 -0.711 . . . . 53.05 110.015 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 21.7 t70 -110.88 104.28 55.9 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.001 -0.74 . . . . 64.45 109.001 175.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HG3' ' OG1' ' B' ' 16' ' ' THR . 83.2 Cg_endo -79.44 158.22 25.67 Favored 'Trans proline' 0 N--CA 1.423 -2.659 0 C-N-CA 121.563 1.509 . . . . 41.45 111.411 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 C--N 1.309 -1.166 0 C-N-CA 125.424 1.49 . . . . 71.02 113.517 172.956 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 93.3 mtt180 . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 121.063 0.458 . . . . 73.43 110.368 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 30.9 p -89.03 128.75 35.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.695 -0.684 . . . . 73.14 110.713 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 63.8 m -131.62 148.47 52.61 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.543 -0.91 . . . . 62.34 108.543 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.43 145.31 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 109.445 -0.576 . . . . 71.24 109.445 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 65.9 p -115.33 125.45 53.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.136 0.493 . . . . 64.41 110.838 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.484 HD11 ' CG2' ' A' ' 12' ' ' VAL . 3.2 mm? -103.47 121.51 42.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 116.045 -0.525 . . . . 75.42 111.094 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 38.7 p -93.8 113.31 25.33 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.805 -0.634 . . . . 71.13 109.748 176.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' THR . . . . . 0.412 ' OG1' ' HG3' ' A' ' 51' ' ' PRO . 9.1 t -129.09 -171.0 2.38 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.623 -1.251 . . . . 73.11 107.623 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -77.55 108.19 10.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.54 1.162 . . . . 72.35 110.117 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.429 ' H ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -125.4 150.9 46.83 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.89 -1.505 . . . . 75.43 114.199 -174.403 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.469 ' H ' HD23 ' B' ' 19' ' ' LEU . 2.2 pt? -74.64 167.42 36.46 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.297 -1.32 . . . . 53.22 108.636 175.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 19.0 Cg_endo -65.2 135.07 41.79 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.131 1.22 . . . . 70.02 109.951 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 86.2 t -129.81 123.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.726 -0.842 . . . . 64.41 108.726 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.8 m -90.11 -73.71 0.51 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.037 0.446 . . . . 72.32 110.064 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -92.38 146.94 23.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.475 -0.784 . . . . 75.14 109.301 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.402 HD12 HG22 ' B' ' 41' ' ' THR . 43.5 mm -84.07 134.78 26.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.96 -0.385 . . . . 73.55 109.96 -175.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -100.77 125.72 47.27 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.036 -1.098 . . . . 62.15 108.036 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 31.7 p -106.3 128.38 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.113 0.482 . . . . 74.03 110.414 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.43 ' HB2' ' HB ' ' B' ' 38' ' ' ILE . 71.3 m-85 -127.07 126.91 43.83 Favored 'General case' 0 CA--C 1.473 -2.017 0 CA-C-N 116.038 -0.528 . . . . 72.24 110.688 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.554 HG22 HG22 ' B' ' 37' ' ' VAL . 58.8 p -115.38 131.47 56.92 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.349 -0.842 . . . . 73.31 112.416 -173.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.628 HD12 HD12 ' A' ' 38' ' ' ILE . 54.8 mt -133.6 124.32 47.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.656 0.382 . . . . 71.44 110.199 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -111.19 127.09 55.48 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.87 -0.789 . . . . 74.22 108.87 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.543 ' O ' HD23 ' B' ' 34' ' ' LEU . 12.6 tp10 -130.22 97.89 4.57 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.731 -0.668 . . . . 75.42 109.848 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.68 -87.32 0.35 Allowed Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.436 -0.802 . . . . 64.4 112.021 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 54.8 m -119.89 -13.18 9.08 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 112.847 0.684 . . . . 73.01 112.847 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.543 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -107.85 136.5 47.46 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 117.736 -1.586 . . . . 75.41 112.293 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -102.84 120.09 39.99 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.489 -1.232 . . . . 74.11 108.405 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.32 53.17 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.689 -0.485 . . . . 75.44 109.689 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.554 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -124.64 128.66 73.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.979 -0.378 . . . . 72.54 109.979 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 29' ' ' ILE . 83.8 mt -102.2 124.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 C-N-CA 123.923 0.889 . . . . 73.54 108.696 178.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.21 116.6 32.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.445 -0.946 . . . . 73.41 108.445 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.454 HG23 HD21 ' A' ' 34' ' ' LEU . 48.1 mm -87.82 113.69 25.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.031 -1.84 . . . . 75.04 106.031 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' THR . . . . . 0.402 HG22 HD12 ' B' ' 24' ' ' ILE . 76.0 p -123.4 179.51 4.71 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.745 -0.661 . . . . 61.25 111.338 -171.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' B' ' 42' ' ' LYS . 1.1 ptpt -83.1 -7.41 59.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 72.43 110.276 176.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' B' ' 15' ' ' THR . 98.8 mtt180 -87.04 -16.73 34.76 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.848 -1.538 . . . . 73.44 106.848 170.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.18 -103.28 1.03 Allowed Glycine 0 N--CA 1.423 -2.202 0 CA-C-N 114.507 -1.224 . . . . 63.31 112.039 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 49' ' ' ALA . 3.0 tm? -116.38 122.68 45.56 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.106 0.479 . . . . 53.4 111.856 -174.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.0 143.83 50.18 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.68 -0.691 . . . . 63.25 109.152 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 11.0 p -131.18 140.93 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.307 -0.406 . . . . 64.53 110.085 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 52.9 m -122.42 136.51 54.91 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.336 -0.393 . . . . 72.32 110.689 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . . . -117.89 124.59 48.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.535 -0.757 . . . . 62.12 111.291 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -122.76 95.81 46.05 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.87 -0.789 . . . . 65.04 108.87 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 91.1 Cg_endo . . . . . 0 N--CA 1.411 -3.36 0 C-N-CA 120.477 0.785 . . . . 71.34 112.35 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.25 0 N-CA-C 112.409 0.522 . . . . 72.4 112.409 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.47 127.89 49.32 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.955 -0.566 . . . . 64.31 111.024 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.524 ' CB ' ' HA ' ' A' ' 48' ' ' CYS . 20.0 m -140.55 148.05 40.41 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.772 -1.196 . . . . 41.23 107.772 -174.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.34 145.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.421 0.555 . . . . 71.33 110.753 -175.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 39.9 p -107.56 125.87 51.84 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.201 0.524 . . . . 62.5 110.377 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.07 137.84 45.36 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.819 -0.628 . . . . 65.52 111.442 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -98.51 112.58 24.56 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 115.445 -0.798 . . . . 65.15 109.293 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -142.4 -176.56 4.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.763 -1.199 . . . . 71.4 107.763 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 6.2 tp60 -79.33 105.11 10.41 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.604 0.716 . . . . 72.25 110.436 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.665 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.01 147.46 49.54 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.349 -0.841 . . . . 74.24 109.559 -178.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.5 pt? -74.55 136.07 74.89 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 107.682 -1.229 . . . . 73.24 107.682 174.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.49 133.9 27.21 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 120.825 1.017 . . . . 71.14 110.562 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.513 HG22 ' H ' ' A' ' 23' ' ' ARG . 14.5 p -133.42 137.33 53.28 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.737 -0.665 . . . . 63.45 109.352 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 m -87.86 -19.27 27.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.338 0.59 . . . . 61.14 110.036 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.513 ' H ' HG22 ' A' ' 21' ' ' VAL . 37.6 mmt180 -102.86 133.12 48.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.078 -0.712 . . . . 74.33 109.078 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mm -93.58 115.71 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.873 -0.788 . . . . 75.03 108.873 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -89.78 135.93 33.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 120.384 -0.526 . . . . 75.44 111.196 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 p -114.55 128.24 56.22 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.959 -1.019 . . . . 61.34 109.715 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.513 ' HB3' HD13 ' B' ' 29' ' ' ILE . 68.0 m-85 -126.44 125.67 42.52 Favored 'General case' 0 CA--C 1.462 -2.419 0 N-CA-C 109.401 -0.592 . . . . 73.35 109.401 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 37' ' ' VAL . 63.7 p -116.73 131.72 56.88 Favored 'General case' 0 C--N 1.283 -2.308 0 O-C-N 123.861 0.726 . . . . 74.53 112.344 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.663 HD12 HD12 ' B' ' 38' ' ' ILE . 56.5 mt -127.55 121.17 56.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 120.905 0.383 . . . . 71.23 110.05 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -102.97 123.58 46.86 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.776 -1.194 . . . . 71.52 107.776 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' HD23 ' A' ' 34' ' ' LEU . 10.6 tp10 -142.31 97.11 3.06 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.354 -0.538 . . . . 74.53 111.642 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -72.96 0.38 Allowed Glycine 0 C--N 1.319 -0.378 0 N-CA-C 115.287 0.875 . . . . 64.32 115.287 171.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.1 m -126.94 -1.09 6.58 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 112.719 0.637 . . . . 71.02 112.719 -173.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.588 HD21 HG23 ' B' ' 40' ' ' ILE . 2.0 pt? -146.33 140.46 26.44 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.271 -0.972 . . . . 73.4 112.278 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 121.55 44.99 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.006 -1.452 . . . . 64.25 108.956 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.23 137.2 49.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.805 -0.18 . . . . 60.02 110.531 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 39.2 t -124.31 125.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.215 -0.661 . . . . 72.22 109.215 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.827 HD12 HD12 ' B' ' 29' ' ' ILE . 86.4 mt -102.95 123.49 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 108.654 -0.869 . . . . 75.33 108.654 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 92.9 m-85 -106.79 114.48 28.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.362 -0.977 . . . . 70.15 108.362 177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.478 HG13 ' HG2' ' B' ' 31' ' ' GLU . 49.0 mm -89.42 114.75 27.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.208 -1.404 . . . . 72.31 107.208 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.78 156.87 47.94 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 115.806 -0.633 . . . . 63.14 110.953 -175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -62.59 -14.58 44.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.579 0.752 . . . . 74.45 110.734 176.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -85.35 -18.71 32.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.618 0.723 . . . . 75.42 109.491 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.35 -138.79 9.28 Favored Glycine 0 CA--C 1.48 -2.155 0 C-N-CA 119.909 -1.138 . . . . 72.35 112.176 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 2.7 tm? -113.31 121.32 44.07 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.61 -0.885 . . . . 72.21 108.61 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 23.0 tptm -118.62 121.81 41.06 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.383 -0.969 . . . . 74.05 108.383 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG11 HG11 ' B' ' 47' ' ' VAL . 14.9 p -116.97 140.33 40.06 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 107.765 -1.198 . . . . 72.3 107.765 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.524 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 13.6 t -132.76 136.04 46.1 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 106.716 -1.587 . . . . 72.04 106.716 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' CB ' ' HG ' ' B' ' 45' ' ' LEU . . . -136.18 124.57 23.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 119.328 -0.949 . . . . 72.01 111.312 -177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.63 108.81 62.51 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 114.84 -1.073 . . . . 74.44 109.792 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -89.04 148.13 5.6 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.342 2.028 . . . . 75.11 111.079 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 33' ' ' SER . 9.2 pt20 . . . . . 0 C--N 1.297 -1.686 0 CA-C-N 115.905 -0.589 . . . . 73.3 109.778 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.391 -3.383 0 CA-C-O 122.152 0.977 . . . . 75.02 110.053 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.1 p -87.12 117.79 26.09 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.539 -1.664 . . . . 64.13 110.099 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.482 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 19.4 m -137.28 148.22 46.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.945 -1.131 . . . . 63.51 107.945 -175.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -142.96 146.79 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.833 -0.432 . . . . 75.44 109.833 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' SER . . . . . 0.48 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 23.7 p -106.96 125.56 51.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.17 0.588 . . . . 72.11 110.46 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.34 119.41 39.38 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.236 -1.024 . . . . 73.4 108.236 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -121.59 112.69 18.77 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.267 -1.012 . . . . 70.2 108.267 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -173.29 113.44 0.22 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.348 0.499 . . . . 74.13 112.348 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 59.42 22.47 10.94 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.581 1.152 . . . . 74.21 112.887 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.502 ' HD2' ' HA2' ' B' ' 44' ' ' GLY . 27.3 mtt180 -105.74 121.51 44.17 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.107 -0.996 . . . . 73.21 108.853 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.735 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.6 pt? -74.39 152.28 87.78 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 116.095 -0.502 . . . . 74.44 111.885 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.19 136.65 74.07 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.379 2.719 . . . . 64.23 113.648 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.73 149.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.659 -1.237 . . . . 75.13 107.659 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 -36.42 59.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.022 0.378 . . . . 64.45 112.022 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -124.18 135.89 53.79 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.939 -0.304 . . . . 61.11 110.787 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' B' ' 41' ' ' THR . 49.5 mm -77.57 115.16 19.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.755 -1.202 . . . . 74.21 107.755 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.19 126.47 43.67 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.161 -0.472 . . . . 62.11 110.444 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.435 HG22 ' CD1' ' B' ' 39' ' ' PHE . 41.1 p -106.66 127.36 53.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.436 -0.579 . . . . 72.34 109.436 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 75.3 m-85 -126.57 127.45 45.3 Favored 'General case' 0 CA--C 1.474 -1.956 0 CA-C-N 116.092 -0.504 . . . . 72.35 110.626 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.68 HG22 HG22 ' B' ' 37' ' ' VAL . 43.4 p -114.51 121.3 43.07 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.618 -0.719 . . . . 72.14 112.021 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.827 HD12 HD12 ' A' ' 38' ' ' ILE . 94.5 mt -119.48 121.46 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.785 -0.643 . . . . 71.41 110.864 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -105.71 139.84 39.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.257 -1.016 . . . . 60.34 108.257 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.478 ' HG2' HG13 ' A' ' 40' ' ' ILE . 17.0 tp10 -142.51 97.59 3.14 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.404 0.621 . . . . 72.14 109.566 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.22 2.59 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.218 -0.901 . . . . 71.53 112.834 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 39.8 m -146.12 -25.25 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.279 0.844 . . . . 70.41 113.279 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.512 ' H ' HD23 ' B' ' 34' ' ' LEU . 2.6 pt? -92.89 141.39 28.47 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.037 -0.665 . . . . 64.32 110.534 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.413 ' N ' ' HD3' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -111.51 123.15 49.62 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.049 -0.523 . . . . 73.52 110.006 177.124 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.4 54.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.714 -0.476 . . . . 73.15 109.714 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.68 HG22 HG22 ' B' ' 28' ' ' THR . 39.2 t -119.76 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.273 0.559 . . . . 74.11 110.538 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.663 HD12 HD12 ' A' ' 29' ' ' ILE . 97.0 mt -103.91 116.65 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 107.846 -1.168 . . . . 63.4 107.846 177.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 97.8 m-85 -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.472 -0.936 . . . . 65.13 108.472 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.588 HG23 HD21 ' A' ' 34' ' ' LEU . 41.9 mm -88.5 113.7 25.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 106.501 -1.666 . . . . 73.24 106.501 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' THR . . . . . 0.44 ' HA ' HD12 ' B' ' 24' ' ' ILE . 8.9 t -119.5 166.02 13.64 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 120.356 -0.538 . . . . 72.45 111.479 -174.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.97 -3.76 43.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.426 0.898 . . . . 73.44 113.426 -173.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -116.22 -1.75 12.31 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.195 0.521 . . . . 72.55 110.518 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . 0.502 ' HA2' ' HD2' ' B' ' 18' ' ' ARG . . . 155.52 -140.65 7.47 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.04 -1.553 . . . . 63.45 113.96 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 tm? -122.13 126.58 48.66 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.441 0.696 . . . . 74.41 109.355 -177.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -117.45 121.75 41.88 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.821 -0.807 . . . . 74.51 108.821 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.541 HG11 HG11 ' A' ' 47' ' ' VAL . 9.7 p -108.23 140.39 26.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.621 -0.881 . . . . 61.31 108.621 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.482 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 10.5 t -139.7 136.86 34.66 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 107.752 -1.203 . . . . 44.44 107.752 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . . . -125.55 125.77 43.75 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 110.144 -0.317 . . . . 55.03 110.144 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -115.07 109.69 46.62 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-O 121.278 0.561 . . . . 75.53 109.827 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.439 -1.713 0 C-N-CA 122.719 2.279 . . . . 70.33 112.939 -177.456 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 14.5 ptt180 . . . . . 0 N--CA 1.444 -0.74 0 CA-C-O 121.529 0.681 . . . . 63.54 111.904 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -88.86 148.07 24.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.198 -0.91 . . . . 74.21 110.98 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 65.9 m -141.71 149.23 40.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.458 -1.312 . . . . 64.14 107.458 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.536 HG11 HG11 ' B' ' 12' ' ' VAL . 57.1 t -139.76 145.15 27.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 110.163 -0.31 . . . . 62.11 110.163 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 m -111.77 124.8 53.12 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.216 -1.031 . . . . 73.11 108.216 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -132.09 141.01 49.03 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 123.749 0.819 . . . . 74.11 108.802 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 t -123.32 141.9 51.51 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.843 -0.743 . . . . 44.35 111.004 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 t -111.56 26.61 10.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.245 -1.02 . . . . 74.03 108.245 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 77.43 117.26 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 112.998 -1.91 . . . . 72.12 108.468 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.576 HH12 HD22 ' B' ' 34' ' ' LEU . 14.9 mmm180 -95.46 148.01 22.93 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 116.561 2.06 . . . . 74.41 116.561 -172.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.9 mt -114.37 153.83 46.49 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 112.922 -1.945 . . . . 60.43 106.358 172.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.45 145.08 16.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.349 3.366 . . . . 74.24 115.286 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.34 137.86 54.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 114.084 -1.417 . . . . 73.44 109.164 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 m -98.11 -45.09 6.36 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.712 0.292 . . . . 73.01 110.848 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -119.3 133.84 55.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 62.34 109.757 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -85.48 135.91 23.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.767 -0.457 . . . . 64.2 109.767 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.03 151.63 33.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.9 0.704 . . . . 73.4 112.9 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 m -133.99 127.22 31.89 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.607 -1.178 . . . . 51.41 108.38 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 74.8 m-85 -127.61 134.7 49.67 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 111.879 0.325 . . . . 74.55 111.879 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.673 HG22 HG22 ' A' ' 37' ' ' VAL . 36.1 p -115.51 139.23 50.25 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.64 -0.709 . . . . 52.32 111.556 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.782 HD12 HD12 ' B' ' 38' ' ' ILE . 82.3 mt -130.72 133.14 63.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.216 -0.902 . . . . 65.31 108.78 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -117.19 123.65 47.2 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 121.631 0.729 . . . . 73.14 109.171 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.8 tp10 -125.16 98.35 5.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.752 0.787 . . . . 65.14 108.965 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.52 -71.9 2.91 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 109.703 -1.359 . . . . 64.31 109.703 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -154.97 -22.7 0.12 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.519 0.933 . . . . 71.14 113.519 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.416 HD11 HD12 ' B' ' 40' ' ' ILE . 2.6 pt? -69.23 141.06 54.54 Favored 'General case' 0 C--N 1.367 1.37 0 CA-C-N 118.934 0.788 . . . . 64.32 110.817 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 31.6 mmt180 -100.58 118.71 37.31 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.884 -0.598 . . . . 60.1 109.745 174.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 123.97 49.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.894 -0.78 . . . . 44.13 108.894 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 28' ' ' THR . 71.5 t -110.89 133.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.3 -0.409 . . . . 75.03 110.142 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.552 HD12 HD12 ' B' ' 29' ' ' ILE . 75.6 mt -115.49 118.29 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 C-N-CA 123.702 0.801 . . . . 63.35 108.997 176.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.52 122.1 43.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.567 -0.901 . . . . 75.23 108.567 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.456 HD12 HD21 ' B' ' 34' ' ' LEU . 47.6 mm -100.63 113.37 36.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.684 -1.228 . . . . 75.03 107.684 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -131.92 177.03 7.85 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.635 -0.876 . . . . 74.13 108.635 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -90.51 -1.74 57.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.487 -0.931 . . . . 73.31 108.487 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -89.63 -30.83 17.85 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.558 -0.904 . . . . 63.43 108.558 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.12 -157.53 29.85 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.702 -1.136 . . . . 74.34 111.737 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -113.63 121.57 44.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.888 -1.523 . . . . 73.45 106.888 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -121.08 140.16 52.33 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 121.202 0.525 . . . . 74.42 111.381 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.602 HG11 HG11 ' B' ' 47' ' ' VAL . 23.2 m -131.45 141.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.035 -0.984 . . . . 74.53 110.866 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 61.6 m -121.35 137.52 54.66 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.936 -0.575 . . . . 73.42 110.623 174.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.75 124.58 47.62 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.294 -0.632 . . . . 64.33 109.294 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 14.2 t70 -115.84 127.13 27.03 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.933 -0.765 . . . . 53.22 108.933 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.8 148.17 22.96 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.915 3.077 . . . . 62.45 113.854 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.62 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 1.2 mp0 . . . . . 0 C--N 1.321 -0.632 0 C-N-CA 124.227 1.011 . . . . 74.11 110.937 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.425 ' HB3' ' HD3' ' B' ' 51' ' ' PRO . 22.4 ptt180 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 121.767 0.794 . . . . 75.02 113.046 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.1 p -103.21 149.76 24.35 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-N 114.846 -1.07 . . . . 55.32 111.282 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 63.1 m -139.85 148.84 42.68 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.352 -1.722 . . . . 62.41 106.352 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.536 HG11 HG11 ' A' ' 12' ' ' VAL . 60.2 t -141.88 144.0 26.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.592 -0.521 . . . . 44.15 109.592 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -107.98 124.82 50.73 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.091 -1.077 . . . . 75.44 108.091 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.432 HD23 ' N ' ' B' ' 14' ' ' LEU . 0.3 OUTLIER -119.41 122.73 42.43 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.08 -0.711 . . . . 62.13 109.08 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -107.22 130.64 54.71 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.87 0.843 . . . . 54.44 111.01 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -144.78 -162.45 1.49 Allowed 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.001 -1.481 . . . . 62.05 107.001 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -71.1 102.73 2.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.701 0.762 . . . . 63.33 109.177 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 mmm-85 -125.0 139.49 53.77 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 114.874 -1.057 . . . . 63.24 109.214 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 46.8 mt -89.02 137.24 29.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 106.649 -1.612 . . . . 61.14 106.649 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.68 135.17 41.6 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.647 2.231 . . . . 63.33 112.695 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.91 135.83 61.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.834 -1.543 . . . . 64.23 106.834 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 26.3 m -89.79 -20.28 23.7 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.32 0.489 . . . . 74.51 112.32 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -112.73 138.63 49.26 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.783 -0.19 . . . . 52.52 110.779 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mm -89.93 118.95 36.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.305 -0.628 . . . . 74.11 109.305 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.07 152.53 18.68 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.312 0.577 . . . . 64.0 112.333 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 73.1 m -131.31 127.91 38.67 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.693 -1.14 . . . . 51.11 108.595 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.438 ' HB3' HD13 ' A' ' 29' ' ' ILE . 67.5 m-85 -129.35 125.58 36.98 Favored 'General case' 0 CA--C 1.452 -2.793 0 N-CA-C 108.94 -0.763 . . . . 62.02 108.94 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.425 HG23 HG22 ' B' ' 37' ' ' VAL . 18.6 m -117.88 122.07 42.37 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 119.686 -0.806 . . . . 63.01 112.544 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.552 HD12 HD12 ' A' ' 38' ' ' ILE . 64.2 mt -116.48 121.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.509 . . . . 74.12 109.9 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -105.02 128.42 53.31 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.225 -1.398 . . . . 72.55 107.225 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.567 ' O ' HD23 ' B' ' 34' ' ' LEU . 14.7 tp10 -139.38 118.49 12.65 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.258 -0.645 . . . . 71.3 109.258 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.73 -78.79 1.16 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.858 -1.163 . . . . 54.43 110.271 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -155.37 -14.58 0.11 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 112.924 0.712 . . . . 70.52 112.924 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.576 HD22 HH12 ' A' ' 18' ' ' ARG . 2.4 pt? -84.2 142.07 30.57 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.329 0.513 . . . . 73.32 110.818 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.452 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 32.3 mmt180 -100.66 118.08 36.08 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.324 -1.361 . . . . 72.11 107.324 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.98 29.53 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.43 -0.581 . . . . 72.12 109.43 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.425 HG22 HG23 ' B' ' 28' ' ' THR . 86.2 t -108.37 124.02 64.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.211 -0.449 . . . . 50.13 110.626 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.782 HD12 HD12 ' A' ' 29' ' ' ILE . 63.2 mt -102.97 123.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 C-N-CA 123.429 0.691 . . . . 62.2 109.205 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -104.85 114.88 29.36 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.219 -1.03 . . . . 72.32 108.219 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.423 HG13 ' HG2' ' A' ' 31' ' ' GLU . 47.5 mm -90.18 112.57 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 106.869 -1.53 . . . . 75.42 106.869 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -110.61 -176.58 3.01 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.922 -0.77 . . . . 64.11 108.922 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.593 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -92.11 -17.98 24.19 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 120.968 0.413 . . . . 74.05 110.219 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -100.58 -16.94 17.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.127 -0.488 . . . . 63.41 111.01 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.34 -145.59 7.28 Favored Glycine 0 C--N 1.295 -1.711 0 C-N-CA 118.7 -1.714 . . . . 50.13 113.199 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.2 122.82 23.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.574 -1.269 . . . . 74.34 107.574 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -125.04 141.57 52.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.215 0.531 . . . . 73.23 110.383 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 47' ' ' VAL . 30.8 m -131.9 141.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.298 -0.865 . . . . 75.25 111.03 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -120.03 136.98 54.36 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 115.929 -0.578 . . . . 72.11 110.11 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.69 123.91 47.24 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.186 -0.672 . . . . 75.35 109.186 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 17.1 t70 -102.04 135.73 19.61 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 107.655 -1.239 . . . . 71.15 107.655 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' B' ' 9' ' ' ARG . 17.9 Cg_endo . . . . . 0 CA--C 1.505 -0.944 0 C-N-CA 123.49 2.793 . . . . 73.44 114.34 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 CA--C 1.498 -1.042 0 N-CA-C 107.06 -1.459 . . . . 74.13 107.06 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 120.241 -0.584 . . . . 70.42 110.859 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.7 m -129.85 148.94 51.77 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.089 -1.078 . . . . 65.32 108.089 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.3 147.01 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 120.84 -0.344 . . . . 63.14 110.883 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.3 p -112.21 126.94 55.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.903 0.382 . . . . 64.21 110.003 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.08 141.95 47.3 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.771 -0.825 . . . . 62.53 108.771 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -127.9 112.98 15.3 Favored 'General case' 0 N--CA 1.405 -2.693 0 C-N-CA 119.534 -0.866 . . . . 71.32 111.04 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.415 ' HB ' ' OG1' ' B' ' 10' ' ' THR . 9.0 t -121.71 -170.09 1.98 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.3 -1.0 . . . . 64.1 108.3 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 5.9 tp60 -72.38 93.36 1.51 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.712 0.768 . . . . 51.42 110.822 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.405 HH22 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -126.5 148.17 49.73 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.95 -1.023 . . . . 74.1 108.838 -178.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.07 141.42 46.86 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.347 -0.983 . . . . 63.42 108.347 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 39.9 Cg_endo -65.91 143.83 74.49 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.541 2.161 . . . . 63.11 112.715 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 21.4 t -122.4 148.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.404 -1.332 . . . . 73.42 107.404 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -92.38 -39.84 11.23 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 120.305 -0.558 . . . . 71.2 110.843 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -89.61 133.15 34.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.31 -0.405 . . . . 65.13 111.246 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.73 124.11 42.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.761 -0.829 . . . . 72.33 108.761 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 35.1 mmtp -104.53 146.57 28.7 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.009 -0.676 . . . . 60.5 111.292 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 m -127.29 127.79 44.91 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.436 -0.949 . . . . 54.51 108.436 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 88.2 m-85 -128.13 134.73 49.15 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-N 116.352 -0.385 . . . . 72.33 111.8 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 37' ' ' VAL . 17.7 p -114.64 120.08 38.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.295 -0.866 . . . . 74.51 111.711 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.698 HD12 HD12 ' B' ' 38' ' ' ILE . 93.9 mt -114.94 125.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.569 -0.741 . . . . 65.13 109.589 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -106.91 128.87 54.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.277 0.56 . . . . 75.04 109.794 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.594 ' O ' HD23 ' A' ' 34' ' ' LEU . 17.1 tp10 -142.99 119.18 10.78 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.715 -0.675 . . . . 73.55 109.59 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.59 -87.37 0.12 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 111.6 -0.6 . . . . 50.14 111.6 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.489 ' HB3' HD21 ' B' ' 19' ' ' LEU . 26.8 t -151.14 13.88 0.69 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.406 -0.59 . . . . 71.22 109.406 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -110.49 140.51 44.69 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.7 -0.8 . . . . 72.52 108.891 174.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -116.3 134.03 55.35 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.58 -0.736 . . . . 73.15 110.192 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.97 131.46 55.38 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.383 -0.599 . . . . 52.0 109.383 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 28' ' ' THR . 87.5 t -113.11 120.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.014 -0.539 . . . . 74.55 110.139 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.64 HD12 HD12 ' B' ' 29' ' ' ILE . 96.2 mt -101.33 117.39 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 N-CA-C 109.003 -0.739 . . . . 74.23 109.003 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.51 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.2 m-85 -102.96 114.82 29.43 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.554 -0.906 . . . . 74.0 108.554 177.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.481 HD12 HD21 ' B' ' 34' ' ' LEU . 47.7 mm -90.75 112.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 106.57 -1.641 . . . . 74.54 106.57 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -116.62 173.28 6.71 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.525 0.516 . . . . 52.34 110.248 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.91 -33.01 71.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 116.482 2.03 . . . . 75.31 116.482 -171.145 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.577 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 1.5 tmt_? -117.21 3.76 12.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 119.694 -0.803 . . . . 70.25 109.472 -176.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.5 -158.73 12.03 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 118.353 -1.88 . . . . 44.24 115.058 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.29 123.1 24.87 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 125.636 1.575 . . . . 61.15 108.457 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -121.45 143.4 49.26 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.745 0.307 . . . . 74.44 110.721 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.92 140.2 48.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 115.948 -0.569 . . . . 51.13 110.126 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 26.7 m -118.9 145.05 46.04 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.5 -0.773 . . . . 74.3 110.232 172.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.76 125.75 53.16 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.252 -1.018 . . . . 61.53 108.252 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.93 78.43 31.81 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.218 -1.401 . . . . 72.4 107.218 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 27.8 Cg_endo -99.53 134.13 0.23 Allowed 'Trans proline' 0 N--CA 1.413 -3.229 0 C-N-CA 122.303 2.002 . . . . 74.45 113.858 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 114.052 -1.431 . . . . 63.05 113.229 173.194 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' B' ' 50' ' ' ASP . 94.7 mtt180 . . . . . 0 N--CA 1.41 -2.441 0 N-CA-C 108.173 -1.047 . . . . 54.33 108.173 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.415 ' OG1' ' HB ' ' A' ' 16' ' ' THR . 49.5 m -108.88 116.66 32.42 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.334 -1.358 . . . . 73.13 107.334 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -135.61 146.76 48.24 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.115 -1.068 . . . . 61.43 108.115 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 12.4 p -147.12 156.06 10.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 117.486 0.13 . . . . 60.02 110.788 -176.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -117.16 126.69 53.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.345 0.258 . . . . 71.2 110.618 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.41 HD22 ' N ' ' B' ' 14' ' ' LEU . 1.7 mm? -112.11 121.12 44.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.98 -1.119 . . . . 73.24 107.98 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -93.05 111.81 23.56 Favored 'General case' 0 C--N 1.284 -2.246 0 C-N-CA 118.271 -1.372 . . . . 71.44 109.147 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.6 t -153.58 107.81 3.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.181 -0.918 . . . . 64.0 112.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 51' ' ' PRO . 6.1 tp60 43.1 85.66 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.708 1.603 . . . . 51.43 113.259 174.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.412 ' N ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -125.57 148.47 48.92 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.173 -1.011 . . . . 72.01 110.275 -173.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' A' ' 33' ' ' SER . 2.8 mp -84.21 159.46 59.36 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.676 -1.231 . . . . 72.14 107.676 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.88 133.85 28.3 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 N-CA-C 108.54 -1.369 . . . . 61.22 108.54 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.626 ' H ' ' HB3' ' B' ' 42' ' ' LYS . 32.5 t -132.15 136.64 56.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.098 -1.075 . . . . 72.24 108.098 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -85.89 -30.31 22.98 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.057 0.456 . . . . 74.22 111.767 -175.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -114.63 166.74 11.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.745 0.307 . . . . 71.15 111.689 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.04 115.12 40.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 106.799 -1.556 . . . . 64.32 106.799 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 35.4 mmtp -90.62 147.18 23.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.733 -0.787 . . . . 65.04 110.482 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 90.4 m -133.13 127.88 34.88 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.648 -0.871 . . . . 55.13 108.648 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' TYR . . . . . 0.44 ' HB3' HD13 ' A' ' 29' ' ' ILE . 70.9 m-85 -128.51 125.78 39.09 Favored 'General case' 0 CA--C 1.446 -3.021 0 N-CA-C 109.474 -0.565 . . . . 75.33 109.474 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.8 m -117.61 130.93 56.69 Favored 'General case' 0 C--N 1.266 -3.048 0 O-C-N 123.996 0.81 . . . . 71.22 112.022 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.64 HD12 HD12 ' A' ' 38' ' ' ILE . 49.7 mt -125.01 129.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.866 -0.606 . . . . 75.45 109.988 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.433 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 9.7 t -106.82 122.27 46.06 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.461 -0.94 . . . . 72.54 108.461 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.444 ' O ' HD23 ' B' ' 34' ' ' LEU . 19.8 tp10 -142.69 97.82 3.18 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.359 -0.536 . . . . 75.44 111.69 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.81 -69.97 1.48 Allowed Glycine 0 C--N 1.313 -0.741 0 N-CA-C 115.324 0.89 . . . . 75.11 115.324 172.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -137.13 0.38 2.34 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.56 0.578 . . . . 55.54 112.56 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 40' ' ' ILE . 2.2 pt? -141.16 141.52 34.12 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.062 -1.055 . . . . 64.1 112.667 -175.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.433 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 19.2 mmm180 -98.31 113.72 25.77 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.382 -1.71 . . . . 75.13 106.382 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.77 120.0 40.07 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.743 -0.465 . . . . 73.23 109.743 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 27' ' ' TYR . 90.1 t -113.65 129.31 69.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.755 -0.657 . . . . 62.23 110.325 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.698 HD12 HD12 ' A' ' 29' ' ' ILE . 67.3 mt -113.25 131.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 123.387 0.675 . . . . 75.23 109.807 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 96.3 m-85 -112.44 118.29 34.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.958 -0.756 . . . . 75.12 108.958 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' B' ' 25' ' ' LYS . 47.2 mm -96.92 118.99 44.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.518 -0.919 . . . . 75.41 108.518 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.34 157.99 45.49 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 109.43 -0.581 . . . . 41.51 109.43 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.626 ' HB3' ' H ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -67.2 -17.87 65.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.812 -0.631 . . . . 74.44 111.666 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.669 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.6 tmt_? -90.91 -17.31 26.65 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.309 -0.626 . . . . 73.11 109.309 -176.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -172.28 43.32 Favored Glycine 0 C--O 1.223 -0.567 0 C-N-CA 118.942 -1.599 . . . . 74.32 114.611 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -112.85 121.4 44.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.977 -1.49 . . . . 73.54 106.977 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 12' ' ' VAL . 86.8 tttt -119.66 142.01 48.84 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.484 0.659 . . . . 72.11 111.231 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.13 140.68 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 107.607 -1.257 . . . . 70.54 107.607 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 34.1 t -138.54 136.56 36.18 Favored 'General case' 0 C--N 1.268 -2.948 0 N-CA-C 108.107 -1.072 . . . . 72.2 108.107 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.28 123.74 44.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.027 -0.669 . . . . 62.34 110.485 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' B' ' 9' ' ' ARG . 25.8 t70 -113.87 122.43 34.85 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.753 -1.203 . . . . 74.33 107.753 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 N--CA 1.44 -1.64 0 C-N-CA 121.862 1.708 . . . . 72.24 112.944 -173.551 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 107.22 -1.4 . . . . 72.04 107.22 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 p -91.1 144.0 26.1 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.028 -0.533 . . . . 74.11 112.378 -172.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -138.4 149.89 45.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.132 -0.692 . . . . 74.02 109.132 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD21 ' B' ' 14' ' ' LEU . 60.5 t -143.3 139.79 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 110.232 -0.285 . . . . 75.23 110.232 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 p -112.45 124.93 53.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.719 -0.475 . . . . 65.34 109.719 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.12 120.35 39.47 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.122 -0.49 . . . . 70.43 109.899 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 p -105.54 118.07 35.62 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.045 -0.525 . . . . 64.05 109.686 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -161.12 116.15 2.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.367 -0.379 . . . . 73.52 111.743 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 43.45 78.06 0.06 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 125.22 1.408 . . . . 55.3 113.029 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.511 HH22 ' HB1' ' B' ' 49' ' ' ALA . 34.7 mmt-85 -125.91 149.61 48.58 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.503 0.668 . . . . 73.23 111.878 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -99.67 159.16 30.69 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 106.036 -1.839 . . . . 75.33 106.036 172.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.65 135.98 67.78 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.766 1.644 . . . . 62.24 111.133 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.58 149.18 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 74.4 108.19 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -85.54 -35.63 20.99 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.404 0.52 . . . . 71.1 112.404 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -131.11 147.73 52.65 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.217 -0.302 . . . . 61.43 110.665 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -86.63 124.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.678 -0.86 . . . . 73.25 108.678 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.25 150.44 25.13 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.361 0.601 . . . . 72.25 112.506 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 m -133.43 126.94 32.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.244 -1.391 . . . . 73.31 107.244 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -128.36 134.91 48.95 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-N 116.419 -0.355 . . . . 71.23 110.672 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.617 HG22 HG22 ' A' ' 37' ' ' VAL . 31.7 p -113.56 117.49 31.78 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.462 -0.79 . . . . 71.45 110.864 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.657 HD12 HD12 ' B' ' 38' ' ' ILE . 64.3 mt -110.49 123.02 66.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.295 -0.631 . . . . 64.31 109.295 177.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -116.3 115.89 26.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.135 -0.939 . . . . 73.13 109.127 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -129.55 107.01 9.13 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.186 -0.916 . . . . 55.51 109.748 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.68 -72.74 1.73 Allowed Glycine 0 C--N 1.303 -1.274 0 C-N-CA 121.121 -0.561 . . . . 51.01 111.95 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -154.91 4.63 0.22 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.172 0.804 . . . . 74.42 113.172 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.599 HD21 HD12 ' B' ' 40' ' ' ILE . 2.0 pt? -107.25 136.45 47.04 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 117.205 -1.798 . . . . 61.35 111.379 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -93.84 113.41 25.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.274 -0.875 . . . . 64.1 109.268 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.29 119.23 38.89 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.918 -0.771 . . . . 74.43 108.918 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 28' ' ' THR . 66.5 t -108.39 123.09 63.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 116.519 -0.309 . . . . 74.52 111.224 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.528 HD12 HD12 ' B' ' 29' ' ' ILE . 84.5 mt -102.06 116.2 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.511 -0.768 . . . . 70.54 109.163 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -102.6 116.94 33.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.817 -1.179 . . . . 71.3 107.817 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.596 HG23 HD21 ' B' ' 34' ' ' LEU . 40.6 mm -93.54 114.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 108.109 -1.071 . . . . 73.55 108.109 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -124.23 178.54 5.29 Favored 'General case' 0 N--CA 1.406 -2.649 0 C-N-CA 120.476 -0.489 . . . . 75.32 110.209 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 42' ' ' LYS . 58.7 pttt -74.83 -41.58 59.63 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 113.968 1.099 . . . . 73.3 113.968 -171.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -98.97 -10.73 22.32 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.765 -0.774 . . . . 72.54 110.045 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.22 -145.89 4.9 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 117.484 -2.293 . . . . 75.11 116.61 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 47.1 tp -130.36 141.45 50.57 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 125.26 1.424 . . . . 74.04 108.166 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.44 139.98 47.03 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.975 -0.69 . . . . 64.55 109.579 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.492 HG11 HG11 ' B' ' 47' ' ' VAL . 11.4 p -131.57 141.04 46.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 115.913 -0.585 . . . . 54.01 110.213 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.3 m -122.17 139.38 53.83 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.187 -0.461 . . . . 63.42 111.023 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.62 124.45 49.82 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 72.55 108.566 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -138.5 91.27 12.46 Favored Pre-proline 0 C--N 1.281 -2.402 0 CA-C-N 115.452 -0.794 . . . . 64.24 108.947 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.2 Cg_exo -80.83 141.45 13.45 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 122.829 2.353 . . . . 75.22 113.149 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 . . . . . 0 C--N 1.339 0.131 0 CA-C-N 114.749 -1.114 . . . . 74.04 110.84 172.194 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 2.8 ptm180 . . . . . 0 C--O 1.245 0.844 0 N-CA-C 115.267 1.58 . . . . 74.23 115.267 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 28.5 p -109.08 145.94 34.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.089 -1.078 . . . . 71.41 108.089 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 77.8 m -144.47 151.16 38.78 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.045 -0.724 . . . . 74.45 109.045 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 91.4 t -144.41 141.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 73.41 109.284 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -107.38 130.69 54.77 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.211 0.529 . . . . 74.22 109.8 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' LEU . . . . . 0.538 HD21 ' CG2' ' A' ' 12' ' ' VAL . 95.3 mt -102.23 121.36 42.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.781 -0.645 . . . . 55.1 110.694 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -85.25 113.93 21.96 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.616 -1.253 . . . . 74.44 107.616 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -153.76 170.05 21.88 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.22 -0.592 . . . . 71.2 109.878 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -72.2 93.52 1.46 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.295 0.569 . . . . 73.34 110.826 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ARG . . . . . 0.544 ' HE ' HD22 ' A' ' 34' ' ' LEU . 1.5 tmt_? -126.08 132.31 51.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.181 -1.785 . . . . 73.44 106.181 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.04 155.67 90.16 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 112.653 0.612 . . . . 71.22 112.653 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.97 140.39 23.99 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.937 3.091 . . . . 53.3 114.648 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' NH1' ' B' ' 18' ' ' ARG . 12.4 p -131.81 149.14 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.303 -1.369 . . . . 74.51 107.303 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -89.37 -45.57 9.38 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.754 0.312 . . . . 54.32 111.776 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -117.81 141.68 48.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.319 -0.4 . . . . 75.5 110.844 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.047 -0.723 . . . . 63.5 109.047 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.525 0.678 . . . . 73.01 112.03 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 77.1 m -130.64 128.51 41.12 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.751 -1.203 . . . . 75.11 107.751 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.36 125.03 37.86 Favored 'General case' 0 CA--C 1.446 -3.039 0 N-CA-C 108.617 -0.882 . . . . 75.14 108.617 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.441 HG23 HG22 ' B' ' 37' ' ' VAL . 19.7 m -117.61 119.51 35.22 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 115.202 -0.908 . . . . 71.43 111.317 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 38' ' ' ILE . 52.4 mt -111.97 121.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 109.654 -0.499 . . . . 51.21 109.654 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -101.74 118.88 37.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.992 -1.484 . . . . 73.32 106.992 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.514 ' O ' HD23 ' B' ' 34' ' ' LEU . 14.1 tp10 -132.87 122.37 24.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.481 -0.781 . . . . 73.52 109.397 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.23 -96.13 0.16 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 111.096 -0.802 . . . . 53.13 111.096 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' SER . . . . . 0.435 ' HB2' HD21 ' A' ' 19' ' ' LEU . 18.0 m -138.12 10.93 2.82 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.906 0.384 . . . . 53.2 110.364 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.596 HD21 HG23 ' A' ' 40' ' ' ILE . 2.1 pt? -118.3 141.38 48.58 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 120.57 -0.452 . . . . 75.31 109.827 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -112.48 134.31 54.08 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 115.894 -0.594 . . . . 74.11 112.216 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.97 53.14 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.088 -0.96 . . . . 51.43 109.272 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' B' ' 48' ' ' CYS . 76.1 t -114.17 127.12 71.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.019 -0.537 . . . . 74.3 110.151 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.657 HD12 HD12 ' A' ' 29' ' ' ILE . 62.9 mt -110.62 129.52 65.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 115.826 -0.625 . . . . 74.32 110.599 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.455 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.4 m-85 -109.48 116.92 32.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.824 -0.806 . . . . 72.11 108.824 176.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ILE . . . . . 0.599 HD12 HD21 ' A' ' 34' ' ' LEU . 49.1 mm -91.39 116.43 32.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.745 -0.662 . . . . 73.43 109.547 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.2 t -133.15 167.87 19.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.029 -0.73 . . . . 74.1 109.029 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.579 ' HE3' ' C ' ' B' ' 42' ' ' LYS 0.349 0.0 OUTLIER -86.37 2.42 47.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.639 0.978 . . . . 63.21 113.639 179.425 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -90.14 -13.26 36.05 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.036 -1.098 . . . . 74.55 108.036 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.07 -134.34 6.11 Favored Glycine 0 N--CA 1.424 -2.153 0 CA-C-N 115.245 -0.889 . . . . 73.1 112.059 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.47 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 60.1 tp -113.51 144.32 43.05 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 122.873 0.469 . . . . 74.25 109.833 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 83.3 tttt -129.37 136.12 49.59 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.618 -0.512 . . . . 54.42 109.618 168.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.492 HG11 HG11 ' A' ' 47' ' ' VAL . 14.8 p -120.42 140.69 43.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.094 -0.957 . . . . 63.0 110.512 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' CYS . . . . . 0.486 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 36.4 m -129.39 137.3 50.85 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.666 -0.697 . . . . 61.03 110.654 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' ALA . . . . . 0.511 ' HB1' HH22 ' A' ' 18' ' ' ARG . . . -117.8 124.02 47.39 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 107.803 -1.184 . . . . 71.42 107.803 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -121.82 110.88 33.04 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.946 -1.131 . . . . 64.32 107.946 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.434 -1.981 0 C-N-CA 121.408 1.405 . . . . 74.1 112.712 -177.184 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 109.992 -0.373 . . . . 74.11 109.992 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.97 36.25 6.09 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 109.979 -1.249 . . . . 65.01 109.979 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t 73.62 87.59 0.1 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.598 1.159 . . . . 62.12 110.229 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.2 119.12 22.45 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.283 -0.872 . . . . 62.34 108.703 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.62 90.97 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.0 0.905 . . . . 63.24 111.336 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -91.41 156.23 17.89 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.749 -0.834 . . . . 70.3 108.749 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.51 -6.89 21.32 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.752 -0.462 . . . . 73.21 109.752 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -92.62 -77.26 0.44 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.509 -0.552 . . . . 74.32 109.509 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -143.04 119.21 10.77 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.446 -0.946 . . . . 74.24 108.446 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.4 ' HB ' HD13 ' B' ' 14' ' ' LEU . 24.4 m -109.59 144.04 38.45 Favored 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 119.531 -0.868 . . . . 71.15 109.494 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.69 149.32 43.4 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.43 -1.322 . . . . 74.51 107.43 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 12' ' ' VAL . 58.6 t -140.54 139.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 121.157 -0.217 . . . . 72.04 110.929 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -110.98 131.0 55.41 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 122.998 0.519 . . . . 73.03 109.64 172.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 14' ' ' LEU . 4.2 pp -119.88 136.27 54.56 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.261 -1.015 . . . . 60.54 108.261 174.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 m -107.57 120.78 43.15 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.069 -0.715 . . . . 75.44 109.069 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -131.71 -169.24 2.16 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.392 -0.367 . . . . 54.43 110.957 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' B' ' 7' ' ' ASP . 18.6 pt20 -69.93 104.13 2.43 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.547 1.165 . . . . 73.51 108.043 174.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 18' ' ' ARG . 1.6 mmp_? -125.53 149.51 48.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 114.871 1.434 . . . . 61.14 114.871 -170.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.4 pp -101.84 148.26 35.05 Favored Pre-proline 0 N--CA 1.417 -2.093 0 CA-C-N 113.512 -1.677 . . . . 75.33 107.668 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.25 143.89 32.43 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.051 1.834 . . . . 75.31 112.496 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -131.36 140.0 49.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.984 -1.117 . . . . 74.12 107.984 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 p -58.66 -59.81 4.81 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.673 0.62 . . . . 64.11 112.673 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -115.98 166.92 11.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 112.148 0.425 . . . . 73.24 112.148 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mm -89.46 125.26 42.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.853 -0.612 . . . . 71.32 109.445 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 33.7 mmtm -89.57 145.46 25.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.88 -0.728 . . . . 71.1 109.68 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.6 m -120.86 126.96 51.39 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.101 -1.074 . . . . 61.5 108.101 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.429 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 67.8 m-85 -124.92 129.41 50.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.921 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 37' ' ' VAL . 66.3 p -114.14 130.57 56.59 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.659 -0.7 . . . . 63.52 111.929 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.717 HD12 HD12 ' B' ' 38' ' ' ILE . 76.1 mt -126.35 126.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.637 -0.711 . . . . 75.13 109.735 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -102.42 133.8 46.77 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.915 -0.772 . . . . 61.15 108.915 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HG2' HG13 ' B' ' 40' ' ' ILE . 11.9 tp10 -141.56 97.65 3.2 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.232 -0.44 . . . . 74.21 109.954 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.5 -85.33 0.26 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.501 -0.772 . . . . 75.32 111.769 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.595 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 37.3 p -137.54 14.83 2.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.867 0.841 . . . . 74.25 110.024 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' CD2' HD12 ' B' ' 40' ' ' ILE . 24.9 tp -106.67 132.49 52.6 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 115.387 -0.824 . . . . 62.45 110.844 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -108.84 115.88 30.92 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.36 -0.837 . . . . 61.42 110.339 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.06 120.08 40.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.631 -0.877 . . . . 64.51 108.631 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 28' ' ' THR . 87.5 t -114.79 126.04 72.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.286 0.565 . . . . 55.4 111.145 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.579 HD11 HD11 ' B' ' 38' ' ' ILE . 77.9 mt -106.16 122.91 60.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 124.259 1.024 . . . . 63.21 110.009 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 97.8 m-85 -107.8 118.11 35.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.254 -1.017 . . . . 74.21 108.254 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.546 HG13 ' HG2' ' B' ' 31' ' ' GLU . 45.2 mm -88.58 118.93 35.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.036 -0.727 . . . . 70.24 109.036 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.2 p -119.7 165.81 14.03 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.0 -0.546 . . . . 71.31 109.642 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.08 -17.91 63.25 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 122.859 0.463 . . . . 75.33 111.211 178.041 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -94.99 -23.79 17.22 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.123 0.487 . . . . 54.02 110.401 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.541 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 160.8 -139.8 6.29 Favored Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 118.497 -1.811 . . . . 74.21 114.988 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.1 tp -113.07 122.45 47.61 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.474 -0.863 . . . . 72.4 109.148 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 1.8 tmtm? -116.83 122.12 43.49 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.279 -2.119 . . . . 71.44 105.279 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.54 140.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 C-N-CA 120.745 -0.382 . . . . 65.02 110.661 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.461 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 59.3 m -122.94 141.43 51.93 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.259 -0.428 . . . . 62.24 110.983 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.42 124.85 51.04 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.825 -0.625 . . . . 65.51 110.421 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -123.31 91.98 49.33 Favored Pre-proline 0 C--N 1.298 -1.668 0 C-N-CA 124.264 1.026 . . . . 65.21 108.52 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -98.61 133.12 0.26 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.297 1.998 . . . . 72.25 114.15 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 52.04 22.51 1.88 Allowed 'General case' 0 C--O 1.243 0.729 0 CA-C-N 113.818 -1.537 . . . . 74.13 114.329 171.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.09 -60.63 2.99 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.826 0.822 . . . . 55.14 109.517 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.2 p -105.16 175.05 5.62 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 114.479 -1.237 . . . . 52.11 107.792 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -80.89 116.75 21.02 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.008 -0.677 . . . . 75.15 109.328 174.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 33' ' ' SER . 38.6 t -107.8 153.47 9.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.148 -0.933 . . . . 54.52 108.656 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -86.61 145.36 26.77 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.359 -0.608 . . . . 73.22 109.359 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -80.64 59.74 3.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.872 0.844 . . . . 74.33 110.032 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.2 t 64.41 112.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.869 0 C-N-CA 125.046 1.338 . . . . 62.23 112.767 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.305 -1.358 0 CA-C-N 115.614 -0.721 . . . . 72.24 110.49 179.795 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.24 0.584 0 N-CA-C 109.518 -0.549 . . . . 75.43 109.518 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.62 39.57 3.01 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 121.073 -0.584 . . . . 70.41 112.204 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 22.2 t 64.62 15.71 9.86 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.184 0.994 . . . . 72.53 110.309 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -144.3 143.06 30.82 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.587 -0.733 . . . . 72.52 109.597 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.22 133.62 63.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.512 -1.662 . . . . 62.1 106.512 171.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 39.2 t -127.32 140.48 52.17 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.867 -0.733 . . . . 74.12 111.408 -172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 13.7 m-20 -63.36 -32.37 73.78 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.393 -0.821 . . . . 74.24 110.037 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.603 ' O ' ' HD2' ' B' ' 51' ' ' PRO . 93.4 mttt -59.28 -66.2 0.55 Allowed 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 124.381 1.051 . . . . 65.41 110.194 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' B' ' 9' ' ' ARG . 60.1 mtt180 -156.41 124.0 5.47 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.36 -0.978 . . . . 75.34 108.36 175.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.9 m -110.29 141.86 42.7 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.975 -0.75 . . . . 63.14 108.975 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 79.6 m -127.82 148.98 50.47 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.037 -1.097 . . . . 73.24 108.037 173.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 12' ' ' VAL . 40.7 t -139.77 142.17 32.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.361 -0.607 . . . . 63.22 109.361 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.9 p -107.49 125.27 51.06 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.874 -1.158 . . . . 52.21 107.874 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' B' ' 45' ' ' LEU . 3.9 pp -112.91 144.02 43.19 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.036 0.446 . . . . 71.0 111.547 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -83.24 135.78 34.64 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.606 -0.724 . . . . 74.02 110.407 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p -156.44 153.49 28.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.833 0.853 . . . . 62.14 109.743 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -76.05 93.83 3.35 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.341 1.067 . . . . 75.04 109.398 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -123.24 148.34 45.97 Favored 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 114.937 -1.028 . . . . 62.32 113.369 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.81 153.81 72.96 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 114.044 -1.434 . . . . 61.31 109.343 172.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.04 149.94 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.504 2.136 . . . . 54.25 112.586 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.7 124.59 72.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 108.124 -1.065 . . . . 62.34 108.124 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.9 m -58.7 -47.08 85.79 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.169 0.588 . . . . 50.42 112.285 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -122.5 145.8 47.98 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.498 -0.556 . . . . 72.04 109.498 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.58 114.97 16.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.238 -1.023 . . . . 74.04 108.238 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -92.53 144.34 25.44 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.715 -0.675 . . . . 64.24 109.678 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 75.2 m -131.24 126.99 36.9 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.421 -0.955 . . . . 73.03 108.421 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 85.5 m-85 -122.95 131.48 53.74 Favored 'General case' 0 CA--C 1.465 -2.305 0 CA-C-N 115.716 -0.674 . . . . 72.25 110.733 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.614 HG22 HG22 ' B' ' 37' ' ' VAL . 23.1 p -115.35 131.22 57.0 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 124.254 0.971 . . . . 62.41 111.813 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 38' ' ' ILE . 49.2 mt -128.61 134.23 64.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 116.029 -0.532 . . . . 73.11 109.881 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -110.32 133.11 53.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.898 -0.778 . . . . 74.05 108.898 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.546 ' HG2' HG13 ' A' ' 40' ' ' ILE . 26.7 tp10 -142.4 102.02 4.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.216 0.531 . . . . 72.44 109.57 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.08 -78.02 1.29 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.521 -0.763 . . . . 43.23 111.412 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.422 ' HA ' ' HB ' ' B' ' 56' ' ' VAL . 48.8 m -157.74 33.64 0.26 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.324 -1.361 . . . . 72.23 107.324 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 40' ' ' ILE . 31.6 tp -120.61 125.26 47.29 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.449 -0.796 . . . . 64.32 110.307 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 32.7 mmt180 -99.75 115.18 28.92 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.746 0.654 . . . . 74.22 111.099 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 124.48 49.46 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.418 -0.956 . . . . 73.32 108.418 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.614 HG22 HG22 ' B' ' 28' ' ' THR . 67.8 t -120.47 135.01 62.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.16 0.505 . . . . 75.2 110.355 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.717 HD12 HD12 ' A' ' 29' ' ' ILE . 77.2 mt -118.79 122.36 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 CA-C-N 115.293 -0.867 . . . . 74.4 109.524 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.479 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.4 m-85 -107.77 115.78 30.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.063 -1.088 . . . . 73.2 108.063 176.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.515 HG13 ' HG2' ' A' ' 31' ' ' GLU . 48.5 mm -88.61 114.85 27.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.27 -0.641 . . . . 72.24 109.27 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 76.7 p -122.43 162.31 21.89 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.156 -0.474 . . . . 75.13 110.294 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.503 ' N ' ' HD3' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -56.69 -25.58 54.53 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.768 0.827 . . . . 71.44 112.83 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -89.78 -16.13 30.9 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 111.893 0.331 . . . . 74.33 111.893 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.89 -134.59 4.41 Favored Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 118.88 -1.629 . . . . 72.03 113.314 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.507 ' HB3' HD11 ' B' ' 14' ' ' LEU . 58.9 tp -113.3 125.59 54.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.293 -0.632 . . . . 70.02 109.293 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 2.6 tmtm? -115.65 121.67 43.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.754 -1.943 . . . . 61.54 105.754 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 p -114.74 140.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 116.61 -0.268 . . . . 74.45 110.977 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 47.6 m -130.81 137.93 49.66 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 122.893 0.477 . . . . 74.13 111.53 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -117.68 125.26 50.37 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.058 -0.519 . . . . 33.43 110.5 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 32.6 t70 -120.99 83.91 38.35 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.347 -0.983 . . . . 64.53 108.347 174.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' B' ' 8' ' ' LYS . 80.6 Cg_endo -89.07 135.44 2.74 Favored 'Trans proline' 0 N--CA 1.431 -2.196 0 C-N-CA 122.675 2.25 . . . . 45.03 114.485 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 69.5 -74.77 0.08 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 125.639 1.576 . . . . 74.31 113.294 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 52.66 -91.52 0.02 OUTLIER 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.509 1.124 . . . . 70.22 112.924 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 29.8 p -137.39 -73.05 0.42 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-O 120.619 0.247 . . . . 75.42 111.508 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -126.87 92.22 3.49 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.208 0.527 . . . . 73.5 112.194 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' B' ' 33' ' ' SER . 68.2 t -97.26 113.0 30.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.617 -1.253 . . . . 63.22 107.617 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -86.77 163.66 17.15 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 112.445 0.535 . . . . 70.13 112.445 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.85 -25.97 59.36 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 114.839 -1.073 . . . . 72.33 109.104 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 61.4 t 66.82 74.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 114.872 -1.058 . . . . 70.43 110.848 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.431 -1.42 0 CA-C-N 114.476 -1.238 . . . . 72.25 110.136 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 110.139 -0.319 . . . . 62.24 110.139 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.47 38.03 18.77 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.178 -1.169 . . . . 70.3 110.178 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.7 m -60.56 135.54 57.79 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.314 0.645 . . . . 74.44 111.704 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.08 117.83 16.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.304 -0.862 . . . . 72.45 108.778 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 m -79.78 87.04 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.236 1.017 . . . . 74.44 112.082 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 m -73.38 -15.44 61.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.577 -1.192 . . . . 40.21 111.929 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -79.98 -18.43 50.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.95 -0.389 . . . . 70.11 109.95 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.531 ' HE3' ' N ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -76.56 93.43 3.58 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.785 -1.561 . . . . 74.15 106.785 167.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 98.8 mtt180 70.28 100.5 0.06 Allowed 'General case' 0 C--N 1.313 -1.014 0 O-C-N 124.508 1.13 . . . . 72.1 110.425 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.2 p -86.11 117.86 25.21 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.359 -0.978 . . . . 63.02 108.359 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 56.7 m -121.48 149.33 43.22 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.672 -0.694 . . . . 70.3 109.385 -176.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG23 HD11 ' B' ' 14' ' ' LEU . 78.0 t -142.62 149.71 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 123.468 0.707 . . . . 71.1 109.383 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 p -106.58 125.72 51.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.978 0.418 . . . . 72.25 111.186 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.9 mm? -102.94 123.57 46.8 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.223 1.009 . . . . 75.35 110.16 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -107.63 112.26 24.89 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.54 -0.541 . . . . 72.44 109.54 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -151.54 95.68 2.16 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.156 0.503 . . . . 73.44 111.515 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.55 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 56.3 tp60 48.59 84.06 0.03 OUTLIER 'General case' 0 C--O 1.247 0.943 0 CA-C-N 114.774 -1.103 . . . . 74.52 111.752 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -124.73 145.7 49.56 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 114.115 1.154 . . . . 74.41 114.115 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.13 148.15 48.46 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 106.919 -1.511 . . . . 70.2 106.919 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 136.22 43.29 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.741 1.627 . . . . 73.33 113.595 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 23' ' ' ARG . 11.3 p -124.16 139.46 50.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 64.24 106.675 175.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 m -98.2 9.3 43.27 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.538 0.57 . . . . 72.14 112.538 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' H ' HG22 ' A' ' 21' ' ' VAL . 31.1 tpt180 -131.16 133.33 45.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.867 -0.79 . . . . 74.13 108.867 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -90.75 116.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.476 -0.935 . . . . 74.45 108.476 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.71 127.19 45.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.324 -0.551 . . . . 74.13 110.821 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.4 HG22 ' CD1' ' A' ' 39' ' ' PHE . 54.0 p -108.68 127.77 54.28 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 107.991 -1.114 . . . . 53.33 107.991 175.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -126.5 125.8 42.67 Favored 'General case' 0 CA--C 1.467 -2.22 0 CA-C-N 116.316 -0.402 . . . . 70.43 109.949 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.601 HG22 HG22 ' A' ' 37' ' ' VAL . 67.2 p -115.78 121.9 43.83 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.707 -0.679 . . . . 52.33 111.351 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.626 HD12 HD12 ' B' ' 38' ' ' ILE . 51.1 mt -117.79 123.08 71.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 116.207 -0.451 . . . . 72.41 110.193 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -105.83 129.06 54.08 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.349 -0.982 . . . . 54.2 108.349 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.01 111.7 6.68 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.302 -0.863 . . . . 65.04 109.498 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.21 -67.89 2.09 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.97 -0.559 . . . . 64.51 111.764 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 23.0 t -162.1 -21.05 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 122.027 0.131 . . . . 62.15 111.052 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 34' ' ' LEU . 2.3 pt? -89.34 141.71 28.3 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.661 -0.496 . . . . 61.04 109.661 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -117.86 118.6 32.46 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.764 -0.653 . . . . 72.43 109.262 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.33 133.72 48.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.005 -0.543 . . . . 75.54 109.602 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.601 HG22 HG22 ' A' ' 28' ' ' THR . 25.9 t -116.53 130.77 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.121 0.486 . . . . 74.32 110.435 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.537 HD12 HD12 ' B' ' 29' ' ' ILE . 74.2 mt -108.26 116.95 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 C-N-CA 124.583 1.153 . . . . 64.34 108.612 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.634 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 95.6 m-85 -105.78 116.06 31.29 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.177 -1.046 . . . . 72.15 108.177 175.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.542 HG23 HD21 ' B' ' 34' ' ' LEU . 44.9 mm -88.85 119.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 108.193 -1.04 . . . . 71.34 108.193 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -128.1 162.58 26.56 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.099 -0.501 . . . . 75.22 110.343 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -63.28 -18.21 63.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.214 0.605 . . . . 74.51 110.969 177.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -94.43 -9.28 36.1 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.541 0.686 . . . . 74.23 109.837 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.99 -134.37 7.39 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.593 -0.813 . . . . 72.14 113.119 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 56.1 tp -111.76 125.51 54.07 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.901 -0.407 . . . . 74.34 109.901 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.2 tptm -115.22 121.65 43.59 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.824 -1.546 . . . . 52.14 106.824 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.547 HG11 HG11 ' B' ' 47' ' ' VAL . 14.4 p -112.13 140.57 31.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 116.496 -0.32 . . . . 74.11 110.646 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -127.55 138.51 52.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.392 -0.367 . . . . 71.12 111.114 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.1 123.64 48.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.119 -0.491 . . . . 70.24 109.718 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 29.6 t70 -101.62 119.36 57.5 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.136 -0.69 . . . . 71.25 109.136 176.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HB3' ' HB3' ' B' ' 17' ' ' GLN . 93.0 Cg_exo -48.65 135.88 27.33 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.247 3.298 . . . . 75.43 114.536 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.9 mt-30 -51.18 112.2 0.69 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.114 -0.948 . . . . 74.4 110.456 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.08 -66.56 1.06 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.973 -0.558 . . . . 73.34 110.215 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.4 m -104.08 135.86 44.78 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.977 -1.12 . . . . 74.42 107.977 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -71.21 126.55 29.91 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.359 -1.348 . . . . 75.32 107.359 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.8 p -75.08 113.39 13.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.933 0.873 . . . . 40.31 112.287 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -104.37 75.0 1.21 Allowed 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.345 -0.983 . . . . 74.23 108.345 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t70 170.39 87.93 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.273 1.429 . . . . 54.32 108.622 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.35 133.17 61.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.333 0.587 . . . . 54.45 111.55 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.299 -1.606 0 CA-C-N 115.519 -0.764 . . . . 72.04 109.833 179.361 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.246 0.895 0 CA-C-O 121.656 0.741 . . . . 72.44 109.839 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.43 63.47 0.55 Allowed Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 114.641 -1.163 . . . . 61.55 111.088 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 30.4 p -57.58 111.69 1.2 Allowed 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.72 0.772 . . . . 61.33 111.727 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.26 151.6 35.02 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.002 -0.999 . . . . 74.23 110.877 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' B' ' 8' ' ' LYS . 27.7 m -67.06 104.24 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 122.078 0.942 . . . . 61.32 111.963 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 48.2 m -98.44 -67.31 0.85 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.254 -0.885 . . . . 72.01 110.037 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.45 -3.7 30.38 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.168 0.508 . . . . 73.44 109.868 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.511 ' O ' ' HB ' ' B' ' 5' ' ' VAL . 39.9 ttmt -88.28 102.79 15.18 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.302 -0.999 . . . . 74.44 108.302 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 87.1 mtt180 60.68 92.64 0.05 OUTLIER 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.748 1.219 . . . . 73.04 111.193 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.7 p -91.4 135.5 33.78 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.255 0.55 . . . . 73.15 110.672 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 55.5 m -131.04 149.79 52.45 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.119 -1.067 . . . . 74.21 108.119 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.444 HG23 HD11 ' A' ' 14' ' ' LEU . 76.1 t -144.29 145.55 21.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.546 -0.539 . . . . 64.42 109.546 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.6 p -106.88 135.08 49.04 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.12 0.486 . . . . 63.44 109.833 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 2.8 mm? -109.56 121.56 45.47 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.77 -0.65 . . . . 74.25 110.124 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 27.2 p -106.95 112.75 25.85 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.466 -0.939 . . . . 51.13 108.466 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' B' ' 18' ' ' ARG . 10.5 t -134.44 -167.56 1.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.844 -1.169 . . . . 72.32 107.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLN . . . . . 0.519 ' HB3' ' HB3' ' A' ' 51' ' ' PRO . 56.3 tp60 -62.51 88.08 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.731 0.777 . . . . 54.25 110.251 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' B' ' 16' ' ' THR . 5.5 ppt_? -126.77 150.15 49.27 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.242 0.83 . . . . 75.24 113.242 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.15 159.0 31.79 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 107.039 -1.467 . . . . 71.23 107.039 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.47 135.64 31.66 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.233 1.288 . . . . 73.3 111.624 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.479 HG22 ' H ' ' B' ' 23' ' ' ARG . 7.4 p -129.43 130.52 67.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.774 -0.824 . . . . 71.24 108.774 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -94.16 1.05 56.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.134 0.492 . . . . 53.34 112.128 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.479 ' H ' HG22 ' B' ' 21' ' ' VAL . 22.6 tpt180 -112.02 142.82 43.98 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.755 -0.461 . . . . 75.34 109.755 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.7 131.23 50.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.049 -1.093 . . . . 61.25 108.049 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 34.3 mmtp -124.97 143.58 50.81 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.163 -0.31 . . . . 72.14 110.163 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 41.4 p -126.37 127.98 46.33 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.107 -0.701 . . . . 74.53 109.107 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 80.1 m-85 -127.81 132.28 49.48 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 120.694 0.283 . . . . 72.43 111.118 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.533 HG22 HG22 ' B' ' 37' ' ' VAL . 36.6 p -115.09 125.31 53.35 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.357 -0.838 . . . . 63.34 112.405 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 38' ' ' ILE . 58.0 mt -127.75 125.3 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-O 120.809 0.338 . . . . 74.32 110.523 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -108.91 131.68 54.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.469 -0.937 . . . . 72.11 108.469 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.605 ' O ' HD23 ' B' ' 34' ' ' LEU . 11.6 tp10 -142.99 116.34 9.04 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.68 -0.691 . . . . 74.52 109.463 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.36 -59.78 2.81 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.669 -0.572 . . . . 32.22 111.669 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -174.13 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.563 0.745 . . . . 75.1 110.461 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.605 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -77.5 140.84 39.86 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.158 -0.682 . . . . 70.31 109.158 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -119.8 121.71 39.75 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.99 -0.55 . . . . 74.01 109.53 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.54 52.01 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.843 -0.617 . . . . 73.23 109.888 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.533 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -114.13 125.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.752 -0.658 . . . . 41.31 109.895 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.626 HD12 HD12 ' A' ' 29' ' ' ILE . 77.9 mt -101.63 119.06 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 C-N-CA 123.664 0.786 . . . . 72.35 109.297 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.402 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.2 m-85 -104.72 114.86 29.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.411 -0.813 . . . . 72.24 108.857 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.501 HG23 HD21 ' A' ' 34' ' ' LEU . 41.8 mm -89.49 115.24 28.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 106.408 -1.701 . . . . 75.45 106.408 176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.0 p -133.47 163.22 29.87 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.092 0.472 . . . . 62.25 111.949 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.557 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -57.06 -21.83 34.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.829 1.252 . . . . 75.01 111.413 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -88.22 -16.25 33.75 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.524 0.73 . . . . 70.13 109.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.43 -122.71 4.3 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 111.072 -0.811 . . . . 72.41 111.072 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.506 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 56.4 tp -112.19 144.98 40.67 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.653 -0.499 . . . . 71.25 109.653 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -141.41 141.72 33.73 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.479 -1.304 . . . . 74.23 107.479 168.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.547 HG11 HG11 ' A' ' 47' ' ' VAL . 11.8 p -131.51 140.7 47.66 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.029 0 N-CA-C 109.368 -0.604 . . . . 75.34 109.368 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.402 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.8 m -119.49 138.39 53.18 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.995 -0.548 . . . . 54.53 110.205 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.41 123.86 49.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.25 -0.648 . . . . 73.05 109.25 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' B' ' 9' ' ' ARG . 34.2 t70 -100.45 125.86 37.83 Favored Pre-proline 0 C--N 1.289 -2.036 0 CA-C-N 115.732 -0.667 . . . . 71.2 109.993 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.55 ' HB3' ' HB3' ' A' ' 17' ' ' GLN . 5.0 Cg_exo -38.72 140.3 0.39 Allowed 'Trans proline' 0 C--N 1.356 0.945 1 C-N-CA 125.671 4.248 . . . . 62.43 116.018 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.44 ' HG3' ' HB3' ' B' ' 34' ' ' LEU . 54.5 mt-30 -68.65 73.65 0.25 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.395 -0.82 . . . . 70.23 110.575 170.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.49 8.03 2.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.911 -0.774 . . . . 71.32 108.911 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 4.8 m -82.35 136.38 35.01 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.125 -0.943 . . . . 61.15 108.938 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -85.33 89.14 7.59 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.713 -0.847 . . . . 62.22 108.713 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.78 107.11 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 121.806 0.813 . . . . 63.45 111.012 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -123.59 92.01 3.59 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.349 -0.842 . . . . 72.21 108.997 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -178.88 88.99 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.565 -1.198 . . . . 71.21 108.987 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.05 152.58 31.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.488 -0.778 . . . . 74.54 109.507 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.299 -1.599 0 CA-C-N 116.556 -0.293 . . . . 71.43 110.624 -179.894 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 110.093 -0.336 . . . . 53.21 110.093 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.55 31.33 8.38 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.726 -0.75 . . . . 24.1 113.053 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 p -93.86 136.87 33.69 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.664 0.232 . . . . 63.03 110.486 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.6 149.28 23.66 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.093 -0.706 . . . . 64.45 109.093 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t 70.07 107.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.629 1.172 . . . . 70.42 112.686 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -99.36 106.73 18.85 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.151 -0.685 . . . . 70.13 109.151 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -152.08 -167.57 2.81 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.354 -0.98 . . . . 73.42 108.354 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.11 119.08 25.1 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.255 0.55 . . . . 74.14 110.012 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 92.6 mtt180 68.83 90.33 0.1 Allowed 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 125.965 1.706 . . . . 70.23 111.443 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 p -99.45 134.36 42.43 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.834 -0.621 . . . . 72.22 109.576 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -130.09 148.94 51.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.488 -0.56 . . . . 73.34 109.488 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.9 139.14 22.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.365 0.416 . . . . 72.04 109.9 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 p -112.43 130.9 55.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.761 0.315 . . . . 73.23 110.75 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.421 HD11 HG23 ' B' ' 12' ' ' VAL . 1.7 mm? -101.73 122.32 43.71 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.921 -0.581 . . . . 74.03 109.951 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -101.66 113.72 27.13 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 113.838 1.051 . . . . 75.14 113.838 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.516 HG22 ' CZ ' ' A' ' 18' ' ' ARG . 14.6 t -155.91 165.79 35.42 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.661 -1.978 . . . . 75.44 105.661 166.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -86.08 90.33 8.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.811 1.291 . . . . 73.22 110.685 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.516 ' CZ ' HG22 ' A' ' 16' ' ' THR . 80.6 mtt85 -96.61 149.62 21.57 Favored 'General case' 0 N--CA 1.393 -3.282 0 N-CA-C 105.472 -2.048 . . . . 73.25 105.472 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 2.3 mm? -73.26 128.33 87.72 Favored Pre-proline 0 C--N 1.284 -2.243 0 C-N-CA 120.725 -0.39 . . . . 63.15 111.571 -171.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 72.9 Cg_exo -49.84 141.97 27.05 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 124.527 3.485 . . . . 70.45 115.394 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.17 135.17 58.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.332 -1.729 . . . . 73.21 106.332 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.7 m -59.12 -59.66 5.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.109 0.411 . . . . 64.52 112.109 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -97.56 146.11 25.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.523 -0.547 . . . . 63.3 109.523 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 41' ' ' THR . 52.1 mm -79.94 118.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.603 -0.888 . . . . 63.31 108.603 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.59 146.57 25.16 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.172 0.511 . . . . 62.04 111.626 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 39.2 p -126.0 127.64 46.21 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.917 -1.038 . . . . 72.14 108.977 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -124.24 130.46 52.57 Favored 'General case' 0 CA--C 1.468 -2.189 0 CA-C-N 116.197 -0.456 . . . . 70.32 110.782 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.529 HG22 HG22 ' A' ' 37' ' ' VAL . 61.8 p -114.86 128.67 56.43 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.177 -0.919 . . . . 73.1 111.103 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.67 HD12 HD12 ' B' ' 38' ' ' ILE . 58.2 mt -126.91 123.46 62.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 120.931 0.396 . . . . 65.05 110.492 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.7 t -106.15 121.81 44.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.453 -0.943 . . . . 74.03 108.453 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.19 106.92 4.86 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.36 0.6 . . . . 63.01 111.279 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.05 -66.8 2.14 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.857 -0.61 . . . . 72.34 112.931 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -154.11 12.88 0.43 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.483 0.549 . . . . 73.33 112.483 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.516 HD21 HD12 ' B' ' 40' ' ' ILE . 1.6 pt? -128.58 141.56 51.33 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 118.062 -1.455 . . . . 71.05 111.877 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 53' ' ' ALA . 23.5 mmm180 -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.014 -1.476 . . . . 72.53 107.014 167.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.47 129.4 52.47 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.323 -0.621 . . . . 73.21 109.323 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 28' ' ' THR . 58.9 t -118.17 126.86 75.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.083 0.468 . . . . 70.53 110.912 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.576 HD12 HD12 ' B' ' 29' ' ' ILE . 69.6 mt -105.78 122.24 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.206 -0.906 . . . . 64.3 109.607 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.489 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.1 m-85 -103.36 114.89 29.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.885 -0.783 . . . . 74.11 108.885 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.71 HG23 HD21 ' B' ' 34' ' ' LEU . 40.6 mm -91.98 114.5 29.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.572 -0.899 . . . . 73.32 108.572 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.438 HG22 HD12 ' A' ' 24' ' ' ILE . 70.4 p -130.74 170.61 14.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.283 -0.636 . . . . 64.53 109.283 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -83.49 -4.73 58.79 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.876 -0.787 . . . . 73.14 108.876 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 3.1 tmt_? -98.64 6.11 47.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 106.949 -1.5 . . . . 71.05 106.949 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.35 -143.67 18.07 Favored Glycine 0 N--CA 1.423 -2.232 0 CA-C-N 114.228 -1.351 . . . . 52.31 113.148 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.631 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 55.0 tp -112.34 136.7 51.48 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.599 -0.519 . . . . 74.21 109.599 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 82.8 tttt -128.2 140.71 51.76 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.059 -0.719 . . . . 70.12 109.059 170.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.693 HG11 HG11 ' B' ' 47' ' ' VAL . 9.6 p -128.72 141.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 115.58 -0.736 . . . . 74.03 109.996 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.489 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 60.5 m -128.45 137.52 51.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.313 -0.403 . . . . 52.03 110.705 174.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.831 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.45 121.73 42.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.411 -0.589 . . . . 61.42 109.411 175.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -119.3 101.94 48.81 Favored Pre-proline 0 C--N 1.284 -2.242 0 C-N-CA 123.837 0.855 . . . . 75.01 109.718 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.07 133.44 13.58 Favored 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 120.839 1.026 . . . . 64.12 110.562 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 47.78 75.47 0.13 Allowed 'General case' 0 CA--C 1.546 0.806 0 O-C-N 124.261 0.976 . . . . 64.14 112.988 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB2' ' HG3' ' A' ' 35' ' ' ARG . . . -59.03 -52.14 67.05 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.278 0.561 . . . . 43.41 111.813 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.1 t -161.92 -51.97 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.55 -0.907 . . . . 74.21 108.55 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -148.88 112.54 5.06 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.071 -1.455 . . . . 73.12 107.071 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.9 128.68 39.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 109.569 -0.53 . . . . 73.22 109.569 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.1 161.77 13.51 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.302 -0.559 . . . . 74.51 110.842 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -83.72 4.89 26.8 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.292 -0.867 . . . . 63.25 110.375 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t 76.08 105.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.796 1.239 . . . . 70.21 110.215 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.305 -1.369 0 CA-C-N 115.845 -0.616 . . . . 64.04 110.319 -178.261 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 49.6 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.36 -0.607 . . . . 74.31 109.36 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.8 -77.87 0.78 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.471 -0.786 . . . . 53.02 113.729 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 43.8 m -81.26 88.18 6.07 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.499 0.666 . . . . 71.42 112.067 -176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -159.92 116.06 2.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.198 -1.779 . . . . 64.14 106.198 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 53.8 t 58.52 74.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 107.747 -1.205 . . . . 64.54 107.747 -170.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -122.44 160.16 26.09 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 114.64 -1.164 . . . . 73.11 110.855 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.31 -160.52 1.06 Allowed 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 104.577 -2.379 . . . . 63.53 104.577 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . 0.372 97.4 mttt -74.92 -2.07 25.31 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 119.573 1.079 . . . . 72.33 113.422 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 92.4 mtt180 -129.01 109.75 11.48 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 108.19 -1.041 . . . . 74.15 108.19 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 m -108.49 127.07 53.6 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.507 -1.294 . . . . 74.32 107.507 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 61.9 m -121.66 148.97 43.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.947 -1.131 . . . . 64.12 107.947 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.421 HG23 HD11 ' A' ' 14' ' ' LEU . 92.8 t -144.45 146.77 20.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.681 -0.489 . . . . 43.4 109.681 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.505 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 35.3 p -106.16 135.84 46.91 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.91 -1.145 . . . . 74.43 107.91 174.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 3.2 mm? -100.2 122.56 43.22 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.497 -0.557 . . . . 74.42 109.497 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -84.62 112.56 20.56 Favored 'General case' 0 N--CA 1.397 -3.075 0 CA-C-N 115.441 -0.799 . . . . 61.4 109.803 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -154.65 177.79 10.83 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.191 -1.411 . . . . 75.53 107.191 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -108.2 108.55 19.63 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.44 0.638 . . . . 75.23 109.379 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.419 HH22 HG21 ' B' ' 21' ' ' VAL . 19.2 mtm105 -124.62 150.33 46.11 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.368 -0.833 . . . . 74.15 110.19 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.45 HD22 ' H ' ' B' ' 19' ' ' LEU . 2.1 mm? -74.93 145.32 81.03 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 114.857 -1.065 . . . . 73.22 108.86 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.75 135.67 63.17 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 123.02 2.48 . . . . 72.23 112.806 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.419 HG21 HH22 ' B' ' 18' ' ' ARG . 61.3 t -103.72 131.2 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.658 -1.238 . . . . 72.31 107.658 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.9 m -56.29 -46.33 79.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 113.798 1.036 . . . . 61.41 113.798 -174.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' B' ' 23' ' ' ARG . 0.4 OUTLIER -127.22 155.45 43.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.783 -0.821 . . . . 71.35 108.783 -175.441 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.3 131.53 33.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.947 0.403 . . . . 55.42 109.968 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' B' ' 27' ' ' TYR . 1.5 mptm? -116.72 143.5 45.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 112.322 0.49 . . . . 61.14 112.322 177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -125.85 127.12 45.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.444 -1.317 . . . . 70.22 107.444 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' B' ' 25' ' ' LYS . 75.9 m-85 -124.65 126.85 46.41 Favored 'General case' 0 CA--C 1.45 -2.899 0 CA-C-N 116.244 -0.435 . . . . 75.23 110.566 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.606 HG22 HG22 ' B' ' 37' ' ' VAL . 81.5 p -114.01 135.47 53.97 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 115.073 -0.967 . . . . 72.32 109.507 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.576 HD12 HD12 ' A' ' 38' ' ' ILE . 60.6 mt -127.97 121.65 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 116.114 -0.494 . . . . 63.2 110.772 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.516 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 6.2 t -100.96 117.46 35.05 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.589 -0.732 . . . . 54.42 109.1 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.517 ' O ' HD23 ' B' ' 34' ' ' LEU . 10.4 tp10 -140.39 110.29 6.47 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.553 -0.749 . . . . 63.22 110.286 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 -84.7 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.593 -0.73 . . . . 73.33 114.341 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.566 ' HA ' HG11 ' B' ' 56' ' ' VAL . 47.8 m -137.19 12.73 3.06 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 112.982 0.734 . . . . 52.54 112.982 -176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.71 HD21 HG23 ' A' ' 40' ' ' ILE . 2.2 pt? -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.753 -0.779 . . . . 72.42 112.107 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.516 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 18.6 mmm180 -103.67 113.52 27.1 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.1 -1.444 . . . . 72.35 107.1 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.37 131.64 52.55 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 110.023 -0.362 . . . . 74.22 110.023 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.606 HG22 HG22 ' B' ' 28' ' ' THR . 59.8 t -122.61 124.84 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-O 120.836 0.351 . . . . 74.33 111.031 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.67 HD12 HD12 ' A' ' 29' ' ' ILE . 94.1 mt -104.53 122.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.651 -0.87 . . . . 64.22 108.651 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.1 m-85 -104.24 121.04 42.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.233 -1.395 . . . . 74.43 107.233 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.516 HD12 HD21 ' A' ' 34' ' ' LEU . 50.6 mm -89.48 114.68 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.653 0 CA-C-O 122.398 1.094 . . . . 71.12 110.014 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -127.04 149.47 49.9 Favored 'General case' 1 N--CA 1.369 -4.492 0 CA-C-N 112.503 -2.135 . . . . 74.2 106.475 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' B' ' 42' ' ' LYS . 17.5 ptmt -71.74 -18.93 62.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 118.62 0.645 . . . . 54.2 112.666 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 0.1 OUTLIER -86.89 6.14 33.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.165 0.984 . . . . 72.12 109.056 -172.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.94 -129.33 4.05 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.469 -0.872 . . . . 44.54 112.738 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.492 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 64.6 tp -125.64 144.55 50.54 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.584 0.754 . . . . 64.25 109.003 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.4 tptm -134.75 122.9 22.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.167 -1.42 . . . . 72.53 107.167 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.693 HG11 HG11 ' A' ' 47' ' ' VAL . 10.2 p -127.23 141.42 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 120.883 -0.327 . . . . 75.3 110.956 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 56.5 m -123.71 137.02 54.78 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.144 -0.48 . . . . 64.44 111.012 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.64 122.9 44.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.912 -0.586 . . . . 64.42 110.971 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -132.33 118.4 16.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 123.688 0.795 . . . . 74.34 109.324 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 48.3 Cg_endo -76.62 134.24 15.0 Favored 'Trans proline' 0 N--CA 1.431 -2.153 0 C-N-CA 121.127 1.218 . . . . 71.43 112.352 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.497 ' HA ' ' CG1' ' B' ' 56' ' ' VAL . 41.8 mt-30 65.87 -57.48 0.34 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.974 1.71 . . . . 65.03 115.297 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 68.69 -75.77 0.06 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.161 1.384 . . . . 63.13 110.47 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.2 t -149.32 -48.46 0.14 Allowed 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.993 -0.743 . . . . 72.2 108.993 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -139.86 92.11 2.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.154 0.502 . . . . 74.25 111.826 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' B' ' 33' ' ' SER . 8.6 p -100.97 131.16 49.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.123 -1.065 . . . . 73.03 108.123 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.27 172.59 9.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.598 -0.841 . . . . 51.13 111.403 -177.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.6 49.11 0.85 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.497 1.519 . . . . 73.41 109.725 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.4 t 65.01 80.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.499 1.12 . . . . 74.43 110.457 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.248 0.987 0 CA-C-N 115.072 -0.967 . . . . 72.42 109.279 -178.568 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 110.068 -0.345 . . . . 63.54 110.068 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.43 131.38 10.69 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.976 -0.85 . . . . 74.01 110.976 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -154.81 109.59 3.02 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 122.568 0.347 . . . . 73.41 110.543 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -77.61 115.05 17.06 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.849 -0.426 . . . . 74.2 109.849 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.7 m -81.72 99.37 4.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.692 0.758 . . . . 74.41 111.024 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.5 m -154.84 178.29 10.32 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.396 0.678 . . . . 73.14 109.416 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -77.97 86.88 4.15 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 112.796 0.665 . . . . 74.15 112.796 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -154.8 -82.36 0.08 Allowed 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 126.88 2.072 . . . . 73.41 106.834 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -151.09 120.99 7.09 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 107.325 -1.361 . . . . 72.41 107.325 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.427 ' HB ' HD13 ' B' ' 14' ' ' LEU . 28.3 m -108.8 140.2 42.57 Favored 'General case' 0 N--CA 1.403 -2.801 0 C-N-CA 119.101 -1.04 . . . . 55.42 109.597 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.94 149.56 50.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.69 -1.226 . . . . 75.52 107.69 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.5 t -140.69 135.72 34.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 110.068 -0.345 . . . . 62.23 110.068 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.471 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 30.2 p -107.45 135.9 48.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.58 -0.526 . . . . 74.32 109.58 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 4.2 pp -130.66 127.95 39.95 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.057 0.456 . . . . 72.0 110.595 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 t -110.03 119.51 39.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 55.42 110.193 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -159.56 114.67 2.42 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.677 -0.692 . . . . 74.34 109.856 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HG3' ' HB2' ' B' ' 51' ' ' PRO . 12.0 pt20 35.85 81.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.848 1.659 . . . . 62.33 114.446 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -125.56 149.59 48.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.591 0.96 . . . . 71.12 113.591 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 19' ' ' LEU . 3.2 mp -111.26 155.54 42.54 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 107.692 -1.225 . . . . 62.35 107.692 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.26 142.83 94.76 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.724 2.283 . . . . 75.15 111.089 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.07 146.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.442 -0.947 . . . . 72.23 108.442 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.9 m -71.13 -39.9 71.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.738 0.644 . . . . 74.53 112.738 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 29.2 tpt180 -134.46 138.91 45.13 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.778 -0.576 . . . . 72.43 110.154 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.84 115.32 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 107.624 -1.25 . . . . 72.41 107.624 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.2 mmtp -101.29 132.16 46.97 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.387 -0.525 . . . . 72.52 111.388 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 p -113.05 126.65 55.72 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 106.671 -1.603 . . . . 63.32 106.671 173.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 69.7 m-85 -121.57 129.9 53.17 Favored 'General case' 0 CA--C 1.458 -2.572 0 CA-C-N 116.575 -0.284 . . . . 75.41 110.693 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.558 HG22 HG22 ' A' ' 37' ' ' VAL . 61.7 p -114.54 127.65 55.91 Favored 'General case' 0 C--N 1.286 -2.161 0 O-C-N 123.86 0.725 . . . . 75.24 111.171 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.651 HD12 HD12 ' B' ' 38' ' ' ILE . 62.7 mt -127.79 121.73 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.262 -0.644 . . . . 73.44 109.262 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -106.34 126.34 52.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.326 -0.99 . . . . 74.33 108.326 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.0 tp10 -142.34 99.97 3.61 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.183 -0.462 . . . . 74.11 111.869 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 -66.36 1.37 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 114.908 0.723 . . . . 44.31 114.908 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.4 m -139.29 -8.15 1.32 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.314 -0.521 . . . . 74.1 112.399 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.511 HD21 HD12 ' B' ' 40' ' ' ILE . 2.3 pt? -130.27 140.35 50.69 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 119.043 -1.063 . . . . 63.14 111.769 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 3.1 mpt_? -99.54 119.58 38.26 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.449 -1.315 . . . . 74.21 107.449 169.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.16 127.11 51.73 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.489 -0.56 . . . . 75.1 109.489 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 44.7 t -117.19 128.51 74.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.336 -0.393 . . . . 73.54 110.425 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.695 HD12 HD12 ' B' ' 29' ' ' ILE . 96.6 mt -108.59 121.29 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 N-CA-C 108.274 -1.01 . . . . 72.53 108.274 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 93.2 m-85 -104.88 114.63 28.95 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.197 -1.038 . . . . 74.33 108.197 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.539 HD12 HD21 ' B' ' 34' ' ' LEU . 48.4 mm -90.79 113.39 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.063 -1.088 . . . . 74.21 108.063 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -125.65 177.75 6.06 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.181 -1.044 . . . . 72.41 108.181 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -81.4 -32.67 32.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.956 1.095 . . . . 62.35 113.956 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -86.65 -20.1 28.31 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.829 -0.749 . . . . 72.25 110.863 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.73 -162.65 29.38 Favored Glycine 0 C--N 1.294 -1.779 0 C-N-CA 119.171 -1.49 . . . . 61.55 114.134 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 14' ' ' LEU . 2.0 tm? -113.69 122.88 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.475 -0.935 . . . . 70.41 108.475 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.0 tptm -115.76 122.43 45.44 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.408 -0.96 . . . . 72.33 108.408 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.601 HG11 HG11 ' B' ' 47' ' ' VAL . 13.8 p -119.23 140.53 42.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.868 -0.419 . . . . 64.23 109.868 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -125.71 139.79 53.24 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.969 -0.56 . . . . 63.25 111.332 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -117.0 123.68 47.5 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 108.429 -0.952 . . . . 54.54 108.429 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 18.1 t70 -113.72 87.44 12.19 Favored Pre-proline 0 C--N 1.282 -2.362 0 N-CA-C 108.197 -1.038 . . . . 71.53 108.197 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.3 Cg_endo -87.79 133.28 3.02 Favored 'Trans proline' 0 N--CA 1.417 -3.023 0 C-N-CA 121.57 1.513 . . . . 75.04 111.354 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 58.78 -176.46 0.08 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.09 -1.414 . . . . 74.44 113.37 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 179.45 -71.44 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.192 1.397 . . . . 74.52 107.725 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.6 p -143.61 -62.2 0.4 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.275 -1.75 . . . . 73.13 106.275 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -131.88 141.1 49.28 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.128 -1.434 . . . . 71.2 107.128 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.6 t -104.94 122.73 58.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.72 -0.844 . . . . 74.41 108.72 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -77.6 146.92 35.91 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.237 0.542 . . . . 74.33 111.673 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -97.57 108.32 21.01 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.247 -1.02 . . . . 73.23 108.247 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.04 127.37 33.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.109 0.481 . . . . 63.44 110.275 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--O 1.251 1.143 0 CA-C-N 115.668 -0.697 . . . . 65.52 110.218 -177.517 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' VAL . . . . . 0.507 HG23 ' H ' ' B' ' 3' ' ' SER . 32.2 m . . . . . 0 C--O 1.239 0.537 0 N-CA-C 109.451 -0.574 . . . . 75.44 109.451 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.03 -1.49 63.18 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.176 0.298 . . . . 73.0 113.418 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.507 ' H ' HG23 ' B' ' 1' ' ' VAL . 18.2 m -86.94 112.34 21.7 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.661 -0.496 . . . . 72.21 109.661 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -90.54 102.64 15.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.723 -1.584 . . . . 63.22 106.723 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' B' ' 10' ' ' THR . 31.6 m -128.75 117.3 44.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 112.935 0.717 . . . . 72.05 112.935 -172.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -149.71 -80.44 0.12 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.952 -0.567 . . . . 70.44 112.393 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -121.05 -7.26 9.44 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 113.783 1.031 . . . . 72.52 113.783 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.73 -56.19 3.34 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 109.393 -0.595 . . . . 72.33 109.393 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -140.57 132.57 27.77 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 107.938 -1.134 . . . . 73.44 107.938 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.48 ' HB ' HD13 ' A' ' 14' ' ' LEU . 25.1 m -109.64 128.59 55.34 Favored 'General case' 0 N--CA 1.393 -3.298 0 N-CA-C 107.564 -1.273 . . . . 74.22 107.564 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.439 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 34.8 m -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.572 -2.011 . . . . 62.12 105.572 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 141.71 28.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.71 0.291 . . . . 63.23 110.885 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.5 p -108.7 126.68 53.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.236 -0.438 . . . . 75.32 110.881 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' B' ' 45' ' ' LEU . 4.3 pp -125.23 137.52 54.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.984 -0.747 . . . . 63.13 108.984 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -120.19 125.99 49.55 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 109.06 -0.719 . . . . 74.13 109.06 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -161.85 115.6 1.87 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.277 -0.42 . . . . 55.4 111.202 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 34.29 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 126.276 1.83 . . . . 65.12 114.849 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.432 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 53.2 mmm-85 -127.51 146.73 50.41 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 114.008 1.114 . . . . 54.52 114.008 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.88 153.96 47.53 Favored Pre-proline 0 C--O 1.25 1.126 0 N-CA-C 106.501 -1.666 . . . . 73.13 106.501 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.78 135.55 38.77 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.705 1.603 . . . . 54.42 112.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.548 HG12 ' H ' ' B' ' 23' ' ' ARG . 91.4 t -131.39 131.85 62.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.858 -1.164 . . . . 64.12 107.858 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 m -98.18 3.24 49.01 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 111.959 0.355 . . . . 74.41 111.959 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.548 ' H ' HG12 ' B' ' 21' ' ' VAL . 6.9 mpt_? -117.22 139.38 50.86 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.666 -0.243 . . . . 53.33 110.553 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.05 115.44 41.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.996 -1.483 . . . . 62.13 106.996 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.485 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 34.7 mmtp -103.92 141.44 36.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.632 -0.427 . . . . 71.22 110.41 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.408 HG22 ' CD2' ' B' ' 39' ' ' PHE . 51.3 p -121.89 127.07 50.04 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.79 -0.819 . . . . 75.14 108.79 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -123.62 129.58 51.36 Favored 'General case' 0 CA--C 1.467 -2.229 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.391 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.544 HG22 HG22 ' B' ' 37' ' ' VAL . 72.6 p -115.47 130.53 56.91 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.824 -0.625 . . . . 72.23 112.268 -174.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 38' ' ' ILE . 80.2 mt -136.85 127.44 40.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.303 -0.628 . . . . 43.11 109.303 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.422 ' HB ' ' HD3' ' B' ' 35' ' ' ARG . 12.4 t -119.39 135.73 54.6 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.155 -1.054 . . . . 72.41 108.155 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.596 ' O ' HD23 ' B' ' 34' ' ' LEU . 12.5 tp10 -142.44 112.23 6.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.614 -0.434 . . . . 72.44 111.424 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.46 -67.05 1.92 Allowed Glycine 0 C--N 1.311 -0.836 0 CA-C-N 116.156 -0.475 . . . . 52.44 112.54 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.423 ' HA ' HG21 ' B' ' 56' ' ' VAL . 9.6 m -140.79 -35.93 0.47 Allowed 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 120.683 0.278 . . . . 14.11 110.582 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.596 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.6 pt? -84.29 141.21 31.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.707 0.632 . . . . 63.25 112.707 -171.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 22.8 tpp180 -101.93 113.77 27.27 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.382 -1.34 . . . . 73.42 107.382 171.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.2 133.12 52.9 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.13 -0.356 . . . . 65.42 110.109 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.544 HG22 HG22 ' B' ' 28' ' ' THR . 58.3 t -126.83 130.78 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.172 0.51 . . . . 63.44 109.974 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.651 HD12 HD12 ' A' ' 29' ' ' ILE . 92.2 mt -106.08 126.24 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 N-CA-C 108.332 -0.988 . . . . 72.11 108.332 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 87.0 m-85 -109.1 114.33 27.97 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.508 -1.293 . . . . 61.32 107.508 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.511 HD12 HD21 ' A' ' 34' ' ' LEU . 51.4 mm -92.09 113.97 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 109.037 -0.727 . . . . 61.14 109.037 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -120.28 177.42 5.03 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.532 -1.284 . . . . 71.42 107.532 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.447 ' HB3' ' H ' ' B' ' 21' ' ' VAL . 17.2 ptmt -91.66 -12.92 32.78 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.145 -0.687 . . . . 72.44 109.145 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -86.51 1.62 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.145 0.974 . . . . 74.42 109.826 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.54 -146.56 18.56 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 114.885 -1.052 . . . . 43.34 113.357 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.45 ' HB3' ' CD1' ' B' ' 14' ' ' LEU . 2.1 tm? -122.26 124.14 43.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.708 0.803 . . . . 71.32 109.448 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 53.7 tptt -115.42 121.65 43.41 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.594 -1.262 . . . . 71.31 107.594 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.601 HG11 HG11 ' A' ' 47' ' ' VAL . 13.9 p -111.58 140.81 29.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.279 -1.008 . . . . 42.32 108.279 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.439 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 15.9 t -139.11 136.72 35.47 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 119.336 -0.946 . . . . 73.42 108.541 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.21 125.79 35.79 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 120.978 0.418 . . . . 45.32 111.523 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 26.8 t70 -109.5 97.6 28.04 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 108.016 -1.105 . . . . 60.23 108.016 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.503 ' HB2' ' HG3' ' A' ' 17' ' ' GLN . 12.6 Cg_exo -71.49 134.39 24.32 Favored 'Trans proline' 0 N--CA 1.431 -2.182 0 C-N-CA 122.279 1.986 . . . . 64.55 112.378 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 68.35 80.54 0.2 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.635 -1.62 . . . . 53.1 112.938 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.04 145.11 27.22 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.567 -1.197 . . . . 53.4 108.667 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 28.7 p -58.92 -40.68 85.31 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 112.285 0.476 . . . . 70.03 112.285 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -126.78 105.83 8.94 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.156 0.503 . . . . 73.24 110.429 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' B' ' 33' ' ' SER . 91.9 t -104.6 140.53 22.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.572 -0.74 . . . . 73.3 109.469 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -135.01 136.03 41.83 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.039 -0.726 . . . . 74.33 109.039 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -65.69 107.81 1.88 Allowed 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.446 0.466 . . . . 72.23 110.126 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.35 110.91 23.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.977 0.894 . . . . 61.13 111.404 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.301 -1.501 0 N-CA-C 107.633 -1.247 . . . . 71.11 107.633 178.498 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 111.995 0.368 . . . . 75.34 111.995 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.0 -166.01 53.67 Favored Glycine 0 C--O 1.246 0.898 0 C-N-CA 121.051 -0.595 . . . . 71.33 111.921 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.4 t -125.04 97.49 5.27 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.688 -0.856 . . . . 71.3 108.688 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.64 -37.08 42.92 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.951 -1.129 . . . . 64.44 107.951 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.77 157.0 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.589 -1.187 . . . . 73.43 108.216 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.7 p -105.79 -25.27 12.25 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.586 0.708 . . . . 71.31 109.192 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.89 83.12 7.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.672 -0.695 . . . . 71.44 109.604 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt 174.96 155.0 0.14 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.191 -1.781 . . . . 61.25 106.191 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -73.12 115.25 12.22 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 121.465 0.65 . . . . 72.1 110.968 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -92.5 140.99 29.0 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 115.593 -0.731 . . . . 54.14 109.524 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.6 m -142.17 148.87 38.95 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.471 -0.566 . . . . 65.52 109.471 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.489 HG23 HD21 ' B' ' 14' ' ' LEU . 69.4 t -144.75 145.72 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.274 0.629 . . . . 71.51 109.696 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 p -109.16 136.14 49.12 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 122.835 0.454 . . . . 63.42 110.505 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.427 HD21 ' CG2' ' B' ' 12' ' ' VAL . 95.2 mt -119.62 121.93 40.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.365 0.602 . . . . 70.41 111.617 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 p -95.17 114.03 25.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.1 -0.955 . . . . 70.21 109.698 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 t -139.12 -170.55 2.9 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.89 -1.522 . . . . 74.24 106.89 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -76.86 91.48 3.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.058 0.933 . . . . 63.13 111.362 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -126.15 141.83 51.77 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.867 -1.06 . . . . 43.2 109.57 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.4 mm? -82.45 146.34 53.66 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.534 -0.757 . . . . 54.31 109.031 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 20.7 Cg_exo -64.66 134.87 42.73 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.8 1.666 . . . . 73.52 112.209 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 23' ' ' ARG . 43.7 t -131.74 143.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 114.428 -1.26 . . . . 70.0 108.179 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 m -90.56 -22.35 21.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.204 0.446 . . . . 73.31 112.204 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' H ' HG12 ' A' ' 21' ' ' VAL . 28.9 mmm180 -105.88 133.45 50.59 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.472 -0.331 . . . . 71.21 110.68 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.87 116.41 31.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.789 -0.819 . . . . 71.24 108.789 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -91.98 133.6 35.56 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 120.313 -0.555 . . . . 73.32 110.928 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.4 p -118.0 127.36 53.74 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.396 -0.82 . . . . 65.41 110.426 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 67.9 m-85 -121.5 130.77 53.76 Favored 'General case' 0 CA--C 1.477 -1.845 0 CA-C-N 115.837 -0.62 . . . . 75.21 111.029 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 37' ' ' VAL . 57.4 p -114.56 131.58 56.62 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.382 -0.826 . . . . 73.1 111.286 -175.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 38' ' ' ILE . 40.1 mt -125.23 130.4 73.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 116.432 -0.349 . . . . 73.02 110.695 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -109.96 115.76 30.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 122.21 1.005 . . . . 54.32 110.269 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.3 tp10 -143.13 123.06 13.51 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.197 -0.91 . . . . 65.45 108.926 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 52.31 32.11 36.3 Favored Glycine 0 C--O 1.218 -0.849 0 O-C-N 123.219 0.325 . . . . 73.12 113.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.439 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 22.2 t 84.55 -10.19 0.87 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.475 1.11 . . . . 75.43 113.37 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.6 pt? -89.36 140.22 29.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 117.07 -1.852 . . . . 65.12 109.239 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.73 118.32 36.43 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.309 -1.367 . . . . 72.35 107.309 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.99 129.54 51.59 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.51 -0.552 . . . . 71.15 109.51 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 61.9 t -118.91 122.24 68.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.186 0.517 . . . . 73.3 110.427 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.659 HD12 HD12 ' B' ' 29' ' ' ILE . 87.0 mt -103.54 123.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 C-N-CA 124.093 0.957 . . . . 52.42 109.075 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.5 114.52 28.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.423 -0.584 . . . . 64.12 109.423 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 47.2 mm -92.52 114.32 29.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.971 -1.863 . . . . 74.34 105.971 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.441 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 9.5 t -129.06 173.74 10.18 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.587 -0.445 . . . . 65.12 111.28 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -70.5 -25.22 63.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.624 . . . . 65.51 109.96 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -92.02 -4.39 54.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 73.51 110.675 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.29 -125.43 3.51 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 119.411 -1.376 . . . . 42.32 114.149 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 2.1 tm? -126.19 126.81 44.69 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 123.772 0.829 . . . . 74.41 110.06 -176.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -122.93 141.08 52.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.612 -0.514 . . . . 71.03 109.612 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.415 HG11 HG11 ' B' ' 47' ' ' VAL . 13.4 p -123.33 140.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 CA-C-N 115.739 -0.664 . . . . 70.12 110.52 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -129.76 137.72 50.69 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.558 -0.746 . . . . 72.12 110.664 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.41 123.01 46.49 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.935 -1.505 . . . . 54.2 106.935 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -117.02 101.98 53.09 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 105.684 -1.969 . . . . 70.34 105.684 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.47 132.07 17.09 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.238 1.292 . . . . 74.13 111.932 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 48.87 37.17 9.46 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 124.214 0.946 . . . . 65.22 110.371 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -38.74 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.512 1.925 . . . . 63.25 115.405 -172.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 m 68.32 -69.59 0.15 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.526 1.13 . . . . 45.4 110.809 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -156.28 110.09 2.73 Favored 'General case' 0 N--CA 1.395 -3.193 0 N-CA-C 106.927 -1.509 . . . . 75.32 106.927 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 33' ' ' SER . 42.3 t -135.92 98.92 2.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.151 -0.685 . . . . 74.15 109.151 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -85.16 125.33 32.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.614 -0.884 . . . . 75.41 108.614 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -75.07 101.4 4.52 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.459 0.647 . . . . 71.23 110.431 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.76 -27.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.266 -0.879 . . . . 71.31 109.715 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.304 -1.392 0 CA-C-N 115.641 -0.709 . . . . 73.43 110.983 -178.395 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 121.394 0.616 . . . . 75.21 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.47 -24.35 70.83 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.417 -0.81 . . . . 62.23 113.094 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -81.53 111.64 18.03 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.738 0.304 . . . . 73.25 110.209 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.15 -70.78 0.7 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.923 0.392 . . . . 61.42 111.093 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.58 -177.68 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.845 -0.616 . . . . 54.13 111.638 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 20.9 p -89.39 -40.94 12.41 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.036 -0.529 . . . . 51.43 111.77 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -133.85 123.88 25.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.223 -0.444 . . . . 65.43 111.009 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' B' ' 9' ' ' ARG . 39.5 ttmt 177.89 154.42 0.32 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.309 -1.367 . . . . 75.51 107.309 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptm180 -72.71 97.23 2.15 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 121.598 0.714 . . . . 72.22 110.179 171.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.2 p -87.1 142.66 27.76 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.56 -0.745 . . . . 42.52 110.741 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 62.8 m -135.04 149.79 50.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.38 -0.6 . . . . 55.25 109.38 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.427 ' CG2' HD21 ' A' ' 14' ' ' LEU . 99.2 t -139.42 139.62 38.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.16 -0.473 . . . . 71.21 110.419 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.6 p -107.92 125.68 51.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.051 -0.722 . . . . 71.41 109.051 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.489 HD21 HG23 ' A' ' 12' ' ' VAL . 96.8 mt -113.6 124.3 52.01 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 122.819 0.448 . . . . 74.24 111.78 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 24.9 p -85.16 113.63 21.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.493 -0.776 . . . . 62.11 109.244 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.1 t -139.33 178.4 7.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.483 -0.932 . . . . 74.01 108.483 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -71.04 88.76 0.78 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.161 0.981 . . . . 72.11 110.431 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.442 ' NH2' ' HB2' ' B' ' 19' ' ' LEU . 6.9 tpm_? -126.91 129.5 48.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.64 -1.164 . . . . 70.13 110.173 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.445 HD22 ' H ' ' B' ' 19' ' ' LEU . 1.7 mm? -74.49 146.21 83.44 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.373 -1.343 . . . . 74.0 107.373 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.2 135.04 52.25 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 122.517 2.144 . . . . 61.22 113.881 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.29 127.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.523 -1.658 . . . . 74.11 106.523 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -88.9 -36.74 15.77 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.587 -0.445 . . . . 74.24 111.409 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -112.96 134.15 54.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.304 . . . . 71.23 111.353 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.86 123.86 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.96 -0.564 . . . . 75.01 111.625 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 0.6 OUTLIER -90.51 132.84 35.45 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.577 -0.449 . . . . 62.23 110.161 173.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 39.1 p -106.66 128.31 54.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.286 -0.87 . . . . 74.5 109.753 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 54.3 m-85 -128.16 126.83 41.83 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 116.052 -0.522 . . . . 73.55 110.752 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.498 HG22 HG22 ' B' ' 37' ' ' VAL . 77.8 p -114.85 131.19 56.92 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.947 -0.57 . . . . 53.54 112.069 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.659 HD12 HD12 ' A' ' 38' ' ' ILE . 59.7 mt -136.52 122.21 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.322 -0.992 . . . . 71.41 108.322 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.3 121.63 40.04 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.786 -0.766 . . . . 75.01 109.41 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.598 ' O ' HD23 ' B' ' 34' ' ' LEU . 11.7 tp10 -119.7 113.8 21.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.428 -0.806 . . . . 75.23 110.546 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.26 -75.48 1.35 Allowed Glycine 0 C--N 1.298 -1.568 0 C-N-CA 121.174 -0.536 . . . . 71.24 112.125 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' B' ' 56' ' ' VAL . 13.7 t -153.56 6.99 0.36 Allowed 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 120.797 0.332 . . . . 71.32 111.403 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.598 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -114.75 140.03 49.22 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 118.522 -1.271 . . . . 54.24 109.712 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.414 HH12 ' HB3' ' B' ' 53' ' ' ALA . 4.2 mpt_? -98.06 131.03 44.82 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.022 -0.732 . . . . 74.32 109.022 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.37 114.83 23.53 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.353 -0.98 . . . . 74.43 108.353 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.498 HG22 HG22 ' B' ' 28' ' ' THR . 51.6 t -111.52 125.7 68.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.103 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 29' ' ' ILE . 81.6 mt -101.59 130.7 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.663 0 C-N-CA 124.017 0.927 . . . . 60.3 109.573 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.39 114.66 26.16 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.057 -1.09 . . . . 74.03 108.057 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' B' ' 25' ' ' LYS . 50.2 mm -88.64 117.73 32.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.697 -1.223 . . . . 73.41 107.697 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.7 t -132.04 169.32 16.51 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.402 0.439 . . . . 73.0 110.465 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.454 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -70.53 -18.52 62.93 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.031 0.443 . . . . 72.01 110.837 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -86.71 -16.48 36.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 70.13 109.11 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.6 -124.93 2.5 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.268 -0.967 . . . . 62.43 113.223 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.95 124.25 42.18 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.929 -0.636 . . . . 60.13 110.737 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -121.29 140.69 51.74 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.885 0.374 . . . . 64.51 110.11 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.415 HG11 HG11 ' A' ' 47' ' ' VAL . 13.1 p -131.77 141.37 45.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.806 -0.633 . . . . 74.52 110.011 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 65.2 m -123.75 136.65 54.56 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 123.242 0.339 . . . . 75.15 110.531 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.58 123.76 47.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.585 -0.524 . . . . 41.34 109.585 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.93 105.6 37.51 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.791 -0.818 . . . . 74.51 108.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -92.01 133.06 1.28 Allowed 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 121.349 1.366 . . . . 74.12 115.406 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.48 ' OE1' HD21 ' A' ' 19' ' ' LEU . 35.9 mt-30 55.9 -3.24 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 118.507 2.78 . . . . 72.24 118.507 165.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.414 ' HB3' HH12 ' B' ' 35' ' ' ARG . . . -52.58 121.81 7.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.993 0.738 . . . . 52.32 112.993 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 40.9 m 76.03 -75.39 0.07 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.918 1.287 . . . . 62.11 112.587 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -175.81 134.79 0.29 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 122.877 0.471 . . . . 74.14 110.294 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' B' ' 33' ' ' SER . 39.4 t -141.5 130.78 24.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.68 -1.23 . . . . 75.2 107.68 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -162.94 135.81 5.63 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.642 -0.503 . . . . 74.14 109.642 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -123.54 166.05 16.09 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.506 -1.294 . . . . 73.14 107.506 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -82.9 -37.56 14.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 120.712 0.292 . . . . 71.21 111.705 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.253 1.255 0 N-CA-C 109.334 -0.617 . . . . 71.05 109.334 -175.615 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.795 0.331 . . . . 74.23 111.473 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.55 124.98 5.53 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.777 -0.725 . . . . 71.34 112.111 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 m -91.52 -15.11 29.23 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.861 0.362 . . . . 71.33 110.517 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.18 88.5 4.87 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 109.057 -0.72 . . . . 74.04 109.057 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.99 -69.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.976 -0.556 . . . . 72.44 110.04 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.0 m -86.71 132.98 33.72 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.357 -0.383 . . . . 53.22 110.289 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -83.41 86.93 6.99 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.954 0.883 . . . . 74.24 110.278 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -140.65 -62.84 0.48 Allowed 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.294 -1.743 . . . . 72.34 106.294 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -133.48 113.38 12.43 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 105.496 -2.039 . . . . 74.45 105.496 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 p -86.26 117.16 24.9 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.803 -0.759 . . . . 72.03 109.695 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.6 m -123.94 148.94 46.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.934 -0.575 . . . . 63.44 109.495 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG23 HD11 ' B' ' 14' ' ' LEU . 89.6 t -145.45 142.41 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.825 0.45 . . . . 72.51 110.242 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -111.35 138.37 47.93 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 122.65 0.38 . . . . 72.43 110.871 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.438 HD11 ' CG2' ' B' ' 12' ' ' VAL . 3.5 mm? -114.42 140.54 48.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 112.331 0.493 . . . . 70.21 112.331 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.312 -0.858 . . . . 74.02 109.506 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -134.49 -177.7 4.72 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.578 -1.268 . . . . 73.34 107.578 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -76.31 96.79 4.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.337 1.065 . . . . 74.44 109.32 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -125.85 140.02 53.0 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.108 -0.951 . . . . 75.34 111.63 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' B' ' 33' ' ' SER . 4.8 mp -82.55 136.5 45.42 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.284 -1.006 . . . . 64.34 108.284 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.17 137.53 40.8 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 122.48 2.12 . . . . 71.41 112.675 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -131.8 148.96 32.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.618 -1.174 . . . . 73.31 107.973 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -97.49 -23.83 15.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.009 0.433 . . . . 62.21 111.71 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -102.91 132.12 49.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.293 -0.632 . . . . 74.45 109.293 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -98.07 129.99 47.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.837 -0.62 . . . . 74.34 109.592 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.83 141.51 30.74 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.359 -0.536 . . . . 73.54 110.894 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.1 p -119.76 127.66 53.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.077 -0.965 . . . . 74.45 108.767 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 70.5 m-85 -126.35 126.27 43.63 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 110.17 -0.307 . . . . 74.02 110.17 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 37' ' ' VAL . 59.3 p -115.89 131.35 56.96 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.754 -0.657 . . . . 72.21 111.405 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.572 HD12 HD12 ' B' ' 38' ' ' ILE . 50.2 mt -127.39 121.33 57.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.116 -0.493 . . . . 71.11 110.004 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -103.88 121.47 43.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.779 -1.193 . . . . 65.25 107.779 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 34' ' ' LEU . 13.6 tp10 -142.62 100.43 3.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 112.242 0.46 . . . . 74.12 112.242 -174.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.54 -66.15 3.55 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 114.592 0.597 . . . . 54.53 114.592 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 p -158.94 18.8 0.19 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.655 0.613 . . . . 72.1 112.655 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.566 HD22 ' CZ ' ' B' ' 18' ' ' ARG . 2.1 pt? -145.27 140.35 27.75 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.499 -0.556 . . . . 74.33 109.499 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -107.77 120.88 43.5 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.46 -0.941 . . . . 75.34 108.46 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.32 134.92 46.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.785 -0.45 . . . . 71.44 109.785 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 48.5 t -118.22 125.41 74.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 60.53 110.184 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.637 HD12 HD12 ' B' ' 29' ' ' ILE . 74.6 mt -101.77 120.61 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 CA-C-N 115.555 -0.748 . . . . 63.45 109.077 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 94.7 m-85 -102.58 115.44 30.59 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.819 -0.808 . . . . 75.32 108.819 175.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.563 HG23 HD21 ' B' ' 34' ' ' LEU . 37.1 mm -88.29 112.24 23.49 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 106.504 -1.665 . . . . 33.12 106.504 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.443 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 7.0 t -126.09 153.04 45.06 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.922 -0.581 . . . . 73.32 112.553 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -52.33 -32.82 39.88 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.948 1.299 . . . . 42.32 113.233 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -87.64 -12.64 44.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.369 0.604 . . . . 73.22 110.706 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.27 -109.97 0.43 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.673 -1.251 . . . . 52.04 113.624 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 60.7 tp -134.09 145.99 49.87 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 123.911 0.885 . . . . 73.42 109.846 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -141.04 142.66 34.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.251 -0.648 . . . . 61.13 109.251 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.459 HG11 HG11 ' B' ' 47' ' ' VAL . 12.9 p -127.03 140.62 48.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.872 -0.604 . . . . 62.23 109.949 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 33.7 m -125.15 143.19 51.06 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 116.119 -0.491 . . . . 74.31 110.871 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.82 124.14 49.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.973 -1.121 . . . . 73.11 107.973 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.03 101.22 54.48 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 107.47 -1.307 . . . . 63.4 107.47 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.96 150.3 72.91 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 122.59 2.193 . . . . 74.13 111.763 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -47.4 132.63 13.15 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.967 -1.015 . . . . 71.14 110.349 172.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.86 -43.36 18.33 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.816 0.817 . . . . 62.3 109.759 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.0 m -153.74 69.61 0.81 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.725 -1.954 . . . . 70.53 105.725 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 60.46 -166.96 0.19 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 114.653 -1.158 . . . . 71.12 109.524 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.14 146.23 16.18 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 108.364 -0.976 . . . . 73.24 108.364 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -72.8 177.86 4.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.582 -0.525 . . . . 73.13 109.582 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -74.41 97.78 3.14 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.315 0.579 . . . . 62.51 111.548 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.24 131.87 2.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.285 -1.005 . . . . 72.43 108.285 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 120.858 -0.337 . . . . 73.33 110.7 -176.888 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.242 0.709 0 N-CA-C 109.428 -0.582 . . . . 62.25 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.89 43.49 41.36 Favored Glycine 0 CA--C 1.501 -0.83 0 N-CA-C 110.609 -0.996 . . . . 53.32 110.609 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 31.1 m -78.55 -69.9 0.53 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.079 -0.56 . . . . 75.3 112.074 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -93.77 95.47 9.16 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.923 -0.769 . . . . 64.33 108.923 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -119.8 -70.81 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 115.708 -0.678 . . . . 75.04 109.899 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 27.0 m -92.04 131.32 37.41 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.297 -0.631 . . . . 74.14 109.297 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.05 87.24 6.9 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.022 -0.733 . . . . 51.04 109.022 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.427 ' HG3' ' HG3' ' B' ' 9' ' ' ARG . 23.3 tptm -168.79 -71.41 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.787 -1.097 . . . . 72.51 108.199 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.523 ' HG2' ' HD2' ' B' ' 51' ' ' PRO . 35.0 mtp180 -120.47 92.65 3.82 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.097 -1.075 . . . . 74.24 108.097 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -89.39 148.17 23.64 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.541 -0.754 . . . . 64.41 111.446 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 84.0 m -133.16 149.69 52.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.716 -1.216 . . . . 62.32 107.716 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.438 ' CG2' HD11 ' A' ' 14' ' ' LEU . 65.8 t -136.86 140.53 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 120.81 -0.356 . . . . 74.33 111.434 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 22.4 p -106.81 125.81 51.49 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.495 0.718 . . . . 53.23 109.912 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.419 HD11 HG23 ' A' ' 12' ' ' VAL . 2.7 mm? -106.44 129.67 54.38 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.424 -0.584 . . . . 75.53 109.424 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 12.1 p -123.84 112.36 17.19 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.934 0.873 . . . . 62.34 111.559 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -141.69 -166.43 2.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.502 -1.666 . . . . 65.22 106.502 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -66.99 94.89 0.35 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.212 0.914 . . . . 51.32 112.146 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.566 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 7.2 tpt180 -126.38 137.95 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.993 -1.003 . . . . 41.23 110.878 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.59 136.23 42.61 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.119 -1.067 . . . . 75.15 108.119 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' B' ' 42' ' ' LYS . 57.9 Cg_endo -70.13 148.65 63.16 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.352 2.035 . . . . 72.13 113.236 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 23' ' ' ARG . 12.0 p -131.88 142.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 71.35 107.923 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 16.1 m -91.52 9.93 29.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.293 0.568 . . . . 75.31 111.074 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.516 ' H ' HG22 ' B' ' 21' ' ' VAL . 35.6 mmt180 -128.87 133.9 48.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.443 -0.577 . . . . 70.5 109.443 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.48 117.17 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.397 -0.594 . . . . 62.04 109.397 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.1 139.31 34.94 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.899 0.38 . . . . 74.13 111.617 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.403 HG22 ' CD1' ' B' ' 39' ' ' PHE . 37.8 p -117.89 127.77 54.17 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.298 -0.865 . . . . 74.4 108.884 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.15 124.21 34.1 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 108.683 -0.858 . . . . 64.31 108.683 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.448 HG23 HG22 ' B' ' 37' ' ' VAL . 18.8 m -118.07 122.01 42.05 Favored 'General case' 0 C--N 1.264 -3.144 0 C-N-CA 119.507 -0.877 . . . . 63.2 111.859 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.637 HD12 HD12 ' A' ' 38' ' ' ILE . 60.4 mt -112.9 123.49 68.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.279 -0.637 . . . . 65.43 109.279 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -104.82 121.48 43.75 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.654 0.74 . . . . 73.14 109.239 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.513 ' O ' HD23 ' B' ' 34' ' ' LEU . 13.9 tp10 -136.7 97.33 3.52 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.18 0.514 . . . . 75.3 111.592 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.53 -80.2 0.23 Allowed Glycine 0 C--N 1.312 -0.778 0 CA-C-N 115.615 -0.72 . . . . 44.33 114.831 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.45 ' HB3' HD13 ' A' ' 19' ' ' LEU . 28.1 m -123.69 6.59 8.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.685 0.624 . . . . 74.0 112.685 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.563 HD21 HG23 ' A' ' 40' ' ' ILE . 2.1 pt? -147.0 140.97 25.93 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 119.11 -1.036 . . . . 71.12 111.517 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 86.8 mtm180 -108.18 119.47 39.56 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 114.784 -1.098 . . . . 75.34 109.088 170.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 126.99 51.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.632 -0.507 . . . . 72.33 109.632 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.448 HG22 HG23 ' B' ' 28' ' ' THR . 46.3 t -109.41 124.92 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.083 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 29' ' ' ILE . 70.3 mt -101.33 119.7 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.661 -0.866 . . . . 60.33 108.661 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.479 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.9 m-85 -102.92 114.56 28.95 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.255 -1.017 . . . . 73.02 108.255 175.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.485 HD12 HD21 ' A' ' 34' ' ' LEU . 48.4 mm -89.97 112.88 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 106.014 -1.847 . . . . 75.51 106.014 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -115.66 -178.02 3.29 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 115.555 -0.748 . . . . 74.14 109.372 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.664 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -73.0 -45.24 58.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 113.972 1.101 . . . . 75.21 113.972 -173.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -93.81 -6.32 46.18 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.802 -0.759 . . . . 72.11 111.955 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.93 -143.12 6.39 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.354 -1.879 . . . . 62.11 114.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' B' ' 14' ' ' LEU . 59.0 tp -114.53 149.13 36.91 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.43 1.092 . . . . 64.13 109.689 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' B' ' 12' ' ' VAL . 84.7 tttt -143.56 143.11 31.38 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.234 -0.654 . . . . 61.44 109.234 170.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.459 HG11 HG11 ' A' ' 47' ' ' VAL . 11.7 p -131.52 141.22 46.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.649 -0.5 . . . . 71.01 109.649 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.479 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 63.5 m -121.29 146.21 47.07 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 110.32 -0.252 . . . . 42.14 110.32 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -115.81 124.3 50.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 121.265 0.555 . . . . 75.31 109.748 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 20.4 t70 -114.87 108.46 48.69 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 115.085 -0.961 . . . . 75.23 109.136 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.523 ' HD2' ' HG2' ' B' ' 9' ' ' ARG . 87.4 Cg_endo -79.58 151.92 22.65 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 C-N-CA 122.174 1.916 . . . . 74.52 110.875 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.426 ' OE1' ' HA ' ' B' ' 55' ' ' TRP . 2.1 pp0? -43.92 133.39 4.97 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 113.972 -1.467 . . . . 73.03 113.911 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.93 -3.85 15.43 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.033 -0.985 . . . . 65.34 109.899 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 45.5 p -115.83 19.77 14.96 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.109 -0.951 . . . . 71.14 108.918 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' TRP . . . . . 0.426 ' HA ' ' OE1' ' B' ' 52' ' ' GLN . 29.9 m-90 73.86 -38.59 0.41 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.936 1.295 . . . . 72.32 111.755 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p 170.74 149.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 126.791 2.036 . . . . 75.2 105.689 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -143.25 157.68 44.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 120.526 -0.47 . . . . 73.51 110.297 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.32 93.08 8.62 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.77 -0.826 . . . . 64.45 108.77 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.19 92.74 2.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-O 122.153 0.977 . . . . 74.44 110.904 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.292 -1.9 0 N-CA-C 108.103 -1.073 . . . . 64.3 108.103 -179.687 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 CA--C 1.513 -0.445 0 CA-C-O 120.799 0.333 . . . . 73.32 110.656 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.17 -26.57 1.65 Allowed Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 110.214 -1.154 . . . . 62.23 110.214 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.8 t -178.73 -74.57 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.304 -1.369 . . . . 72.13 107.304 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 67.13 134.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.849 1.26 . . . . 74.32 113.763 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 m -105.01 171.35 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.65 -0.704 . . . . 75.41 110.488 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' B' ' 15' ' ' THR . 52.3 p -100.51 10.57 41.01 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.088 0.47 . . . . 62.24 110.785 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.49 110.53 14.89 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 112.727 0.639 . . . . 64.03 112.727 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 56.21 -96.37 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.643 1.577 . . . . 70.25 114.861 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -122.34 117.84 27.04 Favored 'General case' 0 CA--C 1.475 -1.911 0 C-N-CA 120.548 -0.461 . . . . 71.24 109.948 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m -108.67 132.48 53.87 Favored 'General case' 0 C--N 1.262 -3.217 0 C-N-CA 119.835 -0.746 . . . . 71.54 110.058 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.25 147.88 45.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.312 . . . . 62.13 107.459 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.14 150.44 15.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.561 -0.533 . . . . 72.2 109.561 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 p -107.18 140.49 39.95 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 121.229 0.538 . . . . 72.5 111.433 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 3.7 mm? -104.79 135.42 46.2 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 124.305 1.042 . . . . 74.51 110.536 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -108.59 117.99 35.61 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-N 115.348 -0.842 . . . . 72.22 110.122 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -147.2 177.38 9.23 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 107.49 -1.3 . . . . 63.32 107.49 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -68.59 96.18 0.69 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.28 1.038 . . . . 61.44 111.706 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.553 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 14.5 mmm180 -126.03 141.69 51.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.138 1.162 . . . . 74.43 114.138 -174.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.5 pt? -89.57 150.37 44.18 Favored Pre-proline 0 C--N 1.293 -1.849 0 CA-C-N 113.944 -1.48 . . . . 55.21 108.377 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.85 137.35 41.37 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.489 2.126 . . . . 54.22 113.028 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.14 142.36 43.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.626 -1.17 . . . . 62.11 108.024 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -89.77 -40.53 12.43 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.787 0.327 . . . . 75.34 111.728 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -91.2 135.0 34.09 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.953 0.406 . . . . 72.12 111.963 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.62 115.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.079 -1.082 . . . . 71.55 108.079 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.73 127.6 42.87 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.29 -0.564 . . . . 75.53 110.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.1 p -106.62 128.6 54.29 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.442 -0.799 . . . . 72.04 109.461 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.2 126.33 42.6 Favored 'General case' 0 CA--C 1.463 -2.379 0 CA-C-N 116.118 -0.492 . . . . 72.11 109.945 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.554 HG22 HG22 ' A' ' 37' ' ' VAL . 81.9 p -114.94 124.25 51.21 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.445 -0.798 . . . . 73.14 110.861 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.695 HD12 HD12 ' B' ' 38' ' ' ILE . 50.0 mt -116.24 124.63 72.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.798 -0.637 . . . . 73.23 110.286 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.47 ' HB ' ' NH1' ' A' ' 35' ' ' ARG . 6.2 t -100.19 127.32 46.48 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.76 -1.109 . . . . 74.52 109.682 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.2 tp10 -142.13 103.39 4.29 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.638 -0.71 . . . . 71.42 110.209 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -91.05 0.73 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 115.231 -0.895 . . . . 34.42 111.523 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.496 ' HA ' HG21 ' A' ' 56' ' ' VAL . 31.3 p -134.62 6.36 3.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.801 0.81 . . . . 71.33 109.339 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.555 HD23 HD12 ' B' ' 40' ' ' ILE . 52.2 tp -98.22 136.08 38.94 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.387 -0.824 . . . . 74.21 110.7 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.47 ' NH1' ' HB ' ' A' ' 30' ' ' THR . 22.2 mmm180 -111.44 112.91 24.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.466 -0.788 . . . . 64.21 108.946 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.8 124.58 49.67 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.971 -0.751 . . . . 62.44 108.971 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 28' ' ' THR . 60.4 t -116.38 129.09 73.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.205 0.526 . . . . 70.21 111.298 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.608 HD12 HD12 ' B' ' 29' ' ' ILE . 59.2 mt -108.43 129.31 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-N 115.058 -0.974 . . . . 34.2 109.956 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.445 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 97.3 m-85 -113.41 117.35 31.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.305 -0.998 . . . . 70.41 108.305 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.642 HD12 HD23 ' B' ' 34' ' ' LEU . 35.0 mm -90.45 116.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 107.742 -1.207 . . . . 73.51 107.742 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.8 p -118.72 177.91 4.67 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.429 0.633 . . . . 74.31 111.261 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.99 -22.03 62.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.326 -0.852 . . . . 75.45 110.011 175.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -87.36 -29.73 21.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.443 -0.947 . . . . 54.23 108.443 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 150.64 -112.59 0.55 Allowed Glycine 0 N--CA 1.413 -2.862 0 C-N-CA 120.311 -0.947 . . . . 55.51 113.108 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 55.2 tp -119.84 139.94 51.58 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.64 -0.28 . . . . 71.41 110.331 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.7 143.32 48.44 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.483 -0.932 . . . . 62.03 108.483 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.442 HG11 HG11 ' B' ' 47' ' ' VAL . 12.4 p -123.92 140.8 46.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-N 116.146 -0.479 . . . . 75.14 110.574 -174.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 22.9 m -124.88 138.78 54.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.096 -0.502 . . . . 70.13 110.967 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.44 124.1 49.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.769 -0.65 . . . . 65.33 110.067 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 21.1 t70 -116.71 110.4 42.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.021 . . . . 73.43 108.245 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -84.21 134.61 6.0 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 122.418 2.079 . . . . 61.44 114.301 -173.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.1 mt-30 39.09 79.39 0.03 OUTLIER 'General case' 0 C--O 1.255 1.377 0 C-N-CA 125.672 1.589 . . . . 53.02 113.836 172.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.93 155.6 17.07 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.071 -1.422 . . . . 73.25 111.168 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.3 m -68.7 -52.29 32.43 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.542 -0.91 . . . . 73.13 108.542 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -94.12 96.85 9.9 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.946 -1.131 . . . . 71.42 107.946 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 33' ' ' SER . 9.4 p -120.82 -41.8 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 120.217 -0.593 . . . . 43.02 111.603 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 61.0 93.61 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.663 0.785 . . . . 72.54 111.317 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.66 96.91 4.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.285 0.564 . . . . 73.01 109.87 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 60' ' ' VAL . 11.2 p -139.28 -26.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.319 -0.855 . . . . 54.35 110.625 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG23 HG13 ' A' ' 59' ' ' VAL . 61.0 t . . . . . 0 C--N 1.315 -0.92 0 N-CA-C 109.427 -0.583 . . . . 62.43 109.427 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.247 0.95 0 CA-C-O 121.141 0.496 . . . . 72.0 111.307 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.74 -73.15 0.71 Allowed Glycine 0 CA--C 1.493 -1.323 0 C-N-CA 120.618 -0.801 . . . . 74.15 111.139 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 41.1 t -150.6 -59.15 0.18 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.754 -1.202 . . . . 62.5 107.754 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 46.26 82.93 0.03 OUTLIER 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.505 1.522 . . . . 73.23 114.049 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -104.34 141.33 20.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.335 -0.987 . . . . 63.12 108.335 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.7 p -84.71 31.1 0.54 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.226 0.536 . . . . 55.12 111.451 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -118.39 125.98 51.12 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.137 -0.483 . . . . 72.31 111.643 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.645 ' HG2' ' H ' ' B' ' 9' ' ' ARG . 39.9 ttmt 69.45 -174.82 0.19 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.022 0.929 . . . . 61.45 110.158 176.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.645 ' H ' ' HG2' ' B' ' 8' ' ' LYS . 4.6 mpt_? -88.63 113.21 23.97 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 121.358 0.599 . . . . 71.14 111.972 -173.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -96.26 148.38 22.8 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.932 -1.031 . . . . 71.24 110.508 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.8 m -137.14 155.98 48.92 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.518 -0.919 . . . . 73.14 108.518 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.01 138.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.288 0.235 . . . . 64.12 111.364 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.9 p -107.38 125.66 51.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.325 0.65 . . . . 63.42 109.715 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.24 122.0 44.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.608 -0.724 . . . . 40.03 110.823 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 6' ' ' SER . 37.5 p -85.76 113.76 22.18 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.469 -0.937 . . . . 53.24 108.469 173.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -139.26 -173.86 3.71 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.668 -0.493 . . . . 54.44 109.668 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.32 105.64 11.74 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.796 -0.816 . . . . 71.53 108.796 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.541 ' HG3' ' HA2' ' B' ' 44' ' ' GLY . 20.3 mmm180 -125.64 141.07 52.21 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.682 -0.69 . . . . 70.12 112.703 -172.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.561 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.9 pt? -90.35 159.62 41.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 107.15 -1.426 . . . . 73.33 107.15 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.36 135.55 54.49 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.565 1.51 . . . . 63.13 112.244 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.22 141.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.065 -1.457 . . . . 74.43 107.065 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -85.83 -68.38 0.74 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.806 0.336 . . . . 63.13 111.032 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -99.47 139.65 34.81 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 120.844 -0.342 . . . . 74.3 111.185 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.61 133.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.983 -0.747 . . . . 74.12 108.983 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' B' ' 39' ' ' PHE . 43.9 mmtm -100.13 138.81 36.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.322 -0.551 . . . . 63.42 110.161 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.1 p -115.84 127.22 54.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.256 -0.646 . . . . 72.42 109.256 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -128.75 130.82 47.6 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-N 116.411 -0.359 . . . . 64.2 111.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.528 HG22 HG22 ' B' ' 37' ' ' VAL . 57.6 p -114.94 132.62 56.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.698 -0.683 . . . . 72.13 111.936 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.608 HD12 HD12 ' A' ' 38' ' ' ILE . 72.3 mt -134.73 128.48 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.817 -0.629 . . . . 73.34 109.719 176.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -112.33 136.96 51.15 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 108.713 -0.847 . . . . 62.55 108.713 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.516 ' HG2' HG13 ' A' ' 40' ' ' ILE . 12.0 tp10 -141.57 112.12 7.07 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.543 -0.54 . . . . 73.3 109.543 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.455 ' H ' HG11 ' B' ' 60' ' ' VAL . . . 59.98 -104.12 0.55 Allowed Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 110.834 -0.906 . . . . 62.45 110.834 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.44 ' C ' ' HA ' ' B' ' 52' ' ' GLN . 45.4 m -126.49 69.6 1.24 Allowed 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.839 -0.801 . . . . 75.03 108.839 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.642 HD23 HD12 ' A' ' 40' ' ' ILE . 28.4 tp -159.13 137.2 10.44 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.045 -0.98 . . . . 74.41 109.61 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 18.8 mmm180 -113.89 116.88 29.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 123.673 0.608 . . . . 73.02 110.108 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 130.18 55.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.9 -0.408 . . . . 70.43 109.9 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.528 HG22 HG22 ' B' ' 28' ' ' THR . 86.7 t -121.64 130.87 74.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.851 0.357 . . . . 71.44 110.538 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 29' ' ' ILE . 80.8 mt -110.28 130.51 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 C-N-CA 123.442 0.697 . . . . 62.42 109.863 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 95.7 m-85 -114.57 114.76 26.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.908 -1.145 . . . . 74.55 107.908 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.555 HD12 HD23 ' A' ' 34' ' ' LEU . 40.7 mm -89.58 113.92 26.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.335 -0.987 . . . . 75.01 108.335 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -106.55 175.3 5.55 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.731 -0.47 . . . . 74.3 109.731 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.724 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -85.37 -18.05 34.89 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.775 -0.648 . . . . 61.31 110.978 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -104.31 -17.22 14.91 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.13 0.49 . . . . 73.2 110.641 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.541 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . -174.06 -139.22 2.89 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 119.097 -1.525 . . . . 64.15 114.164 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.413 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 40.6 tp -135.63 134.73 39.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 125.184 1.394 . . . . 43.32 107.513 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -128.96 140.72 51.53 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.341 -0.944 . . . . 71.44 110.132 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 47' ' ' VAL . 11.4 p -131.51 141.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.775 -0.648 . . . . 52.14 109.754 -175.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 66.7 m -123.87 140.23 53.18 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.683 0.278 . . . . 74.2 111.061 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' A' ' 45' ' ' LEU . . . -116.92 125.24 51.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.876 -0.602 . . . . 75.15 110.681 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 21.6 t70 -114.96 125.1 29.37 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.434 -0.803 . . . . 74.32 109.348 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.26 133.95 23.87 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.16 1.907 . . . . 43.42 113.508 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.44 ' HA ' ' C ' ' B' ' 33' ' ' SER . 67.9 mt-30 46.32 99.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.227 1.811 . . . . 74.33 115.154 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.65 105.65 0.1 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.501 -1.681 . . . . 71.42 113.612 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 27.8 m -69.1 -38.78 79.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.796 -1.928 . . . . 70.4 105.796 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -106.26 104.54 14.26 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 114.285 -1.325 . . . . 72.33 107.7 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.66 -42.63 2.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.099 -0.501 . . . . 74.12 111.24 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 62.58 179.99 0.14 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.583 0.753 . . . . 74.24 110.0 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -101.42 69.69 1.26 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.597 -1.241 . . . . 74.24 109.782 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -115.11 -3.76 11.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 114.262 -1.336 . . . . 73.33 107.898 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.455 HG11 ' H ' ' B' ' 32' ' ' GLY . 43.0 t . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 108.051 -1.092 . . . . 54.41 108.051 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.233 0.231 0 N-CA-C 109.223 -0.658 . . . . 34.34 109.223 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.54 -95.21 0.15 Allowed Glycine 0 N--CA 1.428 -1.895 0 CA-C-N 115.941 -0.572 . . . . 73.12 111.998 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 p -79.85 -4.39 52.01 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 114.208 1.188 . . . . 61.4 114.208 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.47 98.71 9.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.983 0.896 . . . . 71.2 111.149 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 m -88.79 107.25 17.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.566 -0.743 . . . . 74.4 111.138 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.2 t -167.7 156.4 9.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.592 -0.731 . . . . 73.54 109.507 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.646 ' OD1' ' HB2' ' A' ' 51' ' ' PRO . 27.4 t70 -80.27 115.82 20.02 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.956 -1.127 . . . . 70.43 107.956 173.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -154.11 159.54 41.53 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.768 0.318 . . . . 75.33 110.692 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -97.63 95.19 7.43 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 122.335 1.064 . . . . 73.41 112.805 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -87.74 120.11 28.73 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.194 -1.366 . . . . 60.33 109.945 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 m -133.81 146.41 50.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.798 -1.186 . . . . 55.11 107.798 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.1 t -146.93 153.76 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 122.702 0.401 . . . . 62.22 110.085 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.3 p -121.57 125.77 47.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.876 -0.416 . . . . 73.32 109.876 173.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.466 HD21 ' CG2' ' B' ' 12' ' ' VAL . 97.7 mt -101.23 122.4 43.59 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 123.16 0.584 . . . . 71.12 112.197 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 p -85.79 114.31 22.63 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.075 -0.966 . . . . 73.53 110.733 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -147.43 166.99 25.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.474 -0.935 . . . . 72.41 108.474 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -82.24 102.37 11.1 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.465 0.65 . . . . 73.34 110.007 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' NH1' ' HB3' ' B' ' 51' ' ' PRO . 65.8 mmt-85 -125.93 150.21 48.15 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 114.938 -1.028 . . . . 74.21 109.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.22 134.16 80.55 Favored Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.718 -0.845 . . . . 73.42 108.718 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.51 135.28 48.68 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.813 2.342 . . . . 62.24 114.899 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.23 133.75 60.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.468 -1.696 . . . . 73.31 107.671 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -89.87 -18.51 26.05 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.436 0.636 . . . . 55.45 110.734 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -91.38 132.65 36.06 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.108 -0.701 . . . . 74.42 109.108 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.4 mm -98.72 135.14 34.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.336 -0.616 . . . . 74.51 109.336 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -110.95 150.7 28.85 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.196 0.522 . . . . 75.35 111.905 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 91.1 m -129.74 127.09 39.71 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.057 -1.09 . . . . 72.11 108.057 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -128.46 128.66 44.83 Favored 'General case' 0 CA--C 1.477 -1.843 0 CA-C-N 116.189 -0.459 . . . . 71.54 110.914 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.612 HG22 HG22 ' A' ' 37' ' ' VAL . 55.7 p -114.36 124.98 53.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.419 -0.81 . . . . 75.44 110.646 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.692 HD12 HD12 ' B' ' 38' ' ' ILE . 62.5 mt -119.12 138.79 48.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.556 -0.535 . . . . 73.43 109.556 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' HH11 ' A' ' 35' ' ' ARG . 10.6 t -118.68 127.48 53.61 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.098 -0.705 . . . . 74.14 109.098 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.7 tp10 -139.24 97.27 3.26 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 108.507 -0.923 . . . . 74.31 108.507 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.09 -119.34 7.94 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 110.533 -1.027 . . . . 72.13 110.533 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 36.8 m -102.01 3.31 38.72 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.45 0.643 . . . . 72.23 110.091 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.524 HD23 HD12 ' B' ' 40' ' ' ILE . 47.1 tp -99.75 131.61 45.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 C-N-CA 123.676 0.79 . . . . 72.12 110.138 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' A' ' 50' ' ' ASP . 28.8 tpt180 -121.37 122.46 39.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.12 -1.067 . . . . 74.33 108.12 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.07 141.53 46.78 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.953 -0.467 . . . . 54.42 110.603 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG22 HG22 ' A' ' 28' ' ' THR . 58.3 t -125.09 131.08 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 63.31 111.144 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.626 HD11 HD11 ' B' ' 38' ' ' ILE . 75.6 mt -108.41 125.86 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 124.274 1.03 . . . . 72.01 109.383 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.6 m-85 -112.14 119.04 37.04 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.098 -1.075 . . . . 75.34 108.098 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.587 HG23 HD21 ' B' ' 34' ' ' LEU . 36.7 mm -88.8 121.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.602 -0.726 . . . . 63.01 109.233 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.4 p -124.99 164.66 19.67 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.372 -0.603 . . . . 53.25 109.372 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -70.96 -21.69 62.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.875 0.369 . . . . 72.23 110.734 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -94.73 1.6 55.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.087 0.47 . . . . 72.25 110.689 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.62 -142.47 13.08 Favored Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 119.434 -1.365 . . . . 43.43 113.329 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD11 HG23 ' A' ' 38' ' ' ILE . 59.6 tp -114.9 134.52 55.08 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.303 -0.449 . . . . 72.53 111.241 -173.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 78.7 tttt -115.58 137.01 52.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.398 0.618 . . . . 71.0 110.264 170.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.473 HG11 HG11 ' B' ' 47' ' ' VAL . 10.7 p -121.62 140.58 45.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.747 -1.115 . . . . 70.01 108.357 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.3 t -137.85 143.13 40.8 Favored 'General case' 0 C--N 1.27 -2.873 0 N-CA-C 107.456 -1.313 . . . . 61.22 107.456 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.68 125.26 53.53 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.026 -0.67 . . . . 75.4 110.202 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.6 t70 -101.44 100.7 14.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 106.278 -1.749 . . . . 72.32 106.278 175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HB2' ' OD1' ' A' ' 7' ' ' ASP . 95.0 Cg_endo -79.0 132.97 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.501 2.134 . . . . 70.31 115.276 -172.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 41.4 mt-30 31.46 -104.97 0.02 OUTLIER 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.494 1.917 . . . . 75.2 114.252 169.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 157.73 167.98 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 129.049 2.94 . . . . 54.35 103.22 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.1 m -67.85 -31.52 71.4 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.391 -0.966 . . . . 75.51 108.391 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -127.53 112.55 15.05 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.219 -0.9 . . . . 74.12 109.252 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.94 157.18 6.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 109.621 -0.511 . . . . 71.44 109.621 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -135.85 172.92 12.31 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.643 -0.873 . . . . 75.31 108.643 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -54.15 -50.06 67.84 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.047 0.451 . . . . 74.41 110.245 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.4 99.5 8.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.769 -0.651 . . . . 70.52 109.28 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--O 1.246 0.898 0 C-N-CA 124.817 1.247 . . . . 64.34 112.524 178.72 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--O 1.243 0.754 0 N-CA-C 109.07 -0.715 . . . . 74.22 109.07 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.48 124.12 3.09 Favored Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 110.268 -1.133 . . . . 70.03 110.268 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -88.37 -27.26 21.73 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.213 0.449 . . . . 70.23 112.213 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' B' ' 4' ' ' GLU . 0.1 OUTLIER -82.95 92.75 7.39 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.083 0.944 . . . . 61.3 111.235 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.82 114.09 30.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 115.065 -0.97 . . . . 74.34 110.735 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 31.6 m -154.82 -168.92 3.04 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.098 -1.075 . . . . 70.35 108.098 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.01 100.55 0.75 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.854 -1.165 . . . . 64.33 107.854 172.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -163.96 161.38 22.77 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 116.338 -0.392 . . . . 63.53 110.308 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptp180 -109.14 114.56 28.38 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 115.351 -0.841 . . . . 74.32 110.981 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -89.59 123.04 33.31 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 108.413 -0.958 . . . . 70.34 108.413 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 81.5 m -125.35 149.17 48.36 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.75 -0.463 . . . . 71.41 109.75 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.466 ' CG2' HD21 ' A' ' 14' ' ' LEU . 98.1 t -140.68 133.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.258 -0.428 . . . . 74.42 110.222 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.8 p -107.42 125.68 51.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.585 -0.895 . . . . 71.43 108.585 174.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.418 ' O ' ' HA3' ' B' ' 44' ' ' GLY . 79.9 mt -101.52 140.84 35.26 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.751 -0.659 . . . . 54.54 110.968 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 22.1 p -99.38 113.82 26.37 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.674 0.749 . . . . 72.52 111.528 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -158.64 159.86 35.84 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.67 -1.233 . . . . 72.32 107.67 173.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -78.27 106.51 10.23 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.919 0.866 . . . . 71.13 110.275 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.561 ' HA ' ' HE ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -109.95 151.16 27.45 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 113.921 -1.491 . . . . 75.5 110.126 -176.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.441 ' H ' HD12 ' B' ' 19' ' ' LEU . 3.6 mp -73.52 143.88 82.93 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.143 -1.058 . . . . 65.31 108.143 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -65.72 135.0 39.93 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.688 1.592 . . . . 75.12 111.461 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.23 139.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 107.731 -1.211 . . . . 74.2 107.731 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.6 m -84.22 -50.67 7.67 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.786 -0.365 . . . . 55.22 111.537 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -89.38 142.23 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.649 -0.871 . . . . 73.33 108.649 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.77 121.19 37.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.791 -0.818 . . . . 75.21 108.791 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -89.86 138.86 31.13 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.549 -0.86 . . . . 72.2 111.477 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 89.0 m -128.95 127.34 41.53 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.537 -1.21 . . . . 73.42 108.381 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 81.1 m-85 -122.11 130.45 53.25 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.66 -0.7 . . . . 75.13 110.798 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.475 HG22 HG22 ' B' ' 37' ' ' VAL . 57.0 p -115.12 130.78 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.1 -0.955 . . . . 74.54 111.173 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.596 HD12 HD12 ' A' ' 38' ' ' ILE . 55.0 mt -131.01 120.65 47.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.307 -0.627 . . . . 72.43 109.307 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -103.87 121.59 43.39 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.565 -0.902 . . . . 71.23 108.565 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.484 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.6 tp10 -136.68 100.88 4.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.72 -0.673 . . . . 73.21 111.065 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.22 -102.59 0.61 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.619 -0.719 . . . . 74.4 112.966 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 33.9 m -112.45 13.05 20.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 112.049 0.389 . . . . 34.43 112.049 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.587 HD21 HG23 ' A' ' 40' ' ' ILE . 2.4 pt? -137.83 140.62 40.58 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.669 0.747 . . . . 75.11 110.396 175.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.426 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 33.7 ttt180 -117.27 134.07 55.24 Favored 'General case' 0 C--N 1.258 -3.394 0 CA-C-N 114.737 -1.12 . . . . 72.24 108.608 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.98 140.97 47.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 122.347 -0.221 . . . . 65.2 110.821 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.475 HG22 HG22 ' B' ' 28' ' ' THR . 96.4 t -127.46 127.94 69.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.007 -0.542 . . . . 71.34 110.07 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.692 HD12 HD12 ' A' ' 29' ' ' ILE . 92.6 mt -113.15 126.77 70.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 123.4 0.68 . . . . 74.41 109.884 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.8 118.5 36.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.9 -0.778 . . . . 73.42 108.9 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.524 HD12 HD23 ' A' ' 34' ' ' LEU . 35.9 mm -94.61 115.58 33.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.26 -1.015 . . . . 71.12 108.26 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -129.68 162.97 27.13 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 110.07 -0.345 . . . . 74.21 110.07 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -20.8 66.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.023 0.44 . . . . 74.53 110.863 177.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -91.2 -17.23 26.39 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 111.946 0.351 . . . . 74.12 111.946 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' B' ' 14' ' ' LEU . . . 158.49 -156.29 27.28 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.69 -1.719 . . . . 71.14 113.583 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -112.81 122.69 48.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.698 -0.853 . . . . 70.33 108.698 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -117.39 138.45 51.8 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.119 -0.632 . . . . 64.31 110.013 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 47' ' ' VAL . 9.8 p -131.1 140.95 47.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.207 -0.906 . . . . 53.31 109.334 -176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.52 143.21 51.21 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 116.295 -0.411 . . . . 75.12 110.641 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.42 122.92 47.27 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.406 -0.961 . . . . 72.21 108.406 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' B' ' 35' ' ' ARG . 32.1 t70 -112.99 126.9 27.51 Favored Pre-proline 0 C--N 1.275 -2.641 0 CA-C-N 114.918 -1.037 . . . . 73.41 108.294 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.508 ' HB3' ' NH1' ' A' ' 18' ' ' ARG . 61.2 Cg_endo -76.95 133.06 13.39 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.553 1.502 . . . . 70.15 114.564 -175.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 41.09 -141.47 0.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.497 1.519 . . . . 73.45 113.768 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.52 176.06 10.82 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 104.016 -2.587 . . . . 41.42 104.016 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 23.5 p -58.25 -51.43 69.78 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.614 0.721 . . . . 60.55 109.707 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -123.53 118.9 28.42 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.13 -1.433 . . . . 74.21 107.13 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.15 107.92 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.998 0.904 . . . . 74.54 110.641 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -89.61 130.78 35.86 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.049 -0.978 . . . . 72.24 110.033 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -75.67 -27.05 58.18 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.257 0.551 . . . . 75.02 110.799 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.72 102.98 13.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.774 -0.824 . . . . 75.32 108.774 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--O 1.261 1.698 0 C-N-CA 123.467 0.707 . . . . 52.2 110.858 -179.008 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.588 0.232 . . . . 73.22 111.428 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.14 141.13 15.53 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.138 -1.185 . . . . 74.34 110.138 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.7 m -79.11 95.06 5.46 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.479 -0.563 . . . . 65.21 109.479 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 59.72 -171.09 0.13 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.785 0.834 . . . . 72.21 111.326 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 m -110.86 92.97 2.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 120.018 -0.673 . . . . 52.13 112.731 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' B' ' 15' ' ' THR . 50.4 m 53.75 33.33 16.58 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.518 -1.219 . . . . 52.53 113.126 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -139.36 157.86 45.15 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.966 -0.753 . . . . 70.31 108.966 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 74.16 -178.8 0.18 Allowed 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.732 1.213 . . . . 71.32 112.465 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.415 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 94.7 mtt180 -100.2 106.41 18.09 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.085 -0.961 . . . . 73.34 110.042 -173.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p -87.41 143.82 27.05 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.638 -1.164 . . . . 73.43 111.422 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.7 m -132.74 148.51 52.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.784 -0.821 . . . . 54.11 108.784 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.0 t -143.68 142.02 25.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 110.055 -0.35 . . . . 71.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.3 t -107.92 128.45 54.64 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.51 -0.922 . . . . 62.24 108.51 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.7 mm? -100.94 121.61 42.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.134 -0.691 . . . . 55.21 109.134 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 p -97.35 114.24 26.01 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-O 121.797 0.808 . . . . 65.34 109.682 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -139.33 -169.72 2.73 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.38 -1.341 . . . . 63.02 107.38 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -73.04 101.13 3.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.389 -0.967 . . . . 71.43 108.389 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -125.31 149.21 48.28 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.076 -0.65 . . . . 72.03 112.29 -173.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.3 pt? -89.99 148.73 40.25 Favored Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 107.639 -1.245 . . . . 75.2 107.639 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.44 136.35 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 121.519 1.479 . . . . 64.41 110.655 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -108.48 148.49 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.429 -0.582 . . . . 41.44 109.429 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 p -67.9 -57.26 6.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.005 0.431 . . . . 73.24 111.881 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -117.07 157.87 25.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.357 -0.383 . . . . 71.22 110.023 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -80.75 115.09 22.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.131 -1.433 . . . . 71.33 107.131 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -94.29 131.83 39.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.327 -0.549 . . . . 61.23 109.682 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.6 p -106.23 128.11 53.71 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.13 0.491 . . . . 72.43 109.861 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.521 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 80.0 m-85 -123.3 125.74 45.6 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 116.04 -0.527 . . . . 73.21 109.906 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.53 HG22 HG22 ' A' ' 37' ' ' VAL . 41.1 p -114.53 118.18 33.01 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.071 -0.968 . . . . 63.22 112.278 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.609 HD12 HD12 ' B' ' 38' ' ' ILE . 54.7 mt -121.95 121.51 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.095 -0.705 . . . . 73.44 109.095 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 57' ' ' ARG . 5.2 t -118.28 124.7 48.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 CA-C-O 122.164 0.983 . . . . 64.31 109.683 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.4 tp10 -124.38 98.37 5.72 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.573 -1.649 . . . . 64.1 108.479 -175.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' A' ' 58' ' ' ASP . . . 68.5 -132.44 27.33 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 109.976 -1.25 . . . . 71.51 109.976 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.2 m -90.61 18.48 6.3 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.226 0.536 . . . . 65.43 110.878 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 HG23 ' B' ' 40' ' ' ILE . 32.8 tp -121.06 136.06 55.06 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.726 -0.472 . . . . 73.12 109.726 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -129.85 135.34 48.27 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 116.287 -0.415 . . . . 71.35 111.294 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.26 140.2 52.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.562 -0.533 . . . . 73.41 109.562 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.53 HG22 HG22 ' A' ' 28' ' ' THR . 63.6 t -121.97 125.92 73.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.969 0.414 . . . . 73.55 110.861 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 86.1 mt -102.15 124.94 56.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.384 -0.825 . . . . 74.03 109.629 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -110.72 119.04 37.81 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.797 -1.186 . . . . 62.25 107.797 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.575 HD12 HD23 ' B' ' 34' ' ' LEU . 34.4 mm -88.18 114.83 27.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.272 -1.381 . . . . 73.34 107.272 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.413 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 7.2 t -130.99 165.66 22.68 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.078 0.466 . . . . 74.54 111.275 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -68.04 -16.1 63.89 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.434 0.694 . . . . 74.2 109.994 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -86.83 -14.76 41.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.403 -0.962 . . . . 74.24 108.403 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 129.6 -117.34 2.35 Favored Glycine 0 CA--C 1.48 -2.125 0 CA-C-N 114.977 -1.011 . . . . 71.35 112.478 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 64.5 tp -113.41 132.87 55.46 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.583 -0.525 . . . . 64.5 109.583 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -128.42 134.99 48.91 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.484 -0.561 . . . . 52.12 109.484 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.563 HG11 HG11 ' B' ' 47' ' ' VAL . 12.4 p -128.57 140.59 48.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.043 0 CA-C-N 115.721 -0.672 . . . . 74.04 109.95 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.3 m -120.0 147.83 44.31 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 115.587 -0.733 . . . . 71.42 109.743 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' B' ' 45' ' ' LEU . . . -115.19 124.53 51.67 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 106.845 -1.539 . . . . 44.05 106.845 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.415 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 17.7 t70 -124.01 83.69 55.35 Favored Pre-proline 0 C--N 1.271 -2.819 0 N-CA-C 107.146 -1.427 . . . . 71.44 107.146 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 9' ' ' ARG . 11.2 Cg_endo -93.18 134.79 1.11 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 122.318 2.012 . . . . 71.44 112.661 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 49.39 83.66 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.209 -1.359 . . . . 74.35 111.912 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.86 -167.13 1.76 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.463 -0.789 . . . . 72.53 109.932 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.9 m -58.37 -56.62 19.8 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 123.637 0.585 . . . . 62.42 111.201 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -113.98 91.71 3.73 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 120.159 -0.616 . . . . 74.03 111.946 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.2 m -129.49 120.69 51.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.245 -0.888 . . . . 64.33 109.562 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 30' ' ' THR . 44.5 ttp180 -165.66 143.18 5.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.959 -1.126 . . . . 70.31 107.959 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 4.8 p-10 -74.43 95.97 2.81 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.405 -0.918 . . . . 71.51 110.951 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.33 2.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.434 -1.257 . . . . 63.02 111.638 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG21 ' OH ' ' B' ' 27' ' ' TYR . 27.2 m . . . . . 0 C--N 1.296 -1.734 0 CA-C-N 115.844 -0.616 . . . . 63.15 110.469 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.239 0.507 0 CA-C-O 121.191 0.52 . . . . 64.14 111.164 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.26 68.73 2.41 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.132 -0.787 . . . . 33.02 111.132 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 46.0 m -71.18 106.73 3.89 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 122.694 0.398 . . . . 63.25 111.59 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.45 ' OE2' ' HD3' ' B' ' 8' ' ' LYS . 40.1 mt-10 58.36 -162.97 0.21 Allowed 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.531 -0.759 . . . . 75.5 111.48 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.03 34.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.578 0.751 . . . . 64.53 110.882 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m 68.05 79.46 0.22 Allowed 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.083 0.953 . . . . 64.2 109.794 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -150.93 157.75 43.28 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 114.872 -1.058 . . . . 70.23 108.866 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.45 ' HD3' ' OE2' ' B' ' 4' ' ' GLU . 12.7 mptt 68.47 -176.59 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.914 0.886 . . . . 75.13 111.01 -173.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' ' 9' ' ' ARG . 56.9 mtt180 -79.31 110.33 14.49 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.287 -0.635 . . . . 74.01 109.287 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -90.25 143.31 26.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.238 -0.437 . . . . 65.12 110.384 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.414 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 69.5 m -144.91 149.39 35.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.827 -0.349 . . . . 74.42 110.116 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 92.7 t -141.2 141.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.741 0.416 . . . . 65.53 110.074 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' B' ' 46' ' ' LYS . 21.7 t -107.65 132.39 53.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.216 0.531 . . . . 61.3 109.687 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.77 120.84 43.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.704 -0.68 . . . . 71.21 110.661 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.1 p -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.291 -1.003 . . . . 65.52 108.291 173.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 t -142.57 -169.02 2.89 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.528 -0.915 . . . . 74.1 108.528 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.36 85.11 1.96 Allowed 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.292 1.044 . . . . 64.55 110.655 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -125.89 121.75 34.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.783 -1.099 . . . . 74.35 110.919 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.651 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.7 pt? -74.66 147.56 84.59 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.019 -0.991 . . . . 74.24 108.535 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.74 147.56 81.43 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.383 2.055 . . . . 54.43 114.933 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.405 HG22 ' H ' ' B' ' 23' ' ' ARG . 13.4 p -131.66 141.36 45.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.636 -1.616 . . . . 63.41 106.636 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 p -82.79 -14.15 54.96 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.316 0.858 . . . . 74.24 113.316 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.405 ' H ' HG22 ' B' ' 21' ' ' VAL . 52.8 mtm180 -127.39 146.75 50.36 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.354 -0.216 . . . . 74.55 111.012 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -91.79 115.79 31.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.659 -0.867 . . . . 75.21 108.659 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 14.4 mmmm -89.83 131.55 35.71 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.28 -0.568 . . . . 72.45 109.795 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 23.8 p -109.65 127.2 54.39 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.634 -0.712 . . . . 71.43 109.936 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.523 ' OH ' HG21 ' A' ' 60' ' ' VAL . 87.4 m-85 -128.35 126.24 40.33 Favored 'General case' 0 CA--C 1.468 -2.197 0 CA-C-N 116.404 -0.362 . . . . 72.01 110.811 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.532 HG22 HG22 ' B' ' 37' ' ' VAL . 76.0 p -115.16 132.6 56.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.431 -0.804 . . . . 62.34 112.023 -175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.509 HD12 HD12 ' A' ' 38' ' ' ILE . 66.9 mt -136.64 124.8 34.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.184 -0.672 . . . . 75.41 109.184 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -115.35 140.89 48.72 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.808 -0.812 . . . . 73.42 108.808 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 40' ' ' ILE . 9.5 tp10 -142.06 116.59 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.263 -0.88 . . . . 70.11 110.168 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' B' ' 56' ' ' VAL . . . 75.66 -76.66 1.33 Allowed Glycine 0 C--O 1.222 -0.655 0 N-CA-C 111.058 -0.817 . . . . 53.03 111.058 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' B' ' 52' ' ' GLN . 37.9 m -153.14 -5.09 0.2 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.499 -0.926 . . . . 52.05 108.499 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.575 HD23 HD12 ' A' ' 40' ' ' ILE . 21.5 tp -88.2 140.13 29.79 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.377 1.071 . . . . 72.35 109.057 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -129.92 132.39 46.35 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.16 -0.616 . . . . 73.22 111.898 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.91 44.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.238 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.532 HG22 HG22 ' B' ' 28' ' ' THR . 60.2 t -127.84 127.26 67.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.465 -0.569 . . . . 55.1 109.465 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 29' ' ' ILE . 77.3 mt -104.93 128.92 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 115.457 -0.792 . . . . 60.23 109.051 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.6 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 96.9 m-85 -113.2 116.6 30.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.939 -1.134 . . . . 63.03 107.939 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.513 HG23 HD23 ' A' ' 34' ' ' LEU . 39.1 mm -88.7 114.66 27.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 107.471 -1.307 . . . . 75.42 107.471 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -116.13 -179.83 3.78 Favored 'General case' 0 N--CA 1.412 -2.337 0 C-N-CA 120.549 -0.46 . . . . 62.15 110.642 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.655 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -82.73 -31.39 28.47 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.327 0.862 . . . . 74.33 113.327 -172.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -102.36 -5.04 24.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.138 -0.625 . . . . 75.23 110.636 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.58 -136.74 4.0 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.154 -1.498 . . . . 53.31 114.195 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 49' ' ' ALA . 67.3 tp -118.83 143.05 47.19 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 124.226 1.011 . . . . 44.12 108.998 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.6 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -129.83 121.68 27.22 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.262 -1.384 . . . . 55.41 107.262 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.563 HG11 HG11 ' A' ' 47' ' ' VAL . 13.9 p -114.81 140.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.423 -0.353 . . . . 72.12 110.464 -176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 46.4 m -131.11 141.63 50.16 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.513 0.508 . . . . 64.51 111.804 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.86 124.74 51.43 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.399 -0.819 . . . . 71.02 109.295 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.73 103.78 52.6 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.052 -1.092 . . . . 72.03 108.052 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.67 133.91 24.92 Favored 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 121.603 1.535 . . . . 62.24 112.632 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' B' ' 33' ' ' SER . 77.4 mt-30 47.32 91.6 0.01 OUTLIER 'General case' 0 C--O 1.24 0.554 0 N-CA-C 116.13 1.9 . . . . 73.11 116.13 174.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.35 146.21 34.81 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.054 -1.091 . . . . 70.34 108.054 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 89.7 m -72.46 -36.53 68.51 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.278 -0.638 . . . . 71.12 109.278 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -100.31 105.73 17.29 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.168 -1.049 . . . . 70.03 108.168 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' B' ' 32' ' ' GLY . 32.7 m -89.65 1.06 7.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.236 -0.893 . . . . 73.2 113.006 -171.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -59.2 116.25 3.74 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.924 -0.399 . . . . 72.22 109.924 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.28 134.06 50.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.413 0.625 . . . . 63.24 110.597 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.42 12.8 5.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.339 -0.846 . . . . 44.44 111.726 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 118.277 -0.868 . . . . 75.24 111.542 -178.325 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 110.049 -0.352 . . . . 73.11 110.049 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.96 59.07 0.37 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.483 -1.047 . . . . 63.32 110.483 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 m -118.63 105.79 11.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 109.802 -0.444 . . . . 70.31 109.802 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -131.9 -36.81 1.18 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.882 -0.414 . . . . 72.13 109.882 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -46.62 125.63 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 112.985 0.735 . . . . 61.24 112.985 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' B' ' 15' ' ' THR . 50.2 m -130.82 5.9 4.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.712 -0.677 . . . . 71.33 111.417 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -122.75 142.09 51.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.388 -0.597 . . . . 63.53 109.388 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.406 ' HG2' ' N ' ' A' ' 9' ' ' ARG . 87.8 tttt 75.04 164.51 0.27 Allowed 'General case' 0 C--O 1.242 0.709 0 O-C-N 124.447 1.092 . . . . 52.23 111.83 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.406 ' N ' ' HG2' ' A' ' 8' ' ' LYS . 77.2 mtp180 -56.52 116.86 3.35 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.925 -0.768 . . . . 74.35 108.925 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.555 ' OG1' HD13 ' B' ' 14' ' ' LEU . 3.5 p -108.23 149.51 28.49 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 112.237 0.458 . . . . 75.24 112.237 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 72.2 m -133.79 149.32 51.41 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.264 -1.384 . . . . 71.12 107.264 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.429 HG22 HD23 ' B' ' 14' ' ' LEU . 27.1 m -141.21 148.95 20.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.828 0.347 . . . . 73.4 110.698 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.523 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 32.5 t -125.06 144.63 50.31 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.818 -0.628 . . . . 73.43 109.655 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.469 HD13 ' HB ' ' B' ' 10' ' ' THR . 3.9 pp -125.96 142.59 51.45 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.648 -0.705 . . . . 75.22 109.719 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 p -98.6 119.54 37.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.095 -0.706 . . . . 53.23 109.095 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -143.63 -171.84 3.6 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.219 -0.592 . . . . 75.33 110.288 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.0 88.93 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.407 0.683 . . . . 75.34 110.948 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 23.5 mmm180 -126.38 149.24 49.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.442 0.904 . . . . 75.45 113.442 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -108.4 158.11 34.71 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.508 -1.293 . . . . 64.11 107.508 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 27.6 Cg_endo -62.28 136.06 57.71 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.29 1.993 . . . . 72.44 112.533 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -116.49 141.77 32.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.943 -1.026 . . . . 71.21 109.666 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.9 m -67.33 -34.59 77.66 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.204 0.816 . . . . 74.31 113.204 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -132.3 149.87 52.27 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.813 -0.554 . . . . 75.13 111.4 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.9 mm -86.05 115.5 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.59 -1.633 . . . . 51.5 106.59 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.82 128.67 45.1 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 116.125 -0.489 . . . . 64.45 109.695 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.9 p -106.6 127.68 53.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.366 -0.605 . . . . 75.33 109.366 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -123.07 127.96 49.47 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.911 -0.586 . . . . 72.41 110.71 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.688 HG22 HG22 ' A' ' 37' ' ' VAL . 12.1 p -114.41 126.68 55.25 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 74.11 112.329 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.646 HD12 HD12 ' B' ' 38' ' ' ILE . 49.0 mt -123.66 121.66 62.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.754 -0.657 . . . . 75.43 109.729 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 59' ' ' VAL . 9.6 t -110.25 120.97 44.14 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.622 -1.251 . . . . 73.31 107.622 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.573 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.7 tp10 -134.4 106.6 7.15 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.709 -0.396 . . . . 64.2 111.402 -175.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.82 -67.39 1.68 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 116.053 -0.521 . . . . 52.23 113.138 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.5 m -154.91 10.15 0.33 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.257 0.466 . . . . 71.01 112.257 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -128.13 140.74 51.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 118.701 -1.2 . . . . 72.21 111.06 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.555 ' NH2' ' HB3' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -110.0 121.99 46.53 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.307 -0.86 . . . . 75.2 110.32 175.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.42 130.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.323 -0.399 . . . . 42.33 110.007 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.688 HG22 HG22 ' A' ' 28' ' ' THR . 49.8 t -110.06 125.19 67.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.243 -0.435 . . . . 73.24 109.912 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.609 HD12 HD12 ' B' ' 29' ' ' ILE . 70.6 mt -101.19 122.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 108.561 -0.903 . . . . 61.13 108.561 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 75.8 m-85 -104.39 119.08 38.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.608 -1.256 . . . . 71.02 107.608 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HD21 ' B' ' 34' ' ' LEU . 47.2 mm -87.48 113.97 25.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 107.641 -1.244 . . . . 70.43 107.641 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -119.75 -177.7 3.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.89 -0.596 . . . . 74.54 110.674 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -97.26 -20.55 17.82 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.474 0.546 . . . . 74.02 112.474 -177.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.522 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 45.6 ttp180 -91.34 -29.27 17.22 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.773 0.797 . . . . 73.12 109.996 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 178.82 -121.79 0.77 Allowed Glycine 0 C--N 1.293 -1.825 0 C-N-CA 119.18 -1.486 . . . . 71.12 113.276 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HB3' HD11 ' A' ' 14' ' ' LEU . 61.7 tp -137.61 147.05 44.68 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.085 -0.709 . . . . 71.33 109.085 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HD3' ' HB2' ' A' ' 13' ' ' SER . 24.0 tptm -139.42 129.24 24.78 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.208 -1.405 . . . . 73.23 107.208 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 11.4 p -131.13 140.99 47.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.97 -0.382 . . . . 74.02 109.97 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.5 m -119.85 137.91 53.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.314 -0.403 . . . . 71.13 110.707 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.33 124.73 47.34 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.286 0.565 . . . . 65.21 110.554 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.65 104.02 55.31 Favored Pre-proline 0 C--N 1.278 -2.507 0 N-CA-C 107.315 -1.365 . . . . 71.42 107.315 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -95.39 133.46 0.56 Allowed 'Trans proline' 0 N--CA 1.409 -3.497 0 C-N-CA 120.846 1.031 . . . . 70.24 114.076 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 45.84 44.61 11.09 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 126.101 1.76 . . . . 61.12 114.339 167.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB3' ' NH2' ' A' ' 35' ' ' ARG . . . -82.82 72.29 9.9 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 119.686 -0.805 . . . . 43.02 111.892 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 m 61.48 -79.38 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 125.008 1.323 . . . . 65.23 113.786 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -97.46 120.69 38.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.037 -0.727 . . . . 74.03 109.037 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' HD2' ' A' ' 35' ' ' ARG . 9.0 p -58.55 -37.19 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 O-C-N 123.658 0.599 . . . . 52.12 112.487 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 69.64 137.33 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.038 0.935 . . . . 72.45 112.724 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.59 161.21 16.28 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.681 -0.69 . . . . 75.54 109.75 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.48 HG12 HG22 ' A' ' 30' ' ' THR . 10.2 p -156.98 152.88 7.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.414 -0.588 . . . . 74.1 109.414 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.6 t . . . . . 0 C--N 1.307 -1.253 0 N-CA-C 109.815 -0.439 . . . . 71.02 109.815 177.891 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 108.647 -0.871 . . . . 64.31 108.647 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.63 42.34 0.09 OUTLIER Glycine 0 C--N 1.298 -1.56 0 C-N-CA 119.699 -1.239 . . . . 74.11 112.976 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -89.18 91.58 8.84 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.769 -0.456 . . . . 75.23 109.769 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.31 -29.71 60.11 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 122.101 0.953 . . . . 71.23 109.232 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.43 134.77 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.816 -1.084 . . . . 72.3 108.981 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 38.3 m -111.75 20.42 17.08 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.452 -0.944 . . . . 73.21 108.452 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -152.18 -177.72 6.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 104.555 -2.387 . . . . 72.34 104.555 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt 67.4 -92.42 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.733 0.697 . . . . 55.23 110.834 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' B' ' 50' ' ' ASP . 99.2 mtt180 -161.21 124.4 3.24 Favored 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 107.158 -1.423 . . . . 72.23 107.158 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.469 ' HB ' HD13 ' A' ' 14' ' ' LEU . 8.6 m -102.54 142.98 32.83 Favored 'General case' 0 N--CA 1.382 -3.834 0 N-CA-C 107.041 -1.466 . . . . 62.43 107.041 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 73.3 m -134.46 148.36 50.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.805 -1.183 . . . . 70.41 107.805 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.66 156.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 123.903 0.752 . . . . 75.2 109.344 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -130.69 145.82 52.02 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.752 -0.462 . . . . 54.43 109.752 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' B' ' 45' ' ' LEU . 4.2 pp -130.04 134.98 47.76 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 109.062 -0.718 . . . . 73.11 109.062 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.0 p -106.73 141.79 37.41 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 120.414 -0.514 . . . . 73.51 110.726 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -157.41 -171.47 3.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.81 -1.182 . . . . 75.21 107.81 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -69.08 104.41 2.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.888 0.851 . . . . 53.44 109.91 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.427 ' HG3' ' HA2' ' B' ' 44' ' ' GLY . 20.6 mmm180 -125.95 148.08 49.33 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.085 -0.961 . . . . 65.43 111.405 -174.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.602 ' H ' HD23 ' B' ' 19' ' ' LEU . 2.0 pt? -103.52 152.88 38.88 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.067 -1.086 . . . . 64.44 108.067 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.56 136.45 54.46 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.048 1.832 . . . . 61.04 111.788 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.93 149.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 108.351 -0.981 . . . . 74.51 108.351 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -79.53 -41.29 27.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.828 0.347 . . . . 63.01 111.431 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -125.23 134.15 52.44 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.319 -0.238 . . . . 71.44 110.662 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.16 119.92 20.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 107.712 -1.218 . . . . 73.22 107.712 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -91.29 139.12 31.04 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.997 -0.681 . . . . 72.32 110.368 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.1 p -120.37 127.56 52.42 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.87 -0.789 . . . . 35.52 108.87 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -126.84 126.65 43.7 Favored 'General case' 0 CA--C 1.458 -2.593 0 CA-C-N 116.022 -0.536 . . . . 71.01 110.154 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.674 HG22 HG22 ' B' ' 37' ' ' VAL . 53.0 p -115.9 127.46 55.01 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.549 -0.75 . . . . 72.53 111.056 -176.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 38' ' ' ILE . 54.9 mt -121.12 121.27 64.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.098 -0.704 . . . . 61.44 109.098 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 9.2 t -112.39 115.92 29.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.528 -0.916 . . . . 75.21 108.528 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.491 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.2 tp10 -120.71 97.6 5.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.915 -1.039 . . . . 74.4 111.048 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -66.12 0.47 Allowed Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.689 -0.687 . . . . 53.23 114.601 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.447 ' HB3' ' HG2' ' B' ' 52' ' ' GLN . 48.2 m -145.15 23.83 1.48 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.34 -0.506 . . . . 72.43 111.688 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 40' ' ' ILE . 2.5 pt? -148.49 134.92 19.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 119.049 -1.06 . . . . 71.14 111.767 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.532 ' HD2' ' HB ' ' B' ' 28' ' ' THR . 8.6 tpp180 -101.44 114.08 27.76 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.111 -1.404 . . . . 71.31 108.559 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.65 133.36 51.43 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.584 -0.525 . . . . 71.44 109.584 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.674 HG22 HG22 ' B' ' 28' ' ' THR . 48.2 t -118.85 127.0 75.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.738 0.304 . . . . 71.34 110.967 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.646 HD12 HD12 ' A' ' 29' ' ' ILE . 73.5 mt -102.77 121.87 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 C-N-CA 123.946 0.898 . . . . 75.22 109.039 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.411 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 93.7 m-85 -103.86 114.3 28.46 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.309 -0.997 . . . . 74.22 108.309 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 34' ' ' LEU . 51.1 mm -88.44 112.61 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 106.697 -1.594 . . . . 75.04 106.697 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -121.13 -179.57 4.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 116.424 -0.353 . . . . 74.11 110.181 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -95.93 -17.8 20.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.902 0.382 . . . . 73.24 111.145 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 73.6 ttt180 -98.83 -17.92 18.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.128 0.49 . . . . 73.32 109.842 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . 179.51 -143.07 5.51 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.027 -1.082 . . . . 61.52 113.37 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' B' ' 14' ' ' LEU . 1.9 tm? -139.38 122.86 17.25 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 124.673 1.189 . . . . 74.22 108.04 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -118.53 143.68 46.58 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.961 0.41 . . . . 71.33 110.977 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.57 141.25 46.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.62 -0.718 . . . . 74.42 110.559 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.411 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 62.3 m -127.69 142.17 51.41 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.118 -0.492 . . . . 63.34 111.045 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.04 124.01 48.25 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.187 -0.461 . . . . 33.42 110.202 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 24.2 t70 -118.15 88.09 31.15 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 107.552 -1.277 . . . . 73.14 107.552 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 85.9 Cg_endo -91.6 134.43 1.56 Allowed 'Trans proline' 0 N--CA 1.42 -2.851 0 C-N-CA 121.64 1.56 . . . . 73.41 114.034 -173.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.447 ' HG2' ' HB3' ' B' ' 33' ' ' SER . 40.2 mt-30 62.21 15.55 7.62 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.73 -1.123 . . . . 42.54 113.411 172.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.71 148.5 23.79 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.255 0.55 . . . . 65.31 112.447 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 62.5 m 68.95 -75.19 0.07 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.185 1.394 . . . . 73.13 113.212 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -177.41 151.47 0.77 Allowed 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 106.999 -1.482 . . . . 72.42 106.999 -173.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.41 -47.41 92.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 123.266 0.354 . . . . 61.54 111.816 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 63.19 85.75 0.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.853 1.261 . . . . 74.41 111.211 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -119.51 105.49 11.29 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.931 -1.137 . . . . 63.33 107.931 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.98 155.02 40.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.785 -1.098 . . . . 72.01 110.566 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.312 -1.056 0 N-CA-C 108.541 -0.911 . . . . 74.53 108.541 177.794 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 111.828 0.307 . . . . 64.1 111.828 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.89 -133.55 4.21 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 119.938 -1.125 . . . . 62.11 112.315 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -149.59 135.31 18.59 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.867 -0.42 . . . . 71.41 109.867 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.277 0.9 OUTLIER -106.6 98.04 7.76 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.141 0.972 . . . . 73.24 111.025 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -98.77 128.01 50.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.056 -0.974 . . . . 64.21 111.269 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.2 m -156.1 170.41 22.24 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.801 -1.555 . . . . 73.32 106.801 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.5 93.76 6.72 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.345 -1.354 . . . . 73.2 107.345 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -159.7 166.23 30.96 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.533 -0.758 . . . . 72.2 110.168 -171.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.671 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 6.1 ppt_? -111.12 128.87 56.02 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.759 -0.83 . . . . 71.44 108.759 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.445 ' CB ' HD13 ' B' ' 14' ' ' LEU . 18.9 p -101.57 148.62 25.01 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 122.112 -0.368 . . . . 71.54 110.959 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.1 m -136.49 157.35 46.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.008 0.432 . . . . 74.41 111.021 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG23 HD11 ' B' ' 14' ' ' LEU . 86.5 t -130.77 134.71 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.58 -0.737 . . . . 52.14 110.776 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -117.93 125.62 50.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.522 -0.547 . . . . 54.24 109.522 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.97 121.77 27.2 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 123.311 0.644 . . . . 72.15 109.817 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 p -125.17 112.79 16.86 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.228 -0.442 . . . . 64.42 111.753 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.587 HG23 ' H ' ' A' ' 17' ' ' GLN . 4.2 t -156.52 -92.07 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.265 1.209 . . . . 74.21 114.265 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.587 ' H ' HG23 ' A' ' 16' ' ' THR . 26.7 tp60 -94.07 91.68 6.95 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.659 0.742 . . . . 74.14 109.198 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 2.5 ppt_? -126.72 149.25 49.68 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.479 -0.782 . . . . 75.14 112.776 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.642 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.2 pt? -110.33 155.19 42.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.283 -1.006 . . . . 70.43 108.283 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.84 136.64 49.93 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.874 1.716 . . . . 43.14 110.986 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.04 144.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.405 -0.816 . . . . 54.3 109.295 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.8 m -87.09 -35.41 18.71 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.259 0.552 . . . . 53.41 111.32 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -123.25 133.14 54.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.782 -0.645 . . . . 54.43 110.976 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.16 115.63 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 107.164 -1.421 . . . . 55.41 107.164 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.1 mmtp -99.35 134.95 41.48 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 120.372 -0.531 . . . . 75.53 110.859 -176.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -114.33 127.16 55.72 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.893 -1.151 . . . . 72.34 107.893 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -120.25 130.39 54.49 Favored 'General case' 0 CA--C 1.457 -2.599 0 CA-C-N 116.224 -0.444 . . . . 75.32 109.992 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.54 HG22 HG22 ' A' ' 37' ' ' VAL . 68.4 p -114.68 122.59 46.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 119.766 -0.773 . . . . 74.24 111.183 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.71 HD12 HD12 ' B' ' 38' ' ' ILE . 89.5 mt -115.82 124.67 72.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.628 -0.878 . . . . 64.13 108.628 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -117.02 116.18 26.86 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.117 0.96 . . . . 71.41 108.794 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.616 ' O ' HD23 ' A' ' 34' ' ' LEU . 15.3 tp10 -136.96 123.18 20.51 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.284 -0.871 . . . . 74.02 110.388 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.81 -84.99 0.37 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.21 -0.756 . . . . 72.14 111.21 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.424 ' HB2' HD22 ' B' ' 19' ' ' LEU . 33.6 m -150.47 10.56 0.66 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 122.726 -0.279 . . . . 63.24 111.06 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -114.81 140.21 49.11 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 119.193 -1.003 . . . . 73.41 111.584 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' NH2' ' HA ' ' A' ' 56' ' ' VAL . 2.8 mpt_? -100.08 118.05 35.62 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.112 -0.949 . . . . 62.21 108.781 176.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.07 116.18 31.48 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.471 -0.566 . . . . 70.11 109.471 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 28' ' ' THR . 60.1 t -108.48 120.7 60.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.167 0.508 . . . . 71.34 110.179 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.66 HD12 HD12 ' B' ' 29' ' ' ILE . 95.0 mt -101.34 124.7 55.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 115.147 -0.933 . . . . 64.32 108.721 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -106.92 115.14 29.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.378 -0.971 . . . . 63.11 108.378 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.69 HD12 HD23 ' B' ' 34' ' ' LEU . 37.3 mm -90.69 114.53 28.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.326 -1.361 . . . . 72.43 107.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -129.47 156.46 44.08 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 120.543 -0.463 . . . . 73.24 110.609 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.529 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -67.4 -13.74 62.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.447 0.699 . . . . 73.42 110.793 -178.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -87.18 -22.56 25.21 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.724 -0.473 . . . . 70.21 109.724 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.17 -138.02 6.5 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.259 -0.972 . . . . 72.02 113.629 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -113.37 128.59 56.51 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.159 0.504 . . . . 62.44 110.597 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 54.4 tptt -137.1 127.96 27.34 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.454 -1.313 . . . . 65.41 107.454 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG11 HG21 ' B' ' 47' ' ' VAL . 9.9 p -132.1 139.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 110.599 -0.149 . . . . 63.13 110.599 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.4 137.71 54.02 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.621 0.248 . . . . 65.54 110.446 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.79 43.07 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.411 -0.359 . . . . 43.35 110.245 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -115.0 104.62 53.89 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.334 -0.848 . . . . 63.54 109.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 89.3 Cg_endo -94.73 134.72 0.72 Allowed 'Trans proline' 0 N--CA 1.427 -2.408 0 C-N-CA 121.712 1.608 . . . . 72.1 114.641 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG2' ' HB3' ' A' ' 33' ' ' SER . 41.7 mt-30 53.03 -83.12 0.01 OUTLIER 'General case' 0 C--O 1.247 0.949 0 C-N-CA 126.446 1.898 . . . . 75.44 115.546 170.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 71.44 -74.1 0.09 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.999 1.32 . . . . 72.24 112.123 -177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.6 m -138.8 -71.38 0.41 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.415 -0.957 . . . . 75.24 108.415 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -123.25 149.88 44.18 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.013 -1.106 . . . . 74.23 108.013 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.434 ' HA ' ' NH2' ' A' ' 35' ' ' ARG . 7.2 p -130.74 120.57 48.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.433 0.635 . . . . 75.24 110.767 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 1.7 tpm_? -95.92 90.34 5.56 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.011 -1.477 . . . . 73.42 107.011 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.6 95.71 9.85 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.287 1.041 . . . . 55.42 110.217 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.9 t -80.09 108.85 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.498 -1.228 . . . . 62.53 110.695 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 115.964 -0.562 . . . . 74.11 110.609 178.868 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.292 0.568 . . . . 63.52 110.121 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.71 64.7 3.58 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.296 -0.866 . . . . 44.52 113.321 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 16.0 p -88.8 112.71 23.54 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.231 0.539 . . . . 74.13 110.238 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.21 97.03 5.06 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.55 0.69 . . . . 64.23 111.794 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -96.25 114.67 33.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.652 -0.703 . . . . 61.44 110.326 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.418 ' HB2' ' HG2' ' B' ' 8' ' ' LYS . 49.2 m -148.21 178.42 8.57 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.941 -0.763 . . . . 75.13 108.941 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.77 9.17 6.64 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.721 0.296 . . . . 73.51 111.203 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.418 ' HG2' ' HB2' ' B' ' 6' ' ' SER . 21.3 ptmt -67.44 114.44 6.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.047 0.927 . . . . 75.04 111.628 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 69.2 mtt180 -98.3 105.63 17.8 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.003 -1.11 . . . . 75.22 108.003 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -87.8 143.42 27.15 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.168 -0.924 . . . . 71.34 112.378 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 66.8 m -141.51 149.45 40.88 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.114 -1.069 . . . . 53.24 108.114 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.58 146.21 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 110.339 -0.245 . . . . 62.14 110.339 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 22.5 p -107.26 135.51 48.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.214 0.606 . . . . 70.15 110.767 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.519 HD11 HG23 ' A' ' 12' ' ' VAL . 96.7 mt -116.73 130.59 56.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.122 -0.49 . . . . 73.45 110.642 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -101.66 122.67 44.32 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.871 -0.789 . . . . 52.34 108.871 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.7 t -151.27 -174.96 4.98 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 120.725 0.298 . . . . 75.13 110.58 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -72.06 86.42 1.03 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.522 0.729 . . . . 74.34 109.947 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -126.52 149.24 49.49 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 114.204 1.187 . . . . 71.35 114.204 -179.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.553 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.7 pt? -78.5 134.73 61.56 Favored Pre-proline 0 C--N 1.29 -1.996 0 CA-C-N 114.944 -1.025 . . . . 70.41 109.361 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.96 136.33 34.85 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.093 1.862 . . . . 54.53 111.468 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' B' ' 42' ' ' LYS . 10.9 p -131.29 133.27 62.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.372 -0.831 . . . . 54.23 108.912 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.4 m -84.79 -13.43 51.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.084 0.468 . . . . 73.15 111.928 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.47 ' H ' HG22 ' B' ' 21' ' ' VAL . 30.5 mmm180 -105.94 133.83 50.04 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.812 -0.81 . . . . 75.22 108.812 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -94.29 115.39 32.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.591 -0.892 . . . . 62.25 108.591 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.65 128.72 39.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.905 -0.588 . . . . 71.43 110.39 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.2 p -110.63 127.98 55.49 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.457 -0.792 . . . . 42.04 109.951 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.481 ' HB3' HD13 ' A' ' 29' ' ' ILE . 70.4 m-85 -126.19 127.44 45.7 Favored 'General case' 0 CA--C 1.459 -2.549 0 CA-C-N 115.887 -0.597 . . . . 74.45 110.674 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.546 HG22 HG22 ' B' ' 37' ' ' VAL . 78.0 p -115.14 139.54 49.83 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.942 -1.026 . . . . 72.23 110.802 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 38' ' ' ILE . 49.4 mt -136.89 133.84 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.674 -0.491 . . . . 74.2 109.674 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.514 ' OG1' ' HA ' ' B' ' 56' ' ' VAL . 7.9 t -117.47 131.91 56.65 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.636 -0.505 . . . . 72.14 109.636 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.416 ' OE1' ' HG3' ' A' ' 25' ' ' LYS . 10.9 tp10 -142.43 114.77 8.38 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.636 -0.711 . . . . 73.51 109.788 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -76.73 0.86 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.118 -0.793 . . . . 72.14 111.118 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' B' ' 52' ' ' GLN . 39.8 m -156.92 10.52 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.625 -1.25 . . . . 71.31 107.625 174.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.69 HD23 HD12 ' A' ' 40' ' ' ILE . 45.5 tp -95.52 115.67 27.76 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 115.28 -0.873 . . . . 72.23 108.871 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -107.12 113.54 27.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.983 -1.118 . . . . 71.3 107.983 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.45 34.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.882 -0.414 . . . . 71.1 109.882 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.546 HG22 HG22 ' B' ' 28' ' ' THR . 67.1 t -129.0 129.97 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.849 -0.426 . . . . 44.03 109.849 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 29' ' ' ILE . 80.1 mt -114.78 125.15 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 109.09 -0.707 . . . . 63.21 109.09 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 64.6 m-85 -106.84 116.68 32.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.534 -1.284 . . . . 74.32 107.534 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.17 114.28 26.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 105.922 -1.881 . . . . 63.54 105.922 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -125.6 156.74 38.68 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.117 0.484 . . . . 51.12 110.593 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' B' ' 21' ' ' VAL . 0.1 OUTLIER -60.03 -25.91 65.69 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.47 -0.786 . . . . 72.24 112.435 -177.571 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -97.1 -8.29 30.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.515 -0.474 . . . . 73.52 111.528 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.0 -153.88 24.79 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 118.305 -1.902 . . . . 70.45 114.547 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.5 HD12 HD12 ' B' ' 14' ' ' LEU . 3.2 tm? -113.66 122.28 46.69 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.19 -1.041 . . . . 64.13 108.19 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 56.9 tptt -117.38 122.13 42.98 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.004 -1.11 . . . . 62.21 108.004 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 47' ' ' VAL . 11.1 p -115.42 139.7 40.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 110.338 -0.245 . . . . 74.54 110.338 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.28 140.44 52.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.127 -0.488 . . . . 60.43 111.585 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.57 124.16 48.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 108.817 -0.809 . . . . 64.15 108.817 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' B' ' 9' ' ' ARG . 15.1 t70 -119.07 95.23 49.18 Favored Pre-proline 0 C--N 1.284 -2.249 0 N-CA-C 104.875 -2.268 . . . . 63.21 104.875 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.408 ' CD ' ' HG2' ' B' ' 9' ' ' ARG . 79.5 Cg_endo -98.7 135.08 0.29 Allowed 'Trans proline' 0 N--CA 1.429 -2.275 0 C-N-CA 121.935 1.757 . . . . 71.13 116.357 -171.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.469 ' HA ' ' HB3' ' B' ' 33' ' ' SER . 53.0 mt-30 60.78 14.84 5.41 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 116.192 1.923 . . . . 63.41 116.192 170.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.11 -48.39 7.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.426 -0.953 . . . . 61.22 108.426 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.0 m -107.41 143.7 35.36 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 108.16 -1.052 . . . . 44.11 108.16 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -80.79 -178.02 6.61 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 116.05 -0.523 . . . . 74.04 111.244 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.514 ' HA ' ' OG1' ' B' ' 30' ' ' THR . 12.6 p -92.96 142.9 12.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.299 -0.41 . . . . 73.41 110.774 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -168.25 105.52 0.47 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.203 1.001 . . . . 60.31 109.012 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.41 133.47 44.9 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.748 -0.834 . . . . 72.12 108.748 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.07 121.32 4.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 O-C-N 123.735 0.647 . . . . 64.13 112.509 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.43 -1.435 0 CA-C-O 118.465 -0.779 . . . . 43.01 110.428 176.163 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--O 1.238 0.461 0 N-CA-C 109.342 -0.614 . . . . 73.44 109.342 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.16 -151.6 7.73 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.798 -1.321 . . . . 53.44 109.798 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 t -100.39 95.81 7.0 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.95 -0.759 . . . . 71.44 108.95 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -133.11 117.32 17.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.275 -0.639 . . . . 65.34 109.275 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.01 78.76 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-O 121.785 0.802 . . . . 74.34 109.161 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.8 p -100.83 137.68 38.89 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.984 -1.007 . . . . 74.33 108.745 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -81.75 92.28 6.61 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.845 0.831 . . . . 73.53 111.693 -172.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -145.28 144.9 31.02 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.608 -1.627 . . . . 73.44 106.608 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.437 ' HD3' ' OD1' ' A' ' 50' ' ' ASP . 18.0 ptt180 -66.1 105.85 1.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.635 0.731 . . . . 74.02 110.892 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -96.97 148.83 22.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.931 -1.032 . . . . 55.35 111.945 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -127.21 156.23 42.16 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.396 -0.964 . . . . 52.21 108.396 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG2' HD21 ' B' ' 14' ' ' LEU . 94.2 t -134.49 140.76 45.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.663 0.268 . . . . 54.53 110.661 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 p -109.83 125.83 53.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.44 -0.948 . . . . 71.51 108.44 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.51 HD12 HD23 ' A' ' 45' ' ' LEU . 86.5 mt -109.57 127.84 54.78 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.018 0.437 . . . . 65.13 111.987 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.93 114.1 25.79 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.434 -0.95 . . . . 64.1 108.434 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -143.6 -169.89 3.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.861 -1.163 . . . . 64.13 107.861 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.65 99.76 1.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 72.11 109.645 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -125.44 148.38 48.85 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.792 1.034 . . . . 73.04 113.792 -175.311 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' B' ' 33' ' ' SER . 1.7 pp -102.46 161.75 22.32 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 114.094 -1.412 . . . . 71.3 108.9 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.62 135.98 51.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.587 1.525 . . . . 62.53 111.647 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.7 t -123.91 124.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.347 -0.982 . . . . 64.01 108.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.0 m -86.5 -56.39 3.45 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.432 0.53 . . . . 70.11 112.432 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -93.47 133.39 36.81 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.138 -0.625 . . . . 74.52 110.109 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -83.27 123.31 38.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.533 -0.914 . . . . 65.41 108.533 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -106.5 143.01 35.22 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.318 -0.401 . . . . 74.5 110.303 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -119.72 127.69 53.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.684 -0.858 . . . . 75.03 108.684 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 78.4 m-85 -124.44 130.26 52.15 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-N 115.994 -0.548 . . . . 65.34 110.806 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.526 HG22 HG22 ' A' ' 37' ' ' VAL . 44.9 p -115.22 125.03 52.87 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.103 -0.953 . . . . 71.1 112.158 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.582 HD12 HD12 ' B' ' 38' ' ' ILE . 59.5 mt -129.9 128.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.299 -0.63 . . . . 63.52 109.299 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -119.46 137.16 53.96 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.44 -0.948 . . . . 72.45 108.44 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.567 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.86 111.37 6.23 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.814 0.34 . . . . 73.54 110.195 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.64 -67.94 3.28 Favored Glycine 0 C--N 1.298 -1.528 0 C-N-CA 120.749 -0.738 . . . . 74.22 112.572 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.2 m -156.93 -16.21 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.791 0.437 . . . . 44.55 112.063 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -88.67 140.59 29.3 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 118.468 -1.293 . . . . 64.22 110.615 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 19.8 mmt180 -103.49 119.37 38.76 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.951 -1.5 . . . . 75.24 106.951 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.98 124.74 51.95 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.215 -0.661 . . . . 73.11 109.215 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.526 HG22 HG22 ' A' ' 28' ' ' THR . 99.1 t -117.02 125.52 73.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.035 0.445 . . . . 71.45 111.417 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.564 HD12 HD12 ' B' ' 29' ' ' ILE . 92.4 mt -104.59 121.45 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 C-N-CA 124.033 0.933 . . . . 70.05 109.144 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.0 m-85 -108.54 117.15 33.42 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.767 -1.197 . . . . 71.54 107.767 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.629 HG23 HD21 ' B' ' 34' ' ' LEU . 45.9 mm -88.41 118.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.674 -0.861 . . . . 75.2 108.674 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -134.59 171.95 13.61 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.5 0.667 . . . . 62.01 110.402 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 42' ' ' LYS . 19.4 ptmt -77.21 -15.38 59.51 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.879 0.872 . . . . 75.04 110.419 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -87.88 10.42 18.71 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.162 -1.422 . . . . 73.11 107.162 -177.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -124.73 8.0 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.626 -1.17 . . . . 74.3 112.549 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 14' ' ' LEU . 64.4 tp -112.26 135.04 53.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.865 -0.421 . . . . 74.01 109.865 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 1.5 tmtm? -128.85 122.4 30.32 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.158 -2.164 . . . . 62.43 105.158 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG11 HG11 ' B' ' 47' ' ' VAL . 13.6 p -128.29 140.96 47.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 110.171 -0.307 . . . . 72.41 110.171 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 93.7 m -121.07 143.12 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 122.319 0.248 . . . . 43.32 111.035 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.45 123.85 48.51 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.044 -0.724 . . . . 64.34 109.044 177.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 18.5 t70 -124.25 100.53 35.76 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 107.693 -1.225 . . . . 73.14 107.693 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.13 134.19 4.27 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 122.067 1.845 . . . . 32.31 115.143 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.474 ' NE2' ' HG3' ' B' ' 17' ' ' GLN . 49.9 mt-30 57.0 42.37 26.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.916 -1.493 . . . . 61.34 112.006 169.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.41 -78.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.199 1.0 . . . . 41.51 113.685 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 33.3 p -132.29 -82.07 0.5 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.635 0.255 . . . . 71.51 111.54 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -139.43 148.59 42.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.976 -0.556 . . . . 74.31 109.537 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 p -95.38 161.24 2.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.674 -0.861 . . . . 71.0 108.674 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -124.64 176.96 6.21 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.744 -0.836 . . . . 64.4 108.744 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -70.87 115.52 10.11 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 108.186 -1.042 . . . . 75.11 108.186 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -69.87 115.16 8.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.714 -0.676 . . . . 70.53 110.469 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 115.676 -0.693 . . . . 73.31 109.896 178.847 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 57.1 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 109.519 -0.549 . . . . 74.22 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.61 173.09 20.73 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.138 -1.185 . . . . 64.43 110.138 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 19.9 t -84.36 129.45 34.87 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.096 -1.075 . . . . 73.5 108.096 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.1 114.24 8.96 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-O 120.802 0.334 . . . . 72.15 111.044 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -80.14 96.34 2.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.496 -0.928 . . . . 64.34 108.496 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 62.7 p -146.56 -177.54 5.69 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.741 -0.663 . . . . 74.21 109.242 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -92.92 108.71 20.21 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.315 0.579 . . . . 64.04 109.998 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -174.97 157.42 2.35 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.897 -1.89 . . . . 64.32 105.897 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -63.61 110.47 2.01 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.793 0.683 . . . . 44.51 109.292 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.8 p -92.45 145.65 24.29 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.311 -0.404 . . . . 42.41 111.631 -175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.21 149.44 47.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.7 -0.481 . . . . 75.12 109.7 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -142.74 148.73 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.915 0.486 . . . . 72.21 110.147 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 60.5 p -110.62 146.21 36.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 122.482 0.313 . . . . 61.34 110.343 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.499 HD21 ' CG2' ' A' ' 12' ' ' VAL . 96.2 mt -125.74 125.74 43.47 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 123.053 0.541 . . . . 65.44 111.079 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.7 p -104.69 114.31 28.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.939 -0.763 . . . . 71.01 108.939 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -166.75 120.19 1.03 Allowed 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.225 0.328 . . . . 73.24 110.671 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLN . . . . . 0.474 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 6.6 tp-100 34.89 72.55 0.09 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.04 1.736 . . . . 64.52 112.252 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.647 ' NH2' HG21 ' B' ' 21' ' ' VAL . 24.5 tpt180 -126.11 109.98 13.0 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 119.673 -0.811 . . . . 60.04 112.512 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.23 153.88 88.28 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 114.368 -1.287 . . . . 43.33 112.313 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.16 135.63 65.16 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.52 2.813 . . . . 72.15 114.2 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.647 HG21 ' NH2' ' B' ' 18' ' ' ARG . 55.9 t -132.11 137.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.268 -1.333 . . . . 74.41 107.998 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 38.3 m -92.56 -26.94 17.67 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.467 0.914 . . . . 71.05 113.467 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -127.69 154.61 45.1 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.36 0.504 . . . . 70.13 112.36 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.94 132.75 47.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.76 -0.459 . . . . 50.22 109.76 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.511 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 39.8 mmtm -106.27 159.72 15.9 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.638 -0.425 . . . . 64.12 110.028 177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -133.67 126.41 30.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.038 -1.097 . . . . 72.41 108.038 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 74.3 m-85 -126.57 128.6 47.08 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.48 -0.327 . . . . 54.11 110.795 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.608 HG22 HG22 ' B' ' 37' ' ' VAL . 62.2 p -115.93 135.66 53.77 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.858 0.724 . . . . 74.34 111.3 -176.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.564 HD12 HD12 ' A' ' 38' ' ' ILE . 58.4 mt -131.13 127.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.184 -0.462 . . . . 75.42 109.937 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.404 ' HB ' ' NE ' ' B' ' 35' ' ' ARG . 11.5 t -104.35 123.99 48.39 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.226 0.536 . . . . 73.31 109.682 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.668 ' O ' HD23 ' B' ' 34' ' ' LEU . 10.6 tp10 -142.88 123.55 14.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.65 -0.5 . . . . 73.3 109.65 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.08 -77.71 0.3 Allowed Glycine 0 C--O 1.217 -0.938 0 N-CA-C 111.208 -0.757 . . . . 64.33 111.208 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.416 ' HB2' HD21 ' A' ' 19' ' ' LEU . 69.4 m -157.65 -0.22 0.11 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.838 0.855 . . . . 54.42 110.847 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.668 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -101.34 137.84 39.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.422 -1.311 . . . . 54.44 110.106 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.442 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 38.3 mmm-85 -100.92 122.82 44.14 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.285 -1.376 . . . . 64.23 107.285 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.87 117.77 35.12 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.949 -1.13 . . . . 55.01 107.949 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.608 HG22 HG22 ' B' ' 28' ' ' THR . 58.0 t -110.29 128.05 66.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.37 0.605 . . . . 64.11 110.308 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 29' ' ' ILE . 85.3 mt -111.55 120.08 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.908 -1.042 . . . . 64.12 109.257 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 95.8 m-85 -102.65 116.43 32.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.965 -1.124 . . . . 72.43 107.965 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.547 HD12 HD21 ' A' ' 34' ' ' LEU . 49.7 mm -88.47 114.03 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.28 -1.007 . . . . 63.24 108.28 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 t -127.3 169.47 13.51 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 115.623 -0.717 . . . . 70.2 109.729 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -83.0 -13.48 55.87 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.746 -0.465 . . . . 73.55 109.746 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.66 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.5 tmt_? -87.68 3.17 48.92 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.317 1.056 . . . . 65.43 108.6 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' B' ' 18' ' ' ARG . . . 128.17 -138.42 10.37 Favored Glycine 0 CA--C 1.504 -0.608 0 CA-C-N 115.26 -0.882 . . . . 75.42 113.087 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 68.1 tp -112.24 126.05 54.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.733 -0.84 . . . . 74.21 108.733 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 1.8 tmtm? -116.78 121.13 40.69 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.526 -2.027 . . . . 73.05 105.526 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 47' ' ' VAL . 14.0 p -116.58 140.84 37.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 116.639 -0.255 . . . . 72.31 110.722 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.523 ' SG ' ' HE3' ' B' ' 46' ' ' LYS . 68.4 m -130.41 140.78 50.56 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.656 0.382 . . . . 73.51 111.237 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -116.2 123.25 47.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.564 -0.902 . . . . 73.33 108.564 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 13.7 t70 -122.42 103.0 38.83 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.877 -1.157 . . . . 71.21 107.877 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -98.25 134.99 0.32 Allowed 'Trans proline' 0 N--CA 1.434 -1.976 0 C-N-CA 122.263 1.975 . . . . 74.45 116.549 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 64.66 15.31 9.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.589 1.556 . . . . 73.51 114.976 165.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.54 -52.37 6.91 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.204 0.526 . . . . 74.24 110.079 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 70.9 p -100.87 171.52 7.61 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.751 -0.659 . . . . 62.45 110.81 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -81.27 -177.5 6.5 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.609 -0.723 . . . . 65.55 111.352 175.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.59 156.53 29.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 116.236 -0.438 . . . . 63.03 110.476 -174.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -125.84 167.45 15.2 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.79 -1.189 . . . . 75.22 107.79 172.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.49 98.12 8.11 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.022 -1.473 . . . . 72.4 107.022 172.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.12 105.36 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.587 -0.733 . . . . 74.02 112.882 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.417 -2.091 0 CA-C-N 113.987 -1.46 . . . . 62.11 107.878 175.723 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 CA--C 1.518 -0.259 0 N-CA-C 108.885 -0.783 . . . . 54.54 108.885 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.11 106.21 0.25 Allowed Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.69 -0.767 . . . . 44.11 111.826 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -94.65 -172.67 2.81 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.92 -0.771 . . . . 70.22 108.92 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.19 -32.13 70.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.075 0.464 . . . . 73.34 110.36 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.98 104.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.758 0.789 . . . . 63.22 110.112 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.0 m -102.61 100.7 10.79 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.495 -0.928 . . . . 63.43 108.495 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.94 86.69 4.14 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.44 -0.346 . . . . 70.23 111.388 -174.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 pttt 178.82 -176.22 0.23 Allowed 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.9 1.28 . . . . 62.44 108.562 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -80.99 102.36 10.11 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.315 -0.994 . . . . 70.4 108.315 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -87.73 135.65 33.28 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.822 -0.627 . . . . 53.2 111.406 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.6 m -130.38 148.45 52.2 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.201 -0.666 . . . . 53.31 109.201 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.9 t -144.66 141.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.473 -0.331 . . . . 62.12 110.174 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 p -109.24 130.71 55.49 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.21 0.528 . . . . 71.35 109.896 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.73 120.33 40.18 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.448 -1.686 . . . . 73.12 106.448 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.5 m -97.26 111.71 23.83 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.831 -1.544 . . . . 54.11 106.831 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' B' ' 51' ' ' PRO . 8.6 t -133.47 154.11 51.07 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.206 -0.907 . . . . 51.12 110.199 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -72.4 99.44 2.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.888 0.852 . . . . 65.1 110.383 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -126.71 148.47 49.86 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.079 -1.452 . . . . 53.24 107.079 178.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.677 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.4 pt? -73.19 127.71 88.78 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.191 -1.041 . . . . 74.13 108.191 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.86 152.91 60.52 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 123.904 3.07 . . . . 72.42 116.772 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 13.1 p -131.82 149.18 32.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.298 -1.774 . . . . 74.0 106.908 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.6 m -102.1 16.24 26.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.751 -0.38 . . . . 74.23 111.53 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -134.0 152.79 51.99 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 122.196 -0.315 . . . . 71.15 110.795 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -101.72 132.12 48.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.955 -0.757 . . . . 73.12 108.955 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 14.0 mmmm -121.65 126.28 48.63 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.602 -0.888 . . . . 44.53 108.602 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -106.38 127.75 53.51 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.092 -0.707 . . . . 42.53 109.092 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -123.89 126.58 46.64 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.123 -0.489 . . . . 61.03 110.865 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.59 HG22 HG22 ' A' ' 37' ' ' VAL . 81.6 p -115.04 131.42 56.93 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.213 -0.903 . . . . 71.43 111.106 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.597 HD12 HD12 ' B' ' 38' ' ' ILE . 52.8 mt -128.63 121.54 55.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.173 -0.677 . . . . 54.42 109.173 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' A' ' 56' ' ' VAL . 9.9 t -111.48 128.26 55.95 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.737 -1.208 . . . . 71.54 107.737 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.3 tp10 -140.4 119.44 12.73 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.145 -176.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.91 -86.76 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 116.164 -0.471 . . . . 73.34 112.937 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.473 ' CB ' HD21 ' B' ' 19' ' ' LEU . 40.5 m -142.58 15.34 1.98 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.012 0.434 . . . . 74.5 110.446 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.657 HD21 HG23 ' B' ' 40' ' ' ILE . 2.0 pt? -127.35 141.35 51.72 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.552 -0.459 . . . . 72.45 109.841 176.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -122.14 131.82 54.15 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.685 -0.689 . . . . 54.15 110.169 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.47 143.88 49.0 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.248 -0.433 . . . . 63.34 110.435 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 28' ' ' THR . 96.6 t -124.85 127.05 72.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.067 -0.515 . . . . 72.53 110.986 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.568 HD12 HD12 ' B' ' 29' ' ' ILE . 75.8 mt -103.43 122.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 C-N-CA 123.984 0.914 . . . . 71.52 109.174 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.9 m-85 -106.1 114.8 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.427 -0.953 . . . . 75.51 108.427 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.608 HG23 HD21 ' B' ' 34' ' ' LEU . 42.0 mm -88.51 114.67 27.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.416 -0.811 . . . . 71.42 108.834 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -126.96 162.05 26.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.662 -0.699 . . . . 53.41 109.405 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -71.11 -0.69 10.18 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 121.037 0.446 . . . . 75.42 112.087 173.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -87.69 -22.07 24.86 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.304 -0.998 . . . . 65.33 108.304 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.555 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 133.77 -119.93 2.4 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.849 -1.068 . . . . 61.23 110.844 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.4 tp -115.51 143.88 44.67 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 115.236 -0.482 . . . . 74.23 111.18 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -140.87 139.56 34.43 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.949 -0.76 . . . . 55.21 108.949 170.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.01 141.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 116.332 -0.394 . . . . 75.53 111.134 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.414 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 49.5 m -120.2 139.29 52.87 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.979 -0.555 . . . . 63.04 110.684 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HB1' HH22 ' B' ' 18' ' ' ARG . . . -116.53 125.28 51.67 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.001 -0.545 . . . . 74.4 110.448 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -124.43 108.92 29.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.046 -0.525 . . . . 74.32 109.833 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HB3' ' NE ' ' B' ' 18' ' ' ARG . 73.6 Cg_endo -94.22 134.26 0.82 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 121.786 1.657 . . . . 30.11 114.99 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 52.9 25.99 4.34 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 114.049 -1.432 . . . . 62.53 114.065 165.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.27 -81.36 0.09 Allowed 'General case' 0 C--O 1.241 0.612 0 N-CA-C 114.126 1.158 . . . . 73.01 114.126 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.7 p -124.5 -85.19 0.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 114.0 1.111 . . . . 75.13 114.0 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -88.28 109.03 19.62 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.633 0.73 . . . . 73.53 112.283 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.619 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 31.1 m -136.2 141.56 41.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.796 -1.093 . . . . 71.42 108.962 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -162.45 172.65 15.2 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 110.308 -0.256 . . . . 71.23 110.308 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -91.95 118.78 31.08 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.156 -1.053 . . . . 72.31 108.156 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.96 102.98 14.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.481 0.657 . . . . 71.42 112.374 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.4 t . . . . . 0 C--O 1.24 0.586 0 CA-C-N 115.171 -0.922 . . . . 74.34 111.383 -179.444 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 C--O 1.241 0.618 0 N-CA-C 109.68 -0.489 . . . . 73.43 109.68 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.1 -154.21 12.35 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.925 -0.87 . . . . 75.53 110.925 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -133.91 173.87 11.08 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.124 -0.695 . . . . 72.33 109.124 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -57.55 -46.5 83.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.034 0.534 . . . . 70.25 111.345 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.12 90.52 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.353 1.073 . . . . 72.25 109.927 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 18.0 m -105.18 91.52 3.83 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.219 -0.901 . . . . 65.15 109.322 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -92.22 -16.29 26.39 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.814 0.816 . . . . 71.24 109.08 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -75.13 167.86 21.1 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.746 -1.115 . . . . 73.03 109.914 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -75.46 109.58 9.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 110.241 -0.281 . . . . 74.4 110.241 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -87.77 128.74 35.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 110.267 -0.272 . . . . 52.14 110.267 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 82.2 m -129.88 149.37 51.65 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.831 -0.433 . . . . 74.12 109.831 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.2 t -144.14 138.57 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.47 0.481 . . . . 73.34 110.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -107.58 129.01 55.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.311 0.577 . . . . 60.21 111.499 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.82 121.67 44.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.387 -0.824 . . . . 70.11 109.754 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 18.0 m -106.82 116.19 31.49 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 108.056 -1.091 . . . . 73.45 108.056 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -138.68 -169.76 2.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.287 -0.87 . . . . 72.22 108.763 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -74.12 93.7 2.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.607 -0.886 . . . . 61.12 108.607 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.52 ' NE ' ' HB3' ' A' ' 51' ' ' PRO . 8.5 tpp85 -127.51 133.94 49.81 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.696 -0.853 . . . . 74.05 108.696 -177.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -74.95 162.63 72.68 Favored Pre-proline 0 C--N 1.294 -1.832 0 CA-C-N 116.232 -0.44 . . . . 71.41 111.705 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 36.0 Cg_endo -66.73 147.95 82.07 Favored 'Trans proline' 0 C--O 1.254 1.32 0 C-N-CA 122.123 1.882 . . . . 71.34 112.17 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -125.78 146.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.244 -1.021 . . . . 63.11 108.244 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 m -67.73 -53.15 29.77 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 123.104 0.253 . . . . 62.23 111.574 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -125.36 151.31 46.27 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 110.018 -0.364 . . . . 73.32 110.018 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.75 114.58 23.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.762 -1.199 . . . . 61.23 107.762 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.15 148.19 22.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.587 -0.523 . . . . 71.22 109.587 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.7 m -128.46 127.54 42.68 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.075 -1.083 . . . . 64.4 108.075 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -123.59 127.14 47.86 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-O 121.046 0.45 . . . . 74.54 111.296 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.582 HG22 HG22 ' B' ' 37' ' ' VAL . 76.7 p -114.52 132.99 56.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 114.879 -1.055 . . . . 75.54 110.02 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 38' ' ' ILE . 51.2 mt -129.51 120.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 109.285 -0.635 . . . . 63.42 109.285 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' B' ' 56' ' ' VAL . 7.2 t -100.12 124.66 45.77 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.908 -1.145 . . . . 75.13 107.908 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.493 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.0 tp10 -142.41 101.0 3.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.92 -0.582 . . . . 75.12 112.353 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.85 -67.65 0.45 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 116.071 1.188 . . . . 72.31 116.071 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 42.1 m -137.8 -3.38 1.85 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.458 0.54 . . . . 54.34 112.458 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 40' ' ' ILE . 2.3 pt? -140.65 141.09 35.09 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 120.235 -0.586 . . . . 72.32 109.883 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.506 ' NH2' HG21 ' B' ' 54' ' ' THR . 18.8 ttp180 -109.48 125.42 52.44 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 119.558 -0.857 . . . . 71.25 108.885 171.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.27 145.0 30.86 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.564 -0.289 . . . . 71.45 110.777 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.582 HG22 HG22 ' B' ' 28' ' ' THR . 95.0 t -124.05 128.18 73.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.888 -0.596 . . . . 72.21 110.725 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 29' ' ' ILE . 68.9 mt -108.36 123.78 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 C-N-CA 124.334 1.054 . . . . 75.22 109.454 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.442 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 99.1 m-85 -103.29 120.19 40.29 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.859 -0.793 . . . . 75.45 108.859 175.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.657 HG23 HD21 ' A' ' 34' ' ' LEU . 39.7 mm -87.73 114.47 26.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 107.688 -1.227 . . . . 62.43 107.688 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -135.34 154.97 51.33 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.917 -0.583 . . . . 75.54 111.263 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.728 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -71.77 -14.7 62.07 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.972 -0.558 . . . . 71.0 111.219 177.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' B' ' 15' ' ' THR . 54.0 mtp180 -86.34 -16.19 38.2 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.536 0.684 . . . . 73.34 109.366 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.16 -108.16 0.44 Allowed Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 119.916 -1.135 . . . . 31.52 112.67 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 53.0 tp -139.36 143.7 37.87 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.833 -0.684 . . . . 64.33 109.47 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -131.5 140.46 49.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.262 -1.014 . . . . 75.33 108.262 167.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.7 140.48 48.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.719 -0.673 . . . . 63.4 110.209 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.492 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 36.5 m -127.58 141.11 51.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.88 -0.6 . . . . 73.25 110.967 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.38 124.39 49.93 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.899 -0.591 . . . . 71.42 110.308 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -110.72 95.91 25.87 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.014 -1.106 . . . . 53.52 108.014 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.485 ' HG3' ' OG1' ' A' ' 16' ' ' THR . 93.6 Cg_endo -89.56 132.1 2.07 Favored 'Trans proline' 0 N--CA 1.411 -3.361 0 C-N-CA 120.097 0.531 . . . . 74.42 111.597 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 57.0 -0.89 0.06 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 116.146 1.906 . . . . 74.14 116.146 170.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.6 -60.79 2.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 118.388 0.54 . . . . 75.11 110.643 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.506 HG21 ' NH2' ' B' ' 35' ' ' ARG . 36.5 p -77.14 175.98 9.14 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.693 -0.685 . . . . 62.5 111.349 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -69.35 110.92 4.92 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.573 0.702 . . . . 74.55 111.044 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.488 ' HA ' ' OG1' ' B' ' 30' ' ' THR . 31.4 m -99.78 140.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 115.349 -0.841 . . . . 63.03 110.764 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -139.8 136.97 34.61 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.796 -0.638 . . . . 73.33 109.448 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.46 116.7 20.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.694 -1.225 . . . . 73.41 107.694 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.6 m -109.88 107.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 113.989 1.107 . . . . 74.41 113.989 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 C--O 1.25 1.091 0 C-N-CA 124.92 1.288 . . . . 74.52 110.736 178.797 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.256 0.55 . . . . 71.22 110.111 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.85 -5.33 27.49 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 109.57 -1.412 . . . . 74.24 109.57 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -90.72 -25.53 19.98 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.918 -0.641 . . . . 64.0 109.65 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.36 107.14 19.12 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.536 -0.756 . . . . 75.13 109.654 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.0 t -85.2 -42.39 16.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.211 0.529 . . . . 63.21 109.941 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.6 p -140.86 95.08 2.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.601 0.715 . . . . 64.12 110.146 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -109.8 161.33 15.55 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.996 -1.112 . . . . 61.24 107.996 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.8 -57.37 3.89 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 112.207 0.447 . . . . 73.4 112.207 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -143.59 115.56 8.32 Favored 'General case' 0 CA--C 1.476 -1.889 0 N-CA-C 107.665 -1.235 . . . . 73.4 107.665 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -108.04 134.98 50.17 Favored 'General case' 0 C--N 1.272 -2.792 0 C-N-CA 120.077 -0.649 . . . . 64.44 111.073 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.3 m -125.55 147.56 49.22 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.606 -0.516 . . . . 75.42 109.606 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -145.99 147.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.721 0.808 . . . . 73.43 109.741 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 17.9 t -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.222 -0.659 . . . . 73.21 109.222 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.7 mm? -101.47 132.39 47.11 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 123.572 0.749 . . . . 74.14 110.522 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -99.84 110.93 23.28 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.108 0.956 . . . . 75.31 109.474 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.0 p -140.95 179.81 6.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.082 -0.963 . . . . 75.33 110.68 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' B' ' 51' ' ' PRO . 22.3 tp60 -67.55 95.8 0.49 Allowed 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.839 -0.8 . . . . 74.13 108.839 174.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.54 149.37 45.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.826 -0.749 . . . . 73.12 110.999 -173.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mp -77.04 140.3 66.26 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 106.159 -1.793 . . . . 74.02 106.159 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.68 134.66 45.05 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.023 1.149 . . . . 62.24 109.551 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.52 138.87 48.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.8 -0.637 . . . . 73.55 110.108 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.2 m -90.28 -58.98 2.31 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.184 -0.462 . . . . 74.52 111.022 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -89.78 133.99 34.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.834 -0.432 . . . . 73.41 109.834 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.23 122.56 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.637 -0.505 . . . . 65.44 109.637 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.43 153.94 20.44 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.057 0.456 . . . . 70.43 110.994 178.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.4 m -132.69 127.97 35.94 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.459 -0.941 . . . . 55.42 108.459 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' B' ' 29' ' ' ILE . 72.5 m-85 -127.35 126.8 43.17 Favored 'General case' 0 CA--C 1.467 -2.245 0 CA-C-N 115.863 -0.608 . . . . 63.04 110.088 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 37' ' ' VAL . 69.2 p -115.82 131.69 56.86 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.317 -0.856 . . . . 71.23 111.795 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.596 HD12 HD12 ' B' ' 38' ' ' ILE . 49.4 mt -131.27 124.57 55.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.129 -0.487 . . . . 50.4 109.867 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -102.45 132.46 48.47 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.46 -0.941 . . . . 74.43 108.46 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.5 tp10 -140.25 106.44 5.24 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.271 -0.64 . . . . 64.23 109.271 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -96.97 0.33 Allowed Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.823 -0.626 . . . . 64.22 112.289 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -120.34 1.53 10.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 111.983 0.364 . . . . 64.42 111.983 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.4 pt? -118.14 140.87 49.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.891 -1.124 . . . . 74.31 111.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.62 120.94 43.6 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.618 -1.174 . . . . 72.03 108.114 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.28 128.91 52.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.847 -0.797 . . . . 75.35 108.847 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 28' ' ' THR . 67.1 t -119.1 135.23 60.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.017 0.437 . . . . 63.24 110.693 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.772 HD12 HD12 ' B' ' 29' ' ' ILE . 72.4 mt -116.14 131.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-N 115.525 -0.761 . . . . 62.4 109.966 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 99.2 m-85 -115.22 120.61 40.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.387 -0.968 . . . . 74.44 108.387 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.622 HG13 ' HG2' ' B' ' 31' ' ' GLU . 32.1 mm -92.59 114.88 30.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.065 -1.457 . . . . 75.44 107.065 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -120.32 178.23 4.73 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.897 -0.592 . . . . 75.45 111.426 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -71.77 -16.7 62.2 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.559 0.695 . . . . 73.43 110.112 175.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.563 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 75.9 ttt180 -90.17 -12.62 37.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.718 -1.128 . . . . 63.04 108.176 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -109.84 1.42 Allowed Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 114.526 -1.215 . . . . 63.22 112.216 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.45 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 64.1 tp -113.06 143.78 43.75 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.15 -0.525 . . . . 74.04 110.26 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 87.2 tttt -141.01 142.85 34.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.041 -0.725 . . . . 65.04 109.041 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.7 140.59 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-N 115.615 -0.72 . . . . 64.41 109.677 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.4 m -126.76 142.02 51.66 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.561 -0.745 . . . . 74.42 110.687 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -114.82 124.78 52.62 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.659 -0.701 . . . . 72.04 109.574 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -126.3 90.02 50.97 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.479 -0.934 . . . . 72.23 108.479 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 97.7 Cg_endo -103.13 148.39 0.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 122.952 2.435 . . . . 73.13 115.045 -177.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' B' ' 18' ' ' ARG . 17.7 mt-30 67.33 -175.64 0.2 Allowed 'General case' 0 C--O 1.244 0.789 0 CA-C-N 113.83 -1.532 . . . . 64.44 114.616 163.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 72.24 -64.1 0.4 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.201 1.401 . . . . 62.34 114.316 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.9 p -101.13 -88.62 0.37 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 115.681 1.734 . . . . 74.32 115.681 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.9 t90 -81.68 114.15 20.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.639 0.733 . . . . 73.24 112.684 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.97 134.04 60.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.417 -0.81 . . . . 71.24 109.046 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -149.55 95.27 2.32 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.618 0.723 . . . . 63.44 109.121 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -86.87 -19.52 28.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.718 -1.128 . . . . 64.11 111.121 -175.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.62 15.57 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 N-CA-C 113.137 0.791 . . . . 71.13 113.137 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 120.826 0.346 . . . . 75.12 110.527 179.524 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--O 1.237 0.4 0 CA-C-O 121.59 0.709 . . . . 44.4 109.32 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.09 -18.09 4.79 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.116 -1.194 . . . . 62.34 110.116 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -69.78 -34.91 74.4 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.242 -1.021 . . . . 65.42 108.242 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' B' ' 4' ' ' GLU . 0.2 OUTLIER -99.53 134.65 42.09 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.589 -1.187 . . . . 65.03 108.727 177.048 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.7 -45.78 20.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.414 -0.958 . . . . 64.34 108.414 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 27.6 p -151.44 96.68 2.31 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.844 -1.071 . . . . 75.05 110.265 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -94.05 172.28 8.32 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.383 -0.969 . . . . 73.42 108.383 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -66.87 -70.76 0.23 Allowed 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 117.847 0.294 . . . . 73.44 111.175 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -135.74 108.56 7.56 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.831 -0.433 . . . . 74.22 109.831 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -103.25 148.47 25.77 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.177 0.513 . . . . 52.4 111.469 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 67.9 m -134.61 149.4 50.57 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.906 -1.146 . . . . 73.22 107.906 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -141.56 143.05 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.192 0.308 . . . . 60.24 110.253 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 47.1 t -107.26 137.13 45.88 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.806 -0.812 . . . . 22.41 108.806 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.15 121.47 43.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.394 -0.821 . . . . 72.14 109.641 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 9.6 p -95.19 111.52 23.35 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.369 -0.974 . . . . 71.31 108.369 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -126.75 165.62 18.93 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.92 -1.037 . . . . 60.4 109.086 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -70.59 105.84 3.27 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.468 -1.678 . . . . 74.43 106.468 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.641 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 35.4 mmm-85 -125.98 148.37 49.28 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 117.639 2.459 . . . . 71.23 117.639 -168.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.631 ' HG ' ' CD ' ' A' ' 52' ' ' GLN . 68.9 mt -84.79 131.61 48.8 Favored Pre-proline 0 C--O 1.255 1.391 0 CA-C-N 112.878 -1.965 . . . . 74.31 106.469 168.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.56 136.23 41.99 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.909 1.739 . . . . 72.31 111.626 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.422 HG12 ' H ' ' B' ' 23' ' ' ARG . 94.7 t -114.03 135.14 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.968 -1.015 . . . . 51.34 108.452 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -78.18 -22.58 48.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.058 0.762 . . . . 51.13 113.058 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.422 ' H ' HG12 ' B' ' 21' ' ' VAL . 14.7 tpt180 -127.95 139.44 52.58 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.596 -0.841 . . . . 74.45 109.61 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' B' ' 41' ' ' THR . 50.4 mm -90.9 138.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.597 -0.52 . . . . 71.34 109.597 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -118.39 157.18 27.64 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.451 0.643 . . . . 74.21 112.134 178.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.1 m -133.5 126.4 31.01 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.973 -1.012 . . . . 70.3 108.952 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.43 ' HB2' ' HB ' ' B' ' 38' ' ' ILE . 68.7 m-85 -124.77 135.77 53.26 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 116.121 -0.49 . . . . 74.33 111.43 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.556 HG22 HG22 ' B' ' 37' ' ' VAL . 44.9 p -115.17 128.36 56.13 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.196 -0.911 . . . . 75.22 111.278 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.772 HD12 HD12 ' A' ' 38' ' ' ILE . 72.0 mt -124.7 127.72 72.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.286 0.634 . . . . 71.1 109.578 177.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.4 ' HG1' ' HE3' ' B' ' 55' ' ' TRP . 10.7 t -112.83 128.41 56.44 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 109.515 -0.55 . . . . 75.15 109.515 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.622 ' HG2' HG13 ' A' ' 40' ' ' ILE . 11.5 tp10 -132.06 97.87 4.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.412 0.625 . . . . 70.24 110.205 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.49 -74.41 1.08 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 114.742 -1.117 . . . . 71.04 112.421 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.547 ' OG ' ' HA ' ' B' ' 52' ' ' GLN . 24.1 t -144.94 -1.62 0.85 Allowed 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.658 0.742 . . . . 64.24 109.075 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.552 HD23 HD12 ' A' ' 40' ' ' ILE . 35.5 tp -99.32 118.63 36.4 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 115.89 -0.595 . . . . 63.55 110.71 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 21.2 tpp180 -98.86 114.75 27.47 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.513 -0.767 . . . . 72.45 109.657 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.13 136.26 48.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 110.087 -0.338 . . . . 72.03 110.087 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.556 HG22 HG22 ' B' ' 28' ' ' THR . 97.0 t -121.52 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.866 0.365 . . . . 74.22 111.341 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.596 HD12 HD12 ' A' ' 29' ' ' ILE . 82.8 mt -105.73 117.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 C-N-CA 124.586 1.154 . . . . 74.2 109.175 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.522 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.1 m-85 -102.78 116.22 32.13 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.893 -0.78 . . . . 71.12 108.893 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 34' ' ' LEU . 47.1 mm -89.06 113.54 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.187 -1.412 . . . . 73.4 107.187 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' THR . . . . . 0.408 ' HA ' HD12 ' B' ' 24' ' ' ILE . 39.7 p -115.03 170.17 8.55 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 116.136 -0.484 . . . . 72.2 110.201 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.551 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -80.48 -19.93 44.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.854 0.359 . . . . 53.15 111.346 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.551 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 70.2 ttt180 -94.97 -17.49 21.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.59 0.71 . . . . 75.01 109.905 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.526 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . 164.08 -128.94 1.9 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.427 -1.368 . . . . 55.01 113.921 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.409 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 67.7 tp -130.41 147.36 52.1 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 109.031 -0.729 . . . . 61.52 109.031 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 85.5 tttt -139.75 143.16 36.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.148 -0.686 . . . . 73.53 109.148 172.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 13.7 p -130.45 140.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.877 -0.602 . . . . 74.42 109.915 -175.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.522 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.6 m -124.84 138.51 54.26 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.37 -0.377 . . . . 72.4 110.839 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -115.86 124.75 51.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.082 -0.508 . . . . 71.14 112.034 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 18.0 t70 -122.37 95.84 46.64 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 108.636 -0.876 . . . . 63.25 108.636 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.491 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 56.5 Cg_endo -96.53 134.98 0.47 Allowed 'Trans proline' 0 N--CA 1.411 -3.364 0 C-N-CA 121.456 1.438 . . . . 64.4 113.48 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.547 ' HA ' ' OG ' ' B' ' 33' ' ' SER . 22.6 mt-30 71.38 -11.46 0.7 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.129 1.529 . . . . 63.04 115.129 171.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.2 -60.04 2.12 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.411 -0.516 . . . . 32.43 112.389 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.0 p -61.82 -53.01 61.79 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.441 1.275 . . . . 64.55 114.441 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' TRP . . . . . 0.488 ' CZ2' ' HB3' ' B' ' 57' ' ' ARG . 9.3 t90 -139.97 158.24 44.39 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.23 -0.588 . . . . 74.33 110.082 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.48 95.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.469 0.652 . . . . 71.33 110.769 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.488 ' HB3' ' CZ2' ' B' ' 55' ' ' TRP . 63.8 ttt180 -172.97 112.53 0.23 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.654 -0.703 . . . . 71.14 109.131 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -86.88 90.49 8.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.678 0.751 . . . . 62.33 112.532 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.2 m -133.49 16.86 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.834 -1.075 . . . . 74.43 108.931 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--N 1.31 -1.139 0 CA-C-N 115.371 -0.831 . . . . 60.21 109.297 -176.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.566 -0.902 . . . . 73.44 108.566 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.89 -129.03 1.75 Allowed Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 120.577 -0.821 . . . . 50.14 111.552 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t -136.93 16.06 3.06 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.784 0.326 . . . . 74.04 110.225 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -77.86 91.35 4.14 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.902 0.858 . . . . 52.52 111.872 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 8' ' ' LYS . 35.2 m -84.42 -31.08 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-N 114.117 -1.402 . . . . 74.35 110.081 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.9 m 49.55 -72.99 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 116.422 2.008 . . . . 54.11 116.422 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -105.89 7.0 31.98 Favored 'General case' 0 CA--C 1.493 -1.216 0 O-C-N 121.826 -0.546 . . . . 71.34 111.538 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.576 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 87.3 tttt -65.33 101.29 0.55 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.186 0.517 . . . . 65.43 111.708 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 3.8 ppt_? -83.18 124.92 30.98 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.914 -1.039 . . . . 74.23 108.272 172.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -94.18 138.97 31.61 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 115.912 -0.586 . . . . 64.22 111.141 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 79.7 m -137.13 147.6 46.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.454 -0.943 . . . . 53.14 108.454 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG11 HG11 ' B' ' 12' ' ' VAL . 53.9 t -144.4 144.42 22.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 123.078 0.236 . . . . 74.12 110.38 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -107.24 138.26 43.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 109.408 -0.59 . . . . 53.55 109.408 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mp -114.91 133.67 55.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.467 -0.333 . . . . 70.04 110.618 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 p -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.599 0.714 . . . . 72.22 111.319 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -150.05 167.87 25.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.942 -1.503 . . . . 72.32 106.942 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 100.44 1.46 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 122.368 1.08 . . . . 61.41 111.905 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -125.64 139.98 53.1 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.108 -0.951 . . . . 62.12 110.219 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.46 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.9 mm? -74.73 141.73 76.15 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.973 -1.012 . . . . 75.01 109.067 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.07 135.89 42.38 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.171 1.914 . . . . 73.24 111.784 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 23' ' ' ARG . 11.6 p -131.98 136.15 57.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.006 -1.109 . . . . 73.41 108.006 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 m -84.23 2.18 41.13 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.371 0.508 . . . . 73.1 112.371 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 21' ' ' VAL . 29.0 mmm180 -116.56 155.66 28.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.529 -0.545 . . . . 65.34 109.529 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.22 114.88 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.035 0 N-CA-C 105.121 -2.177 . . . . 73.04 105.121 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 35.1 tptt -100.74 125.57 47.21 Favored 'General case' 0 N--CA 1.406 -2.645 0 C-N-CA 117.45 -1.7 . . . . 71.22 108.904 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 31.2 m -109.81 128.41 55.3 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.92 -0.582 . . . . 74.42 109.975 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 76.2 m-85 -125.76 128.02 47.08 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.954 -0.566 . . . . 72.05 109.846 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.492 HG22 HG22 ' A' ' 37' ' ' VAL . 79.3 p -115.37 119.02 34.88 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.218 -0.593 . . . . 70.34 111.914 -175.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.604 HD12 HD12 ' B' ' 38' ' ' ILE . 63.8 mt -120.6 121.42 65.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 109.336 -0.616 . . . . 73.35 109.336 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.417 ' CB ' HH11 ' A' ' 35' ' ' ARG . 5.7 t -108.49 134.25 51.52 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.449 -0.945 . . . . 74.53 108.449 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 97.52 3.48 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-O 121.751 0.786 . . . . 73.21 110.231 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.96 -82.85 1.5 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 114.692 -1.14 . . . . 72.55 112.123 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.478 ' HA ' HG11 ' A' ' 56' ' ' VAL . 22.9 t -144.34 32.73 1.2 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.139 -1.43 . . . . 71.13 107.139 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.648 HD23 HD12 ' B' ' 40' ' ' ILE . 33.7 tp -135.76 117.8 15.37 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 115.276 -0.874 . . . . 63.53 110.694 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' CB ' ' A' ' 30' ' ' THR . 30.4 mmt180 -96.79 116.5 29.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.159 -0.682 . . . . 53.44 109.159 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.9 126.88 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.347 -0.612 . . . . 61.24 109.347 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 28' ' ' THR . 97.2 t -120.16 126.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.964 0.411 . . . . 63.11 110.741 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.62 HD12 HD12 ' B' ' 29' ' ' ILE . 80.2 mt -105.41 131.61 54.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.656 -0.702 . . . . 73.15 109.596 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 95.6 m-85 -115.9 114.88 25.28 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.327 -0.99 . . . . 73.12 108.327 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.539 HD12 HD23 ' B' ' 34' ' ' LEU . 37.3 mm -89.53 121.4 39.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.665 -1.235 . . . . 75.11 107.665 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 p -125.52 174.53 8.16 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.535 0.683 . . . . 73.24 110.942 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.9 -19.86 56.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.676 -1.147 . . . . 54.14 109.025 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -86.6 -25.73 24.79 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.648 -1.241 . . . . 74.15 107.648 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -130.92 3.66 Favored Glycine 0 C--N 1.291 -1.948 0 CA-C-N 114.098 -1.41 . . . . 63.31 112.942 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 61.5 tp -113.22 137.12 51.94 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.601 -0.518 . . . . 74.22 109.601 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -134.63 142.36 46.86 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.938 -0.764 . . . . 62.11 108.938 171.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 7.2 p -131.58 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.999 -0.546 . . . . 64.02 110.041 -175.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.428 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 52.6 m -123.1 139.41 54.09 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.119 -0.492 . . . . 52.14 111.045 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -117.36 124.32 48.62 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.903 -0.777 . . . . 64.34 108.903 177.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.58 82.64 67.9 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 106.615 -1.624 . . . . 45.24 106.615 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.602 ' HD2' ' NE2' ' B' ' 17' ' ' GLN . 3.3 Cg_exo -76.82 145.67 25.66 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.093 1.862 . . . . 72.22 112.688 -176.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 69.82 -41.34 0.48 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.536 1.534 . . . . 74.04 114.252 175.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 67.84 -78.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.008 1.323 . . . . 61.23 112.166 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.8 m -162.38 -60.14 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.527 -2.027 . . . . 73.24 105.527 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -142.36 95.8 2.85 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 106.469 -1.678 . . . . 71.33 106.469 172.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 33' ' ' SER . 8.3 p -67.08 117.25 7.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 114.182 1.178 . . . . 63.32 114.182 -172.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.33 97.58 11.19 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 107.39 -1.337 . . . . 74.34 107.39 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.99 76.03 9.85 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.329 1.062 . . . . 40.34 112.346 -174.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.68 137.95 23.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 113.669 -1.605 . . . . 74.22 110.673 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 C--N 1.311 -1.082 0 O-C-N 121.774 -0.579 . . . . 71.15 110.239 179.114 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.251 1.146 0 N-CA-C 109.466 -0.568 . . . . 73.0 109.466 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.08 79.01 1.75 Allowed Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.849 -1.3 . . . . 61.42 109.849 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 45.3 t -78.97 -54.79 5.68 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.96 0.41 . . . . 63.34 111.127 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -85.67 90.98 8.16 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.252 -0.647 . . . . 70.41 109.252 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 31.5 m -136.84 14.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.79 -0.641 . . . . 53.24 111.359 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 42.3 m 73.09 -37.34 0.38 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.316 1.046 . . . . 72.42 112.894 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.89 -10.56 59.45 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.419 0.896 . . . . 64.24 113.419 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -86.15 79.6 9.07 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.129 0.966 . . . . 71.03 110.413 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 15.8 ptt-85 -94.43 135.48 35.81 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.991 -1.459 . . . . 75.03 108.748 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -91.81 144.73 25.2 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.839 -0.345 . . . . 65.24 110.906 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -141.43 149.46 41.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 62.21 108.595 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.425 HG11 HG11 ' A' ' 12' ' ' VAL . 55.3 t -141.85 138.01 31.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.495 -0.321 . . . . 72.25 110.257 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 26.5 p -107.37 125.23 50.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.553 -0.906 . . . . 75.21 108.553 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.61 123.66 45.98 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.047 -0.524 . . . . 64.22 109.931 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 37.0 p -89.17 112.42 23.42 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.504 -0.554 . . . . 74.41 109.504 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -141.49 -172.47 3.53 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.551 -0.907 . . . . 73.11 108.551 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLN . . . . . 0.602 ' NE2' ' HD2' ' A' ' 51' ' ' PRO . 4.9 pm0 -79.95 89.26 5.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.285 1.041 . . . . 74.32 110.934 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.409 ' CB ' ' HA2' ' B' ' 44' ' ' GLY . 26.4 tpt180 -126.34 142.57 51.48 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.418 -0.81 . . . . 70.01 111.236 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.03 152.09 52.77 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.05 -0.977 . . . . 62.53 108.628 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.94 145.81 86.4 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.945 1.763 . . . . 74.52 111.052 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.416 HG22 ' H ' ' B' ' 23' ' ' ARG . 14.3 p -131.53 141.71 45.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.41 -0.814 . . . . 62.44 109.298 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 49.7 m -82.0 -27.04 33.34 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.07 0.396 . . . . 74.31 112.07 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.416 ' H ' HG22 ' B' ' 21' ' ' VAL . 30.1 mmm180 -113.99 132.75 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 120.729 -0.388 . . . . 64.35 110.649 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -90.69 115.11 29.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.789 -1.189 . . . . 73.11 107.789 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.407 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 75.3 mmtt -94.15 137.92 32.78 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.034 -0.53 . . . . 53.04 111.391 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.4 m -116.27 127.93 55.14 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.992 -1.004 . . . . 60.42 108.867 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -127.88 126.64 41.94 Favored 'General case' 0 CA--C 1.461 -2.46 0 CA-C-N 115.605 -0.725 . . . . 74.41 109.749 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.667 HG22 HG22 ' B' ' 37' ' ' VAL . 64.4 p -115.38 132.56 56.58 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.76 -0.654 . . . . 73.42 111.13 -177.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.62 HD12 HD12 ' A' ' 38' ' ' ILE . 55.1 mt -126.04 136.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 109.213 -0.662 . . . . 63.31 109.213 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.603 HG21 ' H ' ' B' ' 57' ' ' ARG . 10.1 t -119.15 127.28 53.18 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 121.744 0.783 . . . . 63.1 109.653 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -135.86 110.61 8.7 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.37 -0.832 . . . . 74.31 110.236 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -68.12 3.05 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.143 -0.783 . . . . 75.25 111.143 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.9 t -165.82 11.71 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.065 -1.457 . . . . 74.02 107.065 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.539 HD23 HD12 ' A' ' 40' ' ' ILE . 29.4 tp -102.13 123.65 46.37 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.494 -0.775 . . . . 63.23 111.56 -174.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 35.5 mmt180 -94.46 113.7 25.6 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.021 -0.536 . . . . 63.21 110.501 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.1 124.55 49.73 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.79 -1.189 . . . . 73.41 107.79 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.667 HG22 HG22 ' B' ' 28' ' ' THR . 65.8 t -117.2 128.64 74.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.002 0.43 . . . . 54.12 111.373 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.604 HD12 HD12 ' A' ' 29' ' ' ILE . 67.3 mt -106.96 128.19 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.283 -0.871 . . . . 71.11 109.995 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.8 m-85 -111.74 118.37 35.43 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.418 -0.956 . . . . 74.2 108.418 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.648 HD12 HD23 ' A' ' 34' ' ' LEU . 38.2 mm -87.87 114.62 26.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.441 -1.688 . . . . 75.22 106.441 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 69.5 p -123.1 -177.93 3.82 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.63 0.729 . . . . 74.24 112.323 -173.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' B' ' 43' ' ' ARG . 54.7 pttt -80.2 -29.81 38.63 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.886 -1.506 . . . . 75.54 109.488 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.579 ' N ' ' HG3' ' B' ' 42' ' ' LYS . 77.1 ttt180 -88.02 -17.41 31.24 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.211 1.005 . . . . 74.45 109.19 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' B' ' 18' ' ' ARG . . . 147.83 -121.99 1.46 Allowed Glycine 0 N--CA 1.425 -2.055 0 CA-C-N 114.305 -1.316 . . . . 73.1 112.549 177.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 67.0 tp -119.47 133.77 55.54 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.646 -0.777 . . . . 72.14 109.285 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 82.7 tttt -124.77 141.53 52.05 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.455 -0.572 . . . . 65.0 109.455 172.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.42 HG11 HG11 ' A' ' 47' ' ' VAL . 12.1 p -131.23 141.11 46.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 115.673 -0.694 . . . . 54.44 110.231 -175.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.434 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 65.9 m -125.63 141.59 51.94 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 116.29 -0.414 . . . . 73.45 110.577 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -116.31 123.89 48.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.741 -0.837 . . . . 61.3 108.741 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 13.2 t70 -132.26 97.8 17.68 Favored Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 107.516 -1.29 . . . . 61.21 107.516 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -94.15 138.61 1.19 Allowed 'Trans proline' 0 N--CA 1.425 -2.523 0 C-N-CA 121.775 1.65 . . . . 72.14 115.357 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 62.91 14.29 7.33 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.04 -1.436 . . . . 74.12 114.282 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.31 -70.4 0.55 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 113.736 1.013 . . . . 72.33 113.736 -176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.6 p -83.96 -99.56 0.05 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 116.261 1.948 . . . . 52.11 116.261 -173.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -145.65 166.34 26.07 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-O 120.919 0.39 . . . . 72.32 110.488 -172.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 8.6 p -119.97 104.23 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.938 0.875 . . . . 73.53 109.984 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.603 ' H ' HG21 ' B' ' 30' ' ' THR . 74.9 ttt180 -149.87 113.78 5.09 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.845 -1.168 . . . . 74.54 107.845 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.62 113.88 26.01 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.245 0.545 . . . . 74.45 112.023 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.57 113.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.28 -0.873 . . . . 54.44 109.381 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.312 -1.025 0 CA-C-O 118.456 -0.783 . . . . 72.31 109.462 -178.176 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.243 0.714 0 CA-C-O 120.916 0.389 . . . . 53.14 111.617 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.18 101.36 0.62 Allowed Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.21 -0.995 . . . . 72.31 112.022 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 m -138.82 18.12 2.67 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.799 -1.185 . . . . 65.14 107.799 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.58 100.45 0.88 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.316 -1.311 . . . . 71.12 111.437 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.63 118.52 56.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.551 -0.749 . . . . 72.43 110.75 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.1 m -160.6 179.74 8.32 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.883 -1.525 . . . . 74.33 106.883 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' B' ' 17' ' ' GLN . 21.5 m-20 -76.12 -1.65 27.13 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.77 0.795 . . . . 71.4 110.281 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -87.95 -174.34 4.66 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.867 -1.061 . . . . 75.33 109.45 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 97.3 mtt180 -68.53 119.77 13.51 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.021 -0.733 . . . . 74.22 109.021 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 p -98.57 125.48 43.83 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.151 -0.477 . . . . 72.23 109.972 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.2 m -127.83 148.59 50.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.442 -0.503 . . . . 73.42 110.125 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' CG2' HD11 ' B' ' 14' ' ' LEU . 98.7 t -144.17 143.25 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.774 0.429 . . . . 73.3 109.994 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.8 p -123.56 125.49 44.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.377 0.423 . . . . 65.43 110.397 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 mm? -106.56 121.84 45.11 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.189 -0.46 . . . . 63.03 111.243 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.5 p -92.28 112.88 24.99 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.757 0.789 . . . . 71.2 109.071 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.454 ' CG2' ' HG3' ' B' ' 51' ' ' PRO . 5.1 t -134.54 -172.62 3.07 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.918 -1.037 . . . . 60.54 109.367 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' B' ' 7' ' ' ASP . 29.2 pt20 -74.69 81.98 2.06 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.469 1.128 . . . . 71.31 111.251 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -127.21 142.37 51.5 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.283 -0.871 . . . . 71.31 110.297 -178.016 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -74.46 147.73 85.2 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.342 -0.984 . . . . 55.51 108.342 176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.52 136.89 29.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.944 1.763 . . . . 54.23 112.03 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 23' ' ' ARG . 34.6 t -115.41 142.68 27.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.753 -1.203 . . . . 75.11 107.753 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 m -88.43 -2.28 58.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.631 0.604 . . . . 71.54 112.631 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.567 ' H ' HG12 ' A' ' 21' ' ' VAL . 64.0 ttt180 -134.58 148.75 50.52 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.953 -0.467 . . . . 75.15 110.44 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -92.4 120.45 41.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.503 -0.925 . . . . 74.01 108.503 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 35.0 mmtp -96.96 132.21 42.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.917 -0.713 . . . . 72.4 109.914 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 p -107.25 128.04 54.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.66 -0.7 . . . . 72.3 109.75 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.467 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 67.2 m-85 -128.24 126.79 41.62 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.699 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 37' ' ' VAL . 47.9 p -115.13 129.84 56.77 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.423 -0.808 . . . . 55.11 112.696 -174.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.652 HD12 HD12 ' B' ' 38' ' ' ILE . 59.0 mt -137.41 121.6 22.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.912 -0.585 . . . . 74.23 109.467 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -113.23 126.48 55.46 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 119.666 -0.813 . . . . 64.42 109.162 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.8 tp10 -121.35 103.61 9.09 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.861 -0.609 . . . . 72.52 109.598 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.13 -93.57 0.23 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.612 -0.722 . . . . 60.24 112.967 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.456 ' HB2' HD22 ' B' ' 19' ' ' LEU . 43.7 m -113.75 -7.18 13.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.268 0.84 . . . . 65.11 113.268 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -114.5 140.67 48.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.142 -1.023 . . . . 75.55 111.125 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 1.9 mpt_? -108.71 119.58 39.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.249 -0.887 . . . . 75.2 108.69 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.31 130.92 55.48 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.754 0.312 . . . . 75.3 110.247 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 28' ' ' THR . 60.1 t -121.19 127.17 75.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.476 -0.564 . . . . 74.22 109.476 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.628 HD12 HD12 ' B' ' 29' ' ' ILE . 83.7 mt -101.66 125.85 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.587 0 N-CA-C 108.672 -0.862 . . . . 70.42 108.672 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -108.69 114.65 28.63 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.238 -1.023 . . . . 72.32 108.238 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 49.9 mm -88.84 113.14 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.353 0 N-CA-C 106.499 -1.667 . . . . 73.13 106.499 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.2 p -109.99 -177.07 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.816 -0.629 . . . . 71.15 110.343 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.8 -13.0 32.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.941 -0.762 . . . . 55.01 108.941 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -96.55 -24.61 15.97 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.182 -0.917 . . . . 71.54 110.705 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 171.27 -133.52 2.78 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 118.394 -1.86 . . . . 54.14 114.368 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 1.6 tm? -126.99 122.59 34.92 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 124.186 0.994 . . . . 62.5 108.567 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -123.07 143.02 50.25 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-O 121.093 0.473 . . . . 75.4 110.74 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.55 140.81 47.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 115.455 -0.793 . . . . 63.33 109.14 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.8 m -124.05 136.88 54.56 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.089 -0.505 . . . . 70.41 110.302 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HB2' ' HG ' ' B' ' 45' ' ' LEU . . . -117.21 124.3 48.74 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.636 -0.711 . . . . 53.05 110.015 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 21.7 t70 -110.88 104.28 55.9 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.001 -0.74 . . . . 64.45 109.001 175.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HG3' ' OG1' ' B' ' 16' ' ' THR . 83.2 Cg_endo -79.44 158.22 25.67 Favored 'Trans proline' 0 N--CA 1.423 -2.659 0 C-N-CA 121.563 1.509 . . . . 41.45 111.411 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -36.71 -49.83 0.79 Allowed 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 125.424 1.49 . . . . 71.02 113.517 172.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HA ' ' NE2' ' B' ' 17' ' ' GLN . . . 66.9 -69.09 0.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.556 1.142 . . . . 74.32 113.248 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.6 p -86.99 -76.65 0.35 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.203 0.525 . . . . 72.44 110.204 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -168.08 157.83 9.89 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.597 -1.631 . . . . 55.24 106.597 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.89 162.98 35.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 120.981 0.419 . . . . 65.22 110.557 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -119.09 179.21 4.23 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 104.696 -2.335 . . . . 73.43 104.696 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -69.04 90.39 0.45 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.2 1.185 . . . . 74.14 114.2 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.6 t -95.41 111.87 26.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.849 -1.167 . . . . 71.32 107.849 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.6 m . . . . . 0 C--N 1.298 -1.661 0 CA-C-N 116.225 -0.443 . . . . 62.23 111.58 -177.976 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.243 0.73 0 CA-C-O 121.9 0.857 . . . . 74.41 110.41 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.97 6.84 24.12 Favored Glycine 0 N--CA 1.432 -1.597 0 CA-C-N 114.787 -1.097 . . . . 51.15 112.085 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 25.4 m -63.6 100.23 0.26 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.121 0.486 . . . . 75.43 111.322 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -144.83 126.52 15.19 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.893 -0.594 . . . . 74.41 110.143 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.96 125.55 54.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 121.374 0.607 . . . . 51.01 110.302 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -154.4 172.71 17.29 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.906 -1.146 . . . . 70.33 107.906 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 8.0 m-20 -85.08 -14.94 45.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.884 0.849 . . . . 74.15 109.236 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -78.31 -173.76 3.42 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.213 -0.903 . . . . 61.03 110.552 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 93.3 mtt180 -68.63 107.39 2.95 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.826 -0.624 . . . . 73.43 110.368 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 30.9 p -89.03 128.75 35.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.695 -0.684 . . . . 73.14 110.713 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 63.8 m -131.62 148.47 52.61 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.543 -0.91 . . . . 62.34 108.543 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.43 145.31 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 109.445 -0.576 . . . . 71.24 109.445 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 65.9 p -115.33 125.45 53.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.136 0.493 . . . . 64.41 110.838 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.484 HD11 ' CG2' ' A' ' 12' ' ' VAL . 3.2 mm? -103.47 121.51 42.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 116.045 -0.525 . . . . 75.42 111.094 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 38.7 p -93.8 113.31 25.33 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.805 -0.634 . . . . 71.13 109.748 176.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.412 ' OG1' ' HG3' ' A' ' 51' ' ' PRO . 9.1 t -129.09 -171.0 2.38 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.623 -1.251 . . . . 73.11 107.623 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 53' ' ' ALA . 27.6 pt20 -77.55 108.19 10.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.54 1.162 . . . . 72.35 110.117 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.429 ' H ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -125.4 150.9 46.83 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.89 -1.505 . . . . 75.43 114.199 -174.403 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.469 ' H ' HD23 ' B' ' 19' ' ' LEU . 2.2 pt? -74.64 167.42 36.46 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.297 -1.32 . . . . 53.22 108.636 175.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 19.0 Cg_endo -65.2 135.07 41.79 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.131 1.22 . . . . 70.02 109.951 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 86.2 t -129.81 123.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.726 -0.842 . . . . 64.41 108.726 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.8 m -90.11 -73.71 0.51 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.037 0.446 . . . . 72.32 110.064 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -92.38 146.94 23.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.475 -0.784 . . . . 75.14 109.301 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.402 HD12 HG22 ' B' ' 41' ' ' THR . 43.5 mm -84.07 134.78 26.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.96 -0.385 . . . . 73.55 109.96 -175.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -100.77 125.72 47.27 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.036 -1.098 . . . . 62.15 108.036 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 31.7 p -106.3 128.38 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.113 0.482 . . . . 74.03 110.414 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.43 ' HB2' ' HB ' ' B' ' 38' ' ' ILE . 71.3 m-85 -127.07 126.91 43.83 Favored 'General case' 0 CA--C 1.473 -2.017 0 CA-C-N 116.038 -0.528 . . . . 72.24 110.688 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.554 HG22 HG22 ' B' ' 37' ' ' VAL . 58.8 p -115.38 131.47 56.92 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.349 -0.842 . . . . 73.31 112.416 -173.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.628 HD12 HD12 ' A' ' 38' ' ' ILE . 54.8 mt -133.6 124.32 47.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.656 0.382 . . . . 71.44 110.199 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -111.19 127.09 55.48 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.87 -0.789 . . . . 74.22 108.87 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.543 ' O ' HD23 ' B' ' 34' ' ' LEU . 12.6 tp10 -130.22 97.89 4.57 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.731 -0.668 . . . . 75.42 109.848 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.68 -87.32 0.35 Allowed Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.436 -0.802 . . . . 64.4 112.021 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' B' ' 52' ' ' GLN . 54.8 m -119.89 -13.18 9.08 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 112.847 0.684 . . . . 73.01 112.847 -177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.543 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -107.85 136.5 47.46 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 117.736 -1.586 . . . . 75.41 112.293 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -102.84 120.09 39.99 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.489 -1.232 . . . . 74.11 108.405 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.32 53.17 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.689 -0.485 . . . . 75.44 109.689 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.554 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -124.64 128.66 73.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.979 -0.378 . . . . 72.54 109.979 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 29' ' ' ILE . 83.8 mt -102.2 124.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 C-N-CA 123.923 0.889 . . . . 73.54 108.696 178.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.21 116.6 32.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.445 -0.946 . . . . 73.41 108.445 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.454 HG23 HD21 ' A' ' 34' ' ' LEU . 48.1 mm -87.82 113.69 25.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.031 -1.84 . . . . 75.04 106.031 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' THR . . . . . 0.402 HG22 HD12 ' B' ' 24' ' ' ILE . 76.0 p -123.4 179.51 4.71 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.745 -0.661 . . . . 61.25 111.338 -171.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' B' ' 42' ' ' LYS . 1.1 ptpt -83.1 -7.41 59.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 72.43 110.276 176.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' B' ' 15' ' ' THR . 98.8 mtt180 -87.04 -16.73 34.76 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.848 -1.538 . . . . 73.44 106.848 170.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.18 -103.28 1.03 Allowed Glycine 0 N--CA 1.423 -2.202 0 CA-C-N 114.507 -1.224 . . . . 63.31 112.039 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 49' ' ' ALA . 3.0 tm? -116.38 122.68 45.56 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.106 0.479 . . . . 53.4 111.856 -174.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.0 143.83 50.18 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.68 -0.691 . . . . 63.25 109.152 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 11.0 p -131.18 140.93 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.307 -0.406 . . . . 64.53 110.085 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 52.9 m -122.42 136.51 54.91 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.336 -0.393 . . . . 72.32 110.689 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . . . -117.89 124.59 48.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.535 -0.757 . . . . 62.12 111.291 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -122.76 95.81 46.05 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.87 -0.789 . . . . 65.04 108.87 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 91.1 Cg_endo -96.39 132.64 0.43 Allowed 'Trans proline' 0 N--CA 1.411 -3.36 0 C-N-CA 120.477 0.785 . . . . 71.34 112.35 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.443 ' HB3' ' HB3' ' B' ' 33' ' ' SER 0.302 6.7 pt20 36.04 -50.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 121.158 3.762 . . . . 74.31 121.158 169.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' B' ' 51' ' ' PRO . . . 78.21 -31.55 0.16 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.194 1.798 . . . . 74.24 111.363 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 56.5 m -152.92 -58.58 0.14 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.924 -1.51 . . . . 71.52 106.924 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -175.4 177.11 1.88 Allowed 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.052 -2.203 . . . . 74.32 105.052 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.427 HG21 ' HA ' ' B' ' 33' ' ' SER . 34.6 m -134.69 179.3 4.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 119.161 0.891 . . . . 72.11 112.788 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -131.56 152.54 50.69 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.544 -2.021 . . . . 72.34 105.544 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -66.94 88.85 0.16 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.372 0.606 . . . . 63.22 111.725 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 83.0 t -138.6 109.24 4.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.699 -1.223 . . . . 71.41 107.699 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.428 -1.529 0 CA-C-O 118.602 -0.713 . . . . 71.42 110.562 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.556 1.199 0 N-CA-C 112.877 0.695 . . . . 74.52 112.877 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.8 -145.39 5.48 Favored Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 119.64 -1.267 . . . . 61.21 112.484 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 m 66.31 100.75 0.04 OUTLIER 'General case' 0 C--O 1.248 0.992 0 C-N-CA 124.225 1.01 . . . . 75.2 113.031 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -78.39 111.61 14.58 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.119 -1.808 . . . . 73.35 106.119 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 8' ' ' LYS . 46.3 t -83.07 -77.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 112.39 0.515 . . . . 53.31 112.39 -172.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.1 m 70.13 134.81 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.866 1.266 . . . . 74.54 111.636 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 72.05 -54.59 0.68 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.488 1.115 . . . . 72.0 112.011 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 86.8 tttt -70.91 111.13 6.07 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 122.165 0.983 . . . . 74.31 110.417 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.49 ' CD ' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -40.42 132.3 2.07 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 112.859 -1.973 . . . . 72.4 112.409 172.532 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.47 127.89 49.32 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.955 -0.566 . . . . 64.31 111.024 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.524 ' CB ' ' HA ' ' A' ' 48' ' ' CYS . 20.0 m -140.55 148.05 40.41 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.772 -1.196 . . . . 41.23 107.772 -174.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.34 145.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.421 0.555 . . . . 71.33 110.753 -175.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 39.9 p -107.56 125.87 51.84 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.201 0.524 . . . . 62.5 110.377 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.07 137.84 45.36 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.819 -0.628 . . . . 65.52 111.442 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -98.51 112.58 24.56 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 115.445 -0.798 . . . . 65.15 109.293 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -142.4 -176.56 4.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.763 -1.199 . . . . 71.4 107.763 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 6.2 tp60 -79.33 105.11 10.41 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.604 0.716 . . . . 72.25 110.436 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.665 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.01 147.46 49.54 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.349 -0.841 . . . . 74.24 109.559 -178.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.5 pt? -74.55 136.07 74.89 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 107.682 -1.229 . . . . 73.24 107.682 174.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.49 133.9 27.21 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 120.825 1.017 . . . . 71.14 110.562 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.513 HG22 ' H ' ' A' ' 23' ' ' ARG . 14.5 p -133.42 137.33 53.28 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.737 -0.665 . . . . 63.45 109.352 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 m -87.86 -19.27 27.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.338 0.59 . . . . 61.14 110.036 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.513 ' H ' HG22 ' A' ' 21' ' ' VAL . 37.6 mmt180 -102.86 133.12 48.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.078 -0.712 . . . . 74.33 109.078 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mm -93.58 115.71 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.873 -0.788 . . . . 75.03 108.873 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -89.78 135.93 33.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 120.384 -0.526 . . . . 75.44 111.196 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 p -114.55 128.24 56.22 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.959 -1.019 . . . . 61.34 109.715 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.513 ' HB3' HD13 ' B' ' 29' ' ' ILE . 68.0 m-85 -126.44 125.67 42.52 Favored 'General case' 0 CA--C 1.462 -2.419 0 N-CA-C 109.401 -0.592 . . . . 73.35 109.401 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 37' ' ' VAL . 63.7 p -116.73 131.72 56.88 Favored 'General case' 0 C--N 1.283 -2.308 0 O-C-N 123.861 0.726 . . . . 74.53 112.344 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.663 HD12 HD12 ' B' ' 38' ' ' ILE . 56.5 mt -127.55 121.17 56.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 120.905 0.383 . . . . 71.23 110.05 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -102.97 123.58 46.86 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.776 -1.194 . . . . 71.52 107.776 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' HD23 ' A' ' 34' ' ' LEU . 10.6 tp10 -142.31 97.11 3.06 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.354 -0.538 . . . . 74.53 111.642 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -72.96 0.38 Allowed Glycine 0 C--N 1.319 -0.378 0 N-CA-C 115.287 0.875 . . . . 64.32 115.287 171.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.1 m -126.94 -1.09 6.58 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 112.719 0.637 . . . . 71.02 112.719 -173.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.588 HD21 HG23 ' B' ' 40' ' ' ILE . 2.0 pt? -146.33 140.46 26.44 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.271 -0.972 . . . . 73.4 112.278 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 121.55 44.99 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.006 -1.452 . . . . 64.25 108.956 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.23 137.2 49.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.805 -0.18 . . . . 60.02 110.531 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 39.2 t -124.31 125.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.215 -0.661 . . . . 72.22 109.215 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.827 HD12 HD12 ' B' ' 29' ' ' ILE . 86.4 mt -102.95 123.49 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 108.654 -0.869 . . . . 75.33 108.654 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 92.9 m-85 -106.79 114.48 28.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.362 -0.977 . . . . 70.15 108.362 177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.478 HG13 ' HG2' ' B' ' 31' ' ' GLU . 49.0 mm -89.42 114.75 27.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.208 -1.404 . . . . 72.31 107.208 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.78 156.87 47.94 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 115.806 -0.633 . . . . 63.14 110.953 -175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -62.59 -14.58 44.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.579 0.752 . . . . 74.45 110.734 176.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -85.35 -18.71 32.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.618 0.723 . . . . 75.42 109.491 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.35 -138.79 9.28 Favored Glycine 0 CA--C 1.48 -2.155 0 C-N-CA 119.909 -1.138 . . . . 72.35 112.176 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 2.7 tm? -113.31 121.32 44.07 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.61 -0.885 . . . . 72.21 108.61 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 23.0 tptm -118.62 121.81 41.06 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.383 -0.969 . . . . 74.05 108.383 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG11 HG11 ' B' ' 47' ' ' VAL . 14.9 p -116.97 140.33 40.06 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 107.765 -1.198 . . . . 72.3 107.765 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.524 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 13.6 t -132.76 136.04 46.1 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 106.716 -1.587 . . . . 72.04 106.716 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' CB ' ' HG ' ' B' ' 45' ' ' LEU . . . -136.18 124.57 23.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 119.328 -0.949 . . . . 72.01 111.312 -177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.63 108.81 62.51 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 114.84 -1.073 . . . . 74.44 109.792 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -89.04 148.13 5.6 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.342 2.028 . . . . 75.11 111.079 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 33' ' ' SER . 9.2 pt20 -62.87 129.77 41.89 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.905 -0.589 . . . . 73.3 109.778 174.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.44 -55.92 2.27 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.306 -0.627 . . . . 72.04 109.306 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.5 p -107.21 -66.3 1.03 Allowed 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.702 -0.681 . . . . 73.24 110.328 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -109.38 166.67 10.7 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.651 -0.5 . . . . 73.03 109.651 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.86 122.56 11.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.476 0.655 . . . . 73.23 111.787 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -98.87 108.38 21.05 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.083 -1.451 . . . . 71.4 107.083 170.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -153.9 142.46 20.79 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.313 -0.403 . . . . 70.25 111.444 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.3 t -109.64 -17.9 7.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.425 -0.807 . . . . 75.43 110.324 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 C--O 1.246 0.918 0 O-C-N 122.103 -0.373 . . . . 74.43 111.416 -176.284 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.238 0.488 0 CA-C-O 121.514 0.673 . . . . 71.2 109.797 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.87 141.92 12.42 Favored Glycine 0 N--CA 1.434 -1.497 0 N-CA-C 109.423 -1.471 . . . . 63.14 109.423 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 46.1 t 71.68 134.04 0.04 OUTLIER 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.706 0.803 . . . . 72.51 110.615 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -76.6 97.84 4.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.052 0.453 . . . . 74.14 110.148 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 56.3 t -90.8 -24.43 5.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.813 -0.63 . . . . 64.24 109.458 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m 67.28 -73.25 0.08 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.51 1.124 . . . . 61.33 110.437 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -87.44 83.86 7.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 122.164 0.983 . . . . 72.05 109.606 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -143.91 128.61 18.22 Favored 'General case' 0 CA--C 1.467 -2.219 0 CA-C-N 114.289 -1.323 . . . . 74.43 108.606 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.671 ' H ' ' HD2' ' B' ' 9' ' ' ARG . 0.0 OUTLIER -80.18 100.27 8.2 Favored 'General case' 0 N--CA 1.391 -3.383 0 CA-C-N 114.63 -1.168 . . . . 75.02 110.053 177.141 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.1 p -87.12 117.79 26.09 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.539 -1.664 . . . . 64.13 110.099 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.482 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 19.4 m -137.28 148.22 46.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.945 -1.131 . . . . 63.51 107.945 -175.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -142.96 146.79 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.833 -0.432 . . . . 75.44 109.833 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' SER . . . . . 0.48 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 23.7 p -106.96 125.56 51.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.17 0.588 . . . . 72.11 110.46 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.34 119.41 39.38 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.236 -1.024 . . . . 73.4 108.236 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -121.59 112.69 18.77 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.267 -1.012 . . . . 70.2 108.267 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -173.29 113.44 0.22 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.348 0.499 . . . . 74.13 112.348 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 59.42 22.47 10.94 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.581 1.152 . . . . 74.21 112.887 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.502 ' HD2' ' HA2' ' B' ' 44' ' ' GLY . 27.3 mtt180 -105.74 121.51 44.17 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.107 -0.996 . . . . 73.21 108.853 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.735 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.6 pt? -74.39 152.28 87.78 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 116.095 -0.502 . . . . 74.44 111.885 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.19 136.65 74.07 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.379 2.719 . . . . 64.23 113.648 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.73 149.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.659 -1.237 . . . . 75.13 107.659 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 -36.42 59.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.022 0.378 . . . . 64.45 112.022 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -124.18 135.89 53.79 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.939 -0.304 . . . . 61.11 110.787 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' B' ' 41' ' ' THR . 49.5 mm -77.57 115.16 19.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.755 -1.202 . . . . 74.21 107.755 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.19 126.47 43.67 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.161 -0.472 . . . . 62.11 110.444 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.435 HG22 ' CD1' ' B' ' 39' ' ' PHE . 41.1 p -106.66 127.36 53.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.436 -0.579 . . . . 72.34 109.436 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 75.3 m-85 -126.57 127.45 45.3 Favored 'General case' 0 CA--C 1.474 -1.956 0 CA-C-N 116.092 -0.504 . . . . 72.35 110.626 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.68 HG22 HG22 ' B' ' 37' ' ' VAL . 43.4 p -114.51 121.3 43.07 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.618 -0.719 . . . . 72.14 112.021 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.827 HD12 HD12 ' A' ' 38' ' ' ILE . 94.5 mt -119.48 121.46 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.785 -0.643 . . . . 71.41 110.864 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -105.71 139.84 39.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.257 -1.016 . . . . 60.34 108.257 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.478 ' HG2' HG13 ' A' ' 40' ' ' ILE . 17.0 tp10 -142.51 97.59 3.14 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.404 0.621 . . . . 72.14 109.566 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.22 2.59 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.218 -0.901 . . . . 71.53 112.834 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.609 ' HA ' HG21 ' B' ' 56' ' ' VAL . 39.8 m -146.12 -25.25 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.279 0.844 . . . . 70.41 113.279 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.512 ' H ' HD23 ' B' ' 34' ' ' LEU . 2.6 pt? -92.89 141.39 28.47 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.037 -0.665 . . . . 64.32 110.534 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.413 ' N ' ' HD3' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -111.51 123.15 49.62 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.049 -0.523 . . . . 73.52 110.006 177.124 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.4 54.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.714 -0.476 . . . . 73.15 109.714 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.68 HG22 HG22 ' B' ' 28' ' ' THR . 39.2 t -119.76 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.273 0.559 . . . . 74.11 110.538 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.663 HD12 HD12 ' A' ' 29' ' ' ILE . 97.0 mt -103.91 116.65 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 107.846 -1.168 . . . . 63.4 107.846 177.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 97.8 m-85 -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.472 -0.936 . . . . 65.13 108.472 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.588 HG23 HD21 ' A' ' 34' ' ' LEU . 41.9 mm -88.5 113.7 25.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 106.501 -1.666 . . . . 73.24 106.501 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' THR . . . . . 0.44 ' HA ' HD12 ' B' ' 24' ' ' ILE . 8.9 t -119.5 166.02 13.64 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 120.356 -0.538 . . . . 72.45 111.479 -174.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.97 -3.76 43.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.426 0.898 . . . . 73.44 113.426 -173.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -116.22 -1.75 12.31 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.195 0.521 . . . . 72.55 110.518 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . 0.502 ' HA2' ' HD2' ' B' ' 18' ' ' ARG . . . 155.52 -140.65 7.47 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.04 -1.553 . . . . 63.45 113.96 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 tm? -122.13 126.58 48.66 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.441 0.696 . . . . 74.41 109.355 -177.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -117.45 121.75 41.88 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.821 -0.807 . . . . 74.51 108.821 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.541 HG11 HG11 ' A' ' 47' ' ' VAL . 9.7 p -108.23 140.39 26.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.621 -0.881 . . . . 61.31 108.621 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.482 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 10.5 t -139.7 136.86 34.66 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 107.752 -1.203 . . . . 44.44 107.752 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . . . -125.55 125.77 43.75 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 110.144 -0.317 . . . . 55.03 110.144 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -115.07 109.69 46.62 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-O 121.278 0.561 . . . . 75.53 109.827 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.87 158.56 49.84 Favored 'Trans proline' 0 N--CA 1.439 -1.713 0 C-N-CA 122.719 2.279 . . . . 70.33 112.939 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.404 ' HB3' ' HB3' ' B' ' 33' ' ' SER . 12.5 pt20 -55.63 99.21 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.539 -1.664 . . . . 70.33 111.036 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.91 -91.53 0.08 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.134 -0.485 . . . . 43.14 112.089 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.7 p -119.22 3.07 11.41 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.05 0.453 . . . . 72.54 110.684 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -161.59 168.21 23.92 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.66 -0.7 . . . . 73.44 109.708 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' B' ' 33' ' ' SER . 5.5 p -151.79 135.77 8.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 123.713 0.805 . . . . 72.42 108.948 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -122.51 83.1 2.06 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.204 -1.036 . . . . 71.4 108.204 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.95 105.41 16.19 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.856 -1.065 . . . . 61.24 108.529 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.34 -36.91 3.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.512 0.93 . . . . 72.22 113.512 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 108.169 -1.049 . . . . 72.34 108.169 178.27 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 C--O 1.236 0.35 0 N-CA-C 110.289 -0.263 . . . . 74.35 110.289 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.06 152.0 19.73 Favored Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 110.847 -0.901 . . . . 65.15 110.847 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 t 64.87 12.62 7.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.259 1.024 . . . . 72.21 111.639 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.15 168.41 24.74 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.653 -0.499 . . . . 60.1 109.653 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -109.06 100.36 10.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.875 0.845 . . . . 70.31 111.07 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 8' ' ' LYS . 24.4 t -160.49 144.63 14.03 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.33 -1.359 . . . . 64.21 107.33 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.676 ' H ' ' HB2' ' B' ' 17' ' ' GLN . 5.0 m-20 71.52 -33.87 0.28 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.079 1.352 . . . . 75.15 112.662 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 6' ' ' SER . 55.8 mtpt -72.92 115.44 12.23 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.372 -1.344 . . . . 63.12 107.372 174.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 14.5 ptt180 -68.85 114.49 7.22 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.529 0.681 . . . . 63.54 111.904 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -88.86 148.07 24.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.198 -0.91 . . . . 74.21 110.98 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 65.9 m -141.71 149.23 40.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.458 -1.312 . . . . 64.14 107.458 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.536 HG11 HG11 ' B' ' 12' ' ' VAL . 57.1 t -139.76 145.15 27.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 110.163 -0.31 . . . . 62.11 110.163 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 m -111.77 124.8 53.12 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.216 -1.031 . . . . 73.11 108.216 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -132.09 141.01 49.03 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 123.749 0.819 . . . . 74.11 108.802 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 t -123.32 141.9 51.51 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.843 -0.743 . . . . 44.35 111.004 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 t -111.56 26.61 10.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.245 -1.02 . . . . 74.03 108.245 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' HB3' ' H ' ' B' ' 7' ' ' ASP . 6.6 tp-100 77.43 117.26 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 112.998 -1.91 . . . . 72.12 108.468 -173.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.576 HH12 HD22 ' B' ' 34' ' ' LEU . 14.9 mmm180 -95.46 148.01 22.93 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 116.561 2.06 . . . . 74.41 116.561 -172.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.9 mt -114.37 153.83 46.49 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 112.922 -1.945 . . . . 60.43 106.358 172.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.45 145.08 16.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.349 3.366 . . . . 74.24 115.286 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.34 137.86 54.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 114.084 -1.417 . . . . 73.44 109.164 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 m -98.11 -45.09 6.36 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.712 0.292 . . . . 73.01 110.848 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -119.3 133.84 55.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 62.34 109.757 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -85.48 135.91 23.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.767 -0.457 . . . . 64.2 109.767 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.03 151.63 33.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.9 0.704 . . . . 73.4 112.9 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 m -133.99 127.22 31.89 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.607 -1.178 . . . . 51.41 108.38 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 74.8 m-85 -127.61 134.7 49.67 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 111.879 0.325 . . . . 74.55 111.879 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.673 HG22 HG22 ' A' ' 37' ' ' VAL . 36.1 p -115.51 139.23 50.25 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.64 -0.709 . . . . 52.32 111.556 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.782 HD12 HD12 ' B' ' 38' ' ' ILE . 82.3 mt -130.72 133.14 63.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.216 -0.902 . . . . 65.31 108.78 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -117.19 123.65 47.2 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 121.631 0.729 . . . . 73.14 109.171 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.8 tp10 -125.16 98.35 5.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.752 0.787 . . . . 65.14 108.965 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.52 -71.9 2.91 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 109.703 -1.359 . . . . 64.31 109.703 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -154.97 -22.7 0.12 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.519 0.933 . . . . 71.14 113.519 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.416 HD11 HD12 ' B' ' 40' ' ' ILE . 2.6 pt? -69.23 141.06 54.54 Favored 'General case' 0 C--N 1.367 1.37 0 CA-C-N 118.934 0.788 . . . . 64.32 110.817 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 31.6 mmt180 -100.58 118.71 37.31 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.884 -0.598 . . . . 60.1 109.745 174.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 123.97 49.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.894 -0.78 . . . . 44.13 108.894 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 28' ' ' THR . 71.5 t -110.89 133.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.3 -0.409 . . . . 75.03 110.142 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.552 HD12 HD12 ' B' ' 29' ' ' ILE . 75.6 mt -115.49 118.29 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 C-N-CA 123.702 0.801 . . . . 63.35 108.997 176.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.52 122.1 43.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.567 -0.901 . . . . 75.23 108.567 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.456 HD12 HD21 ' B' ' 34' ' ' LEU . 47.6 mm -100.63 113.37 36.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.684 -1.228 . . . . 75.03 107.684 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -131.92 177.03 7.85 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.635 -0.876 . . . . 74.13 108.635 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -90.51 -1.74 57.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.487 -0.931 . . . . 73.31 108.487 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -89.63 -30.83 17.85 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.558 -0.904 . . . . 63.43 108.558 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.12 -157.53 29.85 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.702 -1.136 . . . . 74.34 111.737 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -113.63 121.57 44.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.888 -1.523 . . . . 73.45 106.888 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -121.08 140.16 52.33 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 121.202 0.525 . . . . 74.42 111.381 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.602 HG11 HG11 ' B' ' 47' ' ' VAL . 23.2 m -131.45 141.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.035 -0.984 . . . . 74.53 110.866 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 61.6 m -121.35 137.52 54.66 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.936 -0.575 . . . . 73.42 110.623 174.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.75 124.58 47.62 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.294 -0.632 . . . . 64.33 109.294 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 14.2 t70 -115.84 127.13 27.03 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.933 -0.765 . . . . 53.22 108.933 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.8 148.17 22.96 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.915 3.077 . . . . 62.45 113.854 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.62 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 1.2 mp0 -51.93 107.41 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.227 1.011 . . . . 74.11 110.937 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.13 147.75 25.33 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 106.194 -1.78 . . . . 71.43 106.194 173.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.0 m -74.03 83.77 1.77 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.861 0.839 . . . . 73.55 109.501 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -165.06 148.7 8.56 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 105.642 -1.984 . . . . 72.24 105.642 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t 75.05 94.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.027 0.931 . . . . 75.03 110.229 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -80.05 -47.39 14.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.701 -1.222 . . . . 74.5 107.701 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.42 -91.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.159 1.384 . . . . 73.0 112.368 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t 42.58 81.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.118 0 C-N-CA 124.43 1.092 . . . . 73.1 112.81 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.895 -0.593 . . . . 63.41 109.52 -179.2 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.242 0.662 0 N-CA-C 110.222 -0.288 . . . . 65.54 110.222 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.03 151.72 23.84 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 109.731 -1.348 . . . . 73.14 109.731 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 37.7 t 74.42 -45.55 0.59 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.446 1.098 . . . . 72.03 111.357 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -93.81 157.23 16.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.136 -0.483 . . . . 52.21 109.891 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.99 149.4 26.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 120.937 0.398 . . . . 75.01 110.438 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 59.4 m -150.19 122.27 8.28 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.84 -0.538 . . . . 75.5 111.006 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ASP . . . . . 0.401 ' H ' ' HB3' ' A' ' 17' ' ' GLN . 15.5 m-20 63.35 24.22 14.11 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.888 0.875 . . . . 74.13 112.74 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.33 107.24 19.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.606 -0.887 . . . . 71.21 108.606 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.425 ' HB3' ' HD3' ' B' ' 51' ' ' PRO . 22.4 ptt180 -64.88 121.29 14.28 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 115.177 -0.92 . . . . 75.02 113.046 -177.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.1 p -103.21 149.76 24.35 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-N 114.846 -1.07 . . . . 55.32 111.282 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 63.1 m -139.85 148.84 42.68 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.352 -1.722 . . . . 62.41 106.352 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.536 HG11 HG11 ' A' ' 12' ' ' VAL . 60.2 t -141.88 144.0 26.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.592 -0.521 . . . . 44.15 109.592 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -107.98 124.82 50.73 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.091 -1.077 . . . . 75.44 108.091 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.432 HD23 ' N ' ' B' ' 14' ' ' LEU . 0.3 OUTLIER -119.41 122.73 42.43 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.08 -0.711 . . . . 62.13 109.08 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -107.22 130.64 54.71 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.87 0.843 . . . . 54.44 111.01 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -144.78 -162.45 1.49 Allowed 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.001 -1.481 . . . . 62.05 107.001 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLN . . . . . 0.676 ' HB2' ' H ' ' A' ' 7' ' ' ASP . 6.5 tp-100 -71.1 102.73 2.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.701 0.762 . . . . 63.33 109.177 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 mmm-85 -125.0 139.49 53.77 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 114.874 -1.057 . . . . 63.24 109.214 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 46.8 mt -89.02 137.24 29.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 106.649 -1.612 . . . . 61.14 106.649 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.68 135.17 41.6 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.647 2.231 . . . . 63.33 112.695 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.91 135.83 61.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.834 -1.543 . . . . 64.23 106.834 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 26.3 m -89.79 -20.28 23.7 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.32 0.489 . . . . 74.51 112.32 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -112.73 138.63 49.26 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.783 -0.19 . . . . 52.52 110.779 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mm -89.93 118.95 36.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.305 -0.628 . . . . 74.11 109.305 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.07 152.53 18.68 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.312 0.577 . . . . 64.0 112.333 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 73.1 m -131.31 127.91 38.67 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.693 -1.14 . . . . 51.11 108.595 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.438 ' HB3' HD13 ' A' ' 29' ' ' ILE . 67.5 m-85 -129.35 125.58 36.98 Favored 'General case' 0 CA--C 1.452 -2.793 0 N-CA-C 108.94 -0.763 . . . . 62.02 108.94 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.425 HG23 HG22 ' B' ' 37' ' ' VAL . 18.6 m -117.88 122.07 42.37 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 119.686 -0.806 . . . . 63.01 112.544 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.552 HD12 HD12 ' A' ' 38' ' ' ILE . 64.2 mt -116.48 121.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.509 . . . . 74.12 109.9 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -105.02 128.42 53.31 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.225 -1.398 . . . . 72.55 107.225 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.567 ' O ' HD23 ' B' ' 34' ' ' LEU . 14.7 tp10 -139.38 118.49 12.65 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.258 -0.645 . . . . 71.3 109.258 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.73 -78.79 1.16 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.858 -1.163 . . . . 54.43 110.271 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' B' ' 52' ' ' GLN . 49.3 m -155.37 -14.58 0.11 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 112.924 0.712 . . . . 70.52 112.924 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.576 HD22 HH12 ' A' ' 18' ' ' ARG . 2.4 pt? -84.2 142.07 30.57 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.329 0.513 . . . . 73.32 110.818 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.452 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 32.3 mmt180 -100.66 118.08 36.08 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.324 -1.361 . . . . 72.11 107.324 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.98 29.53 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.43 -0.581 . . . . 72.12 109.43 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.425 HG22 HG23 ' B' ' 28' ' ' THR . 86.2 t -108.37 124.02 64.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.211 -0.449 . . . . 50.13 110.626 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.782 HD12 HD12 ' A' ' 29' ' ' ILE . 63.2 mt -102.97 123.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 C-N-CA 123.429 0.691 . . . . 62.2 109.205 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -104.85 114.88 29.36 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.219 -1.03 . . . . 72.32 108.219 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.423 HG13 ' HG2' ' A' ' 31' ' ' GLU . 47.5 mm -90.18 112.57 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 106.869 -1.53 . . . . 75.42 106.869 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -110.61 -176.58 3.01 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.922 -0.77 . . . . 64.11 108.922 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.593 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -92.11 -17.98 24.19 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 120.968 0.413 . . . . 74.05 110.219 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -100.58 -16.94 17.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.127 -0.488 . . . . 63.41 111.01 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.34 -145.59 7.28 Favored Glycine 0 C--N 1.295 -1.711 0 C-N-CA 118.7 -1.714 . . . . 50.13 113.199 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.2 122.82 23.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.574 -1.269 . . . . 74.34 107.574 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -125.04 141.57 52.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.215 0.531 . . . . 73.23 110.383 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 47' ' ' VAL . 30.8 m -131.9 141.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.298 -0.865 . . . . 75.25 111.03 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -120.03 136.98 54.36 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 115.929 -0.578 . . . . 72.11 110.11 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.69 123.91 47.24 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.186 -0.672 . . . . 75.35 109.186 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 17.1 t70 -102.04 135.73 19.61 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 107.655 -1.239 . . . . 71.15 107.655 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' B' ' 9' ' ' ARG . 17.9 Cg_endo -55.92 143.28 82.73 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 123.49 2.793 . . . . 73.44 114.34 -174.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' GLN . . . . . 0.527 ' CD ' ' H ' ' B' ' 52' ' ' GLN . 1.1 mp0 -50.56 110.72 0.44 Allowed 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.588 -1.187 . . . . 73.15 108.891 174.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.97 175.56 8.99 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.965 -0.561 . . . . 61.41 110.717 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.2 m -86.01 12.17 10.04 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 122.236 1.017 . . . . 74.42 109.206 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -121.54 -174.81 2.94 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.182 -1.414 . . . . 72.24 107.182 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 41.1 t 76.24 107.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.688 1.195 . . . . 72.41 110.626 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -134.68 -75.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.54 -0.755 . . . . 62.22 109.64 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 65.71 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.832 0.853 . . . . 71.3 111.782 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t 37.24 80.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.042 1.737 . . . . 73.54 114.698 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 52.4 t . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 107.741 -1.207 . . . . 71.32 107.741 177.651 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.241 0.63 0 N-CA-C 110.135 -0.32 . . . . 75.23 110.135 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.45 74.93 1.29 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.638 -0.791 . . . . 31.32 111.92 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.6 m -102.96 -12.68 17.31 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 110.037 -0.357 . . . . 73.23 110.037 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 59.55 88.32 0.07 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.721 1.208 . . . . 73.13 112.196 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.0 p -130.16 100.11 4.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.98 0.895 . . . . 73.41 110.941 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.7 p -106.45 120.25 41.42 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.22 -0.9 . . . . 63.23 109.637 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.71 99.82 0.49 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.481 0.657 . . . . 71.02 110.432 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 173.88 -68.22 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.223 -2.14 . . . . 74.34 105.223 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -152.27 115.57 4.72 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.06 -1.459 . . . . 74.13 107.06 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 120.241 -0.584 . . . . 70.42 110.859 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.7 m -129.85 148.94 51.77 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.089 -1.078 . . . . 65.32 108.089 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.3 147.01 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 120.84 -0.344 . . . . 63.14 110.883 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.3 p -112.21 126.94 55.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.903 0.382 . . . . 64.21 110.003 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.08 141.95 47.3 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.771 -0.825 . . . . 62.53 108.771 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -127.9 112.98 15.3 Favored 'General case' 0 N--CA 1.405 -2.693 0 C-N-CA 119.534 -0.866 . . . . 71.32 111.04 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.415 ' HB ' ' OG1' ' B' ' 10' ' ' THR . 9.0 t -121.71 -170.09 1.98 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.3 -1.0 . . . . 64.1 108.3 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 5.9 tp60 -72.38 93.36 1.51 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.712 0.768 . . . . 51.42 110.822 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.405 HH22 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -126.5 148.17 49.73 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.95 -1.023 . . . . 74.1 108.838 -178.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.07 141.42 46.86 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.347 -0.983 . . . . 63.42 108.347 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 39.9 Cg_endo -65.91 143.83 74.49 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.541 2.161 . . . . 63.11 112.715 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 21.4 t -122.4 148.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.404 -1.332 . . . . 73.42 107.404 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -92.38 -39.84 11.23 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 120.305 -0.558 . . . . 71.2 110.843 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -89.61 133.15 34.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.31 -0.405 . . . . 65.13 111.246 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.73 124.11 42.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.761 -0.829 . . . . 72.33 108.761 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 35.1 mmtp -104.53 146.57 28.7 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.009 -0.676 . . . . 60.5 111.292 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 m -127.29 127.79 44.91 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.436 -0.949 . . . . 54.51 108.436 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 88.2 m-85 -128.13 134.73 49.15 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-N 116.352 -0.385 . . . . 72.33 111.8 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 37' ' ' VAL . 17.7 p -114.64 120.08 38.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.295 -0.866 . . . . 74.51 111.711 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.698 HD12 HD12 ' B' ' 38' ' ' ILE . 93.9 mt -114.94 125.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.569 -0.741 . . . . 65.13 109.589 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 58' ' ' ASP . 9.0 t -106.91 128.87 54.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.277 0.56 . . . . 75.04 109.794 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.594 ' O ' HD23 ' A' ' 34' ' ' LEU . 17.1 tp10 -142.99 119.18 10.78 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.715 -0.675 . . . . 73.55 109.59 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.59 -87.37 0.12 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 111.6 -0.6 . . . . 50.14 111.6 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.489 ' HB3' HD21 ' B' ' 19' ' ' LEU . 26.8 t -151.14 13.88 0.69 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.406 -0.59 . . . . 71.22 109.406 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -110.49 140.51 44.69 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.7 -0.8 . . . . 72.52 108.891 174.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -116.3 134.03 55.35 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.58 -0.736 . . . . 73.15 110.192 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.97 131.46 55.38 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.383 -0.599 . . . . 52.0 109.383 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 28' ' ' THR . 87.5 t -113.11 120.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.014 -0.539 . . . . 74.55 110.139 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.64 HD12 HD12 ' B' ' 29' ' ' ILE . 96.2 mt -101.33 117.39 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 N-CA-C 109.003 -0.739 . . . . 74.23 109.003 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.2 m-85 -102.96 114.82 29.43 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.554 -0.906 . . . . 74.0 108.554 177.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.481 HD12 HD21 ' B' ' 34' ' ' LEU . 47.7 mm -90.75 112.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 106.57 -1.641 . . . . 74.54 106.57 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -116.62 173.28 6.71 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.525 0.516 . . . . 52.34 110.248 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.91 -33.01 71.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 116.482 2.03 . . . . 75.31 116.482 -171.145 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.577 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 1.5 tmt_? -117.21 3.76 12.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 119.694 -0.803 . . . . 70.25 109.472 -176.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.5 -158.73 12.03 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 118.353 -1.88 . . . . 44.24 115.058 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.29 123.1 24.87 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 125.636 1.575 . . . . 61.15 108.457 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -121.45 143.4 49.26 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.745 0.307 . . . . 74.44 110.721 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.92 140.2 48.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 115.948 -0.569 . . . . 51.13 110.126 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 26.7 m -118.9 145.05 46.04 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.5 -0.773 . . . . 74.3 110.232 172.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.76 125.75 53.16 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.252 -1.018 . . . . 61.53 108.252 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.93 78.43 31.81 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.218 -1.401 . . . . 72.4 107.218 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 27.8 Cg_endo -99.53 134.13 0.23 Allowed 'Trans proline' 0 N--CA 1.413 -3.229 0 C-N-CA 122.303 2.002 . . . . 74.45 113.858 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 50.74 68.76 0.72 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.052 -1.431 . . . . 63.05 113.229 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.83 -53.38 4.94 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.152 -0.619 . . . . 63.04 111.279 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 m -153.45 29.86 0.48 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 107.33 -1.359 . . . . 72.51 107.33 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.1 m95 73.33 130.32 0.04 OUTLIER 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.566 -1.197 . . . . 64.04 110.666 -173.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.96 118.14 57.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.795 -0.639 . . . . 62.21 112.382 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -126.24 105.67 8.99 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.834 -1.913 . . . . 71.53 105.834 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.497 ' OD1' HG12 ' A' ' 60' ' ' VAL . 12.5 t70 -111.04 161.99 15.33 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.226 -1.027 . . . . 74.32 108.226 -176.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.16 -25.72 23.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 111.802 0.297 . . . . 70.43 111.802 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.497 HG12 ' OD1' ' A' ' 58' ' ' ASP . 14.4 p . . . . . 0 C--O 1.25 1.081 0 C-N-CA 120.336 -0.546 . . . . 75.32 110.649 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 109.609 -0.515 . . . . 70.02 109.609 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.33 5.24 28.45 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.29 -0.957 . . . . 75.23 112.601 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -75.02 -33.72 61.83 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.554 -0.535 . . . . 61.14 109.554 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 58.47 90.92 0.04 OUTLIER 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.451 1.101 . . . . 73.22 113.376 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.502 ' HA ' HG23 ' B' ' 10' ' ' THR . 6.8 p -159.54 84.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 114.472 -1.24 . . . . 74.45 110.189 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.4 p -85.21 138.63 32.23 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.491 -1.231 . . . . 72.42 112.084 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.87 90.15 2.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.576 -0.738 . . . . 73.24 110.813 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt 163.54 -73.09 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.655 0 C-N-CA 127.424 2.29 . . . . 75.23 105.336 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' B' ' 50' ' ' ASP . 94.7 mtt180 -126.24 129.42 48.9 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 108.173 -1.047 . . . . 54.33 108.173 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.502 HG23 ' HA ' ' B' ' 5' ' ' VAL . 49.5 m -108.88 116.66 32.42 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.334 -1.358 . . . . 73.13 107.334 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -135.61 146.76 48.24 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.115 -1.068 . . . . 61.43 108.115 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 12.4 p -147.12 156.06 10.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 117.486 0.13 . . . . 60.02 110.788 -176.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -117.16 126.69 53.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.345 0.258 . . . . 71.2 110.618 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.41 HD22 ' N ' ' B' ' 14' ' ' LEU . 1.7 mm? -112.11 121.12 44.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.98 -1.119 . . . . 73.24 107.98 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -93.05 111.81 23.56 Favored 'General case' 0 C--N 1.284 -2.246 0 C-N-CA 118.271 -1.372 . . . . 71.44 109.147 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.6 t -153.58 107.81 3.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.181 -0.918 . . . . 64.0 112.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 51' ' ' PRO . 6.1 tp60 43.1 85.66 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.708 1.603 . . . . 51.43 113.259 174.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.412 ' N ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -125.57 148.47 48.92 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.173 -1.011 . . . . 72.01 110.275 -173.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' A' ' 33' ' ' SER . 2.8 mp -84.21 159.46 59.36 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.676 -1.231 . . . . 72.14 107.676 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.88 133.85 28.3 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 N-CA-C 108.54 -1.369 . . . . 61.22 108.54 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.626 ' H ' ' HB3' ' B' ' 42' ' ' LYS . 32.5 t -132.15 136.64 56.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.098 -1.075 . . . . 72.24 108.098 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -85.89 -30.31 22.98 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.057 0.456 . . . . 74.22 111.767 -175.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -114.63 166.74 11.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.745 0.307 . . . . 71.15 111.689 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.04 115.12 40.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 106.799 -1.556 . . . . 64.32 106.799 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 35.4 mmtp -90.62 147.18 23.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.733 -0.787 . . . . 65.04 110.482 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 90.4 m -133.13 127.88 34.88 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.648 -0.871 . . . . 55.13 108.648 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.44 ' HB3' HD13 ' A' ' 29' ' ' ILE . 70.9 m-85 -128.51 125.78 39.09 Favored 'General case' 0 CA--C 1.446 -3.021 0 N-CA-C 109.474 -0.565 . . . . 75.33 109.474 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.8 m -117.61 130.93 56.69 Favored 'General case' 0 C--N 1.266 -3.048 0 O-C-N 123.996 0.81 . . . . 71.22 112.022 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.64 HD12 HD12 ' A' ' 38' ' ' ILE . 49.7 mt -125.01 129.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.866 -0.606 . . . . 75.45 109.988 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.433 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 9.7 t -106.82 122.27 46.06 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.461 -0.94 . . . . 72.54 108.461 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.444 ' O ' HD23 ' B' ' 34' ' ' LEU . 19.8 tp10 -142.69 97.82 3.18 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.359 -0.536 . . . . 75.44 111.69 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.81 -69.97 1.48 Allowed Glycine 0 C--N 1.313 -0.741 0 N-CA-C 115.324 0.89 . . . . 75.11 115.324 172.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -137.13 0.38 2.34 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.56 0.578 . . . . 55.54 112.56 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 40' ' ' ILE . 2.2 pt? -141.16 141.52 34.12 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.062 -1.055 . . . . 64.1 112.667 -175.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.433 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 19.2 mmm180 -98.31 113.72 25.77 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.382 -1.71 . . . . 75.13 106.382 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.77 120.0 40.07 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.743 -0.465 . . . . 73.23 109.743 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 27' ' ' TYR . 90.1 t -113.65 129.31 69.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.755 -0.657 . . . . 62.23 110.325 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.698 HD12 HD12 ' A' ' 29' ' ' ILE . 67.3 mt -113.25 131.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 123.387 0.675 . . . . 75.23 109.807 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 96.3 m-85 -112.44 118.29 34.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.958 -0.756 . . . . 75.12 108.958 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' B' ' 25' ' ' LYS . 47.2 mm -96.92 118.99 44.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.518 -0.919 . . . . 75.41 108.518 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.34 157.99 45.49 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 109.43 -0.581 . . . . 41.51 109.43 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.626 ' HB3' ' H ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -67.2 -17.87 65.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.812 -0.631 . . . . 74.44 111.666 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.669 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.6 tmt_? -90.91 -17.31 26.65 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.309 -0.626 . . . . 73.11 109.309 -176.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -172.28 43.32 Favored Glycine 0 C--O 1.223 -0.567 0 C-N-CA 118.942 -1.599 . . . . 74.32 114.611 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -112.85 121.4 44.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.977 -1.49 . . . . 73.54 106.977 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 12' ' ' VAL . 86.8 tttt -119.66 142.01 48.84 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.484 0.659 . . . . 72.11 111.231 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.13 140.68 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 107.607 -1.257 . . . . 70.54 107.607 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 34.1 t -138.54 136.56 36.18 Favored 'General case' 0 C--N 1.268 -2.948 0 N-CA-C 108.107 -1.072 . . . . 72.2 108.107 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.28 123.74 44.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.027 -0.669 . . . . 62.34 110.485 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' B' ' 9' ' ' ARG . 25.8 t70 -113.87 122.43 34.85 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.753 -1.203 . . . . 74.33 107.753 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.54 134.43 13.81 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.862 1.708 . . . . 72.24 112.944 -173.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 55.29 -167.1 0.1 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.662 -1.154 . . . . 74.32 112.841 174.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -169.9 -163.38 0.36 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 104.197 -2.519 . . . . 62.04 104.197 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 35.6 m -76.98 83.93 3.51 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.338 -0.945 . . . . 73.23 109.36 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 82.2 m95 59.74 84.34 0.12 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.917 1.287 . . . . 71.23 113.007 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -74.61 99.73 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 116.008 -0.542 . . . . 74.45 110.125 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -125.55 101.78 7.07 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.671 -0.695 . . . . 75.23 109.196 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -89.07 97.51 11.24 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.496 -0.775 . . . . 54.12 110.056 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 30.1 m -90.6 -15.24 8.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.824 0.821 . . . . 60.2 109.112 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.416 -2.159 0 CA-C-N 114.434 -1.257 . . . . 70.32 108.348 177.984 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.247 0.925 0 N-CA-C 110.233 -0.284 . . . . 74.01 110.233 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.38 143.72 16.76 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.441 -0.409 . . . . 72.44 112.134 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -88.67 -17.65 29.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.756 0.312 . . . . 72.21 111.795 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -70.48 -27.37 64.15 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.089 0.403 . . . . 72.41 112.089 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.8 7.8 9.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 112.146 0.424 . . . . 71.01 112.146 -176.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' B' ' 16' ' ' THR . 49.8 m -72.6 120.56 18.39 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.016 0.436 . . . . 73.32 110.493 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -92.45 155.5 17.81 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.624 -0.716 . . . . 72.51 112.231 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 mttp 59.5 -101.45 0.12 Allowed 'General case' 0 C--O 1.242 0.663 0 C-N-CA 126.193 1.797 . . . . 50.11 115.784 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 121.05 0.96 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.22 -1.4 . . . . 72.04 107.22 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 p -91.1 144.0 26.1 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.028 -0.533 . . . . 74.11 112.378 -172.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -138.4 149.89 45.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.132 -0.692 . . . . 74.02 109.132 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD21 ' B' ' 14' ' ' LEU . 60.5 t -143.3 139.79 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 110.232 -0.285 . . . . 75.23 110.232 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 p -112.45 124.93 53.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.719 -0.475 . . . . 65.34 109.719 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.12 120.35 39.47 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.122 -0.49 . . . . 70.43 109.899 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' B' ' 3' ' ' SER . 11.9 p -105.54 118.07 35.62 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.045 -0.525 . . . . 64.05 109.686 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -161.12 116.15 2.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.367 -0.379 . . . . 73.52 111.743 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 43.45 78.06 0.06 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 125.22 1.408 . . . . 55.3 113.029 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.511 HH22 ' HB1' ' B' ' 49' ' ' ALA . 34.7 mmt-85 -125.91 149.61 48.58 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.503 0.668 . . . . 73.23 111.878 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -99.67 159.16 30.69 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 106.036 -1.839 . . . . 75.33 106.036 172.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.65 135.98 67.78 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.766 1.644 . . . . 62.24 111.133 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.58 149.18 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 74.4 108.19 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -85.54 -35.63 20.99 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.404 0.52 . . . . 71.1 112.404 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -131.11 147.73 52.65 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.217 -0.302 . . . . 61.43 110.665 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -86.63 124.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.678 -0.86 . . . . 73.25 108.678 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.25 150.44 25.13 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.361 0.601 . . . . 72.25 112.506 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 m -133.43 126.94 32.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.244 -1.391 . . . . 73.31 107.244 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -128.36 134.91 48.95 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-N 116.419 -0.355 . . . . 71.23 110.672 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.617 HG22 HG22 ' A' ' 37' ' ' VAL . 31.7 p -113.56 117.49 31.78 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.462 -0.79 . . . . 71.45 110.864 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.657 HD12 HD12 ' B' ' 38' ' ' ILE . 64.3 mt -110.49 123.02 66.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.295 -0.631 . . . . 64.31 109.295 177.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -116.3 115.89 26.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.135 -0.939 . . . . 73.13 109.127 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -129.55 107.01 9.13 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.186 -0.916 . . . . 55.51 109.748 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.68 -72.74 1.73 Allowed Glycine 0 C--N 1.303 -1.274 0 C-N-CA 121.121 -0.561 . . . . 51.01 111.95 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -154.91 4.63 0.22 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.172 0.804 . . . . 74.42 113.172 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.599 HD21 HD12 ' B' ' 40' ' ' ILE . 2.0 pt? -107.25 136.45 47.04 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 117.205 -1.798 . . . . 61.35 111.379 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -93.84 113.41 25.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.274 -0.875 . . . . 64.1 109.268 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.29 119.23 38.89 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.918 -0.771 . . . . 74.43 108.918 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 28' ' ' THR . 66.5 t -108.39 123.09 63.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 116.519 -0.309 . . . . 74.52 111.224 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.528 HD12 HD12 ' B' ' 29' ' ' ILE . 84.5 mt -102.06 116.2 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.511 -0.768 . . . . 70.54 109.163 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -102.6 116.94 33.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.817 -1.179 . . . . 71.3 107.817 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.596 HG23 HD21 ' B' ' 34' ' ' LEU . 40.6 mm -93.54 114.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 108.109 -1.071 . . . . 73.55 108.109 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -124.23 178.54 5.29 Favored 'General case' 0 N--CA 1.406 -2.649 0 C-N-CA 120.476 -0.489 . . . . 75.32 110.209 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 42' ' ' LYS . 58.7 pttt -74.83 -41.58 59.63 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 113.968 1.099 . . . . 73.3 113.968 -171.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -98.97 -10.73 22.32 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.765 -0.774 . . . . 72.54 110.045 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.22 -145.89 4.9 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 117.484 -2.293 . . . . 75.11 116.61 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 47.1 tp -130.36 141.45 50.57 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 125.26 1.424 . . . . 74.04 108.166 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.44 139.98 47.03 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.975 -0.69 . . . . 64.55 109.579 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.492 HG11 HG11 ' B' ' 47' ' ' VAL . 11.4 p -131.57 141.04 46.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 115.913 -0.585 . . . . 54.01 110.213 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.3 m -122.17 139.38 53.83 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.187 -0.461 . . . . 63.42 111.023 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.62 124.45 49.82 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 72.55 108.566 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -138.5 91.27 12.46 Favored Pre-proline 0 C--N 1.281 -2.402 0 CA-C-N 115.452 -0.794 . . . . 64.24 108.947 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.2 Cg_exo -80.83 141.45 13.45 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 122.829 2.353 . . . . 75.22 113.149 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 65.32 34.12 8.54 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 114.749 -1.114 . . . . 74.04 110.84 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.43 -171.35 0.77 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.604 -1.18 . . . . 63.24 112.152 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 p -69.3 106.36 2.87 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.887 -0.597 . . . . 75.12 112.356 -177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.455 ' CH2' ' HD3' ' A' ' 57' ' ' ARG . 46.3 t90 67.06 103.84 0.05 OUTLIER 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.756 1.223 . . . . 71.41 112.574 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.68 143.63 21.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.556 -0.747 . . . . 71.44 110.916 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' HD3' ' CH2' ' A' ' 55' ' ' TRP . 37.8 ptt180 -134.21 152.55 51.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.802 -1.185 . . . . 75.34 107.802 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -106.58 -13.76 15.22 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.695 -0.802 . . . . 72.31 112.044 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.02 104.15 7.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 120.38 -0.528 . . . . 71.12 109.958 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 115.611 -0.722 . . . . 73.21 109.936 -179.748 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.908 -0.404 . . . . 74.24 109.908 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.44 51.13 0.73 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 110.927 -0.869 . . . . 62.31 110.927 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 15' ' ' THR . 46.1 m -89.72 3.1 53.8 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.571 0.952 . . . . 63.13 113.571 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.63 -19.94 58.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.785 0.802 . . . . 74.21 109.96 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.12 4.52 10.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.191 -0.913 . . . . 54.33 110.272 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 36.8 m -92.58 104.29 16.6 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.307 0.575 . . . . 55.2 109.931 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.62 161.37 13.92 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.28 -0.873 . . . . 55.1 109.508 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.492 ' NZ ' ' HB2' ' B' ' 8' ' ' LYS . 8.7 mtmp? 78.77 158.16 0.17 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.057 1.132 . . . . 55.43 114.057 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 2.8 ptm180 -55.83 131.98 48.28 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.593 -1.64 . . . . 74.23 115.267 -176.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 28.5 p -109.08 145.94 34.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.089 -1.078 . . . . 71.41 108.089 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 77.8 m -144.47 151.16 38.78 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.045 -0.724 . . . . 74.45 109.045 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 91.4 t -144.41 141.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 73.41 109.284 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -107.38 130.69 54.77 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.211 0.529 . . . . 74.22 109.8 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.538 HD21 ' CG2' ' A' ' 12' ' ' VAL . 95.3 mt -102.23 121.36 42.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.781 -0.645 . . . . 55.1 110.694 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -85.25 113.93 21.96 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.616 -1.253 . . . . 74.44 107.616 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 14.9 t -153.76 170.05 21.88 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.22 -0.592 . . . . 71.2 109.878 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -72.2 93.52 1.46 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.295 0.569 . . . . 73.34 110.826 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ARG . . . . . 0.544 ' HE ' HD22 ' A' ' 34' ' ' LEU . 1.5 tmt_? -126.08 132.31 51.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.181 -1.785 . . . . 73.44 106.181 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.04 155.67 90.16 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 112.653 0.612 . . . . 71.22 112.653 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.97 140.39 23.99 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.937 3.091 . . . . 53.3 114.648 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' NH1' ' B' ' 18' ' ' ARG . 12.4 p -131.81 149.14 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.303 -1.369 . . . . 74.51 107.303 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -89.37 -45.57 9.38 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.754 0.312 . . . . 54.32 111.776 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -117.81 141.68 48.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.319 -0.4 . . . . 75.5 110.844 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.047 -0.723 . . . . 63.5 109.047 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.525 0.678 . . . . 73.01 112.03 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 77.1 m -130.64 128.51 41.12 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.751 -1.203 . . . . 75.11 107.751 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.36 125.03 37.86 Favored 'General case' 0 CA--C 1.446 -3.039 0 N-CA-C 108.617 -0.882 . . . . 75.14 108.617 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.441 HG23 HG22 ' B' ' 37' ' ' VAL . 19.7 m -117.61 119.51 35.22 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 115.202 -0.908 . . . . 71.43 111.317 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 38' ' ' ILE . 52.4 mt -111.97 121.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 109.654 -0.499 . . . . 51.21 109.654 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -101.74 118.88 37.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.992 -1.484 . . . . 73.32 106.992 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.514 ' O ' HD23 ' B' ' 34' ' ' LEU . 14.1 tp10 -132.87 122.37 24.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.481 -0.781 . . . . 73.52 109.397 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.23 -96.13 0.16 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 111.096 -0.802 . . . . 53.13 111.096 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' SER . . . . . 0.435 ' HB2' HD21 ' A' ' 19' ' ' LEU . 18.0 m -138.12 10.93 2.82 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.906 0.384 . . . . 53.2 110.364 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.596 HD21 HG23 ' A' ' 40' ' ' ILE . 2.1 pt? -118.3 141.38 48.58 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 120.57 -0.452 . . . . 75.31 109.827 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -112.48 134.31 54.08 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 115.894 -0.594 . . . . 74.11 112.216 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.97 53.14 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.088 -0.96 . . . . 51.43 109.272 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' B' ' 48' ' ' CYS . 76.1 t -114.17 127.12 71.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.019 -0.537 . . . . 74.3 110.151 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.657 HD12 HD12 ' A' ' 29' ' ' ILE . 62.9 mt -110.62 129.52 65.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 115.826 -0.625 . . . . 74.32 110.599 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.455 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.4 m-85 -109.48 116.92 32.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.824 -0.806 . . . . 72.11 108.824 176.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ILE . . . . . 0.599 HD12 HD21 ' A' ' 34' ' ' LEU . 49.1 mm -91.39 116.43 32.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.745 -0.662 . . . . 73.43 109.547 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.2 t -133.15 167.87 19.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.029 -0.73 . . . . 74.1 109.029 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.579 ' HE3' ' C ' ' B' ' 42' ' ' LYS 0.349 0.0 OUTLIER -86.37 2.42 47.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.639 0.978 . . . . 63.21 113.639 179.425 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -90.14 -13.26 36.05 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.036 -1.098 . . . . 74.55 108.036 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.07 -134.34 6.11 Favored Glycine 0 N--CA 1.424 -2.153 0 CA-C-N 115.245 -0.889 . . . . 73.1 112.059 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.47 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 60.1 tp -113.51 144.32 43.05 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 122.873 0.469 . . . . 74.25 109.833 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 83.3 tttt -129.37 136.12 49.59 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.618 -0.512 . . . . 54.42 109.618 168.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.492 HG11 HG11 ' A' ' 47' ' ' VAL . 14.8 p -120.42 140.69 43.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.094 -0.957 . . . . 63.0 110.512 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' CYS . . . . . 0.486 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 36.4 m -129.39 137.3 50.85 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.666 -0.697 . . . . 61.03 110.654 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ALA . . . . . 0.511 ' HB1' HH22 ' A' ' 18' ' ' ARG . . . -117.8 124.02 47.39 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 107.803 -1.184 . . . . 71.42 107.803 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -121.82 110.88 33.04 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.946 -1.131 . . . . 64.32 107.946 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.16 132.62 11.62 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.408 1.405 . . . . 74.1 112.712 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 39.24 73.53 0.11 Allowed 'General case' 0 C--O 1.242 0.66 0 O-C-N 125.021 1.45 . . . . 72.5 113.582 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.46 -154.11 0.09 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.188 -0.914 . . . . 52.21 110.626 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.9 p -65.73 -161.6 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.746 0.819 . . . . 52.32 111.04 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 70.6 t90 -52.6 106.0 0.14 Allowed 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.36 0.6 . . . . 74.14 112.427 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 34.4 m -90.03 160.83 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 108.651 -0.87 . . . . 71.52 108.651 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' B' ' 60' ' ' VAL . 12.4 ptt180 -140.18 154.12 46.83 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.326 -0.549 . . . . 73.31 109.798 -175.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -83.29 -27.5 29.77 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.03 0.443 . . . . 72.3 110.695 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.73 98.62 7.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.769 -0.826 . . . . 51.51 108.769 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.517 ' HA ' ' HE ' ' B' ' 57' ' ' ARG . 3.8 p . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 115.888 -0.596 . . . . 72.04 112.394 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 108.446 -0.946 . . . . 74.24 108.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.4 ' HB ' HD13 ' B' ' 14' ' ' LEU . 24.4 m -109.59 144.04 38.45 Favored 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 119.531 -0.868 . . . . 71.15 109.494 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.69 149.32 43.4 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.43 -1.322 . . . . 74.51 107.43 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 12' ' ' VAL . 58.6 t -140.54 139.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 121.157 -0.217 . . . . 72.04 110.929 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -110.98 131.0 55.41 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 122.998 0.519 . . . . 73.03 109.64 172.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 14' ' ' LEU . 4.2 pp -119.88 136.27 54.56 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.261 -1.015 . . . . 60.54 108.261 174.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 m -107.57 120.78 43.15 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.069 -0.715 . . . . 75.44 109.069 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -131.71 -169.24 2.16 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.392 -0.367 . . . . 54.43 110.957 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -69.93 104.13 2.43 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.547 1.165 . . . . 73.51 108.043 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 18' ' ' ARG . 1.6 mmp_? -125.53 149.51 48.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 114.871 1.434 . . . . 61.14 114.871 -170.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.4 pp -101.84 148.26 35.05 Favored Pre-proline 0 N--CA 1.417 -2.093 0 CA-C-N 113.512 -1.677 . . . . 75.33 107.668 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.25 143.89 32.43 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.051 1.834 . . . . 75.31 112.496 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -131.36 140.0 49.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.984 -1.117 . . . . 74.12 107.984 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 p -58.66 -59.81 4.81 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.673 0.62 . . . . 64.11 112.673 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -115.98 166.92 11.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 112.148 0.425 . . . . 73.24 112.148 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mm -89.46 125.26 42.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.853 -0.612 . . . . 71.32 109.445 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 33.7 mmtm -89.57 145.46 25.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.88 -0.728 . . . . 71.1 109.68 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.6 m -120.86 126.96 51.39 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.101 -1.074 . . . . 61.5 108.101 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.429 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 67.8 m-85 -124.92 129.41 50.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.921 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 37' ' ' VAL . 66.3 p -114.14 130.57 56.59 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.659 -0.7 . . . . 63.52 111.929 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.717 HD12 HD12 ' B' ' 38' ' ' ILE . 76.1 mt -126.35 126.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.637 -0.711 . . . . 75.13 109.735 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -102.42 133.8 46.77 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.915 -0.772 . . . . 61.15 108.915 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HG2' HG13 ' B' ' 40' ' ' ILE . 11.9 tp10 -141.56 97.65 3.2 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.232 -0.44 . . . . 74.21 109.954 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.5 -85.33 0.26 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.501 -0.772 . . . . 75.32 111.769 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.3 p -137.54 14.83 2.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.867 0.841 . . . . 74.25 110.024 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' CD2' HD12 ' B' ' 40' ' ' ILE . 24.9 tp -106.67 132.49 52.6 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 115.387 -0.824 . . . . 62.45 110.844 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -108.84 115.88 30.92 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.36 -0.837 . . . . 61.42 110.339 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.06 120.08 40.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.631 -0.877 . . . . 64.51 108.631 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 28' ' ' THR . 87.5 t -114.79 126.04 72.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.286 0.565 . . . . 55.4 111.145 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.579 HD11 HD11 ' B' ' 38' ' ' ILE . 77.9 mt -106.16 122.91 60.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 124.259 1.024 . . . . 63.21 110.009 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 97.8 m-85 -107.8 118.11 35.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.254 -1.017 . . . . 74.21 108.254 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.546 HG13 ' HG2' ' B' ' 31' ' ' GLU . 45.2 mm -88.58 118.93 35.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.036 -0.727 . . . . 70.24 109.036 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.2 p -119.7 165.81 14.03 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.0 -0.546 . . . . 71.31 109.642 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.08 -17.91 63.25 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 122.859 0.463 . . . . 75.33 111.211 178.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -94.99 -23.79 17.22 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.123 0.487 . . . . 54.02 110.401 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.541 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 160.8 -139.8 6.29 Favored Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 118.497 -1.811 . . . . 74.21 114.988 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.1 tp -113.07 122.45 47.61 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.474 -0.863 . . . . 72.4 109.148 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 1.8 tmtm? -116.83 122.12 43.49 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.279 -2.119 . . . . 71.44 105.279 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.54 140.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 C-N-CA 120.745 -0.382 . . . . 65.02 110.661 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.461 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 59.3 m -122.94 141.43 51.93 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.259 -0.428 . . . . 62.24 110.983 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.42 124.85 51.04 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.825 -0.625 . . . . 65.51 110.421 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -123.31 91.98 49.33 Favored Pre-proline 0 C--N 1.298 -1.668 0 C-N-CA 124.264 1.026 . . . . 65.21 108.52 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -98.61 133.12 0.26 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.297 1.998 . . . . 72.25 114.15 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.475 ' NE2' ' HG ' ' B' ' 19' ' ' LEU . 56.9 mt-30 . . . . . 0 C--O 1.243 0.729 0 CA-C-N 113.818 -1.537 . . . . 74.13 114.329 171.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' B' ' 9' ' ' ARG . 60.1 mtt180 . . . . . 0 CA--C 1.499 -0.993 0 N-CA-C 108.36 -0.978 . . . . 75.34 108.36 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.9 m -110.29 141.86 42.7 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.975 -0.75 . . . . 63.14 108.975 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 79.6 m -127.82 148.98 50.47 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.037 -1.097 . . . . 73.24 108.037 173.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 12' ' ' VAL . 40.7 t -139.77 142.17 32.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.361 -0.607 . . . . 63.22 109.361 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.9 p -107.49 125.27 51.06 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.874 -1.158 . . . . 52.21 107.874 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' B' ' 45' ' ' LEU . 3.9 pp -112.91 144.02 43.19 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.036 0.446 . . . . 71.0 111.547 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -83.24 135.78 34.64 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.606 -0.724 . . . . 74.02 110.407 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p -156.44 153.49 28.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.833 0.853 . . . . 62.14 109.743 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -76.05 93.83 3.35 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.341 1.067 . . . . 75.04 109.398 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -123.24 148.34 45.97 Favored 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 114.937 -1.028 . . . . 62.32 113.369 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.475 ' HG ' ' NE2' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -80.81 153.81 72.96 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 114.044 -1.434 . . . . 61.31 109.343 172.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.04 149.94 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.504 2.136 . . . . 54.25 112.586 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.7 124.59 72.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 108.124 -1.065 . . . . 62.34 108.124 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.9 m -58.7 -47.08 85.79 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.169 0.588 . . . . 50.42 112.285 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -122.5 145.8 47.98 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.498 -0.556 . . . . 72.04 109.498 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.58 114.97 16.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.238 -1.023 . . . . 74.04 108.238 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -92.53 144.34 25.44 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.715 -0.675 . . . . 64.24 109.678 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 75.2 m -131.24 126.99 36.9 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.421 -0.955 . . . . 73.03 108.421 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 85.5 m-85 -122.95 131.48 53.74 Favored 'General case' 0 CA--C 1.465 -2.305 0 CA-C-N 115.716 -0.674 . . . . 72.25 110.733 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.614 HG22 HG22 ' B' ' 37' ' ' VAL . 23.1 p -115.35 131.22 57.0 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 124.254 0.971 . . . . 62.41 111.813 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 38' ' ' ILE . 49.2 mt -128.61 134.23 64.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 116.029 -0.532 . . . . 73.11 109.881 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -110.32 133.11 53.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.898 -0.778 . . . . 74.05 108.898 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.546 ' HG2' HG13 ' A' ' 40' ' ' ILE . 26.7 tp10 -142.4 102.02 4.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.216 0.531 . . . . 72.44 109.57 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.08 -78.02 1.29 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.521 -0.763 . . . . 43.23 111.412 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -157.74 33.64 0.26 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.324 -1.361 . . . . 72.23 107.324 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 40' ' ' ILE . 31.6 tp -120.61 125.26 47.29 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.449 -0.796 . . . . 64.32 110.307 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 32.7 mmt180 -99.75 115.18 28.92 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.746 0.654 . . . . 74.22 111.099 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 124.48 49.46 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.418 -0.956 . . . . 73.32 108.418 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.614 HG22 HG22 ' B' ' 28' ' ' THR . 67.8 t -120.47 135.01 62.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.16 0.505 . . . . 75.2 110.355 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.717 HD12 HD12 ' A' ' 29' ' ' ILE . 77.2 mt -118.79 122.36 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 CA-C-N 115.293 -0.867 . . . . 74.4 109.524 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.479 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.4 m-85 -107.77 115.78 30.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.063 -1.088 . . . . 73.2 108.063 176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.515 HG13 ' HG2' ' A' ' 31' ' ' GLU . 48.5 mm -88.61 114.85 27.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.27 -0.641 . . . . 72.24 109.27 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 76.7 p -122.43 162.31 21.89 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.156 -0.474 . . . . 75.13 110.294 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.503 ' N ' ' HD3' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -56.69 -25.58 54.53 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.768 0.827 . . . . 71.44 112.83 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -89.78 -16.13 30.9 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 111.893 0.331 . . . . 74.33 111.893 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.89 -134.59 4.41 Favored Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 118.88 -1.629 . . . . 72.03 113.314 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.507 ' HB3' HD11 ' B' ' 14' ' ' LEU . 58.9 tp -113.3 125.59 54.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.293 -0.632 . . . . 70.02 109.293 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 2.6 tmtm? -115.65 121.67 43.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.754 -1.943 . . . . 61.54 105.754 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 p -114.74 140.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 116.61 -0.268 . . . . 74.45 110.977 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 47.6 m -130.81 137.93 49.66 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 122.893 0.477 . . . . 74.13 111.53 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -117.68 125.26 50.37 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.058 -0.519 . . . . 33.43 110.5 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 32.6 t70 -120.99 83.91 38.35 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.347 -0.983 . . . . 64.53 108.347 174.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo . . . . . 0 N--CA 1.431 -2.196 0 C-N-CA 122.675 2.25 . . . . 45.03 114.485 -176.146 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 98.8 mtt180 . . . . . 0 CA--C 1.509 -0.627 0 CA-C-O 121.438 0.637 . . . . 72.1 110.425 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.2 p -86.11 117.86 25.21 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.359 -0.978 . . . . 63.02 108.359 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 56.7 m -121.48 149.33 43.22 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.672 -0.694 . . . . 70.3 109.385 -176.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG23 HD11 ' B' ' 14' ' ' LEU . 78.0 t -142.62 149.71 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 123.468 0.707 . . . . 71.1 109.383 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 p -106.58 125.72 51.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.978 0.418 . . . . 72.25 111.186 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.9 mm? -102.94 123.57 46.8 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.223 1.009 . . . . 75.35 110.16 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -107.63 112.26 24.89 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.54 -0.541 . . . . 72.44 109.54 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' B' ' 9' ' ' ARG . 7.1 t -151.54 95.68 2.16 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.156 0.503 . . . . 73.44 111.515 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.55 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 56.3 tp60 48.59 84.06 0.03 OUTLIER 'General case' 0 C--O 1.247 0.943 0 CA-C-N 114.774 -1.103 . . . . 74.52 111.752 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -124.73 145.7 49.56 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 114.115 1.154 . . . . 74.41 114.115 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.13 148.15 48.46 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 106.919 -1.511 . . . . 70.2 106.919 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 136.22 43.29 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.741 1.627 . . . . 73.33 113.595 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 23' ' ' ARG . 11.3 p -124.16 139.46 50.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 64.24 106.675 175.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 m -98.2 9.3 43.27 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.538 0.57 . . . . 72.14 112.538 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.42 ' H ' HG22 ' A' ' 21' ' ' VAL . 31.1 tpt180 -131.16 133.33 45.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.867 -0.79 . . . . 74.13 108.867 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -90.75 116.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.476 -0.935 . . . . 74.45 108.476 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.71 127.19 45.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.324 -0.551 . . . . 74.13 110.821 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.4 HG22 ' CD1' ' A' ' 39' ' ' PHE . 54.0 p -108.68 127.77 54.28 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 107.991 -1.114 . . . . 53.33 107.991 175.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -126.5 125.8 42.67 Favored 'General case' 0 CA--C 1.467 -2.22 0 CA-C-N 116.316 -0.402 . . . . 70.43 109.949 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.601 HG22 HG22 ' A' ' 37' ' ' VAL . 67.2 p -115.78 121.9 43.83 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.707 -0.679 . . . . 52.33 111.351 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.626 HD12 HD12 ' B' ' 38' ' ' ILE . 51.1 mt -117.79 123.08 71.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 116.207 -0.451 . . . . 72.41 110.193 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -105.83 129.06 54.08 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.349 -0.982 . . . . 54.2 108.349 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.536 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.01 111.7 6.68 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.302 -0.863 . . . . 65.04 109.498 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.21 -67.89 2.09 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.97 -0.559 . . . . 64.51 111.764 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 23.0 t -162.1 -21.05 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 122.027 0.131 . . . . 62.15 111.052 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 34' ' ' LEU . 2.3 pt? -89.34 141.71 28.3 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.661 -0.496 . . . . 61.04 109.661 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -117.86 118.6 32.46 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.764 -0.653 . . . . 72.43 109.262 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.33 133.72 48.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.005 -0.543 . . . . 75.54 109.602 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.601 HG22 HG22 ' A' ' 28' ' ' THR . 25.9 t -116.53 130.77 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.121 0.486 . . . . 74.32 110.435 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.537 HD12 HD12 ' B' ' 29' ' ' ILE . 74.2 mt -108.26 116.95 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 C-N-CA 124.583 1.153 . . . . 64.34 108.612 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.634 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 95.6 m-85 -105.78 116.06 31.29 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.177 -1.046 . . . . 72.15 108.177 175.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.542 HG23 HD21 ' B' ' 34' ' ' LEU . 44.9 mm -88.85 119.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 108.193 -1.04 . . . . 71.34 108.193 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -128.1 162.58 26.56 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.099 -0.501 . . . . 75.22 110.343 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -63.28 -18.21 63.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.214 0.605 . . . . 74.51 110.969 177.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -94.43 -9.28 36.1 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.541 0.686 . . . . 74.23 109.837 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.99 -134.37 7.39 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.593 -0.813 . . . . 72.14 113.119 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 56.1 tp -111.76 125.51 54.07 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.901 -0.407 . . . . 74.34 109.901 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.2 tptm -115.22 121.65 43.59 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.824 -1.546 . . . . 52.14 106.824 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.547 HG11 HG11 ' B' ' 47' ' ' VAL . 14.4 p -112.13 140.57 31.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 116.496 -0.32 . . . . 74.11 110.646 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -127.55 138.51 52.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.392 -0.367 . . . . 71.12 111.114 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.1 123.64 48.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.119 -0.491 . . . . 70.24 109.718 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 29.6 t70 -101.62 119.36 57.5 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.136 -0.69 . . . . 71.25 109.136 176.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HB3' ' HB3' ' B' ' 17' ' ' GLN . 93.0 Cg_exo -48.65 135.88 27.33 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.247 3.298 . . . . 75.43 114.536 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.9 mt-30 . . . . . 0 N--CA 1.443 -0.777 0 CA-C-N 115.114 -0.948 . . . . 74.4 110.456 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 87.1 mtt180 . . . . . 0 C--O 1.242 0.702 0 CA-C-O 121.13 0.491 . . . . 73.04 111.193 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.7 p -91.4 135.5 33.78 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.255 0.55 . . . . 73.15 110.672 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 55.5 m -131.04 149.79 52.45 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.119 -1.067 . . . . 74.21 108.119 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.444 HG23 HD11 ' A' ' 14' ' ' LEU . 76.1 t -144.29 145.55 21.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.546 -0.539 . . . . 64.42 109.546 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.6 p -106.88 135.08 49.04 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.12 0.486 . . . . 63.44 109.833 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 2.8 mm? -109.56 121.56 45.47 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.77 -0.65 . . . . 74.25 110.124 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 27.2 p -106.95 112.75 25.85 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.466 -0.939 . . . . 51.13 108.466 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' B' ' 18' ' ' ARG . 10.5 t -134.44 -167.56 1.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.844 -1.169 . . . . 72.32 107.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . 0.519 ' HB3' ' HB3' ' A' ' 51' ' ' PRO . 56.3 tp60 -62.51 88.08 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.731 0.777 . . . . 54.25 110.251 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' B' ' 16' ' ' THR . 5.5 ppt_? -126.77 150.15 49.27 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.242 0.83 . . . . 75.24 113.242 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.15 159.0 31.79 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 107.039 -1.467 . . . . 71.23 107.039 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.47 135.64 31.66 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.233 1.288 . . . . 73.3 111.624 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.479 HG22 ' H ' ' B' ' 23' ' ' ARG . 7.4 p -129.43 130.52 67.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.774 -0.824 . . . . 71.24 108.774 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -94.16 1.05 56.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.134 0.492 . . . . 53.34 112.128 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.479 ' H ' HG22 ' B' ' 21' ' ' VAL . 22.6 tpt180 -112.02 142.82 43.98 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.755 -0.461 . . . . 75.34 109.755 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.7 131.23 50.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.049 -1.093 . . . . 61.25 108.049 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 34.3 mmtp -124.97 143.58 50.81 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.163 -0.31 . . . . 72.14 110.163 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 41.4 p -126.37 127.98 46.33 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.107 -0.701 . . . . 74.53 109.107 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 80.1 m-85 -127.81 132.28 49.48 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 120.694 0.283 . . . . 72.43 111.118 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.533 HG22 HG22 ' B' ' 37' ' ' VAL . 36.6 p -115.09 125.31 53.35 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.357 -0.838 . . . . 63.34 112.405 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 38' ' ' ILE . 58.0 mt -127.75 125.3 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-O 120.809 0.338 . . . . 74.32 110.523 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -108.91 131.68 54.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.469 -0.937 . . . . 72.11 108.469 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.605 ' O ' HD23 ' B' ' 34' ' ' LEU . 11.6 tp10 -142.99 116.34 9.04 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.68 -0.691 . . . . 74.52 109.463 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.36 -59.78 2.81 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.669 -0.572 . . . . 32.22 111.669 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -174.13 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.563 0.745 . . . . 75.1 110.461 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.605 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -77.5 140.84 39.86 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.158 -0.682 . . . . 70.31 109.158 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -119.8 121.71 39.75 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.99 -0.55 . . . . 74.01 109.53 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.54 52.01 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.843 -0.617 . . . . 73.23 109.888 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.533 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -114.13 125.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.752 -0.658 . . . . 41.31 109.895 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.626 HD12 HD12 ' A' ' 29' ' ' ILE . 77.9 mt -101.63 119.06 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 C-N-CA 123.664 0.786 . . . . 72.35 109.297 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.402 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.2 m-85 -104.72 114.86 29.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.411 -0.813 . . . . 72.24 108.857 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.501 HG23 HD21 ' A' ' 34' ' ' LEU . 41.8 mm -89.49 115.24 28.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 106.408 -1.701 . . . . 75.45 106.408 176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.0 p -133.47 163.22 29.87 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.092 0.472 . . . . 62.25 111.949 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.557 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -57.06 -21.83 34.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.829 1.252 . . . . 75.01 111.413 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -88.22 -16.25 33.75 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.524 0.73 . . . . 70.13 109.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.43 -122.71 4.3 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 111.072 -0.811 . . . . 72.41 111.072 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.506 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 56.4 tp -112.19 144.98 40.67 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.653 -0.499 . . . . 71.25 109.653 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -141.41 141.72 33.73 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.479 -1.304 . . . . 74.23 107.479 168.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.547 HG11 HG11 ' A' ' 47' ' ' VAL . 11.8 p -131.51 140.7 47.66 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.029 0 N-CA-C 109.368 -0.604 . . . . 75.34 109.368 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.402 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.8 m -119.49 138.39 53.18 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.995 -0.548 . . . . 54.53 110.205 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.41 123.86 49.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.25 -0.648 . . . . 73.05 109.25 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' B' ' 9' ' ' ARG . 34.2 t70 -100.45 125.86 37.83 Favored Pre-proline 0 C--N 1.289 -2.036 0 CA-C-N 115.732 -0.667 . . . . 71.2 109.993 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.55 ' HB3' ' HB3' ' A' ' 17' ' ' GLN . 5.0 Cg_exo . . . . . 0 C--N 1.356 0.945 1 C-N-CA 125.671 4.248 . . . . 62.43 116.018 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 92.6 mtt180 . . . . . 0 CA--C 1.495 -1.135 0 CA-C-O 121.305 0.574 . . . . 70.23 111.443 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 p -99.45 134.36 42.43 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.834 -0.621 . . . . 72.22 109.576 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -130.09 148.94 51.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.488 -0.56 . . . . 73.34 109.488 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.9 139.14 22.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.365 0.416 . . . . 72.04 109.9 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 p -112.43 130.9 55.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.761 0.315 . . . . 73.23 110.75 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.421 HD11 HG23 ' B' ' 12' ' ' VAL . 1.7 mm? -101.73 122.32 43.71 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.921 -0.581 . . . . 74.03 109.951 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -101.66 113.72 27.13 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 113.838 1.051 . . . . 75.14 113.838 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.516 HG22 ' CZ ' ' A' ' 18' ' ' ARG . 14.6 t -155.91 165.79 35.42 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.661 -1.978 . . . . 75.44 105.661 166.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -86.08 90.33 8.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.811 1.291 . . . . 73.22 110.685 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.516 ' CZ ' HG22 ' A' ' 16' ' ' THR . 80.6 mtt85 -96.61 149.62 21.57 Favored 'General case' 0 N--CA 1.393 -3.282 0 N-CA-C 105.472 -2.048 . . . . 73.25 105.472 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 2.3 mm? -73.26 128.33 87.72 Favored Pre-proline 0 C--N 1.284 -2.243 0 C-N-CA 120.725 -0.39 . . . . 63.15 111.571 -171.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 72.9 Cg_exo -49.84 141.97 27.05 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 124.527 3.485 . . . . 70.45 115.394 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.17 135.17 58.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.332 -1.729 . . . . 73.21 106.332 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.7 m -59.12 -59.66 5.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.109 0.411 . . . . 64.52 112.109 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -97.56 146.11 25.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.523 -0.547 . . . . 63.3 109.523 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 41' ' ' THR . 52.1 mm -79.94 118.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.603 -0.888 . . . . 63.31 108.603 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.59 146.57 25.16 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.172 0.511 . . . . 62.04 111.626 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 39.2 p -126.0 127.64 46.21 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.917 -1.038 . . . . 72.14 108.977 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -124.24 130.46 52.57 Favored 'General case' 0 CA--C 1.468 -2.189 0 CA-C-N 116.197 -0.456 . . . . 70.32 110.782 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.529 HG22 HG22 ' A' ' 37' ' ' VAL . 61.8 p -114.86 128.67 56.43 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.177 -0.919 . . . . 73.1 111.103 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.67 HD12 HD12 ' B' ' 38' ' ' ILE . 58.2 mt -126.91 123.46 62.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 120.931 0.396 . . . . 65.05 110.492 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.7 t -106.15 121.81 44.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.453 -0.943 . . . . 74.03 108.453 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.19 106.92 4.86 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.36 0.6 . . . . 63.01 111.279 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.05 -66.8 2.14 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.857 -0.61 . . . . 72.34 112.931 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -154.11 12.88 0.43 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.483 0.549 . . . . 73.33 112.483 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.516 HD21 HD12 ' B' ' 40' ' ' ILE . 1.6 pt? -128.58 141.56 51.33 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 118.062 -1.455 . . . . 71.05 111.877 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.014 -1.476 . . . . 72.53 107.014 167.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.47 129.4 52.47 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.323 -0.621 . . . . 73.21 109.323 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 28' ' ' THR . 58.9 t -118.17 126.86 75.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.083 0.468 . . . . 70.53 110.912 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.576 HD12 HD12 ' B' ' 29' ' ' ILE . 69.6 mt -105.78 122.24 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.206 -0.906 . . . . 64.3 109.607 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.489 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.1 m-85 -103.36 114.89 29.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.885 -0.783 . . . . 74.11 108.885 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.71 HG23 HD21 ' B' ' 34' ' ' LEU . 40.6 mm -91.98 114.5 29.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.572 -0.899 . . . . 73.32 108.572 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.438 HG22 HD12 ' A' ' 24' ' ' ILE . 70.4 p -130.74 170.61 14.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.283 -0.636 . . . . 64.53 109.283 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -83.49 -4.73 58.79 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.876 -0.787 . . . . 73.14 108.876 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 3.1 tmt_? -98.64 6.11 47.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 106.949 -1.5 . . . . 71.05 106.949 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.35 -143.67 18.07 Favored Glycine 0 N--CA 1.423 -2.232 0 CA-C-N 114.228 -1.351 . . . . 52.31 113.148 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.631 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 55.0 tp -112.34 136.7 51.48 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.599 -0.519 . . . . 74.21 109.599 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 82.8 tttt -128.2 140.71 51.76 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.059 -0.719 . . . . 70.12 109.059 170.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.693 HG11 HG11 ' B' ' 47' ' ' VAL . 9.6 p -128.72 141.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 115.58 -0.736 . . . . 74.03 109.996 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.489 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 60.5 m -128.45 137.52 51.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.313 -0.403 . . . . 52.03 110.705 174.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.831 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.45 121.73 42.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.411 -0.589 . . . . 61.42 109.411 175.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -119.3 101.94 48.81 Favored Pre-proline 0 C--N 1.284 -2.242 0 C-N-CA 123.837 0.855 . . . . 75.01 109.718 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.07 133.44 13.58 Favored 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 120.839 1.026 . . . . 64.12 110.562 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 . . . . . 0 CA--C 1.546 0.806 0 O-C-N 124.261 0.976 . . . . 64.14 112.988 177.396 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 92.4 mtt180 . . . . . 0 N--CA 1.403 -2.788 0 N-CA-C 108.19 -1.041 . . . . 74.15 108.19 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 m -108.49 127.07 53.6 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.507 -1.294 . . . . 74.32 107.507 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 61.9 m -121.66 148.97 43.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.947 -1.131 . . . . 64.12 107.947 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.421 HG23 HD11 ' A' ' 14' ' ' LEU . 92.8 t -144.45 146.77 20.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.681 -0.489 . . . . 43.4 109.681 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.505 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 35.3 p -106.16 135.84 46.91 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.91 -1.145 . . . . 74.43 107.91 174.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 3.2 mm? -100.2 122.56 43.22 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.497 -0.557 . . . . 74.42 109.497 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -84.62 112.56 20.56 Favored 'General case' 0 N--CA 1.397 -3.075 0 CA-C-N 115.441 -0.799 . . . . 61.4 109.803 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -154.65 177.79 10.83 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.191 -1.411 . . . . 75.53 107.191 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -108.2 108.55 19.63 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.44 0.638 . . . . 75.23 109.379 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.419 HH22 HG21 ' B' ' 21' ' ' VAL . 19.2 mtm105 -124.62 150.33 46.11 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.368 -0.833 . . . . 74.15 110.19 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.45 HD22 ' H ' ' B' ' 19' ' ' LEU . 2.1 mm? -74.93 145.32 81.03 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 114.857 -1.065 . . . . 73.22 108.86 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.75 135.67 63.17 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 123.02 2.48 . . . . 72.23 112.806 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.419 HG21 HH22 ' B' ' 18' ' ' ARG . 61.3 t -103.72 131.2 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.658 -1.238 . . . . 72.31 107.658 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.9 m -56.29 -46.33 79.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 113.798 1.036 . . . . 61.41 113.798 -174.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' B' ' 23' ' ' ARG . 0.4 OUTLIER -127.22 155.45 43.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.783 -0.821 . . . . 71.35 108.783 -175.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.3 131.53 33.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.947 0.403 . . . . 55.42 109.968 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' B' ' 27' ' ' TYR . 1.5 mptm? -116.72 143.5 45.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 112.322 0.49 . . . . 61.14 112.322 177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -125.85 127.12 45.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.444 -1.317 . . . . 70.22 107.444 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' B' ' 25' ' ' LYS . 75.9 m-85 -124.65 126.85 46.41 Favored 'General case' 0 CA--C 1.45 -2.899 0 CA-C-N 116.244 -0.435 . . . . 75.23 110.566 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.606 HG22 HG22 ' B' ' 37' ' ' VAL . 81.5 p -114.01 135.47 53.97 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 115.073 -0.967 . . . . 72.32 109.507 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.576 HD12 HD12 ' A' ' 38' ' ' ILE . 60.6 mt -127.97 121.65 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 116.114 -0.494 . . . . 63.2 110.772 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.516 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 6.2 t -100.96 117.46 35.05 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.589 -0.732 . . . . 54.42 109.1 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.517 ' O ' HD23 ' B' ' 34' ' ' LEU . 10.4 tp10 -140.39 110.29 6.47 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.553 -0.749 . . . . 63.22 110.286 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 -84.7 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.593 -0.73 . . . . 73.33 114.341 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 47.8 m -137.19 12.73 3.06 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 112.982 0.734 . . . . 52.54 112.982 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.71 HD21 HG23 ' A' ' 40' ' ' ILE . 2.2 pt? -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.753 -0.779 . . . . 72.42 112.107 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.516 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 18.6 mmm180 -103.67 113.52 27.1 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.1 -1.444 . . . . 72.35 107.1 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.37 131.64 52.55 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 110.023 -0.362 . . . . 74.22 110.023 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.606 HG22 HG22 ' B' ' 28' ' ' THR . 59.8 t -122.61 124.84 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-O 120.836 0.351 . . . . 74.33 111.031 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.67 HD12 HD12 ' A' ' 29' ' ' ILE . 94.1 mt -104.53 122.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.651 -0.87 . . . . 64.22 108.651 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.1 m-85 -104.24 121.04 42.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.233 -1.395 . . . . 74.43 107.233 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.516 HD12 HD21 ' A' ' 34' ' ' LEU . 50.6 mm -89.48 114.68 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.653 0 CA-C-O 122.398 1.094 . . . . 71.12 110.014 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -127.04 149.47 49.9 Favored 'General case' 1 N--CA 1.369 -4.492 0 CA-C-N 112.503 -2.135 . . . . 74.2 106.475 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' B' ' 42' ' ' LYS . 17.5 ptmt -71.74 -18.93 62.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 118.62 0.645 . . . . 54.2 112.666 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 0.1 OUTLIER -86.89 6.14 33.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.165 0.984 . . . . 72.12 109.056 -172.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.94 -129.33 4.05 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.469 -0.872 . . . . 44.54 112.738 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.492 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 64.6 tp -125.64 144.55 50.54 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.584 0.754 . . . . 64.25 109.003 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.4 tptm -134.75 122.9 22.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.167 -1.42 . . . . 72.53 107.167 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.693 HG11 HG11 ' A' ' 47' ' ' VAL . 10.2 p -127.23 141.42 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 120.883 -0.327 . . . . 75.3 110.956 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 56.5 m -123.71 137.02 54.78 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.144 -0.48 . . . . 64.44 111.012 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.64 122.9 44.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.912 -0.586 . . . . 64.42 110.971 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -132.33 118.4 16.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 123.688 0.795 . . . . 74.34 109.324 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 48.3 Cg_endo . . . . . 0 N--CA 1.431 -2.153 0 C-N-CA 121.127 1.218 . . . . 71.43 112.352 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 . . . . . 0 CA--C 1.493 -1.231 0 N-CA-C 107.325 -1.361 . . . . 72.41 107.325 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.427 ' HB ' HD13 ' B' ' 14' ' ' LEU . 28.3 m -108.8 140.2 42.57 Favored 'General case' 0 N--CA 1.403 -2.801 0 C-N-CA 119.101 -1.04 . . . . 55.42 109.597 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.94 149.56 50.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.69 -1.226 . . . . 75.52 107.69 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.5 t -140.69 135.72 34.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 110.068 -0.345 . . . . 62.23 110.068 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.471 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 30.2 p -107.45 135.9 48.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.58 -0.526 . . . . 74.32 109.58 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 4.2 pp -130.66 127.95 39.95 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.057 0.456 . . . . 72.0 110.595 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 t -110.03 119.51 39.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 55.42 110.193 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -159.56 114.67 2.42 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.677 -0.692 . . . . 74.34 109.856 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HG3' ' HB2' ' B' ' 51' ' ' PRO . 12.0 pt20 35.85 81.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.848 1.659 . . . . 62.33 114.446 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -125.56 149.59 48.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.591 0.96 . . . . 71.12 113.591 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 19' ' ' LEU . 3.2 mp -111.26 155.54 42.54 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 107.692 -1.225 . . . . 62.35 107.692 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.26 142.83 94.76 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.724 2.283 . . . . 75.15 111.089 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.07 146.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.442 -0.947 . . . . 72.23 108.442 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.9 m -71.13 -39.9 71.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.738 0.644 . . . . 74.53 112.738 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 29.2 tpt180 -134.46 138.91 45.13 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.778 -0.576 . . . . 72.43 110.154 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.84 115.32 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 107.624 -1.25 . . . . 72.41 107.624 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.2 mmtp -101.29 132.16 46.97 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.387 -0.525 . . . . 72.52 111.388 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 p -113.05 126.65 55.72 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 106.671 -1.603 . . . . 63.32 106.671 173.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 69.7 m-85 -121.57 129.9 53.17 Favored 'General case' 0 CA--C 1.458 -2.572 0 CA-C-N 116.575 -0.284 . . . . 75.41 110.693 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.558 HG22 HG22 ' A' ' 37' ' ' VAL . 61.7 p -114.54 127.65 55.91 Favored 'General case' 0 C--N 1.286 -2.161 0 O-C-N 123.86 0.725 . . . . 75.24 111.171 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.651 HD12 HD12 ' B' ' 38' ' ' ILE . 62.7 mt -127.79 121.73 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.262 -0.644 . . . . 73.44 109.262 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -106.34 126.34 52.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.326 -0.99 . . . . 74.33 108.326 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.0 tp10 -142.34 99.97 3.61 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.183 -0.462 . . . . 74.11 111.869 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 -66.36 1.37 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 114.908 0.723 . . . . 44.31 114.908 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.4 m -139.29 -8.15 1.32 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.314 -0.521 . . . . 74.1 112.399 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.511 HD21 HD12 ' B' ' 40' ' ' ILE . 2.3 pt? -130.27 140.35 50.69 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 119.043 -1.063 . . . . 63.14 111.769 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 3.1 mpt_? -99.54 119.58 38.26 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.449 -1.315 . . . . 74.21 107.449 169.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.16 127.11 51.73 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.489 -0.56 . . . . 75.1 109.489 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 44.7 t -117.19 128.51 74.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.336 -0.393 . . . . 73.54 110.425 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.695 HD12 HD12 ' B' ' 29' ' ' ILE . 96.6 mt -108.59 121.29 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 N-CA-C 108.274 -1.01 . . . . 72.53 108.274 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 93.2 m-85 -104.88 114.63 28.95 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.197 -1.038 . . . . 74.33 108.197 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.539 HD12 HD21 ' B' ' 34' ' ' LEU . 48.4 mm -90.79 113.39 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.063 -1.088 . . . . 74.21 108.063 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -125.65 177.75 6.06 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.181 -1.044 . . . . 72.41 108.181 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -81.4 -32.67 32.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.956 1.095 . . . . 62.35 113.956 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -86.65 -20.1 28.31 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.829 -0.749 . . . . 72.25 110.863 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.73 -162.65 29.38 Favored Glycine 0 C--N 1.294 -1.779 0 C-N-CA 119.171 -1.49 . . . . 61.55 114.134 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 14' ' ' LEU . 2.0 tm? -113.69 122.88 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.475 -0.935 . . . . 70.41 108.475 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.0 tptm -115.76 122.43 45.44 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.408 -0.96 . . . . 72.33 108.408 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.601 HG11 HG11 ' B' ' 47' ' ' VAL . 13.8 p -119.23 140.53 42.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.868 -0.419 . . . . 64.23 109.868 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -125.71 139.79 53.24 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.969 -0.56 . . . . 63.25 111.332 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.446 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -117.0 123.68 47.5 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 108.429 -0.952 . . . . 54.54 108.429 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 18.1 t70 -113.72 87.44 12.19 Favored Pre-proline 0 C--N 1.282 -2.362 0 N-CA-C 108.197 -1.038 . . . . 71.53 108.197 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.3 Cg_endo -87.79 133.28 3.02 Favored 'Trans proline' 0 N--CA 1.417 -3.023 0 C-N-CA 121.57 1.513 . . . . 75.04 111.354 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 114.09 -1.414 . . . . 74.44 113.37 174.435 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 . . . . . 0 N--CA 1.42 -1.964 0 N-CA-C 107.938 -1.134 . . . . 73.44 107.938 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.48 ' HB ' HD13 ' A' ' 14' ' ' LEU . 25.1 m -109.64 128.59 55.34 Favored 'General case' 0 N--CA 1.393 -3.298 0 N-CA-C 107.564 -1.273 . . . . 74.22 107.564 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.439 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 34.8 m -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.572 -2.011 . . . . 62.12 105.572 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 141.71 28.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.71 0.291 . . . . 63.23 110.885 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.5 p -108.7 126.68 53.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.236 -0.438 . . . . 75.32 110.881 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' B' ' 45' ' ' LEU . 4.3 pp -125.23 137.52 54.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.984 -0.747 . . . . 63.13 108.984 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -120.19 125.99 49.55 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 109.06 -0.719 . . . . 74.13 109.06 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -161.85 115.6 1.87 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.277 -0.42 . . . . 55.4 111.202 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 34.29 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 126.276 1.83 . . . . 65.12 114.849 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.432 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 53.2 mmm-85 -127.51 146.73 50.41 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 114.008 1.114 . . . . 54.52 114.008 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.88 153.96 47.53 Favored Pre-proline 0 C--O 1.25 1.126 0 N-CA-C 106.501 -1.666 . . . . 73.13 106.501 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.78 135.55 38.77 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.705 1.603 . . . . 54.42 112.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.548 HG12 ' H ' ' B' ' 23' ' ' ARG . 91.4 t -131.39 131.85 62.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.858 -1.164 . . . . 64.12 107.858 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 m -98.18 3.24 49.01 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 111.959 0.355 . . . . 74.41 111.959 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.548 ' H ' HG12 ' B' ' 21' ' ' VAL . 6.9 mpt_? -117.22 139.38 50.86 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.666 -0.243 . . . . 53.33 110.553 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.05 115.44 41.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.996 -1.483 . . . . 62.13 106.996 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.485 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 34.7 mmtp -103.92 141.44 36.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.632 -0.427 . . . . 71.22 110.41 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.408 HG22 ' CD2' ' B' ' 39' ' ' PHE . 51.3 p -121.89 127.07 50.04 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.79 -0.819 . . . . 75.14 108.79 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -123.62 129.58 51.36 Favored 'General case' 0 CA--C 1.467 -2.229 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.391 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.544 HG22 HG22 ' B' ' 37' ' ' VAL . 72.6 p -115.47 130.53 56.91 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.824 -0.625 . . . . 72.23 112.268 -174.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 38' ' ' ILE . 80.2 mt -136.85 127.44 40.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.303 -0.628 . . . . 43.11 109.303 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.422 ' HB ' ' HD3' ' B' ' 35' ' ' ARG . 12.4 t -119.39 135.73 54.6 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.155 -1.054 . . . . 72.41 108.155 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.596 ' O ' HD23 ' B' ' 34' ' ' LEU . 12.5 tp10 -142.44 112.23 6.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.614 -0.434 . . . . 72.44 111.424 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.46 -67.05 1.92 Allowed Glycine 0 C--N 1.311 -0.836 0 CA-C-N 116.156 -0.475 . . . . 52.44 112.54 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 9.6 m -140.79 -35.93 0.47 Allowed 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 120.683 0.278 . . . . 14.11 110.582 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.596 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.6 pt? -84.29 141.21 31.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.707 0.632 . . . . 63.25 112.707 -171.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 22.8 tpp180 -101.93 113.77 27.27 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.382 -1.34 . . . . 73.42 107.382 171.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.2 133.12 52.9 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.13 -0.356 . . . . 65.42 110.109 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.544 HG22 HG22 ' B' ' 28' ' ' THR . 58.3 t -126.83 130.78 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.172 0.51 . . . . 63.44 109.974 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.651 HD12 HD12 ' A' ' 29' ' ' ILE . 92.2 mt -106.08 126.24 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 N-CA-C 108.332 -0.988 . . . . 72.11 108.332 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 87.0 m-85 -109.1 114.33 27.97 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.508 -1.293 . . . . 61.32 107.508 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.511 HD12 HD21 ' A' ' 34' ' ' LEU . 51.4 mm -92.09 113.97 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 109.037 -0.727 . . . . 61.14 109.037 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -120.28 177.42 5.03 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.532 -1.284 . . . . 71.42 107.532 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.447 ' HB3' ' H ' ' B' ' 21' ' ' VAL . 17.2 ptmt -91.66 -12.92 32.78 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.145 -0.687 . . . . 72.44 109.145 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -86.51 1.62 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.145 0.974 . . . . 74.42 109.826 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.54 -146.56 18.56 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 114.885 -1.052 . . . . 43.34 113.357 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.45 ' HB3' ' CD1' ' B' ' 14' ' ' LEU . 2.1 tm? -122.26 124.14 43.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.708 0.803 . . . . 71.32 109.448 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 53.7 tptt -115.42 121.65 43.41 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.594 -1.262 . . . . 71.31 107.594 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.601 HG11 HG11 ' A' ' 47' ' ' VAL . 13.9 p -111.58 140.81 29.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.279 -1.008 . . . . 42.32 108.279 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.439 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 15.9 t -139.11 136.72 35.47 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 119.336 -0.946 . . . . 73.42 108.541 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.21 125.79 35.79 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 120.978 0.418 . . . . 45.32 111.523 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 26.8 t70 -109.5 97.6 28.04 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 108.016 -1.105 . . . . 60.23 108.016 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.503 ' HB2' ' HG3' ' A' ' 17' ' ' GLN . 12.6 Cg_exo . . . . . 0 N--CA 1.431 -2.182 0 C-N-CA 122.279 1.986 . . . . 64.55 112.378 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 . . . . . 0 N--CA 1.425 -1.694 0 CA-C-O 121.465 0.65 . . . . 72.1 110.968 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -92.5 140.99 29.0 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 115.593 -0.731 . . . . 54.14 109.524 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.6 m -142.17 148.87 38.95 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.471 -0.566 . . . . 65.52 109.471 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.489 HG23 HD21 ' B' ' 14' ' ' LEU . 69.4 t -144.75 145.72 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.274 0.629 . . . . 71.51 109.696 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 p -109.16 136.14 49.12 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 122.835 0.454 . . . . 63.42 110.505 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.427 HD21 ' CG2' ' B' ' 12' ' ' VAL . 95.2 mt -119.62 121.93 40.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.365 0.602 . . . . 70.41 111.617 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 p -95.17 114.03 25.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.1 -0.955 . . . . 70.21 109.698 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 t -139.12 -170.55 2.9 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.89 -1.522 . . . . 74.24 106.89 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -76.86 91.48 3.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.058 0.933 . . . . 63.13 111.362 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -126.15 141.83 51.77 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.867 -1.06 . . . . 43.2 109.57 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.4 mm? -82.45 146.34 53.66 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.534 -0.757 . . . . 54.31 109.031 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 20.7 Cg_exo -64.66 134.87 42.73 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.8 1.666 . . . . 73.52 112.209 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 23' ' ' ARG . 43.7 t -131.74 143.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 114.428 -1.26 . . . . 70.0 108.179 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 m -90.56 -22.35 21.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.204 0.446 . . . . 73.31 112.204 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' H ' HG12 ' A' ' 21' ' ' VAL . 28.9 mmm180 -105.88 133.45 50.59 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.472 -0.331 . . . . 71.21 110.68 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.87 116.41 31.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.789 -0.819 . . . . 71.24 108.789 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -91.98 133.6 35.56 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 120.313 -0.555 . . . . 73.32 110.928 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.4 p -118.0 127.36 53.74 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.396 -0.82 . . . . 65.41 110.426 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 67.9 m-85 -121.5 130.77 53.76 Favored 'General case' 0 CA--C 1.477 -1.845 0 CA-C-N 115.837 -0.62 . . . . 75.21 111.029 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 37' ' ' VAL . 57.4 p -114.56 131.58 56.62 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.382 -0.826 . . . . 73.1 111.286 -175.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 38' ' ' ILE . 40.1 mt -125.23 130.4 73.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 116.432 -0.349 . . . . 73.02 110.695 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -109.96 115.76 30.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 122.21 1.005 . . . . 54.32 110.269 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.3 tp10 -143.13 123.06 13.51 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.197 -0.91 . . . . 65.45 108.926 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 52.31 32.11 36.3 Favored Glycine 0 C--O 1.218 -0.849 0 O-C-N 123.219 0.325 . . . . 73.12 113.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.2 t 84.55 -10.19 0.87 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.475 1.11 . . . . 75.43 113.37 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.6 pt? -89.36 140.22 29.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 117.07 -1.852 . . . . 65.12 109.239 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.73 118.32 36.43 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.309 -1.367 . . . . 72.35 107.309 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.99 129.54 51.59 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.51 -0.552 . . . . 71.15 109.51 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 61.9 t -118.91 122.24 68.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.186 0.517 . . . . 73.3 110.427 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.659 HD12 HD12 ' B' ' 29' ' ' ILE . 87.0 mt -103.54 123.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 C-N-CA 124.093 0.957 . . . . 52.42 109.075 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.5 114.52 28.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.423 -0.584 . . . . 64.12 109.423 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 47.2 mm -92.52 114.32 29.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.971 -1.863 . . . . 74.34 105.971 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.441 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 9.5 t -129.06 173.74 10.18 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.587 -0.445 . . . . 65.12 111.28 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -70.5 -25.22 63.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.624 . . . . 65.51 109.96 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -92.02 -4.39 54.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 73.51 110.675 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.29 -125.43 3.51 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 119.411 -1.376 . . . . 42.32 114.149 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 2.1 tm? -126.19 126.81 44.69 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 123.772 0.829 . . . . 74.41 110.06 -176.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -122.93 141.08 52.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.612 -0.514 . . . . 71.03 109.612 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.415 HG11 HG11 ' B' ' 47' ' ' VAL . 13.4 p -123.33 140.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 CA-C-N 115.739 -0.664 . . . . 70.12 110.52 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -129.76 137.72 50.69 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.558 -0.746 . . . . 72.12 110.664 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.41 123.01 46.49 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.935 -1.505 . . . . 54.2 106.935 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -117.02 101.98 53.09 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 105.684 -1.969 . . . . 70.34 105.684 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.47 132.07 17.09 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.238 1.292 . . . . 74.13 111.932 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 . . . . . 0 CA--C 1.54 0.573 0 O-C-N 124.214 0.946 . . . . 65.22 110.371 175.903 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptm180 . . . . . 0 N--CA 1.418 -2.053 0 CA-C-O 121.598 0.714 . . . . 72.22 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.2 p -87.1 142.66 27.76 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.56 -0.745 . . . . 42.52 110.741 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 62.8 m -135.04 149.79 50.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.38 -0.6 . . . . 55.25 109.38 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.427 ' CG2' HD21 ' A' ' 14' ' ' LEU . 99.2 t -139.42 139.62 38.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.16 -0.473 . . . . 71.21 110.419 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.6 p -107.92 125.68 51.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.051 -0.722 . . . . 71.41 109.051 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.489 HD21 HG23 ' A' ' 12' ' ' VAL . 96.8 mt -113.6 124.3 52.01 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 122.819 0.448 . . . . 74.24 111.78 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 24.9 p -85.16 113.63 21.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.493 -0.776 . . . . 62.11 109.244 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.1 t -139.33 178.4 7.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.483 -0.932 . . . . 74.01 108.483 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -71.04 88.76 0.78 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.161 0.981 . . . . 72.11 110.431 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.442 ' NH2' ' HB2' ' B' ' 19' ' ' LEU . 6.9 tpm_? -126.91 129.5 48.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.64 -1.164 . . . . 70.13 110.173 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.445 HD22 ' H ' ' B' ' 19' ' ' LEU . 1.7 mm? -74.49 146.21 83.44 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.373 -1.343 . . . . 74.0 107.373 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.2 135.04 52.25 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 122.517 2.144 . . . . 61.22 113.881 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.29 127.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.523 -1.658 . . . . 74.11 106.523 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -88.9 -36.74 15.77 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.587 -0.445 . . . . 74.24 111.409 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -112.96 134.15 54.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.304 . . . . 71.23 111.353 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.86 123.86 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.96 -0.564 . . . . 75.01 111.625 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 0.6 OUTLIER -90.51 132.84 35.45 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.577 -0.449 . . . . 62.23 110.161 173.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 39.1 p -106.66 128.31 54.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.286 -0.87 . . . . 74.5 109.753 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 54.3 m-85 -128.16 126.83 41.83 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 116.052 -0.522 . . . . 73.55 110.752 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.498 HG22 HG22 ' B' ' 37' ' ' VAL . 77.8 p -114.85 131.19 56.92 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.947 -0.57 . . . . 53.54 112.069 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.659 HD12 HD12 ' A' ' 38' ' ' ILE . 59.7 mt -136.52 122.21 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.322 -0.992 . . . . 71.41 108.322 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.3 121.63 40.04 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.786 -0.766 . . . . 75.01 109.41 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.598 ' O ' HD23 ' B' ' 34' ' ' LEU . 11.7 tp10 -119.7 113.8 21.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.428 -0.806 . . . . 75.23 110.546 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.26 -75.48 1.35 Allowed Glycine 0 C--N 1.298 -1.568 0 C-N-CA 121.174 -0.536 . . . . 71.24 112.125 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 13.7 t -153.56 6.99 0.36 Allowed 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 120.797 0.332 . . . . 71.32 111.403 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.598 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -114.75 140.03 49.22 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 118.522 -1.271 . . . . 54.24 109.712 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -98.06 131.03 44.82 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.022 -0.732 . . . . 74.32 109.022 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.37 114.83 23.53 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.353 -0.98 . . . . 74.43 108.353 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.498 HG22 HG22 ' B' ' 28' ' ' THR . 51.6 t -111.52 125.7 68.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.103 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 29' ' ' ILE . 81.6 mt -101.59 130.7 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.663 0 C-N-CA 124.017 0.927 . . . . 60.3 109.573 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.39 114.66 26.16 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.057 -1.09 . . . . 74.03 108.057 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' B' ' 25' ' ' LYS . 50.2 mm -88.64 117.73 32.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.697 -1.223 . . . . 73.41 107.697 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.7 t -132.04 169.32 16.51 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.402 0.439 . . . . 73.0 110.465 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.454 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -70.53 -18.52 62.93 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.031 0.443 . . . . 72.01 110.837 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -86.71 -16.48 36.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 70.13 109.11 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.6 -124.93 2.5 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.268 -0.967 . . . . 62.43 113.223 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.95 124.25 42.18 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.929 -0.636 . . . . 60.13 110.737 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -121.29 140.69 51.74 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.885 0.374 . . . . 64.51 110.11 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.415 HG11 HG11 ' A' ' 47' ' ' VAL . 13.1 p -131.77 141.37 45.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.806 -0.633 . . . . 74.52 110.011 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 65.2 m -123.75 136.65 54.56 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 123.242 0.339 . . . . 75.15 110.531 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.58 123.76 47.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.585 -0.524 . . . . 41.34 109.585 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.93 105.6 37.51 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.791 -0.818 . . . . 74.51 108.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.432 -2.139 0 C-N-CA 121.349 1.366 . . . . 74.12 115.406 -175.937 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 . . . . . 0 N--CA 1.411 -2.403 0 N-CA-C 105.496 -2.039 . . . . 74.45 105.496 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 p -86.26 117.16 24.9 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.803 -0.759 . . . . 72.03 109.695 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.6 m -123.94 148.94 46.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.934 -0.575 . . . . 63.44 109.495 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG23 HD11 ' B' ' 14' ' ' LEU . 89.6 t -145.45 142.41 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.825 0.45 . . . . 72.51 110.242 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -111.35 138.37 47.93 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 122.65 0.38 . . . . 72.43 110.871 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.438 HD11 ' CG2' ' B' ' 12' ' ' VAL . 3.5 mm? -114.42 140.54 48.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 112.331 0.493 . . . . 70.21 112.331 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.312 -0.858 . . . . 74.02 109.506 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -134.49 -177.7 4.72 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.578 -1.268 . . . . 73.34 107.578 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -76.31 96.79 4.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.337 1.065 . . . . 74.44 109.32 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -125.85 140.02 53.0 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.108 -0.951 . . . . 75.34 111.63 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' B' ' 33' ' ' SER . 4.8 mp -82.55 136.5 45.42 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.284 -1.006 . . . . 64.34 108.284 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.17 137.53 40.8 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 122.48 2.12 . . . . 71.41 112.675 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -131.8 148.96 32.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.618 -1.174 . . . . 73.31 107.973 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -97.49 -23.83 15.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.009 0.433 . . . . 62.21 111.71 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -102.91 132.12 49.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.293 -0.632 . . . . 74.45 109.293 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -98.07 129.99 47.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.837 -0.62 . . . . 74.34 109.592 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.83 141.51 30.74 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.359 -0.536 . . . . 73.54 110.894 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.1 p -119.76 127.66 53.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.077 -0.965 . . . . 74.45 108.767 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 70.5 m-85 -126.35 126.27 43.63 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 110.17 -0.307 . . . . 74.02 110.17 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 37' ' ' VAL . 59.3 p -115.89 131.35 56.96 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.754 -0.657 . . . . 72.21 111.405 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.572 HD12 HD12 ' B' ' 38' ' ' ILE . 50.2 mt -127.39 121.33 57.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.116 -0.493 . . . . 71.11 110.004 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -103.88 121.47 43.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.779 -1.193 . . . . 65.25 107.779 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 34' ' ' LEU . 13.6 tp10 -142.62 100.43 3.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 112.242 0.46 . . . . 74.12 112.242 -174.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.54 -66.15 3.55 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 114.592 0.597 . . . . 54.53 114.592 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 p -158.94 18.8 0.19 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.655 0.613 . . . . 72.1 112.655 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.566 HD22 ' CZ ' ' B' ' 18' ' ' ARG . 2.1 pt? -145.27 140.35 27.75 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.499 -0.556 . . . . 74.33 109.499 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -107.77 120.88 43.5 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.46 -0.941 . . . . 75.34 108.46 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.32 134.92 46.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.785 -0.45 . . . . 71.44 109.785 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 48.5 t -118.22 125.41 74.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 60.53 110.184 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.637 HD12 HD12 ' B' ' 29' ' ' ILE . 74.6 mt -101.77 120.61 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 CA-C-N 115.555 -0.748 . . . . 63.45 109.077 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 94.7 m-85 -102.58 115.44 30.59 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.819 -0.808 . . . . 75.32 108.819 175.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.563 HG23 HD21 ' B' ' 34' ' ' LEU . 37.1 mm -88.29 112.24 23.49 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 106.504 -1.665 . . . . 33.12 106.504 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.443 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 7.0 t -126.09 153.04 45.06 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.922 -0.581 . . . . 73.32 112.553 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -52.33 -32.82 39.88 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.948 1.299 . . . . 42.32 113.233 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -87.64 -12.64 44.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.369 0.604 . . . . 73.22 110.706 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.27 -109.97 0.43 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.673 -1.251 . . . . 52.04 113.624 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 60.7 tp -134.09 145.99 49.87 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 123.911 0.885 . . . . 73.42 109.846 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -141.04 142.66 34.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.251 -0.648 . . . . 61.13 109.251 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.459 HG11 HG11 ' B' ' 47' ' ' VAL . 12.9 p -127.03 140.62 48.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.872 -0.604 . . . . 62.23 109.949 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 33.7 m -125.15 143.19 51.06 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 116.119 -0.491 . . . . 74.31 110.871 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.82 124.14 49.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.973 -1.121 . . . . 73.11 107.973 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.03 101.22 54.48 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 107.47 -1.307 . . . . 63.4 107.47 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.96 150.3 72.91 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 122.59 2.193 . . . . 74.13 111.763 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? . . . . . 0 N--CA 1.428 -1.572 0 CA-C-N 114.967 -1.015 . . . . 71.14 110.349 172.807 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.523 ' HG2' ' HD2' ' B' ' 51' ' ' PRO . 35.0 mtp180 . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 108.097 -1.075 . . . . 74.24 108.097 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -89.39 148.17 23.64 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.541 -0.754 . . . . 64.41 111.446 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 84.0 m -133.16 149.69 52.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.716 -1.216 . . . . 62.32 107.716 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.438 ' CG2' HD11 ' A' ' 14' ' ' LEU . 65.8 t -136.86 140.53 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 120.81 -0.356 . . . . 74.33 111.434 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 22.4 p -106.81 125.81 51.49 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.495 0.718 . . . . 53.23 109.912 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.419 HD11 HG23 ' A' ' 12' ' ' VAL . 2.7 mm? -106.44 129.67 54.38 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.424 -0.584 . . . . 75.53 109.424 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 12.1 p -123.84 112.36 17.19 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.934 0.873 . . . . 62.34 111.559 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -141.69 -166.43 2.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.502 -1.666 . . . . 65.22 106.502 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -66.99 94.89 0.35 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.212 0.914 . . . . 51.32 112.146 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.566 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 7.2 tpt180 -126.38 137.95 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.993 -1.003 . . . . 41.23 110.878 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.59 136.23 42.61 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.119 -1.067 . . . . 75.15 108.119 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' B' ' 42' ' ' LYS . 57.9 Cg_endo -70.13 148.65 63.16 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.352 2.035 . . . . 72.13 113.236 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 23' ' ' ARG . 12.0 p -131.88 142.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 71.35 107.923 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 16.1 m -91.52 9.93 29.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.293 0.568 . . . . 75.31 111.074 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.516 ' H ' HG22 ' B' ' 21' ' ' VAL . 35.6 mmt180 -128.87 133.9 48.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.443 -0.577 . . . . 70.5 109.443 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.48 117.17 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.397 -0.594 . . . . 62.04 109.397 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.1 139.31 34.94 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.899 0.38 . . . . 74.13 111.617 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.403 HG22 ' CD1' ' B' ' 39' ' ' PHE . 37.8 p -117.89 127.77 54.17 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.298 -0.865 . . . . 74.4 108.884 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.15 124.21 34.1 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 108.683 -0.858 . . . . 64.31 108.683 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.448 HG23 HG22 ' B' ' 37' ' ' VAL . 18.8 m -118.07 122.01 42.05 Favored 'General case' 0 C--N 1.264 -3.144 0 C-N-CA 119.507 -0.877 . . . . 63.2 111.859 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.637 HD12 HD12 ' A' ' 38' ' ' ILE . 60.4 mt -112.9 123.49 68.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.279 -0.637 . . . . 65.43 109.279 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -104.82 121.48 43.75 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.654 0.74 . . . . 73.14 109.239 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.513 ' O ' HD23 ' B' ' 34' ' ' LEU . 13.9 tp10 -136.7 97.33 3.52 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.18 0.514 . . . . 75.3 111.592 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.53 -80.2 0.23 Allowed Glycine 0 C--N 1.312 -0.778 0 CA-C-N 115.615 -0.72 . . . . 44.33 114.831 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.45 ' HB3' HD13 ' A' ' 19' ' ' LEU . 28.1 m -123.69 6.59 8.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.685 0.624 . . . . 74.0 112.685 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.563 HD21 HG23 ' A' ' 40' ' ' ILE . 2.1 pt? -147.0 140.97 25.93 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 119.11 -1.036 . . . . 71.12 111.517 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 86.8 mtm180 -108.18 119.47 39.56 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 114.784 -1.098 . . . . 75.34 109.088 170.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 126.99 51.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.632 -0.507 . . . . 72.33 109.632 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.448 HG22 HG23 ' B' ' 28' ' ' THR . 46.3 t -109.41 124.92 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.083 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 29' ' ' ILE . 70.3 mt -101.33 119.7 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.661 -0.866 . . . . 60.33 108.661 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.479 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.9 m-85 -102.92 114.56 28.95 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.255 -1.017 . . . . 73.02 108.255 175.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.485 HD12 HD21 ' A' ' 34' ' ' LEU . 48.4 mm -89.97 112.88 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 106.014 -1.847 . . . . 75.51 106.014 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -115.66 -178.02 3.29 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 115.555 -0.748 . . . . 74.14 109.372 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.664 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -73.0 -45.24 58.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 113.972 1.101 . . . . 75.21 113.972 -173.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -93.81 -6.32 46.18 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.802 -0.759 . . . . 72.11 111.955 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.93 -143.12 6.39 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.354 -1.879 . . . . 62.11 114.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' B' ' 14' ' ' LEU . 59.0 tp -114.53 149.13 36.91 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.43 1.092 . . . . 64.13 109.689 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' B' ' 12' ' ' VAL . 84.7 tttt -143.56 143.11 31.38 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.234 -0.654 . . . . 61.44 109.234 170.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.459 HG11 HG11 ' A' ' 47' ' ' VAL . 11.7 p -131.52 141.22 46.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.649 -0.5 . . . . 71.01 109.649 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.479 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 63.5 m -121.29 146.21 47.07 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 110.32 -0.252 . . . . 42.14 110.32 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -115.81 124.3 50.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 121.265 0.555 . . . . 75.31 109.748 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 20.4 t70 -114.87 108.46 48.69 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 115.085 -0.961 . . . . 75.23 109.136 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.523 ' HD2' ' HG2' ' B' ' 9' ' ' ARG . 87.4 Cg_endo . . . . . 0 N--CA 1.434 -1.98 0 C-N-CA 122.174 1.916 . . . . 74.52 110.875 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 . . . . . 0 CA--C 1.475 -1.911 0 N-CA-C 109.948 -0.39 . . . . 71.24 109.948 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m -108.67 132.48 53.87 Favored 'General case' 0 C--N 1.262 -3.217 0 C-N-CA 119.835 -0.746 . . . . 71.54 110.058 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.25 147.88 45.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.312 . . . . 62.13 107.459 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.14 150.44 15.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.561 -0.533 . . . . 72.2 109.561 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 p -107.18 140.49 39.95 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 121.229 0.538 . . . . 72.5 111.433 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 3.7 mm? -104.79 135.42 46.2 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 124.305 1.042 . . . . 74.51 110.536 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -108.59 117.99 35.61 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-N 115.348 -0.842 . . . . 72.22 110.122 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -147.2 177.38 9.23 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 107.49 -1.3 . . . . 63.32 107.49 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -68.59 96.18 0.69 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.28 1.038 . . . . 61.44 111.706 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.553 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 14.5 mmm180 -126.03 141.69 51.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.138 1.162 . . . . 74.43 114.138 -174.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.5 pt? -89.57 150.37 44.18 Favored Pre-proline 0 C--N 1.293 -1.849 0 CA-C-N 113.944 -1.48 . . . . 55.21 108.377 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.85 137.35 41.37 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.489 2.126 . . . . 54.22 113.028 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.14 142.36 43.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.626 -1.17 . . . . 62.11 108.024 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -89.77 -40.53 12.43 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.787 0.327 . . . . 75.34 111.728 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -91.2 135.0 34.09 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.953 0.406 . . . . 72.12 111.963 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.62 115.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.079 -1.082 . . . . 71.55 108.079 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.73 127.6 42.87 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.29 -0.564 . . . . 75.53 110.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.1 p -106.62 128.6 54.29 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.442 -0.799 . . . . 72.04 109.461 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.2 126.33 42.6 Favored 'General case' 0 CA--C 1.463 -2.379 0 CA-C-N 116.118 -0.492 . . . . 72.11 109.945 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.554 HG22 HG22 ' A' ' 37' ' ' VAL . 81.9 p -114.94 124.25 51.21 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.445 -0.798 . . . . 73.14 110.861 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.695 HD12 HD12 ' B' ' 38' ' ' ILE . 50.0 mt -116.24 124.63 72.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.798 -0.637 . . . . 73.23 110.286 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.47 ' HB ' ' NH1' ' A' ' 35' ' ' ARG . 6.2 t -100.19 127.32 46.48 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.76 -1.109 . . . . 74.52 109.682 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.2 tp10 -142.13 103.39 4.29 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.638 -0.71 . . . . 71.42 110.209 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -91.05 0.73 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 115.231 -0.895 . . . . 34.42 111.523 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 31.3 p -134.62 6.36 3.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.801 0.81 . . . . 71.33 109.339 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.555 HD23 HD12 ' B' ' 40' ' ' ILE . 52.2 tp -98.22 136.08 38.94 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.387 -0.824 . . . . 74.21 110.7 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.47 ' NH1' ' HB ' ' A' ' 30' ' ' THR . 22.2 mmm180 -111.44 112.91 24.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.466 -0.788 . . . . 64.21 108.946 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.8 124.58 49.67 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.971 -0.751 . . . . 62.44 108.971 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 28' ' ' THR . 60.4 t -116.38 129.09 73.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.205 0.526 . . . . 70.21 111.298 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.608 HD12 HD12 ' B' ' 29' ' ' ILE . 59.2 mt -108.43 129.31 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-N 115.058 -0.974 . . . . 34.2 109.956 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.445 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 97.3 m-85 -113.41 117.35 31.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.305 -0.998 . . . . 70.41 108.305 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.642 HD12 HD23 ' B' ' 34' ' ' LEU . 35.0 mm -90.45 116.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 107.742 -1.207 . . . . 73.51 107.742 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.8 p -118.72 177.91 4.67 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.429 0.633 . . . . 74.31 111.261 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.99 -22.03 62.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.326 -0.852 . . . . 75.45 110.011 175.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -87.36 -29.73 21.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.443 -0.947 . . . . 54.23 108.443 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 150.64 -112.59 0.55 Allowed Glycine 0 N--CA 1.413 -2.862 0 C-N-CA 120.311 -0.947 . . . . 55.51 113.108 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 55.2 tp -119.84 139.94 51.58 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.64 -0.28 . . . . 71.41 110.331 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.7 143.32 48.44 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.483 -0.932 . . . . 62.03 108.483 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.442 HG11 HG11 ' B' ' 47' ' ' VAL . 12.4 p -123.92 140.8 46.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-N 116.146 -0.479 . . . . 75.14 110.574 -174.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 22.9 m -124.88 138.78 54.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.096 -0.502 . . . . 70.13 110.967 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.44 124.1 49.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.769 -0.65 . . . . 65.33 110.067 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 21.1 t70 -116.71 110.4 42.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.021 . . . . 73.43 108.245 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -84.21 134.61 6.0 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 122.418 2.079 . . . . 61.44 114.301 -173.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.1 mt-30 . . . . . 0 C--O 1.255 1.377 0 C-N-CA 125.672 1.589 . . . . 53.02 113.836 172.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.518 ' HG3' ' HA ' ' B' ' 50' ' ' ASP . 4.6 mpt_? . . . . . 0 N--CA 1.415 -2.213 0 CA-C-O 121.358 0.599 . . . . 71.14 111.972 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -96.26 148.38 22.8 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.932 -1.031 . . . . 71.24 110.508 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.8 m -137.14 155.98 48.92 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.518 -0.919 . . . . 73.14 108.518 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.01 138.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.288 0.235 . . . . 64.12 111.364 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.9 p -107.38 125.66 51.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.325 0.65 . . . . 63.42 109.715 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.24 122.0 44.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.608 -0.724 . . . . 40.03 110.823 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 37.5 p -85.76 113.76 22.18 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.469 -0.937 . . . . 53.24 108.469 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -139.26 -173.86 3.71 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.668 -0.493 . . . . 54.44 109.668 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.32 105.64 11.74 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.796 -0.816 . . . . 71.53 108.796 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.541 ' HG3' ' HA2' ' B' ' 44' ' ' GLY . 20.3 mmm180 -125.64 141.07 52.21 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.682 -0.69 . . . . 70.12 112.703 -172.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.561 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.9 pt? -90.35 159.62 41.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 107.15 -1.426 . . . . 73.33 107.15 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.36 135.55 54.49 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.565 1.51 . . . . 63.13 112.244 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.22 141.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.065 -1.457 . . . . 74.43 107.065 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -85.83 -68.38 0.74 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.806 0.336 . . . . 63.13 111.032 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -99.47 139.65 34.81 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 120.844 -0.342 . . . . 74.3 111.185 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.61 133.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.983 -0.747 . . . . 74.12 108.983 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' B' ' 39' ' ' PHE . 43.9 mmtm -100.13 138.81 36.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.322 -0.551 . . . . 63.42 110.161 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.1 p -115.84 127.22 54.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.256 -0.646 . . . . 72.42 109.256 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -128.75 130.82 47.6 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-N 116.411 -0.359 . . . . 64.2 111.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.528 HG22 HG22 ' B' ' 37' ' ' VAL . 57.6 p -114.94 132.62 56.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.698 -0.683 . . . . 72.13 111.936 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.608 HD12 HD12 ' A' ' 38' ' ' ILE . 72.3 mt -134.73 128.48 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.817 -0.629 . . . . 73.34 109.719 176.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -112.33 136.96 51.15 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 108.713 -0.847 . . . . 62.55 108.713 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.516 ' HG2' HG13 ' A' ' 40' ' ' ILE . 12.0 tp10 -141.57 112.12 7.07 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.543 -0.54 . . . . 73.3 109.543 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.98 -104.12 0.55 Allowed Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 110.834 -0.906 . . . . 62.45 110.834 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 45.4 m -126.49 69.6 1.24 Allowed 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.839 -0.801 . . . . 75.03 108.839 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.642 HD23 HD12 ' A' ' 40' ' ' ILE . 28.4 tp -159.13 137.2 10.44 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.045 -0.98 . . . . 74.41 109.61 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 18.8 mmm180 -113.89 116.88 29.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 123.673 0.608 . . . . 73.02 110.108 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 130.18 55.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.9 -0.408 . . . . 70.43 109.9 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.528 HG22 HG22 ' B' ' 28' ' ' THR . 86.7 t -121.64 130.87 74.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.851 0.357 . . . . 71.44 110.538 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 29' ' ' ILE . 80.8 mt -110.28 130.51 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 C-N-CA 123.442 0.697 . . . . 62.42 109.863 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 95.7 m-85 -114.57 114.76 26.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.908 -1.145 . . . . 74.55 107.908 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.555 HD12 HD23 ' A' ' 34' ' ' LEU . 40.7 mm -89.58 113.92 26.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.335 -0.987 . . . . 75.01 108.335 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -106.55 175.3 5.55 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.731 -0.47 . . . . 74.3 109.731 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.724 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -85.37 -18.05 34.89 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.775 -0.648 . . . . 61.31 110.978 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -104.31 -17.22 14.91 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.13 0.49 . . . . 73.2 110.641 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.541 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . -174.06 -139.22 2.89 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 119.097 -1.525 . . . . 64.15 114.164 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.413 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 40.6 tp -135.63 134.73 39.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 125.184 1.394 . . . . 43.32 107.513 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -128.96 140.72 51.53 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.341 -0.944 . . . . 71.44 110.132 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 47' ' ' VAL . 11.4 p -131.51 141.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.775 -0.648 . . . . 52.14 109.754 -175.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 66.7 m -123.87 140.23 53.18 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.683 0.278 . . . . 74.2 111.061 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' A' ' 45' ' ' LEU . . . -116.92 125.24 51.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.876 -0.602 . . . . 75.15 110.681 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 21.6 t70 -114.96 125.1 29.37 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.434 -0.803 . . . . 74.32 109.348 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.446 -1.295 0 C-N-CA 122.16 1.907 . . . . 43.42 113.508 -174.87 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 . . . . . 0 N--CA 1.42 -1.973 0 CA-C-O 122.335 1.064 . . . . 73.41 112.805 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -87.74 120.11 28.73 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.194 -1.366 . . . . 60.33 109.945 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 m -133.81 146.41 50.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.798 -1.186 . . . . 55.11 107.798 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.1 t -146.93 153.76 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 122.702 0.401 . . . . 62.22 110.085 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.3 p -121.57 125.77 47.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.876 -0.416 . . . . 73.32 109.876 173.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.466 HD21 ' CG2' ' B' ' 12' ' ' VAL . 97.7 mt -101.23 122.4 43.59 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 123.16 0.584 . . . . 71.12 112.197 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 p -85.79 114.31 22.63 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.075 -0.966 . . . . 73.53 110.733 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -147.43 166.99 25.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.474 -0.935 . . . . 72.41 108.474 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -82.24 102.37 11.1 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.465 0.65 . . . . 73.34 110.007 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' NH1' ' HB3' ' B' ' 51' ' ' PRO . 65.8 mmt-85 -125.93 150.21 48.15 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 114.938 -1.028 . . . . 74.21 109.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.22 134.16 80.55 Favored Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.718 -0.845 . . . . 73.42 108.718 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.51 135.28 48.68 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.813 2.342 . . . . 62.24 114.899 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.23 133.75 60.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.468 -1.696 . . . . 73.31 107.671 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -89.87 -18.51 26.05 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.436 0.636 . . . . 55.45 110.734 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -91.38 132.65 36.06 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.108 -0.701 . . . . 74.42 109.108 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.4 mm -98.72 135.14 34.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.336 -0.616 . . . . 74.51 109.336 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -110.95 150.7 28.85 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.196 0.522 . . . . 75.35 111.905 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 91.1 m -129.74 127.09 39.71 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.057 -1.09 . . . . 72.11 108.057 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -128.46 128.66 44.83 Favored 'General case' 0 CA--C 1.477 -1.843 0 CA-C-N 116.189 -0.459 . . . . 71.54 110.914 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.612 HG22 HG22 ' A' ' 37' ' ' VAL . 55.7 p -114.36 124.98 53.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.419 -0.81 . . . . 75.44 110.646 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.692 HD12 HD12 ' B' ' 38' ' ' ILE . 62.5 mt -119.12 138.79 48.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.556 -0.535 . . . . 73.43 109.556 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' HH11 ' A' ' 35' ' ' ARG . 10.6 t -118.68 127.48 53.61 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.098 -0.705 . . . . 74.14 109.098 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.7 tp10 -139.24 97.27 3.26 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 108.507 -0.923 . . . . 74.31 108.507 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.09 -119.34 7.94 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 110.533 -1.027 . . . . 72.13 110.533 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 36.8 m -102.01 3.31 38.72 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.45 0.643 . . . . 72.23 110.091 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.524 HD23 HD12 ' B' ' 40' ' ' ILE . 47.1 tp -99.75 131.61 45.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 C-N-CA 123.676 0.79 . . . . 72.12 110.138 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' A' ' 50' ' ' ASP . 28.8 tpt180 -121.37 122.46 39.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.12 -1.067 . . . . 74.33 108.12 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.07 141.53 46.78 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.953 -0.467 . . . . 54.42 110.603 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG22 HG22 ' A' ' 28' ' ' THR . 58.3 t -125.09 131.08 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 63.31 111.144 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.626 HD11 HD11 ' B' ' 38' ' ' ILE . 75.6 mt -108.41 125.86 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 124.274 1.03 . . . . 72.01 109.383 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.6 m-85 -112.14 119.04 37.04 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.098 -1.075 . . . . 75.34 108.098 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.587 HG23 HD21 ' B' ' 34' ' ' LEU . 36.7 mm -88.8 121.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.602 -0.726 . . . . 63.01 109.233 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.4 p -124.99 164.66 19.67 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.372 -0.603 . . . . 53.25 109.372 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -70.96 -21.69 62.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.875 0.369 . . . . 72.23 110.734 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -94.73 1.6 55.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.087 0.47 . . . . 72.25 110.689 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.62 -142.47 13.08 Favored Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 119.434 -1.365 . . . . 43.43 113.329 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD11 HG23 ' A' ' 38' ' ' ILE . 59.6 tp -114.9 134.52 55.08 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.303 -0.449 . . . . 72.53 111.241 -173.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 78.7 tttt -115.58 137.01 52.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.398 0.618 . . . . 71.0 110.264 170.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.473 HG11 HG11 ' B' ' 47' ' ' VAL . 10.7 p -121.62 140.58 45.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.747 -1.115 . . . . 70.01 108.357 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.3 t -137.85 143.13 40.8 Favored 'General case' 0 C--N 1.27 -2.873 0 N-CA-C 107.456 -1.313 . . . . 61.22 107.456 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.68 125.26 53.53 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.026 -0.67 . . . . 75.4 110.202 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.6 t70 -101.44 100.7 14.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 106.278 -1.749 . . . . 72.32 106.278 175.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HB3' HH12 ' B' ' 18' ' ' ARG . 95.0 Cg_endo -79.0 132.97 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.501 2.134 . . . . 70.31 115.276 -172.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 41.4 mt-30 . . . . . 0 C--O 1.236 0.381 0 C-N-CA 126.494 1.917 . . . . 75.2 114.252 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptp180 . . . . . 0 N--CA 1.42 -1.937 0 CA-C-O 121.259 0.552 . . . . 74.32 110.981 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -89.59 123.04 33.31 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 108.413 -0.958 . . . . 70.34 108.413 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 81.5 m -125.35 149.17 48.36 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.75 -0.463 . . . . 71.41 109.75 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.466 ' CG2' HD21 ' A' ' 14' ' ' LEU . 98.1 t -140.68 133.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.258 -0.428 . . . . 74.42 110.222 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.8 p -107.42 125.68 51.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.585 -0.895 . . . . 71.43 108.585 174.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.418 ' O ' ' HA3' ' B' ' 44' ' ' GLY . 79.9 mt -101.52 140.84 35.26 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.751 -0.659 . . . . 54.54 110.968 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 22.1 p -99.38 113.82 26.37 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.674 0.749 . . . . 72.52 111.528 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -158.64 159.86 35.84 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.67 -1.233 . . . . 72.32 107.67 173.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -78.27 106.51 10.23 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.919 0.866 . . . . 71.13 110.275 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.561 ' HA ' ' HE ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -109.95 151.16 27.45 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 113.921 -1.491 . . . . 75.5 110.126 -176.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.441 ' H ' HD12 ' B' ' 19' ' ' LEU . 3.6 mp -73.52 143.88 82.93 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.143 -1.058 . . . . 65.31 108.143 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -65.72 135.0 39.93 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.688 1.592 . . . . 75.12 111.461 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.23 139.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 107.731 -1.211 . . . . 74.2 107.731 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.6 m -84.22 -50.67 7.67 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.786 -0.365 . . . . 55.22 111.537 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -89.38 142.23 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.649 -0.871 . . . . 73.33 108.649 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.77 121.19 37.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.791 -0.818 . . . . 75.21 108.791 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -89.86 138.86 31.13 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.549 -0.86 . . . . 72.2 111.477 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 89.0 m -128.95 127.34 41.53 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.537 -1.21 . . . . 73.42 108.381 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 81.1 m-85 -122.11 130.45 53.25 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.66 -0.7 . . . . 75.13 110.798 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.475 HG22 HG22 ' B' ' 37' ' ' VAL . 57.0 p -115.12 130.78 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.1 -0.955 . . . . 74.54 111.173 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.596 HD12 HD12 ' A' ' 38' ' ' ILE . 55.0 mt -131.01 120.65 47.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.307 -0.627 . . . . 72.43 109.307 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -103.87 121.59 43.39 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.565 -0.902 . . . . 71.23 108.565 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.484 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.6 tp10 -136.68 100.88 4.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.72 -0.673 . . . . 73.21 111.065 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.22 -102.59 0.61 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.619 -0.719 . . . . 74.4 112.966 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 33.9 m -112.45 13.05 20.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 112.049 0.389 . . . . 34.43 112.049 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.587 HD21 HG23 ' A' ' 40' ' ' ILE . 2.4 pt? -137.83 140.62 40.58 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.669 0.747 . . . . 75.11 110.396 175.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.426 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 33.7 ttt180 -117.27 134.07 55.24 Favored 'General case' 0 C--N 1.258 -3.394 0 CA-C-N 114.737 -1.12 . . . . 72.24 108.608 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.98 140.97 47.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 122.347 -0.221 . . . . 65.2 110.821 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.475 HG22 HG22 ' B' ' 28' ' ' THR . 96.4 t -127.46 127.94 69.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.007 -0.542 . . . . 71.34 110.07 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.692 HD12 HD12 ' A' ' 29' ' ' ILE . 92.6 mt -113.15 126.77 70.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 123.4 0.68 . . . . 74.41 109.884 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.8 118.5 36.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.9 -0.778 . . . . 73.42 108.9 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.524 HD12 HD23 ' A' ' 34' ' ' LEU . 35.9 mm -94.61 115.58 33.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.26 -1.015 . . . . 71.12 108.26 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -129.68 162.97 27.13 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 110.07 -0.345 . . . . 74.21 110.07 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -20.8 66.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.023 0.44 . . . . 74.53 110.863 177.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -91.2 -17.23 26.39 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 111.946 0.351 . . . . 74.12 111.946 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' B' ' 14' ' ' LEU . . . 158.49 -156.29 27.28 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.69 -1.719 . . . . 71.14 113.583 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -112.81 122.69 48.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.698 -0.853 . . . . 70.33 108.698 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -117.39 138.45 51.8 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.119 -0.632 . . . . 64.31 110.013 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 47' ' ' VAL . 9.8 p -131.1 140.95 47.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.207 -0.906 . . . . 53.31 109.334 -176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.52 143.21 51.21 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 116.295 -0.411 . . . . 75.12 110.641 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.42 122.92 47.27 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.406 -0.961 . . . . 72.21 108.406 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' B' ' 35' ' ' ARG . 32.1 t70 -112.99 126.9 27.51 Favored Pre-proline 0 C--N 1.275 -2.641 0 CA-C-N 114.918 -1.037 . . . . 73.41 108.294 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.508 ' HB3' ' NH1' ' A' ' 18' ' ' ARG . 61.2 Cg_endo . . . . . 0 N--CA 1.446 -1.296 0 C-N-CA 121.553 1.502 . . . . 70.15 114.564 -175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.415 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 94.7 mtt180 . . . . . 0 N--CA 1.42 -1.926 0 CA-C-O 121.86 0.838 . . . . 73.34 110.042 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p -87.41 143.82 27.05 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.638 -1.164 . . . . 73.43 111.422 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.7 m -132.74 148.51 52.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.784 -0.821 . . . . 54.11 108.784 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.0 t -143.68 142.02 25.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 110.055 -0.35 . . . . 71.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.3 t -107.92 128.45 54.64 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.51 -0.922 . . . . 62.24 108.51 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.7 mm? -100.94 121.61 42.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.134 -0.691 . . . . 55.21 109.134 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 p -97.35 114.24 26.01 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-O 121.797 0.808 . . . . 65.34 109.682 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -139.33 -169.72 2.73 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.38 -1.341 . . . . 63.02 107.38 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -73.04 101.13 3.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.389 -0.967 . . . . 71.43 108.389 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -125.31 149.21 48.28 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.076 -0.65 . . . . 72.03 112.29 -173.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.3 pt? -89.99 148.73 40.25 Favored Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 107.639 -1.245 . . . . 75.2 107.639 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.44 136.35 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 121.519 1.479 . . . . 64.41 110.655 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -108.48 148.49 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.429 -0.582 . . . . 41.44 109.429 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 p -67.9 -57.26 6.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.005 0.431 . . . . 73.24 111.881 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -117.07 157.87 25.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.357 -0.383 . . . . 71.22 110.023 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -80.75 115.09 22.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.131 -1.433 . . . . 71.33 107.131 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -94.29 131.83 39.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.327 -0.549 . . . . 61.23 109.682 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.6 p -106.23 128.11 53.71 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.13 0.491 . . . . 72.43 109.861 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.521 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 80.0 m-85 -123.3 125.74 45.6 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 116.04 -0.527 . . . . 73.21 109.906 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.53 HG22 HG22 ' A' ' 37' ' ' VAL . 41.1 p -114.53 118.18 33.01 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.071 -0.968 . . . . 63.22 112.278 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.609 HD12 HD12 ' B' ' 38' ' ' ILE . 54.7 mt -121.95 121.51 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.095 -0.705 . . . . 73.44 109.095 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.2 t -118.28 124.7 48.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 CA-C-O 122.164 0.983 . . . . 64.31 109.683 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.4 tp10 -124.38 98.37 5.72 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.573 -1.649 . . . . 64.1 108.479 -175.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.5 -132.44 27.33 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 109.976 -1.25 . . . . 71.51 109.976 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.2 m -90.61 18.48 6.3 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.226 0.536 . . . . 65.43 110.878 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 HG23 ' B' ' 40' ' ' ILE . 32.8 tp -121.06 136.06 55.06 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.726 -0.472 . . . . 73.12 109.726 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -129.85 135.34 48.27 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 116.287 -0.415 . . . . 71.35 111.294 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.26 140.2 52.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.562 -0.533 . . . . 73.41 109.562 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.53 HG22 HG22 ' A' ' 28' ' ' THR . 63.6 t -121.97 125.92 73.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.969 0.414 . . . . 73.55 110.861 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 86.1 mt -102.15 124.94 56.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.384 -0.825 . . . . 74.03 109.629 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -110.72 119.04 37.81 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.797 -1.186 . . . . 62.25 107.797 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.575 HD12 HD23 ' B' ' 34' ' ' LEU . 34.4 mm -88.18 114.83 27.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.272 -1.381 . . . . 73.34 107.272 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.413 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 7.2 t -130.99 165.66 22.68 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.078 0.466 . . . . 74.54 111.275 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -68.04 -16.1 63.89 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.434 0.694 . . . . 74.2 109.994 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -86.83 -14.76 41.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.403 -0.962 . . . . 74.24 108.403 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 129.6 -117.34 2.35 Favored Glycine 0 CA--C 1.48 -2.125 0 CA-C-N 114.977 -1.011 . . . . 71.35 112.478 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 64.5 tp -113.41 132.87 55.46 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.583 -0.525 . . . . 64.5 109.583 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -128.42 134.99 48.91 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.484 -0.561 . . . . 52.12 109.484 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.563 HG11 HG11 ' B' ' 47' ' ' VAL . 12.4 p -128.57 140.59 48.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.043 0 CA-C-N 115.721 -0.672 . . . . 74.04 109.95 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.3 m -120.0 147.83 44.31 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 115.587 -0.733 . . . . 71.42 109.743 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' B' ' 45' ' ' LEU . . . -115.19 124.53 51.67 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 106.845 -1.539 . . . . 44.05 106.845 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.415 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 17.7 t70 -124.01 83.69 55.35 Favored Pre-proline 0 C--N 1.271 -2.819 0 N-CA-C 107.146 -1.427 . . . . 71.44 107.146 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 9' ' ' ARG . 11.2 Cg_endo -93.18 134.79 1.11 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 122.318 2.012 . . . . 71.44 112.661 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 114.209 -1.359 . . . . 74.35 111.912 178.437 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' ' 9' ' ' ARG . 56.9 mtt180 . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 109.287 -0.635 . . . . 74.01 109.287 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -90.25 143.31 26.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.238 -0.437 . . . . 65.12 110.384 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.414 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 69.5 m -144.91 149.39 35.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.827 -0.349 . . . . 74.42 110.116 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 92.7 t -141.2 141.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.741 0.416 . . . . 65.53 110.074 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' B' ' 46' ' ' LYS . 21.7 t -107.65 132.39 53.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.216 0.531 . . . . 61.3 109.687 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.77 120.84 43.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.704 -0.68 . . . . 71.21 110.661 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 34.1 p -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.291 -1.003 . . . . 65.52 108.291 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 t -142.57 -169.02 2.89 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.528 -0.915 . . . . 74.1 108.528 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.36 85.11 1.96 Allowed 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.292 1.044 . . . . 64.55 110.655 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -125.89 121.75 34.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.783 -1.099 . . . . 74.35 110.919 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.651 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.7 pt? -74.66 147.56 84.59 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.019 -0.991 . . . . 74.24 108.535 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.74 147.56 81.43 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.383 2.055 . . . . 54.43 114.933 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.405 HG22 ' H ' ' B' ' 23' ' ' ARG . 13.4 p -131.66 141.36 45.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.636 -1.616 . . . . 63.41 106.636 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 p -82.79 -14.15 54.96 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.316 0.858 . . . . 74.24 113.316 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.405 ' H ' HG22 ' B' ' 21' ' ' VAL . 52.8 mtm180 -127.39 146.75 50.36 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.354 -0.216 . . . . 74.55 111.012 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -91.79 115.79 31.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.659 -0.867 . . . . 75.21 108.659 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 14.4 mmmm -89.83 131.55 35.71 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.28 -0.568 . . . . 72.45 109.795 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 23.8 p -109.65 127.2 54.39 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.634 -0.712 . . . . 71.43 109.936 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.403 ' HB2' ' HB ' ' B' ' 38' ' ' ILE . 87.4 m-85 -128.35 126.24 40.33 Favored 'General case' 0 CA--C 1.468 -2.197 0 CA-C-N 116.404 -0.362 . . . . 72.01 110.811 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.532 HG22 HG22 ' B' ' 37' ' ' VAL . 76.0 p -115.16 132.6 56.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.431 -0.804 . . . . 62.34 112.023 -175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.509 HD12 HD12 ' A' ' 38' ' ' ILE . 66.9 mt -136.64 124.8 34.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.184 -0.672 . . . . 75.41 109.184 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -115.35 140.89 48.72 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.808 -0.812 . . . . 73.42 108.808 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 40' ' ' ILE . 9.5 tp10 -142.06 116.59 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.263 -0.88 . . . . 70.11 110.168 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.66 -76.66 1.33 Allowed Glycine 0 C--O 1.222 -0.655 0 N-CA-C 111.058 -0.817 . . . . 53.03 111.058 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 37.9 m -153.14 -5.09 0.2 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.499 -0.926 . . . . 52.05 108.499 174.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.575 HD23 HD12 ' A' ' 40' ' ' ILE . 21.5 tp -88.2 140.13 29.79 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.377 1.071 . . . . 72.35 109.057 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -129.92 132.39 46.35 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.16 -0.616 . . . . 73.22 111.898 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.91 44.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.238 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.532 HG22 HG22 ' B' ' 28' ' ' THR . 60.2 t -127.84 127.26 67.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.465 -0.569 . . . . 55.1 109.465 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 29' ' ' ILE . 77.3 mt -104.93 128.92 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 115.457 -0.792 . . . . 60.23 109.051 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.6 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 96.9 m-85 -113.2 116.6 30.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.939 -1.134 . . . . 63.03 107.939 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.513 HG23 HD23 ' A' ' 34' ' ' LEU . 39.1 mm -88.7 114.66 27.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 107.471 -1.307 . . . . 75.42 107.471 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -116.13 -179.83 3.78 Favored 'General case' 0 N--CA 1.412 -2.337 0 C-N-CA 120.549 -0.46 . . . . 62.15 110.642 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.655 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -82.73 -31.39 28.47 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.327 0.862 . . . . 74.33 113.327 -172.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -102.36 -5.04 24.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.138 -0.625 . . . . 75.23 110.636 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.58 -136.74 4.0 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.154 -1.498 . . . . 53.31 114.195 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 49' ' ' ALA . 67.3 tp -118.83 143.05 47.19 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 124.226 1.011 . . . . 44.12 108.998 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.6 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -129.83 121.68 27.22 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.262 -1.384 . . . . 55.41 107.262 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.563 HG11 HG11 ' A' ' 47' ' ' VAL . 13.9 p -114.81 140.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.423 -0.353 . . . . 72.12 110.464 -176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 46.4 m -131.11 141.63 50.16 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.513 0.508 . . . . 64.51 111.804 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.86 124.74 51.43 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.399 -0.819 . . . . 71.02 109.295 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.73 103.78 52.6 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.052 -1.092 . . . . 72.03 108.052 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.44 -1.655 0 C-N-CA 121.603 1.535 . . . . 62.24 112.632 -176.872 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 C--O 1.243 0.759 0 N-CA-C 108.925 -0.768 . . . . 74.35 108.925 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.555 ' OG1' HD13 ' B' ' 14' ' ' LEU . 3.5 p -108.23 149.51 28.49 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 112.237 0.458 . . . . 75.24 112.237 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 72.2 m -133.79 149.32 51.41 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.264 -1.384 . . . . 71.12 107.264 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.429 HG22 HD23 ' B' ' 14' ' ' LEU . 27.1 m -141.21 148.95 20.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.828 0.347 . . . . 73.4 110.698 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.523 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 32.5 t -125.06 144.63 50.31 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.818 -0.628 . . . . 73.43 109.655 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.469 HD13 ' HB ' ' B' ' 10' ' ' THR . 3.9 pp -125.96 142.59 51.45 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.648 -0.705 . . . . 75.22 109.719 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 p -98.6 119.54 37.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.095 -0.706 . . . . 53.23 109.095 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -143.63 -171.84 3.6 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.219 -0.592 . . . . 75.33 110.288 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.0 88.93 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.407 0.683 . . . . 75.34 110.948 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 23.5 mmm180 -126.38 149.24 49.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.442 0.904 . . . . 75.45 113.442 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -108.4 158.11 34.71 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.508 -1.293 . . . . 64.11 107.508 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 27.6 Cg_endo -62.28 136.06 57.71 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.29 1.993 . . . . 72.44 112.533 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -116.49 141.77 32.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.943 -1.026 . . . . 71.21 109.666 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.9 m -67.33 -34.59 77.66 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.204 0.816 . . . . 74.31 113.204 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -132.3 149.87 52.27 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.813 -0.554 . . . . 75.13 111.4 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.9 mm -86.05 115.5 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.59 -1.633 . . . . 51.5 106.59 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.82 128.67 45.1 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 116.125 -0.489 . . . . 64.45 109.695 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.9 p -106.6 127.68 53.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.366 -0.605 . . . . 75.33 109.366 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -123.07 127.96 49.47 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.911 -0.586 . . . . 72.41 110.71 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.688 HG22 HG22 ' A' ' 37' ' ' VAL . 12.1 p -114.41 126.68 55.25 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 74.11 112.329 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.646 HD12 HD12 ' B' ' 38' ' ' ILE . 49.0 mt -123.66 121.66 62.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.754 -0.657 . . . . 75.43 109.729 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -110.25 120.97 44.14 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.622 -1.251 . . . . 73.31 107.622 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.7 tp10 -134.4 106.6 7.15 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.709 -0.396 . . . . 64.2 111.402 -175.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.82 -67.39 1.68 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 116.053 -0.521 . . . . 52.23 113.138 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.5 m -154.91 10.15 0.33 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.257 0.466 . . . . 71.01 112.257 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -128.13 140.74 51.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 118.701 -1.2 . . . . 72.21 111.06 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.0 121.99 46.53 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.307 -0.86 . . . . 75.2 110.32 175.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.42 130.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.323 -0.399 . . . . 42.33 110.007 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.688 HG22 HG22 ' A' ' 28' ' ' THR . 49.8 t -110.06 125.19 67.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.243 -0.435 . . . . 73.24 109.912 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.609 HD12 HD12 ' B' ' 29' ' ' ILE . 70.6 mt -101.19 122.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 108.561 -0.903 . . . . 61.13 108.561 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 75.8 m-85 -104.39 119.08 38.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.608 -1.256 . . . . 71.02 107.608 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HD21 ' B' ' 34' ' ' LEU . 47.2 mm -87.48 113.97 25.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 107.641 -1.244 . . . . 70.43 107.641 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -119.75 -177.7 3.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.89 -0.596 . . . . 74.54 110.674 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -97.26 -20.55 17.82 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.474 0.546 . . . . 74.02 112.474 -177.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.522 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 45.6 ttp180 -91.34 -29.27 17.22 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.773 0.797 . . . . 73.12 109.996 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 178.82 -121.79 0.77 Allowed Glycine 0 C--N 1.293 -1.825 0 C-N-CA 119.18 -1.486 . . . . 71.12 113.276 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HB3' HD11 ' A' ' 14' ' ' LEU . 61.7 tp -137.61 147.05 44.68 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.085 -0.709 . . . . 71.33 109.085 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HD3' ' HB2' ' A' ' 13' ' ' SER . 24.0 tptm -139.42 129.24 24.78 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.208 -1.405 . . . . 73.23 107.208 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 11.4 p -131.13 140.99 47.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.97 -0.382 . . . . 74.02 109.97 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.5 m -119.85 137.91 53.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.314 -0.403 . . . . 71.13 110.707 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.33 124.73 47.34 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.286 0.565 . . . . 65.21 110.554 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.65 104.02 55.31 Favored Pre-proline 0 C--N 1.278 -2.507 0 N-CA-C 107.315 -1.365 . . . . 71.42 107.315 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -95.39 133.46 0.56 Allowed 'Trans proline' 0 N--CA 1.409 -3.497 0 C-N-CA 120.846 1.031 . . . . 70.24 114.076 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 . . . . . 0 C--N 1.311 -1.083 0 C-N-CA 126.101 1.76 . . . . 61.12 114.339 167.486 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' B' ' 50' ' ' ASP . 99.2 mtt180 . . . . . 0 CA--C 1.481 -1.709 0 N-CA-C 107.158 -1.423 . . . . 72.23 107.158 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.469 ' HB ' HD13 ' A' ' 14' ' ' LEU . 8.6 m -102.54 142.98 32.83 Favored 'General case' 0 N--CA 1.382 -3.834 0 N-CA-C 107.041 -1.466 . . . . 62.43 107.041 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 73.3 m -134.46 148.36 50.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.805 -1.183 . . . . 70.41 107.805 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.66 156.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 123.903 0.752 . . . . 75.2 109.344 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -130.69 145.82 52.02 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.752 -0.462 . . . . 54.43 109.752 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' B' ' 45' ' ' LEU . 4.2 pp -130.04 134.98 47.76 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 109.062 -0.718 . . . . 73.11 109.062 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 34.0 p -106.73 141.79 37.41 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 120.414 -0.514 . . . . 73.51 110.726 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -157.41 -171.47 3.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.81 -1.182 . . . . 75.21 107.81 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -69.08 104.41 2.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.888 0.851 . . . . 53.44 109.91 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.427 ' HG3' ' HA2' ' B' ' 44' ' ' GLY . 20.6 mmm180 -125.95 148.08 49.33 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.085 -0.961 . . . . 65.43 111.405 -174.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.602 ' H ' HD23 ' B' ' 19' ' ' LEU . 2.0 pt? -103.52 152.88 38.88 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.067 -1.086 . . . . 64.44 108.067 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.56 136.45 54.46 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.048 1.832 . . . . 61.04 111.788 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.93 149.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 108.351 -0.981 . . . . 74.51 108.351 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -79.53 -41.29 27.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.828 0.347 . . . . 63.01 111.431 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -125.23 134.15 52.44 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.319 -0.238 . . . . 71.44 110.662 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.16 119.92 20.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 107.712 -1.218 . . . . 73.22 107.712 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -91.29 139.12 31.04 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.997 -0.681 . . . . 72.32 110.368 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.1 p -120.37 127.56 52.42 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.87 -0.789 . . . . 35.52 108.87 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -126.84 126.65 43.7 Favored 'General case' 0 CA--C 1.458 -2.593 0 CA-C-N 116.022 -0.536 . . . . 71.01 110.154 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.674 HG22 HG22 ' B' ' 37' ' ' VAL . 53.0 p -115.9 127.46 55.01 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.549 -0.75 . . . . 72.53 111.056 -176.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 38' ' ' ILE . 54.9 mt -121.12 121.27 64.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.098 -0.704 . . . . 61.44 109.098 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 9.2 t -112.39 115.92 29.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.528 -0.916 . . . . 75.21 108.528 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.491 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.2 tp10 -120.71 97.6 5.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.915 -1.039 . . . . 74.4 111.048 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -66.12 0.47 Allowed Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.689 -0.687 . . . . 53.23 114.601 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 48.2 m -145.15 23.83 1.48 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.34 -0.506 . . . . 72.43 111.688 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 40' ' ' ILE . 2.5 pt? -148.49 134.92 19.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 119.049 -1.06 . . . . 71.14 111.767 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.532 ' HD2' ' HB ' ' B' ' 28' ' ' THR . 8.6 tpp180 -101.44 114.08 27.76 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.111 -1.404 . . . . 71.31 108.559 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.65 133.36 51.43 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.584 -0.525 . . . . 71.44 109.584 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.674 HG22 HG22 ' B' ' 28' ' ' THR . 48.2 t -118.85 127.0 75.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.738 0.304 . . . . 71.34 110.967 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.646 HD12 HD12 ' A' ' 29' ' ' ILE . 73.5 mt -102.77 121.87 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 C-N-CA 123.946 0.898 . . . . 75.22 109.039 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.411 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 93.7 m-85 -103.86 114.3 28.46 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.309 -0.997 . . . . 74.22 108.309 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 34' ' ' LEU . 51.1 mm -88.44 112.61 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 106.697 -1.594 . . . . 75.04 106.697 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -121.13 -179.57 4.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 116.424 -0.353 . . . . 74.11 110.181 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -95.93 -17.8 20.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.902 0.382 . . . . 73.24 111.145 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 73.6 ttt180 -98.83 -17.92 18.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.128 0.49 . . . . 73.32 109.842 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . 179.51 -143.07 5.51 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.027 -1.082 . . . . 61.52 113.37 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' B' ' 14' ' ' LEU . 1.9 tm? -139.38 122.86 17.25 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 124.673 1.189 . . . . 74.22 108.04 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -118.53 143.68 46.58 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.961 0.41 . . . . 71.33 110.977 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.57 141.25 46.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.62 -0.718 . . . . 74.42 110.559 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.411 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 62.3 m -127.69 142.17 51.41 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.118 -0.492 . . . . 63.34 111.045 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.04 124.01 48.25 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.187 -0.461 . . . . 33.42 110.202 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 24.2 t70 -118.15 88.09 31.15 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 107.552 -1.277 . . . . 73.14 107.552 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 85.9 Cg_endo . . . . . 0 N--CA 1.42 -2.851 0 C-N-CA 121.64 1.56 . . . . 73.41 114.034 -173.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.671 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 6.1 ppt_? . . . . . 0 N--CA 1.425 -1.701 0 N-CA-C 108.759 -0.83 . . . . 71.44 108.759 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.445 ' CB ' HD13 ' B' ' 14' ' ' LEU . 18.9 p -101.57 148.62 25.01 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 122.112 -0.368 . . . . 71.54 110.959 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.1 m -136.49 157.35 46.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.008 0.432 . . . . 74.41 111.021 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG23 HD11 ' B' ' 14' ' ' LEU . 86.5 t -130.77 134.71 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.58 -0.737 . . . . 52.14 110.776 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -117.93 125.62 50.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.522 -0.547 . . . . 54.24 109.522 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.97 121.77 27.2 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 123.311 0.644 . . . . 72.15 109.817 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 p -125.17 112.79 16.86 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.228 -0.442 . . . . 64.42 111.753 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.587 HG23 ' H ' ' A' ' 17' ' ' GLN . 4.2 t -156.52 -92.07 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.265 1.209 . . . . 74.21 114.265 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.587 ' H ' HG23 ' A' ' 16' ' ' THR . 26.7 tp60 -94.07 91.68 6.95 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.659 0.742 . . . . 74.14 109.198 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 2.5 ppt_? -126.72 149.25 49.68 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.479 -0.782 . . . . 75.14 112.776 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.642 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.2 pt? -110.33 155.19 42.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.283 -1.006 . . . . 70.43 108.283 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.84 136.64 49.93 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.874 1.716 . . . . 43.14 110.986 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.04 144.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.405 -0.816 . . . . 54.3 109.295 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.8 m -87.09 -35.41 18.71 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.259 0.552 . . . . 53.41 111.32 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -123.25 133.14 54.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.782 -0.645 . . . . 54.43 110.976 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.16 115.63 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 107.164 -1.421 . . . . 55.41 107.164 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.1 mmtp -99.35 134.95 41.48 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 120.372 -0.531 . . . . 75.53 110.859 -176.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -114.33 127.16 55.72 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.893 -1.151 . . . . 72.34 107.893 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -120.25 130.39 54.49 Favored 'General case' 0 CA--C 1.457 -2.599 0 CA-C-N 116.224 -0.444 . . . . 75.32 109.992 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.54 HG22 HG22 ' A' ' 37' ' ' VAL . 68.4 p -114.68 122.59 46.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 119.766 -0.773 . . . . 74.24 111.183 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.71 HD12 HD12 ' B' ' 38' ' ' ILE . 89.5 mt -115.82 124.67 72.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.628 -0.878 . . . . 64.13 108.628 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -117.02 116.18 26.86 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.117 0.96 . . . . 71.41 108.794 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.616 ' O ' HD23 ' A' ' 34' ' ' LEU . 15.3 tp10 -136.96 123.18 20.51 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.284 -0.871 . . . . 74.02 110.388 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.81 -84.99 0.37 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.21 -0.756 . . . . 72.14 111.21 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.424 ' HB2' HD22 ' B' ' 19' ' ' LEU . 33.6 m -150.47 10.56 0.66 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 122.726 -0.279 . . . . 63.24 111.06 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -114.81 140.21 49.11 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 119.193 -1.003 . . . . 73.41 111.584 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -100.08 118.05 35.62 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.112 -0.949 . . . . 62.21 108.781 176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.07 116.18 31.48 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.471 -0.566 . . . . 70.11 109.471 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 28' ' ' THR . 60.1 t -108.48 120.7 60.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.167 0.508 . . . . 71.34 110.179 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.66 HD12 HD12 ' B' ' 29' ' ' ILE . 95.0 mt -101.34 124.7 55.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 115.147 -0.933 . . . . 64.32 108.721 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -106.92 115.14 29.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.378 -0.971 . . . . 63.11 108.378 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.69 HD12 HD23 ' B' ' 34' ' ' LEU . 37.3 mm -90.69 114.53 28.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.326 -1.361 . . . . 72.43 107.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -129.47 156.46 44.08 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 120.543 -0.463 . . . . 73.24 110.609 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.529 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -67.4 -13.74 62.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.447 0.699 . . . . 73.42 110.793 -178.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -87.18 -22.56 25.21 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.724 -0.473 . . . . 70.21 109.724 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.17 -138.02 6.5 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.259 -0.972 . . . . 72.02 113.629 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -113.37 128.59 56.51 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.159 0.504 . . . . 62.44 110.597 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 54.4 tptt -137.1 127.96 27.34 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.454 -1.313 . . . . 65.41 107.454 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG11 HG21 ' B' ' 47' ' ' VAL . 9.9 p -132.1 139.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 110.599 -0.149 . . . . 63.13 110.599 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.4 137.71 54.02 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.621 0.248 . . . . 65.54 110.446 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.79 43.07 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.411 -0.359 . . . . 43.35 110.245 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -115.0 104.62 53.89 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.334 -0.848 . . . . 63.54 109.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 89.3 Cg_endo -94.73 134.72 0.72 Allowed 'Trans proline' 0 N--CA 1.427 -2.408 0 C-N-CA 121.712 1.608 . . . . 72.1 114.641 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG2' ' HB3' ' A' ' 33' ' ' SER . 41.7 mt-30 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 126.446 1.898 . . . . 75.44 115.546 170.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 69.2 mtt180 . . . . . 0 N--CA 1.433 -1.29 0 N-CA-C 108.003 -1.11 . . . . 75.22 108.003 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -87.8 143.42 27.15 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.168 -0.924 . . . . 71.34 112.378 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 66.8 m -141.51 149.45 40.88 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.114 -1.069 . . . . 53.24 108.114 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.58 146.21 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 110.339 -0.245 . . . . 62.14 110.339 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 22.5 p -107.26 135.51 48.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.214 0.606 . . . . 70.15 110.767 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.519 HD11 HG23 ' A' ' 12' ' ' VAL . 96.7 mt -116.73 130.59 56.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.122 -0.49 . . . . 73.45 110.642 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -101.66 122.67 44.32 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.871 -0.789 . . . . 52.34 108.871 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.7 t -151.27 -174.96 4.98 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 120.725 0.298 . . . . 75.13 110.58 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -72.06 86.42 1.03 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.522 0.729 . . . . 74.34 109.947 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -126.52 149.24 49.49 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 114.204 1.187 . . . . 71.35 114.204 -179.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.553 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.7 pt? -78.5 134.73 61.56 Favored Pre-proline 0 C--N 1.29 -1.996 0 CA-C-N 114.944 -1.025 . . . . 70.41 109.361 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.96 136.33 34.85 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.093 1.862 . . . . 54.53 111.468 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' B' ' 42' ' ' LYS . 10.9 p -131.29 133.27 62.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.372 -0.831 . . . . 54.23 108.912 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.4 m -84.79 -13.43 51.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.084 0.468 . . . . 73.15 111.928 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.47 ' H ' HG22 ' B' ' 21' ' ' VAL . 30.5 mmm180 -105.94 133.83 50.04 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.812 -0.81 . . . . 75.22 108.812 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -94.29 115.39 32.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.591 -0.892 . . . . 62.25 108.591 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.65 128.72 39.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.905 -0.588 . . . . 71.43 110.39 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.2 p -110.63 127.98 55.49 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.457 -0.792 . . . . 42.04 109.951 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.481 ' HB3' HD13 ' A' ' 29' ' ' ILE . 70.4 m-85 -126.19 127.44 45.7 Favored 'General case' 0 CA--C 1.459 -2.549 0 CA-C-N 115.887 -0.597 . . . . 74.45 110.674 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.546 HG22 HG22 ' B' ' 37' ' ' VAL . 78.0 p -115.14 139.54 49.83 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.942 -1.026 . . . . 72.23 110.802 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 38' ' ' ILE . 49.4 mt -136.89 133.84 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.674 -0.491 . . . . 74.2 109.674 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -117.47 131.91 56.65 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.636 -0.505 . . . . 72.14 109.636 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.416 ' OE1' ' HG3' ' A' ' 25' ' ' LYS . 10.9 tp10 -142.43 114.77 8.38 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.636 -0.711 . . . . 73.51 109.788 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -76.73 0.86 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.118 -0.793 . . . . 72.14 111.118 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 39.8 m -156.92 10.52 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.625 -1.25 . . . . 71.31 107.625 174.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.69 HD23 HD12 ' A' ' 40' ' ' ILE . 45.5 tp -95.52 115.67 27.76 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 115.28 -0.873 . . . . 72.23 108.871 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -107.12 113.54 27.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.983 -1.118 . . . . 71.3 107.983 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.45 34.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.882 -0.414 . . . . 71.1 109.882 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.546 HG22 HG22 ' B' ' 28' ' ' THR . 67.1 t -129.0 129.97 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.849 -0.426 . . . . 44.03 109.849 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 29' ' ' ILE . 80.1 mt -114.78 125.15 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 109.09 -0.707 . . . . 63.21 109.09 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 64.6 m-85 -106.84 116.68 32.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.534 -1.284 . . . . 74.32 107.534 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.17 114.28 26.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 105.922 -1.881 . . . . 63.54 105.922 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -125.6 156.74 38.68 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.117 0.484 . . . . 51.12 110.593 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' B' ' 21' ' ' VAL . 0.1 OUTLIER -60.03 -25.91 65.69 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.47 -0.786 . . . . 72.24 112.435 -177.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -97.1 -8.29 30.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.515 -0.474 . . . . 73.52 111.528 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.0 -153.88 24.79 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 118.305 -1.902 . . . . 70.45 114.547 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.5 HD12 HD12 ' B' ' 14' ' ' LEU . 3.2 tm? -113.66 122.28 46.69 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.19 -1.041 . . . . 64.13 108.19 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 56.9 tptt -117.38 122.13 42.98 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.004 -1.11 . . . . 62.21 108.004 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 47' ' ' VAL . 11.1 p -115.42 139.7 40.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 110.338 -0.245 . . . . 74.54 110.338 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.28 140.44 52.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.127 -0.488 . . . . 60.43 111.585 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.57 124.16 48.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 108.817 -0.809 . . . . 64.15 108.817 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' B' ' 9' ' ' ARG . 15.1 t70 -119.07 95.23 49.18 Favored Pre-proline 0 C--N 1.284 -2.249 0 N-CA-C 104.875 -2.268 . . . . 63.21 104.875 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.408 ' CD ' ' HG2' ' B' ' 9' ' ' ARG . 79.5 Cg_endo . . . . . 0 N--CA 1.429 -2.275 0 C-N-CA 121.935 1.757 . . . . 71.13 116.357 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.437 ' HD3' ' OD1' ' A' ' 50' ' ' ASP . 18.0 ptt180 . . . . . 0 N--CA 1.436 -1.155 0 CA-C-O 121.635 0.731 . . . . 74.02 110.892 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -96.97 148.83 22.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.931 -1.032 . . . . 55.35 111.945 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -127.21 156.23 42.16 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.396 -0.964 . . . . 52.21 108.396 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG2' HD21 ' B' ' 14' ' ' LEU . 94.2 t -134.49 140.76 45.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.663 0.268 . . . . 54.53 110.661 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 p -109.83 125.83 53.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.44 -0.948 . . . . 71.51 108.44 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.51 HD12 HD23 ' A' ' 45' ' ' LEU . 86.5 mt -109.57 127.84 54.78 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.018 0.437 . . . . 65.13 111.987 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.93 114.1 25.79 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.434 -0.95 . . . . 64.1 108.434 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -143.6 -169.89 3.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.861 -1.163 . . . . 64.13 107.861 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.65 99.76 1.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 72.11 109.645 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -125.44 148.38 48.85 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.792 1.034 . . . . 73.04 113.792 -175.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' B' ' 33' ' ' SER . 1.7 pp -102.46 161.75 22.32 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 114.094 -1.412 . . . . 71.3 108.9 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.62 135.98 51.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.587 1.525 . . . . 62.53 111.647 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.7 t -123.91 124.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.347 -0.982 . . . . 64.01 108.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.0 m -86.5 -56.39 3.45 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.432 0.53 . . . . 70.11 112.432 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -93.47 133.39 36.81 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.138 -0.625 . . . . 74.52 110.109 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -83.27 123.31 38.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.533 -0.914 . . . . 65.41 108.533 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -106.5 143.01 35.22 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.318 -0.401 . . . . 74.5 110.303 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -119.72 127.69 53.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.684 -0.858 . . . . 75.03 108.684 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 78.4 m-85 -124.44 130.26 52.15 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-N 115.994 -0.548 . . . . 65.34 110.806 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.526 HG22 HG22 ' A' ' 37' ' ' VAL . 44.9 p -115.22 125.03 52.87 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.103 -0.953 . . . . 71.1 112.158 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.582 HD12 HD12 ' B' ' 38' ' ' ILE . 59.5 mt -129.9 128.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.299 -0.63 . . . . 63.52 109.299 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -119.46 137.16 53.96 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.44 -0.948 . . . . 72.45 108.44 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.567 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.86 111.37 6.23 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.814 0.34 . . . . 73.54 110.195 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.64 -67.94 3.28 Favored Glycine 0 C--N 1.298 -1.528 0 C-N-CA 120.749 -0.738 . . . . 74.22 112.572 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.2 m -156.93 -16.21 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.791 0.437 . . . . 44.55 112.063 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -88.67 140.59 29.3 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 118.468 -1.293 . . . . 64.22 110.615 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 19.8 mmt180 -103.49 119.37 38.76 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.951 -1.5 . . . . 75.24 106.951 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.98 124.74 51.95 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.215 -0.661 . . . . 73.11 109.215 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.526 HG22 HG22 ' A' ' 28' ' ' THR . 99.1 t -117.02 125.52 73.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.035 0.445 . . . . 71.45 111.417 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.564 HD12 HD12 ' B' ' 29' ' ' ILE . 92.4 mt -104.59 121.45 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 C-N-CA 124.033 0.933 . . . . 70.05 109.144 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.0 m-85 -108.54 117.15 33.42 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.767 -1.197 . . . . 71.54 107.767 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.629 HG23 HD21 ' B' ' 34' ' ' LEU . 45.9 mm -88.41 118.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.674 -0.861 . . . . 75.2 108.674 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -134.59 171.95 13.61 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.5 0.667 . . . . 62.01 110.402 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 42' ' ' LYS . 19.4 ptmt -77.21 -15.38 59.51 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.879 0.872 . . . . 75.04 110.419 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -87.88 10.42 18.71 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.162 -1.422 . . . . 73.11 107.162 -177.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -124.73 8.0 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.626 -1.17 . . . . 74.3 112.549 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 14' ' ' LEU . 64.4 tp -112.26 135.04 53.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.865 -0.421 . . . . 74.01 109.865 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.511 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 1.5 tmtm? -128.85 122.4 30.32 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.158 -2.164 . . . . 62.43 105.158 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.664 HG11 HG11 ' B' ' 47' ' ' VAL . 13.6 p -128.29 140.96 47.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 110.171 -0.307 . . . . 72.41 110.171 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 93.7 m -121.07 143.12 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 122.319 0.248 . . . . 43.32 111.035 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.45 123.85 48.51 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.044 -0.724 . . . . 64.34 109.044 177.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 18.5 t70 -124.25 100.53 35.76 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 107.693 -1.225 . . . . 73.14 107.693 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.13 134.19 4.27 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 122.067 1.845 . . . . 32.31 115.143 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.474 ' NE2' ' HG3' ' B' ' 17' ' ' GLN . 49.9 mt-30 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 113.916 -1.493 . . . . 61.34 112.006 169.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 109.292 -0.632 . . . . 44.51 109.292 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.8 p -92.45 145.65 24.29 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.311 -0.404 . . . . 42.41 111.631 -175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.21 149.44 47.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.7 -0.481 . . . . 75.12 109.7 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -142.74 148.73 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.915 0.486 . . . . 72.21 110.147 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 60.5 p -110.62 146.21 36.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 122.482 0.313 . . . . 61.34 110.343 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.499 HD21 ' CG2' ' A' ' 12' ' ' VAL . 96.2 mt -125.74 125.74 43.47 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 123.053 0.541 . . . . 65.44 111.079 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.7 p -104.69 114.31 28.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.939 -0.763 . . . . 71.01 108.939 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -166.75 120.19 1.03 Allowed 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.225 0.328 . . . . 73.24 110.671 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . 0.474 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 6.6 tp-100 34.89 72.55 0.09 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.04 1.736 . . . . 64.52 112.252 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.647 ' NH2' HG21 ' B' ' 21' ' ' VAL . 24.5 tpt180 -126.11 109.98 13.0 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 119.673 -0.811 . . . . 60.04 112.512 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.23 153.88 88.28 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 114.368 -1.287 . . . . 43.33 112.313 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.16 135.63 65.16 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.52 2.813 . . . . 72.15 114.2 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.647 HG21 ' NH2' ' B' ' 18' ' ' ARG . 55.9 t -132.11 137.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.268 -1.333 . . . . 74.41 107.998 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 38.3 m -92.56 -26.94 17.67 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.467 0.914 . . . . 71.05 113.467 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -127.69 154.61 45.1 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.36 0.504 . . . . 70.13 112.36 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.94 132.75 47.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.76 -0.459 . . . . 50.22 109.76 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.511 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 39.8 mmtm -106.27 159.72 15.9 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.638 -0.425 . . . . 64.12 110.028 177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -133.67 126.41 30.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.038 -1.097 . . . . 72.41 108.038 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 74.3 m-85 -126.57 128.6 47.08 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.48 -0.327 . . . . 54.11 110.795 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.608 HG22 HG22 ' B' ' 37' ' ' VAL . 62.2 p -115.93 135.66 53.77 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.858 0.724 . . . . 74.34 111.3 -176.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.564 HD12 HD12 ' A' ' 38' ' ' ILE . 58.4 mt -131.13 127.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.184 -0.462 . . . . 75.42 109.937 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.404 ' HB ' ' NE ' ' B' ' 35' ' ' ARG . 11.5 t -104.35 123.99 48.39 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.226 0.536 . . . . 73.31 109.682 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.668 ' O ' HD23 ' B' ' 34' ' ' LEU . 10.6 tp10 -142.88 123.55 14.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.65 -0.5 . . . . 73.3 109.65 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.08 -77.71 0.3 Allowed Glycine 0 C--O 1.217 -0.938 0 N-CA-C 111.208 -0.757 . . . . 64.33 111.208 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.416 ' HB2' HD21 ' A' ' 19' ' ' LEU . 69.4 m -157.65 -0.22 0.11 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.838 0.855 . . . . 54.42 110.847 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.668 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -101.34 137.84 39.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.422 -1.311 . . . . 54.44 110.106 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.442 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 38.3 mmm-85 -100.92 122.82 44.14 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.285 -1.376 . . . . 64.23 107.285 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.87 117.77 35.12 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.949 -1.13 . . . . 55.01 107.949 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.608 HG22 HG22 ' B' ' 28' ' ' THR . 58.0 t -110.29 128.05 66.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.37 0.605 . . . . 64.11 110.308 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 29' ' ' ILE . 85.3 mt -111.55 120.08 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.908 -1.042 . . . . 64.12 109.257 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 95.8 m-85 -102.65 116.43 32.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.965 -1.124 . . . . 72.43 107.965 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.547 HD12 HD21 ' A' ' 34' ' ' LEU . 49.7 mm -88.47 114.03 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.28 -1.007 . . . . 63.24 108.28 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 t -127.3 169.47 13.51 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 115.623 -0.717 . . . . 70.2 109.729 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -83.0 -13.48 55.87 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.746 -0.465 . . . . 73.55 109.746 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.66 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.5 tmt_? -87.68 3.17 48.92 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.317 1.056 . . . . 65.43 108.6 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' B' ' 18' ' ' ARG . . . 128.17 -138.42 10.37 Favored Glycine 0 CA--C 1.504 -0.608 0 CA-C-N 115.26 -0.882 . . . . 75.42 113.087 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 68.1 tp -112.24 126.05 54.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.733 -0.84 . . . . 74.21 108.733 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 1.8 tmtm? -116.78 121.13 40.69 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.526 -2.027 . . . . 73.05 105.526 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 47' ' ' VAL . 14.0 p -116.58 140.84 37.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 116.639 -0.255 . . . . 72.31 110.722 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.523 ' SG ' ' HE3' ' B' ' 46' ' ' LYS . 68.4 m -130.41 140.78 50.56 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.656 0.382 . . . . 73.51 111.237 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -116.2 123.25 47.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.564 -0.902 . . . . 73.33 108.564 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 13.7 t70 -122.42 103.0 38.83 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.877 -1.157 . . . . 71.21 107.877 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 N--CA 1.434 -1.976 0 C-N-CA 122.263 1.975 . . . . 74.45 116.549 -173.911 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 . . . . . 0 N--CA 1.445 -0.677 0 N-CA-C 108.315 -0.994 . . . . 70.4 108.315 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -87.73 135.65 33.28 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.822 -0.627 . . . . 53.2 111.406 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.6 m -130.38 148.45 52.2 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.201 -0.666 . . . . 53.31 109.201 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.9 t -144.66 141.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.473 -0.331 . . . . 62.12 110.174 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 p -109.24 130.71 55.49 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.21 0.528 . . . . 71.35 109.896 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.73 120.33 40.18 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.448 -1.686 . . . . 73.12 106.448 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.5 m -97.26 111.71 23.83 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.831 -1.544 . . . . 54.11 106.831 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' B' ' 51' ' ' PRO . 8.6 t -133.47 154.11 51.07 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.206 -0.907 . . . . 51.12 110.199 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -72.4 99.44 2.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.888 0.852 . . . . 65.1 110.383 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -126.71 148.47 49.86 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.079 -1.452 . . . . 53.24 107.079 178.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.677 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.4 pt? -73.19 127.71 88.78 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.191 -1.041 . . . . 74.13 108.191 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.86 152.91 60.52 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 123.904 3.07 . . . . 72.42 116.772 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 13.1 p -131.82 149.18 32.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.298 -1.774 . . . . 74.0 106.908 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.6 m -102.1 16.24 26.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.751 -0.38 . . . . 74.23 111.53 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -134.0 152.79 51.99 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 122.196 -0.315 . . . . 71.15 110.795 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -101.72 132.12 48.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.955 -0.757 . . . . 73.12 108.955 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 14.0 mmmm -121.65 126.28 48.63 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.602 -0.888 . . . . 44.53 108.602 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -106.38 127.75 53.51 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.092 -0.707 . . . . 42.53 109.092 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -123.89 126.58 46.64 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.123 -0.489 . . . . 61.03 110.865 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.59 HG22 HG22 ' A' ' 37' ' ' VAL . 81.6 p -115.04 131.42 56.93 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.213 -0.903 . . . . 71.43 111.106 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.597 HD12 HD12 ' B' ' 38' ' ' ILE . 52.8 mt -128.63 121.54 55.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.173 -0.677 . . . . 54.42 109.173 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.9 t -111.48 128.26 55.95 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.737 -1.208 . . . . 71.54 107.737 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.3 tp10 -140.4 119.44 12.73 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.145 -176.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.91 -86.76 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 116.164 -0.471 . . . . 73.34 112.937 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.473 ' CB ' HD21 ' B' ' 19' ' ' LEU . 40.5 m -142.58 15.34 1.98 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.012 0.434 . . . . 74.5 110.446 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.657 HD21 HG23 ' B' ' 40' ' ' ILE . 2.0 pt? -127.35 141.35 51.72 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.552 -0.459 . . . . 72.45 109.841 176.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -122.14 131.82 54.15 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.685 -0.689 . . . . 54.15 110.169 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.47 143.88 49.0 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.248 -0.433 . . . . 63.34 110.435 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 28' ' ' THR . 96.6 t -124.85 127.05 72.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.067 -0.515 . . . . 72.53 110.986 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.568 HD12 HD12 ' B' ' 29' ' ' ILE . 75.8 mt -103.43 122.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 C-N-CA 123.984 0.914 . . . . 71.52 109.174 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.9 m-85 -106.1 114.8 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.427 -0.953 . . . . 75.51 108.427 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.608 HG23 HD21 ' B' ' 34' ' ' LEU . 42.0 mm -88.51 114.67 27.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.416 -0.811 . . . . 71.42 108.834 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -126.96 162.05 26.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.662 -0.699 . . . . 53.41 109.405 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -71.11 -0.69 10.18 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 121.037 0.446 . . . . 75.42 112.087 173.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -87.69 -22.07 24.86 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.304 -0.998 . . . . 65.33 108.304 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.555 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 133.77 -119.93 2.4 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.849 -1.068 . . . . 61.23 110.844 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.4 tp -115.51 143.88 44.67 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 115.236 -0.482 . . . . 74.23 111.18 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -140.87 139.56 34.43 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.949 -0.76 . . . . 55.21 108.949 170.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.01 141.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 116.332 -0.394 . . . . 75.53 111.134 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.414 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 49.5 m -120.2 139.29 52.87 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.979 -0.555 . . . . 63.04 110.684 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HB1' HH22 ' B' ' 18' ' ' ARG . . . -116.53 125.28 51.67 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.001 -0.545 . . . . 74.4 110.448 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -124.43 108.92 29.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.046 -0.525 . . . . 74.32 109.833 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HB3' ' NE ' ' B' ' 18' ' ' ARG . 73.6 Cg_endo -94.22 134.26 0.82 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 121.786 1.657 . . . . 30.11 114.99 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 . . . . . 0 CA--C 1.556 1.185 0 CA-C-N 114.049 -1.432 . . . . 62.53 114.065 165.616 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 . . . . . 0 C--O 1.237 0.419 0 N-CA-C 110.241 -0.281 . . . . 74.4 110.241 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -87.77 128.74 35.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 110.267 -0.272 . . . . 52.14 110.267 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 82.2 m -129.88 149.37 51.65 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.831 -0.433 . . . . 74.12 109.831 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.2 t -144.14 138.57 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.47 0.481 . . . . 73.34 110.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -107.58 129.01 55.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.311 0.577 . . . . 60.21 111.499 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.82 121.67 44.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.387 -0.824 . . . . 70.11 109.754 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 18.0 m -106.82 116.19 31.49 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 108.056 -1.091 . . . . 73.45 108.056 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -138.68 -169.76 2.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.287 -0.87 . . . . 72.22 108.763 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -74.12 93.7 2.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.607 -0.886 . . . . 61.12 108.607 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.52 ' NE ' ' HB3' ' A' ' 51' ' ' PRO . 8.5 tpp85 -127.51 133.94 49.81 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.696 -0.853 . . . . 74.05 108.696 -177.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -74.95 162.63 72.68 Favored Pre-proline 0 C--N 1.294 -1.832 0 CA-C-N 116.232 -0.44 . . . . 71.41 111.705 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 36.0 Cg_endo -66.73 147.95 82.07 Favored 'Trans proline' 0 C--O 1.254 1.32 0 C-N-CA 122.123 1.882 . . . . 71.34 112.17 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -125.78 146.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.244 -1.021 . . . . 63.11 108.244 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 m -67.73 -53.15 29.77 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 123.104 0.253 . . . . 62.23 111.574 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -125.36 151.31 46.27 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 110.018 -0.364 . . . . 73.32 110.018 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.75 114.58 23.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.762 -1.199 . . . . 61.23 107.762 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.15 148.19 22.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.587 -0.523 . . . . 71.22 109.587 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.7 m -128.46 127.54 42.68 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.075 -1.083 . . . . 64.4 108.075 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -123.59 127.14 47.86 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-O 121.046 0.45 . . . . 74.54 111.296 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.582 HG22 HG22 ' B' ' 37' ' ' VAL . 76.7 p -114.52 132.99 56.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 114.879 -1.055 . . . . 75.54 110.02 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 38' ' ' ILE . 51.2 mt -129.51 120.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 109.285 -0.635 . . . . 63.42 109.285 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 7.2 t -100.12 124.66 45.77 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.908 -1.145 . . . . 75.13 107.908 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.493 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.0 tp10 -142.41 101.0 3.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.92 -0.582 . . . . 75.12 112.353 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.85 -67.65 0.45 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 116.071 1.188 . . . . 72.31 116.071 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 42.1 m -137.8 -3.38 1.85 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.458 0.54 . . . . 54.34 112.458 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 40' ' ' ILE . 2.3 pt? -140.65 141.09 35.09 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 120.235 -0.586 . . . . 72.32 109.883 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -109.48 125.42 52.44 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 119.558 -0.857 . . . . 71.25 108.885 171.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.27 145.0 30.86 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.564 -0.289 . . . . 71.45 110.777 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.582 HG22 HG22 ' B' ' 28' ' ' THR . 95.0 t -124.05 128.18 73.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.888 -0.596 . . . . 72.21 110.725 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 29' ' ' ILE . 68.9 mt -108.36 123.78 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 C-N-CA 124.334 1.054 . . . . 75.22 109.454 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.442 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 99.1 m-85 -103.29 120.19 40.29 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.859 -0.793 . . . . 75.45 108.859 175.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.657 HG23 HD21 ' A' ' 34' ' ' LEU . 39.7 mm -87.73 114.47 26.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 107.688 -1.227 . . . . 62.43 107.688 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -135.34 154.97 51.33 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.917 -0.583 . . . . 75.54 111.263 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.728 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -71.77 -14.7 62.07 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.972 -0.558 . . . . 71.0 111.219 177.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' B' ' 15' ' ' THR . 54.0 mtp180 -86.34 -16.19 38.2 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.536 0.684 . . . . 73.34 109.366 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.16 -108.16 0.44 Allowed Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 119.916 -1.135 . . . . 31.52 112.67 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 53.0 tp -139.36 143.7 37.87 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.833 -0.684 . . . . 64.33 109.47 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -131.5 140.46 49.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.262 -1.014 . . . . 75.33 108.262 167.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.7 140.48 48.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.719 -0.673 . . . . 63.4 110.209 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.492 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 36.5 m -127.58 141.11 51.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.88 -0.6 . . . . 73.25 110.967 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.38 124.39 49.93 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.899 -0.591 . . . . 71.42 110.308 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -110.72 95.91 25.87 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.014 -1.106 . . . . 53.52 108.014 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.485 ' HG3' ' OG1' ' A' ' 16' ' ' THR . 93.6 Cg_endo . . . . . 0 N--CA 1.411 -3.361 0 C-N-CA 120.097 0.531 . . . . 74.42 111.597 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 . . . . . 0 CA--C 1.476 -1.889 0 N-CA-C 107.665 -1.235 . . . . 73.4 107.665 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -108.04 134.98 50.17 Favored 'General case' 0 C--N 1.272 -2.792 0 C-N-CA 120.077 -0.649 . . . . 64.44 111.073 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.3 m -125.55 147.56 49.22 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.606 -0.516 . . . . 75.42 109.606 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -145.99 147.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.721 0.808 . . . . 73.43 109.741 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 17.9 t -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.222 -0.659 . . . . 73.21 109.222 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.7 mm? -101.47 132.39 47.11 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 123.572 0.749 . . . . 74.14 110.522 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -99.84 110.93 23.28 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.108 0.956 . . . . 75.31 109.474 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.0 p -140.95 179.81 6.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.082 -0.963 . . . . 75.33 110.68 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' B' ' 51' ' ' PRO . 22.3 tp60 -67.55 95.8 0.49 Allowed 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.839 -0.8 . . . . 74.13 108.839 174.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.54 149.37 45.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.826 -0.749 . . . . 73.12 110.999 -173.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mp -77.04 140.3 66.26 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 106.159 -1.793 . . . . 74.02 106.159 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.68 134.66 45.05 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.023 1.149 . . . . 62.24 109.551 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.52 138.87 48.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.8 -0.637 . . . . 73.55 110.108 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.2 m -90.28 -58.98 2.31 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.184 -0.462 . . . . 74.52 111.022 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -89.78 133.99 34.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.834 -0.432 . . . . 73.41 109.834 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.23 122.56 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.637 -0.505 . . . . 65.44 109.637 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.43 153.94 20.44 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.057 0.456 . . . . 70.43 110.994 178.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.4 m -132.69 127.97 35.94 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.459 -0.941 . . . . 55.42 108.459 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' B' ' 29' ' ' ILE . 72.5 m-85 -127.35 126.8 43.17 Favored 'General case' 0 CA--C 1.467 -2.245 0 CA-C-N 115.863 -0.608 . . . . 63.04 110.088 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 37' ' ' VAL . 69.2 p -115.82 131.69 56.86 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.317 -0.856 . . . . 71.23 111.795 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.596 HD12 HD12 ' B' ' 38' ' ' ILE . 49.4 mt -131.27 124.57 55.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.129 -0.487 . . . . 50.4 109.867 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -102.45 132.46 48.47 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.46 -0.941 . . . . 74.43 108.46 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.5 tp10 -140.25 106.44 5.24 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.271 -0.64 . . . . 64.23 109.271 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -96.97 0.33 Allowed Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.823 -0.626 . . . . 64.22 112.289 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -120.34 1.53 10.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 111.983 0.364 . . . . 64.42 111.983 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.4 pt? -118.14 140.87 49.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.891 -1.124 . . . . 74.31 111.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.62 120.94 43.6 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.618 -1.174 . . . . 72.03 108.114 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.28 128.91 52.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.847 -0.797 . . . . 75.35 108.847 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 28' ' ' THR . 67.1 t -119.1 135.23 60.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.017 0.437 . . . . 63.24 110.693 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.772 HD12 HD12 ' B' ' 29' ' ' ILE . 72.4 mt -116.14 131.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-N 115.525 -0.761 . . . . 62.4 109.966 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 99.2 m-85 -115.22 120.61 40.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.387 -0.968 . . . . 74.44 108.387 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.622 HG13 ' HG2' ' B' ' 31' ' ' GLU . 32.1 mm -92.59 114.88 30.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.065 -1.457 . . . . 75.44 107.065 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -120.32 178.23 4.73 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.897 -0.592 . . . . 75.45 111.426 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -71.77 -16.7 62.2 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.559 0.695 . . . . 73.43 110.112 175.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.563 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 75.9 ttt180 -90.17 -12.62 37.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.718 -1.128 . . . . 63.04 108.176 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -109.84 1.42 Allowed Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 114.526 -1.215 . . . . 63.22 112.216 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.45 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 64.1 tp -113.06 143.78 43.75 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.15 -0.525 . . . . 74.04 110.26 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 87.2 tttt -141.01 142.85 34.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.041 -0.725 . . . . 65.04 109.041 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.7 140.59 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-N 115.615 -0.72 . . . . 64.41 109.677 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.4 m -126.76 142.02 51.66 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.561 -0.745 . . . . 74.42 110.687 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -114.82 124.78 52.62 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.659 -0.701 . . . . 72.04 109.574 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -126.3 90.02 50.97 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.479 -0.934 . . . . 72.23 108.479 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 97.7 Cg_endo -103.13 148.39 0.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 122.952 2.435 . . . . 73.13 115.045 -177.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' B' ' 18' ' ' ARG . 17.7 mt-30 . . . . . 0 C--O 1.244 0.789 0 CA-C-N 113.83 -1.532 . . . . 64.44 114.616 163.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 . . . . . 0 N--CA 1.437 -1.094 0 N-CA-C 109.831 -0.433 . . . . 74.22 109.831 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -103.25 148.47 25.77 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.177 0.513 . . . . 52.4 111.469 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 67.9 m -134.61 149.4 50.57 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.906 -1.146 . . . . 73.22 107.906 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -141.56 143.05 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.192 0.308 . . . . 60.24 110.253 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 47.1 t -107.26 137.13 45.88 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.806 -0.812 . . . . 22.41 108.806 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.15 121.47 43.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.394 -0.821 . . . . 72.14 109.641 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 9.6 p -95.19 111.52 23.35 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.369 -0.974 . . . . 71.31 108.369 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -126.75 165.62 18.93 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.92 -1.037 . . . . 60.4 109.086 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -70.59 105.84 3.27 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.468 -1.678 . . . . 74.43 106.468 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.641 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 35.4 mmm-85 -125.98 148.37 49.28 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 117.639 2.459 . . . . 71.23 117.639 -168.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.631 ' HG ' ' CD ' ' A' ' 52' ' ' GLN . 68.9 mt -84.79 131.61 48.8 Favored Pre-proline 0 C--O 1.255 1.391 0 CA-C-N 112.878 -1.965 . . . . 74.31 106.469 168.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.56 136.23 41.99 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.909 1.739 . . . . 72.31 111.626 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.422 HG12 ' H ' ' B' ' 23' ' ' ARG . 94.7 t -114.03 135.14 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.968 -1.015 . . . . 51.34 108.452 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -78.18 -22.58 48.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.058 0.762 . . . . 51.13 113.058 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.422 ' H ' HG12 ' B' ' 21' ' ' VAL . 14.7 tpt180 -127.95 139.44 52.58 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.596 -0.841 . . . . 74.45 109.61 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' B' ' 41' ' ' THR . 50.4 mm -90.9 138.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.597 -0.52 . . . . 71.34 109.597 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -118.39 157.18 27.64 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.451 0.643 . . . . 74.21 112.134 178.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.1 m -133.5 126.4 31.01 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.973 -1.012 . . . . 70.3 108.952 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.43 ' HB2' ' HB ' ' B' ' 38' ' ' ILE . 68.7 m-85 -124.77 135.77 53.26 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 116.121 -0.49 . . . . 74.33 111.43 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.556 HG22 HG22 ' B' ' 37' ' ' VAL . 44.9 p -115.17 128.36 56.13 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.196 -0.911 . . . . 75.22 111.278 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.772 HD12 HD12 ' A' ' 38' ' ' ILE . 72.0 mt -124.7 127.72 72.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.286 0.634 . . . . 71.1 109.578 177.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -112.83 128.41 56.44 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 109.515 -0.55 . . . . 75.15 109.515 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.622 ' HG2' HG13 ' A' ' 40' ' ' ILE . 11.5 tp10 -132.06 97.87 4.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.412 0.625 . . . . 70.24 110.205 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.49 -74.41 1.08 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 114.742 -1.117 . . . . 71.04 112.421 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.1 t -144.94 -1.62 0.85 Allowed 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.658 0.742 . . . . 64.24 109.075 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.552 HD23 HD12 ' A' ' 40' ' ' ILE . 35.5 tp -99.32 118.63 36.4 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 115.89 -0.595 . . . . 63.55 110.71 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 21.2 tpp180 -98.86 114.75 27.47 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.513 -0.767 . . . . 72.45 109.657 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.13 136.26 48.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 110.087 -0.338 . . . . 72.03 110.087 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.556 HG22 HG22 ' B' ' 28' ' ' THR . 97.0 t -121.52 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.866 0.365 . . . . 74.22 111.341 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.596 HD12 HD12 ' A' ' 29' ' ' ILE . 82.8 mt -105.73 117.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 C-N-CA 124.586 1.154 . . . . 74.2 109.175 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.522 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.1 m-85 -102.78 116.22 32.13 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.893 -0.78 . . . . 71.12 108.893 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 34' ' ' LEU . 47.1 mm -89.06 113.54 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.187 -1.412 . . . . 73.4 107.187 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . 0.408 ' HA ' HD12 ' B' ' 24' ' ' ILE . 39.7 p -115.03 170.17 8.55 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 116.136 -0.484 . . . . 72.2 110.201 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.551 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -80.48 -19.93 44.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.854 0.359 . . . . 53.15 111.346 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.551 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 70.2 ttt180 -94.97 -17.49 21.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.59 0.71 . . . . 75.01 109.905 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.526 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . 164.08 -128.94 1.9 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.427 -1.368 . . . . 55.01 113.921 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.409 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 67.7 tp -130.41 147.36 52.1 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 109.031 -0.729 . . . . 61.52 109.031 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 85.5 tttt -139.75 143.16 36.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.148 -0.686 . . . . 73.53 109.148 172.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 13.7 p -130.45 140.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.877 -0.602 . . . . 74.42 109.915 -175.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.522 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.6 m -124.84 138.51 54.26 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.37 -0.377 . . . . 72.4 110.839 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -115.86 124.75 51.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.082 -0.508 . . . . 71.14 112.034 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 18.0 t70 -122.37 95.84 46.64 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 108.636 -0.876 . . . . 63.25 108.636 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.491 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 56.5 Cg_endo . . . . . 0 N--CA 1.411 -3.364 0 C-N-CA 121.456 1.438 . . . . 64.4 113.48 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 3.8 ppt_? . . . . . 0 N--CA 1.413 -2.315 0 N-CA-C 108.272 -1.01 . . . . 74.23 108.272 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -94.18 138.97 31.61 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 115.912 -0.586 . . . . 64.22 111.141 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 79.7 m -137.13 147.6 46.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.454 -0.943 . . . . 53.14 108.454 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG11 HG11 ' B' ' 12' ' ' VAL . 53.9 t -144.4 144.42 22.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 123.078 0.236 . . . . 74.12 110.38 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -107.24 138.26 43.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 109.408 -0.59 . . . . 53.55 109.408 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mp -114.91 133.67 55.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.467 -0.333 . . . . 70.04 110.618 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 p -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.599 0.714 . . . . 72.22 111.319 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -150.05 167.87 25.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.942 -1.503 . . . . 72.32 106.942 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 100.44 1.46 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 122.368 1.08 . . . . 61.41 111.905 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -125.64 139.98 53.1 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.108 -0.951 . . . . 62.12 110.219 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.46 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.9 mm? -74.73 141.73 76.15 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.973 -1.012 . . . . 75.01 109.067 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.07 135.89 42.38 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.171 1.914 . . . . 73.24 111.784 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 23' ' ' ARG . 11.6 p -131.98 136.15 57.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.006 -1.109 . . . . 73.41 108.006 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 m -84.23 2.18 41.13 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.371 0.508 . . . . 73.1 112.371 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 21' ' ' VAL . 29.0 mmm180 -116.56 155.66 28.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.529 -0.545 . . . . 65.34 109.529 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.22 114.88 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.035 0 N-CA-C 105.121 -2.177 . . . . 73.04 105.121 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 35.1 tptt -100.74 125.57 47.21 Favored 'General case' 0 N--CA 1.406 -2.645 0 C-N-CA 117.45 -1.7 . . . . 71.22 108.904 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 31.2 m -109.81 128.41 55.3 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.92 -0.582 . . . . 74.42 109.975 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 76.2 m-85 -125.76 128.02 47.08 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.954 -0.566 . . . . 72.05 109.846 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.492 HG22 HG22 ' A' ' 37' ' ' VAL . 79.3 p -115.37 119.02 34.88 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.218 -0.593 . . . . 70.34 111.914 -175.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.604 HD12 HD12 ' B' ' 38' ' ' ILE . 63.8 mt -120.6 121.42 65.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 109.336 -0.616 . . . . 73.35 109.336 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.417 ' CB ' HH11 ' A' ' 35' ' ' ARG . 5.7 t -108.49 134.25 51.52 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.449 -0.945 . . . . 74.53 108.449 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 97.52 3.48 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-O 121.751 0.786 . . . . 73.21 110.231 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.96 -82.85 1.5 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 114.692 -1.14 . . . . 72.55 112.123 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -144.34 32.73 1.2 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.139 -1.43 . . . . 71.13 107.139 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.648 HD23 HD12 ' B' ' 40' ' ' ILE . 33.7 tp -135.76 117.8 15.37 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 115.276 -0.874 . . . . 63.53 110.694 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' CB ' ' A' ' 30' ' ' THR . 30.4 mmt180 -96.79 116.5 29.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.159 -0.682 . . . . 53.44 109.159 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.9 126.88 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.347 -0.612 . . . . 61.24 109.347 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 28' ' ' THR . 97.2 t -120.16 126.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.964 0.411 . . . . 63.11 110.741 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.62 HD12 HD12 ' B' ' 29' ' ' ILE . 80.2 mt -105.41 131.61 54.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.656 -0.702 . . . . 73.15 109.596 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 95.6 m-85 -115.9 114.88 25.28 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.327 -0.99 . . . . 73.12 108.327 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.539 HD12 HD23 ' B' ' 34' ' ' LEU . 37.3 mm -89.53 121.4 39.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.665 -1.235 . . . . 75.11 107.665 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 p -125.52 174.53 8.16 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.535 0.683 . . . . 73.24 110.942 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.9 -19.86 56.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.676 -1.147 . . . . 54.14 109.025 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -86.6 -25.73 24.79 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.648 -1.241 . . . . 74.15 107.648 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -130.92 3.66 Favored Glycine 0 C--N 1.291 -1.948 0 CA-C-N 114.098 -1.41 . . . . 63.31 112.942 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 61.5 tp -113.22 137.12 51.94 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.601 -0.518 . . . . 74.22 109.601 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -134.63 142.36 46.86 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.938 -0.764 . . . . 62.11 108.938 171.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 7.2 p -131.58 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.999 -0.546 . . . . 64.02 110.041 -175.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.428 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 52.6 m -123.1 139.41 54.09 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.119 -0.492 . . . . 52.14 111.045 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -117.36 124.32 48.62 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.903 -0.777 . . . . 64.34 108.903 177.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.58 82.64 67.9 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 106.615 -1.624 . . . . 45.24 106.615 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HD2' ' OE1' ' B' ' 17' ' ' GLN . 3.3 Cg_exo -76.82 145.67 25.66 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.093 1.862 . . . . 72.22 112.688 -176.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 125.536 1.534 . . . . 74.04 114.252 175.477 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 15.8 ptt-85 . . . . . 0 N--CA 1.425 -1.722 0 N-CA-C 108.748 -0.834 . . . . 75.03 108.748 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -91.81 144.73 25.2 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.839 -0.345 . . . . 65.24 110.906 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -141.43 149.46 41.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 62.21 108.595 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.425 HG11 HG11 ' A' ' 12' ' ' VAL . 55.3 t -141.85 138.01 31.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.495 -0.321 . . . . 72.25 110.257 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 26.5 p -107.37 125.23 50.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.553 -0.906 . . . . 75.21 108.553 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.61 123.66 45.98 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.047 -0.524 . . . . 64.22 109.931 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 37.0 p -89.17 112.42 23.42 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.504 -0.554 . . . . 74.41 109.504 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -141.49 -172.47 3.53 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.551 -0.907 . . . . 73.11 108.551 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . 0.452 ' OE1' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -79.95 89.26 5.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.285 1.041 . . . . 74.32 110.934 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.409 ' CB ' ' HA2' ' B' ' 44' ' ' GLY . 26.4 tpt180 -126.34 142.57 51.48 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.418 -0.81 . . . . 70.01 111.236 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.03 152.09 52.77 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.05 -0.977 . . . . 62.53 108.628 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.94 145.81 86.4 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.945 1.763 . . . . 74.52 111.052 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.416 HG22 ' H ' ' B' ' 23' ' ' ARG . 14.3 p -131.53 141.71 45.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.41 -0.814 . . . . 62.44 109.298 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 49.7 m -82.0 -27.04 33.34 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.07 0.396 . . . . 74.31 112.07 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.416 ' H ' HG22 ' B' ' 21' ' ' VAL . 30.1 mmm180 -113.99 132.75 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 120.729 -0.388 . . . . 64.35 110.649 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -90.69 115.11 29.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.789 -1.189 . . . . 73.11 107.789 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.407 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 75.3 mmtt -94.15 137.92 32.78 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.034 -0.53 . . . . 53.04 111.391 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.4 m -116.27 127.93 55.14 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.992 -1.004 . . . . 60.42 108.867 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -127.88 126.64 41.94 Favored 'General case' 0 CA--C 1.461 -2.46 0 CA-C-N 115.605 -0.725 . . . . 74.41 109.749 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.667 HG22 HG22 ' B' ' 37' ' ' VAL . 64.4 p -115.38 132.56 56.58 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.76 -0.654 . . . . 73.42 111.13 -177.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.62 HD12 HD12 ' A' ' 38' ' ' ILE . 55.1 mt -126.04 136.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 109.213 -0.662 . . . . 63.31 109.213 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 10.1 t -119.15 127.28 53.18 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 121.744 0.783 . . . . 63.1 109.653 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -135.86 110.61 8.7 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.37 -0.832 . . . . 74.31 110.236 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -68.12 3.05 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.143 -0.783 . . . . 75.25 111.143 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.9 t -165.82 11.71 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.065 -1.457 . . . . 74.02 107.065 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.539 HD23 HD12 ' A' ' 40' ' ' ILE . 29.4 tp -102.13 123.65 46.37 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.494 -0.775 . . . . 63.23 111.56 -174.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 35.5 mmt180 -94.46 113.7 25.6 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.021 -0.536 . . . . 63.21 110.501 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.1 124.55 49.73 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.79 -1.189 . . . . 73.41 107.79 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.667 HG22 HG22 ' B' ' 28' ' ' THR . 65.8 t -117.2 128.64 74.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.002 0.43 . . . . 54.12 111.373 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.604 HD12 HD12 ' A' ' 29' ' ' ILE . 67.3 mt -106.96 128.19 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.283 -0.871 . . . . 71.11 109.995 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.8 m-85 -111.74 118.37 35.43 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.418 -0.956 . . . . 74.2 108.418 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.648 HD12 HD23 ' A' ' 34' ' ' LEU . 38.2 mm -87.87 114.62 26.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.441 -1.688 . . . . 75.22 106.441 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 69.5 p -123.1 -177.93 3.82 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.63 0.729 . . . . 74.24 112.323 -173.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' B' ' 43' ' ' ARG . 54.7 pttt -80.2 -29.81 38.63 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.886 -1.506 . . . . 75.54 109.488 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.579 ' N ' ' HG3' ' B' ' 42' ' ' LYS . 77.1 ttt180 -88.02 -17.41 31.24 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.211 1.005 . . . . 74.45 109.19 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' B' ' 18' ' ' ARG . . . 147.83 -121.99 1.46 Allowed Glycine 0 N--CA 1.425 -2.055 0 CA-C-N 114.305 -1.316 . . . . 73.1 112.549 177.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 67.0 tp -119.47 133.77 55.54 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.646 -0.777 . . . . 72.14 109.285 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 82.7 tttt -124.77 141.53 52.05 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.455 -0.572 . . . . 65.0 109.455 172.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.42 HG11 HG11 ' A' ' 47' ' ' VAL . 12.1 p -131.23 141.11 46.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 115.673 -0.694 . . . . 54.44 110.231 -175.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.434 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 65.9 m -125.63 141.59 51.94 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 116.29 -0.414 . . . . 73.45 110.577 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -116.31 123.89 48.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.741 -0.837 . . . . 61.3 108.741 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 13.2 t70 -132.26 97.8 17.68 Favored Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 107.516 -1.29 . . . . 61.21 107.516 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo . . . . . 0 N--CA 1.425 -2.523 0 C-N-CA 121.775 1.65 . . . . 72.14 115.357 -174.267 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 97.3 mtt180 . . . . . 0 N--CA 1.434 -1.235 0 N-CA-C 109.021 -0.733 . . . . 74.22 109.021 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 p -98.57 125.48 43.83 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.151 -0.477 . . . . 72.23 109.972 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.2 m -127.83 148.59 50.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.442 -0.503 . . . . 73.42 110.125 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.484 ' CG2' HD11 ' B' ' 14' ' ' LEU . 98.7 t -144.17 143.25 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.774 0.429 . . . . 73.3 109.994 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.8 p -123.56 125.49 44.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.377 0.423 . . . . 65.43 110.397 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 mm? -106.56 121.84 45.11 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.189 -0.46 . . . . 63.03 111.243 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.5 p -92.28 112.88 24.99 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.757 0.789 . . . . 71.2 109.071 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.454 ' CG2' ' HG3' ' B' ' 51' ' ' PRO . 5.1 t -134.54 -172.62 3.07 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.918 -1.037 . . . . 60.54 109.367 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -74.69 81.98 2.06 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.469 1.128 . . . . 71.31 111.251 -177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.528 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -127.21 142.37 51.5 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.283 -0.871 . . . . 71.31 110.297 -178.016 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -74.46 147.73 85.2 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.342 -0.984 . . . . 55.51 108.342 176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.52 136.89 29.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.944 1.763 . . . . 54.23 112.03 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 23' ' ' ARG . 34.6 t -115.41 142.68 27.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.753 -1.203 . . . . 75.11 107.753 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 m -88.43 -2.28 58.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.631 0.604 . . . . 71.54 112.631 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.567 ' H ' HG12 ' A' ' 21' ' ' VAL . 64.0 ttt180 -134.58 148.75 50.52 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.953 -0.467 . . . . 75.15 110.44 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -92.4 120.45 41.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.503 -0.925 . . . . 74.01 108.503 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 35.0 mmtp -96.96 132.21 42.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.917 -0.713 . . . . 72.4 109.914 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 p -107.25 128.04 54.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.66 -0.7 . . . . 72.3 109.75 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.467 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 67.2 m-85 -128.24 126.79 41.62 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.699 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 37' ' ' VAL . 47.9 p -115.13 129.84 56.77 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.423 -0.808 . . . . 55.11 112.696 -174.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.652 HD12 HD12 ' B' ' 38' ' ' ILE . 59.0 mt -137.41 121.6 22.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.912 -0.585 . . . . 74.23 109.467 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -113.23 126.48 55.46 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 119.666 -0.813 . . . . 64.42 109.162 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.8 tp10 -121.35 103.61 9.09 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.861 -0.609 . . . . 72.52 109.598 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.13 -93.57 0.23 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.612 -0.722 . . . . 60.24 112.967 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.456 ' HB2' HD22 ' B' ' 19' ' ' LEU . 43.7 m -113.75 -7.18 13.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.268 0.84 . . . . 65.11 113.268 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -114.5 140.67 48.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.142 -1.023 . . . . 75.55 111.125 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 1.9 mpt_? -108.71 119.58 39.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.249 -0.887 . . . . 75.2 108.69 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.31 130.92 55.48 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.754 0.312 . . . . 75.3 110.247 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 28' ' ' THR . 60.1 t -121.19 127.17 75.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.476 -0.564 . . . . 74.22 109.476 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.628 HD12 HD12 ' B' ' 29' ' ' ILE . 83.7 mt -101.66 125.85 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.587 0 N-CA-C 108.672 -0.862 . . . . 70.42 108.672 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -108.69 114.65 28.63 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.238 -1.023 . . . . 72.32 108.238 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 49.9 mm -88.84 113.14 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.353 0 N-CA-C 106.499 -1.667 . . . . 73.13 106.499 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.2 p -109.99 -177.07 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.816 -0.629 . . . . 71.15 110.343 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.8 -13.0 32.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.941 -0.762 . . . . 55.01 108.941 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -96.55 -24.61 15.97 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.182 -0.917 . . . . 71.54 110.705 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 171.27 -133.52 2.78 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 118.394 -1.86 . . . . 54.14 114.368 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 1.6 tm? -126.99 122.59 34.92 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 124.186 0.994 . . . . 62.5 108.567 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -123.07 143.02 50.25 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-O 121.093 0.473 . . . . 75.4 110.74 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.55 140.81 47.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 115.455 -0.793 . . . . 63.33 109.14 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.8 m -124.05 136.88 54.56 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.089 -0.505 . . . . 70.41 110.302 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HB2' ' HG ' ' B' ' 45' ' ' LEU . . . -117.21 124.3 48.74 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.636 -0.711 . . . . 53.05 110.015 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 21.7 t70 -110.88 104.28 55.9 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.001 -0.74 . . . . 64.45 109.001 175.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HG3' ' OG1' ' B' ' 16' ' ' THR . 83.2 Cg_endo -79.44 158.22 25.67 Favored 'Trans proline' 0 N--CA 1.423 -2.659 0 C-N-CA 121.563 1.509 . . . . 41.45 111.411 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.309 -1.166 0 C-N-CA 125.424 1.49 . . . . 71.02 113.517 172.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 93.3 mtt180 . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 121.063 0.458 . . . . 73.43 110.368 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 30.9 p -89.03 128.75 35.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.695 -0.684 . . . . 73.14 110.713 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 63.8 m -131.62 148.47 52.61 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.543 -0.91 . . . . 62.34 108.543 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.43 145.31 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 109.445 -0.576 . . . . 71.24 109.445 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 65.9 p -115.33 125.45 53.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.136 0.493 . . . . 64.41 110.838 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.484 HD11 ' CG2' ' A' ' 12' ' ' VAL . 3.2 mm? -103.47 121.51 42.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 116.045 -0.525 . . . . 75.42 111.094 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 38.7 p -93.8 113.31 25.33 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.805 -0.634 . . . . 71.13 109.748 176.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . 0.412 ' OG1' ' HG3' ' A' ' 51' ' ' PRO . 9.1 t -129.09 -171.0 2.38 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.623 -1.251 . . . . 73.11 107.623 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -77.55 108.19 10.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.54 1.162 . . . . 72.35 110.117 178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.429 ' H ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -125.4 150.9 46.83 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.89 -1.505 . . . . 75.43 114.199 -174.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.469 ' H ' HD23 ' B' ' 19' ' ' LEU . 2.2 pt? -74.64 167.42 36.46 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.297 -1.32 . . . . 53.22 108.636 175.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 19.0 Cg_endo -65.2 135.07 41.79 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.131 1.22 . . . . 70.02 109.951 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 86.2 t -129.81 123.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.726 -0.842 . . . . 64.41 108.726 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.8 m -90.11 -73.71 0.51 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.037 0.446 . . . . 72.32 110.064 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -92.38 146.94 23.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.475 -0.784 . . . . 75.14 109.301 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.402 HD12 HG22 ' B' ' 41' ' ' THR . 43.5 mm -84.07 134.78 26.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.96 -0.385 . . . . 73.55 109.96 -175.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -100.77 125.72 47.27 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.036 -1.098 . . . . 62.15 108.036 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 31.7 p -106.3 128.38 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.113 0.482 . . . . 74.03 110.414 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.43 ' HB2' ' HB ' ' B' ' 38' ' ' ILE . 71.3 m-85 -127.07 126.91 43.83 Favored 'General case' 0 CA--C 1.473 -2.017 0 CA-C-N 116.038 -0.528 . . . . 72.24 110.688 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.554 HG22 HG22 ' B' ' 37' ' ' VAL . 58.8 p -115.38 131.47 56.92 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.349 -0.842 . . . . 73.31 112.416 -173.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.628 HD12 HD12 ' A' ' 38' ' ' ILE . 54.8 mt -133.6 124.32 47.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.656 0.382 . . . . 71.44 110.199 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -111.19 127.09 55.48 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.87 -0.789 . . . . 74.22 108.87 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.543 ' O ' HD23 ' B' ' 34' ' ' LEU . 12.6 tp10 -130.22 97.89 4.57 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.731 -0.668 . . . . 75.42 109.848 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.68 -87.32 0.35 Allowed Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.436 -0.802 . . . . 64.4 112.021 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 54.8 m -119.89 -13.18 9.08 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 112.847 0.684 . . . . 73.01 112.847 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.543 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -107.85 136.5 47.46 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 117.736 -1.586 . . . . 75.41 112.293 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -102.84 120.09 39.99 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.489 -1.232 . . . . 74.11 108.405 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.32 53.17 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.689 -0.485 . . . . 75.44 109.689 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.554 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -124.64 128.66 73.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.979 -0.378 . . . . 72.54 109.979 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 29' ' ' ILE . 83.8 mt -102.2 124.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 C-N-CA 123.923 0.889 . . . . 73.54 108.696 178.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.21 116.6 32.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.445 -0.946 . . . . 73.41 108.445 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.454 HG23 HD21 ' A' ' 34' ' ' LEU . 48.1 mm -87.82 113.69 25.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.031 -1.84 . . . . 75.04 106.031 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . 0.402 HG22 HD12 ' B' ' 24' ' ' ILE . 76.0 p -123.4 179.51 4.71 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.745 -0.661 . . . . 61.25 111.338 -171.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' B' ' 42' ' ' LYS . 1.1 ptpt -83.1 -7.41 59.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 72.43 110.276 176.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' B' ' 15' ' ' THR . 98.8 mtt180 -87.04 -16.73 34.76 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.848 -1.538 . . . . 73.44 106.848 170.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.18 -103.28 1.03 Allowed Glycine 0 N--CA 1.423 -2.202 0 CA-C-N 114.507 -1.224 . . . . 63.31 112.039 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 49' ' ' ALA . 3.0 tm? -116.38 122.68 45.56 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.106 0.479 . . . . 53.4 111.856 -174.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.0 143.83 50.18 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.68 -0.691 . . . . 63.25 109.152 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 11.0 p -131.18 140.93 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.307 -0.406 . . . . 64.53 110.085 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 52.9 m -122.42 136.51 54.91 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.336 -0.393 . . . . 72.32 110.689 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . . . -117.89 124.59 48.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.535 -0.757 . . . . 62.12 111.291 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -122.76 95.81 46.05 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.87 -0.789 . . . . 65.04 108.87 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 91.1 Cg_endo . . . . . 0 N--CA 1.411 -3.36 0 C-N-CA 120.477 0.785 . . . . 71.34 112.35 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.25 0 N-CA-C 112.409 0.522 . . . . 72.4 112.409 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.47 127.89 49.32 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.955 -0.566 . . . . 64.31 111.024 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.524 ' CB ' ' HA ' ' A' ' 48' ' ' CYS . 20.0 m -140.55 148.05 40.41 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.772 -1.196 . . . . 41.23 107.772 -174.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.34 145.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.421 0.555 . . . . 71.33 110.753 -175.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 39.9 p -107.56 125.87 51.84 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.201 0.524 . . . . 62.5 110.377 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.07 137.84 45.36 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.819 -0.628 . . . . 65.52 111.442 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -98.51 112.58 24.56 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 115.445 -0.798 . . . . 65.15 109.293 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -142.4 -176.56 4.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.763 -1.199 . . . . 71.4 107.763 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 6.2 tp60 -79.33 105.11 10.41 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.604 0.716 . . . . 72.25 110.436 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.665 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.01 147.46 49.54 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.349 -0.841 . . . . 74.24 109.559 -178.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.5 pt? -74.55 136.07 74.89 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 107.682 -1.229 . . . . 73.24 107.682 174.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.49 133.9 27.21 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 120.825 1.017 . . . . 71.14 110.562 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.513 HG22 ' H ' ' A' ' 23' ' ' ARG . 14.5 p -133.42 137.33 53.28 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.737 -0.665 . . . . 63.45 109.352 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 m -87.86 -19.27 27.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.338 0.59 . . . . 61.14 110.036 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.513 ' H ' HG22 ' A' ' 21' ' ' VAL . 37.6 mmt180 -102.86 133.12 48.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.078 -0.712 . . . . 74.33 109.078 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mm -93.58 115.71 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.873 -0.788 . . . . 75.03 108.873 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -89.78 135.93 33.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 120.384 -0.526 . . . . 75.44 111.196 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 p -114.55 128.24 56.22 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.959 -1.019 . . . . 61.34 109.715 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.513 ' HB3' HD13 ' B' ' 29' ' ' ILE . 68.0 m-85 -126.44 125.67 42.52 Favored 'General case' 0 CA--C 1.462 -2.419 0 N-CA-C 109.401 -0.592 . . . . 73.35 109.401 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 37' ' ' VAL . 63.7 p -116.73 131.72 56.88 Favored 'General case' 0 C--N 1.283 -2.308 0 O-C-N 123.861 0.726 . . . . 74.53 112.344 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.663 HD12 HD12 ' B' ' 38' ' ' ILE . 56.5 mt -127.55 121.17 56.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 120.905 0.383 . . . . 71.23 110.05 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -102.97 123.58 46.86 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.776 -1.194 . . . . 71.52 107.776 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' HD23 ' A' ' 34' ' ' LEU . 10.6 tp10 -142.31 97.11 3.06 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.354 -0.538 . . . . 74.53 111.642 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -72.96 0.38 Allowed Glycine 0 C--N 1.319 -0.378 0 N-CA-C 115.287 0.875 . . . . 64.32 115.287 171.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.1 m -126.94 -1.09 6.58 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 112.719 0.637 . . . . 71.02 112.719 -173.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.588 HD21 HG23 ' B' ' 40' ' ' ILE . 2.0 pt? -146.33 140.46 26.44 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.271 -0.972 . . . . 73.4 112.278 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 121.55 44.99 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.006 -1.452 . . . . 64.25 108.956 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.23 137.2 49.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.805 -0.18 . . . . 60.02 110.531 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 39.2 t -124.31 125.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.215 -0.661 . . . . 72.22 109.215 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.827 HD12 HD12 ' B' ' 29' ' ' ILE . 86.4 mt -102.95 123.49 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 108.654 -0.869 . . . . 75.33 108.654 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 92.9 m-85 -106.79 114.48 28.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.362 -0.977 . . . . 70.15 108.362 177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.478 HG13 ' HG2' ' B' ' 31' ' ' GLU . 49.0 mm -89.42 114.75 27.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.208 -1.404 . . . . 72.31 107.208 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.78 156.87 47.94 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 115.806 -0.633 . . . . 63.14 110.953 -175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -62.59 -14.58 44.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.579 0.752 . . . . 74.45 110.734 176.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -85.35 -18.71 32.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.618 0.723 . . . . 75.42 109.491 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.35 -138.79 9.28 Favored Glycine 0 CA--C 1.48 -2.155 0 C-N-CA 119.909 -1.138 . . . . 72.35 112.176 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 2.7 tm? -113.31 121.32 44.07 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.61 -0.885 . . . . 72.21 108.61 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 23.0 tptm -118.62 121.81 41.06 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.383 -0.969 . . . . 74.05 108.383 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG11 HG11 ' B' ' 47' ' ' VAL . 14.9 p -116.97 140.33 40.06 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 107.765 -1.198 . . . . 72.3 107.765 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.524 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 13.6 t -132.76 136.04 46.1 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 106.716 -1.587 . . . . 72.04 106.716 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' CB ' ' HG ' ' B' ' 45' ' ' LEU . . . -136.18 124.57 23.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 119.328 -0.949 . . . . 72.01 111.312 -177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.63 108.81 62.51 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 114.84 -1.073 . . . . 74.44 109.792 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -89.04 148.13 5.6 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.342 2.028 . . . . 75.11 111.079 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 33' ' ' SER . 9.2 pt20 . . . . . 0 C--N 1.297 -1.686 0 CA-C-N 115.905 -0.589 . . . . 73.3 109.778 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.391 -3.383 0 CA-C-O 122.152 0.977 . . . . 75.02 110.053 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.1 p -87.12 117.79 26.09 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.539 -1.664 . . . . 64.13 110.099 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.482 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 19.4 m -137.28 148.22 46.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.945 -1.131 . . . . 63.51 107.945 -175.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -142.96 146.79 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.833 -0.432 . . . . 75.44 109.833 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . 0.48 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 23.7 p -106.96 125.56 51.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.17 0.588 . . . . 72.11 110.46 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.34 119.41 39.38 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.236 -1.024 . . . . 73.4 108.236 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -121.59 112.69 18.77 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.267 -1.012 . . . . 70.2 108.267 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -173.29 113.44 0.22 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.348 0.499 . . . . 74.13 112.348 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 59.42 22.47 10.94 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.581 1.152 . . . . 74.21 112.887 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.502 ' HD2' ' HA2' ' B' ' 44' ' ' GLY . 27.3 mtt180 -105.74 121.51 44.17 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.107 -0.996 . . . . 73.21 108.853 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.735 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.6 pt? -74.39 152.28 87.78 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 116.095 -0.502 . . . . 74.44 111.885 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.19 136.65 74.07 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.379 2.719 . . . . 64.23 113.648 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.73 149.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.659 -1.237 . . . . 75.13 107.659 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 -36.42 59.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.022 0.378 . . . . 64.45 112.022 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -124.18 135.89 53.79 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.939 -0.304 . . . . 61.11 110.787 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' B' ' 41' ' ' THR . 49.5 mm -77.57 115.16 19.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.755 -1.202 . . . . 74.21 107.755 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.19 126.47 43.67 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.161 -0.472 . . . . 62.11 110.444 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.435 HG22 ' CD1' ' B' ' 39' ' ' PHE . 41.1 p -106.66 127.36 53.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.436 -0.579 . . . . 72.34 109.436 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 75.3 m-85 -126.57 127.45 45.3 Favored 'General case' 0 CA--C 1.474 -1.956 0 CA-C-N 116.092 -0.504 . . . . 72.35 110.626 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.68 HG22 HG22 ' B' ' 37' ' ' VAL . 43.4 p -114.51 121.3 43.07 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.618 -0.719 . . . . 72.14 112.021 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.827 HD12 HD12 ' A' ' 38' ' ' ILE . 94.5 mt -119.48 121.46 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.785 -0.643 . . . . 71.41 110.864 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -105.71 139.84 39.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.257 -1.016 . . . . 60.34 108.257 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.478 ' HG2' HG13 ' A' ' 40' ' ' ILE . 17.0 tp10 -142.51 97.59 3.14 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.404 0.621 . . . . 72.14 109.566 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.22 2.59 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.218 -0.901 . . . . 71.53 112.834 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 39.8 m -146.12 -25.25 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.279 0.844 . . . . 70.41 113.279 -177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.512 ' H ' HD23 ' B' ' 34' ' ' LEU . 2.6 pt? -92.89 141.39 28.47 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.037 -0.665 . . . . 64.32 110.534 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.413 ' N ' ' HD3' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -111.51 123.15 49.62 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.049 -0.523 . . . . 73.52 110.006 177.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.4 54.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.714 -0.476 . . . . 73.15 109.714 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.68 HG22 HG22 ' B' ' 28' ' ' THR . 39.2 t -119.76 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.273 0.559 . . . . 74.11 110.538 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.663 HD12 HD12 ' A' ' 29' ' ' ILE . 97.0 mt -103.91 116.65 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 107.846 -1.168 . . . . 63.4 107.846 177.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 97.8 m-85 -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.472 -0.936 . . . . 65.13 108.472 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.588 HG23 HD21 ' A' ' 34' ' ' LEU . 41.9 mm -88.5 113.7 25.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 106.501 -1.666 . . . . 73.24 106.501 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . 0.44 ' HA ' HD12 ' B' ' 24' ' ' ILE . 8.9 t -119.5 166.02 13.64 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 120.356 -0.538 . . . . 72.45 111.479 -174.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.97 -3.76 43.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.426 0.898 . . . . 73.44 113.426 -173.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -116.22 -1.75 12.31 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.195 0.521 . . . . 72.55 110.518 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . 0.502 ' HA2' ' HD2' ' B' ' 18' ' ' ARG . . . 155.52 -140.65 7.47 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.04 -1.553 . . . . 63.45 113.96 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 tm? -122.13 126.58 48.66 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.441 0.696 . . . . 74.41 109.355 -177.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -117.45 121.75 41.88 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.821 -0.807 . . . . 74.51 108.821 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.541 HG11 HG11 ' A' ' 47' ' ' VAL . 9.7 p -108.23 140.39 26.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.621 -0.881 . . . . 61.31 108.621 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.482 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 10.5 t -139.7 136.86 34.66 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 107.752 -1.203 . . . . 44.44 107.752 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . . . -125.55 125.77 43.75 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 110.144 -0.317 . . . . 55.03 110.144 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -115.07 109.69 46.62 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-O 121.278 0.561 . . . . 75.53 109.827 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.439 -1.713 0 C-N-CA 122.719 2.279 . . . . 70.33 112.939 -177.456 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 14.5 ptt180 . . . . . 0 N--CA 1.444 -0.74 0 CA-C-O 121.529 0.681 . . . . 63.54 111.904 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -88.86 148.07 24.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.198 -0.91 . . . . 74.21 110.98 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 65.9 m -141.71 149.23 40.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.458 -1.312 . . . . 64.14 107.458 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.536 HG11 HG11 ' B' ' 12' ' ' VAL . 57.1 t -139.76 145.15 27.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 110.163 -0.31 . . . . 62.11 110.163 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 m -111.77 124.8 53.12 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.216 -1.031 . . . . 73.11 108.216 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -132.09 141.01 49.03 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 123.749 0.819 . . . . 74.11 108.802 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 t -123.32 141.9 51.51 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.843 -0.743 . . . . 44.35 111.004 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 t -111.56 26.61 10.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.245 -1.02 . . . . 74.03 108.245 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 77.43 117.26 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 112.998 -1.91 . . . . 72.12 108.468 -173.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.576 HH12 HD22 ' B' ' 34' ' ' LEU . 14.9 mmm180 -95.46 148.01 22.93 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 116.561 2.06 . . . . 74.41 116.561 -172.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.9 mt -114.37 153.83 46.49 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 112.922 -1.945 . . . . 60.43 106.358 172.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.45 145.08 16.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.349 3.366 . . . . 74.24 115.286 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.34 137.86 54.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 114.084 -1.417 . . . . 73.44 109.164 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 m -98.11 -45.09 6.36 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.712 0.292 . . . . 73.01 110.848 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -119.3 133.84 55.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 62.34 109.757 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -85.48 135.91 23.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.767 -0.457 . . . . 64.2 109.767 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.03 151.63 33.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.9 0.704 . . . . 73.4 112.9 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 m -133.99 127.22 31.89 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.607 -1.178 . . . . 51.41 108.38 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 74.8 m-85 -127.61 134.7 49.67 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 111.879 0.325 . . . . 74.55 111.879 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.673 HG22 HG22 ' A' ' 37' ' ' VAL . 36.1 p -115.51 139.23 50.25 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.64 -0.709 . . . . 52.32 111.556 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.782 HD12 HD12 ' B' ' 38' ' ' ILE . 82.3 mt -130.72 133.14 63.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.216 -0.902 . . . . 65.31 108.78 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -117.19 123.65 47.2 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 121.631 0.729 . . . . 73.14 109.171 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.8 tp10 -125.16 98.35 5.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.752 0.787 . . . . 65.14 108.965 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.52 -71.9 2.91 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 109.703 -1.359 . . . . 64.31 109.703 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -154.97 -22.7 0.12 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.519 0.933 . . . . 71.14 113.519 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.416 HD11 HD12 ' B' ' 40' ' ' ILE . 2.6 pt? -69.23 141.06 54.54 Favored 'General case' 0 C--N 1.367 1.37 0 CA-C-N 118.934 0.788 . . . . 64.32 110.817 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 31.6 mmt180 -100.58 118.71 37.31 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.884 -0.598 . . . . 60.1 109.745 174.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 123.97 49.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.894 -0.78 . . . . 44.13 108.894 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 28' ' ' THR . 71.5 t -110.89 133.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.3 -0.409 . . . . 75.03 110.142 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.552 HD12 HD12 ' B' ' 29' ' ' ILE . 75.6 mt -115.49 118.29 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 C-N-CA 123.702 0.801 . . . . 63.35 108.997 176.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.52 122.1 43.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.567 -0.901 . . . . 75.23 108.567 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.456 HD12 HD21 ' B' ' 34' ' ' LEU . 47.6 mm -100.63 113.37 36.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.684 -1.228 . . . . 75.03 107.684 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -131.92 177.03 7.85 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.635 -0.876 . . . . 74.13 108.635 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -90.51 -1.74 57.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.487 -0.931 . . . . 73.31 108.487 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -89.63 -30.83 17.85 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.558 -0.904 . . . . 63.43 108.558 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.12 -157.53 29.85 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.702 -1.136 . . . . 74.34 111.737 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -113.63 121.57 44.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.888 -1.523 . . . . 73.45 106.888 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -121.08 140.16 52.33 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 121.202 0.525 . . . . 74.42 111.381 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.602 HG11 HG11 ' B' ' 47' ' ' VAL . 23.2 m -131.45 141.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.035 -0.984 . . . . 74.53 110.866 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 61.6 m -121.35 137.52 54.66 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.936 -0.575 . . . . 73.42 110.623 174.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.75 124.58 47.62 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.294 -0.632 . . . . 64.33 109.294 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.483 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 14.2 t70 -115.84 127.13 27.03 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.933 -0.765 . . . . 53.22 108.933 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.8 148.17 22.96 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.915 3.077 . . . . 62.45 113.854 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.62 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 1.2 mp0 . . . . . 0 C--N 1.321 -0.632 0 C-N-CA 124.227 1.011 . . . . 74.11 110.937 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.425 ' HB3' ' HD3' ' B' ' 51' ' ' PRO . 22.4 ptt180 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 121.767 0.794 . . . . 75.02 113.046 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.1 p -103.21 149.76 24.35 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-N 114.846 -1.07 . . . . 55.32 111.282 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 63.1 m -139.85 148.84 42.68 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.352 -1.722 . . . . 62.41 106.352 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.536 HG11 HG11 ' A' ' 12' ' ' VAL . 60.2 t -141.88 144.0 26.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.592 -0.521 . . . . 44.15 109.592 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -107.98 124.82 50.73 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.091 -1.077 . . . . 75.44 108.091 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.432 HD23 ' N ' ' B' ' 14' ' ' LEU . 0.3 OUTLIER -119.41 122.73 42.43 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.08 -0.711 . . . . 62.13 109.08 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -107.22 130.64 54.71 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.87 0.843 . . . . 54.44 111.01 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -144.78 -162.45 1.49 Allowed 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.001 -1.481 . . . . 62.05 107.001 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -71.1 102.73 2.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.701 0.762 . . . . 63.33 109.177 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 mmm-85 -125.0 139.49 53.77 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 114.874 -1.057 . . . . 63.24 109.214 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 46.8 mt -89.02 137.24 29.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 106.649 -1.612 . . . . 61.14 106.649 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.68 135.17 41.6 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.647 2.231 . . . . 63.33 112.695 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.91 135.83 61.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.834 -1.543 . . . . 64.23 106.834 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 26.3 m -89.79 -20.28 23.7 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.32 0.489 . . . . 74.51 112.32 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -112.73 138.63 49.26 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.783 -0.19 . . . . 52.52 110.779 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mm -89.93 118.95 36.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.305 -0.628 . . . . 74.11 109.305 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.07 152.53 18.68 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.312 0.577 . . . . 64.0 112.333 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 73.1 m -131.31 127.91 38.67 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.693 -1.14 . . . . 51.11 108.595 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.438 ' HB3' HD13 ' A' ' 29' ' ' ILE . 67.5 m-85 -129.35 125.58 36.98 Favored 'General case' 0 CA--C 1.452 -2.793 0 N-CA-C 108.94 -0.763 . . . . 62.02 108.94 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.425 HG23 HG22 ' B' ' 37' ' ' VAL . 18.6 m -117.88 122.07 42.37 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 119.686 -0.806 . . . . 63.01 112.544 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.552 HD12 HD12 ' A' ' 38' ' ' ILE . 64.2 mt -116.48 121.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.509 . . . . 74.12 109.9 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -105.02 128.42 53.31 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.225 -1.398 . . . . 72.55 107.225 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.567 ' O ' HD23 ' B' ' 34' ' ' LEU . 14.7 tp10 -139.38 118.49 12.65 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.258 -0.645 . . . . 71.3 109.258 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.73 -78.79 1.16 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.858 -1.163 . . . . 54.43 110.271 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -155.37 -14.58 0.11 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 112.924 0.712 . . . . 70.52 112.924 177.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.576 HD22 HH12 ' A' ' 18' ' ' ARG . 2.4 pt? -84.2 142.07 30.57 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.329 0.513 . . . . 73.32 110.818 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.452 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 32.3 mmt180 -100.66 118.08 36.08 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.324 -1.361 . . . . 72.11 107.324 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.98 29.53 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.43 -0.581 . . . . 72.12 109.43 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.425 HG22 HG23 ' B' ' 28' ' ' THR . 86.2 t -108.37 124.02 64.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.211 -0.449 . . . . 50.13 110.626 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.782 HD12 HD12 ' A' ' 29' ' ' ILE . 63.2 mt -102.97 123.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 C-N-CA 123.429 0.691 . . . . 62.2 109.205 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -104.85 114.88 29.36 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.219 -1.03 . . . . 72.32 108.219 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.423 HG13 ' HG2' ' A' ' 31' ' ' GLU . 47.5 mm -90.18 112.57 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 106.869 -1.53 . . . . 75.42 106.869 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -110.61 -176.58 3.01 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.922 -0.77 . . . . 64.11 108.922 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.593 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -92.11 -17.98 24.19 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 120.968 0.413 . . . . 74.05 110.219 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -100.58 -16.94 17.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.127 -0.488 . . . . 63.41 111.01 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.34 -145.59 7.28 Favored Glycine 0 C--N 1.295 -1.711 0 C-N-CA 118.7 -1.714 . . . . 50.13 113.199 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.2 122.82 23.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.574 -1.269 . . . . 74.34 107.574 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -125.04 141.57 52.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.215 0.531 . . . . 73.23 110.383 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 47' ' ' VAL . 30.8 m -131.9 141.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.298 -0.865 . . . . 75.25 111.03 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -120.03 136.98 54.36 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 115.929 -0.578 . . . . 72.11 110.11 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.69 123.91 47.24 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.186 -0.672 . . . . 75.35 109.186 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 17.1 t70 -102.04 135.73 19.61 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 107.655 -1.239 . . . . 71.15 107.655 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' B' ' 9' ' ' ARG . 17.9 Cg_endo . . . . . 0 CA--C 1.505 -0.944 0 C-N-CA 123.49 2.793 . . . . 73.44 114.34 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 CA--C 1.498 -1.042 0 N-CA-C 107.06 -1.459 . . . . 74.13 107.06 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 120.241 -0.584 . . . . 70.42 110.859 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.7 m -129.85 148.94 51.77 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.089 -1.078 . . . . 65.32 108.089 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.3 147.01 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 120.84 -0.344 . . . . 63.14 110.883 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.3 p -112.21 126.94 55.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.903 0.382 . . . . 64.21 110.003 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.08 141.95 47.3 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.771 -0.825 . . . . 62.53 108.771 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -127.9 112.98 15.3 Favored 'General case' 0 N--CA 1.405 -2.693 0 C-N-CA 119.534 -0.866 . . . . 71.32 111.04 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.415 ' HB ' ' OG1' ' B' ' 10' ' ' THR . 9.0 t -121.71 -170.09 1.98 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.3 -1.0 . . . . 64.1 108.3 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 5.9 tp60 -72.38 93.36 1.51 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.712 0.768 . . . . 51.42 110.822 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.405 HH22 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -126.5 148.17 49.73 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.95 -1.023 . . . . 74.1 108.838 -178.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.07 141.42 46.86 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.347 -0.983 . . . . 63.42 108.347 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 39.9 Cg_endo -65.91 143.83 74.49 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.541 2.161 . . . . 63.11 112.715 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 21.4 t -122.4 148.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.404 -1.332 . . . . 73.42 107.404 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -92.38 -39.84 11.23 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 120.305 -0.558 . . . . 71.2 110.843 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -89.61 133.15 34.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.31 -0.405 . . . . 65.13 111.246 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.73 124.11 42.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.761 -0.829 . . . . 72.33 108.761 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 35.1 mmtp -104.53 146.57 28.7 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.009 -0.676 . . . . 60.5 111.292 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 m -127.29 127.79 44.91 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.436 -0.949 . . . . 54.51 108.436 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 88.2 m-85 -128.13 134.73 49.15 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-N 116.352 -0.385 . . . . 72.33 111.8 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 37' ' ' VAL . 17.7 p -114.64 120.08 38.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.295 -0.866 . . . . 74.51 111.711 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.698 HD12 HD12 ' B' ' 38' ' ' ILE . 93.9 mt -114.94 125.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.569 -0.741 . . . . 65.13 109.589 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -106.91 128.87 54.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.277 0.56 . . . . 75.04 109.794 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.594 ' O ' HD23 ' A' ' 34' ' ' LEU . 17.1 tp10 -142.99 119.18 10.78 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.715 -0.675 . . . . 73.55 109.59 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.59 -87.37 0.12 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 111.6 -0.6 . . . . 50.14 111.6 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.489 ' HB3' HD21 ' B' ' 19' ' ' LEU . 26.8 t -151.14 13.88 0.69 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.406 -0.59 . . . . 71.22 109.406 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -110.49 140.51 44.69 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.7 -0.8 . . . . 72.52 108.891 174.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -116.3 134.03 55.35 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.58 -0.736 . . . . 73.15 110.192 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.97 131.46 55.38 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.383 -0.599 . . . . 52.0 109.383 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 28' ' ' THR . 87.5 t -113.11 120.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.014 -0.539 . . . . 74.55 110.139 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.64 HD12 HD12 ' B' ' 29' ' ' ILE . 96.2 mt -101.33 117.39 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 N-CA-C 109.003 -0.739 . . . . 74.23 109.003 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.51 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.2 m-85 -102.96 114.82 29.43 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.554 -0.906 . . . . 74.0 108.554 177.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.481 HD12 HD21 ' B' ' 34' ' ' LEU . 47.7 mm -90.75 112.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 106.57 -1.641 . . . . 74.54 106.57 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -116.62 173.28 6.71 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.525 0.516 . . . . 52.34 110.248 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.91 -33.01 71.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 116.482 2.03 . . . . 75.31 116.482 -171.145 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.577 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 1.5 tmt_? -117.21 3.76 12.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 119.694 -0.803 . . . . 70.25 109.472 -176.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.5 -158.73 12.03 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 118.353 -1.88 . . . . 44.24 115.058 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.29 123.1 24.87 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 125.636 1.575 . . . . 61.15 108.457 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -121.45 143.4 49.26 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.745 0.307 . . . . 74.44 110.721 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.92 140.2 48.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 115.948 -0.569 . . . . 51.13 110.126 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 26.7 m -118.9 145.05 46.04 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.5 -0.773 . . . . 74.3 110.232 172.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.76 125.75 53.16 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.252 -1.018 . . . . 61.53 108.252 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.93 78.43 31.81 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.218 -1.401 . . . . 72.4 107.218 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 27.8 Cg_endo -99.53 134.13 0.23 Allowed 'Trans proline' 0 N--CA 1.413 -3.229 0 C-N-CA 122.303 2.002 . . . . 74.45 113.858 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 114.052 -1.431 . . . . 63.05 113.229 173.194 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' B' ' 50' ' ' ASP . 94.7 mtt180 . . . . . 0 N--CA 1.41 -2.441 0 N-CA-C 108.173 -1.047 . . . . 54.33 108.173 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.415 ' OG1' ' HB ' ' A' ' 16' ' ' THR . 49.5 m -108.88 116.66 32.42 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.334 -1.358 . . . . 73.13 107.334 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -135.61 146.76 48.24 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.115 -1.068 . . . . 61.43 108.115 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 12.4 p -147.12 156.06 10.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 117.486 0.13 . . . . 60.02 110.788 -176.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -117.16 126.69 53.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.345 0.258 . . . . 71.2 110.618 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.41 HD22 ' N ' ' B' ' 14' ' ' LEU . 1.7 mm? -112.11 121.12 44.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.98 -1.119 . . . . 73.24 107.98 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -93.05 111.81 23.56 Favored 'General case' 0 C--N 1.284 -2.246 0 C-N-CA 118.271 -1.372 . . . . 71.44 109.147 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.6 t -153.58 107.81 3.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.181 -0.918 . . . . 64.0 112.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 51' ' ' PRO . 6.1 tp60 43.1 85.66 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.708 1.603 . . . . 51.43 113.259 174.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.412 ' N ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -125.57 148.47 48.92 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.173 -1.011 . . . . 72.01 110.275 -173.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' A' ' 33' ' ' SER . 2.8 mp -84.21 159.46 59.36 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.676 -1.231 . . . . 72.14 107.676 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.88 133.85 28.3 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 N-CA-C 108.54 -1.369 . . . . 61.22 108.54 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.626 ' H ' ' HB3' ' B' ' 42' ' ' LYS . 32.5 t -132.15 136.64 56.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.098 -1.075 . . . . 72.24 108.098 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -85.89 -30.31 22.98 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.057 0.456 . . . . 74.22 111.767 -175.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -114.63 166.74 11.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.745 0.307 . . . . 71.15 111.689 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.04 115.12 40.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 106.799 -1.556 . . . . 64.32 106.799 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 35.4 mmtp -90.62 147.18 23.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.733 -0.787 . . . . 65.04 110.482 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 90.4 m -133.13 127.88 34.88 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.648 -0.871 . . . . 55.13 108.648 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . 0.44 ' HB3' HD13 ' A' ' 29' ' ' ILE . 70.9 m-85 -128.51 125.78 39.09 Favored 'General case' 0 CA--C 1.446 -3.021 0 N-CA-C 109.474 -0.565 . . . . 75.33 109.474 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.8 m -117.61 130.93 56.69 Favored 'General case' 0 C--N 1.266 -3.048 0 O-C-N 123.996 0.81 . . . . 71.22 112.022 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.64 HD12 HD12 ' A' ' 38' ' ' ILE . 49.7 mt -125.01 129.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.866 -0.606 . . . . 75.45 109.988 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.433 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 9.7 t -106.82 122.27 46.06 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.461 -0.94 . . . . 72.54 108.461 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.444 ' O ' HD23 ' B' ' 34' ' ' LEU . 19.8 tp10 -142.69 97.82 3.18 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.359 -0.536 . . . . 75.44 111.69 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.81 -69.97 1.48 Allowed Glycine 0 C--N 1.313 -0.741 0 N-CA-C 115.324 0.89 . . . . 75.11 115.324 172.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -137.13 0.38 2.34 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.56 0.578 . . . . 55.54 112.56 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 40' ' ' ILE . 2.2 pt? -141.16 141.52 34.12 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.062 -1.055 . . . . 64.1 112.667 -175.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.433 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 19.2 mmm180 -98.31 113.72 25.77 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.382 -1.71 . . . . 75.13 106.382 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.77 120.0 40.07 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.743 -0.465 . . . . 73.23 109.743 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 27' ' ' TYR . 90.1 t -113.65 129.31 69.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.755 -0.657 . . . . 62.23 110.325 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.698 HD12 HD12 ' A' ' 29' ' ' ILE . 67.3 mt -113.25 131.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 123.387 0.675 . . . . 75.23 109.807 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 96.3 m-85 -112.44 118.29 34.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.958 -0.756 . . . . 75.12 108.958 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' B' ' 25' ' ' LYS . 47.2 mm -96.92 118.99 44.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.518 -0.919 . . . . 75.41 108.518 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.34 157.99 45.49 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 109.43 -0.581 . . . . 41.51 109.43 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.626 ' HB3' ' H ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -67.2 -17.87 65.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.812 -0.631 . . . . 74.44 111.666 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.669 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.6 tmt_? -90.91 -17.31 26.65 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.309 -0.626 . . . . 73.11 109.309 -176.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -172.28 43.32 Favored Glycine 0 C--O 1.223 -0.567 0 C-N-CA 118.942 -1.599 . . . . 74.32 114.611 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -112.85 121.4 44.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.977 -1.49 . . . . 73.54 106.977 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 12' ' ' VAL . 86.8 tttt -119.66 142.01 48.84 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.484 0.659 . . . . 72.11 111.231 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.13 140.68 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 107.607 -1.257 . . . . 70.54 107.607 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 34.1 t -138.54 136.56 36.18 Favored 'General case' 0 C--N 1.268 -2.948 0 N-CA-C 108.107 -1.072 . . . . 72.2 108.107 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.28 123.74 44.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.027 -0.669 . . . . 62.34 110.485 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' B' ' 9' ' ' ARG . 25.8 t70 -113.87 122.43 34.85 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.753 -1.203 . . . . 74.33 107.753 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 N--CA 1.44 -1.64 0 C-N-CA 121.862 1.708 . . . . 72.24 112.944 -173.551 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.484 0 N-CA-C 107.22 -1.4 . . . . 72.04 107.22 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 p -91.1 144.0 26.1 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.028 -0.533 . . . . 74.11 112.378 -172.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -138.4 149.89 45.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.132 -0.692 . . . . 74.02 109.132 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD21 ' B' ' 14' ' ' LEU . 60.5 t -143.3 139.79 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 110.232 -0.285 . . . . 75.23 110.232 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 p -112.45 124.93 53.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.719 -0.475 . . . . 65.34 109.719 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.12 120.35 39.47 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.122 -0.49 . . . . 70.43 109.899 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.9 p -105.54 118.07 35.62 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.045 -0.525 . . . . 64.05 109.686 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -161.12 116.15 2.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.367 -0.379 . . . . 73.52 111.743 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 43.45 78.06 0.06 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 125.22 1.408 . . . . 55.3 113.029 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.511 HH22 ' HB1' ' B' ' 49' ' ' ALA . 34.7 mmt-85 -125.91 149.61 48.58 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.503 0.668 . . . . 73.23 111.878 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -99.67 159.16 30.69 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 106.036 -1.839 . . . . 75.33 106.036 172.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.65 135.98 67.78 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.766 1.644 . . . . 62.24 111.133 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.58 149.18 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 74.4 108.19 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -85.54 -35.63 20.99 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.404 0.52 . . . . 71.1 112.404 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -131.11 147.73 52.65 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.217 -0.302 . . . . 61.43 110.665 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -86.63 124.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.678 -0.86 . . . . 73.25 108.678 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.25 150.44 25.13 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.361 0.601 . . . . 72.25 112.506 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 m -133.43 126.94 32.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.244 -1.391 . . . . 73.31 107.244 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -128.36 134.91 48.95 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-N 116.419 -0.355 . . . . 71.23 110.672 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.617 HG22 HG22 ' A' ' 37' ' ' VAL . 31.7 p -113.56 117.49 31.78 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.462 -0.79 . . . . 71.45 110.864 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.657 HD12 HD12 ' B' ' 38' ' ' ILE . 64.3 mt -110.49 123.02 66.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.295 -0.631 . . . . 64.31 109.295 177.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -116.3 115.89 26.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.135 -0.939 . . . . 73.13 109.127 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -129.55 107.01 9.13 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.186 -0.916 . . . . 55.51 109.748 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.68 -72.74 1.73 Allowed Glycine 0 C--N 1.303 -1.274 0 C-N-CA 121.121 -0.561 . . . . 51.01 111.95 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -154.91 4.63 0.22 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.172 0.804 . . . . 74.42 113.172 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.599 HD21 HD12 ' B' ' 40' ' ' ILE . 2.0 pt? -107.25 136.45 47.04 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 117.205 -1.798 . . . . 61.35 111.379 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -93.84 113.41 25.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.274 -0.875 . . . . 64.1 109.268 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.29 119.23 38.89 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.918 -0.771 . . . . 74.43 108.918 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 28' ' ' THR . 66.5 t -108.39 123.09 63.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 116.519 -0.309 . . . . 74.52 111.224 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.528 HD12 HD12 ' B' ' 29' ' ' ILE . 84.5 mt -102.06 116.2 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.511 -0.768 . . . . 70.54 109.163 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -102.6 116.94 33.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.817 -1.179 . . . . 71.3 107.817 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.596 HG23 HD21 ' B' ' 34' ' ' LEU . 40.6 mm -93.54 114.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 108.109 -1.071 . . . . 73.55 108.109 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -124.23 178.54 5.29 Favored 'General case' 0 N--CA 1.406 -2.649 0 C-N-CA 120.476 -0.489 . . . . 75.32 110.209 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 42' ' ' LYS . 58.7 pttt -74.83 -41.58 59.63 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 113.968 1.099 . . . . 73.3 113.968 -171.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -98.97 -10.73 22.32 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.765 -0.774 . . . . 72.54 110.045 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.22 -145.89 4.9 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 117.484 -2.293 . . . . 75.11 116.61 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 47.1 tp -130.36 141.45 50.57 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 125.26 1.424 . . . . 74.04 108.166 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.44 139.98 47.03 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.975 -0.69 . . . . 64.55 109.579 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.492 HG11 HG11 ' B' ' 47' ' ' VAL . 11.4 p -131.57 141.04 46.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 115.913 -0.585 . . . . 54.01 110.213 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.3 m -122.17 139.38 53.83 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.187 -0.461 . . . . 63.42 111.023 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.62 124.45 49.82 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 72.55 108.566 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -138.5 91.27 12.46 Favored Pre-proline 0 C--N 1.281 -2.402 0 CA-C-N 115.452 -0.794 . . . . 64.24 108.947 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.2 Cg_exo -80.83 141.45 13.45 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 122.829 2.353 . . . . 75.22 113.149 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 . . . . . 0 C--N 1.339 0.131 0 CA-C-N 114.749 -1.114 . . . . 74.04 110.84 172.194 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 2.8 ptm180 . . . . . 0 C--O 1.245 0.844 0 N-CA-C 115.267 1.58 . . . . 74.23 115.267 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 28.5 p -109.08 145.94 34.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.089 -1.078 . . . . 71.41 108.089 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 77.8 m -144.47 151.16 38.78 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.045 -0.724 . . . . 74.45 109.045 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 91.4 t -144.41 141.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 73.41 109.284 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -107.38 130.69 54.77 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.211 0.529 . . . . 74.22 109.8 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' LEU . . . . . 0.538 HD21 ' CG2' ' A' ' 12' ' ' VAL . 95.3 mt -102.23 121.36 42.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.781 -0.645 . . . . 55.1 110.694 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -85.25 113.93 21.96 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.616 -1.253 . . . . 74.44 107.616 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -153.76 170.05 21.88 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.22 -0.592 . . . . 71.2 109.878 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -72.2 93.52 1.46 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.295 0.569 . . . . 73.34 110.826 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ARG . . . . . 0.544 ' HE ' HD22 ' A' ' 34' ' ' LEU . 1.5 tmt_? -126.08 132.31 51.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.181 -1.785 . . . . 73.44 106.181 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.04 155.67 90.16 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 112.653 0.612 . . . . 71.22 112.653 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.97 140.39 23.99 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.937 3.091 . . . . 53.3 114.648 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' NH1' ' B' ' 18' ' ' ARG . 12.4 p -131.81 149.14 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.303 -1.369 . . . . 74.51 107.303 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -89.37 -45.57 9.38 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.754 0.312 . . . . 54.32 111.776 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -117.81 141.68 48.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.319 -0.4 . . . . 75.5 110.844 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.047 -0.723 . . . . 63.5 109.047 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.525 0.678 . . . . 73.01 112.03 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 77.1 m -130.64 128.51 41.12 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.751 -1.203 . . . . 75.11 107.751 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.36 125.03 37.86 Favored 'General case' 0 CA--C 1.446 -3.039 0 N-CA-C 108.617 -0.882 . . . . 75.14 108.617 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.441 HG23 HG22 ' B' ' 37' ' ' VAL . 19.7 m -117.61 119.51 35.22 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 115.202 -0.908 . . . . 71.43 111.317 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 38' ' ' ILE . 52.4 mt -111.97 121.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 109.654 -0.499 . . . . 51.21 109.654 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -101.74 118.88 37.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.992 -1.484 . . . . 73.32 106.992 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.514 ' O ' HD23 ' B' ' 34' ' ' LEU . 14.1 tp10 -132.87 122.37 24.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.481 -0.781 . . . . 73.52 109.397 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.23 -96.13 0.16 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 111.096 -0.802 . . . . 53.13 111.096 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' SER . . . . . 0.435 ' HB2' HD21 ' A' ' 19' ' ' LEU . 18.0 m -138.12 10.93 2.82 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.906 0.384 . . . . 53.2 110.364 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.596 HD21 HG23 ' A' ' 40' ' ' ILE . 2.1 pt? -118.3 141.38 48.58 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 120.57 -0.452 . . . . 75.31 109.827 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -112.48 134.31 54.08 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 115.894 -0.594 . . . . 74.11 112.216 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.97 53.14 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.088 -0.96 . . . . 51.43 109.272 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' B' ' 48' ' ' CYS . 76.1 t -114.17 127.12 71.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.019 -0.537 . . . . 74.3 110.151 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.657 HD12 HD12 ' A' ' 29' ' ' ILE . 62.9 mt -110.62 129.52 65.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 115.826 -0.625 . . . . 74.32 110.599 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.455 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.4 m-85 -109.48 116.92 32.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.824 -0.806 . . . . 72.11 108.824 176.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ILE . . . . . 0.599 HD12 HD21 ' A' ' 34' ' ' LEU . 49.1 mm -91.39 116.43 32.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.745 -0.662 . . . . 73.43 109.547 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.2 t -133.15 167.87 19.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.029 -0.73 . . . . 74.1 109.029 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.579 ' HE3' ' C ' ' B' ' 42' ' ' LYS 0.349 0.0 OUTLIER -86.37 2.42 47.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.639 0.978 . . . . 63.21 113.639 179.425 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -90.14 -13.26 36.05 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.036 -1.098 . . . . 74.55 108.036 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.07 -134.34 6.11 Favored Glycine 0 N--CA 1.424 -2.153 0 CA-C-N 115.245 -0.889 . . . . 73.1 112.059 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.47 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 60.1 tp -113.51 144.32 43.05 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 122.873 0.469 . . . . 74.25 109.833 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 83.3 tttt -129.37 136.12 49.59 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.618 -0.512 . . . . 54.42 109.618 168.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.492 HG11 HG11 ' A' ' 47' ' ' VAL . 14.8 p -120.42 140.69 43.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.094 -0.957 . . . . 63.0 110.512 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' CYS . . . . . 0.486 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 36.4 m -129.39 137.3 50.85 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.666 -0.697 . . . . 61.03 110.654 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' ALA . . . . . 0.511 ' HB1' HH22 ' A' ' 18' ' ' ARG . . . -117.8 124.02 47.39 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 107.803 -1.184 . . . . 71.42 107.803 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -121.82 110.88 33.04 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.946 -1.131 . . . . 64.32 107.946 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.434 -1.981 0 C-N-CA 121.408 1.405 . . . . 74.1 112.712 -177.184 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 109.992 -0.373 . . . . 74.11 109.992 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.97 36.25 6.09 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 109.979 -1.249 . . . . 65.01 109.979 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.2 t 73.62 87.59 0.1 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.598 1.159 . . . . 62.12 110.229 -175.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.2 119.12 22.45 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.283 -0.872 . . . . 62.34 108.703 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.62 90.97 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-O 122.0 0.905 . . . . 63.24 111.336 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -91.41 156.23 17.89 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.749 -0.834 . . . . 70.3 108.749 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -103.51 -6.89 21.32 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.752 -0.462 . . . . 73.21 109.752 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -92.62 -77.26 0.44 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.509 -0.552 . . . . 74.32 109.509 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 65.6 mtt85 -143.04 119.21 10.77 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 108.446 -0.946 . . . . 74.24 108.446 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.4 ' HB ' HD13 ' B' ' 14' ' ' LEU . 24.4 m -109.59 144.04 38.45 Favored 'General case' 0 C--N 1.27 -2.866 0 C-N-CA 119.531 -0.868 . . . . 71.15 109.494 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.69 149.32 43.4 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.43 -1.322 . . . . 74.51 107.43 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.465 HG11 HG11 ' B' ' 12' ' ' VAL . 58.6 t -140.54 139.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 121.157 -0.217 . . . . 72.04 110.929 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.6 p -110.98 131.0 55.41 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 122.998 0.519 . . . . 73.03 109.64 172.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 14' ' ' LEU . 4.2 pp -119.88 136.27 54.56 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.261 -1.015 . . . . 60.54 108.261 174.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.4 m -107.57 120.78 43.15 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.069 -0.715 . . . . 75.44 109.069 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 p -131.71 -169.24 2.16 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.392 -0.367 . . . . 54.43 110.957 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' B' ' 7' ' ' ASP . 18.6 pt20 -69.93 104.13 2.43 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.547 1.165 . . . . 73.51 108.043 174.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.592 ' NE ' ' HA ' ' A' ' 18' ' ' ARG . 1.6 mmp_? -125.53 149.51 48.24 Favored 'General case' 0 N--CA 1.404 -2.761 0 N-CA-C 114.871 1.434 . . . . 61.14 114.871 -170.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' O ' HD12 ' A' ' 19' ' ' LEU . 3.4 pp -101.84 148.26 35.05 Favored Pre-proline 0 N--CA 1.417 -2.093 0 CA-C-N 113.512 -1.677 . . . . 75.33 107.668 175.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.25 143.89 32.43 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.051 1.834 . . . . 75.31 112.496 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.1 p -131.36 140.0 49.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 107.984 -1.117 . . . . 74.12 107.984 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.3 p -58.66 -59.81 4.81 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 112.673 0.62 . . . . 64.11 112.673 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -115.98 166.92 11.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 112.148 0.425 . . . . 73.24 112.148 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mm -89.46 125.26 42.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.853 -0.612 . . . . 71.32 109.445 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 33.7 mmtm -89.57 145.46 25.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.88 -0.728 . . . . 71.1 109.68 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.6 m -120.86 126.96 51.39 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.101 -1.074 . . . . 61.5 108.101 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.429 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 67.8 m-85 -124.92 129.41 50.31 Favored 'General case' 0 CA--C 1.472 -2.048 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.921 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.483 HG22 HG22 ' A' ' 37' ' ' VAL . 66.3 p -114.14 130.57 56.59 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.659 -0.7 . . . . 63.52 111.929 -175.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.717 HD12 HD12 ' B' ' 38' ' ' ILE . 76.1 mt -126.35 126.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.637 -0.711 . . . . 75.13 109.735 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.6 t -102.42 133.8 46.77 Favored 'General case' 0 N--CA 1.422 -1.859 0 N-CA-C 108.915 -0.772 . . . . 61.15 108.915 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HG2' HG13 ' B' ' 40' ' ' ILE . 11.9 tp10 -141.56 97.65 3.2 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 116.232 -0.44 . . . . 74.21 109.954 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.5 -85.33 0.26 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.501 -0.772 . . . . 75.32 111.769 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.595 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 37.3 p -137.54 14.83 2.96 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.867 0.841 . . . . 74.25 110.024 176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' CD2' HD12 ' B' ' 40' ' ' ILE . 24.9 tp -106.67 132.49 52.6 Favored 'General case' 0 N--CA 1.408 -2.529 0 CA-C-N 115.387 -0.824 . . . . 62.45 110.844 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -108.84 115.88 30.92 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.36 -0.837 . . . . 61.42 110.339 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.06 120.08 40.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.631 -0.877 . . . . 64.51 108.631 176.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 28' ' ' THR . 87.5 t -114.79 126.04 72.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.286 0.565 . . . . 55.4 111.145 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.579 HD11 HD11 ' B' ' 38' ' ' ILE . 77.9 mt -106.16 122.91 60.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 124.259 1.024 . . . . 63.21 110.009 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 97.8 m-85 -107.8 118.11 35.89 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.254 -1.017 . . . . 74.21 108.254 174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.546 HG13 ' HG2' ' B' ' 31' ' ' GLU . 45.2 mm -88.58 118.93 35.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 109.036 -0.727 . . . . 70.24 109.036 -178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.2 p -119.7 165.81 14.03 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.0 -0.546 . . . . 71.31 109.642 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.08 -17.91 63.25 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 122.859 0.463 . . . . 75.33 111.211 178.041 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -94.99 -23.79 17.22 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.123 0.487 . . . . 54.02 110.401 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.541 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 160.8 -139.8 6.29 Favored Glycine 0 CA--C 1.486 -1.739 0 C-N-CA 118.497 -1.811 . . . . 74.21 114.988 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.1 tp -113.07 122.45 47.61 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.474 -0.863 . . . . 72.4 109.148 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 1.8 tmtm? -116.83 122.12 43.49 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.279 -2.119 . . . . 71.44 105.279 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 p -123.54 140.47 46.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 C-N-CA 120.745 -0.382 . . . . 65.02 110.661 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.461 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 59.3 m -122.94 141.43 51.93 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 116.259 -0.428 . . . . 62.24 110.983 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.42 124.85 51.04 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.825 -0.625 . . . . 65.51 110.421 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -123.31 91.98 49.33 Favored Pre-proline 0 C--N 1.298 -1.668 0 C-N-CA 124.264 1.026 . . . . 65.21 108.52 176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -98.61 133.12 0.26 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.297 1.998 . . . . 72.25 114.15 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.475 ' NE2' ' HG ' ' B' ' 19' ' ' LEU . 56.9 mt-30 52.04 22.51 1.88 Allowed 'General case' 0 C--O 1.243 0.729 0 CA-C-N 113.818 -1.537 . . . . 74.13 114.329 171.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.09 -60.63 2.99 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.826 0.822 . . . . 55.14 109.517 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.2 p -105.16 175.05 5.62 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 114.479 -1.237 . . . . 52.11 107.792 177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -80.89 116.75 21.02 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.008 -0.677 . . . . 75.15 109.328 174.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 33' ' ' SER . 38.6 t -107.8 153.47 9.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.148 -0.933 . . . . 54.52 108.656 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -86.61 145.36 26.77 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.359 -0.608 . . . . 73.22 109.359 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -80.64 59.74 3.71 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.872 0.844 . . . . 74.33 110.032 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.2 t 64.41 112.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.869 0 C-N-CA 125.046 1.338 . . . . 62.23 112.767 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.305 -1.358 0 CA-C-N 115.614 -0.721 . . . . 72.24 110.49 179.795 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.24 0.584 0 N-CA-C 109.518 -0.549 . . . . 75.43 109.518 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.62 39.57 3.01 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 121.073 -0.584 . . . . 70.41 112.204 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 22.2 t 64.62 15.71 9.86 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.184 0.994 . . . . 72.53 110.309 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -144.3 143.06 30.82 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 115.587 -0.733 . . . . 72.52 109.597 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.22 133.62 63.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 106.512 -1.662 . . . . 62.1 106.512 171.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 39.2 t -127.32 140.48 52.17 Favored 'General case' 0 C--N 1.29 -2.005 0 C-N-CA 119.867 -0.733 . . . . 74.12 111.408 -172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 13.7 m-20 -63.36 -32.37 73.78 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.393 -0.821 . . . . 74.24 110.037 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.603 ' O ' ' HD2' ' B' ' 51' ' ' PRO . 93.4 mttt -59.28 -66.2 0.55 Allowed 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 124.381 1.051 . . . . 65.41 110.194 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' B' ' 9' ' ' ARG . 60.1 mtt180 -156.41 124.0 5.47 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.36 -0.978 . . . . 75.34 108.36 175.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.9 m -110.29 141.86 42.7 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.975 -0.75 . . . . 63.14 108.975 171.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 79.6 m -127.82 148.98 50.47 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.037 -1.097 . . . . 73.24 108.037 173.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.465 HG11 HG11 ' A' ' 12' ' ' VAL . 40.7 t -139.77 142.17 32.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 109.361 -0.607 . . . . 63.22 109.361 177.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 67.9 p -107.49 125.27 51.06 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.874 -1.158 . . . . 52.21 107.874 174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' B' ' 45' ' ' LEU . 3.9 pp -112.91 144.02 43.19 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.036 0.446 . . . . 71.0 111.547 -177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.1 p -83.24 135.78 34.64 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.606 -0.724 . . . . 74.02 110.407 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.0 p -156.44 153.49 28.94 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 123.833 0.853 . . . . 62.14 109.743 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -76.05 93.83 3.35 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 122.341 1.067 . . . . 75.04 109.398 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -123.24 148.34 45.97 Favored 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 114.937 -1.028 . . . . 62.32 113.369 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.475 ' HG ' ' NE2' ' A' ' 52' ' ' GLN . 0.4 OUTLIER -80.81 153.81 72.96 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 114.044 -1.434 . . . . 61.31 109.343 172.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.04 149.94 88.39 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.504 2.136 . . . . 54.25 112.586 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.7 124.59 72.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 108.124 -1.065 . . . . 62.34 108.124 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.9 m -58.7 -47.08 85.79 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.169 0.588 . . . . 50.42 112.285 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -122.5 145.8 47.98 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 109.498 -0.556 . . . . 72.04 109.498 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.2 mm -75.58 114.97 16.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.238 -1.023 . . . . 74.04 108.238 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -92.53 144.34 25.44 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.715 -0.675 . . . . 64.24 109.678 -175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 75.2 m -131.24 126.99 36.9 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.421 -0.955 . . . . 73.03 108.421 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 85.5 m-85 -122.95 131.48 53.74 Favored 'General case' 0 CA--C 1.465 -2.305 0 CA-C-N 115.716 -0.674 . . . . 72.25 110.733 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.614 HG22 HG22 ' B' ' 37' ' ' VAL . 23.1 p -115.35 131.22 57.0 Favored 'General case' 0 C--N 1.284 -2.272 0 O-C-N 124.254 0.971 . . . . 62.41 111.813 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 38' ' ' ILE . 49.2 mt -128.61 134.23 64.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 116.029 -0.532 . . . . 73.11 109.881 175.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -110.32 133.11 53.57 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.898 -0.778 . . . . 74.05 108.898 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.546 ' HG2' HG13 ' A' ' 40' ' ' ILE . 26.7 tp10 -142.4 102.02 4.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.216 0.531 . . . . 72.44 109.57 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.08 -78.02 1.29 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.521 -0.763 . . . . 43.23 111.412 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.422 ' HA ' ' HB ' ' B' ' 56' ' ' VAL . 48.8 m -157.74 33.64 0.26 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.324 -1.361 . . . . 72.23 107.324 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 40' ' ' ILE . 31.6 tp -120.61 125.26 47.29 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.449 -0.796 . . . . 64.32 110.307 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 32.7 mmt180 -99.75 115.18 28.92 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 123.746 0.654 . . . . 74.22 111.099 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 124.48 49.46 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.418 -0.956 . . . . 73.32 108.418 175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.614 HG22 HG22 ' B' ' 28' ' ' THR . 67.8 t -120.47 135.01 62.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.16 0.505 . . . . 75.2 110.355 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.717 HD12 HD12 ' A' ' 29' ' ' ILE . 77.2 mt -118.79 122.36 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 CA-C-N 115.293 -0.867 . . . . 74.4 109.524 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.479 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.4 m-85 -107.77 115.78 30.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.063 -1.088 . . . . 73.2 108.063 176.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.515 HG13 ' HG2' ' A' ' 31' ' ' GLU . 48.5 mm -88.61 114.85 27.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.167 0 N-CA-C 109.27 -0.641 . . . . 72.24 109.27 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 76.7 p -122.43 162.31 21.89 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 116.156 -0.474 . . . . 75.13 110.294 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.503 ' N ' ' HD3' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -56.69 -25.58 54.53 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.768 0.827 . . . . 71.44 112.83 179.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -89.78 -16.13 30.9 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 111.893 0.331 . . . . 74.33 111.893 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 153.89 -134.59 4.41 Favored Glycine 0 N--CA 1.424 -2.135 0 C-N-CA 118.88 -1.629 . . . . 72.03 113.314 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.507 ' HB3' HD11 ' B' ' 14' ' ' LEU . 58.9 tp -113.3 125.59 54.45 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.293 -0.632 . . . . 70.02 109.293 -177.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 2.6 tmtm? -115.65 121.67 43.27 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 105.754 -1.943 . . . . 61.54 105.754 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 p -114.74 140.44 35.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 116.61 -0.268 . . . . 74.45 110.977 -174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 47.6 m -130.81 137.93 49.66 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 122.893 0.477 . . . . 74.13 111.53 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 14' ' ' LEU . . . -117.68 125.26 50.37 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.058 -0.519 . . . . 33.43 110.5 176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 32.6 t70 -120.99 83.91 38.35 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 108.347 -0.983 . . . . 64.53 108.347 174.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.603 ' HD2' ' O ' ' B' ' 8' ' ' LYS . 80.6 Cg_endo -89.07 135.44 2.74 Favored 'Trans proline' 0 N--CA 1.431 -2.196 0 C-N-CA 122.675 2.25 . . . . 45.03 114.485 -176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 69.5 -74.77 0.08 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 125.639 1.576 . . . . 74.31 113.294 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 52.66 -91.52 0.02 OUTLIER 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.509 1.124 . . . . 70.22 112.924 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 29.8 p -137.39 -73.05 0.42 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-O 120.619 0.247 . . . . 75.42 111.508 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -126.87 92.22 3.49 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-O 121.208 0.527 . . . . 73.5 112.194 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' B' ' 33' ' ' SER . 68.2 t -97.26 113.0 30.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.617 -1.253 . . . . 63.22 107.617 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -86.77 163.66 17.15 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 112.445 0.535 . . . . 70.13 112.445 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.85 -25.97 59.36 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 114.839 -1.073 . . . . 72.33 109.104 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 61.4 t 66.82 74.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.001 0 CA-C-N 114.872 -1.058 . . . . 70.43 110.848 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.431 -1.42 0 CA-C-N 114.476 -1.238 . . . . 72.25 110.136 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 110.139 -0.319 . . . . 62.24 110.139 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.47 38.03 18.77 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.178 -1.169 . . . . 70.3 110.178 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.7 m -60.56 135.54 57.79 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 123.314 0.645 . . . . 74.44 111.704 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -74.08 117.83 16.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 115.304 -0.862 . . . . 72.45 108.778 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 m -79.78 87.04 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.236 1.017 . . . . 74.44 112.082 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.0 m -73.38 -15.44 61.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.577 -1.192 . . . . 40.21 111.929 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -79.98 -18.43 50.34 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.95 -0.389 . . . . 70.11 109.95 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.531 ' HE3' ' N ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER -76.56 93.43 3.58 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 106.785 -1.561 . . . . 74.15 106.785 167.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 98.8 mtt180 70.28 100.5 0.06 Allowed 'General case' 0 C--N 1.313 -1.014 0 O-C-N 124.508 1.13 . . . . 72.1 110.425 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.2 p -86.11 117.86 25.21 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 108.359 -0.978 . . . . 63.02 108.359 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 56.7 m -121.48 149.33 43.22 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.672 -0.694 . . . . 70.3 109.385 -176.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG23 HD11 ' B' ' 14' ' ' LEU . 78.0 t -142.62 149.71 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 123.468 0.707 . . . . 71.1 109.383 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.6 p -106.58 125.72 51.36 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.978 0.418 . . . . 72.25 111.186 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.9 mm? -102.94 123.57 46.8 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.223 1.009 . . . . 75.35 110.16 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.3 p -107.63 112.26 24.89 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.54 -0.541 . . . . 72.44 109.54 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 t -151.54 95.68 2.16 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.156 0.503 . . . . 73.44 111.515 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.55 ' HB3' ' HB3' ' B' ' 51' ' ' PRO . 56.3 tp60 48.59 84.06 0.03 OUTLIER 'General case' 0 C--O 1.247 0.943 0 CA-C-N 114.774 -1.103 . . . . 74.52 111.752 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -124.73 145.7 49.56 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 114.115 1.154 . . . . 74.41 114.115 -173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -121.13 148.15 48.46 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 106.919 -1.511 . . . . 70.2 106.919 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.17 136.22 43.29 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.741 1.627 . . . . 73.33 113.595 -175.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 23' ' ' ARG . 11.3 p -124.16 139.46 50.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 106.675 -1.602 . . . . 64.24 106.675 175.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 m -98.2 9.3 43.27 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.538 0.57 . . . . 72.14 112.538 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' H ' HG22 ' A' ' 21' ' ' VAL . 31.1 tpt180 -131.16 133.33 45.46 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.867 -0.79 . . . . 74.13 108.867 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -90.75 116.58 32.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 108.476 -0.935 . . . . 74.45 108.476 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -99.71 127.19 45.85 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.324 -0.551 . . . . 74.13 110.821 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.4 HG22 ' CD1' ' A' ' 39' ' ' PHE . 54.0 p -108.68 127.77 54.28 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 107.991 -1.114 . . . . 53.33 107.991 175.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -126.5 125.8 42.67 Favored 'General case' 0 CA--C 1.467 -2.22 0 CA-C-N 116.316 -0.402 . . . . 70.43 109.949 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.601 HG22 HG22 ' A' ' 37' ' ' VAL . 67.2 p -115.78 121.9 43.83 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.707 -0.679 . . . . 52.33 111.351 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.626 HD12 HD12 ' B' ' 38' ' ' ILE . 51.1 mt -117.79 123.08 71.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 116.207 -0.451 . . . . 72.41 110.193 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -105.83 129.06 54.08 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 108.349 -0.982 . . . . 54.2 108.349 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.536 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.01 111.7 6.68 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 115.302 -0.863 . . . . 65.04 109.498 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.21 -67.89 2.09 Favored Glycine 0 N--CA 1.434 -1.434 0 CA-C-N 115.97 -0.559 . . . . 64.51 111.764 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 23.0 t -162.1 -21.05 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 122.027 0.131 . . . . 62.15 111.052 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.575 ' H ' HD23 ' A' ' 34' ' ' LEU . 2.3 pt? -89.34 141.71 28.3 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.661 -0.496 . . . . 61.04 109.661 178.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -117.86 118.6 32.46 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.764 -0.653 . . . . 72.43 109.262 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.33 133.72 48.75 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.005 -0.543 . . . . 75.54 109.602 -178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.601 HG22 HG22 ' A' ' 28' ' ' THR . 25.9 t -116.53 130.77 70.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 121.121 0.486 . . . . 74.32 110.435 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.537 HD12 HD12 ' B' ' 29' ' ' ILE . 74.2 mt -108.26 116.95 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.578 0 C-N-CA 124.583 1.153 . . . . 64.34 108.612 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.634 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 95.6 m-85 -105.78 116.06 31.29 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.177 -1.046 . . . . 72.15 108.177 175.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.542 HG23 HD21 ' B' ' 34' ' ' LEU . 44.9 mm -88.85 119.07 35.41 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 108.193 -1.04 . . . . 71.34 108.193 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -128.1 162.58 26.56 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 116.099 -0.501 . . . . 75.22 110.343 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -63.28 -18.21 63.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 123.214 0.605 . . . . 74.51 110.969 177.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -94.43 -9.28 36.1 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 121.541 0.686 . . . . 74.23 109.837 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.99 -134.37 7.39 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.593 -0.813 . . . . 72.14 113.119 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 56.1 tp -111.76 125.51 54.07 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.901 -0.407 . . . . 74.34 109.901 -176.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.2 tptm -115.22 121.65 43.59 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.824 -1.546 . . . . 52.14 106.824 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.547 HG11 HG11 ' B' ' 47' ' ' VAL . 14.4 p -112.13 140.57 31.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 116.496 -0.32 . . . . 74.11 110.646 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 57.0 m -127.55 138.51 52.92 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.392 -0.367 . . . . 71.12 111.114 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.1 123.64 48.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.119 -0.491 . . . . 70.24 109.718 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 29.6 t70 -101.62 119.36 57.5 Favored Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 109.136 -0.69 . . . . 71.25 109.136 176.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HB3' ' HB3' ' B' ' 17' ' ' GLN . 93.0 Cg_exo -48.65 135.88 27.33 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 124.247 3.298 . . . . 75.43 114.536 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' SER . 53.9 mt-30 -51.18 112.2 0.69 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.114 -0.948 . . . . 74.4 110.456 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.08 -66.56 1.06 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.973 -0.558 . . . . 73.34 110.215 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.4 m -104.08 135.86 44.78 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.977 -1.12 . . . . 74.42 107.977 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -71.21 126.55 29.91 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.359 -1.348 . . . . 75.32 107.359 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.8 p -75.08 113.39 13.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.933 0.873 . . . . 40.31 112.287 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -104.37 75.0 1.21 Allowed 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.345 -0.983 . . . . 74.23 108.345 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.6 t70 170.39 87.93 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.273 1.429 . . . . 54.32 108.622 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.35 133.17 61.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.333 0.587 . . . . 54.45 111.55 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.299 -1.606 0 CA-C-N 115.519 -0.764 . . . . 72.04 109.833 179.361 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.246 0.895 0 CA-C-O 121.656 0.741 . . . . 72.44 109.839 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.43 63.47 0.55 Allowed Glycine 0 N--CA 1.426 -1.988 0 CA-C-N 114.641 -1.163 . . . . 61.55 111.088 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 30.4 p -57.58 111.69 1.2 Allowed 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.72 0.772 . . . . 61.33 111.727 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -77.26 151.6 35.02 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.002 -0.999 . . . . 74.23 110.877 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' B' ' 8' ' ' LYS . 27.7 m -67.06 104.24 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-O 122.078 0.942 . . . . 61.32 111.963 -178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 48.2 m -98.44 -67.31 0.85 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.254 -0.885 . . . . 72.01 110.037 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.45 -3.7 30.38 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.168 0.508 . . . . 73.44 109.868 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.511 ' O ' ' HB ' ' B' ' 5' ' ' VAL . 39.9 ttmt -88.28 102.79 15.18 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.302 -0.999 . . . . 74.44 108.302 177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 87.1 mtt180 60.68 92.64 0.05 OUTLIER 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.748 1.219 . . . . 73.04 111.193 -176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.7 p -91.4 135.5 33.78 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.255 0.55 . . . . 73.15 110.672 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 55.5 m -131.04 149.79 52.45 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.119 -1.067 . . . . 74.21 108.119 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.444 HG23 HD11 ' A' ' 14' ' ' LEU . 76.1 t -144.29 145.55 21.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.546 -0.539 . . . . 64.42 109.546 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 34.6 p -106.88 135.08 49.04 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.12 0.486 . . . . 63.44 109.833 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 2.8 mm? -109.56 121.56 45.47 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.77 -0.65 . . . . 74.25 110.124 -178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 27.2 p -106.95 112.75 25.85 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.466 -0.939 . . . . 51.13 108.466 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.413 ' O ' ' HG3' ' B' ' 18' ' ' ARG . 10.5 t -134.44 -167.56 1.99 Allowed 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.844 -1.169 . . . . 72.32 107.844 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . 0.519 ' HB3' ' HB3' ' A' ' 51' ' ' PRO . 56.3 tp60 -62.51 88.08 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.731 0.777 . . . . 54.25 110.251 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' B' ' 16' ' ' THR . 5.5 ppt_? -126.77 150.15 49.27 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.242 0.83 . . . . 75.24 113.242 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.15 159.0 31.79 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 107.039 -1.467 . . . . 71.23 107.039 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.47 135.64 31.66 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.233 1.288 . . . . 73.3 111.624 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.479 HG22 ' H ' ' B' ' 23' ' ' ARG . 7.4 p -129.43 130.52 67.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.774 -0.824 . . . . 71.24 108.774 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 19.4 m -94.16 1.05 56.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.134 0.492 . . . . 53.34 112.128 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.479 ' H ' HG22 ' B' ' 21' ' ' VAL . 22.6 tpt180 -112.02 142.82 43.98 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.755 -0.461 . . . . 75.34 109.755 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 40.5 mm -101.7 131.23 50.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 108.049 -1.093 . . . . 61.25 108.049 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 34.3 mmtp -124.97 143.58 50.81 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.163 -0.31 . . . . 72.14 110.163 176.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 41.4 p -126.37 127.98 46.33 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.107 -0.701 . . . . 74.53 109.107 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 80.1 m-85 -127.81 132.28 49.48 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 120.694 0.283 . . . . 72.43 111.118 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.533 HG22 HG22 ' B' ' 37' ' ' VAL . 36.6 p -115.09 125.31 53.35 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.357 -0.838 . . . . 63.34 112.405 -174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 38' ' ' ILE . 58.0 mt -127.75 125.3 64.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-O 120.809 0.338 . . . . 74.32 110.523 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -108.91 131.68 54.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 108.469 -0.937 . . . . 72.11 108.469 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.605 ' O ' HD23 ' B' ' 34' ' ' LEU . 11.6 tp10 -142.99 116.34 9.04 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.68 -0.691 . . . . 74.52 109.463 179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.36 -59.78 2.81 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.669 -0.572 . . . . 32.22 111.669 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -174.13 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.595 0 C-N-CA 123.563 0.745 . . . . 75.1 110.461 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.605 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -77.5 140.84 39.86 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 109.158 -0.682 . . . . 70.31 109.158 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -119.8 121.71 39.75 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 115.99 -0.55 . . . . 74.01 109.53 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.7 131.54 52.01 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.843 -0.617 . . . . 73.23 109.888 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.533 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -114.13 125.37 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.752 -0.658 . . . . 41.31 109.895 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.626 HD12 HD12 ' A' ' 29' ' ' ILE . 77.9 mt -101.63 119.06 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 C-N-CA 123.664 0.786 . . . . 72.35 109.297 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.402 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.2 m-85 -104.72 114.86 29.34 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.411 -0.813 . . . . 72.24 108.857 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.501 HG23 HD21 ' A' ' 34' ' ' LEU . 41.8 mm -89.49 115.24 28.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 106.408 -1.701 . . . . 75.45 106.408 176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.0 p -133.47 163.22 29.87 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.092 0.472 . . . . 62.25 111.949 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.557 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -57.06 -21.83 34.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.829 1.252 . . . . 75.01 111.413 175.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -88.22 -16.25 33.75 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.524 0.73 . . . . 70.13 109.74 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.43 -122.71 4.3 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 111.072 -0.811 . . . . 72.41 111.072 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.506 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 56.4 tp -112.19 144.98 40.67 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 109.653 -0.499 . . . . 71.25 109.653 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -141.41 141.72 33.73 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.479 -1.304 . . . . 74.23 107.479 168.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.547 HG11 HG11 ' A' ' 47' ' ' VAL . 11.8 p -131.51 140.7 47.66 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.029 0 N-CA-C 109.368 -0.604 . . . . 75.34 109.368 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.402 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.8 m -119.49 138.39 53.18 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.995 -0.548 . . . . 54.53 110.205 175.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.41 123.86 49.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 109.25 -0.648 . . . . 73.05 109.25 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.446 ' HA ' ' HG2' ' B' ' 9' ' ' ARG . 34.2 t70 -100.45 125.86 37.83 Favored Pre-proline 0 C--N 1.289 -2.036 0 CA-C-N 115.732 -0.667 . . . . 71.2 109.993 176.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.55 ' HB3' ' HB3' ' A' ' 17' ' ' GLN . 5.0 Cg_exo -38.72 140.3 0.39 Allowed 'Trans proline' 0 C--N 1.356 0.945 1 C-N-CA 125.671 4.248 . . . . 62.43 116.018 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.44 ' HG3' ' HB3' ' B' ' 34' ' ' LEU . 54.5 mt-30 -68.65 73.65 0.25 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.395 -0.82 . . . . 70.23 110.575 170.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.49 8.03 2.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.911 -0.774 . . . . 71.32 108.911 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 4.8 m -82.35 136.38 35.01 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.125 -0.943 . . . . 61.15 108.938 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -85.33 89.14 7.59 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 108.713 -0.847 . . . . 62.22 108.713 174.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.78 107.11 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-O 121.806 0.813 . . . . 63.45 111.012 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -123.59 92.01 3.59 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.349 -0.842 . . . . 72.21 108.997 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -178.88 88.99 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.565 -1.198 . . . . 71.21 108.987 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 26.9 m -125.05 152.58 31.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.488 -0.778 . . . . 74.54 109.507 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.299 -1.599 0 CA-C-N 116.556 -0.293 . . . . 71.43 110.624 -179.894 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 110.093 -0.336 . . . . 53.21 110.093 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.55 31.33 8.38 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.726 -0.75 . . . . 24.1 113.053 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 p -93.86 136.87 33.69 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.664 0.232 . . . . 63.03 110.486 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -156.6 149.28 23.66 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.093 -0.706 . . . . 64.45 109.093 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t 70.07 107.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.629 1.172 . . . . 70.42 112.686 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -99.36 106.73 18.85 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.151 -0.685 . . . . 70.13 109.151 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -152.08 -167.57 2.81 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.354 -0.98 . . . . 73.42 108.354 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.11 119.08 25.1 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.255 0.55 . . . . 74.14 110.012 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 49' ' ' ALA . 92.6 mtt180 68.83 90.33 0.1 Allowed 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 125.965 1.706 . . . . 70.23 111.443 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 p -99.45 134.36 42.43 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-N 115.834 -0.621 . . . . 72.22 109.576 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.0 m -130.09 148.94 51.99 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.488 -0.56 . . . . 73.34 109.488 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.6 t -144.9 139.14 22.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.365 0.416 . . . . 72.04 109.9 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 p -112.43 130.9 55.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 120.761 0.315 . . . . 73.23 110.75 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.421 HD11 HG23 ' B' ' 12' ' ' VAL . 1.7 mm? -101.73 122.32 43.71 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.921 -0.581 . . . . 74.03 109.951 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.5 p -101.66 113.72 27.13 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 113.838 1.051 . . . . 75.14 113.838 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.516 HG22 ' CZ ' ' A' ' 18' ' ' ARG . 14.6 t -155.91 165.79 35.42 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 105.661 -1.978 . . . . 75.44 105.661 166.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -86.08 90.33 8.08 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 122.811 1.291 . . . . 73.22 110.685 -171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.516 ' CZ ' HG22 ' A' ' 16' ' ' THR . 80.6 mtt85 -96.61 149.62 21.57 Favored 'General case' 0 N--CA 1.393 -3.282 0 N-CA-C 105.472 -2.048 . . . . 73.25 105.472 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 2.3 mm? -73.26 128.33 87.72 Favored Pre-proline 0 C--N 1.284 -2.243 0 C-N-CA 120.725 -0.39 . . . . 63.15 111.571 -171.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 19' ' ' LEU . 72.9 Cg_exo -49.84 141.97 27.05 Favored 'Trans proline' 0 C--N 1.361 1.214 0 C-N-CA 124.527 3.485 . . . . 70.45 115.394 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.2 t -117.17 135.17 58.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.332 -1.729 . . . . 73.21 106.332 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.7 m -59.12 -59.66 5.11 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.109 0.411 . . . . 64.52 112.109 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -97.56 146.11 25.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.523 -0.547 . . . . 63.3 109.523 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 41' ' ' THR . 52.1 mm -79.94 118.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 108.603 -0.888 . . . . 63.31 108.603 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.59 146.57 25.16 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 121.172 0.511 . . . . 62.04 111.626 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 39.2 p -126.0 127.64 46.21 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.917 -1.038 . . . . 72.14 108.977 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -124.24 130.46 52.57 Favored 'General case' 0 CA--C 1.468 -2.189 0 CA-C-N 116.197 -0.456 . . . . 70.32 110.782 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.529 HG22 HG22 ' A' ' 37' ' ' VAL . 61.8 p -114.86 128.67 56.43 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.177 -0.919 . . . . 73.1 111.103 -175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.67 HD12 HD12 ' B' ' 38' ' ' ILE . 58.2 mt -126.91 123.46 62.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 120.931 0.396 . . . . 65.05 110.492 177.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.7 t -106.15 121.81 44.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.453 -0.943 . . . . 74.03 108.453 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -142.19 106.92 4.86 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.36 0.6 . . . . 63.01 111.279 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.05 -66.8 2.14 Favored Glycine 0 N--CA 1.439 -1.151 0 CA-C-N 115.857 -0.61 . . . . 72.34 112.931 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.9 m -154.11 12.88 0.43 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.483 0.549 . . . . 73.33 112.483 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.516 HD21 HD12 ' B' ' 40' ' ' ILE . 1.6 pt? -128.58 141.56 51.33 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 118.062 -1.455 . . . . 71.05 111.877 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 53' ' ' ALA . 23.5 mmm180 -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.014 -1.476 . . . . 72.53 107.014 167.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.47 129.4 52.47 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.323 -0.621 . . . . 73.21 109.323 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 28' ' ' THR . 58.9 t -118.17 126.86 75.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-O 121.083 0.468 . . . . 70.53 110.912 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.576 HD12 HD12 ' B' ' 29' ' ' ILE . 69.6 mt -105.78 122.24 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.134 0 CA-C-N 115.206 -0.906 . . . . 64.3 109.607 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.489 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.1 m-85 -103.36 114.89 29.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.885 -0.783 . . . . 74.11 108.885 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.71 HG23 HD21 ' B' ' 34' ' ' LEU . 40.6 mm -91.98 114.5 29.16 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.572 -0.899 . . . . 73.32 108.572 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.438 HG22 HD12 ' A' ' 24' ' ' ILE . 70.4 p -130.74 170.61 14.12 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.283 -0.636 . . . . 64.53 109.283 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -83.49 -4.73 58.79 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.876 -0.787 . . . . 73.14 108.876 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 3.1 tmt_? -98.64 6.11 47.26 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 106.949 -1.5 . . . . 71.05 106.949 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.35 -143.67 18.07 Favored Glycine 0 N--CA 1.423 -2.232 0 CA-C-N 114.228 -1.351 . . . . 52.31 113.148 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.631 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 55.0 tp -112.34 136.7 51.48 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.599 -0.519 . . . . 74.21 109.599 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 82.8 tttt -128.2 140.71 51.76 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.059 -0.719 . . . . 70.12 109.059 170.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.693 HG11 HG11 ' B' ' 47' ' ' VAL . 9.6 p -128.72 141.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 CA-C-N 115.58 -0.736 . . . . 74.03 109.996 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.489 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 60.5 m -128.45 137.52 51.87 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 116.313 -0.403 . . . . 52.03 110.705 174.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.831 ' O ' ' HA ' ' A' ' 9' ' ' ARG . . . -116.45 121.73 42.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 109.411 -0.589 . . . . 61.42 109.411 175.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -119.3 101.94 48.81 Favored Pre-proline 0 C--N 1.284 -2.242 0 C-N-CA 123.837 0.855 . . . . 75.01 109.718 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.07 133.44 13.58 Favored 'Trans proline' 0 N--CA 1.431 -2.175 0 C-N-CA 120.839 1.026 . . . . 64.12 110.562 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 47.78 75.47 0.13 Allowed 'General case' 0 CA--C 1.546 0.806 0 O-C-N 124.261 0.976 . . . . 64.14 112.988 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB2' ' HG3' ' A' ' 35' ' ' ARG . . . -59.03 -52.14 67.05 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 121.278 0.561 . . . . 43.41 111.813 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.1 t -161.92 -51.97 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.55 -0.907 . . . . 74.21 108.55 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -148.88 112.54 5.06 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.071 -1.455 . . . . 73.12 107.071 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.9 128.68 39.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 109.569 -0.53 . . . . 73.22 109.569 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.1 161.77 13.51 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.302 -0.559 . . . . 74.51 110.842 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -83.72 4.89 26.8 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.292 -0.867 . . . . 63.25 110.375 -175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t 76.08 105.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.796 1.239 . . . . 70.21 110.215 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 C--N 1.305 -1.369 0 CA-C-N 115.845 -0.616 . . . . 64.04 110.319 -178.261 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 49.6 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.36 -0.607 . . . . 74.31 109.36 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.8 -77.87 0.78 Allowed Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.471 -0.786 . . . . 53.02 113.729 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 43.8 m -81.26 88.18 6.07 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.499 0.666 . . . . 71.42 112.067 -176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -159.92 116.06 2.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.198 -1.779 . . . . 64.14 106.198 176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 53.8 t 58.52 74.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 107.747 -1.205 . . . . 64.54 107.747 -170.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -122.44 160.16 26.09 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 114.64 -1.164 . . . . 73.11 110.855 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -135.31 -160.52 1.06 Allowed 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 104.577 -2.379 . . . . 63.53 104.577 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . 0.372 97.4 mttt -74.92 -2.07 25.31 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 119.573 1.079 . . . . 72.33 113.422 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 92.4 mtt180 -129.01 109.75 11.48 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 108.19 -1.041 . . . . 74.15 108.19 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 m -108.49 127.07 53.6 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.507 -1.294 . . . . 74.32 107.507 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 61.9 m -121.66 148.97 43.88 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.947 -1.131 . . . . 64.12 107.947 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.421 HG23 HD11 ' A' ' 14' ' ' LEU . 92.8 t -144.45 146.77 20.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 109.681 -0.489 . . . . 43.4 109.681 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.505 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 35.3 p -106.16 135.84 46.91 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 107.91 -1.145 . . . . 74.43 107.91 174.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' B' ' 45' ' ' LEU . 3.2 mm? -100.2 122.56 43.22 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.497 -0.557 . . . . 74.42 109.497 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 38.0 p -84.62 112.56 20.56 Favored 'General case' 0 N--CA 1.397 -3.075 0 CA-C-N 115.441 -0.799 . . . . 61.4 109.803 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -154.65 177.79 10.83 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.191 -1.411 . . . . 75.53 107.191 175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -108.2 108.55 19.63 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.44 0.638 . . . . 75.23 109.379 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.419 HH22 HG21 ' B' ' 21' ' ' VAL . 19.2 mtm105 -124.62 150.33 46.11 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.368 -0.833 . . . . 74.15 110.19 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.45 HD22 ' H ' ' B' ' 19' ' ' LEU . 2.1 mm? -74.93 145.32 81.03 Favored Pre-proline 0 C--N 1.296 -1.725 0 CA-C-N 114.857 -1.065 . . . . 73.22 108.86 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -53.75 135.67 63.17 Favored 'Trans proline' 0 C--O 1.253 1.239 0 C-N-CA 123.02 2.48 . . . . 72.23 112.806 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.419 HG21 HH22 ' B' ' 18' ' ' ARG . 61.3 t -103.72 131.2 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.658 -1.238 . . . . 72.31 107.658 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.9 m -56.29 -46.33 79.8 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 113.798 1.036 . . . . 61.41 113.798 -174.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.416 ' HA ' ' CZ ' ' B' ' 23' ' ' ARG . 0.4 OUTLIER -127.22 155.45 43.41 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.783 -0.821 . . . . 71.35 108.783 -175.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.3 131.53 33.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.947 0.403 . . . . 55.42 109.968 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' B' ' 27' ' ' TYR . 1.5 mptm? -116.72 143.5 45.57 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 112.322 0.49 . . . . 61.14 112.322 177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 53.7 p -125.85 127.12 45.57 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.444 -1.317 . . . . 70.22 107.444 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.474 ' CE2' ' HB3' ' B' ' 25' ' ' LYS . 75.9 m-85 -124.65 126.85 46.41 Favored 'General case' 0 CA--C 1.45 -2.899 0 CA-C-N 116.244 -0.435 . . . . 75.23 110.566 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.606 HG22 HG22 ' B' ' 37' ' ' VAL . 81.5 p -114.01 135.47 53.97 Favored 'General case' 0 N--CA 1.408 -2.568 0 CA-C-N 115.073 -0.967 . . . . 72.32 109.507 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.576 HD12 HD12 ' A' ' 38' ' ' ILE . 60.6 mt -127.97 121.65 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 116.114 -0.494 . . . . 63.2 110.772 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.516 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 6.2 t -100.96 117.46 35.05 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.589 -0.732 . . . . 54.42 109.1 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.517 ' O ' HD23 ' B' ' 34' ' ' LEU . 10.4 tp10 -140.39 110.29 6.47 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 115.553 -0.749 . . . . 63.22 110.286 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.35 -84.7 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.593 -0.73 . . . . 73.33 114.341 175.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.566 ' HA ' HG11 ' B' ' 56' ' ' VAL . 47.8 m -137.19 12.73 3.06 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 112.982 0.734 . . . . 52.54 112.982 -176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.71 HD21 HG23 ' A' ' 40' ' ' ILE . 2.2 pt? -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.753 -0.779 . . . . 72.42 112.107 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.516 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 18.6 mmm180 -103.67 113.52 27.1 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.1 -1.444 . . . . 72.35 107.1 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.37 131.64 52.55 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 110.023 -0.362 . . . . 74.22 110.023 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.606 HG22 HG22 ' B' ' 28' ' ' THR . 59.8 t -122.61 124.84 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-O 120.836 0.351 . . . . 74.33 111.031 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.67 HD12 HD12 ' A' ' 29' ' ' ILE . 94.1 mt -104.53 122.0 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 108.651 -0.87 . . . . 64.22 108.651 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.1 m-85 -104.24 121.04 42.49 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.233 -1.395 . . . . 74.43 107.233 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.516 HD12 HD21 ' A' ' 34' ' ' LEU . 50.6 mm -89.48 114.68 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.653 0 CA-C-O 122.398 1.094 . . . . 71.12 110.014 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 2.0 m -127.04 149.47 49.9 Favored 'General case' 1 N--CA 1.369 -4.492 0 CA-C-N 112.503 -2.135 . . . . 74.2 106.475 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' B' ' 42' ' ' LYS . 17.5 ptmt -71.74 -18.93 62.1 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 118.62 0.645 . . . . 54.2 112.666 -177.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.539 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 0.1 OUTLIER -86.89 6.14 33.41 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.165 0.984 . . . . 72.12 109.056 -172.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.94 -129.33 4.05 Favored Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 120.469 -0.872 . . . . 44.54 112.738 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.492 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 64.6 tp -125.64 144.55 50.54 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 123.584 0.754 . . . . 64.25 109.003 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.4 tptm -134.75 122.9 22.8 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.167 -1.42 . . . . 72.53 107.167 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.693 HG11 HG11 ' A' ' 47' ' ' VAL . 10.2 p -127.23 141.42 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 C-N-CA 120.883 -0.327 . . . . 75.3 110.956 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 56.5 m -123.71 137.02 54.78 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 116.144 -0.48 . . . . 64.44 111.012 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.64 122.9 44.8 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.912 -0.586 . . . . 64.42 110.971 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -132.33 118.4 16.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 123.688 0.795 . . . . 74.34 109.324 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 48.3 Cg_endo -76.62 134.24 15.0 Favored 'Trans proline' 0 N--CA 1.431 -2.153 0 C-N-CA 121.127 1.218 . . . . 71.43 112.352 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.497 ' HA ' ' CG1' ' B' ' 56' ' ' VAL . 41.8 mt-30 65.87 -57.48 0.34 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.974 1.71 . . . . 65.03 115.297 174.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . 68.69 -75.77 0.06 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.161 1.384 . . . . 63.13 110.47 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 6.2 t -149.32 -48.46 0.14 Allowed 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 108.993 -0.743 . . . . 72.2 108.993 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -139.86 92.11 2.53 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.154 0.502 . . . . 74.25 111.826 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' B' ' 33' ' ' SER . 8.6 p -100.97 131.16 49.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.123 -1.065 . . . . 73.03 108.123 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.27 172.59 9.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.598 -0.841 . . . . 51.13 111.403 -177.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -78.6 49.11 0.85 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.497 1.519 . . . . 73.41 109.725 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 47.4 t 65.01 80.6 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.499 1.12 . . . . 74.43 110.457 -177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.248 0.987 0 CA-C-N 115.072 -0.967 . . . . 72.42 109.279 -178.568 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 110.068 -0.345 . . . . 63.54 110.068 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.43 131.38 10.69 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.976 -0.85 . . . . 74.01 110.976 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -154.81 109.59 3.02 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 122.568 0.347 . . . . 73.41 110.543 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -77.61 115.05 17.06 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.849 -0.426 . . . . 74.2 109.849 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.7 m -81.72 99.37 4.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.692 0.758 . . . . 74.41 111.024 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.5 m -154.84 178.29 10.32 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.396 0.678 . . . . 73.14 109.416 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -77.97 86.88 4.15 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 112.796 0.665 . . . . 74.15 112.796 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -154.8 -82.36 0.08 Allowed 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 126.88 2.072 . . . . 73.41 106.834 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -151.09 120.99 7.09 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 107.325 -1.361 . . . . 72.41 107.325 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.427 ' HB ' HD13 ' B' ' 14' ' ' LEU . 28.3 m -108.8 140.2 42.57 Favored 'General case' 0 N--CA 1.403 -2.801 0 C-N-CA 119.101 -1.04 . . . . 55.42 109.597 176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.9 m -128.94 149.56 50.75 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.69 -1.226 . . . . 75.52 107.69 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.5 t -140.69 135.72 34.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 110.068 -0.345 . . . . 62.23 110.068 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.471 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 30.2 p -107.45 135.9 48.14 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.58 -0.526 . . . . 74.32 109.58 174.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 45' ' ' LEU . 4.2 pp -130.66 127.95 39.95 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.057 0.456 . . . . 72.0 110.595 178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.2 t -110.03 119.51 39.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.402 0.62 . . . . 55.42 110.193 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -159.56 114.67 2.42 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.677 -0.692 . . . . 74.34 109.856 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HG3' ' HB2' ' B' ' 51' ' ' PRO . 12.0 pt20 35.85 81.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.848 1.659 . . . . 62.33 114.446 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -125.56 149.59 48.21 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 113.591 0.96 . . . . 71.12 113.591 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 19' ' ' LEU . 3.2 mp -111.26 155.54 42.54 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 107.692 -1.225 . . . . 62.35 107.692 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.26 142.83 94.76 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.724 2.283 . . . . 75.15 111.089 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.07 146.22 18.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.442 -0.947 . . . . 72.23 108.442 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 63.9 m -71.13 -39.9 71.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.738 0.644 . . . . 74.53 112.738 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 29.2 tpt180 -134.46 138.91 45.13 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.778 -0.576 . . . . 72.43 110.154 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -74.84 115.32 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 107.624 -1.25 . . . . 72.41 107.624 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.2 mmtp -101.29 132.16 46.97 Favored 'General case' 0 C--N 1.285 -2.206 0 C-N-CA 120.387 -0.525 . . . . 72.52 111.388 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 42.8 p -113.05 126.65 55.72 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 106.671 -1.603 . . . . 63.32 106.671 173.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 69.7 m-85 -121.57 129.9 53.17 Favored 'General case' 0 CA--C 1.458 -2.572 0 CA-C-N 116.575 -0.284 . . . . 75.41 110.693 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.558 HG22 HG22 ' A' ' 37' ' ' VAL . 61.7 p -114.54 127.65 55.91 Favored 'General case' 0 C--N 1.286 -2.161 0 O-C-N 123.86 0.725 . . . . 75.24 111.171 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.651 HD12 HD12 ' B' ' 38' ' ' ILE . 62.7 mt -127.79 121.73 57.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.262 -0.644 . . . . 73.44 109.262 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -106.34 126.34 52.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.326 -0.99 . . . . 74.33 108.326 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.0 tp10 -142.34 99.97 3.61 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.183 -0.462 . . . . 74.11 111.869 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 -66.36 1.37 Allowed Glycine 0 C--N 1.311 -0.825 0 N-CA-C 114.908 0.723 . . . . 44.31 114.908 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.4 m -139.29 -8.15 1.32 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 122.314 -0.521 . . . . 74.1 112.399 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.511 HD21 HD12 ' B' ' 40' ' ' ILE . 2.3 pt? -130.27 140.35 50.69 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 119.043 -1.063 . . . . 63.14 111.769 -175.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 3.1 mpt_? -99.54 119.58 38.26 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 107.449 -1.315 . . . . 74.21 107.449 169.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.16 127.11 51.73 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.489 -0.56 . . . . 75.1 109.489 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 44.7 t -117.19 128.51 74.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 116.336 -0.393 . . . . 73.54 110.425 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.695 HD12 HD12 ' B' ' 29' ' ' ILE . 96.6 mt -108.59 121.29 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.087 0 N-CA-C 108.274 -1.01 . . . . 72.53 108.274 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.505 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 93.2 m-85 -104.88 114.63 28.95 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.197 -1.038 . . . . 74.33 108.197 176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.539 HD12 HD21 ' B' ' 34' ' ' LEU . 48.4 mm -90.79 113.39 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 N-CA-C 108.063 -1.088 . . . . 74.21 108.063 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 t -125.65 177.75 6.06 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.181 -1.044 . . . . 72.41 108.181 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -81.4 -32.67 32.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.956 1.095 . . . . 62.35 113.956 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -86.65 -20.1 28.31 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.829 -0.749 . . . . 72.25 110.863 -173.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.73 -162.65 29.38 Favored Glycine 0 C--N 1.294 -1.779 0 C-N-CA 119.171 -1.49 . . . . 61.55 114.134 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 14' ' ' LEU . 2.0 tm? -113.69 122.88 48.48 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.475 -0.935 . . . . 70.41 108.475 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 24.0 tptm -115.76 122.43 45.44 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.408 -0.96 . . . . 72.33 108.408 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.601 HG11 HG11 ' B' ' 47' ' ' VAL . 13.8 p -119.23 140.53 42.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 109.868 -0.419 . . . . 64.23 109.868 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -125.71 139.79 53.24 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.969 -0.56 . . . . 63.25 111.332 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' O ' ' HD3' ' A' ' 51' ' ' PRO . . . -117.0 123.68 47.5 Favored 'General case' 0 N--CA 1.407 -2.618 0 N-CA-C 108.429 -0.952 . . . . 54.54 108.429 174.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 18.1 t70 -113.72 87.44 12.19 Favored Pre-proline 0 C--N 1.282 -2.362 0 N-CA-C 108.197 -1.038 . . . . 71.53 108.197 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.3 Cg_endo -87.79 133.28 3.02 Favored 'Trans proline' 0 N--CA 1.417 -3.023 0 C-N-CA 121.57 1.513 . . . . 75.04 111.354 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 58.78 -176.46 0.08 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.09 -1.414 . . . . 74.44 113.37 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 179.45 -71.44 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.192 1.397 . . . . 74.52 107.725 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.6 p -143.61 -62.2 0.4 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.275 -1.75 . . . . 73.13 106.275 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -131.88 141.1 49.28 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.128 -1.434 . . . . 71.2 107.128 172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 55.6 t -104.94 122.73 58.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.72 -0.844 . . . . 74.41 108.72 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -77.6 146.92 35.91 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.237 0.542 . . . . 74.33 111.673 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -97.57 108.32 21.01 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.247 -1.02 . . . . 73.23 108.247 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.04 127.37 33.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.109 0.481 . . . . 63.44 110.275 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--O 1.251 1.143 0 CA-C-N 115.668 -0.697 . . . . 65.52 110.218 -177.517 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . 0.507 HG23 ' H ' ' B' ' 3' ' ' SER . 32.2 m . . . . . 0 C--O 1.239 0.537 0 N-CA-C 109.451 -0.574 . . . . 75.44 109.451 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.03 -1.49 63.18 Favored Glycine 0 CA--C 1.522 0.503 0 O-C-N 123.176 0.298 . . . . 73.0 113.418 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.507 ' H ' HG23 ' B' ' 1' ' ' VAL . 18.2 m -86.94 112.34 21.7 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 109.661 -0.496 . . . . 72.21 109.661 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -90.54 102.64 15.38 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.723 -1.584 . . . . 63.22 106.723 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' B' ' 10' ' ' THR . 31.6 m -128.75 117.3 44.24 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 112.935 0.717 . . . . 72.05 112.935 -172.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 67.6 m -149.71 -80.44 0.12 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.952 -0.567 . . . . 70.44 112.393 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -121.05 -7.26 9.44 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 113.783 1.031 . . . . 72.52 113.783 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -89.73 -56.19 3.34 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 109.393 -0.595 . . . . 72.33 109.393 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -140.57 132.57 27.77 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 107.938 -1.134 . . . . 73.44 107.938 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.48 ' HB ' HD13 ' A' ' 14' ' ' LEU . 25.1 m -109.64 128.59 55.34 Favored 'General case' 0 N--CA 1.393 -3.298 0 N-CA-C 107.564 -1.273 . . . . 74.22 107.564 173.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.439 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 34.8 m -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.572 -2.011 . . . . 62.12 105.572 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 58.0 t -142.21 141.71 28.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 120.71 0.291 . . . . 63.23 110.885 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.5 p -108.7 126.68 53.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.236 -0.438 . . . . 75.32 110.881 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' B' ' 45' ' ' LEU . 4.3 pp -125.23 137.52 54.11 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.984 -0.747 . . . . 63.13 108.984 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -120.19 125.99 49.55 Favored 'General case' 0 C--N 1.278 -2.533 0 N-CA-C 109.06 -0.719 . . . . 74.13 109.06 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 4.2 t -161.85 115.6 1.87 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 116.277 -0.42 . . . . 55.4 111.202 -175.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 34.29 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 126.276 1.83 . . . . 65.12 114.849 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.432 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 53.2 mmm-85 -127.51 146.73 50.41 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 114.008 1.114 . . . . 54.52 114.008 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.88 153.96 47.53 Favored Pre-proline 0 C--O 1.25 1.126 0 N-CA-C 106.501 -1.666 . . . . 73.13 106.501 171.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.78 135.55 38.77 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.705 1.603 . . . . 54.42 112.532 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.548 HG12 ' H ' ' B' ' 23' ' ' ARG . 91.4 t -131.39 131.85 62.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.858 -1.164 . . . . 64.12 107.858 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 m -98.18 3.24 49.01 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 111.959 0.355 . . . . 74.41 111.959 -175.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.548 ' H ' HG12 ' B' ' 21' ' ' VAL . 6.9 mpt_? -117.22 139.38 50.86 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.666 -0.243 . . . . 53.33 110.553 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.05 115.44 41.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 106.996 -1.483 . . . . 62.13 106.996 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.485 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 34.7 mmtp -103.92 141.44 36.15 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 120.632 -0.427 . . . . 71.22 110.41 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.408 HG22 ' CD2' ' B' ' 39' ' ' PHE . 51.3 p -121.89 127.07 50.04 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.79 -0.819 . . . . 75.14 108.79 176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -123.62 129.58 51.36 Favored 'General case' 0 CA--C 1.467 -2.229 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.391 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.544 HG22 HG22 ' B' ' 37' ' ' VAL . 72.6 p -115.47 130.53 56.91 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 115.824 -0.625 . . . . 72.23 112.268 -174.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 38' ' ' ILE . 80.2 mt -136.85 127.44 40.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.303 -0.628 . . . . 43.11 109.303 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.422 ' HB ' ' HD3' ' B' ' 35' ' ' ARG . 12.4 t -119.39 135.73 54.6 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.155 -1.054 . . . . 72.41 108.155 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.596 ' O ' HD23 ' B' ' 34' ' ' LEU . 12.5 tp10 -142.44 112.23 6.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 120.614 -0.434 . . . . 72.44 111.424 -176.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.46 -67.05 1.92 Allowed Glycine 0 C--N 1.311 -0.836 0 CA-C-N 116.156 -0.475 . . . . 52.44 112.54 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.423 ' HA ' HG21 ' B' ' 56' ' ' VAL . 9.6 m -140.79 -35.93 0.47 Allowed 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 120.683 0.278 . . . . 14.11 110.582 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.596 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.6 pt? -84.29 141.21 31.11 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 112.707 0.632 . . . . 63.25 112.707 -171.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.436 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 22.8 tpp180 -101.93 113.77 27.27 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.382 -1.34 . . . . 73.42 107.382 171.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.2 133.12 52.9 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.13 -0.356 . . . . 65.42 110.109 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.544 HG22 HG22 ' B' ' 28' ' ' THR . 58.3 t -126.83 130.78 71.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.172 0.51 . . . . 63.44 109.974 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.651 HD12 HD12 ' A' ' 29' ' ' ILE . 92.2 mt -106.08 126.24 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.412 0 N-CA-C 108.332 -0.988 . . . . 72.11 108.332 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.545 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 87.0 m-85 -109.1 114.33 27.97 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 107.508 -1.293 . . . . 61.32 107.508 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.511 HD12 HD21 ' A' ' 34' ' ' LEU . 51.4 mm -92.09 113.97 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 109.037 -0.727 . . . . 61.14 109.037 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -120.28 177.42 5.03 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 107.532 -1.284 . . . . 71.42 107.532 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.447 ' HB3' ' H ' ' B' ' 21' ' ' VAL . 17.2 ptmt -91.66 -12.92 32.78 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.145 -0.687 . . . . 72.44 109.145 176.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -86.51 1.62 50.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 122.145 0.974 . . . . 74.42 109.826 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.54 -146.56 18.56 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 114.885 -1.052 . . . . 43.34 113.357 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.45 ' HB3' ' CD1' ' B' ' 14' ' ' LEU . 2.1 tm? -122.26 124.14 43.07 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 123.708 0.803 . . . . 71.32 109.448 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.545 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 53.7 tptt -115.42 121.65 43.41 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 107.594 -1.262 . . . . 71.31 107.594 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.601 HG11 HG11 ' A' ' 47' ' ' VAL . 13.9 p -111.58 140.81 29.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.279 -1.008 . . . . 42.32 108.279 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.439 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 15.9 t -139.11 136.72 35.47 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 119.336 -0.946 . . . . 73.42 108.541 176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -130.21 125.79 35.79 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 120.978 0.418 . . . . 45.32 111.523 -177.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 26.8 t70 -109.5 97.6 28.04 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 108.016 -1.105 . . . . 60.23 108.016 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.503 ' HB2' ' HG3' ' A' ' 17' ' ' GLN . 12.6 Cg_exo -71.49 134.39 24.32 Favored 'Trans proline' 0 N--CA 1.431 -2.182 0 C-N-CA 122.279 1.986 . . . . 64.55 112.378 -178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 68.35 80.54 0.2 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.635 -1.62 . . . . 53.1 112.938 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.04 145.11 27.22 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.567 -1.197 . . . . 53.4 108.667 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 28.7 p -58.92 -40.68 85.31 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 112.285 0.476 . . . . 70.03 112.285 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -126.78 105.83 8.94 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.156 0.503 . . . . 73.24 110.429 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' B' ' 33' ' ' SER . 91.9 t -104.6 140.53 22.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.572 -0.74 . . . . 73.3 109.469 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -135.01 136.03 41.83 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.039 -0.726 . . . . 74.33 109.039 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -65.69 107.81 1.88 Allowed 'General case' 0 C--N 1.316 -0.886 0 O-C-N 123.446 0.466 . . . . 72.23 110.126 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -91.35 110.91 23.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.977 0.894 . . . . 61.13 111.404 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.301 -1.501 0 N-CA-C 107.633 -1.247 . . . . 71.11 107.633 178.498 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 111.995 0.368 . . . . 75.34 111.995 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.0 -166.01 53.67 Favored Glycine 0 C--O 1.246 0.898 0 C-N-CA 121.051 -0.595 . . . . 71.33 111.921 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.4 t -125.04 97.49 5.27 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.688 -0.856 . . . . 71.3 108.688 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -78.64 -37.08 42.92 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.951 -1.129 . . . . 64.44 107.951 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.77 157.0 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.524 0 CA-C-N 114.589 -1.187 . . . . 73.43 108.216 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.7 p -105.79 -25.27 12.25 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.586 0.708 . . . . 71.31 109.192 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.89 83.12 7.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.672 -0.695 . . . . 71.44 109.604 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt 174.96 155.0 0.14 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.191 -1.781 . . . . 61.25 106.191 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -73.12 115.25 12.22 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 121.465 0.65 . . . . 72.1 110.968 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -92.5 140.99 29.0 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 115.593 -0.731 . . . . 54.14 109.524 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 81.6 m -142.17 148.87 38.95 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.471 -0.566 . . . . 65.52 109.471 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.489 HG23 HD21 ' B' ' 14' ' ' LEU . 69.4 t -144.75 145.72 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.274 0.629 . . . . 71.51 109.696 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.7 p -109.16 136.14 49.12 Favored 'General case' 0 N--CA 1.426 -1.641 0 C-N-CA 122.835 0.454 . . . . 63.42 110.505 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.427 HD21 ' CG2' ' B' ' 12' ' ' VAL . 95.2 mt -119.62 121.93 40.4 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.365 0.602 . . . . 70.41 111.617 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 p -95.17 114.03 25.78 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 115.1 -0.955 . . . . 70.21 109.698 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.1 t -139.12 -170.55 2.9 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.89 -1.522 . . . . 74.24 106.89 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -76.86 91.48 3.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 122.058 0.933 . . . . 63.13 111.362 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -126.15 141.83 51.77 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.867 -1.06 . . . . 43.2 109.57 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.4 mm? -82.45 146.34 53.66 Favored Pre-proline 0 C--N 1.304 -1.413 0 CA-C-N 115.534 -0.757 . . . . 54.31 109.031 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 20.7 Cg_exo -64.66 134.87 42.73 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.8 1.666 . . . . 73.52 112.209 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 23' ' ' ARG . 43.7 t -131.74 143.11 41.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 CA-C-N 114.428 -1.26 . . . . 70.0 108.179 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 m -90.56 -22.35 21.32 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 112.204 0.446 . . . . 73.31 112.204 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' H ' HG12 ' A' ' 21' ' ' VAL . 28.9 mmm180 -105.88 133.45 50.59 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.472 -0.331 . . . . 71.21 110.68 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.4 mm -89.87 116.41 31.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.789 -0.819 . . . . 71.24 108.789 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.4 OUTLIER -91.98 133.6 35.56 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 120.313 -0.555 . . . . 73.32 110.928 179.13 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.4 p -118.0 127.36 53.74 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.396 -0.82 . . . . 65.41 110.426 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 67.9 m-85 -121.5 130.77 53.76 Favored 'General case' 0 CA--C 1.477 -1.845 0 CA-C-N 115.837 -0.62 . . . . 75.21 111.029 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.475 HG22 HG22 ' A' ' 37' ' ' VAL . 57.4 p -114.56 131.58 56.62 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 115.382 -0.826 . . . . 73.1 111.286 -175.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 38' ' ' ILE . 40.1 mt -125.23 130.4 73.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 116.432 -0.349 . . . . 73.02 110.695 177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -109.96 115.76 30.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 122.21 1.005 . . . . 54.32 110.269 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.3 tp10 -143.13 123.06 13.51 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.197 -0.91 . . . . 65.45 108.926 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 52.31 32.11 36.3 Favored Glycine 0 C--O 1.218 -0.849 0 O-C-N 123.219 0.325 . . . . 73.12 113.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.439 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 22.2 t 84.55 -10.19 0.87 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.475 1.11 . . . . 75.43 113.37 176.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.748 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.6 pt? -89.36 140.22 29.72 Favored 'General case' 0 CA--C 1.499 -0.982 0 C-N-CA 117.07 -1.852 . . . . 65.12 109.239 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -107.73 118.32 36.43 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 107.309 -1.367 . . . . 72.35 107.309 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.99 129.54 51.59 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 109.51 -0.552 . . . . 71.15 109.51 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 61.9 t -118.91 122.24 68.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.186 0.517 . . . . 73.3 110.427 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.659 HD12 HD12 ' B' ' 29' ' ' ILE . 87.0 mt -103.54 123.51 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 C-N-CA 124.093 0.957 . . . . 52.42 109.075 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.5 114.52 28.8 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.423 -0.584 . . . . 64.12 109.423 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 47.2 mm -92.52 114.32 29.22 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 105.971 -1.863 . . . . 74.34 105.971 175.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.441 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 9.5 t -129.06 173.74 10.18 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 120.587 -0.445 . . . . 65.12 111.28 -174.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -70.5 -25.22 63.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.826 -0.624 . . . . 65.51 109.96 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -92.02 -4.39 54.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.829 0.823 . . . . 73.51 110.675 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 136.29 -125.43 3.51 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 119.411 -1.376 . . . . 42.32 114.149 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.481 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 2.1 tm? -126.19 126.81 44.69 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 123.772 0.829 . . . . 74.41 110.06 -176.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -122.93 141.08 52.31 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.612 -0.514 . . . . 71.03 109.612 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.415 HG11 HG11 ' B' ' 47' ' ' VAL . 13.4 p -123.33 140.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.597 0 CA-C-N 115.739 -0.664 . . . . 70.12 110.52 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 55.7 m -129.76 137.72 50.69 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 115.558 -0.746 . . . . 72.12 110.664 172.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.41 123.01 46.49 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 106.935 -1.505 . . . . 54.2 106.935 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -117.02 101.98 53.09 Favored Pre-proline 0 C--N 1.286 -2.168 0 N-CA-C 105.684 -1.969 . . . . 70.34 105.684 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.47 132.07 17.09 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 121.238 1.292 . . . . 74.13 111.932 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 48.87 37.17 9.46 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 124.214 0.946 . . . . 65.22 110.371 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -38.74 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.512 1.925 . . . . 63.25 115.405 -172.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 m 68.32 -69.59 0.15 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.526 1.13 . . . . 45.4 110.809 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 70.4 t90 -156.28 110.09 2.73 Favored 'General case' 0 N--CA 1.395 -3.193 0 N-CA-C 106.927 -1.509 . . . . 75.32 106.927 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 33' ' ' SER . 42.3 t -135.92 98.92 2.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 109.151 -0.685 . . . . 74.15 109.151 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -85.16 125.33 32.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.614 -0.884 . . . . 75.41 108.614 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -75.07 101.4 4.52 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.459 0.647 . . . . 71.23 110.431 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.76 -27.01 4.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.266 -0.879 . . . . 71.31 109.715 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.304 -1.392 0 CA-C-N 115.641 -0.709 . . . . 73.43 110.983 -178.395 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 121.394 0.616 . . . . 75.21 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.47 -24.35 70.83 Favored Glycine 0 C--N 1.313 -0.696 0 CA-C-N 115.417 -0.81 . . . . 62.23 113.094 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -81.53 111.64 18.03 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.738 0.304 . . . . 73.25 110.209 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.15 -70.78 0.7 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.923 0.392 . . . . 61.42 111.093 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 33.6 m -106.58 -177.68 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.845 -0.616 . . . . 54.13 111.638 -174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 20.9 p -89.39 -40.94 12.41 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.036 -0.529 . . . . 51.43 111.77 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -133.85 123.88 25.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.223 -0.444 . . . . 65.43 111.009 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' B' ' 9' ' ' ARG . 39.5 ttmt 177.89 154.42 0.32 Allowed 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 107.309 -1.367 . . . . 75.51 107.309 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptm180 -72.71 97.23 2.15 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-O 121.598 0.714 . . . . 72.22 110.179 171.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.2 p -87.1 142.66 27.76 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.56 -0.745 . . . . 42.52 110.741 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 62.8 m -135.04 149.79 50.19 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.38 -0.6 . . . . 55.25 109.38 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.427 ' CG2' HD21 ' A' ' 14' ' ' LEU . 99.2 t -139.42 139.62 38.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.16 -0.473 . . . . 71.21 110.419 177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 41.6 p -107.92 125.68 51.79 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.051 -0.722 . . . . 71.41 109.051 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.489 HD21 HG23 ' A' ' 12' ' ' VAL . 96.8 mt -113.6 124.3 52.01 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 122.819 0.448 . . . . 74.24 111.78 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 24.9 p -85.16 113.63 21.68 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.493 -0.776 . . . . 62.11 109.244 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 11.1 t -139.33 178.4 7.22 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.483 -0.932 . . . . 74.01 108.483 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -71.04 88.76 0.78 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.161 0.981 . . . . 72.11 110.431 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.442 ' NH2' ' HB2' ' B' ' 19' ' ' LEU . 6.9 tpm_? -126.91 129.5 48.32 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.64 -1.164 . . . . 70.13 110.173 -175.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.445 HD22 ' H ' ' B' ' 19' ' ' LEU . 1.7 mm? -74.49 146.21 83.44 Favored Pre-proline 0 C--N 1.297 -1.675 0 N-CA-C 107.373 -1.343 . . . . 74.0 107.373 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.2 135.04 52.25 Favored 'Trans proline' 0 C--O 1.244 0.778 0 C-N-CA 122.517 2.144 . . . . 61.22 113.881 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.29 127.72 60.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.523 -1.658 . . . . 74.11 106.523 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -88.9 -36.74 15.77 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.587 -0.445 . . . . 74.24 111.409 -176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -112.96 134.15 54.6 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 120.94 -0.304 . . . . 71.23 111.353 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.86 123.86 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.96 -0.564 . . . . 75.01 111.625 -173.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 0.6 OUTLIER -90.51 132.84 35.45 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.577 -0.449 . . . . 62.23 110.161 173.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 39.1 p -106.66 128.31 54.07 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.286 -0.87 . . . . 74.5 109.753 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 54.3 m-85 -128.16 126.83 41.83 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 116.052 -0.522 . . . . 73.55 110.752 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.498 HG22 HG22 ' B' ' 37' ' ' VAL . 77.8 p -114.85 131.19 56.92 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 115.947 -0.57 . . . . 53.54 112.069 -175.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.659 HD12 HD12 ' A' ' 38' ' ' ILE . 59.7 mt -136.52 122.21 28.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.322 -0.992 . . . . 71.41 108.322 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.1 t -119.3 121.63 40.04 Favored 'General case' 0 N--CA 1.416 -2.173 0 C-N-CA 119.786 -0.766 . . . . 75.01 109.41 176.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.598 ' O ' HD23 ' B' ' 34' ' ' LEU . 11.7 tp10 -119.7 113.8 21.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.428 -0.806 . . . . 75.23 110.546 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.26 -75.48 1.35 Allowed Glycine 0 C--N 1.298 -1.568 0 C-N-CA 121.174 -0.536 . . . . 71.24 112.125 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' B' ' 56' ' ' VAL . 13.7 t -153.56 6.99 0.36 Allowed 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 120.797 0.332 . . . . 71.32 111.403 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.598 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -114.75 140.03 49.22 Favored 'General case' 0 CA--C 1.502 -0.865 0 C-N-CA 118.522 -1.271 . . . . 54.24 109.712 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.414 HH12 ' HB3' ' B' ' 53' ' ' ALA . 4.2 mpt_? -98.06 131.03 44.82 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.022 -0.732 . . . . 74.32 109.022 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -118.37 114.83 23.53 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.353 -0.98 . . . . 74.43 108.353 174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.498 HG22 HG22 ' B' ' 28' ' ' THR . 51.6 t -111.52 125.7 68.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.103 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 29' ' ' ILE . 81.6 mt -101.59 130.7 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.663 0 C-N-CA 124.017 0.927 . . . . 60.3 109.573 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -114.39 114.66 26.16 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.057 -1.09 . . . . 74.03 108.057 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' B' ' 25' ' ' LYS . 50.2 mm -88.64 117.73 32.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.697 -1.223 . . . . 73.41 107.697 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.7 t -132.04 169.32 16.51 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 123.402 0.439 . . . . 73.0 110.465 -175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.454 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -70.53 -18.52 62.93 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.031 0.443 . . . . 72.01 110.837 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -86.71 -16.48 36.33 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.11 -0.7 . . . . 70.13 109.11 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.6 -124.93 2.5 Favored Glycine 0 N--CA 1.422 -2.235 0 C-N-CA 120.268 -0.967 . . . . 62.43 113.223 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.95 124.25 42.18 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.929 -0.636 . . . . 60.13 110.737 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -121.29 140.69 51.74 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 120.885 0.374 . . . . 64.51 110.11 174.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.415 HG11 HG11 ' A' ' 47' ' ' VAL . 13.1 p -131.77 141.37 45.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.806 -0.633 . . . . 74.52 110.011 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 65.2 m -123.75 136.65 54.56 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 123.242 0.339 . . . . 75.15 110.531 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -117.58 123.76 47.02 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.585 -0.524 . . . . 41.34 109.585 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -121.93 105.6 37.51 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 108.791 -0.818 . . . . 74.51 108.791 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -92.01 133.06 1.28 Allowed 'Trans proline' 0 N--CA 1.432 -2.139 0 C-N-CA 121.349 1.366 . . . . 74.12 115.406 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.48 ' OE1' HD21 ' A' ' 19' ' ' LEU . 35.9 mt-30 55.9 -3.24 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 118.507 2.78 . . . . 72.24 118.507 165.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.414 ' HB3' HH12 ' B' ' 35' ' ' ARG . . . -52.58 121.81 7.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 112.993 0.738 . . . . 52.32 112.993 -176.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 40.9 m 76.03 -75.39 0.07 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.918 1.287 . . . . 62.11 112.587 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -175.81 134.79 0.29 Allowed 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 122.877 0.471 . . . . 74.14 110.294 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.491 ' HB ' ' HA ' ' B' ' 33' ' ' SER . 39.4 t -141.5 130.78 24.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.68 -1.23 . . . . 75.2 107.68 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -162.94 135.81 5.63 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.642 -0.503 . . . . 74.14 109.642 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -123.54 166.05 16.09 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.506 -1.294 . . . . 73.14 107.506 175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -82.9 -37.56 14.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 120.712 0.292 . . . . 71.21 111.705 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 C--O 1.253 1.255 0 N-CA-C 109.334 -0.617 . . . . 71.05 109.334 -175.615 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.795 0.331 . . . . 74.23 111.473 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.55 124.98 5.53 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.777 -0.725 . . . . 71.34 112.111 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 m -91.52 -15.11 29.23 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.861 0.362 . . . . 71.33 110.517 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -79.18 88.5 4.87 Favored 'General case' 0 C--O 1.251 1.138 0 N-CA-C 109.057 -0.72 . . . . 74.04 109.057 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.99 -69.96 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.976 -0.556 . . . . 72.44 110.04 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.0 m -86.71 132.98 33.72 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.357 -0.383 . . . . 53.22 110.289 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -83.41 86.93 6.99 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.954 0.883 . . . . 74.24 110.278 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -140.65 -62.84 0.48 Allowed 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.294 -1.743 . . . . 72.34 106.294 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -133.48 113.38 12.43 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 105.496 -2.039 . . . . 74.45 105.496 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.0 p -86.26 117.16 24.9 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 119.803 -0.759 . . . . 72.03 109.695 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 68.6 m -123.94 148.94 46.49 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.934 -0.575 . . . . 63.44 109.495 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG23 HD11 ' B' ' 14' ' ' LEU . 89.6 t -145.45 142.41 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 122.825 0.45 . . . . 72.51 110.242 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 p -111.35 138.37 47.93 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 122.65 0.38 . . . . 72.43 110.871 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.438 HD11 ' CG2' ' B' ' 12' ' ' VAL . 3.5 mm? -114.42 140.54 48.6 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 112.331 0.493 . . . . 70.21 112.331 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -103.43 112.79 25.85 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.312 -0.858 . . . . 74.02 109.506 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.2 t -134.49 -177.7 4.72 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.578 -1.268 . . . . 73.34 107.578 177.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -76.31 96.79 4.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.337 1.065 . . . . 74.44 109.32 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -125.85 140.02 53.0 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.108 -0.951 . . . . 75.34 111.63 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' B' ' 33' ' ' SER . 4.8 mp -82.55 136.5 45.42 Favored Pre-proline 0 C--N 1.306 -1.299 0 N-CA-C 108.284 -1.006 . . . . 64.34 108.284 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.17 137.53 40.8 Favored 'Trans proline' 0 C--O 1.251 1.15 0 C-N-CA 122.48 2.12 . . . . 71.41 112.675 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -131.8 148.96 32.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.618 -1.174 . . . . 73.31 107.973 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 m -97.49 -23.83 15.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.009 0.433 . . . . 62.21 111.71 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -102.91 132.12 49.36 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.293 -0.632 . . . . 74.45 109.293 177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -98.07 129.99 47.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.837 -0.62 . . . . 74.34 109.592 -175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.83 141.51 30.74 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.359 -0.536 . . . . 73.54 110.894 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.1 p -119.76 127.66 53.03 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.077 -0.965 . . . . 74.45 108.767 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.404 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 70.5 m-85 -126.35 126.27 43.63 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 110.17 -0.307 . . . . 74.02 110.17 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 37' ' ' VAL . 59.3 p -115.89 131.35 56.96 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.754 -0.657 . . . . 72.21 111.405 -175.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.572 HD12 HD12 ' B' ' 38' ' ' ILE . 50.2 mt -127.39 121.33 57.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.116 -0.493 . . . . 71.11 110.004 176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -103.88 121.47 43.15 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.779 -1.193 . . . . 65.25 107.779 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' O ' HD23 ' A' ' 34' ' ' LEU . 13.6 tp10 -142.62 100.43 3.68 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 112.242 0.46 . . . . 74.12 112.242 -174.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.54 -66.15 3.55 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 114.592 0.597 . . . . 54.53 114.592 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.6 p -158.94 18.8 0.19 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.655 0.613 . . . . 72.1 112.655 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.566 HD22 ' CZ ' ' B' ' 18' ' ' ARG . 2.1 pt? -145.27 140.35 27.75 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.499 -0.556 . . . . 74.33 109.499 176.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.8 mtm180 -107.77 120.88 43.5 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.46 -0.941 . . . . 75.34 108.46 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.32 134.92 46.73 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.785 -0.45 . . . . 71.44 109.785 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 48.5 t -118.22 125.41 74.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-O 121.026 0.441 . . . . 60.53 110.184 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.637 HD12 HD12 ' B' ' 29' ' ' ILE . 74.6 mt -101.77 120.61 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 CA-C-N 115.555 -0.748 . . . . 63.45 109.077 177.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.413 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 94.7 m-85 -102.58 115.44 30.59 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.819 -0.808 . . . . 75.32 108.819 175.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.563 HG23 HD21 ' B' ' 34' ' ' LEU . 37.1 mm -88.29 112.24 23.49 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.621 0 N-CA-C 106.504 -1.665 . . . . 33.12 106.504 177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.443 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 7.0 t -126.09 153.04 45.06 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.922 -0.581 . . . . 73.32 112.553 -171.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -52.33 -32.82 39.88 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 124.948 1.299 . . . . 42.32 113.233 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -87.64 -12.64 44.94 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.369 0.604 . . . . 73.22 110.706 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 155.27 -109.97 0.43 Allowed Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.673 -1.251 . . . . 52.04 113.624 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 60.7 tp -134.09 145.99 49.87 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 123.911 0.885 . . . . 73.42 109.846 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -141.04 142.66 34.17 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.251 -0.648 . . . . 61.13 109.251 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.459 HG11 HG11 ' B' ' 47' ' ' VAL . 12.9 p -127.03 140.62 48.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.872 -0.604 . . . . 62.23 109.949 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 33.7 m -125.15 143.19 51.06 Favored 'General case' 0 C--N 1.284 -2.239 0 CA-C-N 116.119 -0.491 . . . . 74.31 110.871 173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.82 124.14 49.96 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 107.973 -1.121 . . . . 73.11 107.973 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -115.03 101.22 54.48 Favored Pre-proline 0 C--N 1.283 -2.319 0 N-CA-C 107.47 -1.307 . . . . 63.4 107.47 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.96 150.3 72.91 Favored 'Trans proline' 0 CA--C 1.501 -1.161 0 C-N-CA 122.59 2.193 . . . . 74.13 111.763 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -47.4 132.63 13.15 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 114.967 -1.015 . . . . 71.14 110.349 172.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.86 -43.36 18.33 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.816 0.817 . . . . 62.3 109.759 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.0 m -153.74 69.61 0.81 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.725 -1.954 . . . . 70.53 105.725 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 23.0 m-90 60.46 -166.96 0.19 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 114.653 -1.158 . . . . 71.12 109.524 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.14 146.23 16.18 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 108.364 -0.976 . . . . 73.24 108.364 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -72.8 177.86 4.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.582 -0.525 . . . . 73.13 109.582 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -74.41 97.78 3.14 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.315 0.579 . . . . 62.51 111.548 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.24 131.87 2.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.285 -1.005 . . . . 72.43 108.285 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 C--N 1.298 -1.652 0 C-N-CA 120.858 -0.337 . . . . 73.33 110.7 -176.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.242 0.709 0 N-CA-C 109.428 -0.582 . . . . 62.25 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.89 43.49 41.36 Favored Glycine 0 CA--C 1.501 -0.83 0 N-CA-C 110.609 -0.996 . . . . 53.32 110.609 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 31.1 m -78.55 -69.9 0.53 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.079 -0.56 . . . . 75.3 112.074 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -93.77 95.47 9.16 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.923 -0.769 . . . . 64.33 108.923 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 42.6 t -119.8 -70.81 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 115.708 -0.678 . . . . 75.04 109.899 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 27.0 m -92.04 131.32 37.41 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.297 -0.631 . . . . 74.14 109.297 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -83.05 87.24 6.9 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.022 -0.733 . . . . 51.04 109.022 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.427 ' HG3' ' HG3' ' B' ' 9' ' ' ARG . 23.3 tptm -168.79 -71.41 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.787 -1.097 . . . . 72.51 108.199 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.523 ' HG2' ' HD2' ' B' ' 51' ' ' PRO . 35.0 mtp180 -120.47 92.65 3.82 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 108.097 -1.075 . . . . 74.24 108.097 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 11.9 p -89.39 148.17 23.64 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 115.541 -0.754 . . . . 64.41 111.446 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 84.0 m -133.16 149.69 52.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 107.716 -1.216 . . . . 62.32 107.716 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.438 ' CG2' HD11 ' A' ' 14' ' ' LEU . 65.8 t -136.86 140.53 42.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 120.81 -0.356 . . . . 74.33 111.434 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 22.4 p -106.81 125.81 51.49 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 123.495 0.718 . . . . 53.23 109.912 178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.419 HD11 HG23 ' A' ' 12' ' ' VAL . 2.7 mm? -106.44 129.67 54.38 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.424 -0.584 . . . . 75.53 109.424 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 12.1 p -123.84 112.36 17.19 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-O 121.934 0.873 . . . . 62.34 111.559 177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -141.69 -166.43 2.21 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.502 -1.666 . . . . 65.22 106.502 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -66.99 94.89 0.35 Allowed 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.212 0.914 . . . . 51.32 112.146 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.566 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 7.2 tpt180 -126.38 137.95 53.5 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.993 -1.003 . . . . 41.23 110.878 178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -83.59 136.23 42.61 Favored Pre-proline 0 C--N 1.315 -0.927 0 N-CA-C 108.119 -1.067 . . . . 75.15 108.119 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' B' ' 42' ' ' LYS . 57.9 Cg_endo -70.13 148.65 63.16 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.352 2.035 . . . . 72.13 113.236 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 23' ' ' ARG . 12.0 p -131.88 142.96 41.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 71.35 107.923 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 16.1 m -91.52 9.93 29.97 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.293 0.568 . . . . 75.31 111.074 -177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.516 ' H ' HG22 ' B' ' 21' ' ' VAL . 35.6 mmt180 -128.87 133.9 48.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.443 -0.577 . . . . 70.5 109.443 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.48 117.17 44.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 109.397 -0.594 . . . . 62.04 109.397 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.1 139.31 34.94 Favored 'General case' 0 CA--C 1.487 -1.475 0 CA-C-O 120.899 0.38 . . . . 74.13 111.617 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.403 HG22 ' CD1' ' B' ' 39' ' ' PHE . 37.8 p -117.89 127.77 54.17 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.298 -0.865 . . . . 74.4 108.884 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.15 124.21 34.1 Favored 'General case' 0 CA--C 1.449 -2.929 0 N-CA-C 108.683 -0.858 . . . . 64.31 108.683 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.448 HG23 HG22 ' B' ' 37' ' ' VAL . 18.8 m -118.07 122.01 42.05 Favored 'General case' 0 C--N 1.264 -3.144 0 C-N-CA 119.507 -0.877 . . . . 63.2 111.859 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.637 HD12 HD12 ' A' ' 38' ' ' ILE . 60.4 mt -112.9 123.49 68.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.279 -0.637 . . . . 65.43 109.279 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -104.82 121.48 43.75 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 121.654 0.74 . . . . 73.14 109.239 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.513 ' O ' HD23 ' B' ' 34' ' ' LEU . 13.9 tp10 -136.7 97.33 3.52 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.18 0.514 . . . . 75.3 111.592 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.53 -80.2 0.23 Allowed Glycine 0 C--N 1.312 -0.778 0 CA-C-N 115.615 -0.72 . . . . 44.33 114.831 176.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.45 ' HB3' HD13 ' A' ' 19' ' ' LEU . 28.1 m -123.69 6.59 8.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 112.685 0.624 . . . . 74.0 112.685 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.563 HD21 HG23 ' A' ' 40' ' ' ILE . 2.1 pt? -147.0 140.97 25.93 Favored 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 119.11 -1.036 . . . . 71.12 111.517 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 86.8 mtm180 -108.18 119.47 39.56 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 114.784 -1.098 . . . . 75.34 109.088 170.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 126.99 51.94 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.632 -0.507 . . . . 72.33 109.632 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.448 HG22 HG23 ' B' ' 28' ' ' THR . 46.3 t -109.41 124.92 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.083 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 29' ' ' ILE . 70.3 mt -101.33 119.7 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 N-CA-C 108.661 -0.866 . . . . 60.33 108.661 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.479 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 96.9 m-85 -102.92 114.56 28.95 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.255 -1.017 . . . . 73.02 108.255 175.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.485 HD12 HD21 ' A' ' 34' ' ' LEU . 48.4 mm -89.97 112.88 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 106.014 -1.847 . . . . 75.51 106.014 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -115.66 -178.02 3.29 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-N 115.555 -0.748 . . . . 74.14 109.372 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.664 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -73.0 -45.24 58.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 113.972 1.101 . . . . 75.21 113.972 -173.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -93.81 -6.32 46.18 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.802 -0.759 . . . . 72.11 111.955 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 175.93 -143.12 6.39 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 118.354 -1.879 . . . . 62.11 114.682 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' B' ' 14' ' ' LEU . 59.0 tp -114.53 149.13 36.91 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.43 1.092 . . . . 64.13 109.689 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' B' ' 12' ' ' VAL . 84.7 tttt -143.56 143.11 31.38 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.234 -0.654 . . . . 61.44 109.234 170.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.459 HG11 HG11 ' A' ' 47' ' ' VAL . 11.7 p -131.52 141.22 46.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 109.649 -0.5 . . . . 71.01 109.649 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.479 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 63.5 m -121.29 146.21 47.07 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 110.32 -0.252 . . . . 42.14 110.32 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -115.81 124.3 50.36 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 121.265 0.555 . . . . 75.31 109.748 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 20.4 t70 -114.87 108.46 48.69 Favored Pre-proline 0 C--N 1.28 -2.431 0 CA-C-N 115.085 -0.961 . . . . 75.23 109.136 177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.523 ' HD2' ' HG2' ' B' ' 9' ' ' ARG . 87.4 Cg_endo -79.58 151.92 22.65 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 C-N-CA 122.174 1.916 . . . . 74.52 110.875 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.426 ' OE1' ' HA ' ' B' ' 55' ' ' TRP . 2.1 pp0? -43.92 133.39 4.97 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 113.972 -1.467 . . . . 73.03 113.911 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.93 -3.85 15.43 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.033 -0.985 . . . . 65.34 109.899 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 45.5 p -115.83 19.77 14.96 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.109 -0.951 . . . . 71.14 108.918 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . 0.426 ' HA ' ' OE1' ' B' ' 52' ' ' GLN . 29.9 m-90 73.86 -38.59 0.41 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.936 1.295 . . . . 72.32 111.755 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p 170.74 149.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 C-N-CA 126.791 2.036 . . . . 75.2 105.689 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -143.25 157.68 44.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 120.526 -0.47 . . . . 73.51 110.297 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -85.32 93.08 8.62 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.77 -0.826 . . . . 64.45 108.77 177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.19 92.74 2.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-O 122.153 0.977 . . . . 74.44 110.904 -176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--N 1.292 -1.9 0 N-CA-C 108.103 -1.073 . . . . 64.3 108.103 -179.687 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 CA--C 1.513 -0.445 0 CA-C-O 120.799 0.333 . . . . 73.32 110.656 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -123.17 -26.57 1.65 Allowed Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 110.214 -1.154 . . . . 62.23 110.214 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.8 t -178.73 -74.57 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.304 -1.369 . . . . 72.13 107.304 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 67.13 134.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.849 1.26 . . . . 74.32 113.763 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.0 m -105.01 171.35 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.65 -0.704 . . . . 75.41 110.488 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' B' ' 15' ' ' THR . 52.3 p -100.51 10.57 41.01 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.088 0.47 . . . . 62.24 110.785 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.49 110.53 14.89 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 112.727 0.639 . . . . 64.03 112.727 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 56.21 -96.37 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 125.643 1.577 . . . . 70.25 114.861 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -122.34 117.84 27.04 Favored 'General case' 0 CA--C 1.475 -1.911 0 C-N-CA 120.548 -0.461 . . . . 71.24 109.948 -173.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m -108.67 132.48 53.87 Favored 'General case' 0 C--N 1.262 -3.217 0 C-N-CA 119.835 -0.746 . . . . 71.54 110.058 176.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.25 147.88 45.03 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.459 -1.312 . . . . 62.13 107.459 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.14 150.44 15.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 109.561 -0.533 . . . . 72.2 109.561 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 p -107.18 140.49 39.95 Favored 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 121.229 0.538 . . . . 72.5 111.433 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 3.7 mm? -104.79 135.42 46.2 Favored 'General case' 0 CA--C 1.493 -1.219 0 C-N-CA 124.305 1.042 . . . . 74.51 110.536 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -108.59 117.99 35.61 Favored 'General case' 0 N--CA 1.406 -2.625 0 CA-C-N 115.348 -0.842 . . . . 72.22 110.122 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.8 t -147.2 177.38 9.23 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 107.49 -1.3 . . . . 63.32 107.49 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -68.59 96.18 0.69 Allowed 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.28 1.038 . . . . 61.44 111.706 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.553 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 14.5 mmm180 -126.03 141.69 51.85 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 114.138 1.162 . . . . 74.43 114.138 -174.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.5 pt? -89.57 150.37 44.18 Favored Pre-proline 0 C--N 1.293 -1.849 0 CA-C-N 113.944 -1.48 . . . . 55.21 108.377 177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.85 137.35 41.37 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.489 2.126 . . . . 54.22 113.028 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 84.3 t -131.14 142.36 43.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.626 -1.17 . . . . 62.11 108.024 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -89.77 -40.53 12.43 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 120.787 0.327 . . . . 75.34 111.728 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -91.2 135.0 34.09 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 120.953 0.406 . . . . 72.12 111.963 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.3 mm -89.62 115.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.079 -1.082 . . . . 71.55 108.079 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.73 127.6 42.87 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.29 -0.564 . . . . 75.53 110.552 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.1 p -106.62 128.6 54.29 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.442 -0.799 . . . . 72.04 109.461 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.2 126.33 42.6 Favored 'General case' 0 CA--C 1.463 -2.379 0 CA-C-N 116.118 -0.492 . . . . 72.11 109.945 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.554 HG22 HG22 ' A' ' 37' ' ' VAL . 81.9 p -114.94 124.25 51.21 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 115.445 -0.798 . . . . 73.14 110.861 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.695 HD12 HD12 ' B' ' 38' ' ' ILE . 50.0 mt -116.24 124.63 72.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.798 -0.637 . . . . 73.23 110.286 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.47 ' HB ' ' NH1' ' A' ' 35' ' ' ARG . 6.2 t -100.19 127.32 46.48 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 114.76 -1.109 . . . . 74.52 109.682 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.2 tp10 -142.13 103.39 4.29 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.638 -0.71 . . . . 71.42 110.209 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.31 -91.05 0.73 Allowed Glycine 0 N--CA 1.435 -1.4 0 CA-C-N 115.231 -0.895 . . . . 34.42 111.523 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.496 ' HA ' HG21 ' A' ' 56' ' ' VAL . 31.3 p -134.62 6.36 3.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.801 0.81 . . . . 71.33 109.339 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.555 HD23 HD12 ' B' ' 40' ' ' ILE . 52.2 tp -98.22 136.08 38.94 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 115.387 -0.824 . . . . 74.21 110.7 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.47 ' NH1' ' HB ' ' A' ' 30' ' ' THR . 22.2 mmm180 -111.44 112.91 24.99 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.466 -0.788 . . . . 64.21 108.946 175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.8 124.58 49.67 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.971 -0.751 . . . . 62.44 108.971 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 28' ' ' THR . 60.4 t -116.38 129.09 73.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.205 0.526 . . . . 70.21 111.298 -178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.608 HD12 HD12 ' B' ' 29' ' ' ILE . 59.2 mt -108.43 129.31 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 CA-C-N 115.058 -0.974 . . . . 34.2 109.956 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.445 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 97.3 m-85 -113.41 117.35 31.51 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.305 -0.998 . . . . 70.41 108.305 175.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.642 HD12 HD23 ' B' ' 34' ' ' LEU . 35.0 mm -90.45 116.28 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 107.742 -1.207 . . . . 73.51 107.742 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.8 p -118.72 177.91 4.67 Favored 'General case' 0 C--O 1.251 1.16 0 CA-C-O 121.429 0.633 . . . . 74.31 111.261 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.548 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -70.99 -22.03 62.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.326 -0.852 . . . . 75.45 110.011 175.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -87.36 -29.73 21.31 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.443 -0.947 . . . . 54.23 108.443 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 150.64 -112.59 0.55 Allowed Glycine 0 N--CA 1.413 -2.862 0 C-N-CA 120.311 -0.947 . . . . 55.51 113.108 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 55.2 tp -119.84 139.94 51.58 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.64 -0.28 . . . . 71.41 110.331 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -133.7 143.32 48.44 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.483 -0.932 . . . . 62.03 108.483 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.442 HG11 HG11 ' B' ' 47' ' ' VAL . 12.4 p -123.92 140.8 46.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-N 116.146 -0.479 . . . . 75.14 110.574 -174.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.452 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 22.9 m -124.88 138.78 54.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 116.096 -0.502 . . . . 70.13 110.967 174.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.44 124.1 49.14 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.769 -0.65 . . . . 65.33 110.067 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 21.1 t70 -116.71 110.4 42.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 108.245 -1.021 . . . . 73.43 108.245 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -84.21 134.61 6.0 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 122.418 2.079 . . . . 61.44 114.301 -173.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' SER . 44.1 mt-30 39.09 79.39 0.03 OUTLIER 'General case' 0 C--O 1.255 1.377 0 C-N-CA 125.672 1.589 . . . . 53.02 113.836 172.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.93 155.6 17.07 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.071 -1.422 . . . . 73.25 111.168 -175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.3 m -68.7 -52.29 32.43 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.542 -0.91 . . . . 73.13 108.542 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -94.12 96.85 9.9 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.946 -1.131 . . . . 71.42 107.946 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 33' ' ' SER . 9.4 p -120.82 -41.8 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 120.217 -0.593 . . . . 43.02 111.603 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 61.0 93.61 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.663 0.785 . . . . 72.54 111.317 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.66 96.91 4.29 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.285 0.564 . . . . 73.01 109.87 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.448 HG13 HG23 ' A' ' 60' ' ' VAL . 11.2 p -139.28 -26.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.319 -0.855 . . . . 54.35 110.625 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG23 HG13 ' A' ' 59' ' ' VAL . 61.0 t . . . . . 0 C--N 1.315 -0.92 0 N-CA-C 109.427 -0.583 . . . . 62.43 109.427 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.247 0.95 0 CA-C-O 121.141 0.496 . . . . 72.0 111.307 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.74 -73.15 0.71 Allowed Glycine 0 CA--C 1.493 -1.323 0 C-N-CA 120.618 -0.801 . . . . 74.15 111.139 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 41.1 t -150.6 -59.15 0.18 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.754 -1.202 . . . . 62.5 107.754 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 46.26 82.93 0.03 OUTLIER 'General case' 0 C--O 1.242 0.708 0 C-N-CA 125.505 1.522 . . . . 73.23 114.049 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -104.34 141.33 20.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.335 -0.987 . . . . 63.12 108.335 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.7 p -84.71 31.1 0.54 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.226 0.536 . . . . 55.12 111.451 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -118.39 125.98 51.12 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 116.137 -0.483 . . . . 72.31 111.643 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.645 ' HG2' ' H ' ' B' ' 9' ' ' ARG . 39.9 ttmt 69.45 -174.82 0.19 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.022 0.929 . . . . 61.45 110.158 176.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.645 ' H ' ' HG2' ' B' ' 8' ' ' LYS . 4.6 mpt_? -88.63 113.21 23.97 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 121.358 0.599 . . . . 71.14 111.972 -173.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.6 p -96.26 148.38 22.8 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.932 -1.031 . . . . 71.24 110.508 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 68.8 m -137.14 155.98 48.92 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.518 -0.919 . . . . 73.14 108.518 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 69.5 t -139.01 138.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 122.288 0.235 . . . . 64.12 111.364 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.9 p -107.38 125.66 51.48 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.325 0.65 . . . . 63.42 109.715 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -104.24 122.0 44.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.608 -0.724 . . . . 40.03 110.823 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 6' ' ' SER . 37.5 p -85.76 113.76 22.18 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.469 -0.937 . . . . 53.24 108.469 173.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -139.26 -173.86 3.71 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.668 -0.493 . . . . 54.44 109.668 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.32 105.64 11.74 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.796 -0.816 . . . . 71.53 108.796 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.541 ' HG3' ' HA2' ' B' ' 44' ' ' GLY . 20.3 mmm180 -125.64 141.07 52.21 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 115.682 -0.69 . . . . 70.12 112.703 -172.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.561 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.9 pt? -90.35 159.62 41.35 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 107.15 -1.426 . . . . 73.33 107.15 175.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.36 135.55 54.49 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.565 1.51 . . . . 63.13 112.244 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 76.3 t -130.22 141.08 47.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.065 -1.457 . . . . 74.43 107.065 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.8 t -85.83 -68.38 0.74 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.806 0.336 . . . . 63.13 111.032 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -99.47 139.65 34.81 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 120.844 -0.342 . . . . 74.3 111.185 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.61 133.95 30.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.983 -0.747 . . . . 74.12 108.983 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' B' ' 39' ' ' PHE . 43.9 mmtm -100.13 138.81 36.68 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.322 -0.551 . . . . 63.42 110.161 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 45.1 p -115.84 127.22 54.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.256 -0.646 . . . . 72.42 109.256 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -128.75 130.82 47.6 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-N 116.411 -0.359 . . . . 64.2 111.324 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.528 HG22 HG22 ' B' ' 37' ' ' VAL . 57.6 p -114.94 132.62 56.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.698 -0.683 . . . . 72.13 111.936 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.608 HD12 HD12 ' A' ' 38' ' ' ILE . 72.3 mt -134.73 128.48 50.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.817 -0.629 . . . . 73.34 109.719 176.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 9.3 t -112.33 136.96 51.15 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 108.713 -0.847 . . . . 62.55 108.713 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.516 ' HG2' HG13 ' A' ' 40' ' ' ILE . 12.0 tp10 -141.57 112.12 7.07 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.543 -0.54 . . . . 73.3 109.543 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.455 ' H ' HG11 ' B' ' 60' ' ' VAL . . . 59.98 -104.12 0.55 Allowed Glycine 0 CA--C 1.495 -1.214 0 N-CA-C 110.834 -0.906 . . . . 62.45 110.834 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.44 ' C ' ' HA ' ' B' ' 52' ' ' GLN . 45.4 m -126.49 69.6 1.24 Allowed 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 108.839 -0.801 . . . . 75.03 108.839 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.642 HD23 HD12 ' A' ' 40' ' ' ILE . 28.4 tp -159.13 137.2 10.44 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 115.045 -0.98 . . . . 74.41 109.61 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 18.8 mmm180 -113.89 116.88 29.99 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 123.673 0.608 . . . . 73.02 110.108 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.46 130.18 55.8 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 109.9 -0.408 . . . . 70.43 109.9 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.528 HG22 HG22 ' B' ' 28' ' ' THR . 86.7 t -121.64 130.87 74.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.851 0.357 . . . . 71.44 110.538 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.695 HD12 HD12 ' A' ' 29' ' ' ILE . 80.8 mt -110.28 130.51 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 C-N-CA 123.442 0.697 . . . . 62.42 109.863 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 95.7 m-85 -114.57 114.76 26.16 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.908 -1.145 . . . . 74.55 107.908 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.555 HD12 HD23 ' A' ' 34' ' ' LEU . 40.7 mm -89.58 113.92 26.7 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.335 -0.987 . . . . 75.01 108.335 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -106.55 175.3 5.55 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.731 -0.47 . . . . 74.3 109.731 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.724 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -85.37 -18.05 34.89 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.775 -0.648 . . . . 61.31 110.978 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -104.31 -17.22 14.91 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.13 0.49 . . . . 73.2 110.641 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.541 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . -174.06 -139.22 2.89 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 119.097 -1.525 . . . . 64.15 114.164 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.413 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 40.6 tp -135.63 134.73 39.56 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 125.184 1.394 . . . . 43.32 107.513 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -128.96 140.72 51.53 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.341 -0.944 . . . . 71.44 110.132 173.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.442 HG11 HG11 ' A' ' 47' ' ' VAL . 11.4 p -131.51 141.19 46.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.775 -0.648 . . . . 52.14 109.754 -175.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 66.7 m -123.87 140.23 53.18 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 120.683 0.278 . . . . 74.2 111.061 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' A' ' 45' ' ' LEU . . . -116.92 125.24 51.17 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.876 -0.602 . . . . 75.15 110.681 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 21.6 t70 -114.96 125.1 29.37 Favored Pre-proline 0 C--N 1.3 -1.586 0 CA-C-N 115.434 -0.803 . . . . 74.32 109.348 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.26 133.95 23.87 Favored 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.16 1.907 . . . . 43.42 113.508 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.44 ' HA ' ' C ' ' B' ' 33' ' ' SER . 67.9 mt-30 46.32 99.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.227 1.811 . . . . 74.33 115.154 173.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -50.65 105.65 0.1 Allowed 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 113.501 -1.681 . . . . 71.42 113.612 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 27.8 m -69.1 -38.78 79.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.796 -1.928 . . . . 70.4 105.796 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -106.26 104.54 14.26 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 114.285 -1.325 . . . . 72.33 107.7 173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.66 -42.63 2.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 116.099 -0.501 . . . . 74.12 111.24 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 62.58 179.99 0.14 Allowed 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.583 0.753 . . . . 74.24 110.0 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -101.42 69.69 1.26 Allowed 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.597 -1.241 . . . . 74.24 109.782 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 p -115.11 -3.76 11.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 114.262 -1.336 . . . . 73.33 107.898 177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.455 HG11 ' H ' ' B' ' 32' ' ' GLY . 43.0 t . . . . . 0 N--CA 1.435 -1.207 0 N-CA-C 108.051 -1.092 . . . . 54.41 108.051 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.233 0.231 0 N-CA-C 109.223 -0.658 . . . . 34.34 109.223 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.54 -95.21 0.15 Allowed Glycine 0 N--CA 1.428 -1.895 0 CA-C-N 115.941 -0.572 . . . . 73.12 111.998 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 p -79.85 -4.39 52.01 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 114.208 1.188 . . . . 61.4 114.208 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.47 98.71 9.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.983 0.896 . . . . 71.2 111.149 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 m -88.79 107.25 17.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.566 -0.743 . . . . 74.4 111.138 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.2 t -167.7 156.4 9.5 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.592 -0.731 . . . . 73.54 109.507 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.646 ' OD1' ' HB2' ' A' ' 51' ' ' PRO . 27.4 t70 -80.27 115.82 20.02 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.956 -1.127 . . . . 70.43 107.956 173.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -154.11 159.54 41.53 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.768 0.318 . . . . 75.33 110.692 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -97.63 95.19 7.43 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 122.335 1.064 . . . . 73.41 112.805 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -87.74 120.11 28.73 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 114.194 -1.366 . . . . 60.33 109.945 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.2 m -133.81 146.41 50.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.798 -1.186 . . . . 55.11 107.798 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.442 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 41.1 t -146.93 153.76 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 122.702 0.401 . . . . 62.22 110.085 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.3 p -121.57 125.77 47.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.876 -0.416 . . . . 73.32 109.876 173.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.466 HD21 ' CG2' ' B' ' 12' ' ' VAL . 97.7 mt -101.23 122.4 43.59 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 123.16 0.584 . . . . 71.12 112.197 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.2 p -85.79 114.31 22.63 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 115.075 -0.966 . . . . 73.53 110.733 176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -147.43 166.99 25.53 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.474 -0.935 . . . . 72.41 108.474 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -82.24 102.37 11.1 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.465 0.65 . . . . 73.34 110.007 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' NH1' ' HB3' ' B' ' 51' ' ' PRO . 65.8 mmt-85 -125.93 150.21 48.15 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 114.938 -1.028 . . . . 74.21 109.516 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -73.22 134.16 80.55 Favored Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.718 -0.845 . . . . 73.42 108.718 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.51 135.28 48.68 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.813 2.342 . . . . 62.24 114.899 -171.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.23 133.75 60.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 CA-C-N 113.468 -1.696 . . . . 73.31 107.671 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.8 m -89.87 -18.51 26.05 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.436 0.636 . . . . 55.45 110.734 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -91.38 132.65 36.06 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.108 -0.701 . . . . 74.42 109.108 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.4 mm -98.72 135.14 34.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.336 -0.616 . . . . 74.51 109.336 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -110.95 150.7 28.85 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-O 121.196 0.522 . . . . 75.35 111.905 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 91.1 m -129.74 127.09 39.71 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.057 -1.09 . . . . 72.11 108.057 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -128.46 128.66 44.83 Favored 'General case' 0 CA--C 1.477 -1.843 0 CA-C-N 116.189 -0.459 . . . . 71.54 110.914 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.612 HG22 HG22 ' A' ' 37' ' ' VAL . 55.7 p -114.36 124.98 53.33 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.419 -0.81 . . . . 75.44 110.646 -176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.692 HD12 HD12 ' B' ' 38' ' ' ILE . 62.5 mt -119.12 138.79 48.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.556 -0.535 . . . . 73.43 109.556 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.462 ' HB ' HH11 ' A' ' 35' ' ' ARG . 10.6 t -118.68 127.48 53.61 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 109.098 -0.705 . . . . 74.14 109.098 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.7 tp10 -139.24 97.27 3.26 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 108.507 -0.923 . . . . 74.31 108.507 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.09 -119.34 7.94 Favored Glycine 0 N--CA 1.427 -1.935 0 N-CA-C 110.533 -1.027 . . . . 72.13 110.533 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 52' ' ' GLN . 36.8 m -102.01 3.31 38.72 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 121.45 0.643 . . . . 72.23 110.091 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.524 HD23 HD12 ' B' ' 40' ' ' ILE . 47.1 tp -99.75 131.61 45.62 Favored 'General case' 0 N--CA 1.416 -2.162 0 C-N-CA 123.676 0.79 . . . . 72.12 110.138 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.601 ' HB3' ' HB3' ' A' ' 50' ' ' ASP . 28.8 tpt180 -121.37 122.46 39.88 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.12 -1.067 . . . . 74.33 108.12 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -113.07 141.53 46.78 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.953 -0.467 . . . . 54.42 110.603 -177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG22 HG22 ' A' ' 28' ' ' THR . 58.3 t -125.09 131.08 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.049 0.452 . . . . 63.31 111.144 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.626 HD11 HD11 ' B' ' 38' ' ' ILE . 75.6 mt -108.41 125.86 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 124.274 1.03 . . . . 72.01 109.383 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.6 m-85 -112.14 119.04 37.04 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.098 -1.075 . . . . 75.34 108.098 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.587 HG23 HD21 ' B' ' 34' ' ' LEU . 36.7 mm -88.8 121.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 115.602 -0.726 . . . . 63.01 109.233 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.4 p -124.99 164.66 19.67 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 109.372 -0.603 . . . . 53.25 109.372 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -70.96 -21.69 62.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.875 0.369 . . . . 72.23 110.734 179.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -94.73 1.6 55.49 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.087 0.47 . . . . 72.25 110.689 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 138.62 -142.47 13.08 Favored Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 119.434 -1.365 . . . . 43.43 113.329 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD11 HG23 ' A' ' 38' ' ' ILE . 59.6 tp -114.9 134.52 55.08 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.303 -0.449 . . . . 72.53 111.241 -173.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 39' ' ' PHE . 78.7 tttt -115.58 137.01 52.5 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.398 0.618 . . . . 71.0 110.264 170.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.473 HG11 HG11 ' B' ' 47' ' ' VAL . 10.7 p -121.62 140.58 45.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.747 -1.115 . . . . 70.01 108.357 -177.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.3 t -137.85 143.13 40.8 Favored 'General case' 0 C--N 1.27 -2.873 0 N-CA-C 107.456 -1.313 . . . . 61.22 107.456 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.68 125.26 53.53 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.026 -0.67 . . . . 75.4 110.202 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 35' ' ' ARG . 12.6 t70 -101.44 100.7 14.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 106.278 -1.749 . . . . 72.32 106.278 175.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HB2' ' OD1' ' A' ' 7' ' ' ASP . 95.0 Cg_endo -79.0 132.97 10.83 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 122.501 2.134 . . . . 70.31 115.276 -172.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 33' ' ' SER . 41.4 mt-30 31.46 -104.97 0.02 OUTLIER 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.494 1.917 . . . . 75.2 114.252 169.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 157.73 167.98 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 129.049 2.94 . . . . 54.35 103.22 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.1 m -67.85 -31.52 71.4 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.391 -0.966 . . . . 75.51 108.391 175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -127.53 112.55 15.05 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.219 -0.9 . . . . 74.12 109.252 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.0 m -105.94 157.18 6.55 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 109.621 -0.511 . . . . 71.44 109.621 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -135.85 172.92 12.31 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.643 -0.873 . . . . 75.31 108.643 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -54.15 -50.06 67.84 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.047 0.451 . . . . 74.41 110.245 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.4 99.5 8.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.769 -0.651 . . . . 70.52 109.28 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--O 1.246 0.898 0 C-N-CA 124.817 1.247 . . . . 64.34 112.524 178.72 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 59.6 t . . . . . 0 C--O 1.243 0.754 0 N-CA-C 109.07 -0.715 . . . . 74.22 109.07 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.48 124.12 3.09 Favored Glycine 0 N--CA 1.429 -1.801 0 N-CA-C 110.268 -1.133 . . . . 70.03 110.268 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -88.37 -27.26 21.73 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 112.213 0.449 . . . . 70.23 112.213 -177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' B' ' 4' ' ' GLU . 0.1 OUTLIER -82.95 92.75 7.39 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.083 0.944 . . . . 61.3 111.235 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 26.8 m -94.82 114.09 30.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 115.065 -0.97 . . . . 74.34 110.735 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 31.6 m -154.82 -168.92 3.04 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.098 -1.075 . . . . 70.35 108.098 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.01 100.55 0.75 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.854 -1.165 . . . . 64.33 107.854 172.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -163.96 161.38 22.77 Favored 'General case' 0 C--O 1.255 1.344 0 CA-C-N 116.338 -0.392 . . . . 63.53 110.308 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 12.4 ptp180 -109.14 114.56 28.38 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 115.351 -0.841 . . . . 74.32 110.981 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 20.8 p -89.59 123.04 33.31 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 108.413 -0.958 . . . . 70.34 108.413 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 81.5 m -125.35 149.17 48.36 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.75 -0.463 . . . . 71.41 109.75 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.466 ' CG2' HD21 ' A' ' 14' ' ' LEU . 98.1 t -140.68 133.64 32.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.258 -0.428 . . . . 74.42 110.222 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 17.8 p -107.42 125.68 51.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.585 -0.895 . . . . 71.43 108.585 174.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.418 ' O ' ' HA3' ' B' ' 44' ' ' GLY . 79.9 mt -101.52 140.84 35.26 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.751 -0.659 . . . . 54.54 110.968 -175.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 22.1 p -99.38 113.82 26.37 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.674 0.749 . . . . 72.52 111.528 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -158.64 159.86 35.84 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.67 -1.233 . . . . 72.32 107.67 173.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -78.27 106.51 10.23 Favored 'General case' 0 CA--C 1.486 -1.518 0 CA-C-O 121.919 0.866 . . . . 71.13 110.275 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.561 ' HA ' ' HE ' ' B' ' 18' ' ' ARG . 0.4 OUTLIER -109.95 151.16 27.45 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 113.921 -1.491 . . . . 75.5 110.126 -176.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.441 ' H ' HD12 ' B' ' 19' ' ' LEU . 3.6 mp -73.52 143.88 82.93 Favored Pre-proline 0 C--N 1.308 -1.207 0 N-CA-C 108.143 -1.058 . . . . 65.31 108.143 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -65.72 135.0 39.93 Favored 'Trans proline' 0 N--CA 1.442 -1.546 0 C-N-CA 121.688 1.592 . . . . 75.12 111.461 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.23 139.18 51.55 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.359 0 N-CA-C 107.731 -1.211 . . . . 74.2 107.731 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.6 m -84.22 -50.67 7.67 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.786 -0.365 . . . . 55.22 111.537 -175.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -89.38 142.23 27.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.649 -0.871 . . . . 73.33 108.649 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 47.8 mm -86.77 121.19 37.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.791 -0.818 . . . . 75.21 108.791 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -89.86 138.86 31.13 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.549 -0.86 . . . . 72.2 111.477 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 89.0 m -128.95 127.34 41.53 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.537 -1.21 . . . . 73.42 108.381 178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 81.1 m-85 -122.11 130.45 53.25 Favored 'General case' 0 CA--C 1.467 -2.247 0 CA-C-N 115.66 -0.7 . . . . 75.13 110.798 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.475 HG22 HG22 ' B' ' 37' ' ' VAL . 57.0 p -115.12 130.78 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.1 -0.955 . . . . 74.54 111.173 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.596 HD12 HD12 ' A' ' 38' ' ' ILE . 55.0 mt -131.01 120.65 47.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.307 -0.627 . . . . 72.43 109.307 174.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -103.87 121.59 43.39 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.565 -0.902 . . . . 71.23 108.565 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.484 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.6 tp10 -136.68 100.88 4.45 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.72 -0.673 . . . . 73.21 111.065 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.22 -102.59 0.61 Allowed Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.619 -0.719 . . . . 74.4 112.966 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 33.9 m -112.45 13.05 20.14 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 112.049 0.389 . . . . 34.43 112.049 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.587 HD21 HG23 ' A' ' 40' ' ' ILE . 2.4 pt? -137.83 140.62 40.58 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 121.669 0.747 . . . . 75.11 110.396 175.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.426 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 33.7 ttt180 -117.27 134.07 55.24 Favored 'General case' 0 C--N 1.258 -3.394 0 CA-C-N 114.737 -1.12 . . . . 72.24 108.608 177.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.98 140.97 47.34 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 122.347 -0.221 . . . . 65.2 110.821 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.475 HG22 HG22 ' B' ' 28' ' ' THR . 96.4 t -127.46 127.94 69.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.007 -0.542 . . . . 71.34 110.07 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.692 HD12 HD12 ' A' ' 29' ' ' ILE . 92.6 mt -113.15 126.77 70.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 123.4 0.68 . . . . 74.41 109.884 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.8 118.5 36.66 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.9 -0.778 . . . . 73.42 108.9 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.524 HD12 HD23 ' A' ' 34' ' ' LEU . 35.9 mm -94.61 115.58 33.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 108.26 -1.015 . . . . 71.12 108.26 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 82.6 p -129.68 162.97 27.13 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 110.07 -0.345 . . . . 74.21 110.07 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.62 -20.8 66.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.023 0.44 . . . . 74.53 110.863 177.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -91.2 -17.23 26.39 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 111.946 0.351 . . . . 74.12 111.946 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' B' ' 14' ' ' LEU . . . 158.49 -156.29 27.28 Favored Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 118.69 -1.719 . . . . 71.14 113.583 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 60.8 tp -112.81 122.69 48.4 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.698 -0.853 . . . . 70.33 108.698 -178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -117.39 138.45 51.8 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.119 -0.632 . . . . 64.31 110.013 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.473 HG11 HG11 ' A' ' 47' ' ' VAL . 9.8 p -131.1 140.95 47.31 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.677 0 CA-C-N 115.207 -0.906 . . . . 53.31 109.334 -176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.52 143.21 51.21 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 116.295 -0.411 . . . . 75.12 110.641 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' B' ' 9' ' ' ARG . . . -115.42 122.92 47.27 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.406 -0.961 . . . . 72.21 108.406 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.426 ' OD2' ' HD3' ' B' ' 35' ' ' ARG . 32.1 t70 -112.99 126.9 27.51 Favored Pre-proline 0 C--N 1.275 -2.641 0 CA-C-N 114.918 -1.037 . . . . 73.41 108.294 -173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.508 ' HB3' ' NH1' ' A' ' 18' ' ' ARG . 61.2 Cg_endo -76.95 133.06 13.39 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.553 1.502 . . . . 70.15 114.564 -175.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 41.09 -141.47 0.08 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.497 1.519 . . . . 73.45 113.768 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.52 176.06 10.82 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 104.016 -2.587 . . . . 41.42 104.016 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 23.5 p -58.25 -51.43 69.78 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.614 0.721 . . . . 60.55 109.707 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -123.53 118.9 28.42 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.13 -1.433 . . . . 74.21 107.13 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 28.1 m -71.15 107.92 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.998 0.904 . . . . 74.54 110.641 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -89.61 130.78 35.86 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.049 -0.978 . . . . 72.24 110.033 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -75.67 -27.05 58.18 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.257 0.551 . . . . 75.02 110.799 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -89.72 102.98 13.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.774 -0.824 . . . . 75.32 108.774 177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--O 1.261 1.698 0 C-N-CA 123.467 0.707 . . . . 52.2 110.858 -179.008 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.588 0.232 . . . . 73.22 111.428 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.14 141.13 15.53 Favored Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.138 -1.185 . . . . 74.34 110.138 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.7 m -79.11 95.06 5.46 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.479 -0.563 . . . . 65.21 109.479 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 59.72 -171.09 0.13 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.785 0.834 . . . . 72.21 111.326 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 m -110.86 92.97 2.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 120.018 -0.673 . . . . 52.13 112.731 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' B' ' 15' ' ' THR . 50.4 m 53.75 33.33 16.58 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.518 -1.219 . . . . 52.53 113.126 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -139.36 157.86 45.15 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.966 -0.753 . . . . 70.31 108.966 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 74.16 -178.8 0.18 Allowed 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.732 1.213 . . . . 71.32 112.465 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.415 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 94.7 mtt180 -100.2 106.41 18.09 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.085 -0.961 . . . . 73.34 110.042 -173.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p -87.41 143.82 27.05 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 114.638 -1.164 . . . . 73.43 111.422 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.7 m -132.74 148.51 52.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.784 -0.821 . . . . 54.11 108.784 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.0 t -143.68 142.02 25.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 110.055 -0.35 . . . . 71.0 110.055 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.3 t -107.92 128.45 54.64 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 108.51 -0.922 . . . . 62.24 108.51 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.7 mm? -100.94 121.61 42.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.134 -0.691 . . . . 55.21 109.134 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.8 p -97.35 114.24 26.01 Favored 'General case' 0 N--CA 1.401 -2.919 0 CA-C-O 121.797 0.808 . . . . 65.34 109.682 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -139.33 -169.72 2.73 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.38 -1.341 . . . . 63.02 107.38 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -73.04 101.13 3.17 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.389 -0.967 . . . . 71.43 108.389 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.445 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -125.31 149.21 48.28 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.076 -0.65 . . . . 72.03 112.29 -173.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.3 pt? -89.99 148.73 40.25 Favored Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 107.639 -1.245 . . . . 75.2 107.639 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.44 136.35 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 121.519 1.479 . . . . 64.41 110.655 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.9 p -108.48 148.49 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.429 -0.582 . . . . 41.44 109.429 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.4 p -67.9 -57.26 6.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.005 0.431 . . . . 73.24 111.881 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -117.07 157.87 25.15 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.357 -0.383 . . . . 71.22 110.023 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -80.75 115.09 22.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.131 -1.433 . . . . 71.33 107.131 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -94.29 131.83 39.5 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.327 -0.549 . . . . 61.23 109.682 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.6 p -106.23 128.11 53.71 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.13 0.491 . . . . 72.43 109.861 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.521 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 80.0 m-85 -123.3 125.74 45.6 Favored 'General case' 0 CA--C 1.462 -2.429 0 CA-C-N 116.04 -0.527 . . . . 73.21 109.906 177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.53 HG22 HG22 ' A' ' 37' ' ' VAL . 41.1 p -114.53 118.18 33.01 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.071 -0.968 . . . . 63.22 112.278 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.609 HD12 HD12 ' B' ' 38' ' ' ILE . 54.7 mt -121.95 121.51 64.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.095 -0.705 . . . . 73.44 109.095 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 57' ' ' ARG . 5.2 t -118.28 124.7 48.47 Favored 'General case' 0 N--CA 1.405 -2.72 0 CA-C-O 122.164 0.983 . . . . 64.31 109.683 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' HG2' HG13 ' B' ' 40' ' ' ILE . 10.4 tp10 -124.38 98.37 5.72 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.573 -1.649 . . . . 64.1 108.479 -175.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' A' ' 58' ' ' ASP . . . 68.5 -132.44 27.33 Favored Glycine 0 N--CA 1.424 -2.101 0 N-CA-C 109.976 -1.25 . . . . 71.51 109.976 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.2 m -90.61 18.48 6.3 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.226 0.536 . . . . 65.43 110.878 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.513 HD23 HG23 ' B' ' 40' ' ' ILE . 32.8 tp -121.06 136.06 55.06 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.726 -0.472 . . . . 73.12 109.726 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -129.85 135.34 48.27 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 116.287 -0.415 . . . . 71.35 111.294 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.26 140.2 52.37 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.562 -0.533 . . . . 73.41 109.562 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.53 HG22 HG22 ' A' ' 28' ' ' THR . 63.6 t -121.97 125.92 73.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.969 0.414 . . . . 73.55 110.861 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 27' ' ' TYR . 86.1 mt -102.15 124.94 56.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.384 -0.825 . . . . 74.03 109.629 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -110.72 119.04 37.81 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.797 -1.186 . . . . 62.25 107.797 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.575 HD12 HD23 ' B' ' 34' ' ' LEU . 34.4 mm -88.18 114.83 27.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 107.272 -1.381 . . . . 73.34 107.272 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.413 ' OG1' ' HD3' ' A' ' 42' ' ' LYS . 7.2 t -130.99 165.66 22.68 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.078 0.466 . . . . 74.54 111.275 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -68.04 -16.1 63.89 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.434 0.694 . . . . 74.2 109.994 178.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -86.83 -14.76 41.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.403 -0.962 . . . . 74.24 108.403 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 129.6 -117.34 2.35 Favored Glycine 0 CA--C 1.48 -2.125 0 CA-C-N 114.977 -1.011 . . . . 71.35 112.478 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 64.5 tp -113.41 132.87 55.46 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.583 -0.525 . . . . 64.5 109.583 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -128.42 134.99 48.91 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 109.484 -0.561 . . . . 52.12 109.484 170.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.563 HG11 HG11 ' B' ' 47' ' ' VAL . 12.4 p -128.57 140.59 48.81 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.043 0 CA-C-N 115.721 -0.672 . . . . 74.04 109.95 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 65.3 m -120.0 147.83 44.31 Favored 'General case' 0 C--N 1.266 -3.025 0 CA-C-N 115.587 -0.733 . . . . 71.42 109.743 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' B' ' 45' ' ' LEU . . . -115.19 124.53 51.67 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 106.845 -1.539 . . . . 44.05 106.845 178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.415 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 17.7 t70 -124.01 83.69 55.35 Favored Pre-proline 0 C--N 1.271 -2.819 0 N-CA-C 107.146 -1.427 . . . . 71.44 107.146 -177.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 9' ' ' ARG . 11.2 Cg_endo -93.18 134.79 1.11 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 122.318 2.012 . . . . 71.44 112.661 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 49.39 83.66 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.209 -1.359 . . . . 74.35 111.912 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.86 -167.13 1.76 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.463 -0.789 . . . . 72.53 109.932 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.9 m -58.37 -56.62 19.8 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 123.637 0.585 . . . . 62.42 111.201 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -113.98 91.71 3.73 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 120.159 -0.616 . . . . 74.03 111.946 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.2 m -129.49 120.69 51.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.245 -0.888 . . . . 64.33 109.562 176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' O ' HG23 ' A' ' 30' ' ' THR . 44.5 ttp180 -165.66 143.18 5.7 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.959 -1.126 . . . . 70.31 107.959 -176.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 4.8 p-10 -74.43 95.97 2.81 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.405 -0.918 . . . . 71.51 110.951 177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.33 2.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.434 -1.257 . . . . 63.02 111.638 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG21 ' OH ' ' B' ' 27' ' ' TYR . 27.2 m . . . . . 0 C--N 1.296 -1.734 0 CA-C-N 115.844 -0.616 . . . . 63.15 110.469 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.239 0.507 0 CA-C-O 121.191 0.52 . . . . 64.14 111.164 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.26 68.73 2.41 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.132 -0.787 . . . . 33.02 111.132 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 46.0 m -71.18 106.73 3.89 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 122.694 0.398 . . . . 63.25 111.59 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.45 ' OE2' ' HD3' ' B' ' 8' ' ' LYS . 40.1 mt-10 58.36 -162.97 0.21 Allowed 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.531 -0.759 . . . . 75.5 111.48 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 29.0 m -78.03 34.15 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.578 0.751 . . . . 64.53 110.882 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m 68.05 79.46 0.22 Allowed 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.083 0.953 . . . . 64.2 109.794 -174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -150.93 157.75 43.28 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 114.872 -1.058 . . . . 70.23 108.866 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.45 ' HD3' ' OE2' ' B' ' 4' ' ' GLU . 12.7 mptt 68.47 -176.59 0.2 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.914 0.886 . . . . 75.13 111.01 -173.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' B' ' 9' ' ' ARG . 56.9 mtt180 -79.31 110.33 14.49 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.287 -0.635 . . . . 74.01 109.287 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -90.25 143.31 26.88 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 116.238 -0.437 . . . . 65.12 110.384 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.414 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 69.5 m -144.91 149.39 35.2 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.827 -0.349 . . . . 74.42 110.116 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 92.7 t -141.2 141.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 122.741 0.416 . . . . 65.53 110.074 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' B' ' 46' ' ' LYS . 21.7 t -107.65 132.39 53.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.216 0.531 . . . . 61.3 109.687 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.77 120.84 43.39 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.704 -0.68 . . . . 71.21 110.661 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.1 p -91.5 113.85 26.22 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 108.291 -1.003 . . . . 65.52 108.291 173.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 7.7 t -142.57 -169.02 2.89 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.528 -0.915 . . . . 74.1 108.528 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -74.36 85.11 1.96 Allowed 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.292 1.044 . . . . 64.55 110.655 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -125.89 121.75 34.09 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.783 -1.099 . . . . 74.35 110.919 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.651 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.7 pt? -74.66 147.56 84.59 Favored Pre-proline 0 C--N 1.307 -1.271 0 CA-C-N 115.019 -0.991 . . . . 74.24 108.535 175.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.74 147.56 81.43 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.383 2.055 . . . . 54.43 114.933 -174.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.405 HG22 ' H ' ' B' ' 23' ' ' ARG . 13.4 p -131.66 141.36 45.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 106.636 -1.616 . . . . 63.41 106.636 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.3 p -82.79 -14.15 54.96 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 113.316 0.858 . . . . 74.24 113.316 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.405 ' H ' HG22 ' B' ' 21' ' ' VAL . 52.8 mtm180 -127.39 146.75 50.36 Favored 'General case' 0 CA--C 1.51 -0.592 0 O-C-N 122.354 -0.216 . . . . 74.55 111.012 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 50.7 mm -91.79 115.79 31.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 108.659 -0.867 . . . . 75.21 108.659 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 14.4 mmmm -89.83 131.55 35.71 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 120.28 -0.568 . . . . 72.45 109.795 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 23.8 p -109.65 127.2 54.39 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.634 -0.712 . . . . 71.43 109.936 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.523 ' OH ' HG21 ' A' ' 60' ' ' VAL . 87.4 m-85 -128.35 126.24 40.33 Favored 'General case' 0 CA--C 1.468 -2.197 0 CA-C-N 116.404 -0.362 . . . . 72.01 110.811 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.532 HG22 HG22 ' B' ' 37' ' ' VAL . 76.0 p -115.16 132.6 56.55 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.431 -0.804 . . . . 62.34 112.023 -175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.509 HD12 HD12 ' A' ' 38' ' ' ILE . 66.9 mt -136.64 124.8 34.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.184 -0.672 . . . . 75.41 109.184 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -115.35 140.89 48.72 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.808 -0.812 . . . . 73.42 108.808 175.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.443 ' HG2' HG13 ' A' ' 40' ' ' ILE . 9.5 tp10 -142.06 116.59 9.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.263 -0.88 . . . . 70.11 110.168 -175.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' B' ' 56' ' ' VAL . . . 75.66 -76.66 1.33 Allowed Glycine 0 C--O 1.222 -0.655 0 N-CA-C 111.058 -0.817 . . . . 53.03 111.058 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.634 ' O ' ' HA ' ' B' ' 52' ' ' GLN . 37.9 m -153.14 -5.09 0.2 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.499 -0.926 . . . . 52.05 108.499 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.575 HD23 HD12 ' A' ' 40' ' ' ILE . 21.5 tp -88.2 140.13 29.79 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 124.377 1.071 . . . . 72.35 109.057 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -129.92 132.39 46.35 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.16 -0.616 . . . . 73.22 111.898 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.2 144.91 44.26 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.238 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.532 HG22 HG22 ' B' ' 28' ' ' THR . 60.2 t -127.84 127.26 67.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.465 -0.569 . . . . 55.1 109.465 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 29' ' ' ILE . 77.3 mt -104.93 128.92 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.329 0 CA-C-N 115.457 -0.792 . . . . 60.23 109.051 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.6 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 96.9 m-85 -113.2 116.6 30.05 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.939 -1.134 . . . . 63.03 107.939 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.513 HG23 HD23 ' A' ' 34' ' ' LEU . 39.1 mm -88.7 114.66 27.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 107.471 -1.307 . . . . 75.42 107.471 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 11.2 t -116.13 -179.83 3.78 Favored 'General case' 0 N--CA 1.412 -2.337 0 C-N-CA 120.549 -0.46 . . . . 62.15 110.642 -177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.655 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -82.73 -31.39 28.47 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.327 0.862 . . . . 74.33 113.327 -172.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -102.36 -5.04 24.63 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.138 -0.625 . . . . 75.23 110.636 -175.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 171.58 -136.74 4.0 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 119.154 -1.498 . . . . 53.31 114.195 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 49' ' ' ALA . 67.3 tp -118.83 143.05 47.19 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 124.226 1.011 . . . . 44.12 108.998 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.6 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -129.83 121.68 27.22 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.262 -1.384 . . . . 55.41 107.262 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.563 HG11 HG11 ' A' ' 47' ' ' VAL . 13.9 p -114.81 140.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.423 -0.353 . . . . 72.12 110.464 -176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 46.4 m -131.11 141.63 50.16 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 123.513 0.508 . . . . 64.51 111.804 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.86 124.74 51.43 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.399 -0.819 . . . . 71.02 109.295 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -108.73 103.78 52.6 Favored Pre-proline 0 C--N 1.295 -1.785 0 N-CA-C 108.052 -1.092 . . . . 72.03 108.052 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.67 133.91 24.92 Favored 'Trans proline' 0 N--CA 1.44 -1.655 0 C-N-CA 121.603 1.535 . . . . 62.24 112.632 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.634 ' HA ' ' O ' ' B' ' 33' ' ' SER . 77.4 mt-30 47.32 91.6 0.01 OUTLIER 'General case' 0 C--O 1.24 0.554 0 N-CA-C 116.13 1.9 . . . . 73.11 116.13 174.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.35 146.21 34.81 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.054 -1.091 . . . . 70.34 108.054 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 89.7 m -72.46 -36.53 68.51 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.278 -0.638 . . . . 71.12 109.278 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -100.31 105.73 17.29 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.168 -1.049 . . . . 70.03 108.168 176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' B' ' 32' ' ' GLY . 32.7 m -89.65 1.06 7.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.236 -0.893 . . . . 73.2 113.006 -171.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 ttp180 -59.2 116.25 3.74 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.924 -0.399 . . . . 72.22 109.924 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.28 134.06 50.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.413 0.625 . . . . 63.24 110.597 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.42 12.8 5.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.339 -0.846 . . . . 44.44 111.726 -176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 C--N 1.304 -1.398 0 CA-C-O 118.277 -0.868 . . . . 75.24 111.542 -178.325 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 110.049 -0.352 . . . . 73.11 110.049 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.96 59.07 0.37 Allowed Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 110.483 -1.047 . . . . 63.32 110.483 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.1 m -118.63 105.79 11.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 109.802 -0.444 . . . . 70.31 109.802 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -131.9 -36.81 1.18 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.882 -0.414 . . . . 72.13 109.882 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -46.62 125.63 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 112.985 0.735 . . . . 61.24 112.985 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' B' ' 15' ' ' THR . 50.2 m -130.82 5.9 4.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.712 -0.677 . . . . 71.33 111.417 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -122.75 142.09 51.09 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.388 -0.597 . . . . 63.53 109.388 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.406 ' HG2' ' N ' ' A' ' 9' ' ' ARG . 87.8 tttt 75.04 164.51 0.27 Allowed 'General case' 0 C--O 1.242 0.709 0 O-C-N 124.447 1.092 . . . . 52.23 111.83 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.406 ' N ' ' HG2' ' A' ' 8' ' ' LYS . 77.2 mtp180 -56.52 116.86 3.35 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.925 -0.768 . . . . 74.35 108.925 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.555 ' OG1' HD13 ' B' ' 14' ' ' LEU . 3.5 p -108.23 149.51 28.49 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 112.237 0.458 . . . . 75.24 112.237 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 72.2 m -133.79 149.32 51.41 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.264 -1.384 . . . . 71.12 107.264 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.429 HG22 HD23 ' B' ' 14' ' ' LEU . 27.1 m -141.21 148.95 20.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.828 0.347 . . . . 73.4 110.698 178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.523 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 32.5 t -125.06 144.63 50.31 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.818 -0.628 . . . . 73.43 109.655 175.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.469 HD13 ' HB ' ' B' ' 10' ' ' THR . 3.9 pp -125.96 142.59 51.45 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.648 -0.705 . . . . 75.22 109.719 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.5 p -98.6 119.54 37.51 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.095 -0.706 . . . . 53.23 109.095 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -143.63 -171.84 3.6 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 120.219 -0.592 . . . . 75.33 110.288 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -74.0 88.93 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.407 0.683 . . . . 75.34 110.948 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.477 ' HG3' ' HA2' ' A' ' 44' ' ' GLY . 23.5 mmm180 -126.38 149.24 49.35 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 113.442 0.904 . . . . 75.45 113.442 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -108.4 158.11 34.71 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.508 -1.293 . . . . 64.11 107.508 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' A' ' 42' ' ' LYS . 27.6 Cg_endo -62.28 136.06 57.71 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.29 1.993 . . . . 72.44 112.533 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.8 p -116.49 141.77 32.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 114.943 -1.026 . . . . 71.21 109.666 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.9 m -67.33 -34.59 77.66 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.204 0.816 . . . . 74.31 113.204 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -132.3 149.87 52.27 Favored 'General case' 0 CA--C 1.498 -1.041 0 O-C-N 121.813 -0.554 . . . . 75.13 111.4 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.9 mm -86.05 115.5 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 106.59 -1.633 . . . . 51.5 106.59 172.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.82 128.67 45.1 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 116.125 -0.489 . . . . 64.45 109.695 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 40.9 p -106.6 127.68 53.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.366 -0.605 . . . . 75.33 109.366 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -123.07 127.96 49.47 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.911 -0.586 . . . . 72.41 110.71 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.688 HG22 HG22 ' A' ' 37' ' ' VAL . 12.1 p -114.41 126.68 55.25 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 74.11 112.329 -175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.646 HD12 HD12 ' B' ' 38' ' ' ILE . 49.0 mt -123.66 121.66 62.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.754 -0.657 . . . . 75.43 109.729 175.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 59' ' ' VAL . 9.6 t -110.25 120.97 44.14 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.622 -1.251 . . . . 73.31 107.622 177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.573 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.7 tp10 -134.4 106.6 7.15 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.709 -0.396 . . . . 64.2 111.402 -175.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.82 -67.39 1.68 Allowed Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 116.053 -0.521 . . . . 52.23 113.138 176.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.5 m -154.91 10.15 0.33 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 112.257 0.466 . . . . 71.01 112.257 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -128.13 140.74 51.76 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 118.701 -1.2 . . . . 72.21 111.06 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.555 ' NH2' ' HB3' ' A' ' 53' ' ' ALA . 0.6 OUTLIER -110.0 121.99 46.53 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.307 -0.86 . . . . 75.2 110.32 175.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.42 130.08 56.69 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.323 -0.399 . . . . 42.33 110.007 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.688 HG22 HG22 ' A' ' 28' ' ' THR . 49.8 t -110.06 125.19 67.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 116.243 -0.435 . . . . 73.24 109.912 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.609 HD12 HD12 ' B' ' 29' ' ' ILE . 70.6 mt -101.19 122.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.14 0 N-CA-C 108.561 -0.903 . . . . 61.13 108.561 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.508 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 75.8 m-85 -104.39 119.08 38.15 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.608 -1.256 . . . . 71.02 107.608 177.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HD21 ' B' ' 34' ' ' LEU . 47.2 mm -87.48 113.97 25.67 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 107.641 -1.244 . . . . 70.43 107.641 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -119.75 -177.7 3.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.89 -0.596 . . . . 74.54 110.674 -174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -97.26 -20.55 17.82 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.474 0.546 . . . . 74.02 112.474 -177.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.522 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 45.6 ttp180 -91.34 -29.27 17.22 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.773 0.797 . . . . 73.12 109.996 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' HA2' ' HG3' ' A' ' 18' ' ' ARG . . . 178.82 -121.79 0.77 Allowed Glycine 0 C--N 1.293 -1.825 0 C-N-CA 119.18 -1.486 . . . . 71.12 113.276 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HB3' HD11 ' A' ' 14' ' ' LEU . 61.7 tp -137.61 147.05 44.68 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.085 -0.709 . . . . 71.33 109.085 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.523 ' HD3' ' HB2' ' A' ' 13' ' ' SER . 24.0 tptm -139.42 129.24 24.78 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.208 -1.405 . . . . 73.23 107.208 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 11.4 p -131.13 140.99 47.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.97 -0.382 . . . . 74.02 109.97 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 50.5 m -119.85 137.91 53.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 116.314 -0.403 . . . . 71.13 110.707 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.33 124.73 47.34 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-O 121.286 0.565 . . . . 65.21 110.554 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -110.65 104.02 55.31 Favored Pre-proline 0 C--N 1.278 -2.507 0 N-CA-C 107.315 -1.365 . . . . 71.42 107.315 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -95.39 133.46 0.56 Allowed 'Trans proline' 0 N--CA 1.409 -3.497 0 C-N-CA 120.846 1.031 . . . . 70.24 114.076 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 45.84 44.61 11.09 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 126.101 1.76 . . . . 61.12 114.339 167.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB3' ' NH2' ' A' ' 35' ' ' ARG . . . -82.82 72.29 9.9 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 119.686 -0.805 . . . . 43.02 111.892 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.0 m 61.48 -79.38 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 125.008 1.323 . . . . 65.23 113.786 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -97.46 120.69 38.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 109.037 -0.727 . . . . 74.03 109.037 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' HD2' ' A' ' 35' ' ' ARG . 9.0 p -58.55 -37.19 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 O-C-N 123.658 0.599 . . . . 52.12 112.487 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 69.64 137.33 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.038 0.935 . . . . 72.45 112.724 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.59 161.21 16.28 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.681 -0.69 . . . . 75.54 109.75 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.48 HG12 HG22 ' A' ' 30' ' ' THR . 10.2 p -156.98 152.88 7.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 109.414 -0.588 . . . . 74.1 109.414 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.6 t . . . . . 0 C--N 1.307 -1.253 0 N-CA-C 109.815 -0.439 . . . . 71.02 109.815 177.891 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 108.647 -0.871 . . . . 64.31 108.647 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.63 42.34 0.09 OUTLIER Glycine 0 C--N 1.298 -1.56 0 C-N-CA 119.699 -1.239 . . . . 74.11 112.976 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -89.18 91.58 8.84 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.769 -0.456 . . . . 75.23 109.769 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -75.31 -29.71 60.11 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 122.101 0.953 . . . . 71.23 109.232 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 35.9 m -117.43 134.77 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 114.816 -1.084 . . . . 72.3 108.981 177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 38.3 m -111.75 20.42 17.08 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.452 -0.944 . . . . 73.21 108.452 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -152.18 -177.72 6.35 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 104.555 -2.387 . . . . 72.34 104.555 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 84.9 tttt 67.4 -92.42 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 118.733 0.697 . . . . 55.23 110.834 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.411 ' HG2' ' HA ' ' B' ' 50' ' ' ASP . 99.2 mtt180 -161.21 124.4 3.24 Favored 'General case' 0 CA--C 1.481 -1.709 0 N-CA-C 107.158 -1.423 . . . . 72.23 107.158 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.469 ' HB ' HD13 ' A' ' 14' ' ' LEU . 8.6 m -102.54 142.98 32.83 Favored 'General case' 0 N--CA 1.382 -3.834 0 N-CA-C 107.041 -1.466 . . . . 62.43 107.041 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 73.3 m -134.46 148.36 50.57 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.805 -1.183 . . . . 70.41 107.805 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 m -145.66 156.14 12.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 O-C-N 123.903 0.752 . . . . 75.2 109.344 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 29.1 t -130.69 145.82 52.02 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 109.752 -0.462 . . . . 54.43 109.752 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' B' ' 45' ' ' LEU . 4.2 pp -130.04 134.98 47.76 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 109.062 -0.718 . . . . 73.11 109.062 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 6' ' ' SER . 34.0 p -106.73 141.79 37.41 Favored 'General case' 0 C--N 1.28 -2.426 0 C-N-CA 120.414 -0.514 . . . . 73.51 110.726 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -157.41 -171.47 3.61 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.81 -1.182 . . . . 75.21 107.81 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -69.08 104.41 2.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.888 0.851 . . . . 53.44 109.91 -177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.427 ' HG3' ' HA2' ' B' ' 44' ' ' GLY . 20.6 mmm180 -125.95 148.08 49.33 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.085 -0.961 . . . . 65.43 111.405 -174.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.602 ' H ' HD23 ' B' ' 19' ' ' LEU . 2.0 pt? -103.52 152.88 38.88 Favored Pre-proline 0 C--N 1.306 -1.313 0 N-CA-C 108.067 -1.086 . . . . 64.44 108.067 178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.56 136.45 54.46 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.048 1.832 . . . . 61.04 111.788 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.7 p -120.93 149.09 23.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 N-CA-C 108.351 -0.981 . . . . 74.51 108.351 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -79.53 -41.29 27.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.828 0.347 . . . . 63.01 111.431 -178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -125.23 134.15 52.44 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 122.319 -0.238 . . . . 71.44 110.662 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.5 mm -73.16 119.92 20.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 107.712 -1.218 . . . . 73.22 107.712 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -91.29 139.12 31.04 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.997 -0.681 . . . . 72.32 110.368 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.1 p -120.37 127.56 52.42 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.87 -0.789 . . . . 35.52 108.87 177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -126.84 126.65 43.7 Favored 'General case' 0 CA--C 1.458 -2.593 0 CA-C-N 116.022 -0.536 . . . . 71.01 110.154 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.674 HG22 HG22 ' B' ' 37' ' ' VAL . 53.0 p -115.9 127.46 55.01 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 115.549 -0.75 . . . . 72.53 111.056 -176.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 38' ' ' ILE . 54.9 mt -121.12 121.27 64.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.098 -0.704 . . . . 61.44 109.098 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 9.2 t -112.39 115.92 29.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.528 -0.916 . . . . 75.21 108.528 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.491 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.2 tp10 -120.71 97.6 5.62 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.915 -1.039 . . . . 74.4 111.048 -175.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -66.12 0.47 Allowed Glycine 0 C--O 1.226 -0.374 0 CA-C-N 115.689 -0.687 . . . . 53.23 114.601 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.447 ' HB3' ' HG2' ' B' ' 52' ' ' GLN . 48.2 m -145.15 23.83 1.48 Allowed 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 122.34 -0.506 . . . . 72.43 111.688 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 40' ' ' ILE . 2.5 pt? -148.49 134.92 19.59 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 119.049 -1.06 . . . . 71.14 111.767 173.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.532 ' HD2' ' HB ' ' B' ' 28' ' ' THR . 8.6 tpp180 -101.44 114.08 27.76 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.111 -1.404 . . . . 71.31 108.559 175.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.65 133.36 51.43 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.584 -0.525 . . . . 71.44 109.584 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.674 HG22 HG22 ' B' ' 28' ' ' THR . 48.2 t -118.85 127.0 75.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 120.738 0.304 . . . . 71.34 110.967 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.646 HD12 HD12 ' A' ' 29' ' ' ILE . 73.5 mt -102.77 121.87 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 C-N-CA 123.946 0.898 . . . . 75.22 109.039 176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.411 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 93.7 m-85 -103.86 114.3 28.46 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.309 -0.997 . . . . 74.22 108.309 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.48 HG23 HD21 ' A' ' 34' ' ' LEU . 51.1 mm -88.44 112.61 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.898 0 N-CA-C 106.697 -1.594 . . . . 75.04 106.697 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 73.8 p -121.13 -179.57 4.08 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 116.424 -0.353 . . . . 74.11 110.181 -177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -95.93 -17.8 20.78 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 120.902 0.382 . . . . 73.24 111.145 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 73.6 ttt180 -98.83 -17.92 18.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.128 0.49 . . . . 73.32 109.842 -175.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.427 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . 179.51 -143.07 5.51 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.027 -1.082 . . . . 61.52 113.37 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.563 ' HB3' HD11 ' B' ' 14' ' ' LEU . 1.9 tm? -139.38 122.86 17.25 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 124.673 1.189 . . . . 74.22 108.04 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -118.53 143.68 46.58 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.961 0.41 . . . . 71.33 110.977 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.57 141.25 46.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.62 -0.718 . . . . 74.42 110.559 -175.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.411 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 62.3 m -127.69 142.17 51.41 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.118 -0.492 . . . . 63.34 111.045 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.04 124.01 48.25 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 116.187 -0.461 . . . . 33.42 110.202 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 24.2 t70 -118.15 88.09 31.15 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 107.552 -1.277 . . . . 73.14 107.552 175.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 85.9 Cg_endo -91.6 134.43 1.56 Allowed 'Trans proline' 0 N--CA 1.42 -2.851 0 C-N-CA 121.64 1.56 . . . . 73.41 114.034 -173.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.447 ' HG2' ' HB3' ' B' ' 33' ' ' SER . 40.2 mt-30 62.21 15.55 7.62 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.73 -1.123 . . . . 42.54 113.411 172.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.71 148.5 23.79 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.255 0.55 . . . . 65.31 112.447 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 62.5 m 68.95 -75.19 0.07 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.185 1.394 . . . . 73.13 113.212 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -177.41 151.47 0.77 Allowed 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 106.999 -1.482 . . . . 72.42 106.999 -173.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.41 -47.41 92.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 123.266 0.354 . . . . 61.54 111.816 177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 63.19 85.75 0.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.853 1.261 . . . . 74.41 111.211 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -119.51 105.49 11.29 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.931 -1.137 . . . . 63.33 107.931 173.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.98 155.02 40.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.785 -1.098 . . . . 72.01 110.566 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.312 -1.056 0 N-CA-C 108.541 -0.911 . . . . 74.53 108.541 177.794 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 111.828 0.307 . . . . 64.1 111.828 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.89 -133.55 4.21 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 119.938 -1.125 . . . . 62.11 112.315 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 p -149.59 135.31 18.59 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.867 -0.42 . . . . 71.41 109.867 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . 0.277 0.9 OUTLIER -106.6 98.04 7.76 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.141 0.972 . . . . 73.24 111.025 177.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -98.77 128.01 50.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.056 -0.974 . . . . 64.21 111.269 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.2 m -156.1 170.41 22.24 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.801 -1.555 . . . . 73.32 106.801 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -81.5 93.76 6.72 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.345 -1.354 . . . . 73.2 107.345 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -159.7 166.23 30.96 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.533 -0.758 . . . . 72.2 110.168 -171.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.671 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 6.1 ppt_? -111.12 128.87 56.02 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.759 -0.83 . . . . 71.44 108.759 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.445 ' CB ' HD13 ' B' ' 14' ' ' LEU . 18.9 p -101.57 148.62 25.01 Favored 'General case' 0 C--N 1.283 -2.314 0 O-C-N 122.112 -0.368 . . . . 71.54 110.959 -176.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.1 m -136.49 157.35 46.99 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.008 0.432 . . . . 74.41 111.021 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG23 HD11 ' B' ' 14' ' ' LEU . 86.5 t -130.77 134.71 61.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.58 -0.737 . . . . 52.14 110.776 178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.8 p -117.93 125.62 50.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.522 -0.547 . . . . 54.24 109.522 171.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.97 121.77 27.2 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 123.311 0.644 . . . . 72.15 109.817 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.1 p -125.17 112.79 16.86 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 116.228 -0.442 . . . . 64.42 111.753 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.587 HG23 ' H ' ' A' ' 17' ' ' GLN . 4.2 t -156.52 -92.07 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 114.265 1.209 . . . . 74.21 114.265 176.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.587 ' H ' HG23 ' A' ' 16' ' ' THR . 26.7 tp60 -94.07 91.68 6.95 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 121.659 0.742 . . . . 74.14 109.198 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 2.5 ppt_? -126.72 149.25 49.68 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.479 -0.782 . . . . 75.14 112.776 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.642 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.2 pt? -110.33 155.19 42.35 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.283 -1.006 . . . . 70.43 108.283 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.84 136.64 49.93 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.874 1.716 . . . . 43.14 110.986 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.04 144.11 34.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 115.405 -0.816 . . . . 54.3 109.295 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.8 m -87.09 -35.41 18.71 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.259 0.552 . . . . 53.41 111.32 -176.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -123.25 133.14 54.21 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.782 -0.645 . . . . 54.43 110.976 -177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.16 115.63 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 107.164 -1.421 . . . . 55.41 107.164 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.416 ' HG3' ' OE1' ' B' ' 31' ' ' GLU . 35.1 mmtp -99.35 134.95 41.48 Favored 'General case' 0 C--N 1.289 -2.038 0 C-N-CA 120.372 -0.531 . . . . 75.53 110.859 -176.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -114.33 127.16 55.72 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.893 -1.151 . . . . 72.34 107.893 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 63.7 m-85 -120.25 130.39 54.49 Favored 'General case' 0 CA--C 1.457 -2.599 0 CA-C-N 116.224 -0.444 . . . . 75.32 109.992 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.54 HG22 HG22 ' A' ' 37' ' ' VAL . 68.4 p -114.68 122.59 46.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 119.766 -0.773 . . . . 74.24 111.183 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.71 HD12 HD12 ' B' ' 38' ' ' ILE . 89.5 mt -115.82 124.67 72.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.628 -0.878 . . . . 64.13 108.628 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -117.02 116.18 26.86 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.117 0.96 . . . . 71.41 108.794 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.616 ' O ' HD23 ' A' ' 34' ' ' LEU . 15.3 tp10 -136.96 123.18 20.51 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.284 -0.871 . . . . 74.02 110.388 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.81 -84.99 0.37 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.21 -0.756 . . . . 72.14 111.21 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.424 ' HB2' HD22 ' B' ' 19' ' ' LEU . 33.6 m -150.47 10.56 0.66 Allowed 'General case' 0 C--N 1.298 -1.635 0 O-C-N 122.726 -0.279 . . . . 63.24 111.06 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -114.81 140.21 49.11 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 119.193 -1.003 . . . . 73.41 111.584 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' NH2' ' HA ' ' A' ' 56' ' ' VAL . 2.8 mpt_? -100.08 118.05 35.62 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.112 -0.949 . . . . 62.21 108.781 176.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.07 116.18 31.48 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.471 -0.566 . . . . 70.11 109.471 177.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 28' ' ' THR . 60.1 t -108.48 120.7 60.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 121.167 0.508 . . . . 71.34 110.179 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.66 HD12 HD12 ' B' ' 29' ' ' ILE . 95.0 mt -101.34 124.7 55.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 115.147 -0.933 . . . . 64.32 108.721 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -106.92 115.14 29.68 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.378 -0.971 . . . . 63.11 108.378 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.69 HD12 HD23 ' B' ' 34' ' ' LEU . 37.3 mm -90.69 114.53 28.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 N-CA-C 107.326 -1.361 . . . . 72.43 107.326 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -129.47 156.46 44.08 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 120.543 -0.463 . . . . 73.24 110.609 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.529 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -67.4 -13.74 62.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.447 0.699 . . . . 73.42 110.793 -178.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -87.18 -22.56 25.21 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.724 -0.473 . . . . 70.21 109.724 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.17 -138.02 6.5 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.259 -0.972 . . . . 72.02 113.629 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -113.37 128.59 56.51 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.159 0.504 . . . . 62.44 110.597 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 54.4 tptt -137.1 127.96 27.34 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.454 -1.313 . . . . 65.41 107.454 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG11 HG21 ' B' ' 47' ' ' VAL . 9.9 p -132.1 139.99 48.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 110.599 -0.149 . . . . 63.13 110.599 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.3 m -125.4 137.71 54.02 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.621 0.248 . . . . 65.54 110.446 175.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.79 43.07 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.411 -0.359 . . . . 43.35 110.245 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -115.0 104.62 53.89 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.334 -0.848 . . . . 63.54 109.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 89.3 Cg_endo -94.73 134.72 0.72 Allowed 'Trans proline' 0 N--CA 1.427 -2.408 0 C-N-CA 121.712 1.608 . . . . 72.1 114.641 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG2' ' HB3' ' A' ' 33' ' ' SER . 41.7 mt-30 53.03 -83.12 0.01 OUTLIER 'General case' 0 C--O 1.247 0.949 0 C-N-CA 126.446 1.898 . . . . 75.44 115.546 170.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 71.44 -74.1 0.09 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.999 1.32 . . . . 72.24 112.123 -177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.6 m -138.8 -71.38 0.41 Allowed 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.415 -0.957 . . . . 75.24 108.415 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -123.25 149.88 44.18 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 108.013 -1.106 . . . . 74.23 108.013 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.434 ' HA ' ' NH2' ' A' ' 35' ' ' ARG . 7.2 p -130.74 120.57 48.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-O 121.433 0.635 . . . . 75.24 110.767 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 1.7 tpm_? -95.92 90.34 5.56 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.011 -1.477 . . . . 73.42 107.011 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.6 95.71 9.85 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 122.287 1.041 . . . . 55.42 110.217 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.9 t -80.09 108.85 13.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.498 -1.228 . . . . 62.53 110.695 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 115.964 -0.562 . . . . 74.11 110.609 178.868 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.292 0.568 . . . . 63.52 110.121 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.71 64.7 3.58 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.296 -0.866 . . . . 44.52 113.321 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 16.0 p -88.8 112.71 23.54 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.231 0.539 . . . . 74.13 110.238 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -125.21 97.03 5.06 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.55 0.69 . . . . 64.23 111.794 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -96.25 114.67 33.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.652 -0.703 . . . . 61.44 110.326 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.418 ' HB2' ' HG2' ' B' ' 8' ' ' LYS . 49.2 m -148.21 178.42 8.57 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.941 -0.763 . . . . 75.13 108.941 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.77 9.17 6.64 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 120.721 0.296 . . . . 73.51 111.203 -178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.418 ' HG2' ' HB2' ' B' ' 6' ' ' SER . 21.3 ptmt -67.44 114.44 6.12 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 122.047 0.927 . . . . 75.04 111.628 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' B' ' 50' ' ' ASP . 69.2 mtt180 -98.3 105.63 17.8 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.003 -1.11 . . . . 75.22 108.003 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.8 p -87.8 143.42 27.15 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.168 -0.924 . . . . 71.34 112.378 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 66.8 m -141.51 149.45 40.88 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.114 -1.069 . . . . 53.24 108.114 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -140.58 146.21 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 110.339 -0.245 . . . . 62.14 110.339 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.417 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 22.5 p -107.26 135.51 48.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.214 0.606 . . . . 70.15 110.767 177.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.519 HD11 HG23 ' A' ' 12' ' ' VAL . 96.7 mt -116.73 130.59 56.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.122 -0.49 . . . . 73.45 110.642 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 72.7 p -101.66 122.67 44.32 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.871 -0.789 . . . . 52.34 108.871 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.7 t -151.27 -174.96 4.98 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 120.725 0.298 . . . . 75.13 110.58 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -72.06 86.42 1.03 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 123.522 0.729 . . . . 74.34 109.947 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . 0.278 0.0 OUTLIER -126.52 149.24 49.49 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 114.204 1.187 . . . . 71.35 114.204 -179.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.553 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.7 pt? -78.5 134.73 61.56 Favored Pre-proline 0 C--N 1.29 -1.996 0 CA-C-N 114.944 -1.025 . . . . 70.41 109.361 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.96 136.33 34.85 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 122.093 1.862 . . . . 54.53 111.468 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' B' ' 42' ' ' LYS . 10.9 p -131.29 133.27 62.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.372 -0.831 . . . . 54.23 108.912 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.4 m -84.79 -13.43 51.17 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.084 0.468 . . . . 73.15 111.928 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.47 ' H ' HG22 ' B' ' 21' ' ' VAL . 30.5 mmm180 -105.94 133.83 50.04 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.812 -0.81 . . . . 75.22 108.812 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -94.29 115.39 32.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.591 -0.892 . . . . 62.25 108.591 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -93.65 128.72 39.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.905 -0.588 . . . . 71.43 110.39 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 25.2 p -110.63 127.98 55.49 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.457 -0.792 . . . . 42.04 109.951 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.481 ' HB3' HD13 ' A' ' 29' ' ' ILE . 70.4 m-85 -126.19 127.44 45.7 Favored 'General case' 0 CA--C 1.459 -2.549 0 CA-C-N 115.887 -0.597 . . . . 74.45 110.674 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.546 HG22 HG22 ' B' ' 37' ' ' VAL . 78.0 p -115.14 139.54 49.83 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-N 114.942 -1.026 . . . . 72.23 110.802 -176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.66 HD12 HD12 ' A' ' 38' ' ' ILE . 49.4 mt -136.89 133.84 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.674 -0.491 . . . . 74.2 109.674 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.514 ' OG1' ' HA ' ' B' ' 56' ' ' VAL . 7.9 t -117.47 131.91 56.65 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.636 -0.505 . . . . 72.14 109.636 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.416 ' OE1' ' HG3' ' A' ' 25' ' ' LYS . 10.9 tp10 -142.43 114.77 8.38 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.636 -0.711 . . . . 73.51 109.788 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.06 -76.73 0.86 Allowed Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.118 -0.793 . . . . 72.14 111.118 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' B' ' 52' ' ' GLN . 39.8 m -156.92 10.52 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.625 -1.25 . . . . 71.31 107.625 174.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.69 HD23 HD12 ' A' ' 40' ' ' ILE . 45.5 tp -95.52 115.67 27.76 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 115.28 -0.873 . . . . 72.23 108.871 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -107.12 113.54 27.05 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.983 -1.118 . . . . 71.3 107.983 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.45 34.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.882 -0.414 . . . . 71.1 109.882 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.546 HG22 HG22 ' B' ' 28' ' ' THR . 67.1 t -129.0 129.97 68.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 N-CA-C 109.849 -0.426 . . . . 44.03 109.849 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.71 HD12 HD12 ' A' ' 29' ' ' ILE . 80.1 mt -114.78 125.15 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 109.09 -0.707 . . . . 63.21 109.09 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.539 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 64.6 m-85 -106.84 116.68 32.35 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.534 -1.284 . . . . 74.32 107.534 176.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.17 114.28 26.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 105.922 -1.881 . . . . 63.54 105.922 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -125.6 156.74 38.68 Favored 'General case' 0 N--CA 1.415 -2.179 0 CA-C-O 121.117 0.484 . . . . 51.12 110.593 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' B' ' 21' ' ' VAL . 0.1 OUTLIER -60.03 -25.91 65.69 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.47 -0.786 . . . . 72.24 112.435 -177.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -97.1 -8.29 30.6 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.515 -0.474 . . . . 73.52 111.528 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.0 -153.88 24.79 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 118.305 -1.902 . . . . 70.45 114.547 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.5 HD12 HD12 ' B' ' 14' ' ' LEU . 3.2 tm? -113.66 122.28 46.69 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.19 -1.041 . . . . 64.13 108.19 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 56.9 tptt -117.38 122.13 42.98 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.004 -1.11 . . . . 62.21 108.004 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 47' ' ' VAL . 11.1 p -115.42 139.7 40.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 110.338 -0.245 . . . . 74.54 110.338 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 19.0 m -127.28 140.44 52.21 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 116.127 -0.488 . . . . 60.43 111.585 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.57 124.16 48.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 N-CA-C 108.817 -0.809 . . . . 64.15 108.817 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' B' ' 9' ' ' ARG . 15.1 t70 -119.07 95.23 49.18 Favored Pre-proline 0 C--N 1.284 -2.249 0 N-CA-C 104.875 -2.268 . . . . 63.21 104.875 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.408 ' CD ' ' HG2' ' B' ' 9' ' ' ARG . 79.5 Cg_endo -98.7 135.08 0.29 Allowed 'Trans proline' 0 N--CA 1.429 -2.275 0 C-N-CA 121.935 1.757 . . . . 71.13 116.357 -171.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.469 ' HA ' ' HB3' ' B' ' 33' ' ' SER . 53.0 mt-30 60.78 14.84 5.41 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 116.192 1.923 . . . . 63.41 116.192 170.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.11 -48.39 7.76 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.426 -0.953 . . . . 61.22 108.426 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.0 m -107.41 143.7 35.36 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 108.16 -1.052 . . . . 44.11 108.16 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -80.79 -178.02 6.61 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 116.05 -0.523 . . . . 74.04 111.244 178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.514 ' HA ' ' OG1' ' B' ' 30' ' ' THR . 12.6 p -92.96 142.9 12.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.299 -0.41 . . . . 73.41 110.774 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -168.25 105.52 0.47 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 124.203 1.001 . . . . 60.31 109.012 174.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.41 133.47 44.9 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.748 -0.834 . . . . 72.12 108.748 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 57.8 t -57.07 121.32 4.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 O-C-N 123.735 0.647 . . . . 64.13 112.509 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.43 -1.435 0 CA-C-O 118.465 -0.779 . . . . 43.01 110.428 176.163 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--O 1.238 0.461 0 N-CA-C 109.342 -0.614 . . . . 73.44 109.342 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.16 -151.6 7.73 Favored Glycine 0 CA--C 1.484 -1.867 0 N-CA-C 109.798 -1.321 . . . . 53.44 109.798 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 t -100.39 95.81 7.0 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.95 -0.759 . . . . 71.44 108.95 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -133.11 117.32 17.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.275 -0.639 . . . . 65.34 109.275 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.9 t -97.01 78.76 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-O 121.785 0.802 . . . . 74.34 109.161 176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.8 p -100.83 137.68 38.89 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 114.984 -1.007 . . . . 74.33 108.745 176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -81.75 92.28 6.61 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.845 0.831 . . . . 73.53 111.693 -172.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -145.28 144.9 31.02 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 106.608 -1.627 . . . . 73.44 106.608 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.437 ' HD3' ' OD1' ' A' ' 50' ' ' ASP . 18.0 ptt180 -66.1 105.85 1.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.635 0.731 . . . . 74.02 110.892 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.3 p -96.97 148.83 22.56 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.931 -1.032 . . . . 55.35 111.945 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.4 m -127.21 156.23 42.16 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.396 -0.964 . . . . 52.21 108.396 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG2' HD21 ' B' ' 14' ' ' LEU . 94.2 t -134.49 140.76 45.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 120.663 0.268 . . . . 54.53 110.661 177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.6 p -109.83 125.83 53.17 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.44 -0.948 . . . . 71.51 108.44 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.51 HD12 HD23 ' A' ' 45' ' ' LEU . 86.5 mt -109.57 127.84 54.78 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.018 0.437 . . . . 65.13 111.987 -177.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 41.6 p -95.93 114.1 25.79 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.434 -0.95 . . . . 64.1 108.434 175.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -143.6 -169.89 3.17 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 107.861 -1.163 . . . . 64.13 107.861 178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.65 99.76 1.73 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.507 0.67 . . . . 72.11 109.645 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -125.44 148.38 48.85 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 113.792 1.034 . . . . 73.04 113.792 -175.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' B' ' 33' ' ' SER . 1.7 pp -102.46 161.75 22.32 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 114.094 -1.412 . . . . 71.3 108.9 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.62 135.98 51.81 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.587 1.525 . . . . 62.53 111.647 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.7 t -123.91 124.5 69.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.347 -0.982 . . . . 64.01 108.347 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.0 m -86.5 -56.39 3.45 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 112.432 0.53 . . . . 70.11 112.432 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -93.47 133.39 36.81 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.138 -0.625 . . . . 74.52 110.109 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 50.6 mm -83.27 123.31 38.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.533 -0.914 . . . . 65.41 108.533 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -106.5 143.01 35.22 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.318 -0.401 . . . . 74.5 110.303 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -119.72 127.69 53.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.684 -0.858 . . . . 75.03 108.684 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 78.4 m-85 -124.44 130.26 52.15 Favored 'General case' 0 CA--C 1.478 -1.812 0 CA-C-N 115.994 -0.548 . . . . 65.34 110.806 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.526 HG22 HG22 ' A' ' 37' ' ' VAL . 44.9 p -115.22 125.03 52.87 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.103 -0.953 . . . . 71.1 112.158 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.582 HD12 HD12 ' B' ' 38' ' ' ILE . 59.5 mt -129.9 128.1 64.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.299 -0.63 . . . . 63.52 109.299 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -119.46 137.16 53.96 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 108.44 -0.948 . . . . 72.45 108.44 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.567 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.1 tp10 -142.86 111.37 6.23 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.814 0.34 . . . . 73.54 110.195 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.64 -67.94 3.28 Favored Glycine 0 C--N 1.298 -1.528 0 C-N-CA 120.749 -0.738 . . . . 74.22 112.572 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.2 m -156.93 -16.21 0.09 Allowed 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.791 0.437 . . . . 44.55 112.063 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.567 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -88.67 140.59 29.3 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 118.468 -1.293 . . . . 64.22 110.615 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 19.8 mmt180 -103.49 119.37 38.76 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.951 -1.5 . . . . 75.24 106.951 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.98 124.74 51.95 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.215 -0.661 . . . . 73.11 109.215 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.526 HG22 HG22 ' A' ' 28' ' ' THR . 99.1 t -117.02 125.52 73.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.035 0.445 . . . . 71.45 111.417 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.564 HD12 HD12 ' B' ' 29' ' ' ILE . 92.4 mt -104.59 121.45 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 C-N-CA 124.033 0.933 . . . . 70.05 109.144 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 98.0 m-85 -108.54 117.15 33.42 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.767 -1.197 . . . . 71.54 107.767 175.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.629 HG23 HD21 ' B' ' 34' ' ' LEU . 45.9 mm -88.41 118.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.674 -0.861 . . . . 75.2 108.674 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -134.59 171.95 13.61 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.5 0.667 . . . . 62.01 110.402 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 42' ' ' LYS . 19.4 ptmt -77.21 -15.38 59.51 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 123.879 0.872 . . . . 75.04 110.419 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -87.88 10.42 18.71 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 107.162 -1.422 . . . . 73.11 107.162 -177.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -124.73 8.0 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.626 -1.17 . . . . 74.3 112.549 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 14' ' ' LEU . 64.4 tp -112.26 135.04 53.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.865 -0.421 . . . . 74.01 109.865 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' HE3' ' SG ' ' A' ' 48' ' ' CYS . 1.5 tmtm? -128.85 122.4 30.32 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.158 -2.164 . . . . 62.43 105.158 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.664 HG11 HG11 ' B' ' 47' ' ' VAL . 13.6 p -128.29 140.96 47.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 110.171 -0.307 . . . . 72.41 110.171 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' HE3' ' A' ' 46' ' ' LYS . 93.7 m -121.07 143.12 49.24 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 122.319 0.248 . . . . 43.32 111.035 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.45 123.85 48.51 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.044 -0.724 . . . . 64.34 109.044 177.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 18.5 t70 -124.25 100.53 35.76 Favored Pre-proline 0 C--N 1.299 -1.609 0 N-CA-C 107.693 -1.225 . . . . 73.14 107.693 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.13 134.19 4.27 Favored 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 122.067 1.845 . . . . 32.31 115.143 -173.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.474 ' NE2' ' HG3' ' B' ' 17' ' ' GLN . 49.9 mt-30 57.0 42.37 26.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.916 -1.493 . . . . 61.34 112.006 169.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.41 -78.19 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.199 1.0 . . . . 41.51 113.685 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 33.3 p -132.29 -82.07 0.5 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.635 0.255 . . . . 71.51 111.54 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -139.43 148.59 42.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.976 -0.556 . . . . 74.31 109.537 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 p -95.38 161.24 2.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.674 -0.861 . . . . 71.0 108.674 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -124.64 176.96 6.21 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.744 -0.836 . . . . 64.4 108.744 179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -70.87 115.52 10.11 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 108.186 -1.042 . . . . 75.11 108.186 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.0 t -69.87 115.16 8.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.714 -0.676 . . . . 70.53 110.469 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 115.676 -0.693 . . . . 73.31 109.896 178.847 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 57.1 t . . . . . 0 C--O 1.245 0.821 0 N-CA-C 109.519 -0.549 . . . . 74.22 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.61 173.09 20.73 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.138 -1.185 . . . . 64.43 110.138 -177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 19.9 t -84.36 129.45 34.87 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.096 -1.075 . . . . 73.5 108.096 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -71.1 114.24 8.96 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-O 120.802 0.334 . . . . 72.15 111.044 -177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 49.0 t -80.14 96.34 2.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 108.496 -0.928 . . . . 64.34 108.496 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 62.7 p -146.56 -177.54 5.69 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.741 -0.663 . . . . 74.21 109.242 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -92.92 108.71 20.21 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.315 0.579 . . . . 64.04 109.998 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -174.97 157.42 2.35 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 105.897 -1.89 . . . . 64.32 105.897 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -63.61 110.47 2.01 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 123.793 0.683 . . . . 44.51 109.292 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.8 p -92.45 145.65 24.29 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 116.311 -0.404 . . . . 42.41 111.631 -175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.21 149.44 47.2 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.7 -0.481 . . . . 75.12 109.7 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 72.8 t -142.74 148.73 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.915 0.486 . . . . 72.21 110.147 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 60.5 p -110.62 146.21 36.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 122.482 0.313 . . . . 61.34 110.343 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.499 HD21 ' CG2' ' A' ' 12' ' ' VAL . 96.2 mt -125.74 125.74 43.47 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 123.053 0.541 . . . . 65.44 111.079 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 35.7 p -104.69 114.31 28.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.939 -0.763 . . . . 71.01 108.939 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.4 t -166.75 120.19 1.03 Allowed 'General case' 0 C--N 1.311 -1.076 0 O-C-N 123.225 0.328 . . . . 73.24 110.671 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . 0.474 ' HG3' ' NE2' ' A' ' 52' ' ' GLN . 6.6 tp-100 34.89 72.55 0.09 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.04 1.736 . . . . 64.52 112.252 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.647 ' NH2' HG21 ' B' ' 21' ' ' VAL . 24.5 tpt180 -126.11 109.98 13.0 Favored 'General case' 0 N--CA 1.42 -1.966 0 C-N-CA 119.673 -0.811 . . . . 60.04 112.512 -172.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.23 153.88 88.28 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 114.368 -1.287 . . . . 43.33 112.313 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.16 135.63 65.16 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.52 2.813 . . . . 72.15 114.2 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.647 HG21 ' NH2' ' B' ' 18' ' ' ARG . 55.9 t -132.11 137.89 53.69 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.268 -1.333 . . . . 74.41 107.998 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 38.3 m -92.56 -26.94 17.67 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.467 0.914 . . . . 71.05 113.467 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -127.69 154.61 45.1 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 112.36 0.504 . . . . 70.13 112.36 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 45.4 mm -101.94 132.75 47.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.76 -0.459 . . . . 50.22 109.76 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.511 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 39.8 mmtm -106.27 159.72 15.9 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.638 -0.425 . . . . 64.12 110.028 177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 90.5 m -133.67 126.41 30.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.038 -1.097 . . . . 72.41 108.038 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.456 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 74.3 m-85 -126.57 128.6 47.08 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.48 -0.327 . . . . 54.11 110.795 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.608 HG22 HG22 ' B' ' 37' ' ' VAL . 62.2 p -115.93 135.66 53.77 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.858 0.724 . . . . 74.34 111.3 -176.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.564 HD12 HD12 ' A' ' 38' ' ' ILE . 58.4 mt -131.13 127.43 60.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 116.184 -0.462 . . . . 75.42 109.937 175.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.404 ' HB ' ' NE ' ' B' ' 35' ' ' ARG . 11.5 t -104.35 123.99 48.39 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.226 0.536 . . . . 73.31 109.682 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.668 ' O ' HD23 ' B' ' 34' ' ' LEU . 10.6 tp10 -142.88 123.55 14.13 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.65 -0.5 . . . . 73.3 109.65 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.08 -77.71 0.3 Allowed Glycine 0 C--O 1.217 -0.938 0 N-CA-C 111.208 -0.757 . . . . 64.33 111.208 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.416 ' HB2' HD21 ' A' ' 19' ' ' LEU . 69.4 m -157.65 -0.22 0.11 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.838 0.855 . . . . 54.42 110.847 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.668 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -101.34 137.84 39.15 Favored 'General case' 0 CA--C 1.489 -1.383 0 C-N-CA 118.422 -1.311 . . . . 54.44 110.106 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.442 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 38.3 mmm-85 -100.92 122.82 44.14 Favored 'General case' 0 C--N 1.276 -2.628 0 N-CA-C 107.285 -1.376 . . . . 64.23 107.285 174.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.87 117.77 35.12 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.949 -1.13 . . . . 55.01 107.949 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.608 HG22 HG22 ' B' ' 28' ' ' THR . 58.0 t -110.29 128.05 66.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.37 0.605 . . . . 64.11 110.308 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 29' ' ' ILE . 85.3 mt -111.55 120.08 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 114.908 -1.042 . . . . 64.12 109.257 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.567 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 95.8 m-85 -102.65 116.43 32.58 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 107.965 -1.124 . . . . 72.43 107.965 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.547 HD12 HD21 ' A' ' 34' ' ' LEU . 49.7 mm -88.47 114.03 26.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 108.28 -1.007 . . . . 63.24 108.28 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 t -127.3 169.47 13.51 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 115.623 -0.717 . . . . 70.2 109.729 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -83.0 -13.48 55.87 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.746 -0.465 . . . . 73.55 109.746 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.66 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.5 tmt_? -87.68 3.17 48.92 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.317 1.056 . . . . 65.43 108.6 -177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' B' ' 18' ' ' ARG . . . 128.17 -138.42 10.37 Favored Glycine 0 CA--C 1.504 -0.608 0 CA-C-N 115.26 -0.882 . . . . 75.42 113.087 177.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 68.1 tp -112.24 126.05 54.81 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.733 -0.84 . . . . 74.21 108.733 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 1.8 tmtm? -116.78 121.13 40.69 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.526 -2.027 . . . . 73.05 105.526 177.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.664 HG11 HG11 ' A' ' 47' ' ' VAL . 14.0 p -116.58 140.84 37.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 116.639 -0.255 . . . . 72.31 110.722 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.523 ' SG ' ' HE3' ' B' ' 46' ' ' LYS . 68.4 m -130.41 140.78 50.56 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.656 0.382 . . . . 73.51 111.237 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -116.2 123.25 47.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.564 -0.902 . . . . 73.33 108.564 174.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 13.7 t70 -122.42 103.0 38.83 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.877 -1.157 . . . . 71.21 107.877 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -98.25 134.99 0.32 Allowed 'Trans proline' 0 N--CA 1.434 -1.976 0 C-N-CA 122.263 1.975 . . . . 74.45 116.549 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 64.66 15.31 9.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.589 1.556 . . . . 73.51 114.976 165.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.54 -52.37 6.91 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.204 0.526 . . . . 74.24 110.079 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 70.9 p -100.87 171.52 7.61 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.751 -0.659 . . . . 62.45 110.81 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -81.27 -177.5 6.5 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.609 -0.723 . . . . 65.55 111.352 175.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.59 156.53 29.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-N 116.236 -0.438 . . . . 63.03 110.476 -174.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -125.84 167.45 15.2 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.79 -1.189 . . . . 75.22 107.79 172.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -81.49 98.12 8.11 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.022 -1.473 . . . . 72.4 107.022 172.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.12 105.36 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.587 -0.733 . . . . 74.02 112.882 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.417 -2.091 0 CA-C-N 113.987 -1.46 . . . . 62.11 107.878 175.723 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 CA--C 1.518 -0.259 0 N-CA-C 108.885 -0.783 . . . . 54.54 108.885 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.11 106.21 0.25 Allowed Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.69 -0.767 . . . . 44.11 111.826 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.7 m -94.65 -172.67 2.81 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.92 -0.771 . . . . 70.22 108.92 177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.19 -32.13 70.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.075 0.464 . . . . 73.34 110.36 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -158.98 104.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 121.758 0.789 . . . . 63.22 110.112 174.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.0 m -102.61 100.7 10.79 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.495 -0.928 . . . . 63.43 108.495 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.94 86.69 4.14 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.44 -0.346 . . . . 70.23 111.388 -174.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.5 pttt 178.82 -176.22 0.23 Allowed 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.9 1.28 . . . . 62.44 108.562 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -80.99 102.36 10.11 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.315 -0.994 . . . . 70.4 108.315 176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 p -87.73 135.65 33.28 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.822 -0.627 . . . . 53.2 111.406 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.6 m -130.38 148.45 52.2 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.201 -0.666 . . . . 53.31 109.201 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 84.9 t -144.66 141.84 23.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 116.473 -0.331 . . . . 62.12 110.174 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.4 p -109.24 130.71 55.49 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.21 0.528 . . . . 71.35 109.896 175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.73 120.33 40.18 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.448 -1.686 . . . . 73.12 106.448 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.5 m -97.26 111.71 23.83 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 106.831 -1.544 . . . . 54.11 106.831 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' B' ' 51' ' ' PRO . 8.6 t -133.47 154.11 51.07 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.206 -0.907 . . . . 51.12 110.199 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -72.4 99.44 2.45 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.888 0.852 . . . . 65.1 110.383 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -126.71 148.47 49.86 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.079 -1.452 . . . . 53.24 107.079 178.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.677 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.4 pt? -73.19 127.71 88.78 Favored Pre-proline 0 C--N 1.311 -1.074 0 N-CA-C 108.191 -1.041 . . . . 74.13 108.191 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.86 152.91 60.52 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 123.904 3.07 . . . . 72.42 116.772 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 13.1 p -131.82 149.18 32.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.298 -1.774 . . . . 74.0 106.908 177.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.6 m -102.1 16.24 26.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.751 -0.38 . . . . 74.23 111.53 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -134.0 152.79 51.99 Favored 'General case' 0 C--N 1.319 -0.746 0 O-C-N 122.196 -0.315 . . . . 71.15 110.795 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.4 mm -101.72 132.12 48.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.955 -0.757 . . . . 73.12 108.955 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 14.0 mmmm -121.65 126.28 48.63 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.602 -0.888 . . . . 44.53 108.602 177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.9 m -106.38 127.75 53.51 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.092 -0.707 . . . . 42.53 109.092 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -123.89 126.58 46.64 Favored 'General case' 0 CA--C 1.468 -2.203 0 CA-C-N 116.123 -0.489 . . . . 61.03 110.865 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.59 HG22 HG22 ' A' ' 37' ' ' VAL . 81.6 p -115.04 131.42 56.93 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 115.213 -0.903 . . . . 71.43 111.106 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.597 HD12 HD12 ' B' ' 38' ' ' ILE . 52.8 mt -128.63 121.54 55.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.173 -0.677 . . . . 54.42 109.173 176.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.619 ' OG1' ' HA ' ' A' ' 56' ' ' VAL . 9.9 t -111.48 128.26 55.95 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.737 -1.208 . . . . 71.54 107.737 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.3 tp10 -140.4 119.44 12.73 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.172 -0.467 . . . . 74.51 110.145 -176.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.91 -86.76 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 116.164 -0.471 . . . . 73.34 112.937 177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.473 ' CB ' HD21 ' B' ' 19' ' ' LEU . 40.5 m -142.58 15.34 1.98 Allowed 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.012 0.434 . . . . 74.5 110.446 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.657 HD21 HG23 ' B' ' 40' ' ' ILE . 2.0 pt? -127.35 141.35 51.72 Favored 'General case' 0 CA--C 1.489 -1.403 0 C-N-CA 120.552 -0.459 . . . . 72.45 109.841 176.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 51.2 ttp180 -122.14 131.82 54.15 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.685 -0.689 . . . . 54.15 110.169 178.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -121.47 143.88 49.0 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.248 -0.433 . . . . 63.34 110.435 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 28' ' ' THR . 96.6 t -124.85 127.05 72.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 CA-C-N 116.067 -0.515 . . . . 72.53 110.986 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.568 HD12 HD12 ' B' ' 29' ' ' ILE . 75.8 mt -103.43 122.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.311 0 C-N-CA 123.984 0.914 . . . . 71.52 109.174 177.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.9 m-85 -106.1 114.8 29.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.427 -0.953 . . . . 75.51 108.427 176.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.608 HG23 HD21 ' B' ' 34' ' ' LEU . 42.0 mm -88.51 114.67 27.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 CA-C-N 115.416 -0.811 . . . . 71.42 108.834 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.6 p -126.96 162.05 26.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.662 -0.699 . . . . 53.41 109.405 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.679 ' HE2' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -71.11 -0.69 10.18 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-O 121.037 0.446 . . . . 75.42 112.087 173.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -87.69 -22.07 24.86 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.304 -0.998 . . . . 65.33 108.304 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.555 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 133.77 -119.93 2.4 Favored Glycine 0 N--CA 1.404 -3.476 0 CA-C-N 114.849 -1.068 . . . . 61.23 110.844 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.4 tp -115.51 143.88 44.67 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-N 115.236 -0.482 . . . . 74.23 111.18 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -140.87 139.56 34.43 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.949 -0.76 . . . . 55.21 108.949 170.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.01 141.35 45.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 116.332 -0.394 . . . . 75.53 111.134 -174.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.414 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 49.5 m -120.2 139.29 52.87 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.979 -0.555 . . . . 63.04 110.684 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.5 ' HB1' HH22 ' B' ' 18' ' ' ARG . . . -116.53 125.28 51.67 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 116.001 -0.545 . . . . 74.4 110.448 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -124.43 108.92 29.0 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.046 -0.525 . . . . 74.32 109.833 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HB3' ' NE ' ' B' ' 18' ' ' ARG . 73.6 Cg_endo -94.22 134.26 0.82 Allowed 'Trans proline' 0 N--CA 1.424 -2.575 0 C-N-CA 121.786 1.657 . . . . 30.11 114.99 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 52.9 25.99 4.34 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 114.049 -1.432 . . . . 62.53 114.065 165.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.27 -81.36 0.09 Allowed 'General case' 0 C--O 1.241 0.612 0 N-CA-C 114.126 1.158 . . . . 73.01 114.126 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.7 p -124.5 -85.19 0.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 114.0 1.111 . . . . 75.13 114.0 -175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -88.28 109.03 19.62 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.633 0.73 . . . . 73.53 112.283 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.619 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 31.1 m -136.2 141.56 41.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.796 -1.093 . . . . 71.42 108.962 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -162.45 172.65 15.2 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 110.308 -0.256 . . . . 71.23 110.308 -176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -91.95 118.78 31.08 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.156 -1.053 . . . . 72.31 108.156 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.96 102.98 14.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-O 121.481 0.657 . . . . 71.42 112.374 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.4 t . . . . . 0 C--O 1.24 0.586 0 CA-C-N 115.171 -0.922 . . . . 74.34 111.383 -179.444 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 86.2 t . . . . . 0 C--O 1.241 0.618 0 N-CA-C 109.68 -0.489 . . . . 73.43 109.68 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.1 -154.21 12.35 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.925 -0.87 . . . . 75.53 110.925 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 39.4 m -133.91 173.87 11.08 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.124 -0.695 . . . . 72.33 109.124 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -57.55 -46.5 83.84 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.034 0.534 . . . . 70.25 111.345 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.12 90.52 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.353 1.073 . . . . 72.25 109.927 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 18.0 m -105.18 91.52 3.83 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.219 -0.901 . . . . 65.15 109.322 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -92.22 -16.29 26.39 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.814 0.816 . . . . 71.24 109.08 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -75.13 167.86 21.1 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.746 -1.115 . . . . 73.03 109.914 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -75.46 109.58 9.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 110.241 -0.281 . . . . 74.4 110.241 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -87.77 128.74 35.32 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 110.267 -0.272 . . . . 52.14 110.267 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 82.2 m -129.88 149.37 51.65 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.831 -0.433 . . . . 74.12 109.831 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.2 t -144.14 138.57 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 123.47 0.481 . . . . 73.34 110.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 5.2 p -107.58 129.01 55.03 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 121.311 0.577 . . . . 60.21 111.499 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.82 121.67 44.87 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.387 -0.824 . . . . 70.11 109.754 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 18.0 m -106.82 116.19 31.49 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 108.056 -1.091 . . . . 73.45 108.056 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -138.68 -169.76 2.69 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.287 -0.87 . . . . 72.22 108.763 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -74.12 93.7 2.33 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.607 -0.886 . . . . 61.12 108.607 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.52 ' NE ' ' HB3' ' A' ' 51' ' ' PRO . 8.5 tpp85 -127.51 133.94 49.81 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.696 -0.853 . . . . 74.05 108.696 -177.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.473 HD21 ' CB ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -74.95 162.63 72.68 Favored Pre-proline 0 C--N 1.294 -1.832 0 CA-C-N 116.232 -0.44 . . . . 71.41 111.705 178.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 36.0 Cg_endo -66.73 147.95 82.07 Favored 'Trans proline' 0 C--O 1.254 1.32 0 C-N-CA 122.123 1.882 . . . . 71.34 112.17 177.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 13.8 p -125.78 146.6 31.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.244 -1.021 . . . . 63.11 108.244 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.2 m -67.73 -53.15 29.77 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 123.104 0.253 . . . . 62.23 111.574 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -125.36 151.31 46.27 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 110.018 -0.364 . . . . 73.32 110.018 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.7 mm -82.75 114.58 23.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 107.762 -1.199 . . . . 61.23 107.762 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -94.15 148.19 22.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.587 -0.523 . . . . 71.22 109.587 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 37.7 m -128.46 127.54 42.68 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.075 -1.083 . . . . 64.4 108.075 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -123.59 127.14 47.86 Favored 'General case' 0 CA--C 1.468 -2.179 0 CA-C-O 121.046 0.45 . . . . 74.54 111.296 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.582 HG22 HG22 ' B' ' 37' ' ' VAL . 76.7 p -114.52 132.99 56.11 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 114.879 -1.055 . . . . 75.54 110.02 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 38' ' ' ILE . 51.2 mt -129.51 120.35 50.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 109.285 -0.635 . . . . 63.42 109.285 175.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' B' ' 56' ' ' VAL . 7.2 t -100.12 124.66 45.77 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.908 -1.145 . . . . 75.13 107.908 177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.493 ' O ' HD23 ' B' ' 34' ' ' LEU . 9.0 tp10 -142.41 101.0 3.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.92 -0.582 . . . . 75.12 112.353 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.85 -67.65 0.45 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 116.071 1.188 . . . . 72.31 116.071 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 42.1 m -137.8 -3.38 1.85 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.458 0.54 . . . . 54.34 112.458 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 40' ' ' ILE . 2.3 pt? -140.65 141.09 35.09 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 120.235 -0.586 . . . . 72.32 109.883 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.506 ' NH2' HG21 ' B' ' 54' ' ' THR . 18.8 ttp180 -109.48 125.42 52.44 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 119.558 -0.857 . . . . 71.25 108.885 171.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.27 145.0 30.86 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 116.564 -0.289 . . . . 71.45 110.777 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.582 HG22 HG22 ' B' ' 28' ' ' THR . 95.0 t -124.05 128.18 73.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.888 -0.596 . . . . 72.21 110.725 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 29' ' ' ILE . 68.9 mt -108.36 123.78 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 C-N-CA 124.334 1.054 . . . . 75.22 109.454 177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.442 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 99.1 m-85 -103.29 120.19 40.29 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.859 -0.793 . . . . 75.45 108.859 175.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.657 HG23 HD21 ' A' ' 34' ' ' LEU . 39.7 mm -87.73 114.47 26.59 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 N-CA-C 107.688 -1.227 . . . . 62.43 107.688 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -135.34 154.97 51.33 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.917 -0.583 . . . . 75.54 111.263 -173.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.728 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.1 OUTLIER -71.77 -14.7 62.07 Favored 'General case' 0 C--O 1.216 -0.699 0 CA-C-N 115.972 -0.558 . . . . 71.0 111.219 177.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' B' ' 15' ' ' THR . 54.0 mtp180 -86.34 -16.19 38.2 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.536 0.684 . . . . 73.34 109.366 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.16 -108.16 0.44 Allowed Glycine 0 N--CA 1.419 -2.438 0 C-N-CA 119.916 -1.135 . . . . 31.52 112.67 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 53.0 tp -139.36 143.7 37.87 Favored 'General case' 0 C--N 1.273 -2.723 0 CA-C-N 114.833 -0.684 . . . . 64.33 109.47 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -131.5 140.46 49.55 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.262 -1.014 . . . . 75.33 108.262 167.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.7 140.48 48.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 CA-C-N 115.719 -0.673 . . . . 63.4 110.209 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.492 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 36.5 m -127.58 141.11 51.72 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.88 -0.6 . . . . 73.25 110.967 175.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -116.38 124.39 49.93 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.899 -0.591 . . . . 71.42 110.308 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -110.72 95.91 25.87 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.014 -1.106 . . . . 53.52 108.014 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.485 ' HG3' ' OG1' ' A' ' 16' ' ' THR . 93.6 Cg_endo -89.56 132.1 2.07 Favored 'Trans proline' 0 N--CA 1.411 -3.361 0 C-N-CA 120.097 0.531 . . . . 74.42 111.597 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 57.0 -0.89 0.06 Allowed 'General case' 0 CA--C 1.556 1.211 0 N-CA-C 116.146 1.906 . . . . 74.14 116.146 170.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.6 -60.79 2.01 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 118.388 0.54 . . . . 75.11 110.643 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.506 HG21 ' NH2' ' B' ' 35' ' ' ARG . 36.5 p -77.14 175.98 9.14 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.693 -0.685 . . . . 62.5 111.349 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -69.35 110.92 4.92 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.573 0.702 . . . . 74.55 111.044 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.488 ' HA ' ' OG1' ' B' ' 30' ' ' THR . 31.4 m -99.78 140.45 19.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 115.349 -0.841 . . . . 63.03 110.764 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -139.8 136.97 34.61 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.796 -0.638 . . . . 73.33 109.448 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.46 116.7 20.65 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.694 -1.225 . . . . 73.41 107.694 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.6 m -109.88 107.04 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 113.989 1.107 . . . . 74.41 113.989 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.9 t . . . . . 0 C--O 1.25 1.091 0 C-N-CA 124.92 1.288 . . . . 74.52 110.736 178.797 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 121.256 0.55 . . . . 71.22 110.111 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.85 -5.33 27.49 Favored Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 109.57 -1.412 . . . . 74.24 109.57 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 m -90.72 -25.53 19.98 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.918 -0.641 . . . . 64.0 109.65 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.36 107.14 19.12 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.536 -0.756 . . . . 75.13 109.654 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.0 t -85.2 -42.39 16.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.211 0.529 . . . . 63.21 109.941 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.6 p -140.86 95.08 2.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.601 0.715 . . . . 64.12 110.146 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -109.8 161.33 15.55 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.996 -1.112 . . . . 61.24 107.996 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -76.8 -57.37 3.89 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 112.207 0.447 . . . . 73.4 112.207 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -143.59 115.56 8.32 Favored 'General case' 0 CA--C 1.476 -1.889 0 N-CA-C 107.665 -1.235 . . . . 73.4 107.665 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.2 m -108.04 134.98 50.17 Favored 'General case' 0 C--N 1.272 -2.792 0 C-N-CA 120.077 -0.649 . . . . 64.44 111.073 -174.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.3 m -125.55 147.56 49.22 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.606 -0.516 . . . . 75.42 109.606 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.0 t -145.99 147.61 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 123.721 0.808 . . . . 73.43 109.741 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 46' ' ' LYS . 17.9 t -113.81 140.38 48.36 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 109.222 -0.659 . . . . 73.21 109.222 177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 2.7 mm? -101.47 132.39 47.11 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 123.572 0.749 . . . . 74.14 110.522 -176.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.8 p -99.84 110.93 23.28 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-O 122.108 0.956 . . . . 75.31 109.474 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.0 p -140.95 179.81 6.51 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.082 -0.963 . . . . 75.33 110.68 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' B' ' 51' ' ' PRO . 22.3 tp60 -67.55 95.8 0.49 Allowed 'General case' 0 C--O 1.21 -1.012 0 N-CA-C 108.839 -0.8 . . . . 74.13 108.839 174.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -123.54 149.37 45.31 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.826 -0.749 . . . . 73.12 110.999 -173.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mp -77.04 140.3 66.26 Favored Pre-proline 0 C--N 1.316 -0.874 0 N-CA-C 106.159 -1.793 . . . . 74.02 106.159 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.68 134.66 45.05 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 121.023 1.149 . . . . 62.24 109.551 176.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 51.8 t -119.52 138.87 48.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-N 115.8 -0.637 . . . . 73.55 110.108 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.2 m -90.28 -58.98 2.31 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.184 -0.462 . . . . 74.52 111.022 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -89.78 133.99 34.41 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.834 -0.432 . . . . 73.41 109.834 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.23 122.56 37.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.637 -0.505 . . . . 65.44 109.637 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -89.43 153.94 20.44 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.057 0.456 . . . . 70.43 110.994 178.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.4 m -132.69 127.97 35.94 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.459 -0.941 . . . . 55.42 108.459 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.468 ' HB3' HD13 ' B' ' 29' ' ' ILE . 72.5 m-85 -127.35 126.8 43.17 Favored 'General case' 0 CA--C 1.467 -2.245 0 CA-C-N 115.863 -0.608 . . . . 63.04 110.088 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.559 HG22 HG22 ' A' ' 37' ' ' VAL . 69.2 p -115.82 131.69 56.86 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.317 -0.856 . . . . 71.23 111.795 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.596 HD12 HD12 ' B' ' 38' ' ' ILE . 49.4 mt -131.27 124.57 55.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 116.129 -0.487 . . . . 50.4 109.867 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -102.45 132.46 48.47 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.46 -0.941 . . . . 74.43 108.46 176.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 34' ' ' LEU . 11.5 tp10 -140.25 106.44 5.24 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.271 -0.64 . . . . 64.23 109.271 179.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.05 -96.97 0.33 Allowed Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.823 -0.626 . . . . 64.22 112.289 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -120.34 1.53 10.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 111.983 0.364 . . . . 64.42 111.983 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.4 pt? -118.14 140.87 49.14 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.891 -1.124 . . . . 74.31 111.793 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.62 120.94 43.6 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 114.618 -1.174 . . . . 72.03 108.114 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.28 128.91 52.11 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.847 -0.797 . . . . 75.35 108.847 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 28' ' ' THR . 67.1 t -119.1 135.23 60.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.017 0.437 . . . . 63.24 110.693 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.772 HD12 HD12 ' B' ' 29' ' ' ILE . 72.4 mt -116.14 131.45 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-N 115.525 -0.761 . . . . 62.4 109.966 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 25' ' ' LYS . 99.2 m-85 -115.22 120.61 40.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.387 -0.968 . . . . 74.44 108.387 176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.622 HG13 ' HG2' ' B' ' 31' ' ' GLU . 32.1 mm -92.59 114.88 30.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.065 -1.457 . . . . 75.44 107.065 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -120.32 178.23 4.73 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.897 -0.592 . . . . 75.45 111.426 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -71.77 -16.7 62.2 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 121.559 0.695 . . . . 73.43 110.112 175.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.563 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 75.9 ttt180 -90.17 -12.62 37.61 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.718 -1.128 . . . . 63.04 108.176 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 123.16 -109.84 1.42 Allowed Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 114.526 -1.215 . . . . 63.22 112.216 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.45 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 64.1 tp -113.06 143.78 43.75 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.15 -0.525 . . . . 74.04 110.26 -175.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 87.2 tttt -141.01 142.85 34.19 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.041 -0.725 . . . . 65.04 109.041 171.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.7 140.59 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.195 0 CA-C-N 115.615 -0.72 . . . . 64.41 109.677 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.4 m -126.76 142.02 51.66 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.561 -0.745 . . . . 74.42 110.687 175.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.409 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -114.82 124.78 52.62 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.659 -0.701 . . . . 72.04 109.574 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -126.3 90.02 50.97 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 108.479 -0.934 . . . . 72.23 108.479 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 97.7 Cg_endo -103.13 148.39 0.2 Allowed 'Trans proline' 0 N--CA 1.433 -2.087 0 C-N-CA 122.952 2.435 . . . . 73.13 115.045 -177.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.641 ' OE1' ' HA ' ' B' ' 18' ' ' ARG . 17.7 mt-30 67.33 -175.64 0.2 Allowed 'General case' 0 C--O 1.244 0.789 0 CA-C-N 113.83 -1.532 . . . . 64.44 114.616 163.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 72.24 -64.1 0.4 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.201 1.401 . . . . 62.34 114.316 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.9 p -101.13 -88.62 0.37 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 115.681 1.734 . . . . 74.32 115.681 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 19.9 t90 -81.68 114.15 20.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.639 0.733 . . . . 73.24 112.684 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.97 134.04 60.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 115.417 -0.81 . . . . 71.24 109.046 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -149.55 95.27 2.32 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.618 0.723 . . . . 63.44 109.121 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -86.87 -19.52 28.78 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.718 -1.128 . . . . 64.11 111.121 -175.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.62 15.57 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 N-CA-C 113.137 0.791 . . . . 71.13 113.137 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 120.826 0.346 . . . . 75.12 110.527 179.524 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--O 1.237 0.4 0 CA-C-O 121.59 0.709 . . . . 44.4 109.32 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.09 -18.09 4.79 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.116 -1.194 . . . . 62.34 110.116 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 17.3 m -69.78 -34.91 74.4 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.242 -1.021 . . . . 65.42 108.242 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' B' ' 4' ' ' GLU . 0.2 OUTLIER -99.53 134.65 42.09 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.589 -1.187 . . . . 65.03 108.727 177.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.7 -45.78 20.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.414 -0.958 . . . . 64.34 108.414 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 27.6 p -151.44 96.68 2.31 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 114.844 -1.071 . . . . 75.05 110.265 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -94.05 172.28 8.32 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.383 -0.969 . . . . 73.42 108.383 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -66.87 -70.76 0.23 Allowed 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 117.847 0.294 . . . . 73.44 111.175 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -135.74 108.56 7.56 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.831 -0.433 . . . . 74.22 109.831 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 34.1 p -103.25 148.47 25.77 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.177 0.513 . . . . 52.4 111.469 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 67.9 m -134.61 149.4 50.57 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.906 -1.146 . . . . 73.22 107.906 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 85.5 t -141.56 143.05 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 123.192 0.308 . . . . 60.24 110.253 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 47.1 t -107.26 137.13 45.88 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.806 -0.812 . . . . 22.41 108.806 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.15 121.47 43.31 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.394 -0.821 . . . . 72.14 109.641 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 9.6 p -95.19 111.52 23.35 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.369 -0.974 . . . . 71.31 108.369 173.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -126.75 165.62 18.93 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.92 -1.037 . . . . 60.4 109.086 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -70.59 105.84 3.27 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 106.468 -1.678 . . . . 74.43 106.468 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.641 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 35.4 mmm-85 -125.98 148.37 49.28 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 117.639 2.459 . . . . 71.23 117.639 -168.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.631 ' HG ' ' CD ' ' A' ' 52' ' ' GLN . 68.9 mt -84.79 131.61 48.8 Favored Pre-proline 0 C--O 1.255 1.391 0 CA-C-N 112.878 -1.965 . . . . 74.31 106.469 168.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.56 136.23 41.99 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.909 1.739 . . . . 72.31 111.626 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.422 HG12 ' H ' ' B' ' 23' ' ' ARG . 94.7 t -114.03 135.14 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 114.968 -1.015 . . . . 51.34 108.452 178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.3 m -78.18 -22.58 48.41 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 113.058 0.762 . . . . 51.13 113.058 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.422 ' H ' HG12 ' B' ' 21' ' ' VAL . 14.7 tpt180 -127.95 139.44 52.58 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.596 -0.841 . . . . 74.45 109.61 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' B' ' 41' ' ' THR . 50.4 mm -90.9 138.15 20.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 109.597 -0.52 . . . . 71.34 109.597 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' B' ' 25' ' ' LYS . 0.3 OUTLIER -118.39 157.18 27.64 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.451 0.643 . . . . 74.21 112.134 178.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.1 m -133.5 126.4 31.01 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.973 -1.012 . . . . 70.3 108.952 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.43 ' HB2' ' HB ' ' B' ' 38' ' ' ILE . 68.7 m-85 -124.77 135.77 53.26 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-N 116.121 -0.49 . . . . 74.33 111.43 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.556 HG22 HG22 ' B' ' 37' ' ' VAL . 44.9 p -115.17 128.36 56.13 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.196 -0.911 . . . . 75.22 111.278 -177.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.772 HD12 HD12 ' A' ' 38' ' ' ILE . 72.0 mt -124.7 127.72 72.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.286 0.634 . . . . 71.1 109.578 177.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.4 ' HG1' ' HE3' ' B' ' 55' ' ' TRP . 10.7 t -112.83 128.41 56.44 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 109.515 -0.55 . . . . 75.15 109.515 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.622 ' HG2' HG13 ' A' ' 40' ' ' ILE . 11.5 tp10 -132.06 97.87 4.27 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.412 0.625 . . . . 70.24 110.205 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.49 -74.41 1.08 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 114.742 -1.117 . . . . 71.04 112.421 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.547 ' OG ' ' HA ' ' B' ' 52' ' ' GLN . 24.1 t -144.94 -1.62 0.85 Allowed 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.658 0.742 . . . . 64.24 109.075 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.552 HD23 HD12 ' A' ' 40' ' ' ILE . 35.5 tp -99.32 118.63 36.4 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 115.89 -0.595 . . . . 63.55 110.71 -176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.439 ' HB3' ' HB3' ' B' ' 50' ' ' ASP . 21.2 tpp180 -98.86 114.75 27.47 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.513 -0.767 . . . . 72.45 109.657 178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.13 136.26 48.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 110.087 -0.338 . . . . 72.03 110.087 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.556 HG22 HG22 ' B' ' 28' ' ' THR . 97.0 t -121.52 128.78 75.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.866 0.365 . . . . 74.22 111.341 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.596 HD12 HD12 ' A' ' 29' ' ' ILE . 82.8 mt -105.73 117.32 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.169 0 C-N-CA 124.586 1.154 . . . . 74.2 109.175 178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.522 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.1 m-85 -102.78 116.22 32.13 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.893 -0.78 . . . . 71.12 108.893 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.539 HG23 HD21 ' A' ' 34' ' ' LEU . 47.1 mm -89.06 113.54 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 107.187 -1.412 . . . . 73.4 107.187 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . 0.408 ' HA ' HD12 ' B' ' 24' ' ' ILE . 39.7 p -115.03 170.17 8.55 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 116.136 -0.484 . . . . 72.2 110.201 -177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.551 ' HD2' ' N ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -80.48 -19.93 44.84 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.854 0.359 . . . . 53.15 111.346 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.551 ' N ' ' HD2' ' B' ' 42' ' ' LYS . 70.2 ttt180 -94.97 -17.49 21.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.59 0.71 . . . . 75.01 109.905 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.526 ' HA2' ' HG3' ' B' ' 18' ' ' ARG . . . 164.08 -128.94 1.9 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 119.427 -1.368 . . . . 55.01 113.921 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.409 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 67.7 tp -130.41 147.36 52.1 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 109.031 -0.729 . . . . 61.52 109.031 -175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 85.5 tttt -139.75 143.16 36.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 109.148 -0.686 . . . . 73.53 109.148 172.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 13.7 p -130.45 140.53 48.58 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.877 -0.602 . . . . 74.42 109.915 -175.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.522 ' SG ' ' HE2' ' B' ' 39' ' ' PHE . 56.6 m -124.84 138.51 54.26 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 116.37 -0.377 . . . . 72.4 110.839 174.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -115.86 124.75 51.43 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.082 -0.508 . . . . 71.14 112.034 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.439 ' HB3' ' HB3' ' B' ' 35' ' ' ARG . 18.0 t70 -122.37 95.84 46.64 Favored Pre-proline 0 C--N 1.31 -1.119 0 N-CA-C 108.636 -0.876 . . . . 63.25 108.636 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.491 ' HB2' ' O ' ' A' ' 17' ' ' GLN . 56.5 Cg_endo -96.53 134.98 0.47 Allowed 'Trans proline' 0 N--CA 1.411 -3.364 0 C-N-CA 121.456 1.438 . . . . 64.4 113.48 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.547 ' HA ' ' OG ' ' B' ' 33' ' ' SER . 22.6 mt-30 71.38 -11.46 0.7 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 115.129 1.529 . . . . 63.04 115.129 171.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.2 -60.04 2.12 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.411 -0.516 . . . . 32.43 112.389 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 20.0 p -61.82 -53.01 61.79 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.441 1.275 . . . . 64.55 114.441 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . 0.488 ' CZ2' ' HB3' ' B' ' 57' ' ' ARG . 9.3 t90 -139.97 158.24 44.39 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 120.23 -0.588 . . . . 74.33 110.082 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.48 95.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-O 121.469 0.652 . . . . 71.33 110.769 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.488 ' HB3' ' CZ2' ' B' ' 55' ' ' TRP . 63.8 ttt180 -172.97 112.53 0.23 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.654 -0.703 . . . . 71.14 109.131 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -86.88 90.49 8.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.678 0.751 . . . . 62.33 112.532 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.2 m -133.49 16.86 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.834 -1.075 . . . . 74.43 108.931 175.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--N 1.31 -1.139 0 CA-C-N 115.371 -0.831 . . . . 60.21 109.297 -176.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 108.566 -0.902 . . . . 73.44 108.566 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.89 -129.03 1.75 Allowed Glycine 0 N--CA 1.425 -2.055 0 C-N-CA 120.577 -0.821 . . . . 50.14 111.552 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t -136.93 16.06 3.06 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.784 0.326 . . . . 74.04 110.225 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -77.86 91.35 4.14 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-O 121.902 0.858 . . . . 52.52 111.872 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 8' ' ' LYS . 35.2 m -84.42 -31.08 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-N 114.117 -1.402 . . . . 74.35 110.081 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.9 m 49.55 -72.99 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 116.422 2.008 . . . . 54.11 116.422 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -105.89 7.0 31.98 Favored 'General case' 0 CA--C 1.493 -1.216 0 O-C-N 121.826 -0.546 . . . . 71.34 111.538 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.576 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . 87.3 tttt -65.33 101.29 0.55 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.186 0.517 . . . . 65.43 111.708 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 9' ' ' ARG . 3.8 ppt_? -83.18 124.92 30.98 Favored 'General case' 0 N--CA 1.413 -2.315 0 CA-C-N 114.914 -1.039 . . . . 74.23 108.272 172.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.4 p -94.18 138.97 31.61 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-N 115.912 -0.586 . . . . 64.22 111.141 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 79.7 m -137.13 147.6 46.09 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.454 -0.943 . . . . 53.14 108.454 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG11 HG11 ' B' ' 12' ' ' VAL . 53.9 t -144.4 144.42 22.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 O-C-N 123.078 0.236 . . . . 74.12 110.38 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.9 p -107.24 138.26 43.76 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 109.408 -0.59 . . . . 53.55 109.408 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mp -114.91 133.67 55.8 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.467 -0.333 . . . . 70.04 110.618 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.1 p -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.599 0.714 . . . . 72.22 111.319 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -150.05 167.87 25.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.942 -1.503 . . . . 72.32 106.942 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 100.44 1.46 Allowed 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 122.368 1.08 . . . . 61.41 111.905 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -125.64 139.98 53.1 Favored 'General case' 0 C--N 1.286 -2.188 0 CA-C-N 115.108 -0.951 . . . . 62.12 110.219 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.46 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.9 mm? -74.73 141.73 76.15 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.973 -1.012 . . . . 75.01 109.067 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.07 135.89 42.38 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.171 1.914 . . . . 73.24 111.784 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 23' ' ' ARG . 11.6 p -131.98 136.15 57.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 108.006 -1.109 . . . . 73.41 108.006 176.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.5 m -84.23 2.18 41.13 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 112.371 0.508 . . . . 73.1 112.371 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 21' ' ' VAL . 29.0 mmm180 -116.56 155.66 28.3 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.529 -0.545 . . . . 65.34 109.529 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.22 114.88 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.035 0 N-CA-C 105.121 -2.177 . . . . 73.04 105.121 173.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 35.1 tptt -100.74 125.57 47.21 Favored 'General case' 0 N--CA 1.406 -2.645 0 C-N-CA 117.45 -1.7 . . . . 71.22 108.904 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 38' ' ' ILE . 31.2 m -109.81 128.41 55.3 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 115.92 -0.582 . . . . 74.42 109.975 -175.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 76.2 m-85 -125.76 128.02 47.08 Favored 'General case' 0 CA--C 1.471 -2.058 0 CA-C-N 115.954 -0.566 . . . . 72.05 109.846 177.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.492 HG22 HG22 ' A' ' 37' ' ' VAL . 79.3 p -115.37 119.02 34.88 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 120.218 -0.593 . . . . 70.34 111.914 -175.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.604 HD12 HD12 ' B' ' 38' ' ' ILE . 63.8 mt -120.6 121.42 65.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 109.336 -0.616 . . . . 73.35 109.336 176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.417 ' CB ' HH11 ' A' ' 35' ' ' ARG . 5.7 t -108.49 134.25 51.52 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.449 -0.945 . . . . 74.53 108.449 175.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -137.47 97.52 3.48 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-O 121.751 0.786 . . . . 73.21 110.231 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.96 -82.85 1.5 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 114.692 -1.14 . . . . 72.55 112.123 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.478 ' HA ' HG11 ' A' ' 56' ' ' VAL . 22.9 t -144.34 32.73 1.2 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.139 -1.43 . . . . 71.13 107.139 -178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.648 HD23 HD12 ' B' ' 40' ' ' ILE . 33.7 tp -135.76 117.8 15.37 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 115.276 -0.874 . . . . 63.53 110.694 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.417 HH11 ' CB ' ' A' ' 30' ' ' THR . 30.4 mmt180 -96.79 116.5 29.25 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.159 -0.682 . . . . 53.44 109.159 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.9 126.88 53.54 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.347 -0.612 . . . . 61.24 109.347 176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.492 HG22 HG22 ' A' ' 28' ' ' THR . 97.2 t -120.16 126.21 75.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.964 0.411 . . . . 63.11 110.741 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.62 HD12 HD12 ' B' ' 29' ' ' ILE . 80.2 mt -105.41 131.61 54.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.656 -0.702 . . . . 73.15 109.596 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 95.6 m-85 -115.9 114.88 25.28 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.327 -0.99 . . . . 73.12 108.327 175.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.539 HD12 HD23 ' B' ' 34' ' ' LEU . 37.3 mm -89.53 121.4 39.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.665 -1.235 . . . . 75.11 107.665 177.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 81.2 p -125.52 174.53 8.16 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.535 0.683 . . . . 73.24 110.942 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -76.9 -19.86 56.92 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.676 -1.147 . . . . 54.14 109.025 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -86.6 -25.73 24.79 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.648 -1.241 . . . . 74.15 107.648 -176.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.86 -130.92 3.66 Favored Glycine 0 C--N 1.291 -1.948 0 CA-C-N 114.098 -1.41 . . . . 63.31 112.942 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 61.5 tp -113.22 137.12 51.94 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.601 -0.518 . . . . 74.22 109.601 -178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -134.63 142.36 46.86 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.938 -0.764 . . . . 62.11 108.938 171.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' CYS . 7.2 p -131.58 141.06 46.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.999 -0.546 . . . . 64.02 110.041 -175.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.428 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 52.6 m -123.1 139.41 54.09 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 116.119 -0.492 . . . . 52.14 111.045 175.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -117.36 124.32 48.62 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.903 -0.777 . . . . 64.34 108.903 177.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.58 82.64 67.9 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 106.615 -1.624 . . . . 45.24 106.615 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HD2' ' OE1' ' B' ' 17' ' ' GLN . 3.3 Cg_exo -76.82 145.67 25.66 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 C-N-CA 122.093 1.862 . . . . 72.22 112.688 -176.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 69.82 -41.34 0.48 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.536 1.534 . . . . 74.04 114.252 175.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 67.84 -78.98 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.008 1.323 . . . . 61.23 112.166 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.8 m -162.38 -60.14 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.527 -2.027 . . . . 73.24 105.527 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -142.36 95.8 2.85 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 106.469 -1.678 . . . . 71.33 106.469 172.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 33' ' ' SER . 8.3 p -67.08 117.25 7.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 114.182 1.178 . . . . 63.32 114.182 -172.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -91.33 97.58 11.19 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 107.39 -1.337 . . . . 74.34 107.39 169.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.99 76.03 9.85 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.329 1.062 . . . . 40.34 112.346 -174.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.68 137.95 23.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 113.669 -1.605 . . . . 74.22 110.673 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 C--N 1.311 -1.082 0 O-C-N 121.774 -0.579 . . . . 71.15 110.239 179.114 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.251 1.146 0 N-CA-C 109.466 -0.568 . . . . 73.0 109.466 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.08 79.01 1.75 Allowed Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.849 -1.3 . . . . 61.42 109.849 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 45.3 t -78.97 -54.79 5.68 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.96 0.41 . . . . 63.34 111.127 -177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -85.67 90.98 8.16 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.252 -0.647 . . . . 70.41 109.252 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 31.5 m -136.84 14.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.79 -0.641 . . . . 53.24 111.359 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 42.3 m 73.09 -37.34 0.38 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.316 1.046 . . . . 72.42 112.894 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.89 -10.56 59.45 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.419 0.896 . . . . 64.24 113.419 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -86.15 79.6 9.07 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 122.129 0.966 . . . . 71.03 110.413 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' B' ' 49' ' ' ALA . 15.8 ptt-85 -94.43 135.48 35.81 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.991 -1.459 . . . . 75.03 108.748 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 19.8 p -91.81 144.73 25.2 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 120.839 -0.345 . . . . 65.24 110.906 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 80.8 m -141.43 149.46 41.05 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 62.21 108.595 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.425 HG11 HG11 ' A' ' 12' ' ' VAL . 55.3 t -141.85 138.01 31.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 116.495 -0.321 . . . . 72.25 110.257 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 26.5 p -107.37 125.23 50.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.553 -0.906 . . . . 75.21 108.553 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.61 123.66 45.98 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.047 -0.524 . . . . 64.22 109.931 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 37.0 p -89.17 112.42 23.42 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.504 -0.554 . . . . 74.41 109.504 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.9 t -141.49 -172.47 3.53 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.551 -0.907 . . . . 73.11 108.551 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . 0.452 ' OE1' ' HD2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -79.95 89.26 5.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.285 1.041 . . . . 74.32 110.934 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.409 ' CB ' ' HA2' ' B' ' 44' ' ' GLY . 26.4 tpt180 -126.34 142.57 51.48 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.418 -0.81 . . . . 70.01 111.236 -176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -87.03 152.09 52.77 Favored Pre-proline 0 C--N 1.302 -1.479 0 CA-C-N 115.05 -0.977 . . . . 62.53 108.628 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.94 145.81 86.4 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 121.945 1.763 . . . . 74.52 111.052 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.416 HG22 ' H ' ' B' ' 23' ' ' ARG . 14.3 p -131.53 141.71 45.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 115.41 -0.814 . . . . 62.44 109.298 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 49.7 m -82.0 -27.04 33.34 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.07 0.396 . . . . 74.31 112.07 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.416 ' H ' HG22 ' B' ' 21' ' ' VAL . 30.1 mmm180 -113.99 132.75 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 120.729 -0.388 . . . . 64.35 110.649 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -90.69 115.11 29.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.789 -1.189 . . . . 73.11 107.789 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.407 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 75.3 mmtt -94.15 137.92 32.78 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.034 -0.53 . . . . 53.04 111.391 -176.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 88.4 m -116.27 127.93 55.14 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 114.992 -1.004 . . . . 60.42 108.867 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -127.88 126.64 41.94 Favored 'General case' 0 CA--C 1.461 -2.46 0 CA-C-N 115.605 -0.725 . . . . 74.41 109.749 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.667 HG22 HG22 ' B' ' 37' ' ' VAL . 64.4 p -115.38 132.56 56.58 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.76 -0.654 . . . . 73.42 111.13 -177.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.62 HD12 HD12 ' A' ' 38' ' ' ILE . 55.1 mt -126.04 136.6 60.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 109.213 -0.662 . . . . 63.31 109.213 177.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.603 HG21 ' H ' ' B' ' 57' ' ' ARG . 10.1 t -119.15 127.28 53.18 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-O 121.744 0.783 . . . . 63.1 109.653 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -135.86 110.61 8.7 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.37 -0.832 . . . . 74.31 110.236 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.67 -68.12 3.05 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.143 -0.783 . . . . 75.25 111.143 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 24.9 t -165.82 11.71 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.065 -1.457 . . . . 74.02 107.065 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.539 HD23 HD12 ' A' ' 40' ' ' ILE . 29.4 tp -102.13 123.65 46.37 Favored 'General case' 0 N--CA 1.422 -1.852 0 CA-C-N 115.494 -0.775 . . . . 63.23 111.56 -174.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 35.5 mmt180 -94.46 113.7 25.6 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.021 -0.536 . . . . 63.21 110.501 174.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -105.1 124.55 49.73 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.79 -1.189 . . . . 73.41 107.79 175.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.667 HG22 HG22 ' B' ' 28' ' ' THR . 65.8 t -117.2 128.64 74.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 121.002 0.43 . . . . 54.12 111.373 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.604 HD12 HD12 ' A' ' 29' ' ' ILE . 67.3 mt -106.96 128.19 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.116 0 CA-C-N 115.283 -0.871 . . . . 71.11 109.995 177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 98.8 m-85 -111.74 118.37 35.43 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.418 -0.956 . . . . 74.2 108.418 174.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.648 HD12 HD23 ' A' ' 34' ' ' LEU . 38.2 mm -87.87 114.62 26.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.441 -1.688 . . . . 75.22 106.441 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 69.5 p -123.1 -177.93 3.82 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.63 0.729 . . . . 74.24 112.323 -173.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' B' ' 43' ' ' ARG . 54.7 pttt -80.2 -29.81 38.63 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 113.886 -1.506 . . . . 75.54 109.488 177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.579 ' N ' ' HG3' ' B' ' 42' ' ' LYS . 77.1 ttt180 -88.02 -17.41 31.24 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.211 1.005 . . . . 74.45 109.19 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' B' ' 18' ' ' ARG . . . 147.83 -121.99 1.46 Allowed Glycine 0 N--CA 1.425 -2.055 0 CA-C-N 114.305 -1.316 . . . . 73.1 112.549 177.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.422 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 67.0 tp -119.47 133.77 55.54 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.646 -0.777 . . . . 72.14 109.285 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 82.7 tttt -124.77 141.53 52.05 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.455 -0.572 . . . . 65.0 109.455 172.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.42 HG11 HG11 ' A' ' 47' ' ' VAL . 12.1 p -131.23 141.11 46.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 115.673 -0.694 . . . . 54.44 110.231 -175.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.434 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 65.9 m -125.63 141.59 51.94 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 116.29 -0.414 . . . . 73.45 110.577 174.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.435 ' HB2' ' CD2' ' A' ' 45' ' ' LEU . . . -116.31 123.89 48.77 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.741 -0.837 . . . . 61.3 108.741 176.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' B' ' 35' ' ' ARG . 13.2 t70 -132.26 97.8 17.68 Favored Pre-proline 0 C--N 1.284 -2.241 0 N-CA-C 107.516 -1.29 . . . . 61.21 107.516 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -94.15 138.61 1.19 Allowed 'Trans proline' 0 N--CA 1.425 -2.523 0 C-N-CA 121.775 1.65 . . . . 72.14 115.357 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 62.91 14.29 7.33 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 114.04 -1.436 . . . . 74.12 114.282 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.31 -70.4 0.55 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 113.736 1.013 . . . . 72.33 113.736 -176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.6 p -83.96 -99.56 0.05 Allowed 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 116.261 1.948 . . . . 52.11 116.261 -173.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -145.65 166.34 26.07 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-O 120.919 0.39 . . . . 72.32 110.488 -172.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 8.6 p -119.97 104.23 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-O 121.938 0.875 . . . . 73.53 109.984 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.603 ' H ' HG21 ' B' ' 30' ' ' THR . 74.9 ttt180 -149.87 113.78 5.09 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.845 -1.168 . . . . 74.54 107.845 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -90.62 113.88 26.01 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.245 0.545 . . . . 74.45 112.023 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.57 113.37 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.28 -0.873 . . . . 54.44 109.381 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 46.9 t . . . . . 0 C--N 1.312 -1.025 0 CA-C-O 118.456 -0.783 . . . . 72.31 109.462 -178.176 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.243 0.714 0 CA-C-O 120.916 0.389 . . . . 53.14 111.617 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.18 101.36 0.62 Allowed Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.21 -0.995 . . . . 72.31 112.022 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.0 m -138.82 18.12 2.67 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.799 -1.185 . . . . 65.14 107.799 176.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -67.58 100.45 0.88 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.316 -1.311 . . . . 71.12 111.437 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.63 118.52 56.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.551 -0.749 . . . . 72.43 110.75 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.1 m -160.6 179.74 8.32 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.883 -1.525 . . . . 74.33 106.883 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' B' ' 17' ' ' GLN . 21.5 m-20 -76.12 -1.65 27.13 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.77 0.795 . . . . 71.4 110.281 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -87.95 -174.34 4.66 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.867 -1.061 . . . . 75.33 109.45 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 97.3 mtt180 -68.53 119.77 13.51 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.021 -0.733 . . . . 74.22 109.021 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.5 p -98.57 125.48 43.83 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.151 -0.477 . . . . 72.23 109.972 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.2 m -127.83 148.59 50.46 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.442 -0.503 . . . . 73.42 110.125 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.484 ' CG2' HD11 ' B' ' 14' ' ' LEU . 98.7 t -144.17 143.25 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 122.774 0.429 . . . . 73.3 109.994 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.8 p -123.56 125.49 44.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 123.377 0.423 . . . . 65.43 110.397 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' O ' ' HA3' ' A' ' 44' ' ' GLY . 3.0 mm? -106.56 121.84 45.11 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.189 -0.46 . . . . 63.03 111.243 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.5 p -92.28 112.88 24.99 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.757 0.789 . . . . 71.2 109.071 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.454 ' CG2' ' HG3' ' B' ' 51' ' ' PRO . 5.1 t -134.54 -172.62 3.07 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.918 -1.037 . . . . 60.54 109.367 -177.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' B' ' 7' ' ' ASP . 29.2 pt20 -74.69 81.98 2.06 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 122.469 1.128 . . . . 71.31 111.251 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' HG2' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -127.21 142.37 51.5 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.283 -0.871 . . . . 71.31 110.297 -178.016 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -74.46 147.73 85.2 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 108.342 -0.984 . . . . 55.51 108.342 176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.52 136.89 29.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 121.944 1.763 . . . . 54.23 112.03 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 23' ' ' ARG . 34.6 t -115.41 142.68 27.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.753 -1.203 . . . . 75.11 107.753 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.7 m -88.43 -2.28 58.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.631 0.604 . . . . 71.54 112.631 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.567 ' H ' HG12 ' A' ' 21' ' ' VAL . 64.0 ttt180 -134.58 148.75 50.52 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.953 -0.467 . . . . 75.15 110.44 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.4 mm -92.4 120.45 41.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 108.503 -0.925 . . . . 74.01 108.503 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 35.0 mmtp -96.96 132.21 42.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.917 -0.713 . . . . 72.4 109.914 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 p -107.25 128.04 54.08 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.66 -0.7 . . . . 72.3 109.75 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.467 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 67.2 m-85 -128.24 126.79 41.62 Favored 'General case' 0 CA--C 1.48 -1.723 0 CA-C-N 116.144 -0.48 . . . . 72.13 110.699 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 37' ' ' VAL . 47.9 p -115.13 129.84 56.77 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.423 -0.808 . . . . 55.11 112.696 -174.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.652 HD12 HD12 ' B' ' 38' ' ' ILE . 59.0 mt -137.41 121.6 22.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.912 -0.585 . . . . 74.23 109.467 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.4 t -113.23 126.48 55.46 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 119.666 -0.813 . . . . 64.42 109.162 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.8 tp10 -121.35 103.61 9.09 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.861 -0.609 . . . . 72.52 109.598 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.13 -93.57 0.23 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.612 -0.722 . . . . 60.24 112.967 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.456 ' HB2' HD22 ' B' ' 19' ' ' LEU . 43.7 m -113.75 -7.18 13.27 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.268 0.84 . . . . 65.11 113.268 -175.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.5 pt? -114.5 140.67 48.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 119.142 -1.023 . . . . 75.55 111.125 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 35' ' ' ARG . 1.9 mpt_? -108.71 119.58 39.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.249 -0.887 . . . . 75.2 108.69 176.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.31 130.92 55.48 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 120.754 0.312 . . . . 75.3 110.247 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 28' ' ' THR . 60.1 t -121.19 127.17 75.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 N-CA-C 109.476 -0.564 . . . . 74.22 109.476 178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.628 HD12 HD12 ' B' ' 29' ' ' ILE . 83.7 mt -101.66 125.85 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.587 0 N-CA-C 108.672 -0.862 . . . . 70.42 108.672 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -108.69 114.65 28.63 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.238 -1.023 . . . . 72.32 108.238 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 25' ' ' LYS . 49.9 mm -88.84 113.14 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.353 0 N-CA-C 106.499 -1.667 . . . . 73.13 106.499 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.2 p -109.99 -177.07 3.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.816 -0.629 . . . . 71.15 110.343 -176.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.8 -13.0 32.19 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.941 -0.762 . . . . 55.01 108.941 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -96.55 -24.61 15.97 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 115.182 -0.917 . . . . 71.54 110.705 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.528 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 171.27 -133.52 2.78 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 118.394 -1.86 . . . . 54.14 114.368 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 1.6 tm? -126.99 122.59 34.92 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 124.186 0.994 . . . . 62.5 108.567 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -123.07 143.02 50.25 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-O 121.093 0.473 . . . . 75.4 110.74 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.8 p -131.55 140.81 47.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-N 115.455 -0.793 . . . . 63.33 109.14 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 51.8 m -124.05 136.88 54.56 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 116.089 -0.505 . . . . 70.41 110.302 173.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HB2' ' HG ' ' B' ' 45' ' ' LEU . . . -117.21 124.3 48.74 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 115.636 -0.711 . . . . 53.05 110.015 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 9' ' ' ARG . 21.7 t70 -110.88 104.28 55.9 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 109.001 -0.74 . . . . 64.45 109.001 175.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HG3' ' OG1' ' B' ' 16' ' ' THR . 83.2 Cg_endo -79.44 158.22 25.67 Favored 'Trans proline' 0 N--CA 1.423 -2.659 0 C-N-CA 121.563 1.509 . . . . 41.45 111.411 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -36.71 -49.83 0.79 Allowed 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 125.424 1.49 . . . . 71.02 113.517 172.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.553 ' HA ' ' NE2' ' B' ' 17' ' ' GLN . . . 66.9 -69.09 0.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.556 1.142 . . . . 74.32 113.248 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.6 p -86.99 -76.65 0.35 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.203 0.525 . . . . 72.44 110.204 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -168.08 157.83 9.89 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 106.597 -1.631 . . . . 55.24 106.597 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.89 162.98 35.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 120.981 0.419 . . . . 65.22 110.557 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -119.09 179.21 4.23 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 104.696 -2.335 . . . . 73.43 104.696 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -69.04 90.39 0.45 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 114.2 1.185 . . . . 74.14 114.2 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.6 t -95.41 111.87 26.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.849 -1.167 . . . . 71.32 107.849 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.6 m . . . . . 0 C--N 1.298 -1.661 0 CA-C-N 116.225 -0.443 . . . . 62.23 111.58 -177.976 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--O 1.243 0.73 0 CA-C-O 121.9 0.857 . . . . 74.41 110.41 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.97 6.84 24.12 Favored Glycine 0 N--CA 1.432 -1.597 0 CA-C-N 114.787 -1.097 . . . . 51.15 112.085 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 25.4 m -63.6 100.23 0.26 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.121 0.486 . . . . 75.43 111.322 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -144.83 126.52 15.19 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.893 -0.594 . . . . 74.41 110.143 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.96 125.55 54.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-O 121.374 0.607 . . . . 51.01 110.302 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -154.4 172.71 17.29 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.906 -1.146 . . . . 70.33 107.906 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 17' ' ' GLN . 8.0 m-20 -85.08 -14.94 45.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.884 0.849 . . . . 74.15 109.236 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -78.31 -173.76 3.42 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.213 -0.903 . . . . 61.03 110.552 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 93.3 mtt180 -68.63 107.39 2.95 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.826 -0.624 . . . . 73.43 110.368 -179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 30.9 p -89.03 128.75 35.73 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.695 -0.684 . . . . 73.14 110.713 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' B' ' 47' ' ' VAL . 63.8 m -131.62 148.47 52.61 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.543 -0.91 . . . . 62.34 108.543 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -144.43 145.31 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 109.445 -0.576 . . . . 71.24 109.445 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 65.9 p -115.33 125.45 53.25 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.136 0.493 . . . . 64.41 110.838 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.484 HD11 ' CG2' ' A' ' 12' ' ' VAL . 3.2 mm? -103.47 121.51 42.99 Favored 'General case' 0 CA--C 1.487 -1.48 0 CA-C-N 116.045 -0.525 . . . . 75.42 111.094 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' B' ' 43' ' ' ARG . 38.7 p -93.8 113.31 25.33 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 115.805 -0.634 . . . . 71.13 109.748 176.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.412 ' OG1' ' HG3' ' A' ' 51' ' ' PRO . 9.1 t -129.09 -171.0 2.38 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.623 -1.251 . . . . 73.11 107.623 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 53' ' ' ALA . 27.6 pt20 -77.55 108.19 10.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.54 1.162 . . . . 72.35 110.117 178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.429 ' H ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -125.4 150.9 46.83 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 113.89 -1.505 . . . . 75.43 114.199 -174.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.469 ' H ' HD23 ' B' ' 19' ' ' LEU . 2.2 pt? -74.64 167.42 36.46 Favored Pre-proline 0 C--N 1.299 -1.601 0 CA-C-N 114.297 -1.32 . . . . 53.22 108.636 175.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 19.0 Cg_endo -65.2 135.07 41.79 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.131 1.22 . . . . 70.02 109.951 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 86.2 t -129.81 123.71 57.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.726 -0.842 . . . . 64.41 108.726 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.8 m -90.11 -73.71 0.51 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.037 0.446 . . . . 72.32 110.064 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -92.38 146.94 23.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.475 -0.784 . . . . 75.14 109.301 -177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.402 HD12 HG22 ' B' ' 41' ' ' THR . 43.5 mm -84.07 134.78 26.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.96 -0.385 . . . . 73.55 109.96 -175.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -100.77 125.72 47.27 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.036 -1.098 . . . . 62.15 108.036 178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 31.7 p -106.3 128.38 53.95 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.113 0.482 . . . . 74.03 110.414 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.43 ' HB2' ' HB ' ' B' ' 38' ' ' ILE . 71.3 m-85 -127.07 126.91 43.83 Favored 'General case' 0 CA--C 1.473 -2.017 0 CA-C-N 116.038 -0.528 . . . . 72.24 110.688 178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.554 HG22 HG22 ' B' ' 37' ' ' VAL . 58.8 p -115.38 131.47 56.92 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.349 -0.842 . . . . 73.31 112.416 -173.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.628 HD12 HD12 ' A' ' 38' ' ' ILE . 54.8 mt -133.6 124.32 47.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 C-N-CA 122.656 0.382 . . . . 71.44 110.199 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -111.19 127.09 55.48 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.87 -0.789 . . . . 74.22 108.87 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.543 ' O ' HD23 ' B' ' 34' ' ' LEU . 12.6 tp10 -130.22 97.89 4.57 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.731 -0.668 . . . . 75.42 109.848 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.68 -87.32 0.35 Allowed Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.436 -0.802 . . . . 64.4 112.021 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' B' ' 52' ' ' GLN . 54.8 m -119.89 -13.18 9.08 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 112.847 0.684 . . . . 73.01 112.847 -177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.543 HD23 ' O ' ' B' ' 31' ' ' GLU . 2.5 pt? -107.85 136.5 47.46 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 117.736 -1.586 . . . . 75.41 112.293 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -102.84 120.09 39.99 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.489 -1.232 . . . . 74.11 108.405 175.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.51 134.32 53.17 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.689 -0.485 . . . . 75.44 109.689 178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.554 HG22 HG22 ' B' ' 28' ' ' THR . 61.2 t -124.64 128.66 73.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 N-CA-C 109.979 -0.378 . . . . 72.54 109.979 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 29' ' ' ILE . 83.8 mt -102.2 124.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.536 0 C-N-CA 123.923 0.889 . . . . 73.54 108.696 178.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.21 116.6 32.21 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.445 -0.946 . . . . 73.41 108.445 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.454 HG23 HD21 ' A' ' 34' ' ' LEU . 48.1 mm -87.82 113.69 25.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 106.031 -1.84 . . . . 75.04 106.031 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . 0.402 HG22 HD12 ' B' ' 24' ' ' ILE . 76.0 p -123.4 179.51 4.71 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.745 -0.661 . . . . 61.25 111.338 -171.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' B' ' 42' ' ' LYS . 1.1 ptpt -83.1 -7.41 59.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.859 -0.609 . . . . 72.43 110.276 176.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' B' ' 15' ' ' THR . 98.8 mtt180 -87.04 -16.73 34.76 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.848 -1.538 . . . . 73.44 106.848 170.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 118.18 -103.28 1.03 Allowed Glycine 0 N--CA 1.423 -2.202 0 CA-C-N 114.507 -1.224 . . . . 63.31 112.039 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.492 ' HG ' ' HB2' ' A' ' 49' ' ' ALA . 3.0 tm? -116.38 122.68 45.56 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.106 0.479 . . . . 53.4 111.856 -174.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -124.0 143.83 50.18 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.68 -0.691 . . . . 63.25 109.152 173.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 11' ' ' CYS . 11.0 p -131.18 140.93 47.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 116.307 -0.406 . . . . 64.53 110.085 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 52.9 m -122.42 136.51 54.91 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.336 -0.393 . . . . 72.32 110.689 173.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . . . -117.89 124.59 48.66 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.535 -0.757 . . . . 62.12 111.291 177.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -122.76 95.81 46.05 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 108.87 -0.789 . . . . 65.04 108.87 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' B' ' 34' ' ' LEU . 91.1 Cg_endo -96.39 132.64 0.43 Allowed 'Trans proline' 0 N--CA 1.411 -3.36 0 C-N-CA 120.477 0.785 . . . . 71.34 112.35 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.443 ' HB3' ' HB3' ' B' ' 33' ' ' SER 0.302 2.3 pt20 36.04 -50.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 121.158 3.762 . . . . 74.31 121.158 169.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' B' ' 51' ' ' PRO . . . 78.21 -31.55 0.16 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.194 1.798 . . . . 74.24 111.363 -175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 56.5 m -152.92 -58.58 0.14 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.924 -1.51 . . . . 71.52 106.924 175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -175.4 177.11 1.88 Allowed 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.052 -2.203 . . . . 74.32 105.052 175.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.427 HG21 ' HA ' ' B' ' 33' ' ' SER . 34.6 m -134.69 179.3 4.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 119.161 0.891 . . . . 72.11 112.788 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -131.56 152.54 50.69 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.544 -2.021 . . . . 72.34 105.544 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -66.94 88.85 0.16 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 121.372 0.606 . . . . 63.22 111.725 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 83.0 t -138.6 109.24 4.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.699 -1.223 . . . . 71.41 107.699 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.428 -1.529 0 CA-C-O 118.602 -0.713 . . . . 71.42 110.562 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.556 1.199 0 N-CA-C 112.877 0.695 . . . . 74.52 112.877 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.8 -145.39 5.48 Favored Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 119.64 -1.267 . . . . 61.21 112.484 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 m 66.31 100.75 0.04 OUTLIER 'General case' 0 C--O 1.248 0.992 0 C-N-CA 124.225 1.01 . . . . 75.2 113.031 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -78.39 111.61 14.58 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.119 -1.808 . . . . 73.35 106.119 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 8' ' ' LYS . 46.3 t -83.07 -77.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 112.39 0.515 . . . . 53.31 112.39 -172.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.1 m 70.13 134.81 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.866 1.266 . . . . 74.54 111.636 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.4 t70 72.05 -54.59 0.68 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 124.488 1.115 . . . . 72.0 112.011 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 86.8 tttt -70.91 111.13 6.07 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 122.165 0.983 . . . . 74.31 110.417 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.49 ' CD ' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -40.42 132.3 2.07 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 112.859 -1.973 . . . . 72.4 112.409 172.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.47 127.89 49.32 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.955 -0.566 . . . . 64.31 111.024 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.524 ' CB ' ' HA ' ' A' ' 48' ' ' CYS . 20.0 m -140.55 148.05 40.41 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.772 -1.196 . . . . 41.23 107.772 -174.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.7 t -144.34 145.44 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 118.421 0.555 . . . . 71.33 110.753 -175.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 39.9 p -107.56 125.87 51.84 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.201 0.524 . . . . 62.5 110.377 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.07 137.84 45.36 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.819 -0.628 . . . . 65.52 111.442 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.4 p -98.51 112.58 24.56 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 115.445 -0.798 . . . . 65.15 109.293 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.1 t -142.4 -176.56 4.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.763 -1.199 . . . . 71.4 107.763 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 6.2 tp60 -79.33 105.11 10.41 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.604 0.716 . . . . 72.25 110.436 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.665 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -126.01 147.46 49.54 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.349 -0.841 . . . . 74.24 109.559 -178.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.5 pt? -74.55 136.07 74.89 Favored Pre-proline 0 C--N 1.287 -2.118 0 N-CA-C 107.682 -1.229 . . . . 73.24 107.682 174.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.49 133.9 27.21 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 120.825 1.017 . . . . 71.14 110.562 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.513 HG22 ' H ' ' A' ' 23' ' ' ARG . 14.5 p -133.42 137.33 53.28 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.737 -0.665 . . . . 63.45 109.352 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.1 m -87.86 -19.27 27.63 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.338 0.59 . . . . 61.14 110.036 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.513 ' H ' HG22 ' A' ' 21' ' ' VAL . 37.6 mmt180 -102.86 133.12 48.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.078 -0.712 . . . . 74.33 109.078 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.8 mm -93.58 115.71 33.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.873 -0.788 . . . . 75.03 108.873 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -89.78 135.93 33.33 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 120.384 -0.526 . . . . 75.44 111.196 178.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.4 p -114.55 128.24 56.22 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.959 -1.019 . . . . 61.34 109.715 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.513 ' HB3' HD13 ' B' ' 29' ' ' ILE . 68.0 m-85 -126.44 125.67 42.52 Favored 'General case' 0 CA--C 1.462 -2.419 0 N-CA-C 109.401 -0.592 . . . . 73.35 109.401 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 37' ' ' VAL . 63.7 p -116.73 131.72 56.88 Favored 'General case' 0 C--N 1.283 -2.308 0 O-C-N 123.861 0.726 . . . . 74.53 112.344 -174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.663 HD12 HD12 ' B' ' 38' ' ' ILE . 56.5 mt -127.55 121.17 56.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 120.905 0.383 . . . . 71.23 110.05 175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.3 t -102.97 123.58 46.86 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.776 -1.194 . . . . 71.52 107.776 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' O ' HD23 ' A' ' 34' ' ' LEU . 10.6 tp10 -142.31 97.11 3.06 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 120.354 -0.538 . . . . 74.53 111.642 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.93 -72.96 0.38 Allowed Glycine 0 C--N 1.319 -0.378 0 N-CA-C 115.287 0.875 . . . . 64.32 115.287 171.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 58.1 m -126.94 -1.09 6.58 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 112.719 0.637 . . . . 71.02 112.719 -173.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.588 HD21 HG23 ' B' ' 40' ' ' ILE . 2.0 pt? -146.33 140.46 26.44 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.271 -0.972 . . . . 73.4 112.278 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 121.55 44.99 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.006 -1.452 . . . . 64.25 108.956 173.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.23 137.2 49.23 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.805 -0.18 . . . . 60.02 110.531 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 28' ' ' THR . 39.2 t -124.31 125.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.215 -0.661 . . . . 72.22 109.215 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.827 HD12 HD12 ' B' ' 29' ' ' ILE . 86.4 mt -102.95 123.49 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 108.654 -0.869 . . . . 75.33 108.654 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 46' ' ' LYS . 92.9 m-85 -106.79 114.48 28.6 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.362 -0.977 . . . . 70.15 108.362 177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.478 HG13 ' HG2' ' B' ' 31' ' ' GLU . 49.0 mm -89.42 114.75 27.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 N-CA-C 107.208 -1.404 . . . . 72.31 107.208 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.78 156.87 47.94 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-N 115.806 -0.633 . . . . 63.14 110.953 -175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -62.59 -14.58 44.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.579 0.752 . . . . 74.45 110.734 176.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -85.35 -18.71 32.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.618 0.723 . . . . 75.42 109.491 -177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.35 -138.79 9.28 Favored Glycine 0 CA--C 1.48 -2.155 0 C-N-CA 119.909 -1.138 . . . . 72.35 112.176 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' B' ' 49' ' ' ALA . 2.7 tm? -113.31 121.32 44.07 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.61 -0.885 . . . . 72.21 108.61 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 23.0 tptm -118.62 121.81 41.06 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.383 -0.969 . . . . 74.05 108.383 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG11 HG11 ' B' ' 47' ' ' VAL . 14.9 p -116.97 140.33 40.06 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 107.765 -1.198 . . . . 72.3 107.765 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.524 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 13.6 t -132.76 136.04 46.1 Favored 'General case' 0 C--N 1.266 -3.054 0 N-CA-C 106.716 -1.587 . . . . 72.04 106.716 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' CB ' ' HG ' ' B' ' 45' ' ' LEU . . . -136.18 124.57 23.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 119.328 -0.949 . . . . 72.01 111.312 -177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.63 108.81 62.51 Favored Pre-proline 0 C--N 1.297 -1.693 0 CA-C-N 114.84 -1.073 . . . . 74.44 109.792 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -89.04 148.13 5.6 Favored 'Trans proline' 0 N--CA 1.435 -1.949 0 C-N-CA 122.342 2.028 . . . . 75.11 111.079 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 33' ' ' SER . 9.2 pt20 -62.87 129.77 41.89 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.905 -0.589 . . . . 73.3 109.778 174.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.44 -55.92 2.27 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.306 -0.627 . . . . 72.04 109.306 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.5 p -107.21 -66.3 1.03 Allowed 'General case' 0 N--CA 1.426 -1.671 0 CA-C-N 115.702 -0.681 . . . . 73.24 110.328 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -109.38 166.67 10.7 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.651 -0.5 . . . . 73.03 109.651 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.86 122.56 11.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 CA-C-O 121.476 0.655 . . . . 73.23 111.787 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -98.87 108.38 21.05 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.083 -1.451 . . . . 71.4 107.083 170.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -153.9 142.46 20.79 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.313 -0.403 . . . . 70.25 111.444 -177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.3 t -109.64 -17.9 7.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.425 -0.807 . . . . 75.43 110.324 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 C--O 1.246 0.918 0 O-C-N 122.103 -0.373 . . . . 74.43 111.416 -176.284 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.238 0.488 0 CA-C-O 121.514 0.673 . . . . 71.2 109.797 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -138.87 141.92 12.42 Favored Glycine 0 N--CA 1.434 -1.497 0 N-CA-C 109.423 -1.471 . . . . 63.14 109.423 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 46.1 t 71.68 134.04 0.04 OUTLIER 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.706 0.803 . . . . 72.51 110.615 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -76.6 97.84 4.51 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.052 0.453 . . . . 74.14 110.148 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 56.3 t -90.8 -24.43 5.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 CA-C-N 115.813 -0.63 . . . . 64.24 109.458 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m 67.28 -73.25 0.08 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.51 1.124 . . . . 61.33 110.437 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -87.44 83.86 7.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 122.164 0.983 . . . . 72.05 109.606 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -143.91 128.61 18.22 Favored 'General case' 0 CA--C 1.467 -2.219 0 CA-C-N 114.289 -1.323 . . . . 74.43 108.606 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.671 ' H ' ' HD2' ' B' ' 9' ' ' ARG . 0.0 OUTLIER -80.18 100.27 8.2 Favored 'General case' 0 N--CA 1.391 -3.383 0 CA-C-N 114.63 -1.168 . . . . 75.02 110.053 177.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.1 p -87.12 117.79 26.09 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.539 -1.664 . . . . 64.13 110.099 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.482 ' CB ' ' HA ' ' B' ' 48' ' ' CYS . 19.4 m -137.28 148.22 46.24 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 107.945 -1.131 . . . . 63.51 107.945 -175.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -142.96 146.79 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.833 -0.432 . . . . 75.44 109.833 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . 0.48 ' HB3' ' HD3' ' B' ' 46' ' ' LYS . 23.7 p -106.96 125.56 51.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.17 0.588 . . . . 72.11 110.46 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.34 119.41 39.38 Favored 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 108.236 -1.024 . . . . 73.4 108.236 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 64.6 p -121.59 112.69 18.77 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 108.267 -1.012 . . . . 70.2 108.267 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 9.1 t -173.29 113.44 0.22 Allowed 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.348 0.499 . . . . 74.13 112.348 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 59.42 22.47 10.94 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.581 1.152 . . . . 74.21 112.887 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.502 ' HD2' ' HA2' ' B' ' 44' ' ' GLY . 27.3 mtt180 -105.74 121.51 44.17 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.107 -0.996 . . . . 73.21 108.853 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.735 ' H ' HD23 ' B' ' 19' ' ' LEU . 1.6 pt? -74.39 152.28 87.78 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 116.095 -0.502 . . . . 74.44 111.885 -177.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.19 136.65 74.07 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 123.379 2.719 . . . . 64.23 113.648 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.73 149.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.659 -1.237 . . . . 75.13 107.659 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 -36.42 59.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.022 0.378 . . . . 64.45 112.022 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -124.18 135.89 53.79 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.939 -0.304 . . . . 61.11 110.787 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' B' ' 41' ' ' THR . 49.5 mm -77.57 115.16 19.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 107.755 -1.202 . . . . 74.21 107.755 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -98.19 126.47 43.67 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.161 -0.472 . . . . 62.11 110.444 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.435 HG22 ' CD1' ' B' ' 39' ' ' PHE . 41.1 p -106.66 127.36 53.29 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 109.436 -0.579 . . . . 72.34 109.436 178.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' B' ' 37' ' ' VAL . 75.3 m-85 -126.57 127.45 45.3 Favored 'General case' 0 CA--C 1.474 -1.956 0 CA-C-N 116.092 -0.504 . . . . 72.35 110.626 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.68 HG22 HG22 ' B' ' 37' ' ' VAL . 43.4 p -114.51 121.3 43.07 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.618 -0.719 . . . . 72.14 112.021 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.827 HD12 HD12 ' A' ' 38' ' ' ILE . 94.5 mt -119.48 121.46 66.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.785 -0.643 . . . . 71.41 110.864 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -105.71 139.84 39.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.257 -1.016 . . . . 60.34 108.257 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.478 ' HG2' HG13 ' A' ' 40' ' ' ILE . 17.0 tp10 -142.51 97.59 3.14 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.404 0.621 . . . . 72.14 109.566 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.54 -67.22 2.59 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.218 -0.901 . . . . 71.53 112.834 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.609 ' HA ' HG21 ' B' ' 56' ' ' VAL . 39.8 m -146.12 -25.25 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 113.279 0.844 . . . . 70.41 113.279 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.512 ' H ' HD23 ' B' ' 34' ' ' LEU . 2.6 pt? -92.89 141.39 28.47 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 120.037 -0.665 . . . . 64.32 110.534 -179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.413 ' N ' ' HD3' ' B' ' 35' ' ' ARG . 0.0 OUTLIER -111.51 123.15 49.62 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.049 -0.523 . . . . 73.52 110.006 177.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.45 134.4 54.0 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.714 -0.476 . . . . 73.15 109.714 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.68 HG22 HG22 ' B' ' 28' ' ' THR . 39.2 t -119.76 129.99 74.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.273 0.559 . . . . 74.11 110.538 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.663 HD12 HD12 ' A' ' 29' ' ' ILE . 97.0 mt -103.91 116.65 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 107.846 -1.168 . . . . 63.4 107.846 177.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' B' ' 46' ' ' LYS . 97.8 m-85 -104.52 114.85 29.35 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.472 -0.936 . . . . 65.13 108.472 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.588 HG23 HD21 ' A' ' 34' ' ' LEU . 41.9 mm -88.5 113.7 25.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 106.501 -1.666 . . . . 73.24 106.501 177.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . 0.44 ' HA ' HD12 ' B' ' 24' ' ' ILE . 8.9 t -119.5 166.02 13.64 Favored 'General case' 0 N--CA 1.421 -1.925 0 C-N-CA 120.356 -0.538 . . . . 72.45 111.479 -174.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.97 -3.76 43.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.426 0.898 . . . . 73.44 113.426 -173.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -116.22 -1.75 12.31 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.195 0.521 . . . . 72.55 110.518 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . 0.502 ' HA2' ' HD2' ' B' ' 18' ' ' ARG . . . 155.52 -140.65 7.47 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 119.04 -1.553 . . . . 63.45 113.96 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.465 ' HG ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 tm? -122.13 126.58 48.66 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.441 0.696 . . . . 74.41 109.355 -177.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 24.1 tptm -117.45 121.75 41.88 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.821 -0.807 . . . . 74.51 108.821 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.541 HG11 HG11 ' A' ' 47' ' ' VAL . 9.7 p -108.23 140.39 26.91 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 108.621 -0.881 . . . . 61.31 108.621 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.482 ' HA ' ' CB ' ' B' ' 11' ' ' CYS . 10.5 t -139.7 136.86 34.66 Favored 'General case' 0 N--CA 1.415 -2.203 0 N-CA-C 107.752 -1.203 . . . . 44.44 107.752 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . . . -125.55 125.77 43.75 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 110.144 -0.317 . . . . 55.03 110.144 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -115.07 109.69 46.62 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-O 121.278 0.561 . . . . 75.53 109.827 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.87 158.56 49.84 Favored 'Trans proline' 0 N--CA 1.439 -1.713 0 C-N-CA 122.719 2.279 . . . . 70.33 112.939 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.404 ' HB3' ' HB3' ' B' ' 33' ' ' SER . 12.5 pt20 -55.63 99.21 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 113.539 -1.664 . . . . 70.33 111.036 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.91 -91.53 0.08 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.134 -0.485 . . . . 43.14 112.089 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 22.7 p -119.22 3.07 11.41 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.05 0.453 . . . . 72.54 110.684 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -161.59 168.21 23.92 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.66 -0.7 . . . . 73.44 109.708 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' B' ' 33' ' ' SER . 5.5 p -151.79 135.77 8.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 123.713 0.805 . . . . 72.42 108.948 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -122.51 83.1 2.06 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.204 -1.036 . . . . 71.4 108.204 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -101.95 105.41 16.19 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.856 -1.065 . . . . 61.24 108.529 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 30.8 m -105.34 -36.91 3.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 113.512 0.93 . . . . 72.22 113.512 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 108.169 -1.049 . . . . 72.34 108.169 178.27 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.0 m . . . . . 0 C--O 1.236 0.35 0 N-CA-C 110.289 -0.263 . . . . 74.35 110.289 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.06 152.0 19.73 Favored Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 110.847 -0.901 . . . . 65.15 110.847 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 t 64.87 12.62 7.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.259 1.024 . . . . 72.21 111.639 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.15 168.41 24.74 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 109.653 -0.499 . . . . 60.1 109.653 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -109.06 100.36 10.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.875 0.845 . . . . 70.31 111.07 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 8' ' ' LYS . 24.4 t -160.49 144.63 14.03 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.33 -1.359 . . . . 64.21 107.33 177.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.676 ' H ' ' HB2' ' B' ' 17' ' ' GLN . 5.0 m-20 71.52 -33.87 0.28 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 125.079 1.352 . . . . 75.15 112.662 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 6' ' ' SER . 55.8 mtpt -72.92 115.44 12.23 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 107.372 -1.344 . . . . 63.12 107.372 174.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.483 ' HD3' ' OD2' ' A' ' 50' ' ' ASP . 14.5 ptt180 -68.85 114.49 7.22 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.529 0.681 . . . . 63.54 111.904 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.4 p -88.86 148.07 24.06 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.198 -0.91 . . . . 74.21 110.98 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 65.9 m -141.71 149.23 40.27 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.458 -1.312 . . . . 64.14 107.458 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.536 HG11 HG11 ' B' ' 12' ' ' VAL . 57.1 t -139.76 145.15 27.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 110.163 -0.31 . . . . 62.11 110.163 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 m -111.77 124.8 53.12 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.216 -1.031 . . . . 73.11 108.216 172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.443 ' N ' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -132.09 141.01 49.03 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 123.749 0.819 . . . . 74.11 108.802 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 t -123.32 141.9 51.51 Favored 'General case' 0 C--N 1.277 -2.551 0 C-N-CA 119.843 -0.743 . . . . 44.35 111.004 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.2 t -111.56 26.61 10.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.245 -1.02 . . . . 74.03 108.245 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' HB3' ' H ' ' B' ' 7' ' ' ASP . 6.6 tp-100 77.43 117.26 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 112.998 -1.91 . . . . 72.12 108.468 -173.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.576 HH12 HD22 ' B' ' 34' ' ' LEU . 14.9 mmm180 -95.46 148.01 22.93 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 116.561 2.06 . . . . 74.41 116.561 -172.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.9 mt -114.37 153.83 46.49 Favored Pre-proline 0 N--CA 1.426 -1.652 0 CA-C-N 112.922 -1.945 . . . . 60.43 106.358 172.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.45 145.08 16.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.349 3.366 . . . . 74.24 115.286 -175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.34 137.86 54.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 114.084 -1.417 . . . . 73.44 109.164 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.2 m -98.11 -45.09 6.36 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-O 120.712 0.292 . . . . 73.01 110.848 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -119.3 133.84 55.53 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.757 -0.46 . . . . 62.34 109.757 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.3 mm -85.48 135.91 23.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.767 -0.457 . . . . 64.2 109.767 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -115.03 151.63 33.88 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 112.9 0.704 . . . . 73.4 112.9 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.6 m -133.99 127.22 31.89 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.607 -1.178 . . . . 51.41 108.38 176.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 74.8 m-85 -127.61 134.7 49.67 Favored 'General case' 0 CA--C 1.472 -2.057 0 N-CA-C 111.879 0.325 . . . . 74.55 111.879 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.673 HG22 HG22 ' A' ' 37' ' ' VAL . 36.1 p -115.51 139.23 50.25 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.64 -0.709 . . . . 52.32 111.556 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.782 HD12 HD12 ' B' ' 38' ' ' ILE . 82.3 mt -130.72 133.14 63.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 115.216 -0.902 . . . . 65.31 108.78 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -117.19 123.65 47.2 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-O 121.631 0.729 . . . . 73.14 109.171 177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HG2' HG13 ' B' ' 40' ' ' ILE . 17.8 tp10 -125.16 98.35 5.62 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 121.752 0.787 . . . . 65.14 108.965 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.52 -71.9 2.91 Favored Glycine 0 N--CA 1.426 -1.983 0 N-CA-C 109.703 -1.359 . . . . 64.31 109.703 -174.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -154.97 -22.7 0.12 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.519 0.933 . . . . 71.14 113.519 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.416 HD11 HD12 ' B' ' 40' ' ' ILE . 2.6 pt? -69.23 141.06 54.54 Favored 'General case' 0 C--N 1.367 1.37 0 CA-C-N 118.934 0.788 . . . . 64.32 110.817 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' A' ' 50' ' ' ASP . 31.6 mmt180 -100.58 118.71 37.31 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.884 -0.598 . . . . 60.1 109.745 174.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 123.97 49.35 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.894 -0.78 . . . . 44.13 108.894 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 28' ' ' THR . 71.5 t -110.89 133.19 57.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.3 -0.409 . . . . 75.03 110.142 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.552 HD12 HD12 ' B' ' 29' ' ' ILE . 75.6 mt -115.49 118.29 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.993 0 C-N-CA 123.702 0.801 . . . . 63.35 108.997 176.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -102.52 122.1 43.69 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.567 -0.901 . . . . 75.23 108.567 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.456 HD12 HD21 ' B' ' 34' ' ' LEU . 47.6 mm -100.63 113.37 36.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.684 -1.228 . . . . 75.03 107.684 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -131.92 177.03 7.85 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.635 -0.876 . . . . 74.13 108.635 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HD3' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -90.51 -1.74 57.9 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.487 -0.931 . . . . 73.31 108.487 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -89.63 -30.83 17.85 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.558 -0.904 . . . . 63.43 108.558 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 164.12 -157.53 29.85 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.702 -1.136 . . . . 74.34 111.737 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -113.63 121.57 44.56 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 106.888 -1.523 . . . . 73.45 106.888 176.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -121.08 140.16 52.33 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-O 121.202 0.525 . . . . 74.42 111.381 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.602 HG11 HG11 ' B' ' 47' ' ' VAL . 23.2 m -131.45 141.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.035 -0.984 . . . . 74.53 110.866 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 37' ' ' VAL . 61.6 m -121.35 137.52 54.66 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.936 -0.575 . . . . 73.42 110.623 174.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.75 124.58 47.62 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.294 -0.632 . . . . 64.33 109.294 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.483 ' OD2' ' HD3' ' A' ' 9' ' ' ARG . 14.2 t70 -115.84 127.13 27.03 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.933 -0.765 . . . . 53.22 108.933 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.8 148.17 22.96 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.915 3.077 . . . . 62.45 113.854 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.62 ' H ' ' NE2' ' A' ' 52' ' ' GLN . 1.2 mp0 -51.93 107.41 0.2 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 124.227 1.011 . . . . 74.11 110.937 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.13 147.75 25.33 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 106.194 -1.78 . . . . 71.43 106.194 173.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.0 m -74.03 83.77 1.77 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.861 0.839 . . . . 73.55 109.501 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -165.06 148.7 8.56 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 105.642 -1.984 . . . . 72.24 105.642 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.6 t 75.05 94.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.619 0 C-N-CA 124.027 0.931 . . . . 75.03 110.229 -174.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -80.05 -47.39 14.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.701 -1.222 . . . . 74.5 107.701 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 64.42 -91.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.159 1.384 . . . . 73.0 112.368 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t 42.58 81.03 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.118 0 C-N-CA 124.43 1.092 . . . . 73.1 112.81 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.895 -0.593 . . . . 63.41 109.52 -179.2 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.242 0.662 0 N-CA-C 110.222 -0.288 . . . . 65.54 110.222 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.03 151.72 23.84 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 109.731 -1.348 . . . . 73.14 109.731 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 37.7 t 74.42 -45.55 0.59 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.446 1.098 . . . . 72.03 111.357 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -93.81 157.23 16.24 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.136 -0.483 . . . . 52.21 109.891 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.99 149.4 26.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 120.937 0.398 . . . . 75.01 110.438 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 59.4 m -150.19 122.27 8.28 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.84 -0.538 . . . . 75.5 111.006 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . 0.401 ' H ' ' HB3' ' A' ' 17' ' ' GLN . 15.5 m-20 63.35 24.22 14.11 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.888 0.875 . . . . 74.13 112.74 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.33 107.24 19.07 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.606 -0.887 . . . . 71.21 108.606 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.425 ' HB3' ' HD3' ' B' ' 51' ' ' PRO . 22.4 ptt180 -64.88 121.29 14.28 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 115.177 -0.92 . . . . 75.02 113.046 -177.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 17.1 p -103.21 149.76 24.35 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-N 114.846 -1.07 . . . . 55.32 111.282 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 63.1 m -139.85 148.84 42.68 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.352 -1.722 . . . . 62.41 106.352 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.536 HG11 HG11 ' A' ' 12' ' ' VAL . 60.2 t -141.88 144.0 26.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.592 -0.521 . . . . 44.15 109.592 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -107.98 124.82 50.73 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 108.091 -1.077 . . . . 75.44 108.091 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.432 HD23 ' N ' ' B' ' 14' ' ' LEU . 0.3 OUTLIER -119.41 122.73 42.43 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.08 -0.711 . . . . 62.13 109.08 177.41 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.7 t -107.22 130.64 54.71 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-O 121.87 0.843 . . . . 54.44 111.01 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -144.78 -162.45 1.49 Allowed 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 107.001 -1.481 . . . . 62.05 107.001 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . 0.676 ' HB2' ' H ' ' A' ' 7' ' ' ASP . 6.5 tp-100 -71.1 102.73 2.54 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.701 0.762 . . . . 63.33 109.177 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 mmm-85 -125.0 139.49 53.77 Favored 'General case' 0 C--N 1.276 -2.63 0 CA-C-N 114.874 -1.057 . . . . 63.24 109.214 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 46.8 mt -89.02 137.24 29.72 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 106.649 -1.612 . . . . 61.14 106.649 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -50.68 135.17 41.6 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.647 2.231 . . . . 63.33 112.695 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.91 135.83 61.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.834 -1.543 . . . . 64.23 106.834 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 26.3 m -89.79 -20.28 23.7 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.32 0.489 . . . . 74.51 112.32 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -112.73 138.63 49.26 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.783 -0.19 . . . . 52.52 110.779 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.9 mm -89.93 118.95 36.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.305 -0.628 . . . . 74.11 109.305 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.07 152.53 18.68 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.312 0.577 . . . . 64.0 112.333 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . . . . . . . . . 73.1 m -131.31 127.91 38.67 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 114.693 -1.14 . . . . 51.11 108.595 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.438 ' HB3' HD13 ' A' ' 29' ' ' ILE . 67.5 m-85 -129.35 125.58 36.98 Favored 'General case' 0 CA--C 1.452 -2.793 0 N-CA-C 108.94 -0.763 . . . . 62.02 108.94 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.425 HG23 HG22 ' B' ' 37' ' ' VAL . 18.6 m -117.88 122.07 42.37 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 119.686 -0.806 . . . . 63.01 112.544 -175.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.552 HD12 HD12 ' A' ' 38' ' ' ILE . 64.2 mt -116.48 121.91 68.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 116.081 -0.509 . . . . 74.12 109.9 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -105.02 128.42 53.31 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.225 -1.398 . . . . 72.55 107.225 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.567 ' O ' HD23 ' B' ' 34' ' ' LEU . 14.7 tp10 -139.38 118.49 12.65 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.258 -0.645 . . . . 71.3 109.258 -178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.73 -78.79 1.16 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 119.858 -1.163 . . . . 54.43 110.271 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' B' ' 52' ' ' GLN . 49.3 m -155.37 -14.58 0.11 Allowed 'General case' 0 CA--C 1.56 1.34 0 N-CA-C 112.924 0.712 . . . . 70.52 112.924 177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.576 HD22 HH12 ' A' ' 18' ' ' ARG . 2.4 pt? -84.2 142.07 30.57 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 118.329 0.513 . . . . 73.32 110.818 177.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.452 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 32.3 mmt180 -100.66 118.08 36.08 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 107.324 -1.361 . . . . 72.11 107.324 175.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.86 114.98 29.53 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.43 -0.581 . . . . 72.12 109.43 177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.425 HG22 HG23 ' B' ' 28' ' ' THR . 86.2 t -108.37 124.02 64.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 116.211 -0.449 . . . . 50.13 110.626 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.782 HD12 HD12 ' A' ' 29' ' ' ILE . 63.2 mt -102.97 123.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 C-N-CA 123.429 0.691 . . . . 62.2 109.205 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -104.85 114.88 29.36 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.219 -1.03 . . . . 72.32 108.219 176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.423 HG13 ' HG2' ' A' ' 31' ' ' GLU . 47.5 mm -90.18 112.57 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 106.869 -1.53 . . . . 75.42 106.869 178.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -110.61 -176.58 3.01 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.922 -0.77 . . . . 64.11 108.922 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.593 ' HD3' ' H ' ' B' ' 42' ' ' LYS . 0.0 OUTLIER -92.11 -17.98 24.19 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 120.968 0.413 . . . . 74.05 110.219 176.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -100.58 -16.94 17.29 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.127 -0.488 . . . . 63.41 111.01 -172.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 177.34 -145.59 7.28 Favored Glycine 0 C--N 1.295 -1.711 0 C-N-CA 118.7 -1.714 . . . . 50.13 113.199 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.2 122.82 23.34 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.574 -1.269 . . . . 74.34 107.574 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -125.04 141.57 52.04 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.215 0.531 . . . . 73.23 110.383 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 47' ' ' VAL . 30.8 m -131.9 141.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.298 -0.865 . . . . 75.25 111.03 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 53.8 m -120.03 136.98 54.36 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 115.929 -0.578 . . . . 72.11 110.11 174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.69 123.91 47.24 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.186 -0.672 . . . . 75.35 109.186 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' B' ' 35' ' ' ARG . 17.1 t70 -102.04 135.73 19.61 Favored Pre-proline 0 C--N 1.313 -1.015 0 N-CA-C 107.655 -1.239 . . . . 71.15 107.655 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' B' ' 9' ' ' ARG . 17.9 Cg_endo -55.92 143.28 82.73 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 123.49 2.793 . . . . 73.44 114.34 -174.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . 0.527 ' CD ' ' H ' ' B' ' 52' ' ' GLN . 1.1 mp0 -50.56 110.72 0.44 Allowed 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.588 -1.187 . . . . 73.15 108.891 174.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.97 175.56 8.99 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.965 -0.561 . . . . 61.41 110.717 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.2 m -86.01 12.17 10.04 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 122.236 1.017 . . . . 74.42 109.206 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -121.54 -174.81 2.94 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 107.182 -1.414 . . . . 72.24 107.182 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 41.1 t 76.24 107.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.688 1.195 . . . . 72.41 110.626 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 32.6 tpt180 -134.68 -75.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.54 -0.755 . . . . 62.22 109.64 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 65.71 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.832 0.853 . . . . 71.3 111.782 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t 37.24 80.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 126.042 1.737 . . . . 73.54 114.698 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 52.4 t . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 107.741 -1.207 . . . . 71.32 107.741 177.651 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.241 0.63 0 N-CA-C 110.135 -0.32 . . . . 75.23 110.135 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.45 74.93 1.29 Allowed Glycine 0 N--CA 1.44 -1.072 0 C-N-CA 120.638 -0.791 . . . . 31.32 111.92 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.6 m -102.96 -12.68 17.31 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 110.037 -0.357 . . . . 73.23 110.037 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 59.55 88.32 0.07 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.721 1.208 . . . . 73.13 112.196 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.0 p -130.16 100.11 4.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.98 0.895 . . . . 73.41 110.941 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.7 p -106.45 120.25 41.42 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.22 -0.9 . . . . 63.23 109.637 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.71 99.82 0.49 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.481 0.657 . . . . 71.02 110.432 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 173.88 -68.22 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.223 -2.14 . . . . 74.34 105.223 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -152.27 115.57 4.72 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 107.06 -1.459 . . . . 74.13 107.06 176.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.6 m -109.39 145.35 36.25 Favored 'General case' 0 C--N 1.276 -2.614 0 C-N-CA 120.241 -0.584 . . . . 70.42 110.859 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 80.7 m -129.85 148.94 51.77 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.089 -1.078 . . . . 65.32 108.089 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.3 147.01 18.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 120.84 -0.344 . . . . 63.14 110.883 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.3 p -112.21 126.94 55.76 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 120.903 0.382 . . . . 64.21 110.003 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -115.08 141.95 47.3 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.771 -0.825 . . . . 62.53 108.771 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.8 t -127.9 112.98 15.3 Favored 'General case' 0 N--CA 1.405 -2.693 0 C-N-CA 119.534 -0.866 . . . . 71.32 111.04 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.415 ' HB ' ' OG1' ' B' ' 10' ' ' THR . 9.0 t -121.71 -170.09 1.98 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.3 -1.0 . . . . 64.1 108.3 175.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 17' ' ' GLN . 5.9 tp60 -72.38 93.36 1.51 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.712 0.768 . . . . 51.42 110.822 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.405 HH22 HG23 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -126.5 148.17 49.73 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.95 -1.023 . . . . 74.1 108.838 -178.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -82.07 141.42 46.86 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.347 -0.983 . . . . 63.42 108.347 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 42' ' ' LYS . 39.9 Cg_endo -65.91 143.83 74.49 Favored 'Trans proline' 0 C--O 1.248 1.009 0 C-N-CA 122.541 2.161 . . . . 63.11 112.715 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 21.4 t -122.4 148.31 26.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.404 -1.332 . . . . 73.42 107.404 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -92.38 -39.84 11.23 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 120.305 -0.558 . . . . 71.2 110.843 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -89.61 133.15 34.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.31 -0.405 . . . . 65.13 111.246 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.5 mm -89.73 124.11 42.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.761 -0.829 . . . . 72.33 108.761 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . 35.1 mmtp -104.53 146.57 28.7 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.009 -0.676 . . . . 60.5 111.292 -177.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 80.1 m -127.29 127.79 44.91 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.436 -0.949 . . . . 54.51 108.436 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 88.2 m-85 -128.13 134.73 49.15 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-N 116.352 -0.385 . . . . 72.33 111.8 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 37' ' ' VAL . 17.7 p -114.64 120.08 38.91 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.295 -0.866 . . . . 74.51 111.711 -177.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.698 HD12 HD12 ' B' ' 38' ' ' ILE . 93.9 mt -114.94 125.14 72.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.569 -0.741 . . . . 65.13 109.589 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 58' ' ' ASP . 9.0 t -106.91 128.87 54.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.277 0.56 . . . . 75.04 109.794 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.594 ' O ' HD23 ' A' ' 34' ' ' LEU . 17.1 tp10 -142.99 119.18 10.78 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.715 -0.675 . . . . 73.55 109.59 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.59 -87.37 0.12 Allowed Glycine 0 C--O 1.223 -0.535 0 N-CA-C 111.6 -0.6 . . . . 50.14 111.6 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.489 ' HB3' HD21 ' B' ' 19' ' ' LEU . 26.8 t -151.14 13.88 0.69 Allowed 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.406 -0.59 . . . . 71.22 109.406 174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 31' ' ' GLU . 2.3 pt? -110.49 140.51 44.69 Favored 'General case' 0 CA--C 1.489 -1.389 0 C-N-CA 119.7 -0.8 . . . . 72.52 108.891 174.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -116.3 134.03 55.35 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.58 -0.736 . . . . 73.15 110.192 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.97 131.46 55.38 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 109.383 -0.599 . . . . 52.0 109.383 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 28' ' ' THR . 87.5 t -113.11 120.99 64.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 116.014 -0.539 . . . . 74.55 110.139 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.64 HD12 HD12 ' B' ' 29' ' ' ILE . 96.2 mt -101.33 117.39 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 N-CA-C 109.003 -0.739 . . . . 74.23 109.003 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' HE2' ' SG ' ' A' ' 48' ' ' CYS . 98.2 m-85 -102.96 114.82 29.43 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.554 -0.906 . . . . 74.0 108.554 177.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.481 HD12 HD21 ' B' ' 34' ' ' LEU . 47.7 mm -90.75 112.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.528 0 N-CA-C 106.57 -1.641 . . . . 74.54 106.57 177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -116.62 173.28 6.71 Favored 'General case' 0 N--CA 1.429 -1.51 0 O-C-N 123.525 0.516 . . . . 52.34 110.248 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.91 -33.01 71.6 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 116.482 2.03 . . . . 75.31 116.482 -171.145 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.577 ' N ' ' HD2' ' A' ' 42' ' ' LYS . 1.5 tmt_? -117.21 3.76 12.64 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 119.694 -0.803 . . . . 70.25 109.472 -176.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.5 -158.73 12.03 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 118.353 -1.88 . . . . 44.24 115.058 -177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.29 123.1 24.87 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 125.636 1.575 . . . . 61.15 108.457 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -121.45 143.4 49.26 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.745 0.307 . . . . 74.44 110.721 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.92 140.2 48.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 CA-C-N 115.948 -0.569 . . . . 51.13 110.126 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' ' HE2' ' A' ' 39' ' ' PHE . 26.7 m -118.9 145.05 46.04 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 115.5 -0.773 . . . . 74.3 110.232 172.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -115.76 125.75 53.16 Favored 'General case' 0 C--N 1.28 -2.44 0 N-CA-C 108.252 -1.018 . . . . 61.53 108.252 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -120.93 78.43 31.81 Favored Pre-proline 0 C--N 1.287 -2.116 0 N-CA-C 107.218 -1.401 . . . . 72.4 107.218 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 27.8 Cg_endo -99.53 134.13 0.23 Allowed 'Trans proline' 0 N--CA 1.413 -3.229 0 C-N-CA 122.303 2.002 . . . . 74.45 113.858 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 50.74 68.76 0.72 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.052 -1.431 . . . . 63.05 113.229 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.83 -53.38 4.94 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.152 -0.619 . . . . 63.04 111.279 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 m -153.45 29.86 0.48 Allowed 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 107.33 -1.359 . . . . 72.51 107.33 178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 96.1 m95 73.33 130.32 0.04 OUTLIER 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.566 -1.197 . . . . 64.04 110.666 -173.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.96 118.14 57.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.795 -0.639 . . . . 62.21 112.382 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -126.24 105.67 8.99 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.834 -1.913 . . . . 71.53 105.834 169.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.497 ' OD1' HG12 ' A' ' 60' ' ' VAL . 12.5 t70 -111.04 161.99 15.33 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.226 -1.027 . . . . 74.32 108.226 -176.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.16 -25.72 23.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 111.802 0.297 . . . . 70.43 111.802 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.497 HG12 ' OD1' ' A' ' 58' ' ' ASP . 14.4 p . . . . . 0 C--O 1.25 1.081 0 C-N-CA 120.336 -0.546 . . . . 75.32 110.649 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 109.609 -0.515 . . . . 70.02 109.609 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.33 5.24 28.45 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.29 -0.957 . . . . 75.23 112.601 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -75.02 -33.72 61.83 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.554 -0.535 . . . . 61.14 109.554 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 58.47 90.92 0.04 OUTLIER 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.451 1.101 . . . . 73.22 113.376 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.502 ' HA ' HG23 ' B' ' 10' ' ' THR . 6.8 p -159.54 84.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 114.472 -1.24 . . . . 74.45 110.189 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.4 p -85.21 138.63 32.23 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.491 -1.231 . . . . 72.42 112.084 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.87 90.15 2.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.576 -0.738 . . . . 73.24 110.813 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt 163.54 -73.09 0.0 OUTLIER 'General case' 0 CA--C 1.482 -1.655 0 C-N-CA 127.424 2.29 . . . . 75.23 105.336 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' B' ' 50' ' ' ASP . 94.7 mtt180 -126.24 129.42 48.9 Favored 'General case' 0 N--CA 1.41 -2.441 0 N-CA-C 108.173 -1.047 . . . . 54.33 108.173 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.502 HG23 ' HA ' ' B' ' 5' ' ' VAL . 49.5 m -108.88 116.66 32.42 Favored 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 107.334 -1.358 . . . . 73.13 107.334 173.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 31.0 m -135.61 146.76 48.24 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.115 -1.068 . . . . 61.43 108.115 -176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 12.4 p -147.12 156.06 10.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 117.486 0.13 . . . . 60.02 110.788 -176.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 35.1 p -117.16 126.69 53.2 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.345 0.258 . . . . 71.2 110.618 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.41 HD22 ' N ' ' B' ' 14' ' ' LEU . 1.7 mm? -112.11 121.12 44.08 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.98 -1.119 . . . . 73.24 107.98 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 5.2 t -93.05 111.81 23.56 Favored 'General case' 0 C--N 1.284 -2.246 0 C-N-CA 118.271 -1.372 . . . . 71.44 109.147 176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 3.6 t -153.58 107.81 3.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.181 -0.918 . . . . 64.0 112.096 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 51' ' ' PRO . 6.1 tp60 43.1 85.66 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.708 1.603 . . . . 51.43 113.259 174.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.412 ' N ' ' HD3' ' B' ' 18' ' ' ARG . 0.0 OUTLIER -125.57 148.47 48.92 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.173 -1.011 . . . . 72.01 110.275 -173.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.489 HD21 ' HB3' ' A' ' 33' ' ' SER . 2.8 mp -84.21 159.46 59.36 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 107.676 -1.231 . . . . 72.14 107.676 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.88 133.85 28.3 Favored 'Trans proline' 0 N--CA 1.429 -2.279 0 N-CA-C 108.54 -1.369 . . . . 61.22 108.54 171.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.626 ' H ' ' HB3' ' B' ' 42' ' ' LYS . 32.5 t -132.15 136.64 56.2 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 108.098 -1.075 . . . . 72.24 108.098 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -85.89 -30.31 22.98 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.057 0.456 . . . . 74.22 111.767 -175.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -114.63 166.74 11.41 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.745 0.307 . . . . 71.15 111.689 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 49.2 mm -100.04 115.12 40.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 106.799 -1.556 . . . . 64.32 106.799 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' B' ' 40' ' ' ILE . 35.4 mmtp -90.62 147.18 23.48 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.733 -0.787 . . . . 65.04 110.482 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 90.4 m -133.13 127.88 34.88 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.648 -0.871 . . . . 55.13 108.648 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.44 ' HB3' HD13 ' A' ' 29' ' ' ILE . 70.9 m-85 -128.51 125.78 39.09 Favored 'General case' 0 CA--C 1.446 -3.021 0 N-CA-C 109.474 -0.565 . . . . 75.33 109.474 -178.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.8 m -117.61 130.93 56.69 Favored 'General case' 0 C--N 1.266 -3.048 0 O-C-N 123.996 0.81 . . . . 71.22 112.022 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.64 HD12 HD12 ' A' ' 38' ' ' ILE . 49.7 mt -125.01 129.34 73.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 115.866 -0.606 . . . . 75.45 109.988 176.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.433 ' HB ' ' NH1' ' B' ' 35' ' ' ARG . 9.7 t -106.82 122.27 46.06 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.461 -0.94 . . . . 72.54 108.461 178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.444 ' O ' HD23 ' B' ' 34' ' ' LEU . 19.8 tp10 -142.69 97.82 3.18 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.359 -0.536 . . . . 75.44 111.69 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.81 -69.97 1.48 Allowed Glycine 0 C--N 1.313 -0.741 0 N-CA-C 115.324 0.89 . . . . 75.11 115.324 172.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -137.13 0.38 2.34 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.56 0.578 . . . . 55.54 112.56 -172.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 40' ' ' ILE . 2.2 pt? -141.16 141.52 34.12 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.062 -1.055 . . . . 64.1 112.667 -175.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.433 ' NH1' ' HB ' ' B' ' 30' ' ' THR . 19.2 mmm180 -98.31 113.72 25.77 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.382 -1.71 . . . . 75.13 106.382 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.77 120.0 40.07 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.743 -0.465 . . . . 73.23 109.743 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 27' ' ' TYR . 90.1 t -113.65 129.31 69.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.755 -0.657 . . . . 62.23 110.325 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.698 HD12 HD12 ' A' ' 29' ' ' ILE . 67.3 mt -113.25 131.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 C-N-CA 123.387 0.675 . . . . 75.23 109.807 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' B' ' 25' ' ' LYS . 96.3 m-85 -112.44 118.29 34.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.958 -0.756 . . . . 75.12 108.958 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' B' ' 25' ' ' LYS . 47.2 mm -96.92 118.99 44.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 N-CA-C 108.518 -0.919 . . . . 75.41 108.518 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 5.1 t -136.34 157.99 45.49 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 109.43 -0.581 . . . . 41.51 109.43 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.626 ' HB3' ' H ' ' B' ' 21' ' ' VAL . 0.0 OUTLIER -67.2 -17.87 65.01 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.812 -0.631 . . . . 74.44 111.666 179.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.669 ' O ' ' HD3' ' B' ' 43' ' ' ARG . 1.6 tmt_? -90.91 -17.31 26.65 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.309 -0.626 . . . . 73.11 109.309 -176.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 169.16 -172.28 43.32 Favored Glycine 0 C--O 1.223 -0.567 0 C-N-CA 118.942 -1.599 . . . . 74.32 114.611 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -112.85 121.4 44.59 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.977 -1.49 . . . . 73.54 106.977 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' B' ' 12' ' ' VAL . 86.8 tttt -119.66 142.01 48.84 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.484 0.659 . . . . 72.11 111.231 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.13 140.68 47.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.418 0 N-CA-C 107.607 -1.257 . . . . 70.54 107.607 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 34.1 t -138.54 136.56 36.18 Favored 'General case' 0 C--N 1.268 -2.948 0 N-CA-C 108.107 -1.072 . . . . 72.2 108.107 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -119.28 123.74 44.99 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.027 -0.669 . . . . 62.34 110.485 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' B' ' 9' ' ' ARG . 25.8 t70 -113.87 122.43 34.85 Favored Pre-proline 0 C--N 1.291 -1.936 0 N-CA-C 107.753 -1.203 . . . . 74.33 107.753 178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.54 134.43 13.81 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.862 1.708 . . . . 72.24 112.944 -173.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 55.29 -167.1 0.1 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.662 -1.154 . . . . 74.32 112.841 174.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -169.9 -163.38 0.36 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 104.197 -2.519 . . . . 62.04 104.197 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 35.6 m -76.98 83.93 3.51 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.338 -0.945 . . . . 73.23 109.36 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 82.2 m95 59.74 84.34 0.12 Allowed 'General case' 0 C--N 1.342 0.258 0 C-N-CA 124.917 1.287 . . . . 71.23 113.007 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 59.1 t -74.61 99.73 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 116.008 -0.542 . . . . 74.45 110.125 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -125.55 101.78 7.07 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.671 -0.695 . . . . 75.23 109.196 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -89.07 97.51 11.24 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.496 -0.775 . . . . 54.12 110.056 -178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 30.1 m -90.6 -15.24 8.6 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.824 0.821 . . . . 60.2 109.112 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.416 -2.159 0 CA-C-N 114.434 -1.257 . . . . 70.32 108.348 177.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.247 0.925 0 N-CA-C 110.233 -0.284 . . . . 74.01 110.233 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.38 143.72 16.76 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.441 -0.409 . . . . 72.44 112.134 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.9 m -88.67 -17.65 29.56 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.756 0.312 . . . . 72.21 111.795 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -70.48 -27.37 64.15 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.089 0.403 . . . . 72.41 112.089 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -104.8 7.8 9.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 112.146 0.424 . . . . 71.01 112.146 -176.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' B' ' 16' ' ' THR . 49.8 m -72.6 120.56 18.39 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.016 0.436 . . . . 73.32 110.493 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -92.45 155.5 17.81 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.624 -0.716 . . . . 72.51 112.231 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.3 mttp 59.5 -101.45 0.12 Allowed 'General case' 0 C--O 1.242 0.663 0 C-N-CA 126.193 1.797 . . . . 50.11 115.784 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.41 121.05 0.96 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.22 -1.4 . . . . 72.04 107.22 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 p -91.1 144.0 26.1 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.028 -0.533 . . . . 74.11 112.378 -172.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 78.4 m -138.4 149.89 45.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.132 -0.692 . . . . 74.02 109.132 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD21 ' B' ' 14' ' ' LEU . 60.5 t -143.3 139.79 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 110.232 -0.285 . . . . 75.23 110.232 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 p -112.45 124.93 53.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.719 -0.475 . . . . 65.34 109.719 174.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -115.12 120.35 39.47 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.122 -0.49 . . . . 70.43 109.899 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' B' ' 3' ' ' SER . 11.9 p -105.54 118.07 35.62 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 116.045 -0.525 . . . . 64.05 109.686 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -161.12 116.15 2.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.367 -0.379 . . . . 73.52 111.743 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 43.45 78.06 0.06 Allowed 'General case' 0 C--O 1.244 0.79 0 C-N-CA 125.22 1.408 . . . . 55.3 113.029 172.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.511 HH22 ' HB1' ' B' ' 49' ' ' ALA . 34.7 mmt-85 -125.91 149.61 48.58 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.503 0.668 . . . . 73.23 111.878 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -99.67 159.16 30.69 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 106.036 -1.839 . . . . 75.33 106.036 172.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.65 135.98 67.78 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.766 1.644 . . . . 62.24 111.133 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.58 149.18 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.19 -1.041 . . . . 74.4 108.19 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -85.54 -35.63 20.99 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.404 0.52 . . . . 71.1 112.404 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -131.11 147.73 52.65 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.217 -0.302 . . . . 61.43 110.665 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.2 mm -86.63 124.4 40.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 108.678 -0.86 . . . . 73.25 108.678 176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.25 150.44 25.13 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.361 0.601 . . . . 72.25 112.506 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.8 m -133.43 126.94 32.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.244 -1.391 . . . . 73.31 107.244 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -128.36 134.91 48.95 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-N 116.419 -0.355 . . . . 71.23 110.672 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.617 HG22 HG22 ' A' ' 37' ' ' VAL . 31.7 p -113.56 117.49 31.78 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.462 -0.79 . . . . 71.45 110.864 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.657 HD12 HD12 ' B' ' 38' ' ' ILE . 64.3 mt -110.49 123.02 66.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 109.295 -0.631 . . . . 64.31 109.295 177.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 t -116.3 115.89 26.76 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.135 -0.939 . . . . 73.13 109.127 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -129.55 107.01 9.13 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.186 -0.916 . . . . 55.51 109.748 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.68 -72.74 1.73 Allowed Glycine 0 C--N 1.303 -1.274 0 C-N-CA 121.121 -0.561 . . . . 51.01 111.95 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -154.91 4.63 0.22 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.172 0.804 . . . . 74.42 113.172 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.599 HD21 HD12 ' B' ' 40' ' ' ILE . 2.0 pt? -107.25 136.45 47.04 Favored 'General case' 0 CA--C 1.497 -1.086 0 C-N-CA 117.205 -1.798 . . . . 61.35 111.379 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -93.84 113.41 25.44 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.274 -0.875 . . . . 64.1 109.268 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.29 119.23 38.89 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.918 -0.771 . . . . 74.43 108.918 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 28' ' ' THR . 66.5 t -108.39 123.09 63.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 116.519 -0.309 . . . . 74.52 111.224 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.528 HD12 HD12 ' B' ' 29' ' ' ILE . 84.5 mt -102.06 116.2 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 115.511 -0.768 . . . . 70.54 109.163 177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -102.6 116.94 33.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.817 -1.179 . . . . 71.3 107.817 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.596 HG23 HD21 ' B' ' 34' ' ' LEU . 40.6 mm -93.54 114.71 30.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 108.109 -1.071 . . . . 73.55 108.109 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.2 t -124.23 178.54 5.29 Favored 'General case' 0 N--CA 1.406 -2.649 0 C-N-CA 120.476 -0.489 . . . . 75.32 110.209 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 42' ' ' LYS . 58.7 pttt -74.83 -41.58 59.63 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 113.968 1.099 . . . . 73.3 113.968 -171.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -98.97 -10.73 22.32 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 119.765 -0.774 . . . . 72.54 110.045 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -170.22 -145.89 4.9 Favored Glycine 0 C--N 1.313 -0.702 0 C-N-CA 117.484 -2.293 . . . . 75.11 116.61 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' B' ' 49' ' ' ALA . 47.1 tp -130.36 141.45 50.57 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 125.26 1.424 . . . . 74.04 108.166 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -133.44 139.98 47.03 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.975 -0.69 . . . . 64.55 109.579 170.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.492 HG11 HG11 ' B' ' 47' ' ' VAL . 11.4 p -131.57 141.04 46.79 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 115.913 -0.585 . . . . 54.01 110.213 -175.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 59.3 m -122.17 139.38 53.83 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 116.187 -0.461 . . . . 63.42 111.023 173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' B' ' 45' ' ' LEU . . . -116.62 124.45 49.82 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 108.566 -0.902 . . . . 72.55 108.566 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -138.5 91.27 12.46 Favored Pre-proline 0 C--N 1.281 -2.402 0 CA-C-N 115.452 -0.794 . . . . 64.24 108.947 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 34' ' ' LEU . 3.2 Cg_exo -80.83 141.45 13.45 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 122.829 2.353 . . . . 75.22 113.149 -177.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 65.32 34.12 8.54 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 114.749 -1.114 . . . . 74.04 110.84 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.43 -171.35 0.77 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.604 -1.18 . . . . 63.24 112.152 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 p -69.3 106.36 2.87 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.887 -0.597 . . . . 75.12 112.356 -177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.455 ' CH2' ' HD3' ' A' ' 57' ' ' ARG . 46.3 t90 67.06 103.84 0.05 OUTLIER 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.756 1.223 . . . . 71.41 112.574 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.68 143.63 21.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-N 115.556 -0.747 . . . . 71.44 110.916 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' HD3' ' CH2' ' A' ' 55' ' ' TRP . 37.8 ptt180 -134.21 152.55 51.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.802 -1.185 . . . . 75.34 107.802 178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -106.58 -13.76 15.22 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.695 -0.802 . . . . 72.31 112.044 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.02 104.15 7.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 C-N-CA 120.38 -0.528 . . . . 71.12 109.958 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--N 1.312 -1.023 0 CA-C-N 115.611 -0.722 . . . . 73.21 109.936 -179.748 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.908 -0.404 . . . . 74.24 109.908 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.44 51.13 0.73 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 110.927 -0.869 . . . . 62.31 110.927 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 15' ' ' THR . 46.1 m -89.72 3.1 53.8 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.571 0.952 . . . . 63.13 113.571 -175.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.63 -19.94 58.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.785 0.802 . . . . 74.21 109.96 -177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.12 4.52 10.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.191 -0.913 . . . . 54.33 110.272 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 36.8 m -92.58 104.29 16.6 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.307 0.575 . . . . 55.2 109.931 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.62 161.37 13.92 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.28 -0.873 . . . . 55.1 109.508 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.492 ' NZ ' ' HB2' ' B' ' 8' ' ' LYS . 8.7 mtmp? 78.77 158.16 0.17 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.057 1.132 . . . . 55.43 114.057 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' B' ' 49' ' ' ALA . 2.8 ptm180 -55.83 131.98 48.28 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 113.593 -1.64 . . . . 74.23 115.267 -176.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 28.5 p -109.08 145.94 34.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 108.089 -1.078 . . . . 71.41 108.089 171.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . . . . . . . . . 77.8 m -144.47 151.16 38.78 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.045 -0.724 . . . . 74.45 109.045 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 91.4 t -144.41 141.8 23.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.284 -0.636 . . . . 73.41 109.284 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' SER . . . . . . . . . . . . . 50.8 p -107.38 130.69 54.77 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 121.211 0.529 . . . . 74.22 109.8 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.538 HD21 ' CG2' ' A' ' 12' ' ' VAL . 95.3 mt -102.23 121.36 42.1 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.781 -0.645 . . . . 55.1 110.694 -178.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 40.5 p -85.25 113.93 21.96 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 107.616 -1.253 . . . . 74.44 107.616 176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 6' ' ' SER . 14.9 t -153.76 170.05 21.88 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.22 -0.592 . . . . 71.2 109.878 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -72.2 93.52 1.46 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.295 0.569 . . . . 73.34 110.826 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ARG . . . . . 0.544 ' HE ' HD22 ' A' ' 34' ' ' LEU . 1.5 tmt_? -126.08 132.31 51.95 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.181 -1.785 . . . . 73.44 106.181 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.04 155.67 90.16 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 112.653 0.612 . . . . 71.22 112.653 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -48.97 140.39 23.99 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.937 3.091 . . . . 53.3 114.648 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' NH1' ' B' ' 18' ' ' ARG . 12.4 p -131.81 149.14 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.303 -1.369 . . . . 74.51 107.303 177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -89.37 -45.57 9.38 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.754 0.312 . . . . 54.32 111.776 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -117.81 141.68 48.15 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.319 -0.4 . . . . 75.5 110.844 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -80.98 118.71 29.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.047 -0.723 . . . . 63.5 109.047 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.39 153.22 20.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.525 0.678 . . . . 73.01 112.03 178.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' B' ' 38' ' ' ILE . 77.1 m -130.64 128.51 41.12 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.751 -1.203 . . . . 75.11 107.751 177.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -128.36 125.03 37.86 Favored 'General case' 0 CA--C 1.446 -3.039 0 N-CA-C 108.617 -0.882 . . . . 75.14 108.617 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.441 HG23 HG22 ' B' ' 37' ' ' VAL . 19.7 m -117.61 119.51 35.22 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 115.202 -0.908 . . . . 71.43 111.317 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 38' ' ' ILE . 52.4 mt -111.97 121.36 64.29 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 109.654 -0.499 . . . . 51.21 109.654 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -101.74 118.88 37.85 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.992 -1.484 . . . . 73.32 106.992 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.514 ' O ' HD23 ' B' ' 34' ' ' LEU . 14.1 tp10 -132.87 122.37 24.29 Favored 'General case' 0 C--N 1.277 -2.58 0 CA-C-N 115.481 -0.781 . . . . 73.52 109.397 -175.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.23 -96.13 0.16 Allowed Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 111.096 -0.802 . . . . 53.13 111.096 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' SER . . . . . 0.435 ' HB2' HD21 ' A' ' 19' ' ' LEU . 18.0 m -138.12 10.93 2.82 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.906 0.384 . . . . 53.2 110.364 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.596 HD21 HG23 ' A' ' 40' ' ' ILE . 2.1 pt? -118.3 141.38 48.58 Favored 'General case' 0 CA--C 1.494 -1.202 0 C-N-CA 120.57 -0.452 . . . . 75.31 109.827 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -112.48 134.31 54.08 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 115.894 -0.594 . . . . 74.11 112.216 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.72 124.97 53.14 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.088 -0.96 . . . . 51.43 109.272 177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' B' ' 48' ' ' CYS . 76.1 t -114.17 127.12 71.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 116.019 -0.537 . . . . 74.3 110.151 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.657 HD12 HD12 ' A' ' 29' ' ' ILE . 62.9 mt -110.62 129.52 65.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 CA-C-N 115.826 -0.625 . . . . 74.32 110.599 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.455 ' HE2' ' SG ' ' B' ' 48' ' ' CYS . 98.4 m-85 -109.48 116.92 32.7 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.824 -0.806 . . . . 72.11 108.824 176.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ILE . . . . . 0.599 HD12 HD21 ' A' ' 34' ' ' LEU . 49.1 mm -91.39 116.43 32.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.745 -0.662 . . . . 73.43 109.547 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.2 t -133.15 167.87 19.55 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.029 -0.73 . . . . 74.1 109.029 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.579 ' HE3' ' C ' ' B' ' 42' ' ' LYS 0.349 0.0 OUTLIER -86.37 2.42 47.56 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.639 0.978 . . . . 63.21 113.639 179.425 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -90.14 -13.26 36.05 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.036 -1.098 . . . . 74.55 108.036 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.07 -134.34 6.11 Favored Glycine 0 N--CA 1.424 -2.153 0 CA-C-N 115.245 -0.889 . . . . 73.1 112.059 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.47 ' CD2' ' HB2' ' A' ' 49' ' ' ALA . 60.1 tp -113.51 144.32 43.05 Favored 'General case' 0 C--N 1.28 -2.424 0 C-N-CA 122.873 0.469 . . . . 74.25 109.833 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' B' ' 39' ' ' PHE . 83.3 tttt -129.37 136.12 49.59 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.618 -0.512 . . . . 54.42 109.618 168.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.492 HG11 HG11 ' A' ' 47' ' ' VAL . 14.8 p -120.42 140.69 43.72 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.094 -0.957 . . . . 63.0 110.512 -173.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . 0.486 ' HB2' ' HB ' ' B' ' 37' ' ' VAL . 36.4 m -129.39 137.3 50.85 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 115.666 -0.697 . . . . 61.03 110.654 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . 0.511 ' HB1' HH22 ' A' ' 18' ' ' ARG . . . -117.8 124.02 47.39 Favored 'General case' 0 N--CA 1.415 -2.218 0 N-CA-C 107.803 -1.184 . . . . 71.42 107.803 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -121.82 110.88 33.04 Favored Pre-proline 0 C--N 1.285 -2.219 0 N-CA-C 107.946 -1.131 . . . . 64.32 107.946 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.16 132.62 11.62 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.408 1.405 . . . . 74.1 112.712 -177.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 39.24 73.53 0.11 Allowed 'General case' 0 C--O 1.242 0.66 0 O-C-N 125.021 1.45 . . . . 72.5 113.582 173.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.46 -154.11 0.09 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.188 -0.914 . . . . 52.21 110.626 -177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.9 p -65.73 -161.6 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.746 0.819 . . . . 52.32 111.04 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' TRP . . . . . . . . . . . . . 70.6 t90 -52.6 106.0 0.14 Allowed 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.36 0.6 . . . . 74.14 112.427 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 34.4 m -90.03 160.83 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 108.651 -0.87 . . . . 71.52 108.651 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' B' ' 60' ' ' VAL . 12.4 ptt180 -140.18 154.12 46.83 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 120.326 -0.549 . . . . 73.31 109.798 -175.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -83.29 -27.5 29.77 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.03 0.443 . . . . 72.3 110.695 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.73 98.62 7.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 108.769 -0.826 . . . . 51.51 108.769 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.517 ' HA ' ' HE ' ' B' ' 57' ' ' ARG . 3.8 p . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 115.888 -0.596 . . . . 72.04 112.394 -177.004 . . . . . . . . 1 1 . 1 stop_ save_